,Date,Title,Url
0,2019-01-01,신년특집해외시장개척대웅제약나보타,http://www.bosa.co.kr/news/articleView.html?idxno=2097143
1,2019-01-02,기해년빛낼돼지띠CEO윤재춘대웅제약사장,http://www.etoday.co.kr/news/section/newsview.php?idxno=1706126
2,2019-01-02,대웅제약시무식개최AI접목신약연구로개발역량강화할것,http://www.g-enews.com/ko-kr/news/article/news_all/20190102105333669425b4ac5ede_1/article.html
3,2019-01-02,대웅제약신약개발가속화글로벌헬스케어그룹도약,http://kormedi.com/?p=1260126
4,2019-01-02,대웅제약2019년책임경영체제강화혁신신약개발로글로벌헬스케어그룹도약원년,http://www.ekn.kr/news/article.html?no=406959
5,2019-01-02,전승호대웅제약대표책임경영강조글로벌헬스케어그룹도약원년,http://view.asiae.co.kr/news/view.htm?idxno=2019010211060794112
6,2019-01-02,대웅제약책임경영강화‥​글로벌헬스케어그룹도약원년,http://medipana.com/news/news_viewer.asp?NewsNum=232905&MainKind=A&NewsKind=5&vCount=12&vKind=1
7,2019-01-02,대웅제약혁신신약개발글로벌헬스케어그룹원년도약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225956
8,2019-01-02,전승호대웅제약대표책임경영강화글로벌헬스케어그룹도약원년”,http://www.newsway.co.kr/news/view?tp=1&ud=2019010211132464139
9,2019-01-02,신년사전승호대웅제약사장글로벌헬스케어그룹도약원년만들자”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1706322
10,2019-01-02,전승호대웅제약사장글로벌헬스케어그룹도약할것,http://www.m-i.kr/news/articleView.html?idxno=484221
11,2019-01-02,전승호대웅제약사장글로벌헬스케어그룹도약할것,http://www.m-i.kr/news/articleView.html?idxno=484221
12,2019-01-02,전승호대웅제약사장2019년책임경영체제강화글로벌헬스케어그룹도약,http://www.wikileaks-kr.org/news/articleView.html?idxno=44369
13,2019-01-02,신년사전승호대웅제약사장책임경영혁신신약개발로도약,http://www.newspim.com/news/view/20190102000290
14,2019-01-02,대웅제약책임경영체제강화혁신신약개발로글로벌헬스케어그룹도약,http://www.ceoscoredaily.com/news/article.html?no=50476
15,2019-01-02,신년사전승호대웅제약사장책임경영으로글로벌헬스케어그룹도약,http://www.wolyo.co.kr/news/articleView.html?idxno=74861
16,2019-01-02,신년사전승호대웅제약사장책임경영통해체제강화,http://www.ebn.co.kr/news/view/967248
17,2019-01-02,신년사전승호대웅제약사장책임경영혁신신약개발로글로벌도약,http://www.dailian.co.kr/news/view/762472/?sc=naver
18,2019-01-02,대웅제약2019년책임경영체제강화글로벌헬스케어그룹도약,http://www.getnews.co.kr/view.php?ud=20190102113047211541d0c69529_16
19,2019-01-02,대웅제약전승호사장글로벌헬스케어그룹도약원년만들자,http://www.medisobizanews.com/news/articleView.html?idxno=57153
20,2019-01-02,대웅제약책임경영체제강화혁신신약개발로글로벌그룹으로도약”,http://www.ajunews.com/view/20190102113727201
21,2019-01-02,전승호대웅제약대표임직원모두책임경영에힘쓰자,http://www.insightkorea.co.kr//news/articleView.html?idxno=33166
22,2019-01-02,대웅제약2019년시무식가져책임경영체제강화,http://www.seoulwire.com/news/articleView.html?idxno=43256
23,2019-01-02,전승호대웅제약사장글로벌헬스케어그룹도약원년될것,http://www.newsprime.co.kr/news/article.html?no=441892
24,2019-01-02,대웅제약글로벌헬스케어그룹도약원년될것,http://www.economytalk.kr/news/articleView.html?idxno=176616
25,2019-01-02,대웅제약전승호사장2019년혁신신약개발로글로벌헬스케어그룹도약원년될것,http://www.wsobi.com/news/articleView.html?idxno=68366
26,2019-01-02,전승호대웅제약사장책임경영체제강화,http://www.dailymedi.com/detail.php?number=838659&thread=22r05
27,2019-01-02,대웅제약증권매매2일현재187500원,http://www.nbntv.co.kr/news/articleView.html?idxno=154675
28,2019-01-02,신년사전승호대웅제약회장책임경영체제강화,http://news.bizwatch.co.kr/article/consumer/2019/01/02/0050/naver
29,2019-01-02,대웅제약올해경영키워드는책임경영,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019010213392134753
30,2019-01-02,대웅제약책임경영혁신신약개발글로벌도약,http://www.bosa.co.kr/news/articleView.html?idxno=2097221
31,2019-01-02,신년사전승호대웅제약사장글로벌헬스케어그룹도약원년될것,http://www.newsis.com/view/?id=NISX20190102_0000518797&cID=13001&pID=13000
32,2019-01-02,2019신년사전승호대웅제약사장글로벌헬스케어그룹도약원년,http://www.shinailbo.co.kr/news/articleView.html?idxno=1130780
33,2019-01-02,대웅제약2019년글로벌헬스케어그룹도약원년선포,http://www.medigatenews.com/news/576133129
34,2019-01-02,신년사전승호대웅제약사장글로벌2020비전위해역량집중,http://news.mk.co.kr/newsRead.php?year=2019&no=3003
35,2019-01-02,2019신년사대웅제약전승호사장책임경영으로새로운미래성장추진할것”,http://www.news2day.co.kr/117881
36,2019-01-02,전승호대웅제약사장비상경영체제수준경영활동으로내실강화,http://www.businesskorea.co.kr/news/articleView.html?idxno=27933
37,2019-01-02,유통오늘한미약품2019년내실경영슬로건선포대웅제약올해키워드책임경영,http://www.sisaon.co.kr/news/articleView.html?idxno=80937
38,2019-01-02,전승호대웅제약사장혁신신약개발로도약책임경영강화,https://www.insight.co.kr/news/201924
39,2019-01-02,대웅제약신년사책임경영체제강화혁신신약개발로글로벌헬스케어그룹도약원년될것,http://www.fnnews.com/news/201901021600049339
40,2019-01-02,대웅제약신년사2019년책임경영체제강화혁신신약개발로글로벌헬스케어그룹도약원년될것,http://www.lawissue.co.kr/view.php?ud=201901021600483162d7f4c63cc6_12
41,2019-01-02,대웅제약2019년책임경영체제강화글로벌그룹도약할것,http://www.k-health.com/news/articleView.html?idxno=41655
42,2019-01-02,대웅제약혁신신약개발로글로벌헬스케어그룹도약원년될것,http://www.enewstoday.co.kr/news/articleView.html?idxno=1259533
43,2019-01-02,대웅제약책임경영강화로글로벌도약원년”다짐,http://www.edaily.co.kr/news/newspath.asp?newsid=04008166622353784
44,2019-01-02,책임경영강화대웅제약혁신신약개발로글로벌헬스케어도약,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003447835
45,2019-01-02,신년사전승호대웅제약사장책임경영강화다짐,http://www.seoulfn.com/news/articleView.html?idxno=329714
46,2019-01-02,신년사전승호대웅제약사장책임경영혁신신약개발통해글로벌도약,http://www.ftoday.co.kr/news/articleView.html?idxno=105690
47,2019-01-02,전승호대웅제약사장올한해는도전의해로전사역량집중해야,http://www.asiatime.co.kr/news/articleView.html?idxno=220942
48,2019-01-02,전승호대웅제약대표글로벌헬스케어그룹으로도약하는원년,http://www.mdtoday.co.kr/mdtoday/index.html?no=343005
49,2019-01-02,대웅제약2019년시무식열어,http://www.kpanews.co.kr/article/show.asp?idx=200463&table=article&category=D
50,2019-01-02,대웅제약신년사책임경영체제강화혁신신약개발로글로벌도약,http://www.newscj.com/news/articleView.html?idxno=588143
51,2019-01-03,1월3일대웅제약시세보기270180500원,http://www.nbntv.co.kr/news/articleView.html?idxno=156040
52,2019-01-03,ET투자뉴스대웅제약_현재주가근처인186000원대에주요매물대가존재,http://www.etnews.com/20190103000130
53,2019-01-04,1월4일대웅제약배당주식182500원139,http://www.nbntv.co.kr/news/articleView.html?idxno=157510
54,2019-01-04,1월4일대웅제약시세보기222184000원,http://www.nbntv.co.kr/news/articleView.html?idxno=158027
55,2019-01-06,새해벽두글로벌제약산업MA열풍주목받는대웅제약,http://www.edaily.co.kr/news/newspath.asp?newsid=01561286622355096
56,2019-01-07,대웅제약목표가23만원유지전일종가18만6000원하이투자證,http://www.newspim.com/news/view/20190107000079
57,2019-01-07,퀵리포트대웅제약매수유지목표가23만원유지하이투자證,http://www.itooza.com/common/iview.php?no=2019010708303217627
58,2019-01-07,ET투자뉴스대웅제약점점확고해지는펀BUYMAINTAIN하이투자증권,http://www.etnews.com/20190107000009
59,2019-01-07,대웅제약나보타中임상시험계획변경접수마쳐,http://www.metroseoul.co.kr/news/newsview?newscd=2019010700012
60,2019-01-07,대웅제약나보타中임상시험계획변경접수완료,http://news.hankyung.com/article/2019010773946
61,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.m-i.kr/news/articleView.html?idxno=485403
62,2019-01-07,대웅제약나보타중국임상변경접수하반기개시전망,http://www.dailian.co.kr/news/view/763438/?sc=naver
63,2019-01-07,대웅제약나보타중국임상시험계획변경서류접수,http://www.newspim.com/news/view/20190107000160
64,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.newsway.co.kr/news/view?tp=1&ud=2019010709271283417
65,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.ekn.kr/news/article.html?no=407817
66,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.enewstoday.co.kr/news/articleView.html?idxno=1260647
67,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226093
68,2019-01-07,대웅제약나보타변경한중국임상시험계획접수완료,http://www.econovill.com/news/articleView.html?idxno=354117
69,2019-01-07,대웅제약나보타中임상시험계획변경접수완료,http://www.sporbiz.co.kr/news/articleView.html?idxno=302175
70,2019-01-07,대웅제약나보타中임상시험계획변경접수완료,http://www.etoday.co.kr/news/section/newsview.php?idxno=1707741
71,2019-01-07,대웅제약나보타中임상시험제조시설변경접수완료,http://www.dailypharm.com/Users/News/NewsView.html?ID=248292&REFERER=NP
72,2019-01-07,대웅제약나보타제조시설변경中임상시험계획접수,http://medipana.com/news/news_viewer.asp?NewsNum=233096&MainKind=A&NewsKind=5&vCount=12&vKind=1
73,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.g-enews.com/ko-kr/news/article/news_all/201901071006255985f6d02acec0_1/article.html
74,2019-01-07,대웅제약나보타중국임상시험공장변경서류접수,http://www.medisobizanews.com/news/articleView.html?idxno=57223
75,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.shinailbo.co.kr/news/articleView.html?idxno=1131806
76,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.ceoscoredaily.com/news/article.html?no=50661
77,2019-01-07,대웅제약나보타中임상시험계획변경접수올하반기임상개시가능할듯,http://www.segye.com/content/html/2019/01/07/20190107000797.html?OutUrl=naver
78,2019-01-07,대웅제약나보타中임상시험계획변경접수완료,http://www.rapportian.com/news/articleView.html?idxno=115315
79,2019-01-07,대웅제약나보타중국임상시험신청제조시설변경접수완료,http://www.100ssd.co.kr/news/articleView.html?idxno=58719
80,2019-01-07,대웅제약나보타중국임상시험계획변경접수,http://www.newsprime.co.kr/news/article.html?no=442388
81,2019-01-07,대웅제약나보타중국임상시험계획변경접수마쳐,http://www.edaily.co.kr/news/newspath.asp?newsid=02427206622355424
82,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.fnnews.com/news/201901071040392599
83,2019-01-07,대웅제약中의약품당국에나보타임상시약생산공장변경신청,http://news.mk.co.kr/newsRead.php?year=2019&no=11921
84,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1123675&REFERER=NP
85,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.etnews.com/20190107000111
86,2019-01-07,대웅제약나보타중국임상시험계획변경접수,http://www.dailymedi.com/detail.php?number=838874&thread=22r05
87,2019-01-07,대웅제약나보타중국임상시험계획변경,http://www.dt.co.kr/contents.html?article_no=2019010702109931102004&ref=naver
88,2019-01-07,대웅제약나보타中임상시험계획변경접수,http://kormedi.com/?p=1260696
89,2019-01-07,대웅제약중국서나보타임상계획변경접수 ,http://www.seoulfn.com/news/articleView.html?idxno=330095
90,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.newstomato.com/ReadNews.aspx?no=868006
91,2019-01-07,대웅제약점점확고해지는펀더멘털목표가23만원하이투자증권,http://www.ekn.kr/news/article.html?no=407893
92,2019-01-07,대웅제약나보타중국임상시험신청제조시설변경접수,http://www.seoulwire.com/news/articleView.html?idxno=44277
93,2019-01-07,1월7일대웅제약증권투자정보외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=67868
94,2019-01-07,대웅제약중국에나보타임상시험계획변경접수완료,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019010710583173196
95,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.medigatenews.com/news/2398237937
96,2019-01-07,대웅제약中나보타생산능력높이기위해2공장변경접수,http://www.asiatime.co.kr/news/articleView.html?idxno=221628
97,2019-01-07,대웅제약나보타中임상시험계획변경접수,http://www.bosa.co.kr/news/articleView.html?idxno=2097501
98,2019-01-07,대웅제약2공장서중국수출용나보타공급,http://www.finomy.com/news/articleView.html?idxno=61899
99,2019-01-07,대웅제약보톡스나보타중국임상시험계획변경,http://news.mk.co.kr/newsRead.php?year=2019&no=12491
100,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=343304
101,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.economytalk.kr/news/articleView.html?idxno=176986
102,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901070458&t=NN
103,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.inthenews.co.kr/news/article.html?no=12852
104,2019-01-07,대웅제약나보타중국제조시설변경서류접수완료,http://www.kpanews.co.kr/article/show.asp?idx=200579&table=article&category=D
105,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.getnews.co.kr/view.php?ud=20190107153700183341d0c69529_16
106,2019-01-07,대웅제약중국정부에보톡스임상관련해제조공장변경신청,http://www.businesspost.co.kr/BP?command=article_view&num=109180
107,2019-01-07,대웅제약나보타中시장접수가속도 ,http://www.monews.co.kr/news/articleView.html?idxno=200062
108,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.ftoday.co.kr/news/articleView.html?idxno=105795
109,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,https://www.insight.co.kr/news/203033
110,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.businesskorea.co.kr/news/articleView.html?idxno=28069
111,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.newscj.com/news/articleView.html?idxno=589447
112,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.lawissue.co.kr/view.php?ud=201901072112521209d7f4c63cc6_12
113,2019-01-08,빅데이터MSI시장심리톱5유한양행LG화학셀트리온쌍용차대웅제약,http://www.newsis.com/view/?id=NISX20190108_0000523448&cID=10401&pID=10400
114,2019-01-08,실시간분석대웅제약32상승증권사목표가23만원제시,http://www.itooza.com/common/iview.php?no=2019010810003811367
115,2019-01-08,대웅제약주식실시간8일현재189000원,http://www.nbntv.co.kr/news/articleView.html?idxno=161991
116,2019-01-08,1월8일대웅제약증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=68644
117,2019-01-09,클릭e종목대웅제약1분기내한올바이오파마Evolus기대감반영,http://view.asiae.co.kr/news/view.htm?idxno=2019010907440584920
118,2019-01-09,퀵리포트대웅제약매수유지목표가24만원유지NH證,http://www.itooza.com/common/iview.php?no=2019010907481412317
119,2019-01-09,대웅제약2월나보타미국허가기대감유효매수NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1708612
120,2019-01-09,NH투자증권대웅제약1분기내자회사파트너사기대감반영”,http://www.newsway.co.kr/news/view?tp=1&ud=2019010907541048165
121,2019-01-09,대웅제약목표가24만원유지전일종가19만1500원NH證,http://www.newspim.com/news/view/20190109000081
122,2019-01-09,더벨대웅제약4조5000억보툴리눔톡신시장정조준,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201901080100010990000663
123,2019-01-09,실시간분석대웅제약31상승증권사목표가24만원제시,http://www.itooza.com/common/iview.php?no=2019010909073617613
124,2019-01-09,특징주대웅제약1Q한올바이오파마에볼루스기대감에투심개선4↑,http://view.asiae.co.kr/news/view.htm?idxno=2019010909124280271
125,2019-01-09,특징주대웅제약美에볼루스주가상승에동반강세,http://news.mt.co.kr/mtview.php?no=2019010909102575787
126,2019-01-09,한경로보뉴스대웅제약5이상상승20183Q매출액2580억23영업이익72억469,http://news.hankyung.com/article/201901095784L
127,2019-01-09,특징주대웅제약자회사파트너사기대감에5↑,http://www.sentv.co.kr/news/view/547323
128,2019-01-09,대웅제약나보타미국허가기대감에강세,http://news.hankyung.com/article/2019010958356
129,2019-01-09,특징주대웅제약주름개선치료제미국허가기대에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02099206622356080
130,2019-01-09,HotLine대웅제약나보타미국허가기대감에강세,http://news.mk.co.kr/newsRead.php?year=2019&no=16816
131,2019-01-09,특징주대웅제약나보타미국허가기대감에강세,http://www.newsprime.co.kr/news/article.html?no=442678
132,2019-01-09,특징주대웅제약자회사주가상승나보타美판매허가기대감에강세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901090137&t=NN
133,2019-01-09,특징주대웅제약나보타美허가기대감속4대강세,http://moneys.mt.co.kr/news/mwView.php?no=2019010909438082446
134,2019-01-09,대웅제약나보타미국허가기대9일오전강세출발,http://www.choicenews.co.kr/news/articleView.html?idxno=47292
135,2019-01-09,대웅제약나보타미국판매허가기대감에장초반강세,http://www.whitepaper.co.kr/news/articleView.html?idxno=137665
136,2019-01-09,1월9일대웅제약투자주식209195500원,http://www.nbntv.co.kr/news/articleView.html?idxno=163276
137,2019-01-09,특징주대웅제약나보타美허가기대감에강세,http://www.newsway.co.kr/news/view?tp=1&ud=2019010911115996450
138,2019-01-09,ET투자뉴스대웅제약Evolus주가BUY유지NH투자증권,http://www.etnews.com/20190109000149
139,2019-01-09,대웅제약나보타미국진출기대감에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=343520
140,2019-01-09,1월9일대웅제약오늘시세외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=69174
141,2019-01-09,대웅제약美파트너사Evolus최근2주간주가411상승,http://www.newsworks.co.kr/news/articleView.html?idxno=326079
142,2019-01-10,빅데이터MSI시장심리톱5대우건설대웅제약카카오한섬롯데칠성,http://www.newsis.com/view/?id=NISX20190110_0000525901&cID=10401&pID=10400
143,2019-01-10,대웅제약주가오늘시세및증권정보와종목동정10일현재195000원,http://www.gokorea.kr/news/articleView.html?idxno=69953
144,2019-01-11,1월11일대웅제약주식실시간077193500원,http://www.nbntv.co.kr/news/articleView.html?idxno=165784
145,2019-01-11,대웅제약주가1월11일현재193500원,http://www.gokorea.kr/news/articleView.html?idxno=70999
146,2019-01-14,대웅제약오늘증권시세14일현재191000원,http://www.nbntv.co.kr/news/articleView.html?idxno=168278
147,2019-01-14,대웅제약주가1월14일현재191000원,http://www.gokorea.kr/news/articleView.html?idxno=72731
148,2019-01-14,글로벌무대밝히는K바이오대웅제약매출10RD투자섬유증치료제등파이프라인확보,http://www.sedaily.com/NewsView/1VE191KQJA
149,2019-01-15,대웅제약투자주식15일현재190000원,http://www.nbntv.co.kr/news/articleView.html?idxno=170515
150,2019-01-15,대웅제약주가정보15일현재190000원,http://www.gokorea.kr/news/articleView.html?idxno=74556
151,2019-01-16,SK證제약바이오섹터연초에주목해야대웅제약등추천,http://www.newsis.com/view/?id=NISX20190116_0000531337&cID=10401&pID=10400
152,2019-01-16,제약∙바이오연초주목할섹터대웅제약∙한미약품톱픽”,http://www.fntimes.com/html/view.php?ud=2019011608372596251d6f57e61a_18
153,2019-01-16,대웅제약송당암연구센터암환자맞춤산학협력체결,http://www.g-enews.com/ko-kr/news/article/news_all/201901161001465143f6d02acec0_1/article.html
154,2019-01-16,대웅제약연세대암환자맞춤형진단치료체계개발산학협력체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226393
155,2019-01-16,대웅제약유전체정보기반암환자맞춤형진단치료체계개발나서,http://www.wikileaks-kr.org/news/articleView.html?idxno=45481
156,2019-01-16,대웅제약연세의료원과유전자기반맞춤형항암치료개발,http://www.edaily.co.kr/news/newspath.asp?newsid=02394406622358376
157,2019-01-16,대웅제약송당암연구센터와암환자맞춤형항암치료개발,http://medipana.com/news/news_viewer.asp?NewsNum=233514&MainKind=A&NewsKind=5&vCount=12&vKind=1
158,2019-01-16,대웅제약연세대암연구센터와암환자맞춤형진단치료체계개발협력,http://www.koreaittimes.com/news/articleView.html?idxno=88664
159,2019-01-16,대웅제약연세의대송당암연구센터와산학협력,http://www.ebn.co.kr/news/view/968978
160,2019-01-16,대웅제약연세의대송당암연구센터와산학협력,http://news.heraldcorp.com/view.php?ud=20190116000198
161,2019-01-16,대웅제약연세의대송당암연구센터와공동연구,http://www.dailypharm.com/Users/News/NewsView.html?ID=248602&REFERER=NP
162,2019-01-16,대웅제약연세의대암연구센터암정복공동연구개발산학협력,http://view.asiae.co.kr/news/view.htm?idxno=2019011610280533020
163,2019-01-16,대웅제약산학협력통해암환자맞춤형진단치료체계개발,http://www.mhj21.com/118823
164,2019-01-16,대웅제약연세의대손잡고암환자맞춤형진단치료체계개발,http://www.medisobizanews.com/news/articleView.html?idxno=57411
165,2019-01-16,대웅제약연세대암연구센터유전체기반맞춤형항암치료개발,http://kormedi.com/?p=1261766
166,2019-01-16,대웅제약연세의대송당암연구센터와손잡고암정복나선다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1711384
167,2019-01-16,대웅제약송당암센터와암환자진단치료체계개발협력,http://www.dailian.co.kr/news/view/765558/?sc=naver
168,2019-01-16,대웅제약연세암병원과암정복위한산학협력협약체결,http://news.mk.co.kr/newsRead.php?year=2019&no=32540
169,2019-01-16,대웅제약연세암병원암환자맞춤형진단치료체계개발,http://www.newsis.com/view/?id=NISX20190116_0000531619&cID=13001&pID=13000
170,2019-01-16,대웅제약연세암병원과유전체암진단사업협력,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901160209&t=NN
171,2019-01-16,대웅제약연세의대송당암센터와산학협력협약,http://www.insightkorea.co.kr//news/articleView.html?idxno=33488
172,2019-01-16,대웅제약연세의대송당암연구센터암환자맞춤치료위한공동연구나서,http://www.news2day.co.kr/118801
173,2019-01-16,대웅제약연세의대와암환자유전체진단기술공동개발,http://news1.kr/articles/?3525868
174,2019-01-16,대웅제약연세의대송당암연구센터와암환자맞춤형진단개발협약맺어,https://cnbc.sbs.co.kr/article_hub/10000928035?division=NAVER
175,2019-01-16,대웅제약연세의대송당암연구센터와맞춤형항암치료위한산학협력,http://www.mdtoday.co.kr/mdtoday/index.html?no=344082
176,2019-01-16,대웅제약연세의대송당암연구센터암정복공동연구개발협약식,http://news.heraldcorp.com/view.php?ud=20190116000344
177,2019-01-16,대웅제약목표가26만원유지전일종가18만9500원SK證,http://www.newspim.com/news/view/20190116000394
178,2019-01-16,대웅제약암환자맞춤형진단치료체계개발앞장,http://www.wolyo.co.kr/news/articleView.html?idxno=75817
179,2019-01-16,대웅제약유전체기반암치료제시장공략,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019011611161758669
180,2019-01-16,퀵리포트대웅제약매수유지목표가26만원유지SK證,http://www.itooza.com/common/iview.php?no=2019011611263019981
181,2019-01-16,대웅제약연세의대암연구센터맞춤형치료체계개발협력,http://yna.kr/AKR20190116077800017?did=1195m
182,2019-01-16,연세대의대대웅제약과암환자맞춤형치료체계개발협약,http://www.rapportian.com/news/articleView.html?idxno=115513
183,2019-01-16,대웅제약연세송담암연구센터와산학협력체결암치료체계개발추진,http://news.donga.com/3/all/20190116/93726887/2
184,2019-01-16,대웅제약연세의대와유전체기반항암치료체계개발,http://www.biospectator.com/view/news_view.php?varAtcId=6962
185,2019-01-16,대웅제약연세의대송당암연구센터암환자맞춤형진단치료체계개발,http://www.newsprime.co.kr/news/article.html?no=443452
186,2019-01-16,연세대의대대웅제약맞춤형암치료연구개발맞손,http://www.newsworks.co.kr/news/articleView.html?idxno=327945
187,2019-01-16,대웅제약송당암연구센터암환자진단치료체계개발협력체결,http://www.seoulwire.com/news/articleView.html?idxno=52454
188,2019-01-16,1월16일대웅제약오늘시세및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=76084
189,2019-01-16,주식현황대웅제약주가16일현재189500원,http://www.nbntv.co.kr/news/articleView.html?idxno=172742
190,2019-01-16,대웅제약연세의대송당암연구센터와산학협력체결,http://www.vop.co.kr/A00001371275.html
191,2019-01-16,대웅제약연세의대송당암연구센터와산학협력체결,http://www.economytalk.kr/news/articleView.html?idxno=177664
192,2019-01-16,대웅제약연세의대송당암연구센터와MOU,http://www.bosa.co.kr/news/articleView.html?idxno=2098044
193,2019-01-16,대웅제약연세의대송당암연구센터와산학협력체결,http://www.100ssd.co.kr/news/articleView.html?idxno=58944
194,2019-01-16,대웅제약연세의대암진단치료체계개발협력키로,http://news.mk.co.kr/newsRead.php?year=2019&no=33063
195,2019-01-16,연대송당암연구센터대웅제약암환자맞춤형진단치료체계개발,http://www.inthenews.co.kr/news/article.html?no=13033
196,2019-01-16,대웅제약연세의대와암환자맞춤형진단치료체계개발,http://www.shinailbo.co.kr/news/articleView.html?idxno=1134556
197,2019-01-16,대웅제약연세의대송당암연구센터와산학협력체결,http://www.sisajournal-e.com/news/articleView.html?idxno=194389
198,2019-01-16,대웅제약연세의대송당암연구센터와암환자맞춤형진단개발MOU,http://www.ajunews.com/view/20190116143209595
199,2019-01-16,세계무대휘젓는위대한도전제약한류첨병대웅제약,http://www.skyedaily.com/news/news_view.html?ID=80903
200,2019-01-16,대웅제약연세의대암연구센터암정복공동연구개발협력,http://www.etnews.com/20190116000224
201,2019-01-16,대웅제약암환자맞춤형진단치료체계개발위한산학협력체결,http://www.bokuennews.com/news/article.html?no=170692
202,2019-01-16,대웅제약연세의대송당암연구센터와암환자맞춤형진단치료체계개발위한산학협력체결,http://www.ekn.kr/news/article.html?no=409811
203,2019-01-16,대웅제약연세의대송당암연구센터와산학협력,http://www.newsway.co.kr/news/view?tp=1&ud=2019011614555210665
204,2019-01-16,연세의대송당암연구센터대웅제약과산학협력체결,http://www.asiatoday.co.kr/view.php?key=20190116010010045
205,2019-01-16,대웅제약연세의대암환자맞춤형암진단치료체계개발협력,http://www.straightnews.co.kr/news/articleView.html?idxno=41541
206,2019-01-16,ET투자뉴스대웅제약4분기매출액3분매수SK증권,http://www.etnews.com/20190116000261
207,2019-01-16,대웅제약연세의대와맞춤형항암치료협력,http://news.hankyung.com/article/201901160923f
208,2019-01-16,대웅제약연세의료원암환자맞춤치료기술개발맞손,http://biz.chosun.com/site/data/html_dir/2019/01/16/2019011601927.html
209,2019-01-16,대웅제약연세암병원산학협력체결,http://www.whosaeng.com/sub_read.html?uid=107449§ion=sc5
210,2019-01-16,대웅제약연세의대암연구센터맞춤형치료체계개발협력,http://www.seoulfn.com/news/articleView.html?idxno=331068
211,2019-01-16,연세의대대웅제약항암제공동연구나서,http://moneys.mt.co.kr/news/mwView.php?no=2019011615388047588
212,2019-01-16,대웅제약연세의대와암맞춤형진단치료개발목표로협력,http://www.econovill.com/news/articleView.html?idxno=354780
213,2019-01-16,연세의대송당암연구센터대웅제약과암환자맞춤형진단치료체계개발,http://health.chosun.com/site/data/html_dir/2019/01/16/2019011602355.html
214,2019-01-16,연세의대대웅제약과맞춤형암치료플랫폼개발,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1064484
215,2019-01-16,사진표적항암제진단알고리즘개발대웅제약연세대의대맞손,http://www.sedaily.com/NewsView/1VE275UZ03
216,2019-01-16,대웅제약연세의대송당암연구센터와산학협력체결,http://www.medigatenews.com/news/2731891923
217,2019-01-16,대웅제약암환자맞춤형진단치료체계개발산학협력체결,http://www.getnews.co.kr/view.php?ud=20190116171154870241d0c69529_16
218,2019-01-16,대웅제약연세송당암연구센터와산학협력체결암치료체계개발추진,http://www.ftoday.co.kr/news/articleView.html?idxno=106016
219,2019-01-16,대웅제약송당암연구센터암환자맞춤진단체계산학협력,http://www.dt.co.kr/contents.html?article_no=2019011702101631102001&ref=naver
220,2019-01-16,대웅제약암정복위해연세의대송당암연구센터와산학협력체결,https://www.insight.co.kr/news/204978
221,2019-01-16,대웅제약암환자맞춤형진단치료체계개발위한산학협력체결,http://www.newscj.com/news/articleView.html?idxno=592495
222,2019-01-16,대웅제약연세대암연구센터손잡고맞춤형치료체계개발,http://www.businesspost.co.kr/BP?command=article_view&num=110592
223,2019-01-17,연세의대송당암연구센터대웅제약암환자맞춤형진단치료체계개발추진,http://medicalworldnews.co.kr/news/view.php?idx=1510929137
224,2019-01-17,설선물대웅제약과음에지친당신간건강엔우루사,http://news.mk.co.kr/newsRead.php?year=2019&no=34520
225,2019-01-17,대웅제약암환자맞춤진단치료체계개발나선다,http://www.monews.co.kr/news/articleView.html?idxno=200381
226,2019-01-17,유한양행한미약품대웅제약등RD성과주시,http://www.choicenews.co.kr/news/articleView.html?idxno=47526
227,2019-01-17,대웅제약의약품안전성유효성에맞는글로벌기준준수,http://medipana.com/news/news_viewer.asp?NewsNum=233564&MainKind=A&NewsKind=5&vCount=12&vKind=1
228,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226432
229,2019-01-17,대웅제약오라클클라우드로의약품안전보고체계표준화,http://www.dt.co.kr/contents.html?article_no=2019011702109931041002&ref=naver
230,2019-01-17,대웅제약의약품안전관리강화위해오라클서비스전면도입,http://news.mk.co.kr/newsRead.php?year=2019&no=35210
231,2019-01-17,대웅제약오라클클라우드도입의약품안전관리강화,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003463007
232,2019-01-17,유통오늘전자랜드세종시에파워센터세종점신규오픈대웅제약클라우드통해의약품안전관리,http://www.sisaon.co.kr/news/articleView.html?idxno=81452
233,2019-01-17,대웅제약클라우드시스템도입의약품안전관리,http://www.medisobizanews.com/news/articleView.html?idxno=57436
234,2019-01-17,대웅제약의약품안전관리위해오라클아거스클라우드서비스도입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1711891
235,2019-01-17,대웅제약실시간의약품안전관리클라우드서비스도입,http://www.newsis.com/view/?id=NISX20190117_0000532869&cID=13001&pID=13000
236,2019-01-17,대웅제약의약품안전관리에오라클클라우드도입,http://www.dt.co.kr/contents.html?article_no=2019011702109931650003&ref=naver
237,2019-01-17,해외시장진출비용절감목표대웅제약오라클서비스도입,http://moneys.mt.co.kr/news/mwView.php?no=2019011710528079412
238,2019-01-17,대웅제약진화된의약품안전관리클라우드시스템도입,http://www.100ssd.co.kr/news/articleView.html?idxno=58952
239,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1123868&REFERER=NP
240,2019-01-17,대웅제약첨단IT시스템클라우드로의약품안전관리한다,http://www.k-health.com/news/articleView.html?idxno=41933
241,2019-01-17,대웅제약의약품안전관리위해오라클아거스클라우드도입,http://techm.kr/bbs/board.php?bo_table=article&wr_id=5539
242,2019-01-17,1월17일대웅제약주식시세현황186500원106,http://www.nbntv.co.kr/news/articleView.html?idxno=173950
243,2019-01-17,대웅제약클라우드통해의약품안전관리,http://www.g-enews.com/ko-kr/news/article/news_all/201901171246347992f6d02acec0_1/article.html
244,2019-01-17,대웅제약주가및증권시세17일현재186500원,http://www.gokorea.kr/news/articleView.html?idxno=77276
245,2019-01-17,대웅제약의약품안전관리위해오라클클라우드도입,http://www.datanet.co.kr/news/articleView.html?idxno=130363
246,2019-01-17,대웅제약의약품안전관리위한클라우드시스템도입,http://www.insightkorea.co.kr//news/articleView.html?idxno=33528
247,2019-01-17,대웅제약의약품안전관리에클라우드도입,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019011713030501820&objId=A2019011713030501820&portalCode=naver
248,2019-01-17,대웅제약실시간의약품안전관리클라우스시스템도입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019011711245650302
249,2019-01-17,오라클아거스클라우드대웅제약의약품안전보고체계표준화,http://www.koreaittimes.com/news/articleView.html?idxno=88711
250,2019-01-17,대웅제약클라우드통해의약품안전관리실시,http://www.ftoday.co.kr/news/articleView.html?idxno=106033
251,2019-01-17,대웅제약클라우드통해의약품안전관리나선다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1134894
252,2019-01-17,대웅제약클라우드통한의약품안전관리도입,http://www.medigatenews.com/news/320969056
253,2019-01-17,대웅제약클라우드서비스통해의약품안전관리한다,http://www.businesskorea.co.kr/news/articleView.html?idxno=28398
254,2019-01-17,대웅제약실시간의약품안전관리클라우드서비스도입,http://www.wolyo.co.kr/news/articleView.html?idxno=75938
255,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1264003
256,2019-01-17,대웅제약오라클클라우드로의약품안전관리강화,http://www.etnews.com/20190117000147
257,2019-01-17,대웅제약의약품안전관리도글로벌기업수준으로,http://news.heraldcorp.com/view.php?ud=20190117000533
258,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.ekn.kr/news/article.html?no=410090
259,2019-01-17,대웅제약의약품안전관리클라우드시스템도입,http://www.newspim.com/news/view/20190117000493
260,2019-01-17,대웅제약클라우드기반의약품안전관리강화,http://www.dailymedi.com/detail.php?number=839260&thread=22r05
261,2019-01-17,대웅제약클라우드로의약품안전관리,http://www.newstomato.com/ReadNews.aspx?no=870425
262,2019-01-17,대웅제약의약품안전관리클라우드서비스도입,http://view.asiae.co.kr/news/view.htm?idxno=2019011715210316573
263,2019-01-17,대웅제약오라클클라우드시스템도입해의약품안전관리강화,http://www.businesspost.co.kr/BP?command=article_view&num=110686
264,2019-01-17,대웅제약클라우드통해의약품안전관리,http://www.bosa.co.kr/news/articleView.html?idxno=2098122
265,2019-01-17,대웅제약클라우드통해의약품안전관리,http://www.fnnews.com/news/201901171546042749
266,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.economytalk.kr/news/articleView.html?idxno=177755
267,2019-01-17,대웅제약클라우드통해의약품안전관리,http://www.ebn.co.kr/news/view/969224
268,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.bokuennews.com/news/article.html?no=170754
269,2019-01-17,대웅제약의약품관리에클라우드서비스도입,http://www.kpinews.co.kr/news/articleView.html?idxno=88243
270,2019-01-17,대웅제약클라우드서비스통해의약품안전관리,http://www.mdtoday.co.kr/mdtoday/index.html?no=344229
271,2019-01-17,대웅제약클라우드서비스도입의약품안전관리강화,http://www.newsprime.co.kr/news/article.html?no=443679
272,2019-01-17,대웅제약클라우드서비스로의약품안전관리한다,http://www.seoulwire.com/news/articleView.html?idxno=52702
273,2019-01-17,대웅제약의약품개발약물감시플랫폼기술도입,http://www.rapportian.com/news/articleView.html?idxno=115553
274,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.newsway.co.kr/news/view?tp=1&ud=2019011716532097560
275,2019-01-17,클라우드로의약품안전관리나선대웅제약,http://www.monews.co.kr/news/articleView.html?idxno=200429
276,2019-01-17,뉴스투데이L대웅제약클라우드로의약품안전관리한다,http://www.news2day.co.kr/118918
277,2019-01-17,대웅제약오라클아거스클라우드도입,http://www.ddaily.co.kr/news/article.html?no=177049
278,2019-01-17,대웅제약클라우드통한의약품안전관리진행,http://www.asiatime.co.kr/news/articleView.html?idxno=223884
279,2019-01-17,대웅제약클라우드시스템으로의약품안전관리한다,http://www.inthenews.co.kr/news/article.html?no=13070
280,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.getnews.co.kr/view.php?ud=20190117181358803341d0c69529_16
281,2019-01-17,대웅제약오라클아거스클라우드로의약품안전관리,http://www.inews24.com/view/1152233
282,2019-01-17,대웅제약의약품안전관리위한클라우드서비스도입,http://www.dailian.co.kr/news/view/766063/?sc=naver
283,2019-01-17,대웅제약오라클아거스클라우드도입으로의약품안전보고체계표준화한다,//www.dailysecu.com/?mod=news&act=articleView&idxno=44453
284,2019-01-17,대웅제약클라우드통해의약품안전관리,http://www.wsobi.com/news/articleView.html?idxno=68770
285,2019-01-17,대웅제약의약품안전관리클라우드서비스도입,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3737899
286,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.newscj.com/news/articleView.html?idxno=593020
287,2019-01-17,대웅제약아거스클라우드로의약품안전보고체계표준화,http://www.itdaily.kr/news/articleView.html?idxno=92738
288,2019-01-18,대웅제약송당암연구센터암맞춤진단치료체계산학협력,http://www.kpanews.co.kr/article/show.asp?idx=200907&table=article&category=D
289,2019-01-18,대웅제약의약품안전관리 클라우드서비스도입,http://www.kpanews.co.kr/article/show.asp?idx=200910&table=article&category=D
290,2019-01-18,대웅제약클라우드통해의약품안전관리도입,http://www.lawissue.co.kr/view.php?ud=201901172324487417d7f4c63cc6_12
291,2019-01-18,오라클대웅제약글로벌시장규제준수돕는다,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20190118004454
292,2019-01-18,실시간분석대웅제약32상승증권사목표가26만원제시,http://www.itooza.com/common/iview.php?no=2019011809162712724
293,2019-01-18,주식추천주대웅제약주가18일현재188500원,http://www.nbntv.co.kr/news/articleView.html?idxno=176106
294,2019-01-18,대웅제약클라우드로의약품안전관리,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1064540
295,2019-01-18,대웅제약주가종목그래프18일현재189000원,http://www.gokorea.kr/news/articleView.html?idxno=78842
296,2019-01-18,대웅제약신약개발과글로벌진출속도,http://www.straightnews.co.kr/news/articleView.html?idxno=41665
297,2019-01-19,대웅제약클라우드통해의약품안전관리효율화,http://www.kukinews.com/news/article.html?no=623935
298,2019-01-19,대웅제약클라우드통해의약품안전관리한다,http://www.boannews.com/media/view.asp?idx=76259&kind=
299,2019-01-20,대웅제약나보타美FDA심사임박글로벌시장진출채비,http://www.etnews.com/20190118000113
300,2019-01-20,종목시세코오롱인더57900원358E158200원356대웅제약190000원354계양전기우9390원353신세계250500원351↑주식가격주가올라18일장,http://www.fintechpost.co.kr/news/articleView.html?idxno=17461
301,2019-01-21,대웅제약전승호사장10년안에매출영업익시총10조목표”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226413
302,2019-01-21,남다른대웅제약나보타미진출1조매출은기본,http://www.bosa.co.kr/news/articleView.html?idxno=2098215
303,2019-01-21,대웅제약주보판매로실적개선기대목표가↑한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1712828
304,2019-01-21,대웅제약목표가8↑25만원제시한투證,http://www.newspim.com/news/view/20190121000073
305,2019-01-21,퀵리포트대웅제약매수유지목표가8↑25만원한투證,http://www.itooza.com/common/iview.php?no=2019012108335716833
306,2019-01-21,대웅제약올해영업이익580억원전망,http://www.nspna.com/news/?mode=view&newsid=333431
307,2019-01-21,ET투자뉴스대웅제약단기차익실현을고BUY유지한국투자증권,http://www.etnews.com/20190121000120
308,2019-01-21,대웅제약올해영업이익은기존추정치대비24상향,http://www.newsworks.co.kr/news/articleView.html?idxno=329364
309,2019-01-21,대웅제약주가1월21일현재185000원,http://www.gokorea.kr/news/articleView.html?idxno=80356
310,2019-01-22,FDA셧다운업무지연대웅제약나보타미진출늦어지나,http://www.econovill.com/news/articleView.html?idxno=355128
311,2019-01-22,빅데이터MSI시장심리톱5현대건설삼성엔지니어링삼성중공업삼성물산대웅제약,http://www.newsis.com/view/?id=NISX20190122_0000536779&cID=10401&pID=10400
312,2019-01-22,대웅제약오늘주식22일현재185000원,http://www.nbntv.co.kr/news/articleView.html?idxno=179199
313,2019-01-22,대웅제약주가1월22일현재184500원,http://www.gokorea.kr/news/articleView.html?idxno=81735
314,2019-01-22,기술수출기대되는신약파이프라인⑤대웅제약BestinClass꿈꾸는위산분비억제제DWP14012,http://www.news2day.co.kr/119174
315,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.g-enews.com/ko-kr/news/article/news_all/201901230922113279f6d02acec0_1/article.html
316,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226622
317,2019-01-23,대웅제약항혈전제안플원100mg출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=248842&REFERER=NP
318,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.ebn.co.kr/news/view/969808
319,2019-01-23,대웅제약항혈전제안플원라인업확대추가매출기대,http://moneys.mt.co.kr/news/mwView.php?no=2019012309228036420
320,2019-01-23,800억시장노리는대웅제약안플원일반정100mg출시,http://kormedi.com/?p=1262673
321,2019-01-23,대웅제약일반정제형항혈전제안플원100mg출시,http://news.mk.co.kr/newsRead.php?year=2019&no=47088
322,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019012300016
323,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1713952
324,2019-01-23,대웅제약항혈전제안플원정100mg내놔,http://www.wolyo.co.kr/news/articleView.html?idxno=76284
325,2019-01-23,항혈전제안플원제품라인업추가대웅제약시장확대나서,http://www.100ssd.co.kr/news/articleView.html?idxno=59087
326,2019-01-23,대웅제약항혈전제안플원정용량추가100mg출시,http://medipana.com/news/news_viewer.asp?NewsNum=233803&MainKind=A&NewsKind=5&vCount=12&vKind=1
327,2019-01-23,대웅제약안플원서방정이어일반정출시,http://www.whosaeng.com/sub_read.html?uid=107572§ion=sc5
328,2019-01-23,대웅제약항혈전제안플원정100mg출시맞춤처방가능,http://www.medisobizanews.com/news/articleView.html?idxno=57531
329,2019-01-23,대웅제약항혈전제안플원정100㎎출시,http://www.edaily.co.kr/news/newspath.asp?newsid=02240246622360672
330,2019-01-23,대웅제약항혈전제안플원정일반정100mg출시,http://www.k-health.com/news/articleView.html?idxno=42034
331,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019012309354369150
332,2019-01-23,대웅제약항혈전제안플원라인업확대,http://www.dailysmart.co.kr/news/articleView.html?idxno=5343
333,2019-01-23,대웅제약용량줄인항혈전제안플원정100mg출시,http://news1.kr/articles/?3531246
334,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.bokuennews.com/news/article.html?no=170949
335,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1123998&REFERER=NP
336,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.dailian.co.kr/news/view/767239/?sc=naver
337,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.bosa.co.kr/news/articleView.html?idxno=2098396
338,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003468645
339,2019-01-23,대웅제약항혈전제일반정100mg출시,http://www.rapportian.com/news/articleView.html?idxno=115641
340,2019-01-23,대웅제약항혈전제안플원정100mg로시장확대나서,http://www.econovill.com/news/articleView.html?idxno=355227
341,2019-01-23,대웅제약항혈전제안플원시장확대나서일반정출시,http://www.mhj21.com/118977
342,2019-01-23,대웅제약항혈전제라인업확대안플원정100mg출시,http://news.bizwatch.co.kr/article/consumer/2019/01/23/0007/naver
343,2019-01-23,대웅제약항혈전제안플원정100㎎출시,http://news.mk.co.kr/newsRead.php?year=2019&no=47476
344,2019-01-23,유통오늘대웅제약항혈전제안플원정100mg출시공영홈쇼핑24일식품명인전5시간진행,http://www.sisaon.co.kr/news/articleView.html?idxno=81653
345,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.dailymedi.com/detail.php?number=839442&thread=22r05
346,2019-01-23,대웅제약항혈전제안플원정100mg선봬,http://www.medigatenews.com/news/1657558382
347,2019-01-23,안플원정일반정으로확대대웅제약100mg선보여,http://www.sedaily.com/NewsView/1VE5D8Z5XZ
348,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019012311344504986
349,2019-01-23,대웅제약안플원정100mg출시,http://www.monews.co.kr/news/articleView.html?idxno=200523
350,2019-01-23,대웅제약항혈전제안플원정100mg출시라인업확대,http://www.economytalk.kr/news/articleView.html?idxno=178148
351,2019-01-23,대웅제약항혈전제안플원정100mg선봬,http://www.seoulwire.com/news/articleView.html?idxno=55190
352,2019-01-23,대웅제약항혈전제안플원정100mg도내놨다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1064690
353,2019-01-23,대웅제약항혈전제안플원정100mg출시제품군확대,http://news.hankyung.com/article/2019012331646
354,2019-01-23,대웅제약수족냉증해소안플원정100㎎출시,http://www.newsis.com/view/?id=NISX20190123_0000538237&cID=13001&pID=13000
355,2019-01-23,오늘증권시세대웅제약주가23일현재182500원,http://www.nbntv.co.kr/news/articleView.html?idxno=181239
356,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1136472
357,2019-01-23,대웅제약항혈전제안플원정출시제품군확대,http://www.etnews.com/20190123000220
358,2019-01-23,대웅제약다양한처방솔루션위해안플원정100㎎출시,http://www.asiatime.co.kr/news/articleView.html?idxno=224801
359,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=344714
360,2019-01-23,대웅제약항혈전제안플원정100mg출시제품라인업확대,https://www.insight.co.kr/news/206377
361,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.koreaittimes.com/news/articleView.html?idxno=88842
362,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.getnews.co.kr/view.php?ud=20190123172934142641d0c69529_16
363,2019-01-23,빅데이터주식투자코스피대웅제약,http://www.leaders.kr/news/articleView.html?idxno=85332
364,2019-01-23,대웅제약항혈전제안플원일반정출시맞춤처방지원,http://news.donga.com/3/all/20190123/93831151/2
365,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.finomy.com/news/articleView.html?idxno=62364
366,2019-01-23,뉴스투데이L대웅제약항혈전제안플원소용량출시로시장확대,http://www.news2day.co.kr/119299
367,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.newscj.com/news/articleView.html?idxno=595010
368,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.wsobi.com/news/articleView.html?idxno=69005
369,2019-01-24,대웅제약항혈전제안플원정100mg출시,http://www.kpanews.co.kr/article/show.asp?idx=201084&table=article&category=D
370,2019-01-24,대웅제약항혈전제안플원정100mg출시말초동맥질환치료제선두주자로자리매김할것,http://www.segye.com/content/html/2019/01/23/20190123005322.html?OutUrl=naver
371,2019-01-24,대웅제약종근당등국내제약사13곳화이자젤잔즈특허회피성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=344734
372,2019-01-24,빅데이터MSI시장심리톱5삼성물산기업은행대우건설대웅제약GS리테일,http://www.newsis.com/view/?id=NISX20190124_0000539396&cID=10401&pID=10400
373,2019-01-24,1월24일대웅제약오늘시세및매매동향,http://www.gokorea.kr/news/articleView.html?idxno=83049
374,2019-01-24,대웅제약항혈전제안플원제품라인업추가시장확대나서,http://www.ekn.kr/news/article.html?no=411295
375,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.g-enews.com/ko-kr/news/article/news_all/201901251012531632f6d02acec0_1/article.html
376,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.mhj21.com/119047
377,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226704
378,2019-01-25,대웅제약향남공장안전보건경영시스템인증획득,http://www.whosaeng.com/sub_read.html?uid=107637§ion=sc5
379,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003471033
380,2019-01-25,대웅제약향남공장국제표준획득,http://www.medical-tribune.co.kr/news/articleView.html?idxno=83713
381,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템획득,http://biz.chosun.com/site/data/html_dir/2019/01/25/2019012501217.html
382,2019-01-25,대웅제약향남공장ISO45001획득,http://www.bosa.co.kr/news/articleView.html?idxno=2098555
383,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.medigatenews.com/news/769854422
384,2019-01-25,대웅제약향남공장안전보건경영시스템국제표준인증,http://kormedi.com/?p=1263048
385,2019-01-25,대웅제약향남공장안전보건경영시스템국제표준ISO45001인증,http://www.medisobizanews.com/news/articleView.html?idxno=57585
386,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019012510555061846
387,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019012510443370574
388,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.seoulwire.com/news/articleView.html?idxno=56150
389,2019-01-25,대웅제약향남공장안전보건경영시스템국제표준인증획득,http://www.newsprime.co.kr/news/article.html?no=444628
390,2019-01-25,대웅제약배당주식25일현재182500원,http://www.nbntv.co.kr/news/articleView.html?idxno=185588
391,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.bokuennews.com/news/article.html?no=171050
392,2019-01-25,대웅제약향남공장국제표준ISO45001인증획득,http://www.ekn.kr/news/article.html?no=411577
393,2019-01-25,대웅제약향남공장안전보건경영시스템국제표준인증획득,http://www.straightnews.co.kr/news/articleView.html?idxno=42142
394,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1064792
395,2019-01-25,대웅제약향남공장안전보건경영시스템획득 ,http://www.monews.co.kr/news/articleView.html?idxno=200581
396,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템인증,http://www.rapportian.com/news/articleView.html?idxno=115691
397,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템인증,http://www.edaily.co.kr/news/newspath.asp?newsid=02656806622361328
398,2019-01-25,대웅제약주가1월25일현재184000원,http://www.gokorea.kr/news/articleView.html?idxno=84291
399,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1266401
400,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.koreaittimes.com/news/articleView.html?idxno=88902
401,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019012513453201953&objId=A2019012513453201953&portalCode=naver
402,2019-01-25,대웅제약향남공장안전보건경영시스템국제표준획득,http://news.hankyung.com/article/2019012518236
403,2019-01-25,대웅제약향남공장국제표준ISO45001안전보건경영시스템획득,http://www.asiatoday.co.kr/view.php?key=20190125010016355
404,2019-01-25,대웅제약향남공장ISO45001획득,http://www.etnews.com/20190125000195
405,2019-01-25,대웅제약향남공장국제안전보건경영시스템인증획득,http://www.econovill.com/news/articleView.html?idxno=355417
406,2019-01-25,대웅제약향남공장보건경영국제인증획득,http://www.finomy.com/news/articleView.html?idxno=62417
407,2019-01-25,대웅제약향남공장안전보건국제표준ISO45001인증획득,http://news.donga.com/3/all/20190125/93861750/2
408,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.newstomato.com/ReadNews.aspx?no=872216
409,2019-01-25,대웅제약향남공장안전보건국제표준ISO45001획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1715223
410,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템인증획득,http://www.100ssd.co.kr/news/articleView.html?idxno=59170
411,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://medipana.com/news/news_viewer.asp?NewsNum=233940&MainKind=A&NewsKind=5&vCount=12&vKind=1
412,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.inthenews.co.kr/news/article.html?no=13208
413,2019-01-25,대웅제약향남공장안전보건경영시스템인증,http://news.bizwatch.co.kr/article/consumer/2019/01/25/0015/naver
414,2019-01-25,대웅제약향남공장ISO45001인증획득,http://news.mk.co.kr/newsRead.php?year=2019&no=53675
415,2019-01-25,대웅제약향남공장국제안전보건경영시스템ISO45001획득,http://www.ajunews.com/view/20190125164847781
416,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=344933
417,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.ebn.co.kr/news/view/970307
418,2019-01-25,대웅제약향남공장국제표준ISO45001안전보건경영시스템획득,http://www.getnews.co.kr/view.php?ud=20190125173949336441d0c69529_16
419,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.seoulfn.com/news/articleView.html?idxno=332044
420,2019-01-25,대웅제약향남공장안전보건국제표준ISO45001인증획득,https://www.insight.co.kr/news/206914
421,2019-01-25,뉴스투데이L대웅제약향남공장국제표준ISO45001획득,http://www.news2day.co.kr/119497
422,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템획득,http://www.newscj.com/news/articleView.html?idxno=595824
423,2019-01-26,대웅제약향남공장안전보건경영시스템국제표준획득,http://www.wsobi.com/news/articleView.html?idxno=69148
424,2019-01-26,대웅제약질환정도별맞춤처방가능한항혈전제안플원정100mg출시,http://www.lawissue.co.kr/view.php?ud=201901261832288425d7f4c63cc6_12
425,2019-01-27,대웅제약윤재승전회장네이버커넥트재단이사장사퇴,http://yna.kr/AKR20190125079500017?did=1195m
426,2019-01-27,갑질대웅제약윤재승전회장네이버커넥트재단이사장사퇴,https://cnbc.sbs.co.kr/article_hub/10000929193?division=NAVER
427,2019-01-27,대웅제약윤재승전회장네이버커넥트재단이사장사퇴,http://www.newsis.com/view/?id=NISX20190127_0000541905&cID=13001&pID=13000
428,2019-01-27,갑질물의윤재승대웅제약전회장네이버커넥트재단이사장사퇴,http://www.newsway.co.kr/news/view?tp=1&ud=2019012709322264406
429,2019-01-27,폭언갑질윤재승대웅제약전회장네이버커넥트재단이사장사퇴,http://www.fetv.co.kr/news/article.html?no=19520
430,2019-01-27,갑질물의대웅제약윤재승전회장네이버커넥트재단이사장사퇴,http://www.viva100.com/main/view.php?key=20190127010008440
431,2019-01-27,갑질논란대웅제약윤재승전회장네이버커넥트재단이사장사퇴,http://www.ekn.kr/news/article.html?no=411771
432,2019-01-27,대웅제약윤재승전회장네이버와결별갑질물의5개월만,http://www.sporbiz.co.kr/news/articleView.html?idxno=307968
433,2019-01-27,대웅제약윤재승전회장네이버커넥트재단이사장퇴진,http://www.wolyo.co.kr/news/articleView.html?idxno=76579
434,2019-01-27,윤재승전대웅제약회장6년여만에네이버커넥트재단이사장사퇴,http://sports.chosun.com/news/ntype.htm?id=201901280100200810015807&servicedate=20190127
435,2019-01-27,윤재승대웅제약前회장네이버커넥트재단이사장사퇴,http://www.shinailbo.co.kr/news/articleView.html?idxno=1137466
436,2019-01-27,갑질대웅제약윤재승전회장네이버커넥트재단이사장사퇴,http://www.meconomynews.com/news/articleView.html?idxno=20057
437,2019-01-27,욕설갑질윤재승대웅제약전회장네이버커넥트재단이사장사퇴,http://www.4th.kr/news/articleView.html?idxno=8409
438,2019-01-28,대웅제약향남공장국제표준ISO45001안전보건경영시스템획득,http://www.kukinews.com/news/article.html?no=626567
439,2019-01-28,대웅제약종근당올해신약효과로1조클럽이름올린다,http://www.ekn.kr/news/article.html?no=411762
440,2019-01-28,오늘증권시세대웅제약주가28일현재186500원,http://www.nbntv.co.kr/news/articleView.html?idxno=188231
441,2019-01-28,대웅제약윤재승전회장네이버커넥트재단이사장사퇴,https://www.insight.co.kr/news/207340
442,2019-01-28,갑질논란대웅제약윤재승커넥트재단이사장사임,http://www.mediasr.co.kr/news/articleView.html?idxno=51001
443,2019-01-28,대웅제약항혈전제안플원정100mg출시,http://www.kukinews.com/news/article.html?no=626852
444,2019-01-28,대웅제약향남공장국제표준ISO45001안전보건경영시스템획득,http://www.lawissue.co.kr/view.php?ud=201901282319482277d7f4c63cc6_12
445,2019-01-29,갑질논란대웅제약윤제승전회장커넥트재단에서도사퇴,http://www.mdtoday.co.kr/mdtoday/index.html?no=345090
446,2019-01-29,1월29일대웅제약주식종목시세189181500원,http://www.nbntv.co.kr/news/articleView.html?idxno=190566
447,2019-01-29,대웅제약주가증권투자정보및증권정보와종목동정29일현재181500원,http://www.gokorea.kr/news/articleView.html?idxno=86609
448,2019-01-29,44세젊은CEO전승호대표가이끄는대웅제약이올해풀어야할과제,https://www.insight.co.kr/news/207673
449,2019-01-30,대웅제약윤영환창업주2세윤재승vs윤재훈엇갈리는경영행보,http://www.datanews.co.kr/news/article.html?no=102019
450,2019-01-30,대웅제약올해회사채상환액이현금성자산2배이익줄어재무부담가중,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=529776
451,2019-01-30,2018년한미약품17명대웅제약2명CP위반,http://daily.hankooki.com/lpage/ittech/201901/dh20190130093050145630.htm
452,2019-01-30,대웅제약자율책임경영강화대웅인상시행,http://www.asiatoday.co.kr/view.php?key=20190130010019112
453,2019-01-30,야근에찌든직장인피로날려주려탄생한대웅제약임팩타민,https://www.insight.co.kr/news/207824
454,2019-01-30,대웅제약종목검색30일현재181500원,http://www.nbntv.co.kr/news/articleView.html?idxno=192920
455,2019-01-30,1월30일대웅제약정보,http://www.gokorea.kr/news/articleView.html?idxno=87815
456,2019-01-31,한경로보뉴스대웅제약5이상상승주가상승세단기이평선역배열구간,http://news.hankyung.com/article/201901310527L
457,2019-01-31,대웅제약주가정보31일현재192000원,http://www.gokorea.kr/news/articleView.html?idxno=89076
458,2019-01-31,대웅제약나보타美허가임박앨러간방어전략가동,http://biz.newdaily.co.kr/site/data/html/2019/01/31/2019013100147.html
459,2019-01-31,대웅제약한국콜마1조클럽제약사첫합류유력,http://www.etnews.com/20190131000316
460,2019-02-01,글로벌Biz24메디톡스보톡스제조비밀훔친혐의로대웅제약제소북미보톡스치료제판매앞두고비상,http://www.g-enews.com/ko-kr/news/article/news_all/201902010658478404b5d048c6f3_1/article.html
461,2019-02-01,대웅제약전승호윤재춘대표체제늪에빠진수익성,http://www.datanews.co.kr/news/article.html?no=102003
462,2019-02-01,메디톡스제소대웅제약반박연초부터기싸움,http://www.medical-tribune.co.kr/news/articleView.html?idxno=83836
463,2019-02-01,유통오늘NS홈쇼핑2월적립금대잔치진행대웅제약나보타미국시장진출문제없어,http://www.sisaon.co.kr/news/articleView.html?idxno=82050
464,2019-02-01,대웅제약나보타미국진출문제없다,http://www.newsprime.co.kr/news/article.html?no=445636
465,2019-02-01,메디톡스미국ITC에대웅제약과에볼루스제소,http://www.dailypharm.com/Users/News/NewsView.html?ID=249192&REFERER=NP
466,2019-02-01,대웅제약VS메디톡스나보타진실게임2라운드돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226939
467,2019-02-01,대웅제약메디톡스ITC제소에나보타美발매문제없어,http://www.ceoscoredaily.com/news/article.html?no=51676
468,2019-02-01,메디톡스국제무역위에대웅제약제소대웅제약나보타승인문제없어,http://news.hankyung.com/article/2019020159826
469,2019-02-01,보톡스원료도용놓고메디톡스대웅제약미국ITC서다툼,http://yna.kr/AKR20190201078600017?did=1195m
470,2019-02-01,대웅제약앨러간美제소에나보타美진출문제없다,http://www.medisobizanews.com/news/articleView.html?idxno=57733
471,2019-02-01,대웅제약나보타미국시장진출문제없다,http://www.bosa.co.kr/news/articleView.html?idxno=2099002
472,2019-02-01,대웅제약나보타미국시장진출문제없어‥새봄에출시,http://medipana.com/news/news_viewer.asp?NewsNum=234267&MainKind=A&NewsKind=5&vCount=12&vKind=1
473,2019-02-01,메디톡스앨러간과미국ITC에대웅제약에볼루스제소,http://medipana.com/news/news_viewer.asp?NewsNum=234268&MainKind=A&NewsKind=5&vCount=12&vKind=1
474,2019-02-01,메디톡스美ITC에대웅제약제소나보타허가앞두고갈등,http://www.newspim.com/news/view/20190201000596
475,2019-02-01,메디톡스앨러간美ITC에대웅제약에볼루스제소,http://www.medisobizanews.com/news/articleView.html?idxno=57734
476,2019-02-01,메디톡스앨러간과美ITC에대웅제약에볼루스제소,http://www.newsprime.co.kr/news/article.html?no=445648
477,2019-02-01,대웅제약나보타미국시장진출문제없어,http://www.newsway.co.kr/news/view?tp=1&ud=2019020112192644700
478,2019-02-01,메디톡스앨러간과美국제무역위원회에대웅제약에볼루스제소,http://www.newsway.co.kr/news/view?tp=1&ud=2019020112173257283
479,2019-02-01,대웅제약나보타올봄미국시장발매한다,http://www.seoulwire.com/news/articleView.html?idxno=60633
480,2019-02-01,메디톡스VS대웅제약미국서또소송나보타영향없을것,http://kormedi.com/?p=1281541
481,2019-02-01,메디톡스엘러간미국국제무역위원회에대웅제약제소,http://www.etnews.com/20190201000156
482,2019-02-01,메디톡스앨러간과미국국제무역위원회에대웅제약에볼루스제소,http://www.sisafocus.co.kr/news/articleView.html?idxno=201684
483,2019-02-01,메디톡스美ITC에대웅제약에볼루스제소,http://www.mdtoday.co.kr/mdtoday/index.html?no=345605
484,2019-02-01,대웅제약나보타미국시장진출문제없다,http://www.wikileaks-kr.org/news/articleView.html?idxno=46881
485,2019-02-01,작년제약바이오매출1조클럽5곳확정셀트리온대웅제약주목,http://news.mk.co.kr/newsRead.php?year=2019&no=68567
486,2019-02-01,메디톡스보톡스균주논란대웅제약에공개토론제안,http://www.ceoscoredaily.com/news/article.html?no=51683
487,2019-02-01,대웅제약메디톡스의보톡스균주출처논쟁美ITC서도불붙어,http://news.mk.co.kr/newsRead.php?year=2019&no=68574
488,2019-02-01,대웅제약나보타美수입금지피소현지진출문제없어,http://biz.chosun.com/site/data/html_dir/2019/02/01/2019020101409.html
489,2019-02-01,메디톡스美ITC에대웅제약제소대웅측문제없다”,http://www.edaily.co.kr/news/newspath.asp?newsid=03604726622386256
490,2019-02-01,나보타미국진출앞두고대웅제약메디톡스재격돌,http://moneys.mt.co.kr/news/mwView.php?no=2019020112218096295
491,2019-02-01,메디톡스美국제무역위원회에대웅제약제소,http://news.hankyung.com/article/201902016307f
492,2019-02-01,보톡스균주훔쳐갔다”메디톡스이번엔미국ITC에대웅제약제소,http://www.sedaily.com/NewsView/1VF57MPT8T
493,2019-02-01,메디톡스美ITC에대웅제약에볼루스제소,http://news.mt.co.kr/mtview.php?no=2019020111421968659
494,2019-02-01,메디톡스美ITC에대웅제약제소대웅발목잡기행위,http://news1.kr/articles/?3539809
495,2019-02-01,2월1일대웅제약실시간주식현황192500원052,http://www.nbntv.co.kr/news/articleView.html?idxno=197570
496,2019-02-01,메디톡스미국제무역위원회에대웅제약과에볼루스제소,http://www.insightkorea.co.kr//news/articleView.html?idxno=33845
497,2019-02-01,메디톡스대웅제약보툴리눔톡신전쟁재개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065007
498,2019-02-01,메디톡스대웅제약보톡스균주출처공방재점화,http://www.newstomato.com/ReadNews.aspx?no=874083
499,2019-02-01,메디톡스대웅제약보툴리눔균주다툼지속USITC서맞붙어,http://www.econovill.com/news/articleView.html?idxno=355919
500,2019-02-01,2월1일대웅제약증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=90506
501,2019-02-01,대웅제약vs메디톡스보톡스대전美ITC로확전,http://www.dt.co.kr/contents.html?article_no=2019020102109931102003&ref=naver
502,2019-02-01,대웅제약나보타미국시장진출문제없다 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1139159
503,2019-02-01,메디톡스앨러간미국ITC에대웅제약제소,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902010396&t=NN
504,2019-02-01,메디톡스美ITC에대웅제약제소대웅제약측美진출문제없어,http://www.ekn.kr/news/article.html?no=413065
505,2019-02-01,나보타美수입금지피소대웅제약미국진출방해전략,http://www.newsis.com/view/?id=NISX20190201_0000548811&cID=13001&pID=13000
506,2019-02-01,메디톡스대웅제약보톡스균주출처두고재격돌 ,http://www.seoulfn.com/news/articleView.html?idxno=332800
507,2019-02-01,메디톡스미국ITC에대웅제약제소보톡스균주가져갔다,http://news.mk.co.kr/newsRead.php?year=2019&no=68936
508,2019-02-01,대웅제약나보타美진출문제없어,http://www.segye.com/content/html/2019/02/01/20190201002487.html?OutUrl=naver
509,2019-02-01,메디톡스대웅제약보툴리눔톡신분쟁확산,http://daily.hankooki.com/lpage/ittech/201902/dh20190201150156145630.htm
510,2019-02-01,메디톡스美국제무역위원회제소로대웅제약압박,http://www.mhj21.com/119215
511,2019-02-01,대웅제약메디톡스의美ITC제소발목잡기일뿐”,http://www.mhj21.com/119216
512,2019-02-01,대웅제약나보타美시장진출문제없다,http://www.ebn.co.kr/news/view/971430
513,2019-02-01,메디톡스대웅제약나보타미국진출또태클,http://news.bizwatch.co.kr/article/consumer/2019/02/01/0024/naver
514,2019-02-01,대웅제약ICT제소에도나보타미국시장진출문제없다,http://www.getnews.co.kr/view.php?ud=20190201161559208241d0c69529_16
515,2019-02-01,메디톡스앨러간미국국제무역위원회에대웅제약에볼루스제소,http://www.getnews.co.kr/view.php?ud=20190201162436166541d0c69529_16
516,2019-02-01,메디톡스와대웅제약보톡스원료도용놓고미국에서또공방,http://www.businesspost.co.kr/BP?command=article_view&num=112873
517,2019-02-01,대웅제약나보타미국보톡스시장진출문제없다,http://www.rapportian.com/news/articleView.html?idxno=115861
518,2019-02-01,메디톡스대웅제약보툴리눔톡신美허가앞두고불꽃공방,http://view.asiae.co.kr/news/view.htm?idxno=2019020117020641535
519,2019-02-01,대웅제약나보타미국시장진출문제없어,http://www.businesskorea.co.kr/news/articleView.html?idxno=28907
520,2019-02-01,메디톡스대웅제약보톡스공방재점화,http://www.kpinews.co.kr/news/articleView.html?idxno=89606
521,2019-02-01,대웅제약나보타美수입금지피소미국진출방해전략,https://www.insight.co.kr/news/208545
522,2019-02-01,대웅제약앨러간메디톡스방어전략나보타美시장진출문제없어,http://www.ftoday.co.kr/news/articleView.html?idxno=106404
523,2019-02-02,메디톡스앨러간vs대웅제약에볼루스미국국제무역위원회ITC제소,http://medicalworldnews.co.kr/news/view.php?idx=1510929318
524,2019-02-02,대웅제약vs메디톡스나보타진실공방점입가경,http://www.ebn.co.kr/news/view/971488
525,2019-02-02,대웅제약보툴리눔톡신제제나보타美FDA품목허가1보,http://news1.kr/articles/?3540447
526,2019-02-02,대웅제약나보타국산보툴리눔최초美FDA허가획득,http://medipana.com/news/news_viewer.asp?NewsNum=234298&MainKind=A&NewsKind=5&vCount=12&vKind=1
527,2019-02-02,대웅제약나보타美FDA판매허가획득,http://news.hankyung.com/article/201902028584f
528,2019-02-02,대웅제약나보타美FDA판매허가획득,http://www.ebn.co.kr/news/view/971494
529,2019-02-02,대웅제약보툴리눔톡신나보타美FDA판매허가획득,http://biz.chosun.com/site/data/html_dir/2019/02/02/2019020200326.html
530,2019-02-02,대웅제약나보타2조美시장진출FDA판매허가획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1718637
531,2019-02-02,대웅제약나보타국산최초美시장진출FDA판매허가,http://kormedi.com/?p=1281585
532,2019-02-02,대웅제약나보타미국판매허가획득,http://www.newspim.com/news/view/20190201001026
533,2019-02-02,대웅제약나보타美시판허가국산보툴리눔톡신최초상보,http://news1.kr/articles/?3540449
534,2019-02-02,대웅제약나보타최대시장미국뚫었다국산보툴리눔톡신첫진출,http://www.newspim.com/news/view/20190201001031
535,2019-02-02,대웅제약나보타FDA승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=345678
536,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA승인,http://yna.kr/AKR20190201127400017?did=1195m
537,2019-02-02,대웅제약나보타美판매허가획득봄시판예정,http://news.hankyung.com/article/2019020287156
538,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA승인종합,http://yna.kr/AKR20190201127451017?did=1195m
539,2019-02-02,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226954
540,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA허가획득,http://www.dailian.co.kr/news/view/770203/?sc=naver
541,2019-02-02,대웅제약나보타FDA판매허가획득,http://www.doctorsnews.co.kr/news/articleView.html?idxno=127618
542,2019-02-02,대웅제약나보타美FDA판매허가획득,http://www.bosa.co.kr/news/articleView.html?idxno=2099036
543,2019-02-02,대웅제약나보타FDA뚫었다국산제품중최초,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019020207262829382
544,2019-02-02,대웅제약나보타美FDA판매허가국산보툴리눔톡신최초,http://www.newsis.com/view/?id=NISX20190202_0000549352&cID=13001&pID=13000
545,2019-02-02,대웅제약나보타美FDA판매허가획득세계시장정조준,http://biz.newdaily.co.kr/site/data/html/2019/02/02/2019020200005.html
546,2019-02-02,대웅제약나보타美FDA허가국산보툴리눔톡신최초,http://www.medisobizanews.com/news/articleView.html?idxno=57743
547,2019-02-02,대웅제약나보타미FDA최종품목허가승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003478744
548,2019-02-02,대웅제약보툴리눔톡신나보타美FDA승인올해봄출시,http://www.asiatoday.co.kr/view.php?key=20190202010000506
549,2019-02-02,대웅제약보툴리눔톡신나보타美FDA허가획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01600646622386584
550,2019-02-02,대웅제약보툴리눔톡신나보타FDA판매허가획득,http://www.kpanews.co.kr/article/show.asp?idx=201309&table=article&category=D
551,2019-02-02,대웅제약나보타美FDA판매허가획득올봄출시예정,http://www.mdtoday.co.kr/mdtoday/index.html?no=345679
552,2019-02-02,대웅제약나보타美FDA판매허가획득올해RD결실맺는다,http://www.ekn.kr/news/article.html?no=413143
553,2019-02-02,대웅제약나보타국산보툴리눔톡신최초미국FDA판매허가획득,http://www.mediapen.com/news/view/411749
554,2019-02-02,대웅제약나보타세계최대美시장주름잡는다,http://news.mt.co.kr/mtview.php?no=2019020209371829214
555,2019-02-02,대웅제약나보타국산보톡스최초로미국판매허가받아,http://news.mk.co.kr/newsRead.php?year=2019&no=70134
556,2019-02-02,대웅제약나보타국산보툴리눔톡신최초미FDA판매허가획득,http://www.fnnews.com/news/201902020958188200
557,2019-02-02,대웅제약나보타국산보톡스최초FDA판매허가획득,http://www.sedaily.com/NewsView/1VF5NHDK9T
558,2019-02-02,대웅제약나보타美진출글로벌제약사도약분수령,http://www.shinailbo.co.kr/news/articleView.html?idxno=1139258
559,2019-02-02,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019020210255418431
560,2019-02-02,대웅제약나보타미국FDA판매허가쾌거,http://news.bizwatch.co.kr/article/consumer/2019/02/02/0001/naver
561,2019-02-02,대웅제약나보타FDA판매허가미국시장진출,http://www.etnews.com/20190202000006
562,2019-02-02,대웅제약나보타국산보툴리눔톡신최초FDA판매허가획득,http://www.econovill.com/news/articleView.html?idxno=355988
563,2019-02-02,대웅제약나보타국산보톡스최초미국진출,http://www.dailysmart.co.kr/news/articleView.html?idxno=5941
564,2019-02-02,메디톡스vs대웅제약나보타美허가앞두고또,http://www.dailysmart.co.kr/news/articleView.html?idxno=5912
565,2019-02-02,대웅제약나보타미국진출봄시판예정,http://www.cstimes.com/?mod=news&act=articleView&idxno=296225
566,2019-02-02,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가미국진출,http://www.seoulwire.com/news/articleView.html?idxno=61529
567,2019-02-02,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가획득,http://www.sisafocus.co.kr/news/articleView.html?idxno=201722
568,2019-02-02,대웅제약나보타미국FDA승인국산보톡스첫美진출,http://www.kyeongin.com/main/view.php?key=20190202010000211
569,2019-02-02,대웅제약나보타美FDA판매허가획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=46938
570,2019-02-02,대웅제약나보타2조원대美시장뚫었다FDA판매허가획득,http://www.dt.co.kr/contents.html?article_no=2019020202109931102001&ref=naver
571,2019-02-02,대웅제약나보타국산보톡스첫미국시장진출,http://www.ajunews.com/view/20190202125340872
572,2019-02-02,대웅제약오너십위기뚫고보툴리눔톡신나보타美FDA허가획득,http://www.betanews.net:8080/article/969775.html
573,2019-02-02,SR경제라이프대웅제약나보타FDA판매허가획득2조원대美시장뚫었다,http://www.srtimes.kr/news/articleView.html?idxno=32473
574,2019-02-02,대웅제약보툴리눔톡신나보타美FDA판매허가획득,http://www.newsworks.co.kr/news/articleView.html?idxno=333547
575,2019-02-02,대웅제약나보타미국FDA승인,http://www.seoul.co.kr/news/newsView.php?id=20190202500047&wlog_tag3=naver
576,2019-02-02,대웅제약자체개발한보툴리눔톡신나보타미국FDA승인,http://sports.khan.co.kr/news/sk_index.html?art_id=201902021401003&sec_id=564001&pt=nv
577,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA승인,http://www.kukinews.com/news/article.html?no=628897
578,2019-02-02,대웅제약나보타미국FDA승인2조원대美진출,http://www.sporbiz.co.kr/news/articleView.html?idxno=310152
579,2019-02-02,대웅제약나보타국산보툴리눔톡신최초미국판매허가획득,http://www.newstomato.com/ReadNews.aspx?no=874233
580,2019-02-02,대웅제약나보타FDA승인2조원대미국시장진출한다,http://www.joongboo.com/news/articleView.html?idxno=1324703
581,2019-02-02,대웅제약자체개발보툴리눔톡신나보타미국FDA승인쾌거,http://www.kyeonggi.com/news/articleView.html?idxno=2044208
582,2019-02-02,대웅제약나보타美FDA판매허가획득미국시장진출,http://www.upinews.kr/news/newsview.php?ncode=1065594152452058
583,2019-02-02,대웅제약나보타마침내美대륙진출,http://www.whosaeng.com/107807
584,2019-02-02,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가획득,http://www.lawissue.co.kr/view.php?ud=201902021547522858d7f4c63cc6_12
585,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA승인,http://www.asiatime.co.kr/news/articleView.html?idxno=226915
586,2019-02-02,대웅제약나보타美FDA승인올해봄출시,http://sports.khan.co.kr/news/sk_index.html?art_id=201902021724003&sec_id=561801&pt=nv
587,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA승인,http://www.busan.com/view/busan/view.php?code=2019020217362336171
588,2019-02-02,대웅제약국산보톡스효과얼마나좋길래,http://www.ggilbo.com/news/articleView.html?idxno=594576
589,2019-02-02,대웅제약나보타FDA허가획득국산제품첫美시장진출,http://www.rapportian.com/news/articleView.html?idxno=115870
590,2019-02-02,대웅제약보툴리눔톡신나보타美FDA판매허가국산최초,http://view.asiae.co.kr/news/view.htm?idxno=2019020218414304501
591,2019-02-02,대웅제약의독毒한도전통했다,http://www.sisaweek.com/news/articleView.html?idxno=118148
592,2019-02-02,대웅제약나보타미국FDA승인국산보톨리눔톡신최초,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902020030&t=NN
593,2019-02-02,대웅제약나보타미국FDA미간주름적응증승인국산보톨리눔톡신제제최초허가,http://www.greened.kr/news/articleView.html?idxno=92970
594,2019-02-03,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가획득,http://www.wsobi.com/news/articleView.html?idxno=69408
595,2019-02-03,대웅제약보톡스미국시장첫진출,http://biz.chosun.com/site/data/html_dir/2019/02/03/2019020300067.html?utm_source=naver&utm_medium=original&utm_campaign=biz
596,2019-02-03,전승호대웅제약보톡스나보타로미국찍고글로벌간다,http://www.businesspost.co.kr/BP?command=article_view&num=112971
597,2019-02-03,유통오늘BGF설맞이사랑의연탄나눔대웅제약나보타美시장본격진출,http://www.sisaon.co.kr/news/articleView.html?idxno=82085
598,2019-02-03,대웅제약나보타국산최초美FDA판매허가획득,http://www.getnews.co.kr/view.php?ud=20190203103109402641d0c69529_16
599,2019-02-03,나보타는첫발대웅제약차세대먹거리개발박차,http://www.edaily.co.kr/news/newspath.asp?newsid=01377606622386912
600,2019-02-03,대웅제약나보타미국판매허가획득,http://www.finomy.com/news/articleView.html?idxno=62680
601,2019-02-04,종목썰쩐소문에사서뉴스에팔라대웅제약매도시점,http://news.hankyung.com/article/2019020407146
602,2019-02-04,대웅제약설낭보국산주름개선제미국FDA판매허가,http://news.heraldcorp.com/view.php?ud=20190204000009
603,2019-02-04,대웅제약나보타美FDA판매허가획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065023
604,2019-02-05,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가,http://www.kukinews.com/news/article.html?no=629089
605,2019-02-05,대웅제약나보타미국FDA판매허가국산보툴리눔톡신제제보톡스최초,http://www.econonews.co.kr/news/articleView.html?idxno=52724
606,2019-02-06,대웅제약나보타국산보톨리눔톡신최초美판매허가획득,http://www.ceoscoredaily.com/news/article.html?no=51725
607,2019-02-06,대웅제약나보타美FDA판매허가획득,http://www.dailymedi.com/detail.php?number=839779&thread=22r05
608,2019-02-06,대웅제약나보타미국시장진출확정넘어야할벽은,http://www.sporbiz.co.kr/news/articleView.html?idxno=310655
609,2019-02-06,대웅제약헬스케어AI사업부출범,http://www.etnews.com/20190206000008
610,2019-02-06,이슈분석대웅제약메디톡스휴젤등해외시장날개단국산보톡스,http://www.etnews.com/20190206000004
611,2019-02-06,대웅제약나보타美FDA허가미국미용성형시장공략나선다,http://news.hankyung.com/article/2019020642901
612,2019-02-06,대웅제약나보타美FDA판매허가승인,http://www.kpinews.co.kr/news/articleView.html?idxno=89747
613,2019-02-06,양재준기자의알투바이오대웅제약의귀한자식나보타미국시장입성,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902060151&t=NN
614,2019-02-07,메디톡스vs대웅제약보톡스균주논란재점화,http://www.dailymedi.com/detail.php?number=839800&thread=22r05
615,2019-02-07,클릭e종목대웅제약나보타美FDA허가에목표주가상향,http://view.asiae.co.kr/news/view.htm?idxno=2019020706261723639
616,2019-02-07,대웅제약나보타세계시장공략기대된다,http://www.medisobizanews.com/news/articleView.html?idxno=57747
617,2019-02-07,대웅제약주보美허가가치상승의계기한국,http://news.hankyung.com/article/2019020749836
618,2019-02-07,대웅제약현실화되는큰그림하이투자증권,http://news.mt.co.kr/mtview.php?no=2019020707373629392
619,2019-02-07,퀵리포트대웅제약매수유지목표가23만원유지하이투자證,http://www.itooza.com/common/iview.php?no=2019020707415614898
620,2019-02-07,대웅제약나보타미국허가취득성공,http://www.asiatoday.co.kr/view.php?key=20190207010001139
621,2019-02-07,대웅제약나보타美진출성공목표가↑신영證,http://news.mt.co.kr/mtview.php?no=2019020707550748370
622,2019-02-07,대웅제약목표가23만원유지전일종가19만3000원하이투자證,http://www.newspim.com/news/view/20190207000092
623,2019-02-07,대웅제약목표가25↑30만원제시KTB證,http://www.newspim.com/news/view/20190207000181
624,2019-02-07,대웅제약FDA승인으로美수출기대목표가↑KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01476006622388224
625,2019-02-07,오늘의추천종목한국투자증권대웅제약케이아이엔엑스등,http://www.asiatoday.co.kr/view.php?key=20190207010001147
626,2019-02-07,대웅제약목표가24만원유지전일종가19만3000원NH證,http://www.newspim.com/news/view/20190207000110
627,2019-02-07,퀵리포트대웅제약매수유지목표가24만원유지NH證,http://www.itooza.com/common/iview.php?no=2019020708122513730
628,2019-02-07,대웅제약목표가11↑24만5000원제시신영證,http://www.newspim.com/news/view/20190207000117
629,2019-02-07,퀵리포트대웅제약매수유지목표가11↑24만5000원신영證,http://www.itooza.com/common/iview.php?no=2019020708171811595
630,2019-02-07,대웅제약나보타FDA승인상반기실적반영기대하이투자證,http://www.seoulfn.com/news/articleView.html?idxno=332911
631,2019-02-07,신영증권대웅제약나보타미국진출성공목표가↑”,http://www.newsway.co.kr/news/view?tp=1&ud=2019020708204988069
632,2019-02-07,대웅제약나보타미국FDA품목허가목표가↑KTB투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1718976
633,2019-02-07,대웅제약나보타미국품목허가최종승인목표가상향KTB,http://www.newstomato.com/ReadNews.aspx?no=874370
634,2019-02-07,I리포트대웅제약나보타미국시장입성목표가↑KTB證,http://www.inews24.com/view/1155854
635,2019-02-07,대웅제약나보타FDA품목허가취득으로실적모멘텀기대하이투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1718978
636,2019-02-07,HotLine대웅제약美FDA로부터나보타판매승인수출확대기대감,http://news.mk.co.kr/newsRead.php?year=2019&no=74570
637,2019-02-07,대웅제약주보미국시장점유율2025년16로상승전망,http://www.nspna.com/news/?mode=view&newsid=336965
638,2019-02-07,KTB투자대웅제약대미신약수출증가예상목표가↑,http://yna.kr/AKR20190207028900008?did=1195m
639,2019-02-07,하이로우대웅제약나보타FDA승인목표가↑KTB투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019020708352224505
640,2019-02-07,대웅제약美FDA승인이후추가모멘텀주목한국,http://www.edaily.co.kr/news/newspath.asp?newsid=01643286622388224
641,2019-02-07,ET투자뉴스대웅제약현실화되는큰그림BUYMAINTAIN하이투자증권,http://www.etnews.com/20190207000007
642,2019-02-07,대웅제약주가더갈수있다미국에서나보타이르면3월판매,http://www.businesspost.co.kr/BP?command=article_view&num=113065
643,2019-02-07,대웅제약나보타美허가이어중장기모멘텀기대KTB,http://www.sedaily.com/NewsView/1VF7YVY4G5
644,2019-02-07,대웅제약목표가25만원유지전일종가19만3000원한투證,http://www.newspim.com/news/view/20190207000148
645,2019-02-07,퀵리포트대웅제약매수유지목표가25만원유지한투證,http://www.itooza.com/common/iview.php?no=2019020708435513220
646,2019-02-07,대웅제약나보타미FDA허가목표주가24만원으로상향,http://www.whitepaper.co.kr/news/articleView.html?idxno=142097
647,2019-02-07,대웅제약나보타美허가취득업종톱픽NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01715446622388224
648,2019-02-07,대웅제약목표가5↑19만원제시DB금투,http://www.newspim.com/news/view/20190207000178
649,2019-02-07,실시간분석대웅제약101상승증권사목표가25만원제시,http://www.itooza.com/common/iview.php?no=2019020709013011180
650,2019-02-07,대웅제약나보타美시장전격진출,http://daily.hankooki.com/lpage/ittech/201902/dh20190207090406145630.htm
651,2019-02-07,대웅제약보톡스제품美판매허가취득,http://news.mt.co.kr/mtview.php?no=2019020709070390435
652,2019-02-07,대웅제약대웅주보美판매허가에급등,http://news.hankyung.com/article/2019020752596
653,2019-02-07,특징주대웅제약나보타미국진출에장초반급등,http://www.newsway.co.kr/news/view?tp=1&ud=2019020709061055558
654,2019-02-07,한경로보뉴스대웅제약5이상상승현실화되는큰그림하이투자증권BuyMaintain,http://news.hankyung.com/article/201902075267L
655,2019-02-07,대웅제약나보타美FDA판매허가획득,http://www.newspim.com/news/view/20190207000179
656,2019-02-07,대웅제약미간주름치료제美FDA판매허가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1719020
657,2019-02-07,대웅제약나보타美FDA판매허가획득,http://view.asiae.co.kr/news/view.htm?idxno=2019020709093185403
658,2019-02-07,퀵리포트대웅제약보유로하향목표가5↑19만원DB금투,http://www.itooza.com/common/iview.php?no=2019020709021919468
659,2019-02-07,대웅제약나보타美허가에주가급등,http://www.sedaily.com/NewsView/1VF7Y9CYPF
660,2019-02-07,특징주대웅제약나보타FDA품목허가급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1719023
661,2019-02-07,퀵리포트대웅제약매수유지목표가25↑30만원KTB證,http://www.itooza.com/common/iview.php?no=2019020707464916529
662,2019-02-07,특징주대웅제약나보타美FDA품목허가승인소식에강세,http://www.seoulfn.com/news/articleView.html?idxno=332927
663,2019-02-07,특징주대웅제약美FDA판매허가소식에상승세,http://www.edaily.co.kr/news/newspath.asp?newsid=01905686622388224
664,2019-02-07,공시대웅제약나보타美FDA판매허가획득,http://www.fnnews.com/news/201902070912269578
665,2019-02-07,대웅제약나보타FDA품목허가취득성공NH,http://www.fnnews.com/news/201902070911397401
666,2019-02-07,특징주대웅제약美서보톡스판매허가소식에강세,http://www.inews24.com/view/1155877
667,2019-02-07,특징주대웅제약나보타FDA품목허가취득소식에강세,http://www.fetv.co.kr/news/article.html?no=20007
668,2019-02-07,KTB투자證대웅제약대미신약수출증가예상목표가25↑”,http://www.kukinews.com/news/article.html?no=629316
669,2019-02-07,대웅제약나보타美FDA판매허가획득,http://news.heraldcorp.com/view.php?ud=20190207000121
670,2019-02-07,특징주대웅제약나보타미FDA판매승인에강세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902070099&t=NN
671,2019-02-07,특징주대웅제약나보타FDA품목허가에강세,http://www.ebn.co.kr/news/view/971684
672,2019-02-07,특징주대웅제약나보타의美허가소식에강세,http://www.newsis.com/view/?id=NISX20190207_0000550899&cID=10401&pID=10400
673,2019-02-07,특징주대웅제약나보타미국허가에상승,http://www.ekn.kr/news/article.html?no=413467
674,2019-02-07,공시대웅제약나보타美FDA판매허가획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019020709201499533
675,2019-02-07,특징주대웅대웅제약나보타미국판매승인에강세,http://yna.kr/AKR20190207038200008?did=1195m
676,2019-02-07,ET투자뉴스대웅제약_투심과거래량은보통현재주가는강세,http://www.etnews.com/20190207000027
677,2019-02-07,HotLine대웅제약나보타美승인소식에강세,http://news.mk.co.kr/newsRead.php?year=2019&no=74756
678,2019-02-07,특징주대웅제약미간주름개선제나보타美FDA판매허가획득,http://news.mt.co.kr/mtview.php?no=2019020709263433269
679,2019-02-07,특징주대웅제약나보타美FDA판매허가획득소식에강세,http://www.asiatoday.co.kr/view.php?key=20190207010001265
680,2019-02-07,대웅제약나보타美FDA판매허가획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01958166622388224
681,2019-02-07,특징주대웅대웅제약나보타미국판매승인에강세,http://www.asiatime.co.kr/news/articleView.html?idxno=227157
682,2019-02-07,보톡스대항마美진출한대웅제약설연휴후주가↑,http://news.heraldcorp.com/view.php?ud=20190207000149
683,2019-02-07,대웅제약코스닥서급상승세보여눈길나보타美FDA판매허가획득여파,http://www.topstarnews.net/news/articleView.html?idxno=581005
684,2019-02-07,나보타美판매허가에대웅제약강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=345734
685,2019-02-07,대웅제약나보타美진출목표가↑신영,http://news.mt.co.kr/mtview.php?no=2019020709314097321
686,2019-02-07,대웅제약069620종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902070153&t=NN
687,2019-02-07,대웅제약나보타미국FDA판매승인에주가강세,http://www.seoulwire.com/news/articleView.html?idxno=61903
688,2019-02-07,대웅제약나보타국내최초미국FDA판매허가글로벌시장진출신영證,http://www.itooza.com/common/iview.php?no=2019020709241774899
689,2019-02-07,대웅대웅제약나보타미국FDA판매승인에강세특징주,http://sports.khan.co.kr/news/sk_index.html?art_id=201902070949003&sec_id=564001&pt=nv
690,2019-02-07,대웅제약나보타美FDA판매허가획득,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019020709512400946&objId=A2019020709512400946&portalCode=naver
691,2019-02-07,대웅제약나보타미국FDA승인장초반상승,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20190207.99099000512
692,2019-02-07,특징주대웅대웅제약나보타미국FDA판매승인소식에강세,http://www.kyeongin.com/main/view.php?key=20190207000953488
693,2019-02-07,공시대웅제약나보타美FDA판매허가획득,http://www.newsis.com/view/?id=NISX20190207_0000550973&cID=10401&pID=10400
694,2019-02-07,대웅제약나보타미국진출시장에매우긍정적목표주가24만5000원으로올려,http://www.g-enews.com/ko-kr/news/article/news_all/2019020709590564794e4869c120_1/article.html
695,2019-02-07,특징주대웅제약나보타美판매승인에강세,http://news1.kr/articles/?3541828
696,2019-02-07,보톡스도전대웅제약나보타로美주름잡을까,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019020710034201040&objId=A2019020710034201040&portalCode=naver
697,2019-02-07,대웅대웅제약보툴리늄톡신미국수출기대에강세특징주,http://www.kukinews.com/news/article.html?no=629378
698,2019-02-07,대웅제약美FDA판매허가받은나보타어떤제품,http://www.ajunews.com/view/20190207101307054
699,2019-02-07,대웅제약나보타美FDA판매허가,http://www.ebn.co.kr/news/view/971708
700,2019-02-07,KTB투자대웅제약대미신약수출증가예상에목표가상향,http://www.enewstoday.co.kr/news/articleView.html?idxno=1269318
701,2019-02-07,대웅제약나보타미국진출호재에증권가일제히목표주가↑,http://moneys.mt.co.kr/news/mwView.php?no=2019020710218051547
702,2019-02-07,대웅제약메디톡스나보타균주전쟁누가최후승자,http://www.betanews.net:8080/article/970550.html
703,2019-02-07,대웅제약올해잇단낭보기대주가더간다,http://view.asiae.co.kr/news/view.htm?idxno=2019020710385308396
704,2019-02-07,대웅제약나보타美FDA판매허가획득에주가상승,https://news.imaeil.com/Finance/2019020710385514301
705,2019-02-07,특징주대웅제약나보타美진출기대감속강세,http://moneys.mt.co.kr/news/mwView.php?no=2019020710478096107
706,2019-02-07,대웅제약FDA판매허가취득소식에도상승폭시간지날수록줄어들어1대상승,http://www.econonews.co.kr/news/articleView.html?idxno=52842
707,2019-02-07,대웅제약나보타美판매허가에목표주가도쑥,http://www.mdtoday.co.kr/mdtoday/index.html?no=345759
708,2019-02-07,대웅제약보타보툴리눔톡신美FDA판매허가획득,http://www.straightnews.co.kr/news/articleView.html?idxno=42817
709,2019-02-07,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가획득,http://www.inthenews.co.kr/news/article.html?no=13374
710,2019-02-07,대웅제약나보타美FDA판매허가획득,http://www.asiatime.co.kr/news/articleView.html?idxno=227207
711,2019-02-07,KTB투자증권대웅제약대미신약수출증가예상목표주가30만원으로상향조정,http://www.topstarnews.net/news/articleView.html?idxno=581170
712,2019-02-07,대웅제약주가증권투자정보7일현재204500원,http://www.gokorea.kr/news/articleView.html?idxno=92030
713,2019-02-07,ET투자뉴스대웅제약나보타국내제품BUYKTB투자증권,http://www.etnews.com/20190207000220
714,2019-02-07,ET투자뉴스대웅제약제약업종ToppBUY유지NH투자증권,http://www.etnews.com/20190207000228
715,2019-02-07,대웅제약제약업종Toppick유지,http://news.mt.co.kr/mtview.php?no=2019020708451025197
716,2019-02-07,2월7일대웅제약주식그래프440201500원,http://www.nbntv.co.kr/news/articleView.html?idxno=201179
717,2019-02-07,ET투자뉴스대웅제약소문에사서뉴스에매수유지한국투자증권,http://www.etnews.com/20190207000278
718,2019-02-07,ET투자뉴스대웅제약JeuveauFDHOLD하향DB금융투자,http://www.etnews.com/20190207000298
719,2019-02-07,대웅제약나보타국내최초美FDA판매허가득한보툴리눔톡신,http://www.newsworks.co.kr/news/articleView.html?idxno=333993
720,2019-02-07,2월7일대웅제약주가그래프492202500원,http://www.nbntv.co.kr/news/articleView.html?idxno=201390
721,2019-02-07,나보타로첫발뗀대웅제약글로벌공략박차,http://www.newsway.co.kr/news/view?tp=1&ud=2019020713573566637
722,2019-02-07,대웅제약주보美출시허가이후에도다양한모멘텀대기중,http://www.newsworks.co.kr/news/articleView.html?idxno=334024
723,2019-02-07,대웅제약나보타미국허가모멘텀이끝이아니다,http://www.newsworks.co.kr/news/articleView.html?idxno=334031
724,2019-02-07,美진출성공한대웅제약나보타논란은여전,http://www.monews.co.kr/news/articleView.html?idxno=200698
725,2019-02-07,주식시장美보톡스시장진입한대웅제약에환호차기주자는,http://news.mk.co.kr/newsRead.php?year=2019&no=76078
726,2019-02-07,대웅제약나보타美FDA승인에경쟁력확보,http://www.newsprime.co.kr/news/article.html?no=445860
727,2019-02-07,대웅제약나보타美판매허가에훨훨,http://www.edaily.co.kr/news/newspath.asp?newsid=03886806622388224
728,2019-02-07,대웅제약나보타FDA품목허가취득완료,http://www.newsworks.co.kr/news/articleView.html?idxno=334087
729,2019-02-07,대웅제약보톡스대장주메디톡스맹추격,http://news.hankyung.com/article/2019020778751
730,2019-02-07,주보로다시태어난대웅제약나보타美입성후전망은,http://www.inthenews.co.kr/news/article.html?no=13380
731,2019-02-07,대웅제약나보타FDA품목허가소식에함박웃음,http://www.etoday.co.kr/news/section/newsview.php?idxno=1719452
732,2019-02-07,나보타효과대웅제약주가급등57상승,http://www.dailymedi.com/detail.php?number=839831&thread=22r05
733,2019-02-07,메디톡스앨러간과미국국제무역위원회ITC에대웅제약에볼루스제소,http://www.lawissue.co.kr/view.php?ud=201902072216065056d7f4c63cc6_12
734,2019-02-07,대웅제약나보타미국시장진출문제없어일축,http://www.lawissue.co.kr/view.php?ud=20190207221736301d7f4c63cc6_12
735,2019-02-08,전일주요공시동부제철현대모비스대웅제약외,http://www.etoday.co.kr/news/section/newsview.php?idxno=1719459
736,2019-02-08,바이오株주가상승가능성높아져대웅제약美FDA승인시발탄,http://www.newspim.com/news/view/20190208000106
737,2019-02-08,대웅제약나보타미국보톡스시장서성공하려면,http://www.rapportian.com/news/articleView.html?idxno=115897
738,2019-02-08,빅데이터MSI시장심리톱5대웅제약현대차농심삼성전자CJ,http://www.newsis.com/view/?id=NISX20190208_0000552095&cID=10427&pID=10400
739,2019-02-08,대웅제약전일대비약3상승한210500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902080201&t=NN
740,2019-02-08,휴젤메디톡스대웅제약나보타출시영향제한적CS,http://www.choicenews.co.kr/news/articleView.html?idxno=48057
741,2019-02-08,대웅제약주가종목그래프및종목동정과증시정보8일현재208000원,http://www.gokorea.kr/news/articleView.html?idxno=93233
742,2019-02-08,2월8일대웅제약주식추천주196208000원,http://www.nbntv.co.kr/news/articleView.html?idxno=203782
743,2019-02-08,美FDA장벽을넘는제약사들대웅제약이을주인공은누구,http://www.asiatime.co.kr/news/articleView.html?idxno=227384
744,2019-02-09,주목e해외주식에볼루스대웅제약주보로보톡스에도전장,http://www.edaily.co.kr/news/newspath.asp?newsid=01541606622388880
745,2019-02-09,신영증권대웅제약보툴리눔톡신나보타미국진출목표가245000원상향제시,http://www.betanews.net:8080/article/971590.html
746,2019-02-11,윤정훈기자의해외주식톡에볼루스오르는데대웅제약못올라왜,http://www.ajunews.com/view/20190210130845513
747,2019-02-11,뜨거워진보톡스전쟁대웅제약나보타로美시장잡을까,http://www.ekn.kr/news/article.html?no=413934
748,2019-02-11,대웅제약교수3명에대웅학술상상금3000만원지급,http://moneys.mt.co.kr/news/mwView.php?no=2019021110518050427
749,2019-02-11,2월11일대웅제약주식현황208000원097,http://www.nbntv.co.kr/news/articleView.html?idxno=206156
750,2019-02-11,대웅제약주가2월11일현재209000원,http://www.gokorea.kr/news/articleView.html?idxno=94561
751,2019-02-11,돈잘버는증권맨에게듣는다박근형차장제약바이오10개월간주가조정투심개선중대웅제약주목,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021113332146743
752,2019-02-11,메디톡스대웅제약불붙은보톡스균주논란,http://www.dt.co.kr/contents.html?article_no=2019021202101631102001&ref=naver
753,2019-02-12,대웅제약나보타미국이어상반기중유럽허가전망,http://www.medisobizanews.com/news/articleView.html?idxno=57828
754,2019-02-12,더벨대웅제약나보타美출시첫해전체매출500억전망,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201902110100010510000676
755,2019-02-12,대웅제약크레젯정새로운블록버스터제품등극,http://www.g-enews.com/ko-kr/news/article/news_all/201902121044335255fa075a9870_1/article.html
756,2019-02-12,대웅제약크레젯정원외처방액100억원돌파,http://www.ceoscoredaily.com/news/article.html?no=51876
757,2019-02-12,대웅제약크레젯정지난해원외처방액105억원기록,http://www.ebn.co.kr/news/view/972237
758,2019-02-12,대웅제약크레젯정출시3년만에블록버스터등극,http://www.etoday.co.kr/news/section/newsview.php?idxno=1720932
759,2019-02-12,대웅제약크레젯정지난해원외처방액100억넘어,http://news.mk.co.kr/newsRead.php?year=2019&no=84988
760,2019-02-12,대웅제약크레젯정지난해원외처방액100억원돌파,http://www.econovill.com/news/articleView.html?idxno=356382
761,2019-02-12,대웅제약크레젯정새블록버스터제품등극,http://daily.hankooki.com/lpage/ittech/201902/dh20190212105504145630.htm
762,2019-02-12,대웅제약크레젯정새로운블록버스터로등극,http://medipana.com/news/news_viewer.asp?NewsNum=234490&MainKind=A&NewsKind=5&vCount=12&vKind=1
763,2019-02-12,대웅제약크레젯정원외처방액105억48성장,http://www.bosa.co.kr/news/articleView.html?idxno=2099304
764,2019-02-12,대웅제약고지혈증치료제크레젯정출시3년만에블록버스터등극,http://www.newspim.com/news/view/20190212000326
765,2019-02-12,대웅제약크레젯정매출100억돌파블록버스터등극,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227104
766,2019-02-12,대웅제약고지혈증약크레젯정원외처방액100억돌파,http://view.asiae.co.kr/news/view.htm?idxno=2019021211184407141
767,2019-02-12,대웅제약크레젯정원외처방액100억원돌파,http://www.fetv.co.kr/news/article.html?no=20260
768,2019-02-12,대웅제약이상지질혈증복합제크레젯원외처방100억돌파,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902120260&t=NN
769,2019-02-12,대웅제약나보타美FDA승인글로벌진출가속,http://www.mhj21.com/119355
770,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.newsway.co.kr/news/view?tp=1&ud=2019021211243300874
771,2019-02-12,대웅제약주가및증권시세외매매동향12일현재206000원,http://www.gokorea.kr/news/articleView.html?idxno=95720
772,2019-02-12,대웅제약크레젯정2018년매출100억원돌파,http://www.dailypharm.com/Users/News/NewsView.html?ID=249373&REFERER=NP
773,2019-02-12,대웅제약크레젯정2018년매출100억원돌파,http://www.dailypharm.com/Users/News/NewsView.html?ID=249373&REFERER=NP
774,2019-02-12,대웅제약금일증시12일현재206000원,http://www.nbntv.co.kr/news/articleView.html?idxno=208434
775,2019-02-12,대웅제약고지혈증치료제크레젯정출시3년만에100억돌파,http://www.fnnews.com/news/201902121144584790
776,2019-02-12,대웅제약크레젯정출시3년만에처방액100억원돌파,http://www.medisobizanews.com/news/articleView.html?idxno=57845
777,2019-02-12,대웅제약크레젯정블록버스터제품등극,http://www.koreaittimes.com/news/articleView.html?idxno=89198
778,2019-02-12,대웅제약크레젯정작년100억대처방액돌파,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065190
779,2019-02-12,대웅제약크레젯정지난해100억원처방액돌파,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021212341390908
780,2019-02-12,대웅제약크레젯정출시3년만에매출105억달성,http://www.asiatime.co.kr/news/articleView.html?idxno=227971
781,2019-02-12,대웅제약고지혈증치료제크레젯정新주력제품등극,http://www.k-health.com/news/articleView.html?idxno=42338
782,2019-02-12,대웅제약크레젯정폭풍매출성장출시3년만에100억돌파,http://www.enewstoday.co.kr/news/articleView.html?idxno=1270732
783,2019-02-12,대웅제약크레젯정105억원외처방실적기록,http://www.etnews.com/20190212000298
784,2019-02-12,크레젯정원외처방100억돌파대웅제약대형품목으로육성,http://www.dt.co.kr/contents.html?article_no=2019021202109931102008&ref=naver
785,2019-02-12,대웅제약크레젯정출시3년만에블록버스터제품등극,http://www.metroseoul.co.kr/news/newsview?newscd=2019021200040
786,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.medigatenews.com/news/3679659726
787,2019-02-12,대웅제약고지혈증약크레젯연매출100억돌파,http://news.hankyung.com/article/201902121310f
788,2019-02-12,대웅제약크레젯정지난해100억원넘게처방,http://www.ajunews.com/view/20190212145629518
789,2019-02-12,대웅제약크레젯정국내처방액100억돌파,http://www.biospectator.com/view/news_view.php?varAtcId=7106
790,2019-02-12,대웅제약고지혈증치료제크레젯정출시3년만에블록버스터등극,http://www.newsprime.co.kr/news/article.html?no=446398
791,2019-02-12,대웅제약의고지혈증치료제크레젯출시3년만에블록버스터반열올라,http://news.mk.co.kr/newsRead.php?year=2019&no=85894
792,2019-02-12,대웅제약크레젯정새로운블록버스터제품등극,http://www.edaily.co.kr/news/newspath.asp?newsid=03867126622389864
793,2019-02-12,대웅제약크레젯정출시3년만에100억돌파,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019021215352602874&objId=A2019021215352602874&portalCode=naver
794,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.ekn.kr/news/article.html?no=414377
795,2019-02-12,한국경제TV증시라인신영목의시장을이기는종목대웅제약이노메트리,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902120426&t=NNv
796,2019-02-12,대웅제약고지혈증치료제크레젯정지난해처방액100억돌파,http://www.newstomato.com/ReadNews.aspx?no=875507
797,2019-02-12,대웅제약고지혈증치료제크레젯정원외처방액105억원달성,http://www.joseilbo.com/news/news_read.php?uid=370344&class=27&grp=
798,2019-02-12,대웅제약크레젯정출시3년만연매출100억원돌파,http://www.shinailbo.co.kr/news/articleView.html?idxno=1141002
799,2019-02-12,대웅제약크레젯정블록버스터등극작년원외처방105억원,http://www.seoulfn.com/news/articleView.html?idxno=333399
800,2019-02-12,대웅제약크레젯정작년매출105억원달성新블록버스터등극,http://www.inthenews.co.kr/news/article.html?no=13454
801,2019-02-12,대웅제약고질혈증약크레젯정작년매출105억기록,http://www.rapportian.com/news/articleView.html?idxno=115962
802,2019-02-12,대웅제약고지혈증약크레젯정지난해매출100억원돌파,http://kormedi.com/?p=1282116
803,2019-02-12,대웅제약크레젯정블록버스터제품으로등극,http://www.mdtoday.co.kr/mdtoday/index.html?no=346177
804,2019-02-12,대웅제약고지혈증치료제크레젯정새블록버스터제품등극,http://www.getnews.co.kr/view.php?ud=20190212171254156441d0c69529_16
805,2019-02-12,대웅제약크레젯정새블록버스터제품등극,http://www.economytalk.kr/news/articleView.html?idxno=179225
806,2019-02-12,대웅제약고지혈증치료제크레젯정원외처방액100억돌파,https://www.insight.co.kr/news/210361
807,2019-02-12,대웅제약크레젯정원외처방액100억돌파,http://www.wolyo.co.kr/news/articleView.html?idxno=77397
808,2019-02-12,대웅제약고지혈증치료제크레젯정3년만에매출100억원돌파,http://news.donga.com/3/all/20190212/94076449/2
809,2019-02-12,뉴스투데이L대웅제약크레젯정치열한경쟁속매출100억원돌파,http://www.news2day.co.kr/120337
810,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.lawissue.co.kr/view.php?ud=201902121914272751d7f4c63cc6_12
811,2019-02-12,대웅제약고지혈증치료제처방액100억원돌파,http://www.dailysmart.co.kr/news/articleView.html?idxno=6281
812,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.newscj.com/news/articleView.html?idxno=600928
813,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.wsobi.com/news/articleView.html?idxno=69615
814,2019-02-13,대웅제약고지혈증약크레젯정지난해매출105억원기록,http://www.straightnews.co.kr/news/articleView.html?idxno=43182
815,2019-02-13,대웅제약크레젯새블록버스터제품등극,http://www.kpanews.co.kr/article/show.asp?idx=201447&table=article&category=D
816,2019-02-13,대웅제약크레젯정지난해원외처방액105억원,http://www.kukinews.com/news/article.html?no=631306
817,2019-02-13,대웅제약FDA승인이라쓰고미국진출이라읽는다이벤트,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227157
818,2019-02-13,대웅제약나보타美진출기념사내이벤트진행,http://www.kpinews.co.kr/news/articleView.html?idxno=90222
819,2019-02-13,2월13일대웅제약증권주식204000원097,http://www.nbntv.co.kr/news/articleView.html?idxno=210732
820,2019-02-13,대웅제약임직원나보타FDA승인자축,http://www.seoulfn.com/news/articleView.html?idxno=333491
821,2019-02-13,대웅제약FDA승인축하이벤트진행,http://www.newsprime.co.kr/news/article.html?no=446542
822,2019-02-13,대웅제약주름살지우기나보타美진출성공이벤트,http://www.ebn.co.kr/news/view/972435
823,2019-02-13,​대웅제약FDA승인축하성공적인미국진출기원이벤트진행,http://www.seoulwire.com/news/articleView.html?idxno=66519
824,2019-02-13,대웅제약나보타美FDA승인기념사내이벤트진행,http://news.donga.com/3/all/20190213/94086894/2
825,2019-02-13,대웅제약임직원대상FDA승인축하이벤트​,http://www.insightkorea.co.kr//news/articleView.html?idxno=33974
826,2019-02-13,대웅제약임직원대상FDA승인축하이벤트진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1271119
827,2019-02-13,대웅제약임직원대상FDA승인축하행사진행,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003487573
828,2019-02-13,대웅제약임직원과나보타美진출축하이벤트,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021313153565760
829,2019-02-13,대웅제약임직원대상FDA승인축하이벤트진행,http://www.newsway.co.kr/news/view?tp=1&ud=2019021314151483367
830,2019-02-13,대웅제약나보타자축이벤트진행FDA승인이라쓰고미국진출이라읽는다,http://moneys.mt.co.kr/news/mwView.php?no=2019021314058074169
831,2019-02-13,전승호대웅제약사장역사적인출발선”나보타美성공기원,http://www.edaily.co.kr/news/newspath.asp?newsid=03903206622390192
832,2019-02-13,대웅제약나보타美FDA승인축하이벤트,http://www.shinailbo.co.kr/news/articleView.html?idxno=1141352
833,2019-02-13,대웅제약임직원대상FDA승인축하이벤트진행,http://www.ekn.kr/news/article.html?no=414682
834,2019-02-13,기획대웅제약메디톡스美최초진출희비가른cGMP인증전략,http://daily.hankooki.com/lpage/ittech/201902/dh20190213155507145630.htm
835,2019-02-13,대웅제약임직원대상FDA승인축하이벤트진행,http://www.getnews.co.kr/view.php?ud=20190213160750826341d0c69529_16
836,2019-02-13,전승호사장나보타대웅제약성공의역사쓸것,http://www.rapportian.com/news/articleView.html?idxno=115978
837,2019-02-13,대웅제약임직원대상FDA승인축하이벤트진행,http://www.asiatime.co.kr/news/articleView.html?idxno=228298
838,2019-02-13,대웅제약나보타美FDA승인축하이벤트진행,http://www.ftoday.co.kr/news/articleView.html?idxno=106603
839,2019-02-13,대웅제약임직원대상나보타FDA승인축하이벤트진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=346293
840,2019-02-13,나보타FDA승인은여러분덕입니다전승호대웅제약사장임직원에감사서신,http://www.metroseoul.co.kr/news/newsview?newscd=2019021300062
841,2019-02-13,대웅제약나보타美FDA승인기념임직원대상축하이벤트진행,https://www.insight.co.kr/news/210618
842,2019-02-14,대웅제약임직원대상FDA승인축하이벤트진행,http://www.lawissue.co.kr/view.php?ud=201902140128227786d7f4c63cc6_12
843,2019-02-14,2월14일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=98047
844,2019-02-14,시세보기대웅제약주가14일현재201000원,http://www.nbntv.co.kr/news/articleView.html?idxno=212950
845,2019-02-15,대웅제약주가및증권시세15일현재202500원,http://www.gokorea.kr/news/articleView.html?idxno=99222
846,2019-02-15,대웅제약금일증시15일현재202500원,http://www.nbntv.co.kr/news/articleView.html?idxno=215267
847,2019-02-15,대웅제약나보타상반기美출시보톡스보다가격낮췄다,http://news1.kr/articles/?3548722
848,2019-02-15,강스템바이오텍퓨어스템AD대웅제약공동개발계약해지,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227265
849,2019-02-15,강스템바이오텍대웅제약과의세포치료제공동개발계약변경,http://news.mt.co.kr/mtview.php?no=2019021517490256870
850,2019-02-15,강스템바이오텍대웅제약과아토피치료제판권계약해지,http://news.hankyung.com/article/201902155117f
851,2019-02-15,강스템바이오텍퓨어스템AD주독자개발대웅제약과계약변경,http://kormedi.com/?p=1282452
852,2019-02-15,강스템바이오텍대웅제약과공동개발계약변경합의,https://www.sedaily.com/NewsView/1VFBOVWI6A
853,2019-02-15,강스템바이오텍퓨어스템AD대웅제약공동개발서제외,http://medipana.com/news/news_viewer.asp?NewsNum=234670&MainKind=A&NewsKind=5&vCount=12&vKind=1
854,2019-02-15,강스템바이오텍대웅제약과아토피치료제공동개발계약변경,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021518173585278
855,2019-02-15,강스템바이오텍대웅제약과공동개발계약변경,http://view.asiae.co.kr/news/view.htm?idxno=2019021518303867332
856,2019-02-17,대웅제약나보타美FDA승인받았지만균주출처제소에여전히발목,http://news.kmib.co.kr/article/view.asp?arcid=0924061877&code=14130000&cp=nv
857,2019-02-18,오늘의추천종목한국투자증권대웅제약케이아이엔엑스등,http://www.asiatoday.co.kr/view.php?key=20190218010007267
858,2019-02-18,국고처김종철종목상담대웅제약069620,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902160034&t=NNv
859,2019-02-18,대웅제약나보타국내보툴리눔톡신최초美FDA승인획득,http://www.k-health.com/news/articleView.html?idxno=42431
860,2019-02-18,대웅제약국민소화제베아제출시33주년기념TV광고캠페인선보여,http://www.seoulwire.com/news/articleView.html?idxno=69428
861,2019-02-18,대웅제약베아제출시33주년맞아새TV광고선보여,http://www.edaily.co.kr/news/newspath.asp?newsid=02378006622391832
862,2019-02-18,대웅제약베아제출시33주년기념신규광고온에어,http://www.enewstoday.co.kr/news/articleView.html?idxno=1272308
863,2019-02-18,대웅제약출시33주년베아제15년만에신규광고캠페인,http://www.medisobizanews.com/news/articleView.html?idxno=57946
864,2019-02-18,대웅제약베아제출시33돌기념TV광고캠페인선봬,http://www.metroseoul.co.kr/news/newsview?newscd=2019021800044
865,2019-02-18,대웅제약베아제33주년신규광고온에어,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021809514312194
866,2019-02-18,대웅제약베아제출시33주년TV광고진행,http://moneys.mt.co.kr/news/mwView.php?no=2019021810118062273
867,2019-02-18,베아제출시33주년대웅제약신규광고캠페인선봬,http://www.wolyo.co.kr/news/articleView.html?idxno=77773
868,2019-02-18,대웅제약나보타美FDA승인에메디톡스발목잡기,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=97710
869,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.newsway.co.kr/news/view?tp=1&ud=2019021810525715388
870,2019-02-18,유통오늘대웅제약33돌베아제신규광고캠페인선봬롯데그룹부산스타트업지원,http://www.sisaon.co.kr/news/articleView.html?idxno=82434
871,2019-02-18,대웅제약출시33주년베아제신규TV광고선보여,http://www.mhj21.com/119489
872,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인,http://daily.hankooki.com/lpage/ittech/201902/dh20190218111333145630.htm
873,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.bokuennews.com/news/article.html?no=171816
874,2019-02-18,대웅제약베아제출시33주년신규광고캠페인선보여,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227296
875,2019-02-18,2월18일대웅제약증권투자정보외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=100547
876,2019-02-18,대웅제약베아제출시33주년맞아새TV광고온에어,http://www.insightkorea.co.kr//news/articleView.html?idxno=34047
877,2019-02-18,대웅제약주식증권18일현재203000원,http://www.nbntv.co.kr/news/articleView.html?idxno=217882
878,2019-02-18,대웅제약15년만에소화제베아제광고선봬,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065381
879,2019-02-18,대웅제약베아제출시33주년신규광고캠페인,http://kormedi.com/?p=1282534
880,2019-02-18,대웅제약베아제출시33주년맞이신규광고캠페인,http://www.asiatime.co.kr/news/articleView.html?idxno=228984
881,2019-02-18,이중으로강력하게대웅제약베아제출시33주년기념신규광고,https://www.insight.co.kr/news/211479
882,2019-02-18,위에서한번장에서또한번대웅제약베아제신규광고선봬,http://www.shinailbo.co.kr/news/articleView.html?idxno=1142551
883,2019-02-18,대웅제약베아제출시33주년맞아,http://www.wsobi.com/news/articleView.html?idxno=69809
884,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.ekn.kr/news/article.html?no=415548
885,2019-02-18,대웅제약AI플랫폼으로신약개발진단처방사후관리까지,http://view.asiae.co.kr/news/view.htm?idxno=2019021815220943570
886,2019-02-18,대웅제약베아제출시33주년기념신규광고캠페인,http://www.g-enews.com/ko-kr/news/article/news_all/201902181526517974fa075a9870_1/article.html
887,2019-02-18,대웅제약춘향가전수자이영태내세운종합소화제베아제광고론칭,http://news.mk.co.kr/newsRead.php?year=2019&no=98701
888,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.mdtoday.co.kr/mdtoday/index.html?no=346686
889,2019-02-18,대웅제약베아제출시33주년신규광고캠페인선보여,http://www.getnews.co.kr/view.php?ud=20190218161326591541d0c69529_16
890,2019-02-18,대웅제약15년만에베아제광고캠페인론칭,http://www.dailysmart.co.kr/news/articleView.html?idxno=6561
891,2019-02-18,오늘Who윤재춘대웅제약의한올바이오파마인수결실눈앞,http://www.businesspost.co.kr/BP?command=article_view&num=114647
892,2019-02-18,대웅제약베아제출시33주년기념신규TV광고선봬,http://www.newsprime.co.kr/news/article.html?no=447204
893,2019-02-18,대웅제약베아제 출시 33주년맞아신규광고론칭,http://www.businesskorea.co.kr/news/articleView.html?idxno=29226
894,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.newscj.com/news/articleView.html?idxno=602755
895,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.lawissue.co.kr/view.php?ud=201902182241156167d7f4c63cc6_12
896,2019-02-19,오늘주식장대웅제약주가19일현재203000원,http://www.nbntv.co.kr/news/articleView.html?idxno=220198
897,2019-02-19,대웅제약주가오늘시세19일현재202500원,http://www.gokorea.kr/news/articleView.html?idxno=101728
898,2019-02-19,대웅제약강스템신약판권포기한까닭은,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019021914583902484&objId=A2019021914583902484&portalCode=naver
899,2019-02-19,강스템바이오텍퓨어스템대웅제약의공동개발중단선언오히려호재,http://biz.newdaily.co.kr/site/data/html/2019/02/19/2019021900148.html
900,2019-02-20,대웅제약FDA가메디톡스청원거부美진출걸림돌없다,http://medipana.com/news/news_viewer.asp?NewsNum=234829&MainKind=A&NewsKind=5&vCount=12&vKind=1
901,2019-02-20,대웅제약FDA메디톡스청원거부미국진출걸림돌없어,http://www.sisafocus.co.kr/news/articleView.html?idxno=202967
902,2019-02-20,대웅제약”미국FDA메디톡스가낸나보타승인저지청원서거부”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1724303
903,2019-02-20,대웅제약FDA메디톡스청원거부나보타미국진출이상무,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227384
904,2019-02-20,대웅제약나보타미국진출탄탄대로FDA메디톡스청원거부,http://kpenews.com/View.aspx?No=21902
905,2019-02-20,대웅제약FDA가메디톡스청원거부나보타美진출걸림돌없다,http://www.ekn.kr/news/article.html?no=415919
906,2019-02-20,대웅제약美FDA메디톡스의나보타허가저지시민청원서거부,http://www.newspim.com/news/view/20190220000140
907,2019-02-20,대웅제약메디톡스견제에도미국진출순항,http://moneys.mt.co.kr/news/mwView.php?no=2019022009158052404
908,2019-02-20,대웅제약FDA메디톡스청원거부나보타미국진출걸림돌없어,http://www.edaily.co.kr/news/newspath.asp?newsid=02017206622392488
909,2019-02-20,대웅제약FDA메디톡스청원거부나보타美진출이상무”,http://www.newsway.co.kr/news/view?tp=1&ud=2019022009294238914
910,2019-02-20,대웅제약나보타미국진출재확인메디톡스청원거부,http://www.g-enews.com/ko-kr/news/article/news_all/201902200944316603fa075a9870_1/article.html
911,2019-02-20,메디톡스제기FDA청원거절대웅제약나보타美진출이상무,http://biz.chosun.com/site/data/html_dir/2019/02/20/2019022000787.html
912,2019-02-20,대웅제약FDA메디톡스가접수한시민청원거부,http://www.dailysmart.co.kr/news/articleView.html?idxno=6657
913,2019-02-20,대웅제약나보타미국의약품시장진출이상무,http://www.fetv.co.kr/news/article.html?no=20864
914,2019-02-20,대웅제약미FDA메디톡스청원거부나보타미국진출걸림돌제거,http://www.asiatoday.co.kr/view.php?key=20190220010009203
915,2019-02-20,대웅제약FDA메디톡스청원거부나보타美진출이상없어,http://www.medisobizanews.com/news/articleView.html?idxno=58016
916,2019-02-20,美FDA메디톡스문제제기거부대웅제약부정행위못찾아,http://news1.kr/articles/?3552337
917,2019-02-20,대웅제약美FDA메디톡스청원거부나보타미국진출걸림돌제거,http://www.getnews.co.kr/view.php?ud=20190220113500585841d0c69529_16
918,2019-02-20,2월20일대웅제약오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=102924
919,2019-02-20,대웅제약미국진출걸림돌없음재확인,http://www.economytalk.kr/news/articleView.html?idxno=179767
920,2019-02-20,대웅제약FDA메디톡스의균주출처공개청원거부,http://www.rapportian.com/news/articleView.html?idxno=116095
921,2019-02-20,2월20일대웅제약배당주식201500원074,http://www.nbntv.co.kr/news/articleView.html?idxno=222490
922,2019-02-20,대웅제약나보타미국진출재확인미FDA판매허가승인,http://www.100ssd.co.kr/news/articleView.html?idxno=59535
923,2019-02-20,美FDA메디톡스청원거부대웅제약나보타진출걸림돌제거,http://biz.newdaily.co.kr/site/data/html/2019/02/20/2019022000021.html
924,2019-02-20,대웅제약미국당국이메디톡스청원거부해수출지장없어,http://www.businesspost.co.kr/BP?command=article_view&num=114999
925,2019-02-20,대웅제약메디톡스의나보타승인저지FDA가거부,http://news.mk.co.kr/newsRead.php?year=2019&no=103584
926,2019-02-20,美FDA메디톡스청원거부대웅제약나보타부정행위없다,http://www.k-health.com/news/articleView.html?idxno=42493
927,2019-02-20,메디톡스제기FDA청원거절대웅제약나보타이상무,http://www.ebn.co.kr/news/view/973401
928,2019-02-20,FDA의메디톡스청원거부대웅제약나보타미국진출청신호,http://www.kukinews.com/news/article.html?no=633731
929,2019-02-20,대웅제약FDA메디톡스청원거부나보타미국진출이상무,http://www.mdtoday.co.kr/mdtoday/index.html?no=346887
930,2019-02-20,대웅제약미FDA메디톡스청원거부로나보타미국진출순항,http://www.fnnews.com/news/201902201449136823
931,2019-02-20,대웅제약나보타미국진출걸림돌없다,http://www.monews.co.kr/news/articleView.html?idxno=200931
932,2019-02-20,대웅제약FDA메디톡스청원거부나보타美진출걸림돌사라져,http://www.metroseoul.co.kr/news/newsview?newscd=2019022000169
933,2019-02-20,美FDA메디톡스가제기한대웅제약나보타관련청원거부,http://www.inthenews.co.kr/news/article.html?no=13636
934,2019-02-20,대웅제약나보타美진출걸림돌ZERO,http://www.whosaeng.com/108105
935,2019-02-20,대웅제약vs메디톡스나보타균주놓고끈질긴소송전싸움승자는,http://www.wolyo.co.kr/news/articleView.html?idxno=77980
936,2019-02-20,대웅제약FDA가메디톡스청원거부나보타미국진출걸림돌없어,http://www.etnews.com/20190220000320
937,2019-02-20,대웅제약FDA로부터나보타미국진출걸림돌없음확인,http://www.seoulwire.com/news/articleView.html?idxno=72316
938,2019-02-20,메디톡스청원FDA서거부대웅제약나보타진출걸림돌無,http://www.asiatime.co.kr/news/articleView.html?idxno=229573
939,2019-02-20,대웅제약나보타미국FDA최종허가승인,http://www.skyedaily.com/news/news_view.html?ID=82043
940,2019-02-20,대웅제약FDA의메디톡스청원거부나보타美진출걸림돌없음재확인,http://www.segye.com/content/html/2019/02/20/20190220003976.html?OutUrl=naver
941,2019-02-20,대웅제약나보타미국진출걸림돌없어져,http://www.wikileaks-kr.org/news/articleView.html?idxno=48221
942,2019-02-20,FDA메디톡스청원거부대웅제약나보타미국진출이상無,http://www.shinailbo.co.kr/news/articleView.html?idxno=1143513
943,2019-02-20,대웅제약VS메디톡스보톡스진실공방승자는누가될까,http://www.etoday.co.kr/news/section/newsview.php?idxno=1724773
944,2019-02-20,대웅제약FDA메디톡스청원거부나보타미국진출걸림돌없어,https://www.insight.co.kr/news/212015
945,2019-02-20,대웅제약FDA의메디톡스청원거부나보타미국진출걸림돌없음재확인,http://www.newscj.com/news/articleView.html?idxno=603697
946,2019-02-20,대웅제약FDA의메디톡스청원거부로나보타미국진출걸림돌없음재확인밝혀,http://www.lawissue.co.kr/view.php?ud=201902202305182519d7f4c63cc6_12
947,2019-02-21,메디톡스공세차단성공대웅제약나보타,http://www.dailymedi.com/detail.php?number=840230&thread=22r05
948,2019-02-21,더벨A급대웅제약2000억회사채만기대응여력은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201902200100029100001849
949,2019-02-21,대웅제약스마트오피스덕에업무능률올랐죠 ,http://www.seoulfn.com/news/articleView.html?idxno=334318
950,2019-02-21,2월21일대웅제약주식주가125197500원,http://www.nbntv.co.kr/news/articleView.html?idxno=224679
951,2019-02-21,제약동향1월원외처방한미약품→종근당→대웅제약순바이오의약품보톡스수출감소세,http://www.ezyeconomy.com/news/articleView.html?idxno=88340
952,2019-02-21,대웅제약FDA의메디톡스청원거부로나보타미국진출걸림돌없음재확인,http://www.wsobi.com/news/articleView.html?idxno=69963
953,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.g-enews.com/ko-kr/news/article/news_all/201902220954118530fa075a9870_1/article.html
954,2019-02-22,대웅제약직원300여명공정거래자율준수프로그램교육실시,http://www.seoulwire.com/news/articleView.html?idxno=73614
955,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://daily.hankooki.com/lpage/ittech/201902/dh20190222100330145630.htm
956,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.newsway.co.kr/news/view?tp=1&ud=2019022210031519279
957,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227486
958,2019-02-22,대웅제약직원대상컴플라이언스교육진행,http://www.mhj21.com/119607
959,2019-02-22,대웅제약컴플라이언스준수문화확립에앞장,http://www.enewstoday.co.kr/news/articleView.html?idxno=1274075
960,2019-02-22,대웅제약윤리준법경영강화직원들에컴플라이언스교육,http://kpenews.com/View.aspx?No=22099
961,2019-02-22,대웅제약변호사초청해임직원300명에윤리경영교육,http://www.medisobizanews.com/news/articleView.html?idxno=58066
962,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://moneys.mt.co.kr/news/mwView.php?no=2019022210068053844
963,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.ekn.kr/news/article.html?no=416449
964,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.edaily.co.kr/news/newspath.asp?newsid=02223846622393144
965,2019-02-22,유통오늘롯데百플라워마켓바이소공원팝업스토어선봬대웅제약직원대상컴플라이언스교육,http://www.sisaon.co.kr/news/articleView.html?idxno=82622
966,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.fetv.co.kr/news/article.html?no=21106
967,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=347107
968,2019-02-22,윤리경영박차대웅제약직원대상CP교육실시 ,http://www.monews.co.kr/news/articleView.html?idxno=200988
969,2019-02-22,대웅제약임직원대상공정거래준수교육실시 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1143952
970,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.m-i.kr/news/articleView.html?idxno=498490
971,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.bosa.co.kr/news/articleView.html?idxno=2099947
972,2019-02-22,대웅제약직원대상공정거래자율준수교육실시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065552
973,2019-02-22,대웅제약준법경영강화힘쓸것,http://www.bokuennews.com/news/article.html?no=172033
974,2019-02-22,대웅제약직원대상CP교육실시,http://www.asiatime.co.kr/news/articleView.html?idxno=229986
975,2019-02-22,대웅제약직원대상공정거래자율준수교육실시,http://www.econovill.com/news/articleView.html?idxno=357130
976,2019-02-22,대웅제약직원대상공정거래자율준수교육실시,http://www.rapportian.com/news/articleView.html?idxno=116145
977,2019-02-22,2월22일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=104982
978,2019-02-22,주식증권대웅제약주가22일현재197000원,http://www.nbntv.co.kr/news/articleView.html?idxno=227010
979,2019-02-22,대웅제약공정거래자율준수프로그램교육실시,http://www.newsprime.co.kr/news/article.html?no=447968
980,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.100ssd.co.kr/news/articleView.html?idxno=59625
981,2019-02-22,대웅제약전직원대상공정거래준법경영교육실시,http://www.ezyeconomy.com/news/articleView.html?idxno=88384
982,2019-02-22,대웅제약노경화광장변호사초청해CP교육실시,http://news.mk.co.kr/newsRead.php?year=2019&no=109516
983,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1725734
984,2019-02-22,대웅제약직원300명에컴플라이언스준수필요성피력,http://medipana.com/news/news_viewer.asp?NewsNum=234975&MainKind=A&NewsKind=5&vCount=12&vKind=1
985,2019-02-22,대웅제약직원대상준법경영컴플라이언스교육실시,http://www.getnews.co.kr/view.php?ud=20190222161657714041d0c69529_16
986,2019-02-22,대웅제약모든임직원대상으로컴플라이언스교육진행,http://www.k-health.com/news/articleView.html?idxno=42550
987,2019-02-22,대웅제약임직원대상CP교육실시,http://www.dailymedi.com/detail.php?number=840295&thread=22r05
988,2019-02-22,진격의대웅제약임직원대상CP교육,http://www.whosaeng.com/108161
989,2019-02-22,미국에상륙한대웅제약나보타올해500억매출노린다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019022210342122021
990,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.ftoday.co.kr/news/articleView.html?idxno=106794
991,2019-02-22,대웅제약직원대상공정거래자율준수교육실시,https://www.insight.co.kr/news/212450
992,2019-02-22,대웅제약공정거래자율준수임직원교육진행,http://news.donga.com/3/all/20190222/94247691/2
993,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.newscj.com/news/articleView.html?idxno=604479
994,2019-02-24,제약산업이모저모CJ헬스케어동국제약대웅제약한국오츠카제약,http://www.kukinews.com/news/article.html?no=635062
995,2019-02-24,대웅제약직원대상컴플라이언스교육실시,http://www.wsobi.com/news/articleView.html?idxno=70062
996,2019-02-25,대웅제약방문한성윤모의약품수출확대대책조만간발표,http://www.newspim.com/news/view/20190225000001
997,2019-02-25,연구본부장없는대웅제약신약개발시스템확바꿨다”,http://www.edaily.co.kr/news/newspath.asp?newsid=01344806622394128
998,2019-02-25,대웅제약찾은성윤모장관신약개발지원대책마련하겠다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1144422
999,2019-02-25,성윤모산업부장관대웅제약오송공장방문,http://www.dailypharm.com/Users/News/NewsView.html?ID=249788&REFERER=NP
1000,2019-02-25,대웅제약방문한성윤모산업장관신약개발투자하라”지원약속,http://www.asiatoday.co.kr/view.php?key=20190225010011893
1001,2019-02-25,대웅제약오송공장방문한성윤모장관,http://news1.kr/photos/view/?3524033
1002,2019-02-25,성윤모장관의약품수출기업대웅제약오송공장현장방문,http://news1.kr/photos/view/?3524040
1003,2019-02-25,대웅제약오송공장생산라인살펴보는성윤모장관,http://news1.kr/photos/view/?3524028
1004,2019-02-25,성윤모장관대웅제약오송공장방문,http://news1.kr/photos/view/?3524025
1005,2019-02-25,성윤모장관대웅제약공장방문수출지원책발표할것,http://www.sisaweek.com/news/articleView.html?idxno=118748
1006,2019-02-25,성윤모장관대웅제약오송공장방문,http://www.newsis.com/view/?id=NISI20190225_0014933695
1007,2019-02-25,대웅제약오송공장둘러보는성윤모장관,http://www.newsis.com/view/?id=NISI20190225_0014933693
1008,2019-02-25,성윤모장관대웅제약오송공장방문,http://www.newsis.com/view/?id=NISI20190225_0014933696
1009,2019-02-25,대웅제약오송공장둘러보는성윤모장관,http://www.newsis.com/view/?id=NISI20190225_0014933694
1010,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문,http://www.g-enews.com/ko-kr/news/article/news_all/201902251123598971fa075a9870_1/article.html
1011,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문,http://www.newsway.co.kr/news/view?tp=1&ud=2019022511230027360
1012,2019-02-25,성윤모산업부장관대웅제약글로벌제약사독무대서도힘내라”독려,http://www.enewstoday.co.kr/news/articleView.html?idxno=1274718
1013,2019-02-25,대웅제약윤재춘전승호사장성윤모산업부장관면담,http://www.ebn.co.kr/news/view/973969
1014,2019-02-25,성윤모산업부장관대웅제약오송스마트공장격려방문,http://medipana.com/news/news_viewer.asp?NewsNum=235046&MainKind=A&NewsKind=5&vCount=12&vKind=1
1015,2019-02-25,주식장대웅제약주가25일현재197000원,http://www.nbntv.co.kr/news/articleView.html?idxno=229617
1016,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227548
1017,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문윤재춘전승호사장과면담,http://www.ekn.kr/news/article.html?no=416843
1018,2019-02-25,성윤모산자대웅제약전격방문나보타성공극찬,http://news.heraldcorp.com/view.php?ud=20190225000474
1019,2019-02-25,성윤모산업부장관대웅제약공장방문윤재춘전승호사장면담,http://biz.newdaily.co.kr/site/data/html/2019/02/25/2019022500077.html
1020,2019-02-25,산업부성윤모장관대웅제약오송공장방문의약품수출활력대책논의,http://www.kukinews.com/news/article.html?no=635306
1021,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문맞아,http://www.bosa.co.kr/news/articleView.html?idxno=2100068
1022,2019-02-25,성윤모장관대웅제약오송공장방문신약개발투자지속”당부,http://www.etoday.co.kr/news/section/newsview.php?idxno=1726399
1023,2019-02-25,성윤모장관대웅제약공장방문신약개발투자지속할것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019022511243826972
1024,2019-02-25,성윤모장관대웅제약오송스마트공장방문나보타수출격려,http://www.metroseoul.co.kr/news/newsview?newscd=2019022500115
1025,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문,http://www.medigatenews.com/news/3488478394
1026,2019-02-25,성윤모산자부장관등대웅제약오송공장서면담,http://www.mhj21.com/119682
1027,2019-02-25,성윤모산업부장관대웅제약오송스마트공장방문,http://www.dailysmart.co.kr/news/articleView.html?idxno=6881
1028,2019-02-25,성윤모산업부장관대웅제약오송스마트공장방문,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019022514034002405&objId=A2019022514034002405&portalCode=naver
1029,2019-02-25,전승호대웅제약사장성윤모장관에게국내제약사정부지원필요,http://www.ajunews.com/view/20190225142843315
1030,2019-02-25,성윤모장관대웅제약찾아의약품수출신약개발지원대책마련,http://daily.hankooki.com/lpage/ittech/201902/dh20190225144611145630.htm
1031,2019-02-25,산업부장관대웅제약오송스마트공장방문신약개발에계속투자,http://www.asiatime.co.kr/news/articleView.html?idxno=230334
1032,2019-02-25,산자부성윤모장관대웅제약오송스마트공장방문,http://www.monews.co.kr/news/articleView.html?idxno=201023
1033,2019-02-25,성윤모장관대웅제약찾아현장애로청취윤재춘전승호사장지속적지원요청,http://kpenews.com/View.aspx?No=28430
1034,2019-02-25,성윤모산업부장관대웅제약오송공장방문,http://news.mk.co.kr/newsRead.php?year=2019&no=114252
1035,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문윤재춘전승호사장과면담,http://www.segye.com/content/html/2019/02/25/20190225002987.html?OutUrl=naver
1036,2019-02-25,사진기사성윤모산업부장관대웅제약오송공장방문,http://www.etnews.com/20190225000367
1037,2019-02-25,수출우수기업대웅제약오송공장에성윤모산자부장관방문,http://www.medisobizanews.com/news/articleView.html?idxno=58095
1038,2019-02-25,성윤모산자부장관윤재춘전승호대웅제약사장과조우,http://www.fetv.co.kr/news/article.html?no=21331
1039,2019-02-25,산자부장관대웅제약오송공장방문,http://www.whosaeng.com/108201
1040,2019-02-25,성윤모산업부장관대웅제약오송공장방문신약개발위한정부지원지속,http://www.businesskorea.co.kr/news/articleView.html?idxno=29458
1041,2019-02-25,성윤모산업부장관대웅제약오송스마트공장방문,http://www.dt.co.kr/contents.html?article_no=2019022502109931102006&ref=naver
1042,2019-02-25,전승호대웅제약사장신약해외경쟁력확보하려면정부지원절실,http://www.ezyeconomy.com/news/articleView.html?idxno=88430
1043,2019-02-25,성윤모산업부장관대웅제약오송스마트공장방문,http://www.mdtoday.co.kr/mdtoday/index.html?no=347308
1044,2019-02-25,성윤모산업통상자원부장관대웅제약오송공장방문,http://www.newsprime.co.kr/news/article.html?no=448332
1045,2019-02-25,성윤모산업통상자원부장관대웅제약오송스마트공장견학,http://www.edaily.co.kr/news/newspath.asp?newsid=04234486622394128
1046,2019-02-25,성윤모산업부장관대웅제약오송스마트공장격려방문,https://www.insight.co.kr/news/212995
1047,2019-02-25,대웅제약직원대상컴플라이언스교육실시,http://www.lawissue.co.kr/view.php?ud=201902252009256152d7f4c63cc6_12
1048,2019-02-25,성윤모산자부장관오송대웅제약방문간담회,http://www.cctimes.kr/news/articleView.html?idxno=561487
1049,2019-02-25,대웅제약성윤모산업부장관방문윤재춘전승호사장과면담,http://www.getnews.co.kr/view.php?ud=201902252134061441d0c69529_16
1050,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문윤재춘전승호사장과면담가져,http://www.lawissue.co.kr/view.php?ud=20190225222842882d7f4c63cc6_12
1051,2019-02-26,성윤모장관대웅제약스마트공장찾아임직원격려 ,http://www.seoulfn.com/news/articleView.html?idxno=334781
1052,2019-02-26,성윤모장관대웅제약오송공장방문신약개발투자지속,http://www.rapportian.com/news/articleView.html?idxno=116206
1053,2019-02-26,대웅제약주가2월26일현재194000원,http://www.gokorea.kr/news/articleView.html?idxno=107272
1054,2019-02-26,2월26일대웅제약주식현재가178193500원,http://www.nbntv.co.kr/news/articleView.html?idxno=231985
1055,2019-02-27,바른의료연구소식약처대웅제약우루사허위과장광고엄정처분내려야,http://www.medigatenews.com/news/1015413251
1056,2019-02-27,부동산으로돈벌자대웅제약자산의89투자부동산,http://www.datanews.co.kr/news/article.html?no=102246
1057,2019-02-27,대웅제약우루사TV광고허위과장내용으로오남용부추겨,http://www.mdtoday.co.kr/mdtoday/index.html?no=347486
1058,2019-02-27,대웅제약우루사TV광고는거짓과장,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84274
1059,2019-02-27,대웅제약직원대상컴플라이언스교육실시,http://www.wsobi.com/news/articleView.html?idxno=70147
1060,2019-02-27,2월27일대웅제약증권그래프외주식시황,http://www.gokorea.kr/news/articleView.html?idxno=108429
1061,2019-02-27,증권플러스대웅제약주가27일현재194000원,http://www.nbntv.co.kr/news/articleView.html?idxno=234382
1062,2019-02-27,대웅제약우루사허위과장광고엄정한처분내려야”,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065707
1063,2019-02-28,대웅제약우루사광고허위과장논란,http://www.doctorsnews.co.kr/news/articleView.html?idxno=127918
1064,2019-02-28,대웅제약주가증권투자정보28일현재198000원,http://www.gokorea.kr/news/articleView.html?idxno=109593
1065,2019-02-28,퀵리포트대웅제약중립으로유지목표가미제시미래에셋대우,http://www.itooza.com/common/iview.php?no=2019022812443018378
1066,2019-02-28,주식실시간대웅제약주가28일현재199000원,http://www.nbntv.co.kr/news/articleView.html?idxno=236678
1067,2019-02-28,대웅제약고혈압3제복합제올로맥스식약처허가,http://www.medisobizanews.com/news/articleView.html?idxno=58187
1068,2019-02-28,대웅제약올로맥스허가고혈압약라인업구축,http://www.edaily.co.kr/news/newspath.asp?newsid=03588326622395112
1069,2019-02-28,대웅제약고혈압치료제풀라인업구축식약처올로맥스허가,http://kpenews.com/View.aspx?No=28715
1070,2019-02-28,대웅제약고혈압복합신약올로맥스허가획득200억대품목으로키울것”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1728292
1071,2019-02-28,대웅제약올로맥스허가고혈압치료제라인업구축,http://www.ebn.co.kr/news/view/974613
1072,2019-02-28,대웅제약올로맥스허가로고혈압치료제라인업구축,http://www.newsway.co.kr/news/view?tp=1&ud=2019022814551314395
1073,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227706
1074,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.fnnews.com/news/201902281500361419
1075,2019-02-28,대웅제약올로맥스식약처허가고혈압치료제완벽라인업구축,http://www.asiatime.co.kr/news/articleView.html?idxno=231152
1076,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.ekn.kr/news/article.html?no=417713
1077,2019-02-28,대웅제약올로맥스허가로고혈압치료제풀라인업구축,http://www.fetv.co.kr/news/article.html?no=21719
1078,2019-02-28,대웅제약올로맥스판매허가고혈압치료제라인업확대,http://www.newsis.com/view/?id=NISX20190228_0000573135&cID=13001&pID=13000
1079,2019-02-28,대웅제약고혈압치료제라인업추가‥올로맥스허가,http://medipana.com/news/news_viewer.asp?NewsNum=235282&MainKind=A&NewsKind=5&vCount=12&vKind=1
1080,2019-02-28,대웅제약올로맥스허가로고혈압치료제라인업강화,http://www.econovill.com/news/articleView.html?idxno=357612
1081,2019-02-28,대웅제약올로맥스허가고혈압치료제라인업구축,http://www.newsprime.co.kr/news/article.html?no=448943
1082,2019-02-28,대웅제약3제복합제올로맥스추가허가,http://www.sisafocus.co.kr/news/articleView.html?idxno=203741
1083,2019-02-28,대웅제약세계첫복합개량신약으로고혈압이상지질혈증동시관리,http://daily.hankooki.com/lpage/ittech/201902/dh20190228153014145630.htm
1084,2019-02-28,대웅제약올로맥스허가로고혈압치료제라인업강화,http://news.bizwatch.co.kr/article/consumer/2019/02/28/0021/naver
1085,2019-02-28,대웅제약세계첫고혈압복합신약개발라인업완성,http://news.heraldcorp.com/view.php?ud=20190228000692
1086,2019-02-28,대웅제약3제복합제올로맥스허가고혈압치료제라인업강화,http://www.newstomato.com/ReadNews.aspx?no=879331
1087,2019-02-28,대웅제약개량신약올로맥스허가고혈압치료제라인업확대,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902280516&t=NN
1088,2019-02-28,대웅제약올로맥스허가고혈압치료제라인업구축,http://www.bokuennews.com/news/article.html?no=172286
1089,2019-02-28,대웅제약암로디핀추가한고혈압치료제올로맥스허가완료,http://www.seoulwire.com/news/articleView.html?idxno=78705
1090,2019-02-28,대웅제약고혈압3제복합제올로맥스허가획득,http://www.rapportian.com/news/articleView.html?idxno=116279
1091,2019-02-28,대웅제약고혈압고지혈증한꺼번에치료하는올로맥스허가받아,http://news.mk.co.kr/newsRead.php?year=2019&no=123783
1092,2019-02-28,대웅제약고혈압이상지혈증복합제올로맥스허가,http://www.seoulfn.com/news/articleView.html?idxno=335163
1093,2019-02-28,대웅제약올로맥스허가로고혈압치료제라인업,http://www.g-enews.com/ko-kr/news/article/news_all/2019022816532588fa075a9870_1/article.html
1094,2019-02-28,대웅제약3제복합개량고혈압치료제올로맥스허가오는5월출시,http://news.donga.com/3/all/20190228/94340158/2
1095,2019-02-28,대웅제약고혈압치료제올로맥스판매권획득,http://www.ezyeconomy.com/news/articleView.html?idxno=88537
1096,2019-02-28,대웅제약고혈압이상지질혈증관리올로맥스허가,http://view.asiae.co.kr/news/view.htm?idxno=2019022817140159151
1097,2019-02-28,대웅제약고혈압치료신약올로맥스식약처허가받아,http://www.insightkorea.co.kr//news/articleView.html?idxno=34219
1098,2019-02-28,대웅제약고혈압치료제올로맥스허가,http://www.wolyo.co.kr/news/articleView.html?idxno=78591
1099,2019-02-28,대웅제약3제고혈압복합제출격라인업구축,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019022815212694500
1100,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.lawissue.co.kr/view.php?ud=201902281735099667d7f4c63cc6_12
1101,2019-02-28,대웅제약올로맥스허가획득라인업구축완료,http://www.monews.co.kr/news/articleView.html?idxno=201104
1102,2019-02-28,대웅제약올로맥스허가로고혈압치료제라인업강화,http://www.shinailbo.co.kr/news/articleView.html?idxno=1145798
1103,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.mdtoday.co.kr/mdtoday/index.html?no=347701
1104,2019-02-28,대웅제약올로스타허가로고혈압치료제라인업완성,http://www.ajunews.com/view/20190228180232065
1105,2019-02-28,대웅제약고혈압치료복합제올로맥스5월에내놓기로,http://www.businesspost.co.kr/BP?command=article_view&num=116415
1106,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.newscj.com/news/articleView.html?idxno=606706
1107,2019-02-28,대웅제약복합개량신약올로맥스식약처허가,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84320
1108,2019-03-02,대웅제약3제복합제올로맥스내놓는다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065773
1109,2019-03-03,대웅제약3제복합제올로맥스로고혈압시장공략,http://www.viva100.com/main/view.php?key=20190303010000364
1110,2019-03-04,대웅제약나보타미국성과지켜볼때미래에셋대우,http://www.ajunews.com/view/20190303111848643
1111,2019-03-04,단독美무역위대웅제약나보타균주조사착수,http://news.mt.co.kr/mtview.php?no=2019030309031773757
1112,2019-03-04,미국국제무역위원회ITC대웅제약및에볼루스혐의조사착수,http://www.edaily.co.kr/news/newspath.asp?newsid=01958166622420040
1113,2019-03-04,美ITC대웅제약에볼루스상대로불공정혐의조사착수,http://biz.newdaily.co.kr/site/data/html/2019/03/04/2019030400029.html
1114,2019-03-04,메디톡스美국제무역위대웅제약에볼루스의나보타균주탈취혐의조사착수”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1728932
1115,2019-03-04,특징주대웅제약美국제무역위나보타균주조사소식에↓,http://news.mt.co.kr/mtview.php?no=2019030409325838823
1116,2019-03-04,美국제무역위워회ITC대웅제약불공정행의조사착수,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030409351474398
1117,2019-03-04,메디톡스美ITC대웅제약불공정행위혐의조사착수,http://news.hankyung.com/article/2019030463366
1118,2019-03-04,대웅제약발목잡기그만vs메디톡스지재권탈취한불공정행위,http://www.dailysmart.co.kr/news/articleView.html?idxno=7151
1119,2019-03-04,대웅제약급락으로18만원선무너져메디톡스대웅제약에볼루스불공정행위ITC공식조사착수,http://www.econonews.co.kr/news/articleView.html?idxno=55887
1120,2019-03-04,대웅제약발목잡기그만vs메디톡스지재권탈취한불공정행위,http://www.dailysmart.co.kr/news/articleView.html?idxno=7151
1121,2019-03-04,미국국제무역위원회대웅제약및에볼루스혐의조사착수,http://www.mdtoday.co.kr/mdtoday/index.html?no=347802
1122,2019-03-04,대웅제약나보타균주탈취관련ITC공식조사받는다,http://www.mhj21.com/119837
1123,2019-03-04,특징주대웅제약불공정행위조사착수소식에약세,http://www.edaily.co.kr/news/newspath.asp?newsid=02299286622420040
1124,2019-03-04,메디톡스ITC대웅제약불공정행위조사착수,http://www.kpinews.co.kr/news/articleView.html?idxno=91637
1125,2019-03-04,특징주대웅제약미국국제무역위나보타균주조사소식에급락,http://www.asiatime.co.kr/news/articleView.html?idxno=231486
1126,2019-03-04,특징주대웅제약메디톡스와지적재산권분쟁소식에급락,http://moneys.mt.co.kr/news/mwView.php?no=2019030410138014967
1127,2019-03-04,대웅제약美무역위나보타균주조사소식에약세,http://www.seoulwire.com/news/articleView.html?idxno=79222
1128,2019-03-04,메디톡스미국국제무역위원회대웅제약조사착수,http://www.enewstoday.co.kr/news/articleView.html?idxno=1276871
1129,2019-03-04,대웅제약美국제무역위나보타균주조사소식에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=347810
1130,2019-03-04,미국국제무역위대웅제약나보타균주출처조사착수,http://www.viva100.com/main/view.php?key=20190304010000508
1131,2019-03-04,메디톡스美국제무역위원회대웅제약나보타균주탈취조사착수,http://www.insightkorea.co.kr//news/articleView.html?idxno=34257
1132,2019-03-04,대웅제약이지적재산권탈취”혐의美ITC조사,http://news.heraldcorp.com/view.php?ud=20190304000267
1133,2019-03-04,메디톡스ITC대웅제약나보타균주출처조사착수,http://www.rapportian.com/news/articleView.html?idxno=116319
1134,2019-03-04,美ITC대웅제약에볼루스불공정혐의조사착수,http://www.dailypharm.com/Users/News/NewsView.html?ID=250010&REFERER=NP
1135,2019-03-04,美무역위대웅제약나보타균주출처제조공정조사착수,http://www.straightnews.co.kr/news/articleView.html?idxno=44446
1136,2019-03-04,美국제무역위원회대웅제약나보타균주출처조사착수,http://www.newspim.com/news/view/20190304000278
1137,2019-03-04,메디톡스ITC대웅제약불공정행위공식조사착수,http://www.sisafocus.co.kr/news/articleView.html?idxno=203939
1138,2019-03-04,美국제무역위워회ITC대웅제약에볼루스불공정행위조사착수,http://ilyo.co.kr/?ac=article_view&entry_id=327352
1139,2019-03-04,미국국제무역위원회ITC대웅제약및에볼루스혐의조사착수,http://daily.hankooki.com/lpage/ittech/201903/dh20190304111912145630.htm
1140,2019-03-04,메디톡스미국국제무역위원회대웅제약혐의조사착수,http://medipana.com/news/news_viewer.asp?NewsNum=235362&MainKind=A&NewsKind=5&vCount=12&vKind=1
1141,2019-03-04,메디톡스국제무역위대웅제약에볼루스공식조사,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227757
1142,2019-03-04,美ITC대웅제약나보타보툴리눔톡신균주조사나서,http://news1.kr/articles/?3561824
1143,2019-03-04,미국국제무역위원회ITC대웅제약및에볼루스혐의조사착수,http://www.asiatoday.co.kr/view.php?key=20190304010001156
1144,2019-03-04,오늘주식시장대웅제약주가4일현재185000원,http://www.nbntv.co.kr/news/articleView.html?idxno=239339
1145,2019-03-04,대웅제약복합개량신약올로맥스고혈압이상지질혈증동시관리,http://www.100ssd.co.kr/news/articleView.html?idxno=59781
1146,2019-03-04,광동대웅제약제약업계서금융부동산재테크에가장열중,http://www.newsfc.co.kr/news/articleView.html?idxno=35451
1147,2019-03-04,美국제무역委대웅제약조사착수주가하락,http://www.dailymedi.com/detail.php?number=840577&thread=22r05
1148,2019-03-04,미국제무역위원회대웅제약및에볼루스조사착수,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1124772&REFERER=NP
1149,2019-03-04,美국제무역위원회대웅제약및에볼루스조사착수,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065810
1150,2019-03-04,메디톡스미무역위대웅제약불공정혐의조사,http://www.seoulfn.com/news/articleView.html?idxno=335352
1151,2019-03-04,메디톡스ITC대웅제약불공정행위에공식조사,http://moneys.mt.co.kr/news/mwView.php?no=2019030411318090370
1152,2019-03-04,ET투자뉴스대웅제약_거래비중기관1932외국인1762,http://www.etnews.com/20190304000250
1153,2019-03-04,미국국제무역위원회ITC대웅제약및에볼루스혐의조사착수대웅제약주가하락,http://medicalworldnews.co.kr/news/view.php?idx=1510929646
1154,2019-03-04,대웅제약나보타세계시장진출자신감피력ITC소송적극대응해진실밝힐것,http://www.segye.com/content/html/2019/03/04/20190304002377.html?OutUrl=naver
1155,2019-03-04,대웅제약불공정행위조사착수소식에주가급락,https://www.insight.co.kr/news/214316
1156,2019-03-04,대웅제약국제무역위원회ITC소송에적극적으로대응하여진실밝힐것,http://www.fetv.co.kr/news/article.html?no=21869
1157,2019-03-04,대웅제약무너진19만원선끊이지않는균주논란,http://www.skyedaily.com/news/news_view.html?ID=82407
1158,2019-03-04,대웅제약나보타FDA판매승인에따라올봄미국시장진출예정,http://www.seoulwire.com/news/articleView.html?idxno=79540
1159,2019-03-04,대웅제약메디톡스ITC조사에보톡스전쟁재점화대웅미국진출이상무,http://moneys.mt.co.kr/news/mwView.php?no=2019030413368024173
1160,2019-03-04,대웅제약메디톡스미ITC공식조사개시신경전,http://www.asiatoday.co.kr/view.php?key=20190304010001252
1161,2019-03-04,美국제무역위원회대웅제약및에볼루스혐의조사착수,http://www.newsway.co.kr/news/view?tp=1&ud=2019030413535734270
1162,2019-03-04,대웅제약국제무역위원회소송에적극대응할것”,http://www.newsway.co.kr/news/view?tp=1&ud=2019030413571551936
1163,2019-03-04,대웅제약나보타ITC소송에적극적으로대응하겠다,http://www.asiatime.co.kr/news/articleView.html?idxno=231571
1164,2019-03-04,대웅제약거래량강세주가는335하락,http://www.tfnews.co.kr/news/article.html?no=62404
1165,2019-03-04,대웅제약메디톡스의美ITC제소무고책임묻겠다”,http://news.heraldcorp.com/view.php?ud=20190304000568
1166,2019-03-04,대웅제약ITC소송적극대응무고책임묻겠다,http://www.monews.co.kr/news/articleView.html?idxno=201131
1167,2019-03-04,대웅제약나보타이상無진실밝혀질것,http://www.viva100.com/main/view.php?key=20190304010000711
1168,2019-03-04,대웅제약메디톡스ITC소송적극대응할것,http://www.newsprime.co.kr/news/article.html?no=449205
1169,2019-03-04,대웅제약나보타올봄예정대로미국시장진출한다,http://www.businesskorea.co.kr/news/articleView.html?idxno=29633
1170,2019-03-04,대웅제약국제무역위원회소송에적극대응할것”,http://www.mdtoday.co.kr/mdtoday/index.html?no=347840
1171,2019-03-04,대웅제약나보타미국수출문제없다,http://www.koreaittimes.com/news/articleView.html?idxno=89534
1172,2019-03-04,대웅제약ITC제소접수에나보타美수출영향없어,http://www.medisobizanews.com/news/articleView.html?idxno=58218
1173,2019-03-04,대웅제약나보타글로벌진출자신ICT소송에문제없다”,http://kpenews.com/View.aspx?No=28901
1174,2019-03-04,대웅제약ITC소송적극대응해진실밝힐것”,http://daily.hankooki.com/lpage/ittech/201903/dh20190304141650145630.htm
1175,2019-03-04,대웅제약메디톡스허위주장나보타美수출영향없어,http://www.newsis.com/view/?id=NISX20190304_0000575808&cID=13001&pID=13000
1176,2019-03-04,대웅제약ITC소송에적극대응나보타진실밝힐것,http://www.g-enews.com/ko-kr/news/article/news_all/201903041423421007fa075a9870_1/article.html
1177,2019-03-04,대웅제약나보타미국진출앞두고날벼락무역위불공정행위조사,http://www.ezyeconomy.com/news/articleView.html?idxno=88566
1178,2019-03-04,대웅제약나보타올봄예정대로미국시장진출,http://www.economytalk.kr/news/articleView.html?idxno=180482
1179,2019-03-04,美국제무역위원회대웅제약나보타불공정혐의조사착수,http://biz.chosun.com/site/data/html_dir/2019/03/04/2019030401703.html
1180,2019-03-04,대웅제약나보타균주관련美ITC조사따른미국진출영향없어,http://news.mk.co.kr/newsRead.php?year=2019&no=129491
1181,2019-03-04,대웅제약나보타올봄예정대로출시자신감피력,http://medipana.com/news/news_viewer.asp?NewsNum=235378&MainKind=A&NewsKind=5&vCount=12&vKind=1
1182,2019-03-04,대웅제약미국국제무역위소송적극대응해진실밝힐것,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227762
1183,2019-03-04,대웅제약나보타ITC소송강경대응예고,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019030414545302735&objId=A2019030414545302735&portalCode=naver
1184,2019-03-04,대웅제약ITC소송나보타수출에영향없어,http://news.mt.co.kr/mtview.php?no=2019030414433254515
1185,2019-03-04,대웅제약美ITC영업비밀침해소송에적극대응,http://www.dailypharm.com/Users/News/NewsView.html?ID=250018&REFERER=NP
1186,2019-03-04,대웅제약나보타국제무역위원회제소적극대응,http://www.kpanews.co.kr/article/show.asp?idx=201871&table=article&category=D
1187,2019-03-04,대웅제약ITC소송적극대응나보타예정대로美진출,http://news.hankyung.com/article/2019030482066
1188,2019-03-04,국산보툴리눔톡신美출시앞메디톡스대웅제약또신경전,http://view.asiae.co.kr/news/view.htm?idxno=2019030415121297869
1189,2019-03-04,대웅제약메디톡스美소송에적극대응할것,http://www.edaily.co.kr/news/newspath.asp?newsid=03732646622420040
1190,2019-03-04,대웅제약ITC소송적극대응”천명,http://www.whosaeng.com/108355
1191,2019-03-04,대웅제약나보타세계시장진출자신감피력,http://www.ekn.kr/news/article.html?no=418273
1192,2019-03-04,대웅제약올로맥스허가로고혈압치료제라인업구축,http://www.wsobi.com/news/articleView.html?idxno=70341
1193,2019-03-04,ITC조사착수메디톡스기술탈취규명vs대웅제약무고책임묻겠다,http://www.newstomato.com/ReadNews.aspx?no=879788
1194,2019-03-04,대웅제약무고책임엄중히물을것”,http://www.enewstoday.co.kr/news/articleView.html?idxno=1277068
1195,2019-03-04,대웅제약ITC소송에적극대응나보타진출자신감피력,http://www.ajunews.com/view/20190304161428806
1196,2019-03-04,성윤모산업부장관대웅제약오송스마트공장방문윤재춘전승호사장과면담가져,http://www.wsobi.com/news/articleView.html?idxno=70357
1197,2019-03-04,대웅제약ITC소송적극대응진실밝힐것,http://www.sisafocus.co.kr/news/articleView.html?idxno=203967
1198,2019-03-04,메디톡스미국국제무역위원회ITC에대웅제약및에볼루스혐의조사착수,http://www.lawissue.co.kr/view.php?ud=201903041626502822d7f4c63cc6_12
1199,2019-03-04,메디톡스美무역위에나보타제소대웅제약재갈물리기,http://www.shinailbo.co.kr/news/articleView.html?idxno=1146489
1200,2019-03-04,대웅제약나보타글로벌진출자신있다”,http://www.econovill.com/news/articleView.html?idxno=357792
1201,2019-03-04,대웅제약메디톡스의美ITC제소무고책임묻겠다,https://www.insight.co.kr/news/214419
1202,2019-03-04,대웅제약나보타美수출앞두고소송근거없는주장책임묻겠다,http://www.ntoday.co.kr/news/articleView.html?idxno=65738
1203,2019-03-04,메디톡스vs대웅제약보톡스전쟁미국국제무역위조사파장,http://www.insightkorea.co.kr//news/articleView.html?idxno=34275
1204,2019-03-04,대웅제약나보타미국출시앞두고메디톡스공세에다시직면,http://www.businesspost.co.kr/BP?command=article_view&num=116787
1205,2019-03-04,대웅제약메디톡스美ITC제소무고책임묻겠다,http://www.dailymedi.com/detail.php?number=840600&thread=22r05
1206,2019-03-05,대웅제약경쟁업체방해행위정면대응나보타세계화자신감피력,http://www.wikileaks-kr.org/news/articleView.html?idxno=49257
1207,2019-03-05,메디톡스VS대웅제약보톡스전쟁미국서맞붙는다,http://www.hankookilbo.com/news/npath/201903041617736495?did=NA
1208,2019-03-05,대웅제약메디톡스미국서보톡스균주공방팽팽,http://www.rapportian.com/news/articleView.html?idxno=116332
1209,2019-03-05,대웅제약목표가4↑24만원제시케이프證,http://www.newspim.com/news/view/20190305000299
1210,2019-03-05,퀵리포트대웅제약매수유지목표가4↑24만원케이프證,http://www.itooza.com/common/iview.php?no=2019030510475419866
1211,2019-03-05,메디톡스대웅제약나보타의혹관련민형사상책임질것,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227816
1212,2019-03-05,3월5일대웅제약주가그래프185500원159,http://www.nbntv.co.kr/news/articleView.html?idxno=241606
1213,2019-03-05,대웅제약주가3월5일현재185500원,http://www.gokorea.kr/news/articleView.html?idxno=112052
1214,2019-03-05,메디톡스대웅제약나보타의혹관련모든민형사상책임질것,http://biz.newdaily.co.kr/site/data/html/2019/03/05/2019030500087.html
1215,2019-03-05,메디톡스대웅제약나보타의혹관련문제있다면민형사상책임질것,http://www.mdtoday.co.kr/mdtoday/index.html?no=347979
1216,2019-03-05,메디톡스대웅제약보톡스나보타균주공방2라운드,http://www.newsis.com/view/?id=NISX20190305_0000577259&cID=13001&pID=13000
1217,2019-03-05,이상로의새빨간투자더블체크로추천주옥석가리기대웅제약경동나비엔인선이엔티外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030513573149829
1218,2019-03-05,메디톡스대웅제약나보타의혹모든민형사상책임진다”,http://www.edaily.co.kr/news/newspath.asp?newsid=03414486622420368
1219,2019-03-05,연일대웅제약때리는메디톡스,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065868
1220,2019-03-05,보톡스전쟁메디톡스VS대웅제약날선공방美출시앞둔나보타앞날은,http://www.etoday.co.kr/news/section/newsview.php?idxno=1729876
1221,2019-03-05,메디톡스대웅제약끊이지않는포성공개토론하자”,http://news.heraldcorp.com/view.php?ud=20190305000680
1222,2019-03-05,메디톡스대웅제약보톡스문제없으면즉각법적조치취해라,http://moneys.mt.co.kr/news/mwView.php?no=2019030517298048833
1223,2019-03-05,대웅제약작년4Q영업익46억전년비262↓,http://www.newspim.com/news/view/20190305000823
1224,2019-03-05,대웅제약작년연간연결영업익245억전년비369↓,http://www.newspim.com/news/view/20190305000824
1225,2019-03-05,잠정실적대웅제약작년연간연결영업익245억전년비369↓,http://www.itooza.com/common/iview.php?no=2019030518003419597
1226,2019-03-05,잠정실적대웅제약작년연간연결영업익245억전년비369↓,http://www.itooza.com/common/iview.php?no=2019030518003419597
1227,2019-03-05,대웅제약작년영업익307억전년대비311↓,http://view.asiae.co.kr/news/view.htm?idxno=2019030518035212216
1228,2019-03-05,대웅제약지난해영업이익245억전년比369↓,http://news.mt.co.kr/mtview.php?no=2019030518031922643
1229,2019-03-05,대웅제약작년영업익308억전년비31↓,http://www.dailypharm.com/Users/News/NewsView.html?ID=250075&REFERER=NP
1230,2019-03-05,대웅제약작년영업익246억원37감소,http://yna.kr/AKR20190305172800008?did=1195m
1231,2019-03-05,한경로보뉴스실적속보대웅제약작년4Q영업이익대폭하락전분기대비532↓연결잠정,http://news.hankyung.com/article/201903053620L
1232,2019-03-05,ITC조사로코너몰린대웅제약또다시무고죄언급,http://www.mhj21.com/119888
1233,2019-03-05,대웅제약지난해영업익246억전년보다369감소,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730025
1234,2019-03-05,실적발표광전자SK폴리텍대웅제약,http://www.businesspost.co.kr/BP?command=article_view&num=116993
1235,2019-03-05,대웅제약빛바랜매출1조적자전환,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019030518493003757&objId=A2019030518493003757&portalCode=naver
1236,2019-03-05,대웅제약1조원매출시대활짝‥74↑1조314억달성,http://medipana.com/news/news_viewer.asp?NewsNum=235471&MainKind=A&NewsKind=5&vCount=12&vKind=1
1237,2019-03-05,대웅제약지난해첫매출1조돌파영업익은37감소,http://news1.kr/articles/?3563513
1238,2019-03-05,대웅제약지난해매출1조원돌파이익률감소,http://www.medisobizanews.com/news/articleView.html?idxno=58249
1239,2019-03-05,메디톡스대웅제약나보타의혹관련모든민형사상책임질것,http://www.lawissue.co.kr/view.php?ud=201903052257098676d7f4c63cc6_12
1240,2019-03-05,대웅제약우루사TV광고바른의료연구소vs식품의약품안전처,http://medicalworldnews.co.kr/news/view.php?idx=1510929688
1241,2019-03-05,나보타미국국제무역위원회제소대웅제약vs메디톡스,http://medicalworldnews.co.kr/news/view.php?idx=1510929690
1242,2019-03-06,대웅제약우루사TV광고가의약품오남용부추겨,http://www.kukinews.com/news/article.html?no=636618
1243,2019-03-06,대웅제약첫매출1조돌파전문약일반약하모니,http://www.dailypharm.com/Users/News/NewsView.html?ID=250078&REFERER=NP
1244,2019-03-06,전일5일주요공시대웅제약外,http://www.newsway.co.kr/news/view?tp=1&ud=2019030607521012104
1245,2019-03-06,대웅제약목표가30만원유지전일종가18만7500원KTB證,http://www.newspim.com/news/view/20190306000183
1246,2019-03-06,ET투자뉴스대웅제약18년4분기실적발표,http://www.etnews.com/20190306000006
1247,2019-03-06,대웅제약목표가22만원유지전일종가18만7500원유안타證,http://www.newspim.com/news/view/20190306000090
1248,2019-03-06,퀵리포트대웅제약매수유지목표가22만원유지유안타證,http://www.itooza.com/common/iview.php?no=2019030608153910426
1249,2019-03-06,대웅제약vs메디톡스국내외서계속되는소송戰이유는,http://daily.hankooki.com/lpage/ittech/201903/dh20190306081531145630.htm
1250,2019-03-06,I리포트대웅제약나보타미국수출이상無KTB證,http://www.inews24.com/view/1161917
1251,2019-03-06,대웅제약나보타미국수출2분기에본격화KTB투자증권,http://www.ajunews.com/view/20190306082053182
1252,2019-03-06,대웅제약목표가24만원유지전일종가18만7500원신한금투,http://www.newspim.com/news/view/20190306000099
1253,2019-03-06,컨센미달대웅제약작년4Q영업익46억컨센비321↓,http://www.itooza.com/common/iview.php?no=2019030517595110175
1254,2019-03-06,퀵리포트대웅제약매수유지목표가24만원유지신한금투,http://www.itooza.com/common/iview.php?no=2019030608254815039
1255,2019-03-06,대웅제약2분기부터나보타실적가시화KTB투자증권,http://www.newstomato.com/ReadNews.aspx?no=880182
1256,2019-03-06,STOCK대웅제약나보타美수출실적기대감,http://moneys.mt.co.kr/news/mwView.php?no=2019030608348026829
1257,2019-03-06,대웅제약나보타효과로실적개선기대매수신한금융투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730081
1258,2019-03-06,대웅제약메디톡스보톡스균주진실게임전선미국으로확대,http://news.mk.co.kr/newsRead.php?year=2019&no=133823
1259,2019-03-06,HotLine대웅제약작년4분기실적부진보다나보타기대감에주목,http://news.mk.co.kr/newsRead.php?year=2019&no=133829
1260,2019-03-06,대웅제약올해확실한실적개선기대신한,http://www.ebn.co.kr/news/view/975216
1261,2019-03-06,신한금투대웅제약올해영업익48증가예상매수의견,http://www.newsis.com/view/?id=NISX20190306_0000578068&cID=10401&pID=10400
1262,2019-03-06,KTB證대웅제약나보타수출실적확인시상승본격화전망,http://www.newsis.com/view/?id=NISX20190306_0000578052&cID=10401&pID=10400
1263,2019-03-06,대웅제약2분기나보타미국수출본격화주가상승기대KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01685926622420696
1264,2019-03-06,대웅제약주가오를힘갖춰보톡스나보타미국수출본격화,http://www.businesspost.co.kr/BP?command=article_view&num=117031
1265,2019-03-06,DB금융투자대웅제약영업이익기대치하회수출실적관건”,http://www.g-enews.com/ko-kr/news/article/news_all/201903060849111212c642673384_1/article.html
1266,2019-03-06,하이로우대웅제약나보타로실적개선가시화KTB투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030608512667059
1267,2019-03-06,대웅제약올해매출1조원돌파기대신한금투,https://www.sedaily.com/NewsView/1VGHEY2OVN
1268,2019-03-06,대웅제약매출액1조달성기대,http://www.newsprime.co.kr/news/article.html?no=449526
1269,2019-03-06,대웅제약나보타美수출로올해실적긍정적KTB투자證,http://www.seoulfn.com/news/articleView.html?idxno=335598
1270,2019-03-06,대웅제약목표가23만원유지전일종가18만7500원하이투자證,http://www.newspim.com/news/view/20190306000160
1271,2019-03-06,대웅제약목표가5↑20만원제시DB금투,http://www.newspim.com/news/view/20190306000159
1272,2019-03-06,퀵리포트대웅제약보유유지목표가5↑20만원DB금투,http://www.itooza.com/common/iview.php?no=2019030609043715604
1273,2019-03-06,퀵리포트대웅제약매수유지목표가23만원유지하이투자證,http://www.itooza.com/common/iview.php?no=2019030609050717937
1274,2019-03-06,퀵리포트대웅제약매수유지목표가30만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019030607555517656
1275,2019-03-06,ET투자뉴스대웅제약4Q18RevieBUY유지유안타증권,http://www.etnews.com/20190306000038
1276,2019-03-06,특징주대웅제약실적개선전망에상승세,http://www.newsis.com/view/?id=NISX20190306_0000578126&cID=10401&pID=10400
1277,2019-03-06,특징주대웅제약니보타美수출기대감오름세,http://www.seoulfn.com/news/articleView.html?idxno=335611
1278,2019-03-06,ET투자뉴스대웅제약나보타미국수출BUYKTB투자증권,http://www.etnews.com/20190306000044
1279,2019-03-06,ET투자뉴스대웅제약올해는확실한실적BUY유지신한금융투자,http://www.etnews.com/20190306000071
1280,2019-03-06,대웅제약1조클럽가입2018년최대매출경신,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1124840&REFERER=NP
1281,2019-03-06,대웅제약신약개발박차연간매출1조돌파,http://www.g-enews.com/ko-kr/news/article/news_all/201903061014039968fa075a9870_1/article.html
1282,2019-03-06,대웅제약연결최대매출경신하며1조클럽가입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227844
1283,2019-03-06,대웅제약작년매출1조원돌파역대최고매출신기록,http://www.fetv.co.kr/news/article.html?no=22117
1284,2019-03-06,대웅제약지난해연간매출1조돌파최대매출경신,http://www.ekn.kr/news/article.html?no=418673
1285,2019-03-06,대웅제약연매출1조첫돌파영업익은전년比37↓,http://www.edaily.co.kr/news/newspath.asp?newsid=02466566622420696
1286,2019-03-06,대웅제약작년영업익246억원전년比37감소,http://www.seoulfn.com/news/articleView.html?idxno=335628
1287,2019-03-06,대웅제약2018년연결매출1조돌파최고기록경신,http://www.kpinews.co.kr/news/articleView.html?idxno=91841
1288,2019-03-06,1조클럽이지만대웅제약작년영업이익246억원전년比369↓,http://news.mk.co.kr/newsRead.php?year=2019&no=134286
1289,2019-03-06,대웅제약연간매출액1조314억원1조클럽가입,http://www.mhj21.com/119896
1290,2019-03-06,대웅제약사상최대매출로1조클럽입성수익성회복할것”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730164
1291,2019-03-06,대웅제약작년연간매출1조돌파최대매출경신,http://www.seoulwire.com/news/articleView.html?idxno=81521
1292,2019-03-06,대웅제약역대최고매출경신1조클럽가입,http://www.enewstoday.co.kr/news/articleView.html?idxno=1277818
1293,2019-03-06,대웅제약1조클럽가입작년최대매출경신,http://yna.kr/AKR20190306060400017?did=1195m
1294,2019-03-06,대웅제약1조클럽가입쾌거2018년1조314억매출,http://www.viva100.com/main/view.php?key=20190306010001570
1295,2019-03-06,​​대웅제약지난해1조원돌파자체최대매출경신,http://medipana.com/news/news_viewer.asp?NewsNum=235497&MainKind=A&NewsKind=5&vCount=12&vKind=1
1296,2019-03-06,대웅제약나보타신약기대감높아작년매출1조돌파,http://kpenews.com/View.aspx?No=29037
1297,2019-03-06,대웅제약지난해연간매출1조돌파최대매출경신,http://www.wolyo.co.kr/news/articleView.html?idxno=78858
1298,2019-03-06,대웅제약1조클럽가입,https://www.sedaily.com/NewsView/1VGHFMB5K3
1299,2019-03-06,대웅제약1조클럽가입지난해매출1조314억원,http://view.asiae.co.kr/news/view.htm?idxno=2019030611012903651
1300,2019-03-06,대웅제약매출1조클럽입성영업이익은37감소,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903060299&t=NN
1301,2019-03-06,대웅제약매출1조클럽가입제약사중6번째,http://www.newsway.co.kr/news/view?tp=1&ud=2019030611013517783
1302,2019-03-06,대웅제약영업익전년比37↓RD투자비증가탓,http://www.newsis.com/view/?id=NISX20190306_0000578370&cID=13001&pID=13000
1303,2019-03-06,대웅제약지난해영업익246억원전년비37↓,http://www.ebn.co.kr/news/view/975271
1304,2019-03-06,대웅제약지난해사상최대매출올해실적개선전망에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=348071
1305,2019-03-06,대웅제약4번째1조클럽최대매출갱신,http://www.doctorsnews.co.kr/news/articleView.html?idxno=127983
1306,2019-03-06,대웅제약1조클럽입성영업익은37감소,http://www.newspim.com/news/view/20190306000343
1307,2019-03-06,1조클럽입성대웅제약지난해영업익246억전년比369↓,http://biz.newdaily.co.kr/site/data/html/2019/03/06/2019030600057.html
1308,2019-03-06,대웅제약지난해사상최대매출1조클럽가입,http://www.insightkorea.co.kr//news/articleView.html?idxno=34333
1309,2019-03-06,대웅제약매출1조돌파올해FDA승인나보타기대,http://www.dt.co.kr/contents.html?article_no=2019030602109931102001&ref=naver
1310,2019-03-06,대웅제약지난해매출1조원돌파창사이래최대,http://www.ceoscoredaily.com/news/article.html?no=52755
1311,2019-03-06,대웅제약2018년연간매출1조돌파,http://www.fnnews.com/news/201903061115319305
1312,2019-03-06,대웅제약작년매출1조원돌파로최대치경신,http://news.heraldcorp.com/view.php?ud=20190306000359
1313,2019-03-06,ITC대웅제약조사착수가가진의미는,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030610553148793
1314,2019-03-06,대웅제약빛바랜매출1조창사이래최대실적인데당기순손실,http://biz.chosun.com/site/data/html_dir/2019/03/06/2019030601127.html
1315,2019-03-06,대웅제약연매출1조클럽가입,http://www.seoulfn.com/news/articleView.html?idxno=335635
1316,2019-03-06,대웅제약지난해매출1조달성처방약일반약동반성장,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030610353894317
1317,2019-03-06,대웅제약지난해영업이익246억매출액은사상최대,http://www.econonews.co.kr/news/articleView.html?idxno=56257
1318,2019-03-06,대웅제약2018년연간매출1조돌파최대매출경신,http://daily.hankooki.com/lpage/ittech/201903/dh20190306112712145630.htm
1319,2019-03-06,대웅제약나보타미국시장출하주시골드만삭스,http://www.choicenews.co.kr/news/articleView.html?idxno=48686
1320,2019-03-06,대웅제약매출1조클럽가입올해나보타로성장,http://www.biospectator.com/view/news_view.php?varAtcId=7238
1321,2019-03-06,결국ITC까지간나보타대웅제약메디톡스지재권분쟁재점화,http://news.heraldcorp.com/view.php?ud=20190306000363
1322,2019-03-06,대웅제약1조클럽가입지난해최대실적경신,http://www.segye.com/content/html/2019/03/06/20190306001631.html?OutUrl=naver
1323,2019-03-06,대웅제약지난해연매출사상최대1조314억원ETC와OTC지속성장,http://www.asiatime.co.kr/news/articleView.html?idxno=232072
1324,2019-03-06,대웅제약지난해연매출1조돌파1조클럽가입,http://www.sisafocus.co.kr/news/articleView.html?idxno=204138
1325,2019-03-06,주식종목검색대웅제약주가6일현재191500원,http://www.nbntv.co.kr/news/articleView.html?idxno=243799
1326,2019-03-06,실적대웅제약1조클럽입성영업익전년比37하락,http://www.ezyeconomy.com/news/articleView.html?idxno=88644
1327,2019-03-06,3월6일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=113257
1328,2019-03-06,대웅제약지난해연간매출1조돌파,http://www.100ssd.co.kr/news/articleView.html?idxno=59817
1329,2019-03-06,대웅제약매출1조클럽첫입성,http://www.dailymedi.com/detail.php?number=840670&thread=22r05
1330,2019-03-06,대웅제약2018년1조돌파로최대매출경신,http://www.bosa.co.kr/news/articleView.html?idxno=2100667
1331,2019-03-06,대웅제약지난해1조원매출돌파최대매출경신,http://www.metroseoul.co.kr/news/newsview?newscd=2019030600056
1332,2019-03-06,대웅제약1조클럽가입ETCOTC성장견인,http://www.newsprime.co.kr/news/article.html?no=449608
1333,2019-03-06,대웅제약1조클럽가입2018년매출1조314억원,http://www.monews.co.kr/news/articleView.html?idxno=201187
1334,2019-03-06,대웅제약2018년연간매출1조돌파로최대매출경신,http://www.medigatenews.com/news/807116148
1335,2019-03-06,미FDAITC엇박자속대웅제약메디톡스보톡스공방재점화,http://www.asiatoday.co.kr/view.php?key=20190306010003012
1336,2019-03-06,증시분석대웅제약창사이래첫1조클럽유한양행GC녹십자한미약품이어4번째,http://www.news2day.co.kr/121823
1337,2019-03-06,대웅제약매출1조시대열었지만영업익순익은뚝,http://www.ajunews.com/view/20190306134503640
1338,2019-03-06,대웅제약매출최고기록경신하며1조클럽가입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065914
1339,2019-03-06,대웅제약지난해매출1억돌파영업이익전년比369↓,http://moneys.mt.co.kr/news/mwView.php?no=2019030614348021177
1340,2019-03-06,대웅제약작년매출액1조314억원기록역대최고액경신,http://www.inthenews.co.kr/news/article.html?no=13931
1341,2019-03-06,메디톡스vs대웅제약끝나지않은공방같은사안두고시각차여전,http://biz.newdaily.co.kr/site/data/html/2019/03/06/2019030600125.html
1342,2019-03-06,대웅제약지난해매출1조314억원1조클럽가입,http://www.mdtoday.co.kr/mdtoday/index.html?no=348094
1343,2019-03-06,대웅제약매출1조클럽가입영업익은36하락,http://www.etnews.com/20190306000276
1344,2019-03-06,대웅제약지난해매출1조클럽가입전년비89늘어,http://www.kpanews.co.kr/article/show.asp?idx=201953&table=article&category=D
1345,2019-03-06,대웅제약나보타美수출이상무2분기실적으로확인전망,http://www.newsworks.co.kr/news/articleView.html?idxno=341401
1346,2019-03-06,대웅제약작년매출1조314억기록1조클럽가입,http://www.rapportian.com/news/articleView.html?idxno=116371
1347,2019-03-06,대웅제약2018년매출1조돌파영업익하락요인미래투자,http://www.econovill.com/news/articleView.html?idxno=357946
1348,2019-03-06,대웅제약연매출1조원돌파기록경신,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84392
1349,2019-03-06,대웅제약올해영업이익455억원으로기저효과예상,http://www.newsworks.co.kr/news/articleView.html?idxno=341429
1350,2019-03-06,대웅제약2018년연간매출1조돌파,http://www.economytalk.kr/news/articleView.html?idxno=180665
1351,2019-03-06,공시대웅제약보통주1주당600원현금배당,http://www.newsway.co.kr/news/view?tp=1&ud=2019030616593557727
1352,2019-03-06,대웅제약세무조사150억폭탄첫순손실,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019030617002203221&objId=A2019030617002203221&portalCode=naver
1353,2019-03-06,대웅제약보통주1주당600원현금배당결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730515
1354,2019-03-06,대웅제약매출1조클럽가입,http://news.mk.co.kr/newsRead.php?year=2019&no=135911
1355,2019-03-06,대웅제약주당600원현금배당결정,http://news.heraldcorp.com/view.php?ud=20190306000737
1356,2019-03-06,대웅제약2018년연간매출1조돌파최대매출경신,http://www.ftoday.co.kr/news/articleView.html?idxno=107064
1357,2019-03-06,대웅제약2018년매출1조돌파로최대매출경신,http://www.getnews.co.kr/view.php?ud=20190306173426877341d0c69529_16
1358,2019-03-06,굿닥터대웅제약LSKGlobalPS선택과집중으로글로벌무대서주목,http://www.nextdaily.co.kr/news/article.html?id=20190306800070
1359,2019-03-06,대웅제약2018년연간매출1조314억원을기록최대매출경신,http://www.lawissue.co.kr/view.php?ud=201903061734579373d7f4c63cc6_12
1360,2019-03-06,유가증권시장공시우리금융지주삼부토건대웅제약,http://news.mk.co.kr/newsRead.php?year=2019&no=136021
1361,2019-03-06,대웅제약마곡CD센터설립에705억원투자결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730549
1362,2019-03-06,대웅제약마곡CD센터설립에705억원투자결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730549
1363,2019-03-06,대웅제약705억규모신규시설투자,http://news.mt.co.kr/mtview.php?no=2019030617570546630
1364,2019-03-06,공시대웅제약705억원규모신규시설투자,http://www.newsway.co.kr/news/view?tp=1&ud=2019030617592078956
1365,2019-03-06,대웅제약연구개발위해마곡에CD센터건립705억원투자,http://www.ceoscoredaily.com/news/article.html?no=52802
1366,2019-03-06,대웅제약705억투자해마곡CD센터건립,http://view.asiae.co.kr/news/view.htm?idxno=2019030618114938549
1367,2019-03-06,RD의힘대웅제약매출1조클럽가입,http://www.dt.co.kr/contents.html?article_no=2019030702101531102001&ref=naver
1368,2019-03-06,대웅제약1조클럽첫가입작년매출1조314억원 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1147321
1369,2019-03-06,대웅제약마곡CD센터에705억규모투자,http://www.dailian.co.kr/news/view/777265/?sc=naver
1370,2019-03-06,대웅제약705억원규모CD센터신규시설투자,http://www.newspim.com/news/view/20190306000938
1371,2019-03-06,대웅제약마곡신규센터구축에705억원투자,http://www.etnews.com/20190306000411
1372,2019-03-06,대웅제약705억투자통해마곡CD센터건립,https://www.sedaily.com/NewsView/1VGHH9EMJL
1373,2019-03-06,대웅제약주당600원현금배당,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903060585&t=NN
1374,2019-03-06,대웅제약마곡CD센터건립에705억원투자,http://www.dailypharm.com/Users/News/NewsView.html?ID=250125&REFERER=NP
1375,2019-03-06,대웅제약2018년연간매출1조돌파로최대매출경신,http://www.newscj.com/news/articleView.html?idxno=608704
1376,2019-03-06,실적발표롯데칠성음료대상한국토지신탁대웅제약,http://www.businesspost.co.kr/BP?command=article_view&num=117203
1377,2019-03-06,대웅제약마곡CD센터설립에705억원투자,http://medipana.com/news/news_viewer.asp?NewsNum=235536&MainKind=A&NewsKind=5&vCount=12&vKind=1
1378,2019-03-06,대웅제약나보타의세계시장진출자신감피력,http://www.wsobi.com/news/articleView.html?idxno=70473
1379,2019-03-06,대웅제약나보타효과기대감고조,http://www.wsobi.com/news/articleView.html?idxno=70476
1380,2019-03-07,대웅제약2018년연간매출1조원돌파최대매출경신,http://www.nextdaily.co.kr/news/article.html?id=20190306800069
1381,2019-03-07,대웅제약2018년1조클럽가입자사최대매출경신,http://www.wikileaks-kr.org/news/articleView.html?idxno=49484
1382,2019-03-07,대웅제약마곡CD센터구축에705억원투자결정,http://www.itooza.com/common/iview.php?no=2019030708410964065
1383,2019-03-07,대웅제약지난해매출1조돌파최대기록,http://www.bokuennews.com/news/article.html?no=172534
1384,2019-03-07,빅데이터MSI시장심리톱5LG전자삼성화재LS대웅제약삼성물산,http://www.newsis.com/view/?id=NISX20190307_0000579548&cID=10401&pID=10400
1385,2019-03-07,대웅제약마곡CD센터건립705억신규시설투자,http://www.mdtoday.co.kr/mdtoday/index.html?no=348164
1386,2019-03-07,ET투자뉴스대웅제약흔들리지말고나보BUY유지하이투자증권,http://www.etnews.com/20190307000043
1387,2019-03-07,대웅제약주가오를힘충분보톡스제품미국수출로매출밝아,http://www.businesspost.co.kr/BP?command=article_view&num=117241
1388,2019-03-07,대웅제약매출1조클럽가입최대매출경신,http://www.upinews.kr/news/newsview.php?ncode=1065573761463608
1389,2019-03-07,대웅제약보통주1주당600원현금결산배당결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=348188
1390,2019-03-07,3월7일대웅제약금일증시132187500원,http://www.nbntv.co.kr/news/articleView.html?idxno=246819
1391,2019-03-07,대웅제약종목검색7일현재188000원,http://www.nbntv.co.kr/news/articleView.html?idxno=246890
1392,2019-03-07,3월7일대웅제약오늘시세외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=114327
1393,2019-03-07,대웅제약지난해매출89증가,http://www.wsobi.com/news/articleView.html?idxno=70512
1394,2019-03-07,대웅제약1000억투자마곡CD센터설립,http://www.dailymedi.com/detail.php?number=840724&thread=22r05
1395,2019-03-08,대웅제약705억들여마곡CD센터건립추진,http://www.news2day.co.kr/121985
1396,2019-03-08,대웅제약지난해연매출1조돌파최대매출경신,https://www.insight.co.kr/news/214786
1397,2019-03-08,MSI급락주대웅제약어닝쇼크에시장심리↓,http://www.newsis.com/view/?id=NISX20190308_0000581253&cID=10401&pID=10400
1398,2019-03-08,대웅제약개발폐섬유증치료제신약개발지원대상선정,http://www.dailysmart.co.kr/news/articleView.html?idxno=7458
1399,2019-03-08,대웅제약폐섬유증혁신신약정부과제선정글로벌임상지원,http://www.medisobizanews.com/news/articleView.html?idxno=58301
1400,2019-03-08,대웅제약세계최초특발성폐섬유증치료제개발지원받는다,http://www.seoulwire.com/news/articleView.html?idxno=83718
1401,2019-03-08,대웅제약폐섬유증저해제신약정부지원과제선정,http://www.ezyeconomy.com/news/articleView.html?idxno=88716
1402,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.fetv.co.kr/news/article.html?no=22360
1403,2019-03-08,대웅제약폐섬유증치료제정부지원과제선정,http://www.wolyo.co.kr/news/articleView.html?idxno=79057
1404,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.koreaittimes.com/news/articleView.html?idxno=89587
1405,2019-03-08,대웅제약폐섬유증치료제연구정부지원과제선정,http://www.rapportian.com/news/articleView.html?idxno=116417
1406,2019-03-08,대웅제약폐섬유증약후보물질범부처신약개발사업단지원대상선정,http://news.mk.co.kr/newsRead.php?year=2019&no=140532
1407,2019-03-08,대웅제약폐섬유증신약정부지원과제로선정,http://yna.kr/AKR20190308085600017?did=1195m
1408,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.newsway.co.kr/news/view?tp=1&ud=2019030813301221093
1409,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://daily.hankooki.com/lpage/ittech/201903/dh20190308133041145630.htm
1410,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.medigatenews.com/news/1018343666
1411,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030813121441404
1412,2019-03-08,대웅제약폐섬유증신약정부지원임상연구비수혜,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1124916&REFERER=NP
1413,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227953
1414,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.ekn.kr/news/article.html?no=419216
1415,2019-03-08,대웅제약폐섬유증신약개발비지원받는다정부과제선정,http://news1.kr/articles/?3566294
1416,2019-03-08,대웅제약PRS저해제DWN12088정부지원과제선정,http://medipana.com/news/news_viewer.asp?NewsNum=235645&MainKind=A&NewsKind=5&vCount=12&vKind=1
1417,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.seoulfn.com/news/articleView.html?idxno=336015
1418,2019-03-08,대웅제약오늘증권시세8일현재185500원,http://www.nbntv.co.kr/news/articleView.html?idxno=249426
1419,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.fnnews.com/news/201903081444315390
1420,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.dailian.co.kr/news/view/777845/?sc=naver
1421,2019-03-08,대웅제약폐섬유증신약DWN12088정부과제선정,http://kormedi.com/?p=1283823
1422,2019-03-08,대웅제약폐섬유증치료제범부처신약개발사업단연구비지원사업선정,https://www.sedaily.com/NewsView/1VGIDQO3OJ
1423,2019-03-08,대웅제약폐섬유증신약정부지원과제선정임상1상비임상연구비지원,http://news.donga.com/3/all/20190308/94450548/2
1424,2019-03-08,대웅제약주가종목그래프8일현재184500원,http://www.gokorea.kr/news/articleView.html?idxno=115795
1425,2019-03-08,대웅제약폐섬유증치료제정부의신약개발지원대상에뽑혀,http://www.businesspost.co.kr/BP?command=article_view&num=117499
1426,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,https://www.sedaily.com/NewsView/1VGIE8086H
1427,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.viva100.com/main/view.php?key=20190308010002673
1428,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.newsprime.co.kr/news/article.html?no=450028
1429,2019-03-08,대웅제약폐섬유증신약정부지원에개발가속화,http://moneys.mt.co.kr/news/mwView.php?no=2019030815178042898
1430,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제로선정,http://www.mhj21.com/119977
1431,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1731449
1432,2019-03-08,대웅제약폐섬유증신약정부지원과제선정임상연구비수혜,http://www.inthenews.co.kr/news/article.html?no=13995
1433,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.ebn.co.kr/news/view/975674
1434,2019-03-08,대웅제약정부지원으로폐섬유증신약개발,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066023
1435,2019-03-08,대웅제약폐섬유증신약DWN12088신약개발사업지원대상선정,http://www.k-health.com/news/articleView.html?idxno=42798
1436,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://view.asiae.co.kr/news/view.htm?idxno=2019030816075552182
1437,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.ceoscoredaily.com/news/article.html?no=52881
1438,2019-03-08,분석대웅제약1조314억판관비상품매출증가수출감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227963
1439,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.100ssd.co.kr/news/articleView.html?idxno=59882
1440,2019-03-08,대웅제약개발중PRS저해제정부지원과제선정  ,http://www.monews.co.kr/news/articleView.html?idxno=201247
1441,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정글로벌신약기술수출발판마련할것,http://www.segye.com/content/html/2019/03/08/20190308003095.html?OutUrl=naver
1442,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.bosa.co.kr/news/articleView.html?idxno=2100867
1443,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.getnews.co.kr/view.php?ud=20190308171401914941d0c69529_16
1444,2019-03-08,대웅제약폐섬유증신약정부지원과제로선정,http://www.dt.co.kr/contents.html?article_no=2019030802109931102005&ref=naver
1445,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.ftoday.co.kr/news/articleView.html?idxno=107123
1446,2019-03-08,대웅제약폐섬유증신약정부지원과제선정임상시험7월중개시방침,https://www.insight.co.kr/news/215249
1447,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.economytalk.kr/news/articleView.html?idxno=180857
1448,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.bokuennews.com/news/article.html?no=172654
1449,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.econovill.com/news/articleView.html?idxno=358157
1450,2019-03-08,대웅제약폐섬유증치료제후보물질정부지원과제선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=348387
1451,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.newscj.com/news/articleView.html?idxno=609473
1452,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정돼,http://www.kpanews.co.kr/article/show.asp?idx=202035&table=article&category=D
1453,2019-03-09,대웅제약폐섬유증신약개발연구사업정부우선순위로책정,http://www.wikileaks-kr.org/news/articleView.html?idxno=49682
1454,2019-03-09,제약산업소식대웅제약일동제약일양약품동아제약,http://www.kukinews.com/news/article.html?no=639579
1455,2019-03-10,제약바이오한주간이모저모메디톡스VS대웅제약균주기원싸움재점화등,http://www.edaily.co.kr/news/newspath.asp?newsid=01207046622422008
1456,2019-03-10,대웅제약폐섬유증신약정부지원과제선정연구개발비지원,http://www.asiatime.co.kr/news/articleView.html?idxno=232537
1457,2019-03-11,제약빅5영업이익률최대폭하락녹십자2년연속꼴찌대웅제약,http://www.datanews.co.kr/news/article.html?no=102371
1458,2019-03-11,대웅제약50년역사성남공장폐쇄,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019031108311300336&objId=A2019031108311300336&portalCode=naver
1459,2019-03-11,대웅제약주가3월11일현재179500원,http://www.gokorea.kr/news/articleView.html?idxno=116871
1460,2019-03-11,대웅제약폐섬유증신약정부지원과제선정,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84469
1461,2019-03-11,ET투자뉴스대웅제약_상장주식수대비거래량은054로적정수준,http://www.etnews.com/20190311000153
1462,2019-03-11,대웅제약반토막난복리후생비급증한광고비왜,http://www.sisajournal-e.com/news/articleView.html?idxno=196841
1463,2019-03-11,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.wsobi.com/news/articleView.html?idxno=70629
1464,2019-03-12,스마트FOCUS보툴리눔톡신전쟁대웅제약vs메디톡스승자는,http://www.dailysmart.co.kr/news/articleView.html?idxno=7557
1465,2019-03-12,대웅제약한올바이오파마안구건조증신약美3상착수,http://www.medisobizanews.com/news/articleView.html?idxno=58358
1466,2019-03-12,대웅제약한올안구건조증신약미국3상개시,http://www.dailypharm.com/Users/News/NewsView.html?ID=250271&REFERER=NP
1467,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.ebn.co.kr/news/view/975997
1468,2019-03-12,대웅제약나보타미국FDA승인기념심포지엄개최,http://www.seoulwire.com/news/articleView.html?idxno=85619
1469,2019-03-12,대웅제약나보타미FDA승인기념심포지엄개최,http://www.fnnews.com/news/201903120911500925
1470,2019-03-12,대웅제약나보타 美 FDA 승인기념심포지엄 개최,http://www.fetv.co.kr/news/article.html?no=22629
1471,2019-03-12,대웅제약나보타미국진출기념심포지엄개최,http://moneys.mt.co.kr/news/mwView.php?no=2019031209048074164
1472,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,https://www.sedaily.com/NewsView/1VGK77UCJT
1473,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.viva100.com/main/view.php?key=20190312010003629
1474,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.g-enews.com/ko-kr/news/article/news_all/201903120928303915fa075a9870_1/article.html
1475,2019-03-12,대웅제약나보타美FDA승인기념심포지엄,http://www.dailypharm.com/Users/News/NewsView.html?ID=250276&REFERER=NP
1476,2019-03-12,대웅제약美FDA의나보타승인기념심포지엄개최,http://news.mk.co.kr/newsRead.php?year=2019&no=147109
1477,2019-03-12,대웅제약나보타美FDA승인기념심포지엄,http://www.k-health.com/news/articleView.html?idxno=42848
1478,2019-03-12,대웅제약美FDA나보타승인기념심포지엄개최,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903120153&t=NN
1479,2019-03-12,대웅제약미국진출나보타기대높아FDA승인기념전문가심포지엄,http://kpenews.com/View.aspx?No=29376
1480,2019-03-12,대웅제약나보타美FDA승인기념심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2101037
1481,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.newsway.co.kr/news/view?tp=1&ud=2019031210042557165
1482,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최시술법도공유,https://www.insight.co.kr/news/215814
1483,2019-03-12,대웅제약나보타美FDA승인기념심포지엄성료,http://www.bokuennews.com/news/article.html?no=172744
1484,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.wolyo.co.kr/news/articleView.html?idxno=79223
1485,2019-03-12,한올바이오대웅제약안구건조증신약미국임상3상개시,http://yna.kr/AKR20190312061400017?did=1195m
1486,2019-03-12,대웅제약나보타FDA승인기념심포지엄,http://news.mt.co.kr/mtview.php?no=2019031210332930284
1487,2019-03-12,한올바이오대웅제약안구건조증신약미국임상3상개시,https://www.sedaily.com/NewsView/1VGK7EE49I
1488,2019-03-12,대웅제약나보타FDA승인기념심포지엄개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=7589
1489,2019-03-12,한올바이오파마대웅제약안구건조증신약美3상개시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066122
1490,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.economytalk.kr/news/articleView.html?idxno=181080
1491,2019-03-12,대웅제약나보타FDA승인기념심포지엄개최,http://www.ezyeconomy.com/news/articleView.html?idxno=88799
1492,2019-03-12,한울바이오파마대웅제약안구건조증치료제HL036임상개시,http://www.seoulwire.com/news/articleView.html?idxno=85946
1493,2019-03-12,주식그래프대웅제약주가12일현재184000원,http://www.nbntv.co.kr/news/articleView.html?idxno=254500
1494,2019-03-12,대웅제약나보타미국FDA승인기념심포지엄개최,http://www.econovill.com/news/articleView.html?idxno=358371
1495,2019-03-12,한올바이오대웅제약안구건조증신약미국임상3상개시,http://www.asiatoday.co.kr/view.php?key=20190312010006413
1496,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최성황리에마무리,http://www.ftoday.co.kr/news/articleView.html?idxno=107187
1497,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.ekn.kr/news/article.html?no=419847
1498,2019-03-12,뉴스투데이L대웅제약나보타FDA승인기념심포지엄개최,http://www.news2day.co.kr/122266
1499,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066128
1500,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019031200067
1501,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최글로벌브랜드위상다져나갈것,http://www.segye.com/content/html/2019/03/12/20190312509043.html?OutUrl=naver
1502,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=348631
1503,2019-03-12,대웅제약한올바이오파마안구건조증신약미국임상3상시작,http://www.businesspost.co.kr/BP?command=article_view&num=117978
1504,2019-03-12,대웅제약나보타美FDA승인기념심포지엄성황리개최,http://www.wikileaks-kr.org/news/articleView.html?idxno=49951
1505,2019-03-12,대웅제약나보타美FDA승인심포지엄개최,http://www.asiatime.co.kr/news/articleView.html?idxno=233203
1506,2019-03-12,대웅제약나보타FDA승인기념심포지엄개최,http://www.newstomato.com/ReadNews.aspx?no=881668
1507,2019-03-12,대웅제약나보타품질안전성뛰어나,http://www.finomy.com/news/articleView.html?idxno=63682
1508,2019-03-12,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.munhwa.com/news/view.html?no=20190312MW163522685774
1509,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.100ssd.co.kr/news/articleView.html?idxno=59936
1510,2019-03-12,한올바이오대웅제약안구건조증신약미국임상3상개시,http://www.seoulfn.com/news/articleView.html?idxno=336418
1511,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.getnews.co.kr/view.php?ud=20190312173408209441d0c69529_16
1512,2019-03-12,대웅제약복리후생비줄고광고선전비확늘어난까닭은,http://www.insightkorea.co.kr//news/articleView.html?idxno=34583
1513,2019-03-12,대웅제약나보타FDA승인기념심포지엄개최 ,http://www.monews.co.kr/news/articleView.html?idxno=201320
1514,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.newscj.com/news/articleView.html?idxno=610687
1515,2019-03-12,대웅제약나보타FDA승인기념심포지엄열어,http://www.kpanews.co.kr/article/show.asp?idx=202135&table=article&category=D
1516,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.lawissue.co.kr/view.php?ud=201903122218472709d7f4c63cc6_12
1517,2019-03-13,대웅제약소화기계질환최강자로서의면모입증,http://www.bosa.co.kr/news/articleView.html?idxno=2101116
1518,2019-03-13,기획유한양행대웅제약한미약품1조클럽의힘은안정적캐시카우,http://daily.hankooki.com/lpage/column/201903/dh20190313080014145650.htm
1519,2019-03-13,더벨대웅제약1조클럽1등공신은전승호대표,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201903120100017220001097
1520,2019-03-13,매출1조클럽대웅제약적자전환에잉여현금흐름마이너스자금사정문제없나,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=530363
1521,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.edaily.co.kr/news/newspath.asp?newsid=02013926622422992
1522,2019-03-13,대웅제약나보타中시장진출초읽기,http://www.kpinews.co.kr/news/articleView.html?idxno=92277
1523,2019-03-13,대웅제약나보타올하반기중국임상3상돌입전망,http://biz.newdaily.co.kr/site/data/html/2019/03/13/2019031300027.html
1524,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.ekn.kr/news/article.html?no=420027
1525,2019-03-13,대웅제약中나보타3상올해하반기돌입,http://www.biospectator.com/view/news_view.php?varAtcId=7277
1526,2019-03-13,대웅제약나보타해외진출가속화올하반기중국서임상3상진행,http://moneys.mt.co.kr/news/mwView.php?no=2019031309228081208
1527,2019-03-13,대웅제약나보타中진출박차하반기임상3상돌입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1732857
1528,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2019031309323100499
1529,2019-03-13,대웅제약나보타미국이어중국진출가속화,http://www.seoulwire.com/news/articleView.html?idxno=86679
1530,2019-03-13,대웅제약올하반기나보타중국임상3상돌입,http://www.newspim.com/news/view/20190313000216
1531,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.ceoscoredaily.com/news/article.html?no=53006
1532,2019-03-13,대웅제약나보타올하반기중국임상3상돌입 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1148960
1533,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.bokuennews.com/news/article.html?no=172812
1534,2019-03-13,대웅제약나보타하반기中임상3상돌입제조시설변경승인,http://www.viva100.com/main/view.php?key=20190313010004131
1535,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228111
1536,2019-03-13,대웅제약나보타中임상시험신청승인하반기임상3상진행,http://www.ajunews.com/view/20190313094831740
1537,2019-03-13,대웅제약나보타중국진출속도하반기임상3상착수,http://www.medisobizanews.com/news/articleView.html?idxno=58397
1538,2019-03-13,대웅제약나보타중국진출본격화임상시설제조시설변경승인받아,http://kpenews.com/View.aspx?No=29458
1539,2019-03-13,대웅제약나보타올해하반기중국임상3상돌입현지진출박차,https://www.insight.co.kr/news/216021
1540,2019-03-13,대웅제약나보타제조시설변경中승인,http://news.mt.co.kr/mtview.php?no=2019031309375052204
1541,2019-03-13,대웅제약중국서하반기나보타임상3상돌입,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903130199&t=NN
1542,2019-03-13,대웅제약나보타하반기中임상3상돌입,http://www.newsis.com/view/?id=NISX20190313_0000585703&cID=13001&pID=13000
1543,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.econovill.com/news/articleView.html?idxno=358446
1544,2019-03-13,대웅제약나보타제조시설변경중국CFDA최종승인,http://www.fnnews.com/news/201903131011037521
1545,2019-03-13,대웅제약올해하반기부터나보타중국임상3상돌입,http://news.mk.co.kr/newsRead.php?year=2019&no=150198
1546,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.dailian.co.kr/news/view/778872/?sc=naver
1547,2019-03-13,대웅제약나보타中임상3상승인하반기시작,http://news1.kr/articles/?3569774
1548,2019-03-13,대웅제약주가3월13일현재188000원,http://www.gokorea.kr/news/articleView.html?idxno=119322
1549,2019-03-13,대웅제약올하반기나보타中임상3상돌입,http://view.asiae.co.kr/news/view.htm?idxno=2019031310361479517
1550,2019-03-13,대웅제약나보타하반기중임상돌입,http://www.straightnews.co.kr/news/articleView.html?idxno=45117
1551,2019-03-13,대웅제약나보타올해하반기에중국임상3상돌입,http://www.rapportian.com/news/articleView.html?idxno=116511
1552,2019-03-13,대웅제약나보타中본격진출하반기중임상시험3상돌입,https://www.sedaily.com/NewsView/1VGKN4BNVN
1553,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.wolyo.co.kr/news/articleView.html?idxno=79296
1554,2019-03-13,대웅제약나보타올하반기중국임상3상진행,http://www.insightkorea.co.kr//news/articleView.html?idxno=34620
1555,2019-03-13,대웅제약나보타하반기中임상3상돌입,http://www.g-enews.com/ko-kr/news/article/news_all/201903131053305661fa075a9870_1/article.html
1556,2019-03-13,대웅제약나보타미국이어중국진출본격화,http://www.monews.co.kr/news/articleView.html?idxno=201339
1557,2019-03-13,대웅제약나보타오는하반기중국임상3상돌입,http://news.mk.co.kr/newsRead.php?year=2019&no=150391
1558,2019-03-13,대웅제약보툴리눔톡신나보타올하반기중국임상3상돌입,http://www.k-health.com/news/articleView.html?idxno=42883
1559,2019-03-13,대웅제약보툴리눔톡신나보타하반기에중국임상3상,http://yna.kr/AKR20190313067200017?did=1195m
1560,2019-03-13,대웅제약나보타中2공장으로제조시설변경본격임상3상돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=348697
1561,2019-03-13,3월13일대웅제약증권매매326190000원,http://www.nbntv.co.kr/news/articleView.html?idxno=256886
1562,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125033&REFERER=NP
1563,2019-03-13,대웅제약나보타中임상시험제조시설변경최종승인획득,http://www.asiatime.co.kr/news/articleView.html?idxno=233364
1564,2019-03-13,매출액10연구개발투자대웅제약1조클럽의비결,http://news.heraldcorp.com/view.php?ud=20190313000400
1565,2019-03-13,대웅제약나보타올하반기中임상3상본격진행,http://daily.hankooki.com/lpage/ittech/201903/dh20190313114746145630.htm
1566,2019-03-13,대웅제약나보타올하반기내중국임상3상추진,http://www.ezyeconomy.com/news/articleView.html?idxno=88837
1567,2019-03-13,대웅제약중국에서보톡스나보타임상3상시작승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=118179
1568,2019-03-13,대웅제약나보타하반기中임상3상돌입,http://www.koreaittimes.com/news/articleView.html?idxno=89667
1569,2019-03-13,대웅제약나보타올하반기중국3상돌입,http://www.kpanews.co.kr/article/show.asp?idx=202164&table=article&category=D
1570,2019-03-13,대웅제약나보타중국진출본격화,http://www.m-i.kr/news/articleView.html?idxno=503754
1571,2019-03-13,대웅제약나보타15억중국시장본격타겟화,http://www.wikileaks-kr.org/news/articleView.html?idxno=50053
1572,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.bosa.co.kr/news/articleView.html?idxno=2101166
1573,2019-03-13,대웅제약하반기나보타중국3상돌입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066195
1574,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.metroseoul.co.kr/news/newsview?newscd=2019031300109
1575,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.newspost.kr/news/articleView.html?idxno=69510
1576,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.economytalk.kr/news/articleView.html?idxno=181180
1577,2019-03-13,대웅제약나보타올하반기중국임상3상진행,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031314440970632
1578,2019-03-13,대웅제약올해하반기中서나보타임상3상돌입,http://news.donga.com/3/all/20190313/94523526/2
1579,2019-03-13,대웅제약보툴리눔톡신나보타하반기에중국임상3상,http://www.asiatoday.co.kr/view.php?key=20190313010007514
1580,2019-03-13,대웅제약나보타 올하반기중국임상3상돌입 ,http://www.fetv.co.kr/news/article.html?no=22814
1581,2019-03-13,대웅제약하반기나보타중국임상3상개시,http://www.seoulfn.com/news/articleView.html?idxno=336554
1582,2019-03-13,기업분석광고로쌓은명성인가우루사대웅제약매출1조달성했지만영업이익과당기순이익되려고꾸라지고직원복리는줄어,http://www.newsworker.co.kr/news/articleView.html?idxno=27031
1583,2019-03-13,대웅제약나보타올해하반기중국서임상3상돌입,http://www.inthenews.co.kr/news/article.html?no=14084
1584,2019-03-13,대웅제약나보타올하반기中임상3상돌입거대시장진출차질없이준비,http://www.segye.com/content/html/2019/03/13/20190313512132.html?OutUrl=naver
1585,2019-03-13,대웅제약나보타올해하반기중국임상3상돌입,http://www.ftoday.co.kr/news/articleView.html?idxno=107222
1586,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.medigatenews.com/news/121923231
1587,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.getnews.co.kr/view.php?ud=20190313171656957941d0c69529_16
1588,2019-03-13,대웅제약나보타하반기중국임상3상개시,http://www.dt.co.kr/contents.html?article_no=2019031402101531102001&ref=naver
1589,2019-03-13,제약소식대웅제약나보타올하반기중국임상3상돌입外,http://www.kukinews.com/news/article.html?no=641100
1590,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.wsobi.com/news/articleView.html?idxno=70734
1591,2019-03-14,대웅제약나보타올하반기중국임상3상돌입,http://www.lawissue.co.kr/view.php?ud=201903140012253955d7f4c63cc6_12
1592,2019-03-14,익스트림팀으로조직에활력을대웅제약연구조직개편RD전문성강화,http://www.wikileaks-kr.org/news/articleView.html?idxno=50121
1593,2019-03-14,생활경제talktalk대웅제약나보타中임상시험승인하반기진출본격화,http://www.ajunews.com/view/20190313150228102
1594,2019-03-14,대웅제약베트남트라파코사와기술이전생산돌입,http://www.seoulwire.com/news/articleView.html?idxno=87696
1595,2019-03-14,대웅제약베트남현지생산으로입찰정조준,http://www.dailypharm.com/Users/News/NewsView.html?ID=250388&REFERER=NP
1596,2019-03-14,대웅제약베트남최대제약트라파코와﻿기술이전본격화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228175
1597,2019-03-14,대웅제약베트남최대제약사트리파코기술이전본격화,http://www.viva100.com/main/view.php?key=20190314010004654
1598,2019-03-14,ET투자뉴스대웅제약_주가와투자심리는약세거래량은침체,http://www.etnews.com/20190314000037
1599,2019-03-14,우루사베트남간다대웅제약트라파코에생산기술이전진행,http://moneys.mt.co.kr/news/mwView.php?no=2019031409428041066
1600,2019-03-14,대웅제약베트남최대제약사와기술이전시장진출본격화,http://www.newspim.com/news/view/20190314000250
1601,2019-03-14,대웅제약베트남진출속도트라파코와기술이전미팅,http://www.medisobizanews.com/news/articleView.html?idxno=58422
1602,2019-03-14,대웅제약베트남제약사트라파코에기술이전본격화,http://news.hankyung.com/article/2019031438046
1603,2019-03-14,대웅제약베트남최대제약사트라코파와기술이전본격화,http://www.etnews.com/20190314000064
1604,2019-03-14,대웅제약베트남최대제약사와기술이전본격화현지사업혁신주도,https://www.insight.co.kr/news/216258
1605,2019-03-14,대웅제약베트남제약사트라파코에기술이전본격화,http://www.metroseoul.co.kr/news/newsview?newscd=2019031400055
1606,2019-03-14,대웅제약베트남빅2제약사트라파코와협력현지사업혁신주도,http://www.econovill.com/news/articleView.html?idxno=358547
1607,2019-03-14,대웅제약나보타중국임상3상시작중국진출본격화,http://www.news2day.co.kr/122475
1608,2019-03-14,대웅제약베트남제약사와기술이전및현지생산본격화,http://www.dailysmart.co.kr/news/articleView.html?idxno=7701
1609,2019-03-14,대웅제약베트남트라파코와기술이전본격화현지사업혁신주도,http://www.ekn.kr/news/article.html?no=420331
1610,2019-03-14,3월14일대웅제약정보,http://www.gokorea.kr/news/articleView.html?idxno=120636
1611,2019-03-14,대웅제약연내베트남서우루사생산돌입2021년판매목표,http://www.shinailbo.co.kr/news/articleView.html?idxno=1149411
1612,2019-03-14,대웅제약베트남제약사에기술이전2021년현지생산,http://yna.kr/AKR20190314061800017?did=1195m
1613,2019-03-14,대웅제약베트남진출본격화,https://www.sedaily.com/NewsView/1VGL3LE0DX
1614,2019-03-14,대웅제약베트남최대제약사와기술이전본격화,http://news.mk.co.kr/newsRead.php?year=2019&no=153394
1615,2019-03-14,대웅제약베트남기업과우루사등현지생산계약체결,http://www.rapportian.com/news/articleView.html?idxno=116538
1616,2019-03-14,대웅제약베트남최대제약사트라파코와기술이전본격화,http://www.newsway.co.kr/news/view?tp=1&ud=2019031410350695617
1617,2019-03-14,대웅제약베트남제약사트라파코에생산기술이전2021년판매목표”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1733427
1618,2019-03-14,대웅제약베트남현지협력본격화,http://www.edaily.co.kr/news/newspath.asp?newsid=02519046622423320
1619,2019-03-14,대웅제약2021년부터베트남현지생산판매트라파코와기술이전킥오프미팅,http://kpenews.com/View.aspx?No=29553
1620,2019-03-14,대웅제약베트남시장공략트라파코에생산기술이전,http://www.newsis.com/view/?id=NISX20190314_0000587250&cID=13001&pID=13000
1621,2019-03-14,대웅제약베트남에우루사등8개생산기술이전,http://www.biospectator.com/view/news_view.php?varAtcId=7285
1622,2019-03-14,대웅제약베트남최대제약사트라파코사와﻿기술이전본격화,http://www.dailian.co.kr/news/view/779343/?sc=naver
1623,2019-03-14,대웅제약베트남진출날개달았다,http://www.m-i.kr/news/articleView.html?idxno=504112
1624,2019-03-14,대웅제약베트남트라파코社와기술이전진행키로,http://www.mhj21.com/120097
1625,2019-03-14,대웅제약2021년베트남현지생산유통위한시동,http://www.bosa.co.kr/news/articleView.html?idxno=2101235
1626,2019-03-14,대웅제약베트남최대제약사트라파코社와기술이전본격화,http://www.fetv.co.kr/news/article.html?no=22919
1627,2019-03-14,대웅제약베트남최대제약사트라파코와﻿기술이전본격화,http://medipana.com/news/news_viewer.asp?NewsNum=235917&MainKind=A&NewsKind=5&vCount=12&vKind=1
1628,2019-03-14,대웅제약베트남제약사에우루사기술이전2021년현지생산,http://www.seoulfn.com/news/articleView.html?idxno=336637
1629,2019-03-14,대웅제약베트남제약사트라파코社와기술이전본격화,http://www.kukinews.com/news/article.html?no=641305
1630,2019-03-14,대웅제약2021년부터베트남서제품생산,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125076&REFERER=NP
1631,2019-03-14,대웅제약베트남진출본격화현지빅2제약사와협력,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066232
1632,2019-03-14,대웅제약베트남트라파코社와기술이전계약,http://www.bokuennews.com/news/article.html?no=172882
1633,2019-03-14,대웅제약베트남제약사에기술이전2021년현지생산,http://www.asiatoday.co.kr/view.php?key=20190314010008294
1634,2019-03-14,대웅제약지분인수베트남제약사에기술이전본격화,http://news.mt.co.kr/mtview.php?no=2019031413233946224
1635,2019-03-14,대웅제약베트남트라파코와기술이전본격화현지사업혁신주도,http://www.wikileaks-kr.org/news/articleView.html?idxno=50178
1636,2019-03-14,대웅제약베트남최대제약사트라파코사와킥오프,http://www.100ssd.co.kr/news/articleView.html?idxno=59960
1637,2019-03-14,대웅제약베트남제약사트라파코와킥오프Kickoff미팅,http://www.newspost.kr/news/articleView.html?idxno=69543
1638,2019-03-14,대웅제약베트남진출본격화현지제약사와생산기술이전논의,http://www.ezyeconomy.com/news/articleView.html?idxno=88889
1639,2019-03-14,대웅제약베트남최대제약사와현지사업주도한다,http://www.k-health.com/news/articleView.html?idxno=42918
1640,2019-03-14,대웅제약베트남최대제약사에기술이전,http://kormedi.com/?p=1284265
1641,2019-03-14,대웅제약트라파코와기술이전본격화,http://www.ebn.co.kr/news/view/976457
1642,2019-03-14,대웅제약지분인수베트남제약사트라파코에기술이전,http://view.asiae.co.kr/news/view.htm?idxno=2019031414354592803
1643,2019-03-14,대웅제약베트남최대제약사트라파코社와현지사업나서,http://daily.hankooki.com/lpage/ittech/201903/dh20190314145201145630.htm
1644,2019-03-14,대웅제약베트남제약사트라파코와기술이전본격화,http://www.medigatenews.com/news/1009540673
1645,2019-03-14,대웅제약베트남최대제약사와기술이전본격화현지사업혁신주도,http://www.segye.com/content/html/2019/03/14/20190314511363.html?OutUrl=naver
1646,2019-03-14,대웅제약베트남기술이전본격추진현지공략속도↑,http://news.donga.com/3/all/20190314/94544813/2
1647,2019-03-14,대웅제약베트남트라파코에기술이전통한현지입찰시장진입추진,http://news.mk.co.kr/newsRead.php?year=2019&no=154792
1648,2019-03-14,대웅제약베트남제약사트라파코와기술이전및현지생산합의,http://www.fnnews.com/news/201903141615087572
1649,2019-03-14,대웅제약베트남트라파코社와현지공략착수,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031415192844365
1650,2019-03-14,대웅제약베트남에우루사등8개제품기술이전,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84562
1651,2019-03-14,대웅제약베트남제약사트라파코지분인수로현지사업혁신주도,http://www.mdtoday.co.kr/mdtoday/index.html?no=348886
1652,2019-03-14,대웅제약베트남트라파코와﻿기술이전본격화현지사업혁신주도,http://www.asiatime.co.kr/news/articleView.html?idxno=233638
1653,2019-03-14,전승호대웅제약대표1조클럽발담근비결은,http://www.wolyo.co.kr/news/articleView.html?idxno=79521
1654,2019-03-14,대웅제약베트남트라파코에기술이전시작2021년현지생산,http://www.dt.co.kr/contents.html?article_no=2019031402109931102003&ref=naver
1655,2019-03-14,대웅제약베트남제약사에기술이전현지생산유통계획,http://www.kpinews.co.kr/news/articleView.html?idxno=92446
1656,2019-03-14,대웅제약베트남트라파코사와기술이전본격화,http://www.economytalk.kr/news/articleView.html?idxno=181292
1657,2019-03-14,대웅제약베트남제약사트라파코社와기술이전본격화,http://www.getnews.co.kr/view.php?ud=20190314183345733641d0c69529_16
1658,2019-03-14,네이버대웅제약과헬스케어합작사설립,http://news.mt.co.kr/mtview.php?no=2019031418420972742
1659,2019-03-14,네이버대웅제약과의료빅데이터합작기업설립,http://yna.kr/AKR20190314169900017?did=1195m
1660,2019-03-14,네이버대웅제약과의료빅데이터합작기업설립,http://www.etnews.com/20190314000335
1661,2019-03-14,네이버대웅제약의료빅데이터기업다나아데이터설립,http://www.newsway.co.kr/news/view?tp=1&ud=2019031419472756606
1662,2019-03-14,대웅제약베트남진출속도현지사업박차,http://www.dailymedi.com/detail.php?number=840960&thread=22r05
1663,2019-03-14,대웅제약베트남최대제약사트라파코와기술이전본격화현지사업주도,http://www.businesskorea.co.kr/news/articleView.html?idxno=29993
1664,2019-03-14,네이버대웅제약과의료빅데이터벤처다나아데이터설립,http://www.etoday.co.kr/news/section/newsview.php?idxno=1733826
1665,2019-03-14,네이버대웅제약과헬스케어합작사설립,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20190314195009
1666,2019-03-14,네이버대웅제약등과헬스케어합작사설립,http://www.inews24.com/view/1164020
1667,2019-03-14,네이버대웅제약과헬스케어합작법인,http://www.dt.co.kr/contents.html?article_no=2019031502151531033001&ref=naver
1668,2019-03-14,대웅제약베트남제약사트라파코에기술이전,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3781277
1669,2019-03-14,네이버대웅제약등과의료빅데이터합작사설립,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903140567&t=NN
1670,2019-03-14,네이버이번엔헬스케어도전대웅제약과합작기업설립,http://view.asiae.co.kr/news/view.htm?idxno=2019031422554683980
1671,2019-03-15,대웅제약베트남현지와시동케이프,http://news.mt.co.kr/mtview.php?no=2019031507540770382
1672,2019-03-15,네이버대웅제약과헬스케어시장공략속도,http://www.fetv.co.kr/news/article.html?no=22982
1673,2019-03-15,기획매출1조대웅제약전문의약품상위10개중8개도입품목,http://daily.hankooki.com/lpage/column/201903/dh20190315081510145650.htm
1674,2019-03-15,대웅제약베트남현지화전략시동,http://www.asiatoday.co.kr/view.php?key=20190315010008761
1675,2019-03-15,네이버대웅제약의료빅데이터다나아데이터설립,http://www.seoulwire.com/news/articleView.html?idxno=88593
1676,2019-03-15,네이버대웅제약과의료빅데이터합작기업설립,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031508161780725
1677,2019-03-15,대웅제약목표가3↑24만원제시KB證,http://www.newspim.com/news/view/20190315000129
1678,2019-03-15,퀵리포트대웅제약매수유지목표가3↑24만원KB證,http://www.itooza.com/common/iview.php?no=2019031509154014582
1679,2019-03-15,대웅제약베트남로컬사자격으로다양한입찰참가,http://news.heraldcorp.com/view.php?ud=20190315000131
1680,2019-03-15,대웅제약베트남제약사트라파코社와기술이전본격화,http://www.g-enews.com/ko-kr/news/article/news_all/201903150947132973fa075a9870_1/article.html
1681,2019-03-15,네이버와대웅제약의료보건빅데이터회사설립,http://www.gokorea.kr/news/articleView.html?idxno=121624
1682,2019-03-15,대웅제약네이버와합작벤처다나아데이터설립,http://www.econovill.com/news/articleView.html?idxno=358629
1683,2019-03-15,네이버헬스케어시장진출대웅제약과합작회사설립,http://www.segye.com/content/html/2019/03/15/20190315500492.html?OutUrl=naver
1684,2019-03-15,네이버대웅제약과의료빅데이터합작벤처설립,http://www.newsis.com/view/?id=NISX20190315_0000588620&cID=13001&pID=13000
1685,2019-03-15,3월15일대웅제약주식시세현황189500원052,http://www.nbntv.co.kr/news/articleView.html?idxno=261727
1686,2019-03-15,네이버대웅제약빅데이터및인공지능AI 기반의헬스케어사업진출,http://www.newsworks.co.kr/news/articleView.html?idxno=344012
1687,2019-03-15,대웅제약베트남제약사트라파코에기술이전,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1207349
1688,2019-03-15,베트남입성대웅제약2021년부터제품생산판매,http://www.munhwa.com/news/view.html?no=2019031501071627107001
1689,2019-03-15,네이버대웅제약과헬스케어합작사설립다나아데이터로헬스케어빅데이터진출,http://techm.kr/bbs/board.php?bo_table=article&wr_id=5928
1690,2019-03-15,대웅제약베트남현지화전략시동”,http://www.wikitree.co.kr/main/news_view.php?id=411734
1691,2019-03-16,대웅제약올해글로벌현지화로승부수베트남中대륙까지광폭행보,http://www.ekn.kr/news/article.html?no=420764
1692,2019-03-16,네이버대웅제약과빅데이터사업나서,http://www.bosa.co.kr/news/articleView.html?idxno=2101386
1693,2019-03-17,PICKUP대웅제약미국베트남시장진출박차,http://news.heraldcorp.com/view.php?ud=20190317000219
1694,2019-03-17,대웅제약나보타美FDA승인기념심포지엄개최,http://www.wsobi.com/news/articleView.html?idxno=70867
1695,2019-03-18,국고처김종철종목상담대웅제약069620,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903160056&t=NNv
1696,2019-03-18,3월18일대웅제약실시간주식현황190000원080,http://www.nbntv.co.kr/news/articleView.html?idxno=264313
1697,2019-03-18,대웅제약전승호사장약학대실습생과소통간담회,http://www.edaily.co.kr/news/newspath.asp?newsid=02620726622424632
1698,2019-03-18,전승호대웅제약CEO약학대학생실습생과소통간담회,https://www.sedaily.com/NewsView/1VGMY7Z25F
1699,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228309
1700,2019-03-18,Biz인사이드대웅제약글로벌진출가시화제2나보타만든다,http://www.econovill.com/news/articleView.html?idxno=358718
1701,2019-03-18,대웅제약전승호사장약대실습생에차별성키우라,http://www.bosa.co.kr/news/articleView.html?idxno=2101442
1702,2019-03-18,전승호대웅제약사장약대실습생과소통간담회,http://www.dailypharm.com/Users/News/NewsView.html?ID=250511&REFERER=NP
1703,2019-03-18,대웅제약전승호사장약대실습생과소통간담회차별성갖춘인재성장해야,http://www.medisobizanews.com/news/articleView.html?idxno=58500
1704,2019-03-18,젊은피대웅제약전승호사장약학대실습생과소통,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125148&REFERER=NP
1705,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회,http://medipana.com/news/news_viewer.asp?NewsNum=236083&MainKind=A&NewsKind=5&vCount=12&vKind=1
1706,2019-03-18,전승호대웅제약사장직원성장우선되는회사로이끌것,http://www.m-i.kr/news/articleView.html?idxno=505017
1707,2019-03-18,전승호대웅제약사장약학대실습생과소통간담회실질적업무체험제공,http://www.businesskorea.co.kr/news/articleView.html?idxno=30057
1708,2019-03-18,대웅제약약대생실습생30명과소통간담회가져,http://www.seoulwire.com/news/articleView.html?idxno=90319
1709,2019-03-18,전승호대웅제약사장 팜DW실습생과소통,http://www.seoulfn.com/news/articleView.html?idxno=336940
1710,2019-03-18,대웅제약전승호사장약대생멘토로나서팜DW실습생과소통간담회,http://kpenews.com/View.aspx?No=29769
1711,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회가져,http://www.fetv.co.kr/news/article.html?no=23246
1712,2019-03-18,대웅제약전승호대표이사약대생과소통,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031811255013745
1713,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회진행,http://www.inthenews.co.kr/news/article.html?no=14148
1714,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회가져,http://www.newsway.co.kr/news/view?tp=1&ud=2019031813581776613
1715,2019-03-18,전승호대웅제약사장약학대실습생과소통경영방향은,http://www.shinailbo.co.kr/news/articleView.html?idxno=1150315
1716,2019-03-18,대웅제약약학대실습생과소통간담회개최,http://www.etnews.com/20190318000234
1717,2019-03-18,약대생만난대웅제약전승호사장소통행보눈길,http://www.viva100.com/main/view.php?key=20190318010005931
1718,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회가져,http://www.wsobi.com/news/articleView.html?idxno=70930
1719,2019-03-18,대웅제약전승호사장약대생과소통간담회가져,http://www.ebn.co.kr/news/view/976926
1720,2019-03-18,대웅제약약학대학실습생과소통간담회가져,http://daily.hankooki.com/lpage/ittech/201903/dh20190318150657145630.htm
1721,2019-03-18,전승호대웅제약사장약대실습생과소통간담회가져,http://www.rapportian.com/news/articleView.html?idxno=116617
1722,2019-03-18,대웅제약전승호사장예비약사들에전한제약산업의미래,http://www.metroseoul.co.kr/news/newsview?newscd=2019031800191
1723,2019-03-18,전승호대웅제약사장약학전공실습생과소통우수자정규직채용,http://news.donga.com/3/all/20190318/94614322/2
1724,2019-03-18,전승호대웅제약사장회사서실습중인약대생들과간담회가져,http://news.mk.co.kr/newsRead.php?year=2019&no=162183
1725,2019-03-18,★주식인사이드대웅제약주가189000원3월18일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=600160
1726,2019-03-18,전승호대웅제약사장약대실습생과소통간담회개최,http://www.ezyeconomy.com/news/articleView.html?idxno=88987
1727,2019-03-18,약대생전승호사장님대웅제약을어떤방향으로이끌어가실건가요”,http://www.segye.com/content/html/2019/03/18/20190318532034.html?OutUrl=naver
1728,2019-03-18,전승호대웅제약사장약학대학실습생과소통간담회,http://www.newsprime.co.kr/news/article.html?no=451322
1729,2019-03-18,전승호대웅제약사장제약회사의커리어패스차별성키워야,http://www.ajunews.com/view/20190318161410386
1730,2019-03-18,전승호대웅제약사장차세대주역약대실습생과소통간담회가져,http://www.wikileaks-kr.org/news/articleView.html?idxno=50494
1731,2019-03-18,전승호대웅제약전승호사장팜DW실습생과소통간담회,http://www.mhj21.com/120202
1732,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회가져,http://www.ekn.kr/news/article.html?no=421107
1733,2019-03-18,전승호대웅제약사장팜DW참여약대생과소통간담회열어,http://www.econovill.com/news/articleView.html?idxno=358827
1734,2019-03-18,나른한봄건강지키기대웅제약안구건조증신약HL036,https://www.sedaily.com/NewsView/1VGMZAN9R7
1735,2019-03-18,대웅제약전승호사장회사서실습중인약대생들과간담회가져,https://www.insight.co.kr/news/217154
1736,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회가져,http://www.getnews.co.kr/view.php?ud=20190318183923693641d0c69529_16
1737,2019-03-18,제약산업이해도모전승호대웅제약사장약학대학생실습생과소통,http://www.iminju.net/news/articleView.html?idxno=44006
1738,2019-03-18,대웅제약전승호사장약대생소통간담회열어,http://www.kpanews.co.kr/article/show.asp?idx=202300&table=article&category=D
1739,2019-03-18,전승호대웅제약사장약학대학생실습생과소통간담회가져,http://www.dailian.co.kr/news/view/780384/?sc=naver
1740,2019-03-19,대웅제약안구건조증면역항암신약개발박차,http://news.mk.co.kr/newsRead.php?year=2019&no=163357
1741,2019-03-19,★주식인사이드대웅제약주가191000원3월19일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=600368
1742,2019-03-19,오늘의추천종목한국투자증권SK텔레콤대웅제약등,http://www.asiatoday.co.kr/view.php?key=20190319010010731
1743,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.g-enews.com/ko-kr/news/article/news_all/201903190934083186fa075a9870_1/article.html
1744,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031909311615771
1745,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228356
1746,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.ceoscoredaily.com/news/article.html?no=53212
1747,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.koreaittimes.com/news/articleView.html?idxno=89778
1748,2019-03-19,대웅제약경구용장티푸스백신비보티프국내판권확보,http://news1.kr/articles/?3574403
1749,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.edaily.co.kr/news/newspath.asp?newsid=02099206622424960
1750,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수상반기제품출시”,https://www.sedaily.com/NewsView/1VGNE22JM7
1751,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.sisafocus.co.kr/news/articleView.html?idxno=205025
1752,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.ekn.kr/news/article.html?no=421202
1753,2019-03-19,대웅제약비보티프국내판권확보상반기출시,http://www.ajunews.com/view/20190319094010840
1754,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.dailian.co.kr/news/view/780468/?sc=naver
1755,2019-03-19,대웅제약경구용장티푸스백신비보티프국내판권확보,http://www.k-health.com/news/articleView.html?idxno=42989
1756,2019-03-19,대웅제약장티푸스백신비보티프판권인수,http://www.ebn.co.kr/news/view/977041
1757,2019-03-19,대웅제약장티푸스백신비보티프판권인수상반기출시,http://medipana.com/news/news_viewer.asp?NewsNum=236140&MainKind=A&NewsKind=5&vCount=12&vKind=1
1758,2019-03-19,대웅제약비보티프판권인수장티푸스백신공급,http://www.viva100.com/main/view.php?key=20190319010006222
1759,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.kukinews.com/news/article.html?no=642723
1760,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.etoday.co.kr/news/section/newsview.php?idxno=1735150
1761,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.wolyo.co.kr/news/articleView.html?idxno=79797
1762,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.fnnews.com/news/201903191005034300
1763,2019-03-19,대웅제약장티푸스백신비보티프판권확보,http://news.mt.co.kr/mtview.php?no=2019031909531016986
1764,2019-03-19,대웅제약 경구용장티푸스백신비보티프판권인수,http://www.fetv.co.kr/news/article.html?no=23347
1765,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.newspost.kr/news/articleView.html?idxno=69714
1766,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.mdtoday.co.kr/mdtoday/index.html?no=349219
1767,2019-03-19,대웅제약먹는장티푸스예방백신국내판권인수,http://biz.chosun.com/site/data/html_dir/2019/03/19/2019031900888.html
1768,2019-03-19,대웅제약경구용장티푸스백신비보티프올상반기출시,http://moneys.mt.co.kr/news/mwView.php?no=2019031910058025730
1769,2019-03-19,대웅제약먹는장티푸스백신비보티프국내판권인수,http://www.newspim.com/news/view/20190319000217
1770,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.shinailbo.co.kr/news/articleView.html?idxno=1150577
1771,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.econovill.com/news/articleView.html?idxno=358878
1772,2019-03-19,대웅제약장티푸스백신비보티프캡슐판권확보,http://www.medisobizanews.com/news/articleView.html?idxno=58518
1773,2019-03-19,대웅제약경구용장티푸스백신비보티프판권확보,http://www.mhj21.com/120211
1774,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.newsway.co.kr/news/view?tp=1&ud=2019031910314538765
1775,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.etnews.com/20190319000066
1776,2019-03-19,대웅제약경구용장티푸스백신판권인수,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019031910444101462&objId=A2019031910444101462&portalCode=naver
1777,2019-03-19,대웅제약먹는장티푸스백신비보티프국내판권확보,http://www.rapportian.com/news/articleView.html?idxno=116634
1778,2019-03-19,대웅제약장티푸스백신비보티프판권인수상반기출시계획,http://www.asiatime.co.kr/news/articleView.html?idxno=234528
1779,2019-03-19,대웅제약주가오늘시세외매매동향19일현재188000원,http://www.gokorea.kr/news/articleView.html?idxno=124596
1780,2019-03-19,대웅제약먹는장티푸스백신비보티프국내판권인수,http://www.newsis.com/view/?id=NISX20190319_0000591806&cID=13001&pID=13000
1781,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.joseilbo.com/news/news_read.php?uid=372598&class=17&grp=
1782,2019-03-19,대웅제약먹는장티푸스백신판권확보상반기출시,http://yna.kr/AKR20190319069900017?did=1195m
1783,2019-03-19,대웅제약경구용장티푸스백신국내판권확보,http://www.kpinews.co.kr/news/articleView.html?idxno=92655
1784,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수한다,https://www.insight.co.kr/news/217268
1785,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125174&REFERER=NP
1786,2019-03-19,대웅제약국내유일FDA승인받은장티푸스백신비보티프판권인수,http://www.seoulwire.com/news/articleView.html?idxno=90784
1787,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.100ssd.co.kr/news/articleView.html?idxno=60090
1788,2019-03-19,대웅제약장티푸스백신비보티프판권인수상반기출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066385
1789,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.bokuennews.com/news/article.html?no=173074
1790,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.bokuennews.com/news/article.html?no=173074
1791,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://daily.hankooki.com/lpage/ittech/201903/dh20190319112629145630.htm
1792,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.economytalk.kr/news/articleView.html?idxno=181601
1793,2019-03-19,3월19일대웅제약증권플러스026188500원,http://www.nbntv.co.kr/news/articleView.html?idxno=266679
1794,2019-03-19,대웅제약먹는장티푸스백신판권확보,http://www.asiatoday.co.kr/view.php?key=20190319010011052
1795,2019-03-19,대웅제약먹는장티푸스백신판권확보상반기출시,http://www.sentv.co.kr/news/view/550411
1796,2019-03-19,대웅제약올상반기먹는장티푸스백신출시비보티프판권인수,http://kpenews.com/View.aspx?No=29846
1797,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.wikileaks-kr.org/news/articleView.html?idxno=50575
1798,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.biospectator.com/view/news_view.php?varAtcId=7313
1799,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.newstomato.com/ReadNews.aspx?no=883073
1800,2019-03-19,대웅제약먹는장티푸스백신상반기출시판권확보,http://www.dt.co.kr/contents.html?article_no=2019031902109931102001&ref=naver
1801,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://kormedi.com/?p=1284578
1802,2019-03-19,대웅제약장티푸스백신비보티프판권인수 ,http://www.monews.co.kr/news/articleView.html?idxno=201463
1803,2019-03-19,대웅제약장티푸스백신비보티프판권인수올상반기제품출시,http://www.newsprime.co.kr/news/article.html?no=451422
1804,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.medigatenews.com/news/2463015913
1805,2019-03-19,대웅제약먹는장티푸스백신판권확보상반기출시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903190235&t=NN
1806,2019-03-19,대웅제약먹는장티푸스백신판권확보상반기출시예정,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3784741
1807,2019-03-19,대웅제약먹는약장티푸스백신비보티프판권획득,http://www.ezyeconomy.com/news/articleView.html?idxno=89024
1808,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.metroseoul.co.kr/news/newsview?newscd=2019031900146
1809,2019-03-19,주사기공포이제그만대웅제약경구용장티푸스백신비보티프판권인수,http://www.segye.com/content/html/2019/03/19/20190319529634.html?OutUrl=naver
1810,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.kpanews.co.kr/article/show.asp?idx=202344&table=article&category=D
1811,2019-03-19,스타★주식인사이드대웅제약주가187500원3월19일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=601547
1812,2019-03-19,대웅제약경구용장티푸스백신비보티프판권확보,http://www.dailysmart.co.kr/news/articleView.html?idxno=7917
1813,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.ntoday.co.kr/news/articleView.html?idxno=65950
1814,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수상반기출시,http://news.donga.com/3/all/20190319/94631876/2
1815,2019-03-19,대웅제약경구용장티푸스백신비보티프국내판권확보,http://www.businesspost.co.kr/BP?command=article_view&num=119085
1816,2019-03-19,대웅제약장티푸스백신비보티프판권확보상반기중출시키로,http://news.mk.co.kr/newsRead.php?year=2019&no=165457
1817,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.lawissue.co.kr/view.php?ud=201903191617207583d7f4c63cc6_12
1818,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.getnews.co.kr/view.php?ud=20190319173240654041d0c69529_16
1819,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.businesskorea.co.kr/news/articleView.html?idxno=30133
1820,2019-03-19,대웅제약먹는장티푸스백신판권확보,http://www.seoulfn.com/news/articleView.html?idxno=337126
1821,2019-03-20,대웅바이오대웅제약세파계항생제사업인수,http://www.dailypharm.com/Users/News/NewsView.html?ID=250581&REFERER=NP
1822,2019-03-20,대웅제약역류성식도염신약3상순항중연말완료,http://www.medisobizanews.com/news/articleView.html?idxno=58540
1823,2019-03-20,★주식인사이드대웅제약주가190000원3월20일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=602654
1824,2019-03-20,대웅제약이만든마스크팩은달라DNC피어라미지크리스탈스킨마스크선봬,http://www.thekpm.com/view.php?ud=201903200938399126124506bdf1_17
1825,2019-03-20,대웅제약디엔컴퍼니프리미엄마스크4종출시,http://www.yakup.com/news/index.html?mode=view&cat=15&nid=228425
1826,2019-03-20,대웅제약계열사디엔컴퍼니보석담은마스크피어라미지론칭,http://www.ajunews.com/view/20190320095836799
1827,2019-03-20,대웅제약뷰티브랜드피어라미지크리스탈스킨마스크4종韓中동시론칭해외공략시동,http://www.ezyeconomy.com/news/articleView.html?idxno=89060
1828,2019-03-20,대웅제약디엔컴퍼니화장품브랜드피어라미지론칭글로벌출사표,http://www.fetv.co.kr/news/article.html?no=23513
1829,2019-03-20,대웅제약주식창20일현재191500원,http://www.nbntv.co.kr/news/articleView.html?idxno=268993
1830,2019-03-20,스타★주식인사이드대웅제약주가193000원3월20일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=603726
1831,2019-03-20,대웅제약경구용장티푸스백신비보티프판권인수,http://www.wsobi.com/news/articleView.html?idxno=71011
1832,2019-03-20,대웅제약계열사디엔컴퍼니보석담은마스크피어라미지론칭,https://www.insight.co.kr/news/217647
1833,2019-03-21,★주식인사이드대웅제약주가192500원3월21일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=604779
1834,2019-03-21,대웅제약보수적→여성친화적환골탈태나선다,http://www.viva100.com/main/view.php?key=20190321010007165
1835,2019-03-21,3월21일대웅제약증권매매187500원335,http://www.nbntv.co.kr/news/articleView.html?idxno=271440
1836,2019-03-21,ET투자뉴스대웅제약_주가와투자심리는약세거래량은침체,http://www.etnews.com/20190321000141
1837,2019-03-21,대웅제약전일대비약4하락한186000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903210418&t=NN
1838,2019-03-21,대웅제약주가3월21일현재186000원,http://www.gokorea.kr/news/articleView.html?idxno=127357
1839,2019-03-21,스타★주식인사이드대웅제약주가185000원3월21일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=605846
1840,2019-03-21,대웅제약노갑용부사장산업경제발전기여산업포장수상,http://www.seoulwire.com/news/articleView.html?idxno=93767
1841,2019-03-21,대웅제약노갑용부사장제45회상공의날산업포장수상,http://www.medisobizanews.com/news/articleView.html?idxno=58597
1842,2019-03-21,대웅제약노갑용부사장경제발전기여공로인정,http://medipana.com/news/news_viewer.asp?NewsNum=236290&MainKind=A&NewsKind=5&vCount=12&vKind=1
1843,2019-03-21,대웅제약국민건강증진제약업발전기여노갑용부사장산업포장받아,http://kpenews.com/View.aspx?No=29986
1844,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.bosa.co.kr/news/articleView.html?idxno=2101705
1845,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.ebn.co.kr/news/view/977491
1846,2019-03-21,노갑용대웅제약부사장상공의날산업포장수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1736462
1847,2019-03-21,대웅제약노갑용부사장상공의날산업포장,http://www.dailymedi.com/detail.php?number=841188&thread=22r05
1848,2019-03-21,대웅제약노갑용부사장산업포장수상국가경제발전기여,http://www.newsis.com/view/?id=NISX20190321_0000595030&cID=13001&pID=13000
1849,2019-03-21,노갑용대웅제약부사장상공의날산업포장수상,http://www.newsprime.co.kr/news/article.html?no=451899
1850,2019-03-21,노갑용대웅제약부사장상공의날기념식서산업포장수상,http://news.mk.co.kr/newsRead.php?year=2019&no=171572
1851,2019-03-21,노갑용대웅제약부사장국가경제발전기여산업포장수상,http://www.asiatime.co.kr/news/articleView.html?idxno=235220
1852,2019-03-21,대웅제약노갑용부사장46회상공의날산업포장수상,http://www.shinailbo.co.kr/news/articleView.html?idxno=1151584
1853,2019-03-21,대웅제약제46회상공의날노갑용부사장산업포장수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=349551
1854,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.newsway.co.kr/news/view?tp=1&ud=2019032116255594562
1855,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228515
1856,2019-03-21,노갑용대웅제약부사장상공의날산업포장수상,http://www.wolyo.co.kr/news/articleView.html?idxno=79992
1857,2019-03-21,노갑용대웅제약부사장산업포장수상,http://www.dailypharm.com/Users/News/NewsView.html?ID=250692&REFERER=NP
1858,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.metroseoul.co.kr/news/newsview?newscd=2019032100209
1859,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.newspost.kr/news/articleView.html?idxno=69816
1860,2019-03-21,동정노갑용대웅제약부사장산업포장수훈,http://www.dailypharm.com/Users/News/TodayFocus.html?mode=View&nKind=5&ID=16285
1861,2019-03-21,대웅제약노갑용부사장상공의날산업포장,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84686
1862,2019-03-21,대웅제약노갑용부사장상공의날기념식서산업포장수상,http://www.k-health.com/news/articleView.html?idxno=43058
1863,2019-03-21,노갑용대웅제약부사장상공의날산업포장수상,https://www.sedaily.com/NewsView/1VGOD6J3VK
1864,2019-03-21,노갑용대웅제약부사장상공의날산업포장수상ETCOTC종합성장큰기여,http://www.segye.com/content/html/2019/03/21/20190321574756.html?OutUrl=naver
1865,2019-03-21,대웅제약노갑용부사장산업포장수상,http://www.whosaeng.com/108809
1866,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.skyedaily.com/news/news_view.html?ID=83021
1867,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.bokuennews.com/news/article.html?no=173231
1868,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.kpanews.co.kr/article/show.asp?idx=202431&table=article&category=D
1869,2019-03-21,대웅제약노갑용부사장산업포장수상,http://www.g-enews.com/ko-kr/news/article/news_all/201903211825462261fa075a9870_1/article.html
1870,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.getnews.co.kr/view.php?ud=20190321185040156241d0c69529_16
1871,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.ekn.kr/news/article.html?no=421868
1872,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.lawissue.co.kr/view.php?ud=201903212142402065d7f4c63cc6_12
1873,2019-03-22,대웅제약나보타FDA허가로23억마일스톤수령,http://www.dailypharm.com/Users/News/NewsView.html?ID=250706&REFERER=NP
1874,2019-03-22,더벨네이버대웅제약헬스케어협업에인성정보주목,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201903210100038660002455
1875,2019-03-22,노갑용대웅제약부사장상공의날산업포장수상,http://www.ezyeconomy.com/news/articleView.html?idxno=89117
1876,2019-03-22,★주식인사이드대웅제약주가184000원3월22일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=606995
1877,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.ekn.kr/news/article.html?no=421965
1878,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228551
1879,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내행사,http://www.edaily.co.kr/news/newspath.asp?newsid=02358326622425944
1880,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.fetv.co.kr/news/article.html?no=23774
1881,2019-03-22,대웅제약베아제TV광고론칭기념이벤트,http://www.ebn.co.kr/news/view/977623
1882,2019-03-22,동정대웅제약노갑용부사장상공의날산업포장수상 ,http://www.monews.co.kr/news/articleView.html?idxno=201561
1883,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트,http://www.bosa.co.kr/news/articleView.html?idxno=2101769
1884,2019-03-22,33돌맞은베아제대웅제약15년만에TV광고론칭,http://www.viva100.com/main/view.php?key=20190322010007672
1885,2019-03-22,실시간주식현황대웅제약주가22일현재186000원,http://www.nbntv.co.kr/news/articleView.html?idxno=273838
1886,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.newsway.co.kr/news/view?tp=1&ud=2019032211285419650
1887,2019-03-22,대웅제약국민소화제베아제33주년기념사내이벤트개최,http://www.medisobizanews.com/news/articleView.html?idxno=58616
1888,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://daily.hankooki.com/lpage/ittech/201903/dh20190322113733145630.htm
1889,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.segye.com/content/html/2019/03/22/20190322555487.html?OutUrl=naver
1890,2019-03-22,대웅제약베아제33주년기념사내이벤트진행,http://www.asiatime.co.kr/news/articleView.html?idxno=235331
1891,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1151770
1892,2019-03-22,대웅제약1위소화효소제베아제TV광고기념사내이벤트진행,http://www.seoulwire.com/news/articleView.html?idxno=94339
1893,2019-03-22,대웅제약베아제TV광고론칭기념사내이벤트,http://www.ezyeconomy.com/news/articleView.html?idxno=89140
1894,2019-03-22,대웅제약베아제TV광고론칭기념사내행사개최,http://news.mk.co.kr/newsRead.php?year=2019&no=173815
1895,2019-03-22,대웅제약베아제33주년TV광고론칭임직원관심높여,http://www.econovill.com/news/articleView.html?idxno=359256
1896,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.businesskorea.co.kr/news/articleView.html?idxno=30242
1897,2019-03-22,스타★주식인사이드대웅제약주가186000원3월22일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=608030
1898,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트,http://www.mdtoday.co.kr/mdtoday/index.html?no=349693
1899,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.wikileaks-kr.org/news/articleView.html?idxno=50928
1900,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.getnews.co.kr/view.php?ud=2019032217535830741d0c69529_16
1901,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,https://www.insight.co.kr/news/218037
1902,2019-03-22,대웅대웅제약전자증권도입주식매수선택권부여,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228584
1903,2019-03-22,전승호대웅제약대표매출1조원돌파새로운미래성장약속,http://www.newsprime.co.kr/news/article.html?no=452062
1904,2019-03-22,대웅제약베아제TV광고론칭기념사내이벤트,http://www.skyedaily.com/news/news_view.html?ID=83057
1905,2019-03-22,대웅대웅제약주주총회개최윤재춘대표사내이사재선임,http://www.mdtoday.co.kr/mdtoday/index.html?no=349721
1906,2019-03-22,대웅윤재춘대표재선임대웅제약전승호대표나보타글로벌매출기대,http://daily.hankooki.com/lpage/ittech/201903/dh20190322191507145630.htm
1907,2019-03-22,주총현장전승호대웅제약대표글로벌매출이익성장본격화할것”,http://news.mk.co.kr/newsRead.php?year=2019&no=174844
1908,2019-03-22,대웅대웅제약지속적경영실적창출책임경영강화다짐,http://www.medisobizanews.com/news/articleView.html?idxno=58629
1909,2019-03-22,대웅대웅제약주총책임경영내실강화로미래성장추진,http://www.kpanews.co.kr/article/show.asp?idx=202477&table=article&category=D
1910,2019-03-22,대웅대웅제약주주총회개최책임경영통해내실강화,http://www.ekn.kr/news/article.html?no=422100
1911,2019-03-22,대웅제약베아제TV광고론칭기념사내이벤트진행,http://www.newscj.com/news/articleView.html?idxno=613906
1912,2019-03-23,대웅대웅제약주총서주주가치제고입장밝혀,http://www.edaily.co.kr/news/newspath.asp?newsid=01469446622426272
1913,2019-03-24,제약산업단신일동제약대웅제약한미약품한국오츠카제약,http://www.kukinews.com/news/article.html?no=644620
1914,2019-03-24,대웅제약베아제33주년TV광고론칭기념사내이벤트,http://www.metroseoul.co.kr/news/newsview?newscd=2019032200113
1915,2019-03-24,대웅제약우수임직원스톡옵션부여윤재춘대표재선임,http://news.heraldcorp.com/view.php?ud=20190324000186
1916,2019-03-25,★주식인사이드대웅제약주가183000원3월25일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=609129
1917,2019-03-25,대웅제약베아제33주년기념사내이벤트진행,http://www.straightnews.co.kr/news/articleView.html?idxno=45755
1918,2019-03-25,전승호대웅제약사장나보타올해부터본격적인글로벌매출실현,http://www.rapportian.com/news/articleView.html?idxno=116738
1919,2019-03-25,대웅제59기및대웅제약제17기주주총회개최,http://www.k-health.com/news/articleView.html?idxno=43086
1920,2019-03-25,대웅제약나보타美3상결과SCI급국제학술지게재美시장본격진출예정,http://www.newspim.com/news/view/20190325000335
1921,2019-03-25,대웅제약나보타미국3상결과SCI급국제학술지게재,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228624
1922,2019-03-25,3월25일대웅제약주식증권081184500원,http://www.nbntv.co.kr/news/articleView.html?idxno=276631
1923,2019-03-25,대웅제약나보타美국제학술지게재전세계에우수성알려,http://www.seoulwire.com/news/articleView.html?idxno=95564
1924,2019-03-25,대웅제약나보타美3상임상결과SCI급국제학술지게재위약대비우수한주름개선효과안전성입증,http://www.segye.com/content/html/2019/03/25/20190325562585.html?OutUrl=naver
1925,2019-03-25,대웅제약미국임상3상결과SCI급학술지게재,http://news.mk.co.kr/newsRead.php?year=2019&no=178345
1926,2019-03-25,대웅제약나보타美3상임상결과SCI급국제학술지게재,http://www.sisafocus.co.kr/news/articleView.html?idxno=205606
1927,2019-03-25,대웅제약나보타美3상임상결과SCI급국제학술지게재,http://www.medisobizanews.com/news/articleView.html?idxno=58657
1928,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.newsway.co.kr/news/view?tp=1&ud=2019032511351817126
1929,2019-03-25,대웅제약나보타美임상3상국제학술지게재,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019032511044578202
1930,2019-03-25,대웅제약나보타美3상결과주름개선효과안전성입증”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1737489
1931,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.economytalk.kr/news/articleView.html?idxno=181985
1932,2019-03-25,대웅제약나보타주름개선효과SCI급국제학술지실려,http://biz.chosun.com/site/data/html_dir/2019/03/25/2019032501223.html
1933,2019-03-25,대웅제약나보타美임상3상결과더마톨로직서저리게재,http://www.newsprime.co.kr/news/article.html?no=452141
1934,2019-03-25,대웅제약주름개선약나보타임상결과SCI급국제학술지실려,https://cnbc.sbs.co.kr/article_hub/10000935414?division=NAVER
1935,2019-03-25,대웅제약나보타美3상임상결과국제학술지게재,http://www.metroseoul.co.kr/news/newsview?newscd=2019032500107
1936,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.koreaittimes.com/news/articleView.html?idxno=89882
1937,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,https://www.sedaily.com/NewsView/1VGQ7090IE
1938,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.etnews.com/20190325000207
1939,2019-03-25,스타★주식인사이드대웅제약주가183500원3월25일14시14분기준,http://www.newsinside.kr/news/articleView.html?idxno=610160
1940,2019-03-25,대웅제약나보타효과안전성인정3상결과SCI급국제학술지게재,http://kpenews.com/View.aspx?No=30184
1941,2019-03-25,대웅제약나보타미국3상임상결과국제학술지게재,http://www.ebn.co.kr/news/view/977891
1942,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.dailian.co.kr/news/view/782180/?sc=naver
1943,2019-03-25,대웅제약나보타주름개선효과SCI급국제학술지게재,http://www.newsis.com/view/?id=NISX20190325_0000598023&cID=13001&pID=13000
1944,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.mdtoday.co.kr/mdtoday/index.html?no=349838
1945,2019-03-25,美출시앞둔대웅제약나보타SCI급국제학술지에임상결과게재,http://www.inthenews.co.kr/news/article.html?no=14284
1946,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.wolyo.co.kr/news/articleView.html?idxno=80136
1947,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.ekn.kr/news/article.html?no=422435
1948,2019-03-25,대웅제약나보타美진출초읽기임상3상결과SCI급국제학술지게재,http://www.ezyeconomy.com/news/articleView.html?idxno=89196
1949,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.medigatenews.com/news/2695747953
1950,2019-03-25,대웅제약나보타미국3상임상결과국제학술지게재,http://www.asiatime.co.kr/news/articleView.html?idxno=235766
1951,2019-03-25,대웅제약나보타美3상결과국제학술지게재,http://www.biospectator.com/view/news_view.php?varAtcId=7343
1952,2019-03-25,대웅제약나보타美임상3상결과국제학술지게재,http://www.monews.co.kr/news/articleView.html?idxno=201611
1953,2019-03-25,대웅제약나보타SCI급국제학술지게재,http://www.joseilbo.com/news/news_read.php?uid=373024&class=17&grp=
1954,2019-03-25,대웅제약나보타미국3상임상결과더마톨로직서저리게재,http://www.fnnews.com/news/201903251629152816
1955,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.businesskorea.co.kr/news/articleView.html?idxno=30304
1956,2019-03-25,대웅제약나보타임상3상서주름개선효과우수입증,http://www.econovill.com/news/articleView.html?idxno=359411
1957,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,https://www.insight.co.kr/news/218575
1958,2019-03-25,대웅제59기대웅제약제17기주주총회개최,http://www.lawissue.co.kr/view.php?ud=201903251713191745d7f4c63cc6_12
1959,2019-03-25,대웅제약보툴리눔톡신나보타美3상임상서효과입증,http://view.asiae.co.kr/news/view.htm?idxno=2019032517360965760
1960,2019-03-25,대웅제약나보타美3상임상결과국제학술지게재,http://www.skyedaily.com/news/news_view.html?ID=83132
1961,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.wsobi.com/news/articleView.html?idxno=71223
1962,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.ftoday.co.kr/news/articleView.html?idxno=107471
1963,2019-03-26,대웅제약당기순이익적자전환에도배당은그대로,http://www.datanews.co.kr/news/article.html?no=102556
1964,2019-03-26,대웅제약나보타미국3상위약대비우수효과입증,http://www.viva100.com/main/view.php?key=20190326010008709
1965,2019-03-26,★주식인사이드대웅제약주가182500원3월26일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=611274
1966,2019-03-26,대웅제약대신SK바이오랜드와손잡은강스템바이오텍,http://news.hankyung.com/article/201903264939f
1967,2019-03-26,대웅제약주가증권그래프26일현재186500원,http://www.gokorea.kr/news/articleView.html?idxno=131381
1968,2019-03-26,대웅제약시세보기26일현재186500원,http://www.nbntv.co.kr/news/articleView.html?idxno=279072
1969,2019-03-26,대웅제약미국시장진출한목표향한선택과집중,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228691
1970,2019-03-26,스타★주식인사이드대웅제약주가186000원3월26일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=612331
1971,2019-03-26,대웅제약눈덩이적자에도고배당고수왜,http://www.newsfc.co.kr/news/articleView.html?idxno=35690
1972,2019-03-26,대웅제약가족친화중점둔혁신지향기업문화추진한다,http://www.lawissue.co.kr/view.php?ud=2019032617455673259817d053b9_12
1973,2019-03-26,대웅제약우루사미국진출중단TV광고논란이중고,http://www.wolyo.co.kr/news/articleView.html?idxno=80289
1974,2019-03-27,대웅제약해외법인은밑빠진독11개중10곳적자내며사상최대손실,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=530580
1975,2019-03-27,★주식인사이드대웅제약주가185000원3월27일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=613423
1976,2019-03-27,대웅제약오늘주식장27일현재184000원,http://www.nbntv.co.kr/news/articleView.html?idxno=281506
1977,2019-03-27,스타★주식인사이드대웅제약주가183000원3월27일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=614521
1978,2019-03-27,대웅제약주가3월27일현재185000원,http://www.gokorea.kr/news/articleView.html?idxno=133183
1979,2019-03-28,★주식인사이드대웅제약주가183500원3월28일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=615582
1980,2019-03-28,3월28일대웅제약주식추천주183500원027,http://www.nbntv.co.kr/news/articleView.html?idxno=283932
1981,2019-03-28,스타★주식인사이드대웅제약주가183500원3월28일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=616710
1982,2019-03-29,한투證대웅제약하반기실적개선예상매수의견,http://www.newsis.com/view/?id=NISX20190329_0000603142&cID=10401&pID=10400
1983,2019-03-29,대웅제약주보미국출시효과기대매수한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1739547
1984,2019-03-29,대웅제약美파트너사현지보톨리눔톡신출시기대한국투자증권,https://www.sedaily.com/NewsView/1VGS08Y2FQ
1985,2019-03-29,★주식인사이드대웅제약주가185000원3월29일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=617794
1986,2019-03-29,특징주대웅제약실적개선전망에상승세,http://www.newsis.com/view/?id=NISX20190329_0000603286&cID=10401&pID=10400
1987,2019-03-29,대웅제약목표가25만원유지전일종가18만3000원한투證,http://www.newspim.com/news/view/20190329000204
1988,2019-03-29,퀵리포트대웅제약매수유지목표가25만원유지한투證,http://www.itooza.com/common/iview.php?no=2019032909305718215
1989,2019-03-29,대웅제약주가오른다보톡스미국수출로수익성좋아져,http://www.businesspost.co.kr/BP?command=article_view&num=120743
1990,2019-03-29,대웅제약주식종목시세29일현재182500원,http://www.nbntv.co.kr/news/articleView.html?idxno=286356
1991,2019-03-29,대웅제약美주보매출하반기본격장기성장성뚜렷한국證,http://news.mt.co.kr/mtview.php?no=2019032910294495774
1992,2019-03-29,스타★주식인사이드대웅제약주가184000원3월29일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=618895
1993,2019-03-29,대웅제약매출비중확대로주가↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=350365
1994,2019-03-29,대웅제약미국보툴리눔톡신시장진출하반기본격매출발생전망,http://www.econovill.com/news/articleView.html?idxno=359835
1995,2019-04-01,대웅제약목표가30만원유지전일종가18만4000원KTB證,http://www.newspim.com/news/view/20190401000168
1996,2019-04-01,퀵리포트대웅제약매수유지목표가30만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019040108102913073
1997,2019-04-01,★주식인사이드대웅제약주가185500원4월1일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=619972
1998,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228941
1999,2019-04-01,대웅제약 국내최초액상형아세트아미노펜 이지엔6 에이스 출시,http://www.fetv.co.kr/news/article.html?no=24717
2000,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.ebn.co.kr/news/view/978954
2001,2019-04-01,대웅제약액상형아세트아미노펜연질캡슐이지엔6에이스출시,http://www.fnnews.com/news/201904011454029518
2002,2019-04-01,대웅제약국내1위액상진통제이지엔6캡슐로나온다,http://www.seoulwire.com/news/articleView.html?idxno=100623
2003,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.medigatenews.com/news/2508506584
2004,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,http://www.asiatime.co.kr/news/articleView.html?idxno=237269
2005,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=350562
2006,2019-04-01,스타★주식인사이드대웅제약주가186500원4월1일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=621062
2007,2019-04-01,대웅제약임산부도안전한액상형진통제이지엔6에이스출시,http://www.newspim.com/news/view/20190401000982
2008,2019-04-01,대웅제약국내첫액상형아세트아미노펜이지엔6에이스출시,http://www.medisobizanews.com/news/articleView.html?idxno=58833
2009,2019-04-01,대웅제약국내최초액상형연질캡슐이지엔6에이스출시,http://daily.hankooki.com/lpage/ittech/201904/dh20190401152429145630.htm
2010,2019-04-01,대웅제약액상형진통제이지엔6에이스출시,http://www.bokuennews.com/news/article.html?no=173688
2011,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019040100206
2012,2019-04-01,대웅제약캡슐형해열진통제이지엔6에이스출시,http://www.ezyeconomy.com/news/articleView.html?idxno=89431
2013,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.newscj.com/news/articleView.html?idxno=616779
2014,2019-04-01,대웅제약효과빠른액상형진통제시장선점이지엔6에이스출시,http://kpenews.com/View.aspx?No=30597
2015,2019-04-01,대웅제약국내최초액상형아세트아미노펜출시,http://medipana.com/news/news_viewer.asp?NewsNum=236850&MainKind=A&NewsKind=5&vCount=12&vKind=1
2016,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019040115534046759
2017,2019-04-01,대웅제약효과빠른액상진통제이지엔6에이스출시,http://www.newsis.com/view/?id=NISX20190401_0000606039&cID=13001&pID=13000
2018,2019-04-01,대웅제약액상해열진통제이지엔6에이스출시,http://news1.kr/articles/?3586044
2019,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.economytalk.kr/news/articleView.html?idxno=182556
2020,2019-04-01,대웅제약시세보기1일현재185500원,http://www.nbntv.co.kr/news/articleView.html?idxno=289443
2021,2019-04-01,대웅제약지난해4분기연결영업이익34억전년비59↓,http://www.newspim.com/news/view/20190401001840
2022,2019-04-01,실적속보대웅제약지난해4Q영업이익34억전년비59↓,http://www.itooza.com/common/iview.php?no=2019040117151682043
2023,2019-04-01,대웅제약액상형진통제이지엔6에이스출시,http://www.kpinews.co.kr/news/articleView.html?idxno=93446
2024,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,http://www.dailian.co.kr/news/view/784235/?sc=naver
2025,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1740553
2026,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.mhj21.com/120488
2027,2019-04-01,코스피대웅제약2018년매출액1조314억원영업이익245억원연결기준,http://news.kmib.co.kr/article/view.asp?arcid=0013193358&code=61141211&cp=nv
2028,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스내놔,http://www.wolyo.co.kr/news/articleView.html?idxno=80756
2029,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.koreaittimes.com/news/articleView.html?idxno=90042
2030,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,https://www.sedaily.com/NewsView/1VHP3IPKCN
2031,2019-04-01,대웅제약액상형해열진통제이지엔6에이스출시,http://www.viva100.com/main/view.php?key=20190401010000473
2032,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,http://www.getnews.co.kr/view.php?ud=20190401185503851841d0c69529_16
2033,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=51762
2034,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.rapportian.com/news/articleView.html?idxno=116890
2035,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,http://www.lawissue.co.kr/view.php?ud=201904011935478860d7f4c63cc6_12
2036,2019-04-01,대웅제약효과빠른액상진통제이지엔6에이스출시,http://news.mk.co.kr/newsRead.php?year=2019&no=197983
2037,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.ajunews.com/view/20190401222606156
2038,2019-04-02,대웅제약국내첫액상형아세트아미노펜이지엔6에이스출시,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3796713
2039,2019-04-02,대웅제약액상형이지엔6에이스출시빠른진통효과눈길,http://www.sportsworldi.com/content/html/2019/04/01/20190401514609.html
2040,2019-04-02,일간보사창간특집대웅제약글로벌사업현지화전략승부,http://www.bosa.co.kr/news/articleView.html?idxno=2102481
2041,2019-04-02,★주식인사이드대웅제약주가185500원4월2일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=622126
2042,2019-04-02,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=8480
2043,2019-04-02,대웅제약액상형진통제이지엔6에이스출시,http://www.bosa.co.kr/news/articleView.html?idxno=2102506
2044,2019-04-02,정현호메디톡스대표대웅제약나보타보툴리눔균주기원밝혀라,http://www.asiatoday.co.kr/view.php?key=20190402010001382
2045,2019-04-02,제약토크액상형아세트아미노펜진통제대웅제약이지엔6에이스,https://www.insight.co.kr/news/220151
2046,2019-04-02,정종근전대웅제약부사장아들511,http://medipana.com/news/news_viewer.asp?NewsNum=236899&MainKind=A&NewsKind=5&vCount=12&vKind=1
2047,2019-04-02,대웅제약개발SGLT2당뇨신약녹십자에서도입,http://www.dailypharm.com/Users/News/NewsView.html?ID=251117&REFERER=NP
2048,2019-04-02,ET투자뉴스대웅제약_주가거래량투심모두적정주순,http://www.etnews.com/20190402000218
2049,2019-04-02,ET투자뉴스대웅제약지분변동국민연금공단외1명107p증가927보유,http://www.etnews.com/20190402000230
2050,2019-04-02,대웅제약거래량증가하며주가상승주가323↑,http://www.tfnews.co.kr/news/article.html?no=64155
2051,2019-04-02,스타★주식인사이드대웅제약주가191500원4월2일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=623189
2052,2019-04-02,마켓브레인함보름대웅제약인사팀장채용제약실무부터교육시켜야죠,http://www.ajunews.com/view/20190402141527808
2053,2019-04-02,ET투자뉴스대웅제약지분변동국민연금공단외1명107p증가927보유,http://www.etnews.com/20190402000415
2054,2019-04-02,오늘주식시세대웅제약주가2일현재190500원,http://www.nbntv.co.kr/news/articleView.html?idxno=290882
2055,2019-04-02,2일기관순매수Top10TIGER2002009억KODEX코스닥150레버리지107억대웅제약58억코웨이37억기관순매수나서코스닥시장에서는JYPEnt에스엠위메이드상위,http://www.fintechpost.co.kr/news/articleView.html?idxno=29831
2056,2019-04-03,★주식인사이드대웅제약주가189000원4월3일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=624280
2057,2019-04-03,대웅제약항궤양제알비스발매20주년심포지엄개최,http://moneys.mt.co.kr/news/mwView.php?no=2019040309058048469
2058,2019-04-03,대웅제약국내1위알비스20주년심포지엄소화기질환선두주자입지굳힐것,http://www.seoulwire.com/news/articleView.html?idxno=101633
2059,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,https://www.sedaily.com/NewsView/1VHPZ8D6DP
2060,2019-04-03,대웅제약처방1위항궤양제알비스발매20주년심포지엄개최,http://news.mk.co.kr/newsRead.php?year=2019&no=201825
2061,2019-04-03,대웅제약알비스발매20주년심포지엄열어,http://www.dailypharm.com/Users/News/NewsView.html?ID=251153&REFERER=NP
2062,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.ebn.co.kr/news/view/979270
2063,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.fetv.co.kr/news/article.html?no=24907
2064,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.newsway.co.kr/news/view?tp=1&ud=2019040309381448854
2065,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.wolyo.co.kr/news/articleView.html?idxno=80876
2066,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.dailian.co.kr/news/view/784679/?sc=naver
2067,2019-04-03,대웅제약알비스발매20주년기념심포지엄성료,http://www.asiatime.co.kr/news/articleView.html?idxno=237692
2068,2019-04-03,대웅제약항궤양제알비스발매20주년기념심포지엄개최,http://www.newspim.com/news/view/20190403000158
2069,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229014
2070,2019-04-03,대웅제약항궤양제알비스발매20주년기념심포지엄개최,http://www.ezyeconomy.com/news/articleView.html?idxno=89486
2071,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.ekn.kr/news/article.html?no=424265
2072,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.fnnews.com/news/201904031013593157
2073,2019-04-03,더벨대웅제약A급흥행이을까적자전환부담,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904020100004630000293
2074,2019-04-03,대웅제약알비스발매20주년기념심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2102592
2075,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.etnews.com/20190403000097
2076,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://daily.hankooki.com/lpage/ittech/201904/dh20190403103849145630.htm
2077,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125536&REFERER=NP
2078,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.gokorea.kr/news/articleView.html?idxno=139602
2079,2019-04-03,대웅제약항궤양제알비스발매20주년기념심포지엄개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1741250
2080,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019040300067
2081,2019-04-03,대웅제약알비스출시20주년광범위한항궤양제로시장1위굳건,http://www.medisobizanews.com/news/articleView.html?idxno=58880
2082,2019-04-03,20주년맞은대웅제약알비스소화기질환최신지견공유,http://www.viva100.com/main/view.php?key=20190403010001131
2083,2019-04-03,대웅제약알비스발매20주년기념심포지엄성료,http://www.whosaeng.com/109152
2084,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.newspost.kr/news/articleView.html?idxno=70248
2085,2019-04-03,스타★주식인사이드대웅제약주가190500원4월3일13시13분기준,http://www.newsinside.kr/news/articleView.html?idxno=625338
2086,2019-04-03,대웅제약항궤양제알비스발매20주년심포지엄성료,http://www.rapportian.com/news/articleView.html?idxno=116917
2087,2019-04-03,대웅제약주가4월3일현재191500원,http://www.gokorea.kr/news/articleView.html?idxno=139890
2088,2019-04-03,대웅제약항궤양제알비스발매20주년기념심포지엄진행,http://www.newsprime.co.kr/news/article.html?no=453572
2089,2019-04-03,대웅제약오늘주식시장3일현재190500원,http://www.nbntv.co.kr/news/articleView.html?idxno=291940
2090,2019-04-03,대웅제약항궤양제알비스20주년기념심포지엄개최,http://news.donga.com/3/all/20190403/94872252/2
2091,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최지속적인연구개발통해환자삶의질개선주력,http://www.segye.com/content/html/2019/04/03/20190403511126.html?OutUrl=naver
2092,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.joseilbo.com/news/news_read.php?uid=373743&class=27&grp=
2093,2019-04-03,대웅제약알비스발매20주년심포지엄개최 ,http://www.monews.co.kr/news/articleView.html?idxno=201807
2094,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.skyedaily.com/news/news_view.html?ID=83436
2095,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.newscj.com/news/articleView.html?idxno=617723
2096,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.lawissue.co.kr/view.php?ud=20190403233324713d7f4c63cc6_12
2097,2019-04-04,★주식인사이드대웅제약주가190000원4월4일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=626406
2098,2019-04-04,4월4일대웅제약오늘주식시장190000원078,http://www.nbntv.co.kr/news/articleView.html?idxno=293744
2099,2019-04-04,스타★주식인사이드대웅제약주가190000원4월4일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=627507
2100,2019-04-04,대웅제약미국에서보툴리눔톡신나보타적응증확대서둘러,http://www.businesspost.co.kr/BP?command=article_view&num=121687
2101,2019-04-04,주름잡는대웅제약나보타탈모등치료목적연구도활기,http://biz.chosun.com/site/data/html_dir/2019/04/04/2019040402234.html
2102,2019-04-04,대웅제약자회사시지바이오의지젤크루지젤리뉴정확하고바른정보전달한다,http://kor.theasian.asia/archives/216589
2103,2019-04-05,★주식인사이드대웅제약주가189000원4월5일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=628654
2104,2019-04-05,대웅제약주식시세현황5일현재189000원,http://www.nbntv.co.kr/news/articleView.html?idxno=296195
2105,2019-04-05,4월5일대웅제약정보및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=143579
2106,2019-04-05,스타★주식인사이드대웅제약주가187000원4월5일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=629735
2107,2019-04-07,대웅제약젊은전문경영인전승호글로벌진출선봉에서다,http://www.businesspost.co.kr/BP?command=article_view&num=121993
2108,2019-04-08,대웅제약셀트리온제약등시설신축증설돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=351125
2109,2019-04-08,★주식인사이드대웅제약주가188000원4월8일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=630815
2110,2019-04-08,주식시세현황대웅제약주가8일현재186000원,http://www.nbntv.co.kr/news/articleView.html?idxno=299048
2111,2019-04-08,대웅제약액상형진통제이지엔6에이스출시,http://www.skyedaily.com/news/news_view.html?ID=83595
2112,2019-04-08,대웅제약알비스발매20주년기념심포지엄개최,http://www.skyedaily.com/news/news_view.html?ID=83594
2113,2019-04-08,스타★주식인사이드대웅제약주가185000원4월8일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=631901
2114,2019-04-09,대웅제약미국수출본격화로구조적실적개선기대NH,https://www.hankyung.com/article/2019040941256
2115,2019-04-09,단독대웅제약나보타유럽에서누시바로판매된다,http://news1.kr/articles/?3591985
2116,2019-04-09,대웅제약나보타수출본격화에실적개선시작NH,http://www.fnnews.com/news/201904090742399907
2117,2019-04-09,대웅제약목표가24만원유지전일종가18만5500원NH證,http://www.newspim.com/news/view/20190409000080
2118,2019-04-09,퀵리포트대웅제약매수유지목표가24만원유지NH證,http://www.itooza.com/common/iview.php?no=2019040908085016892
2119,2019-04-09,HotLine대웅제약이익구조개선과RD진전예상,http://news.mk.co.kr/newsRead.php?year=2019&no=215977
2120,2019-04-09,★주식인사이드대웅제약주가189000원4월9일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=632988
2121,2019-04-09,GET투자리포트대웅제약투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201904091030303638tpgetnews_16
2122,2019-04-09,주식종목시세대웅제약주가9일현재187500원,http://www.nbntv.co.kr/news/articleView.html?idxno=301404
2123,2019-04-09,대웅제약주가오늘시세및주체별매매동향9일현재188000원,http://www.gokorea.kr/news/articleView.html?idxno=147884
2124,2019-04-09,ET투자뉴스대웅제약구조적이익성장BUY유지NH투자증권,http://www.etnews.com/20190409000117
2125,2019-04-09,나신평대웅제약적자전환에도신용등급A유지,http://www.etoday.co.kr/news/section/newsview.php?idxno=1743103
2126,2019-04-09,스타★주식인사이드대웅제약주가188000원4월9일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=634037
2127,2019-04-09,대웅제약신제품효과로국내영업호조”,http://www.wikitree.co.kr/main/news_view.php?id=418771
2128,2019-04-09,대웅제약2분기중나보타기술료효과거둔다,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019040917413803617&objId=A2019040917413803617&portalCode=naver
2129,2019-04-09,대웅제약나보타유럽상품명누시바로결정,http://www.rapportian.com/news/articleView.html?idxno=117026
2130,2019-04-10,대웅제약안구건조증신약탄파너셉트황반변성치료제로개발,http://www.medisobizanews.com/news/articleView.html?idxno=59013
2131,2019-04-10,★주식인사이드대웅제약주가191500원4월10일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=635162
2132,2019-04-10,실시간분석대웅제약32상승증권사목표가24만원제시,http://www.itooza.com/common/iview.php?no=2019041009183726341
2133,2019-04-10,대웅제약5이상상승구조적이익성장개시NH투자증권BUY유지,https://www.hankyung.com/article/201904109159L
2134,2019-04-10,4월10일대웅제약주식그래프194500원401,http://www.nbntv.co.kr/news/articleView.html?idxno=303781
2135,2019-04-10,스타★주식인사이드대웅제약주가194000원4월10일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=636242
2136,2019-04-11,대웅제약목표가13↑26만원제시하이투자證,http://www.newspim.com/news/view/20190411000076
2137,2019-04-11,퀵리포트대웅제약매수유지목표가13↑26만원하이투자證,http://www.itooza.com/common/iview.php?no=2019041108044614647
2138,2019-04-11,보톨리눔톡신지속성장메디톡스대웅제약주목대신,http://www.edaily.co.kr/news/newspath.asp?newsid=01469446622455136
2139,2019-04-11,대웅제약나보타성공스토리가시화목표가↑”하이투자증권,http://www.dailian.co.kr/news/view/786810/?sc=naver
2140,2019-04-11,대웅제약신약나보타매출확대본격화목표가↑하이,http://www.edaily.co.kr/news/newspath.asp?newsid=01561286622455136
2141,2019-04-11,대웅제약가시화되는나보타성공가능성목표가↑하이,https://www.hankyung.com/article/2019041129976
2142,2019-04-11,바이오뷰티산업비중확대메디톡스대웅제약선호대신증권,http://www.fnnews.com/news/201904110843458881
2143,2019-04-11,하이투자證대웅제약나보타성공가시화매수의견,http://www.newsis.com/view/?id=NISX20190411_0000617012&cID=10401&pID=10400
2144,2019-04-11,ET투자뉴스대웅제약가시화되는나보타BUY유지하이투자증권,http://www.etnews.com/20190411000011
2145,2019-04-11,대웅제약나보타영향으로이익증가전망하이투자證,http://www.seoulfn.com/news/articleView.html?idxno=339427
2146,2019-04-11,대웅제약나보타출시효과로실적개선전망하이투자증권,https://www.sedaily.com/NewsView/1VHTOKJ4EN
2147,2019-04-11,ET투자뉴스대웅제약나보타로예뻐지는BUY유지대신증권,http://www.etnews.com/20190411000022
2148,2019-04-11,★주식인사이드대웅제약주가195000원4월11일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=637352
2149,2019-04-11,GET투자리포트대웅제약투자의견매수유지하이투자증권,http://www.getnews.co.kr/view.php?ud=201904111030303724tpgetnews_16
2150,2019-04-11,GET투자리포트대웅제약투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=201904111030303732tpgetnews_16
2151,2019-04-11,대웅제약주가오른다보톡스나보타5월부터미국수출,http://www.businesspost.co.kr/BP?command=article_view&num=122661
2152,2019-04-11,바이오뷰티시장확대대웅제약메디톡스주목,http://news.heraldcorp.com/view.php?ud=20190411000311
2153,2019-04-11,4월11일대웅제약주식추천주026194000원,http://www.nbntv.co.kr/news/articleView.html?idxno=306236
2154,2019-04-11,바이오뷰티시장다변화대웅제약메디톡스주목,http://news.heraldcorp.com/view.php?ud=20190411000522
2155,2019-04-11,대웅제약목표가25만원신규제시전일종가19만3500원대신證,http://www.newspim.com/news/view/20190411000532
2156,2019-04-11,퀵리포트대웅제약매수목표가25만원신규제시대신證,http://www.itooza.com/common/iview.php?no=2019041112584815966
2157,2019-04-11,특징주대웅제약전사업부문양호한실적성장세유지기대,http://www.sisaon.co.kr/news/articleView.html?idxno=91818
2158,2019-04-11,스타★주식인사이드대웅제약주가195000원4월11일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=638469
2159,2019-04-11,대웅제약가시화되는나보타성공스토리하이투증,http://www.economytalk.kr/news/articleView.html?idxno=183333
2160,2019-04-12,★주식인사이드대웅제약주가197500원4월12일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=639588
2161,2019-04-12,대웅제약나보타임상3상국제성형외과학술지에게재,http://moneys.mt.co.kr/news/mwView.php?no=2019041210258023654
2162,2019-04-12,대웅제약나보타보톡스대비비열등성입증임상결과국제학술지게재,http://www.koreaittimes.com/news/articleView.html?idxno=90273
2163,2019-04-12,대웅제약나보타보톡스대비효과안전성비열등성입증,http://www.viva100.com/main/view.php?key=20190412010004405
2164,2019-04-12,대웅제약나보타보톡스대비임상결과학술지게재,http://www.ebn.co.kr/news/view/980603
2165,2019-04-12,대웅제약나보타보톡스비교임상결과국제학술지에게재,http://news.mk.co.kr/newsRead.php?year=2019&no=225880
2166,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229349
2167,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.newsway.co.kr/news/view?tp=1&ud=2019041210460135439
2168,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.sisafocus.co.kr/news/articleView.html?idxno=207279
2169,2019-04-12,대웅제약나보타보톡스와효과차이없어논문으로입증,http://www.edaily.co.kr/news/newspath.asp?newsid=02751926622455464
2170,2019-04-12,대웅제약나보타보톡스보다미간주름에효과적,http://www.kpinews.co.kr/news/articleView.html?idxno=94104
2171,2019-04-12,대웅제약주가그래프12일현재200000원,http://www.nbntv.co.kr/news/articleView.html?idxno=308690
2172,2019-04-12,실시간분석대웅제약3상승증권사목표가26만원제시,http://www.itooza.com/common/iview.php?no=2019041210573212984
2173,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.etnews.com/20190412000140
2174,2019-04-12,대웅제약나보타보톡스대비3상결과국제학술지게재,http://www.medisobizanews.com/news/articleView.html?idxno=59074
2175,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://medipana.com/news/news_viewer.asp?NewsNum=237435&MainKind=A&NewsKind=5&vCount=12&vKind=1
2176,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.mediapen.com/news/view/426590
2177,2019-04-12,대웅제약나보타보톡스보다미간주름개선효과있어,http://www.newsis.com/view/?id=NISX20190412_0000618772&cID=13001&pID=13000
2178,2019-04-12,대웅제약나보타보톡스비교임상결과국제학술지게재,http://www.newspim.com/news/view/20190412000320
2179,2019-04-12,대웅제약나보타보톡스보다낫다임상결과국제학술지게재,http://kpenews.com/View.aspx?No=31284
2180,2019-04-12,대웅제약나보타보톡스대비비열등성입증국제학술지실려,http://www.etoday.co.kr/news/section/newsview.php?idxno=1744548
2181,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.medigatenews.com/news/1772101178
2182,2019-04-12,대웅제약나보타임상결과국제학술지게재,http://www.mdtoday.co.kr/mdtoday/index.html?no=351708
2183,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.bosa.co.kr/news/articleView.html?idxno=2103271
2184,2019-04-12,대웅제약세계를사로잡은나보타SCI급국제학술지게재,http://www.seoulwire.com/news/articleView.html?idxno=109059
2185,2019-04-12,대웅제약라이선스인신약물질다수임상진전,http://www.dailypharm.com/Users/News/NewsView.html?ID=251520&REFERER=NP
2186,2019-04-12,대웅제약나보타미간주름개선효과안정성보톡스대비비열등성입증,http://www.newsprime.co.kr/news/article.html?no=454917
2187,2019-04-12,대웅제약나보타유럽및캐나다3상임상결과국제학술지게재,http://www.businesskorea.co.kr/news/articleView.html?idxno=30845
2188,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.asiatime.co.kr/news/articleView.html?idxno=239632
2189,2019-04-12,대웅제약보툴리눔톡신나보타미간주름개선입증,http://www.econovill.com/news/articleView.html?idxno=360790
2190,2019-04-12,대웅제약나보타보톡스대비미간주름개선효과더높아유럽캐나다3상임상결과SCI급국제학술지게재,http://www.ezyeconomy.com/news/articleView.html?idxno=89799
2191,2019-04-12,대웅제약나보타미간주름개선효과보톡스비열등성입증,http://www.monews.co.kr/news/articleView.html?idxno=202009
2192,2019-04-12,스타★주식인사이드대웅제약주가200000원4월12일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=640696
2193,2019-04-12,아스트라제네카대웅제약에계열사판매재하청금지통보,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019041215295402631&objId=A2019041215295402631&portalCode=naver
2194,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.newspost.kr/news/articleView.html?idxno=70529
2195,2019-04-12,대웅제약나보타보톡스대비비열등입증,http://daily.hankooki.com/lpage/ittech/201904/dh20190412154804145630.htm
2196,2019-04-12,대웅제약나보타보톡스와동등한미간주름개선효과확인,http://www.businesspost.co.kr/BP?command=article_view&num=122935
2197,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.wikileaks-kr.org/news/articleView.html?idxno=52804
2198,2019-04-12,대웅제약나보타임상국제학술지게재보톡스比비열등성입증”,http://www.inthenews.co.kr/news/article.html?no=14693
2199,2019-04-12,대웅제약나보타미간주름개선효과보톡스와동등이상 ,http://www.seoulfn.com/news/articleView.html?idxno=339704
2200,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.ekn.kr/news/article.html?no=426217
2201,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.dailian.co.kr/news/view/787387/?sc=naver
2202,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.getnews.co.kr/view.php?ud=20190412175143627141d0c69529_16
2203,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.100ssd.co.kr/news/articleView.html?idxno=60654
2204,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.newscj.com/news/articleView.html?idxno=621166
2205,2019-04-13,대웅제약나보타보톡스대비비열등성입증,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067247
2206,2019-04-13,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.lawissue.co.kr/view.php?ud=201904131043508794d7f4c63cc6_12
2207,2019-04-14,대웅제약나보타보톡스대비임상결과국제학술지게재우수한안전성입증,http://www.segye.com/content/html/2019/04/14/20190414504206.html?OutUrl=naver
2208,2019-04-14,美에보톡스본격수출대웅제약실적기지개,http://news.mk.co.kr/newsRead.php?year=2019&no=229552
2209,2019-04-14,대웅제약나보타보톡스대비임상결과국제학술지게재,https://www.insight.co.kr/news/222455
2210,2019-04-15,대웅제약나보타글로벌위상확대의사교육프로그램개최,http://www.seoulwire.com/news/articleView.html?idxno=109974
2211,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알렸다,http://www.segye.com/content/html/2019/04/15/20190415503389.html?OutUrl=naver
2212,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.newsway.co.kr/news/view?tp=1&ud=2019041509463867517
2213,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229403
2214,2019-04-15,대웅제약6개국미용성형의사와톡신최신지견공유,http://medipana.com/news/news_viewer.asp?NewsNum=237506&MainKind=A&NewsKind=5&vCount=12&vKind=1
2215,2019-04-15,★주식인사이드대웅제약주가203500원4월15일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=641792
2216,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.metroseoul.co.kr/news/newsview?newscd=2019041500033
2217,2019-04-15,FDA프리미엄대웅제약나보타브랜드가치↑,http://www.viva100.com/main/view.php?key=20190415010004931
2218,2019-04-15,대웅제약해외의사들과함께나보타마스터클래스성황리마쳐,http://www.medisobizanews.com/news/articleView.html?idxno=59099
2219,2019-04-15,대웅제약2019춘계해외의사마스터클래스개최,http://www.ezyeconomy.com/news/articleView.html?idxno=89832
2220,2019-04-15,대웅제약나보타해외의사교육프로그램개최,http://www.ebn.co.kr/news/view/980818
2221,2019-04-15,대웅제약해외의사교육프로그램개최나보타우수성홍보,http://www.newspim.com/news/view/20190415000233
2222,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.wolyo.co.kr/news/articleView.html?idxno=81730
2223,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.dailian.co.kr/news/view/787744/?sc=naver
2224,2019-04-15,대웅제약멕시코등6개국의사초청해나보타마스터클래스개최,http://news.mk.co.kr/newsRead.php?year=2019&no=230626
2225,2019-04-15,대웅제약해외의사교육나보타마스터클래스개최,http://news.mt.co.kr/mtview.php?no=2019041508480392939
2226,2019-04-15,4월15일대웅제약오늘주식202500원176,http://www.nbntv.co.kr/news/articleView.html?idxno=311434
2227,2019-04-15,대웅제약해외의사교육프로그램서나보타우수성전파,http://www.asiatime.co.kr/news/articleView.html?idxno=239937
2228,2019-04-15,대웅제약해외의사교육프로그램통해나보타소개,http://www.bosa.co.kr/news/articleView.html?idxno=2103366
2229,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.100ssd.co.kr/news/articleView.html?idxno=60726
2230,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://daily.hankooki.com/lpage/ittech/201904/dh20190415113844145630.htm
2231,2019-04-15,대웅제약6개국미용성형분야전문의대상나보타마스터클래스개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067286
2232,2019-04-15,대웅제약나보타마스터클래스개최임상결과시술법최신지견공유,http://www.newsprime.co.kr/news/article.html?no=455198
2233,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.etnews.com/20190415000243
2234,2019-04-15,대웅제약5거래일연속상승전일대비3상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201904150435&t=NN
2235,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.metroseoul.co.kr/news/newsview?newscd=2019041500031
2236,2019-04-15,대웅제약해외의사초청해나보타홍보,http://www.finomy.com/news/articleView.html?idxno=64790
2237,2019-04-15,스타★주식인사이드대웅제약주가203500원4월15일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=642919
2238,2019-04-15,대웅제약나보타마스터클래스개최해외의사45명참가,http://news.donga.com/3/all/20190415/95057754/1
2239,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.wikileaks-kr.org/news/articleView.html?idxno=52940
2240,2019-04-15,대웅제약해외의사교육프로그램성료,http://www.joseilbo.com/news/news_read.php?uid=374595&class=17&grp=
2241,2019-04-15,대웅제약5개국의사45명초청나보타교육,http://www.whosaeng.com/109426
2242,2019-04-15,나보타보러6개국의사45명내한대웅제약기술공유,http://news.heraldcorp.com/view.php?ud=20190415000755
2243,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.economytalk.kr/news/articleView.html?idxno=183527
2244,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.newscj.com/news/articleView.html?idxno=621970
2245,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,https://www.insight.co.kr/news/222702
2246,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.lawissue.co.kr/view.php?ud=201904152240322735d7f4c63cc6_12
2247,2019-04-16,대웅제약1000억조달추진유동사채절반차환,http://www.dailypharm.com/Users/News/NewsView.html?ID=251628&REFERER=NP
2248,2019-04-16,대웅제약나보타로올영업이익93증가목표가↑키움,https://www.hankyung.com/article/2019041681456
2249,2019-04-16,클릭e종목대웅제약나보타덕에이익성장폭높을것,http://view.asiae.co.kr/news/view.htm?idxno=2019041608045142874
2250,2019-04-16,대웅제약나보타로올해이익증가폭커목표가↑키움,http://www.edaily.co.kr/news/newspath.asp?newsid=01623606622456776
2251,2019-04-16,대웅제약목표가4↑25만원제시키움證,http://www.newspim.com/news/view/20190416000124
2252,2019-04-16,퀵리포트대웅제약매수유지목표가4↑25만원키움證,http://www.itooza.com/common/iview.php?no=2019041608301314153
2253,2019-04-16,키움증권대웅제약나보타수출로실적개선목표가↑,http://yna.kr/AKR20190416028100008?did=1195m
2254,2019-04-16,GET투자리포트대웅제약투자의견매수유지키움증권,http://www.getnews.co.kr/view.php?ud=201904161030303927tpgetnews_16
2255,2019-04-16,대웅제약나보타로올해높은이익성장전망키움證,http://www.seoulfn.com/news/articleView.html?idxno=339921
2256,2019-04-16,대웅제약나보타수출로실적개선목표가↑키움증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1745493
2257,2019-04-16,키움證대웅제약나보타실적이올해성장동력목표가↑,http://www.newsis.com/view/?id=NISX20190416_0000621767&cID=10401&pID=10400
2258,2019-04-16,대웅제약나보타수출로실적개선기대키움증권,https://www.sedaily.com/NewsView/1VHVYYZNVT
2259,2019-04-16,ET투자뉴스대웅제약나보타로올해이익BUY유지키움증권,http://www.etnews.com/20190416000016
2260,2019-04-16,★주식인사이드대웅제약주가203500원4월16일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=644087
2261,2019-04-16,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.wsobi.com/news/articleView.html?idxno=72081
2262,2019-04-16,키움증권대웅제약나보타수출호조에실적개선가능성”,http://www.kukinews.com/news/article.html?no=652840
2263,2019-04-16,키움증권대웅제약나보타수출로실적개선목표가↑,https://www.insight.co.kr/news/222766
2264,2019-04-16,대웅제약주식주가16일현재207000원,http://www.nbntv.co.kr/news/articleView.html?idxno=313865
2265,2019-04-16,스타★주식인사이드대웅제약주가206000원4월16일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=645125
2266,2019-04-16,대웅제약전문경영인체제맞나윤재승막후경영의혹,http://www.shinailbo.co.kr/news/articleView.html?idxno=1159131
2267,2019-04-16,대웅제약나보타로올해이익성장폭높아”,http://www.wikitree.co.kr/main/news_view.php?id=420649
2268,2019-04-16,수익해결사내일공략주동운아나텍094170대웅제약069620,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019041618082165055
2269,2019-04-16,대웅제약해외의사교육프로그램서나보타알려,http://www.kpanews.co.kr/article/show.asp?idx=203190&table=article&category=D
2270,2019-04-17,★주식인사이드대웅제약주가208000원4월17일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=646200
2271,2019-04-17,GET투자리포트대웅제약투자의견Positive유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201904171030304004tpgetnews_16
2272,2019-04-17,대웅제약회사채1천억발행4천400억몰려,http://news.einfomax.co.kr/news/articleView.html?idxno=4025956
2273,2019-04-17,더벨대웅제약회사채완판8연타석안타,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904160100031240001929
2274,2019-04-17,4월17일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=160338
2275,2019-04-17,4월17일대웅제약실시간증시206000원000,http://www.nbntv.co.kr/news/articleView.html?idxno=316228
2276,2019-04-17,스타★주식인사이드대웅제약주가205000원4월17일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=647243
2277,2019-04-17,제약산업육성지원법발의에대웅제약녹십자기술수출기대품어,http://www.businesspost.co.kr/BP?command=article_view&num=123610
2278,2019-04-18,★주식인사이드대웅제약주가204000원4월18일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=648337
2279,2019-04-18,대웅제약주식종목18일현재203500원,http://www.nbntv.co.kr/news/articleView.html?idxno=318578
2280,2019-04-18,3월원외처방1위한미약품종근당〉대웅제약順,http://www.dailymedi.com/detail.php?number=842161&thread=22r05
2281,2019-04-18,스타★주식인사이드대웅제약주가202000원4월18일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=649383
2282,2019-04-19,대웅제약목표가18↑26만원제시유안타證,http://www.newspim.com/news/view/20190419000062
2283,2019-04-19,퀵리포트대웅제약매수유지목표가18↑26만원유안타證,http://www.itooza.com/common/iview.php?no=2019041908145118903
2284,2019-04-19,대웅제약나보타美수출개시로1분기호실적목표가↑유안타,http://www.edaily.co.kr/news/newspath.asp?newsid=01446486622457760
2285,2019-04-19,유안타증권대웅제약나보타美매출시작목표주가↑,http://yna.kr/AKR20190419025200008?did=1195m
2286,2019-04-19,HotLine대웅제약나보타미국시장안착기대목표가↑,http://news.mk.co.kr/newsRead.php?year=2019&no=243305
2287,2019-04-19,대웅제약주보미국런칭에목표가상향유안타,http://www.ebn.co.kr/news/view/981471
2288,2019-04-19,유안타證대웅제약나보타美매출시작목표주가18↑”,http://www.kukinews.com/news/article.html?no=654190
2289,2019-04-19,유안타증권대웅제약나보타미국매출시작목표가상향,http://www.sporbiz.co.kr/news/articleView.html?idxno=330551
2290,2019-04-19,GET투자리포트대웅제약투자의견매수유지유안타증권,http://www.getnews.co.kr/view.php?ud=201904191030304097tpgetnews_16
2291,2019-04-19,ET투자뉴스대웅제약봄주보의미국BUY유지유안타증권,http://www.etnews.com/20190419000075
2292,2019-04-19,특징주대웅제약나보타미국매출꾸준히증가,http://www.sisaon.co.kr/news/articleView.html?idxno=92277
2293,2019-04-19,대웅제약주가4월19일현재203500원,http://www.gokorea.kr/news/articleView.html?idxno=163113
2294,2019-04-19,4월19일대웅제약주식추천주203500원074,http://www.nbntv.co.kr/news/articleView.html?idxno=320974
2295,2019-04-19,대웅제약휴젤메디톡스같은톡신다른모멘텀,http://news.mt.co.kr/mtview.php?no=2019041910193840875
2296,2019-04-19,대웅제약나보타의美수출로실적개선기대”,http://www.wikitree.co.kr/main/news_view.php?id=421489
2297,2019-04-19,같은톡신다른모멘텀대웅제약휴젤메디톡스3대톡신파도주목,http://www.mdtoday.co.kr/mdtoday/index.html?no=352321
2298,2019-04-19,대웅제약목표주가상향보톡스와안구건조증치료제가치부각,http://www.businesspost.co.kr/BP?command=article_view&num=123917
2299,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.newsway.co.kr/news/view?tp=1&ud=2019041914453773838
2300,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.fetv.co.kr/news/article.html?no=26513
2301,2019-04-19,대웅제약온라인통해소비자와소통한다,http://www.m-i.kr/news/articleView.html?idxno=515254
2302,2019-04-19,대웅제약대웅제약뉴스룸공식오픈다양한정보빠르게전달하며고객과소통,http://www.segye.com/content/html/2019/04/19/20190419507310.html?OutUrl=naver
2303,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.bosa.co.kr/news/articleView.html?idxno=2103770
2304,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229653
2305,2019-04-19,대웅제약온라인공식채널대웅제약뉴스룸개설,http://www.newspim.com/news/view/20190419000490
2306,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.economytalk.kr/news/articleView.html?idxno=183890
2307,2019-04-19,대웅제약온라인공식채널대웅제약뉴스룸개설,http://www.seoulwire.com/news/articleView.html?idxno=114953
2308,2019-04-19,대웅제약고객소통온라인공식채널뉴스룸오픈,http://medipana.com/news/news_viewer.asp?NewsNum=237788&MainKind=A&NewsKind=5&vCount=12&vKind=1
2309,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.mdtoday.co.kr/mdtoday/index.html?no=352345
2310,2019-04-19,대웅제약온라인공식채널대웅제약뉴스룸오픈,http://www.etoday.co.kr/news/section/newsview.php?idxno=1747082
2311,2019-04-19,대웅제약온라인보도채널대웅제약뉴스룸오픈,http://www.medisobizanews.com/news/articleView.html?idxno=59213
2312,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.metroseoul.co.kr/news/newsview?newscd=2019041900075
2313,2019-04-19,대웅제약새온라인채널대웅제약뉴스룸오픈,http://daily.hankooki.com/lpage/ittech/201904/dh20190419152925145630.htm
2314,2019-04-19,대웅제약나보타미국시장진출초읽기,http://www.dailysmart.co.kr/news/articleView.html?idxno=9519
2315,2019-04-19,대웅제약소통의문연다대웅제약뉴스룸오픈,http://www.viva100.com/main/view.php?key=20190419010007131
2316,2019-04-19,대웅제약온라인공식채널대웅제약뉴스룸개설,http://news.mk.co.kr/newsRead.php?year=2019&no=244916
2317,2019-04-19,온라인공식채널뉴스룸개설한대웅제약고객과소통강화”,https://www.sedaily.com/NewsView/1VHXECG2PG
2318,2019-04-19,대웅제약커뮤니케이션채널뉴스룸개설,http://www.rapportian.com/news/articleView.html?idxno=117204
2319,2019-04-19,온라인공식채널대웅제약뉴스룸개설,http://www.bokuennews.com/news/article.html?no=174636
2320,2019-04-19,대웅제약고객과의소통의창대웅제약뉴스룸오픈,http://www.businesskorea.co.kr/news/articleView.html?idxno=31073
2321,2019-04-19,대웅제약홍보력강화온라인뉴스룸오픈,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85231
2322,2019-04-19,대웅제약소통강화위해뉴스룸공식개설,http://www.econovill.com/news/articleView.html?idxno=361318
2323,2019-04-19,대웅제약회사산업알리는대웅제약뉴스룸개설,http://www.dailysmart.co.kr/news/articleView.html?idxno=9526
2324,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.medigatenews.com/news/1695918610
2325,2019-04-19,대웅제약온라인소통채널뉴스룸오픈,http://www.newsis.com/view/?id=NISX20190419_0000626313&cID=13001&pID=13000
2326,2019-04-19,대웅제약온라인공식채널대웅제약뉴스룸공식오픈,http://www.ftoday.co.kr/news/articleView.html?idxno=107998
2327,2019-04-19,대웅제약소식을한곳에대웅제약뉴스룸오픈,http://www.sisaon.co.kr/news/articleView.html?idxno=92324
2328,2019-04-19,대웅제약온라인대웅제약뉴스룸오픈고객과의소통강화,http://www.getnews.co.kr/view.php?ud=20190419175150830541d0c69529_16
2329,2019-04-19,뉴스투데이L대웅제약온라인공식채널뉴스룸오픈,http://www.news2day.co.kr/125426
2330,2019-04-19,대웅제약자체보도매체채널뉴스룸공식오픈,http://www.inthenews.co.kr/news/article.html?no=14869
2331,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.wikileaks-kr.org/news/articleView.html?idxno=53349
2332,2019-04-19,대웅제약소통강화위해대웅제약뉴스룸오픈,http://www.whosaeng.com/109549
2333,2019-04-19,대웅제약대웅제약뉴스룸공식채널오픈,http://www.lawissue.co.kr/view.php?ud=201904192125461712d7f4c63cc6_12
2334,2019-04-20,대웅제약1000억규모회사채발행이율연2087,http://www.kukinews.com/news/article.html?no=654558
2335,2019-04-20,대웅제약대웅제약뉴스룸공식오픈,http://www.ekn.kr/news/article.html?no=427526
2336,2019-04-20,대웅제약대웅제약뉴스룸공식오픈,http://www.newscj.com/news/articleView.html?idxno=623826
2337,2019-04-21,대웅제약뉴스룸개설,http://www.dt.co.kr/contents.html?article_no=2019042102109931102004&ref=naver
2338,2019-04-22,오늘의추천종목한국투자증권대웅제약LG전자등,http://www.asiatoday.co.kr/view.php?key=20190422010014168
2339,2019-04-22,★주식인사이드대웅제약주가205000원4월22일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=650696
2340,2019-04-22,4월22일대웅제약주식현황049203000원,http://www.nbntv.co.kr/news/articleView.html?idxno=323864
2341,2019-04-22,4월22일장마감대웅제약202500원,http://www.newsinside.kr/news/articleView.html?idxno=651766
2342,2019-04-22,대웅제약온라인공식채널대웅제약뉴스룸개설,http://sports.hankooki.com/lpage/economy/201904/sp20190422130626137020.htm
2343,2019-04-23,대웅제약중부국세청세무조사로153억세금추징당해,http://www.intn.co.kr/news/articleView.html?idxno=2005551
2344,2019-04-23,★주식인사이드대웅제약주가203500원4월23일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=652883
2345,2019-04-23,오늘의신상품대웅제약탄력관리코스메슈티컬리더마3종출시,http://www.econovill.com/news/articleView.html?idxno=361499
2346,2019-04-23,대웅제약이지듀관리솔루션리더마3종출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019042309135957381
2347,2019-04-23,대웅제약이지듀피부탄력솔루션리더마3종내놔,http://www.wolyo.co.kr/news/articleView.html?idxno=82398
2348,2019-04-23,4월23일대웅제약주식증권204000원025,http://www.nbntv.co.kr/news/articleView.html?idxno=326242
2349,2019-04-23,대웅제약고객소통확대온라인뉴스룸오픈,http://www.dailymedi.com/detail.php?number=842309&thread=22r05
2350,2019-04-23,대웅제약대웅제약뉴스룸공식오픈,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=208915
2351,2019-04-23,스타★주식인사이드대웅제약주가204500원4월23일13시33분기준,http://www.newsinside.kr/news/articleView.html?idxno=653915
2352,2019-04-23,의약품허가자진취하압도적1위대웅제약에무슨일이,http://www.bizhankook.com/article/17633
2353,2019-04-23,4월23일장마감대웅제약204500원,http://www.newsinside.kr/news/articleView.html?idxno=654973
2354,2019-04-24,대웅제약임팩타민공급가15인상이가탄F까스활명수등인상,http://www.mdtoday.co.kr/mdtoday/index.html?no=352648
2355,2019-04-24,오늘의추천종목한국투자증권대웅제약위지윅스튜디오등,http://www.asiatoday.co.kr/view.php?key=20190424010016040
2356,2019-04-24,★주식인사이드대웅제약주가203500원4월24일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=656023
2357,2019-04-24,대웅제약장애인일자리창출노력사내매점베어마트설립,http://www.ekn.kr/news/article.html?no=428245
2358,2019-04-24,대웅제약적극적인장애인일자리창출눈길,http://news.heraldcorp.com/view.php?ud=20190424000114
2359,2019-04-24,대웅제약장애인일자리창출노력,http://www.newsway.co.kr/news/view?tp=1&ud=2019042409200666064
2360,2019-04-24,대웅제약발달장애인정직원채용사내매점베어마트설립,http://medipana.com/news/news_viewer.asp?NewsNum=237985&MainKind=A&NewsKind=5&vCount=12&vKind=1
2361,2019-04-24,대웅제약장애인일자리창출노력,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229766
2362,2019-04-24,대웅제약장애인일자리창출앞장사내매점베어마트설립,http://moneys.mt.co.kr/news/mwView.php?no=2019042409278062404
2363,2019-04-24,대웅제약사내매점베어마트서발달장애인정직원으로채용,http://www.econovill.com/news/articleView.html?idxno=361599
2364,2019-04-24,대웅제약사내매점베어마트설립장애인일자리창출앞장,http://www.newsprime.co.kr/news/article.html?no=456745
2365,2019-04-24,대웅제약장애인일자리창출에적극,http://www.wolyo.co.kr/news/articleView.html?idxno=82498
2366,2019-04-24,장애인채용에적극나서는대웅제약사내매점베어마트설립,http://www.segye.com/content/html/2019/04/24/20190424503846.html?OutUrl=naver
2367,2019-04-24,대웅제약발달장애인정규직원들로사내매점베어마트열어,http://www.medisobizanews.com/news/articleView.html?idxno=59283
2368,2019-04-24,대웅제약발달장애인채용한사내매점베어마트설립,http://www.mhj21.com/120968
2369,2019-04-24,대웅제약발달장애인일자리창출에앞장사내매점베어마트설립,http://kpenews.com/View.aspx?No=32013
2370,2019-04-24,대웅제약사내매점베어마트통해발달장애인일자리창출,http://www.newspim.com/news/view/20190424000179
2371,2019-04-24,대웅제약장애인일자리창출노력,http://www.bokuennews.com/news/article.html?no=174787
2372,2019-04-24,대웅제약베어마트열고발달장애인고용,http://www.dailian.co.kr/news/view/790056/?sc=naver
2373,2019-04-24,대웅제약장애인일자리확대동참사내매점베어마트에발달장애인고용,http://www.ezyeconomy.com/news/articleView.html?idxno=90103
2374,2019-04-24,대웅제약장애인일자리창출노력,http://www.bosa.co.kr/news/articleView.html?idxno=2104031
2375,2019-04-24,대웅제약장애인일자리창출위해베어마트설립,http://www.viva100.com/main/view.php?key=20190424010008602
2376,2019-04-24,장애인채용늘리는대웅제약사내매점에발달장애인일자리제공,http://www.ajunews.com/view/20190424101532607
2377,2019-04-24,대웅제약장애인일자리창출노력,http://www.ebn.co.kr/news/view/982066
2378,2019-04-24,대웅제약발달장애인정직원채용사내매점베어마트설립,http://www.newsis.com/view/?id=NISX20190424_0000630530&cID=13001&pID=13000
2379,2019-04-24,대웅제약장애인일자리창출위해사내매점설립,http://www.etnews.com/20190424000121
2380,2019-04-24,대웅제약주가및증권시세및증권정보와종목동정24일현재203500원,http://www.gokorea.kr/news/articleView.html?idxno=168981
2381,2019-04-24,장애인일자리창출발벗고나선대웅제약,http://www.dailymedi.com/detail.php?number=842348&thread=22r05
2382,2019-04-24,대웅제약 장애인일자리창출노력,http://www.fetv.co.kr/news/article.html?no=26910
2383,2019-04-24,대웅제약장애인일자리창출앞장,http://daily.hankooki.com/lpage/ittech/201904/dh20190424110328145630.htm
2384,2019-04-24,4월24일대웅제약시세보기024204000원,http://www.nbntv.co.kr/news/articleView.html?idxno=328641
2385,2019-04-24,대웅제약장애인일자리창출나서,http://www.m-i.kr/news/articleView.html?idxno=516530
2386,2019-04-24,대웅제약장애인일자리창출내달중6명더채용,http://www.asiatime.co.kr/news/articleView.html?idxno=241793
2387,2019-04-24,대웅제약장애인고용시장확대노력,http://www.sisaon.co.kr/news/articleView.html?idxno=92552
2388,2019-04-24,대웅제약발달장애인고용사내매점베어마트설립,http://www.metroseoul.co.kr/news/newsview?newscd=2019042400082
2389,2019-04-24,대웅제약발달장애인채용해매점운영전승호장애인과동행,http://www.businesspost.co.kr/BP?command=article_view&num=124509
2390,2019-04-24,스타★주식인사이드대웅제약주가204000원4월24일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=657124
2391,2019-04-24,장애인일자리창출나선대웅제약 ,http://www.monews.co.kr/news/articleView.html?idxno=202214
2392,2019-04-24,대웅제약베어마트설립장애인일자리창출노력,http://www.ftoday.co.kr/news/articleView.html?idxno=108115
2393,2019-04-24,대웅자회사대웅바이오와대웅제약호조로기업가치커져,http://www.businesspost.co.kr/BP?command=article_view&num=124519
2394,2019-04-24,대웅제약발달장애인정직원채용사내매점베어마트설립,http://www.mdtoday.co.kr/mdtoday/index.html?no=352709
2395,2019-04-24,대웅제약발달장애인정직원으로채용한사내매점베어마트설립,https://www.sedaily.com/NewsView/1VHZO6QZ8K
2396,2019-04-24,단독윤재승전대웅제약회장배임혐의로고발당해,http://www.shinailbo.co.kr/news/articleView.html?idxno=1161524
2397,2019-04-24,대웅제약장애인일자리창출적극나서,
2398,2019-04-24,대웅제약상생가능한장애인일자리창출추진,http://news.donga.com/3/all/20190424/95205960/1
2399,2019-04-24,4월24일장마감대웅제약203000원,http://www.newsinside.kr/news/articleView.html?idxno=658105
2400,2019-04-24,대웅제약발달장애인직원이운영하는사내매점설립,http://www.rapportian.com/news/articleView.html?idxno=117261
2401,2019-04-24,대웅제약사내매점베어마트오픈하고발달장애인12명고용,http://news.mk.co.kr/newsRead.php?year=2019&no=257157
2402,2019-04-24,대웅제약나보타유럽서판매되나유럽약사위의제에올라,http://news1.kr/articles/?3605435
2403,2019-04-24,대웅제약적극적인장애인일자리창출앞장,http://www.skyedaily.com/news/news_view.html?ID=84109
2404,2019-04-24,대웅제약장애인일자리창출노력,http://www.getnews.co.kr/view.php?ud=20190424185503822041d0c69529_16
2405,2019-04-24,대웅제약사내매점베어마트설립발달장애인일자리제공,http://www.newscj.com/news/articleView.html?idxno=625142
2406,2019-04-24,대웅제약장애인일자리창출본격적나서,http://www.lawissue.co.kr/view.php?ud=201904242323442408d7f4c63cc6_12
2407,2019-04-25,대웅제약베어마트통해장애인위한일자리창출나서,http://www.wikileaks-kr.org/news/articleView.html?idxno=53765
2408,2019-04-25,대웅제약임팩타민프리미엄우리가족을위한멀티케어비타민,http://news.donga.com/3/all/20190424/95204553/1
2409,2019-04-25,대웅제약바쁜생활에지친소중한이들에게감사의마음을담아,http://news.donga.com/3/all/20190424/95204720/1
2410,2019-04-25,대웅제약스멕타현탁액등8개품목2세미만소아임수유부사용금지,http://www.mdtoday.co.kr/mdtoday/index.html?no=352750
2411,2019-04-25,★주식인사이드대웅제약주가202000원4월25일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=659225
2412,2019-04-25,대웅제약실시간증시25일현재201500원,http://www.nbntv.co.kr/news/articleView.html?idxno=331022
2413,2019-04-25,스타★주식인사이드대웅제약주가202500원4월25일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=660320
2414,2019-04-25,대웅제약장애인일자리창출우리가앞장섭니다,http://www.kpanews.co.kr/article/show.asp?idx=203449&table=article&category=D
2415,2019-04-25,4월25일장마감주가정보대웅제약200500원,http://www.newsinside.kr/news/articleView.html?idxno=661392
2416,2019-04-26,장애인12人정식채용대웅제약의아름다운실험,http://biz.chosun.com/site/data/html_dir/2019/04/25/2019042503717.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2417,2019-04-26,대웅제약발달장애인정직원채용사내매점설립,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3819612
2418,2019-04-26,오늘의추천종목한국투자증권대웅제약LG전자등,http://www.asiatoday.co.kr/view.php?key=20190426010018200
2419,2019-04-26,NH투자증권대웅제약2분기중신약나보타미국시장수출액100억원추정,http://www.betanews.net:8080/article/1002562.html
2420,2019-04-26,헬스특집피부자극없이상처지우는대웅제약이지덤,http://www.newscj.com/news/articleView.html?idxno=625707
2421,2019-04-26,★주식인사이드대웅제약주가200500원4월26일9시49분기준,http://www.newsinside.kr/news/articleView.html?idxno=662482
2422,2019-04-26,4월26일대웅제약오늘주식200500원000,http://www.nbntv.co.kr/news/articleView.html?idxno=333407
2423,2019-04-26,스타★주식인사이드대웅제약주가200500원4월26일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=663533
2424,2019-04-26,대웅제약발달장애인정직원채용사내매점설립,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1210989
2425,2019-04-26,ET투자뉴스영인프런티어036180수주공급계약주대웅제약과,http://www.etnews.com/20190426000409
2426,2019-04-26,4월26일장마감주가정보대웅제약200500원,http://www.newsinside.kr/news/articleView.html?idxno=664563
2427,2019-04-26,대웅제약나보타유럽CHMP허가승인권고,http://www.ebn.co.kr/news/view/982589
2428,2019-04-26,대웅제약나보타유럽CHMP허가승인권고유럽진출청신호,http://www.viva100.com/main/view.php?key=20190426010009889
2429,2019-04-26,대웅제약나보타유럽약물사용자문위원회서허가승인권고,http://www.newspim.com/news/view/20190426001085
2430,2019-04-26,대웅제약나보타유럽CHMP허가승인권고받아,http://www.kpanews.co.kr/article/show.asp?idx=203500&table=article&category=D
2431,2019-04-26,대웅제약나보타유럽CHMP허가승인권고유럽진출눈앞,http://www.metroseoul.co.kr/news/newsview?newscd=2019042600123
2432,2019-04-26,대웅제약나보타세계최대시장미국유럽동시진출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229896
2433,2019-04-26,유럽시장포문여나대웅제약나보타유럽CHMP허가승인권고,http://www.ajunews.com/view/20190426230315061
2434,2019-04-26,대웅제약나보타유럽약물사용위원회허가권고획득,http://biz.chosun.com/site/data/html_dir/2019/04/26/2019042603536.html
2435,2019-04-26,유럽CHMP대웅제약나보타허가승인권고,http://www.dailypharm.com/Users/News/NewsView.html?ID=252066&REFERER=NP
2436,2019-04-26,유럽CHMP대웅제약보툴리눔톡신나보타허가권고,http://medipana.com/news/news_viewer.asp?NewsNum=238176&MainKind=A&NewsKind=5&vCount=12&vKind=1
2437,2019-04-26,대웅제약나보타유럽CHMP허가승인권고받아진출임박”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1749824
2438,2019-04-26,대웅제약나보타유럽CHMP허가승인권고로유럽진출눈앞,http://www.fnnews.com/news/201904262323223143
2439,2019-04-26,대웅제약나보타유럽CHMP서허가승인권고,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019042623084231274
2440,2019-04-26,대웅제약보툴리눔톡신나보타유럽허가눈앞,http://yna.kr/AKR20190426192100017?did=1195m
2441,2019-04-26,대웅제약보툴리눔톡신제제나보타유럽시판허가권고받아,http://news1.kr/articles/?3607935
2442,2019-04-27,대웅제약나보타유럽시장진출눈앞,http://www.dailysmart.co.kr/news/articleView.html?idxno=9887
2443,2019-04-27,대웅제약vs메디톡스6차전끝안보이는나보타분쟁,http://news.joins.com/article/olink/23044605
2444,2019-04-27,대웅제약나보타유럽CHMP허가승인권고,http://news.mt.co.kr/mtview.php?no=2019042623444026857
2445,2019-04-27,대웅제약나보타유럽약물사용자문위허가승인권고,http://www.kyeongin.com/main/view.php?key=20190427010012213
2446,2019-04-27,제약단신장애인일자리창출나선대웅제약外,http://www.sportsworldi.com/content/html/2019/04/26/20190426502401.html
2447,2019-04-27,대웅제약나보타유럽진출눈앞유럽CHMP허가승인권고받아,http://www.inthenews.co.kr/news/article.html?no=15060
2448,2019-04-27,대웅제약나보타CHMP허가승인권고유럽진출임박,http://www.seoulfn.com/news/articleView.html?idxno=341223
2449,2019-04-27,대웅제약유럽서나보타허가승인권고받아내,http://news.mk.co.kr/newsRead.php?year=2019&no=267693
2450,2019-04-27,대웅제약나보타유럽진출초읽기,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067705
2451,2019-04-27,대웅제약나보타유럽CHMP허가승인권고로유럽진출눈앞,http://www.ekn.kr/news/article.html?no=428906
2452,2019-04-27,대웅제약나보타유럽CHMP허가승인권고유럽진출초읽기,http://www.medisobizanews.com/news/articleView.html?idxno=59358
2453,2019-04-27,대웅제약나보타미국이어유럽허가눈앞,http://www.biospectator.com/view/news_view.php?varAtcId=7541
2454,2019-04-27,대웅제약나보타유럽CHMP허가승인권고로유럽진출눈앞,http://www.lawissue.co.kr/view.php?ud=201904270859044482d7f4c63cc6_12
2455,2019-04-27,대웅제약나보타유럽판매허가받아,http://www.newsis.com/view/?id=NISX20190427_0000634136&cID=13001&pID=13000
2456,2019-04-27,대웅제약나보타유럽시장진출성큼유럽CHMP허가승인권고받아,http://kpenews.com/View.aspx?No=32243
2457,2019-04-27,대웅제약나보타유럽시장진출눈앞,http://moneys.mt.co.kr/news/mwView.php?no=2019042709478046728
2458,2019-04-27,대웅제약보툴리눔톡신나보타유럽서허가승인권고받아,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201904270070&t=NN
2459,2019-04-27,대웅제약나보타美이어유럽진출눈앞,http://www.newscj.com/news/articleView.html?idxno=626095
2460,2019-04-27,대웅제약나보타유럽CHMP허가승인권고로유럽진출청신호,http://www.dailian.co.kr/news/view/791058/?sc=naver
2461,2019-04-27,대웅제약나보타유럽판매허가받아보툴리눔톡신시장진출눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=62941
2462,2019-04-27,유럽사용허가권고의견획득대웅제약나보타3년간주가상승에대형호재,http://www.g-enews.com/ko-kr/news/article/news_all/2019042712080474394e4869c120_1/article.html
2463,2019-04-27,대웅제약보톨리눔톡신나보타유럽판매눈앞,http://www.cstimes.com/?mod=news&act=articleView&idxno=303322
2464,2019-04-27,대웅제약나보타미국이어유럽진출눈앞,http://www.upinews.kr/news/newsview.php?ncode=1065590438991607
2465,2019-04-27,대웅제약나보타유럽보톡스시장진출하나허가승인권고획득,https://www.hankyung.com/article/2019042700837
2466,2019-04-27,대웅제약나보타EMA산하CHMP로부터허가승인권고획득유럽진출눈앞,http://www.segye.com/content/html/2019/04/27/20190427503959.html?OutUrl=naver
2467,2019-04-27,대웅제약나보타유럽CHMP허가승인권고,http://www.newstomato.com/ReadNews.aspx?no=891892
2468,2019-04-27,대웅제약나보타유럽진출가시화,http://www.sisaon.co.kr/news/articleView.html?idxno=92785
2469,2019-04-27,대웅제약나보타미국이어유럽진출눈앞,http://www.mdtoday.co.kr/mdtoday/index.html?no=353005
2470,2019-04-27,대웅제약유럽서나보타허가승인권고받아,http://www.asiatime.co.kr/news/articleView.html?idxno=242437
2471,2019-04-27,대웅제약보툴리눔톡신나보타유럽서허가승인권고,http://view.asiae.co.kr/news/view.htm?idxno=2019042718173357675
2472,2019-04-27,대웅제약나보타유럽CHMP허가승인권고로유럽진출눈앞,http://www.newscj.com/news/articleView.html?idxno=626246
2473,2019-04-28,대웅제약보통리눔톡신나보타석달내유럽허가,http://news.heraldcorp.com/view.php?ud=20190428000046
2474,2019-04-28,대웅제약보툴리눔톡신나보타유럽허가눈앞,http://www.etnews.com/20190428000014
2475,2019-04-28,대웅제약나보타유럽판매허가눈앞,https://www.sedaily.com/NewsView/1VI1HJ8Y3V
2476,2019-04-28,미국유럽들썩이는나보타대웅제약함박웃음,http://www.viva100.com/main/view.php?key=20190428010010076
2477,2019-04-28,대웅제약나보타유럽진출눈앞허가승인권고받아,http://www.dt.co.kr/contents.html?article_no=2019042802109931102002&ref=naver
2478,2019-04-28,전승호대웅제약나보타미국과유럽수출로보톡스아성에도전,http://www.businesspost.co.kr/BP?command=article_view&num=125086
2479,2019-04-28,대웅제약나보타유럽허가임박국산첫美유럽동시진출,https://www.hankyung.com/article/2019042819071
2480,2019-04-28,대웅제약보툴리눔톡신나보타곧유럽허가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3821330
2481,2019-04-29,대웅제약나보타美이어유럽허가임박총35조시장정조준,http://www.etoday.co.kr/news/section/newsview.php?idxno=1749916
2482,2019-04-29,대웅제약나보타미국진출이어유럽상륙임박,http://www.dailymedi.com/detail.php?number=842492&thread=22r05
2483,2019-04-29,클릭e종목대웅제약나보타유럽출시가시권이익증대기대,http://view.asiae.co.kr/news/view.htm?idxno=2019042907120512363
2484,2019-04-29,퀵리포트대웅제약매수유지목표가25만원유지한투證,http://www.itooza.com/common/iview.php?no=2019042907431129117
2485,2019-04-29,대웅제약목표가25만원유지전일종가20만500원한투證,http://www.newspim.com/news/view/20190429000056
2486,2019-04-29,GET투자리포트대웅제약투자의견매수유지한국투자증권,http://www.getnews.co.kr/view.php?ud=201904291030304613tpgetnews_16
2487,2019-04-29,대웅제약나보타로유럽진출가시화한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1750021
2488,2019-04-29,대웅제약나보타유럽판매허가가능성↑한투,http://news.mt.co.kr/mtview.php?no=2019042908493629218
2489,2019-04-29,대웅제약나보타유럽출시효과기대한국투자증권,https://www.sedaily.com/NewsView/1VI1Y6NXWO
2490,2019-04-29,실시간분석대웅제약34상승증권사목표가25만원제시,http://www.itooza.com/common/iview.php?no=2019042909030527083
2491,2019-04-29,대웅제약나보타유럽판매허가권고에강세,https://www.hankyung.com/article/2019042930226
2492,2019-04-29,대웅제약발달장애인안정적일자리환경조성,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=209319
2493,2019-04-29,대웅제약나보타유럽진출가능성커져,http://www.rapportian.com/news/articleView.html?idxno=117322
2494,2019-04-29,4월29일대웅제약및증권시세및매매동향,http://www.gokorea.kr/news/articleView.html?idxno=174416
2495,2019-04-29,대웅제약유럽서나보타허가승인권고에상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=353098
2496,2019-04-29,대웅제약나보타CHMP허가승인권고로유럽진출눈앞,http://kormedi.com/?p=1288171
2497,2019-04-29,4월29일대웅제약오늘증권시세050201500원,http://www.nbntv.co.kr/news/articleView.html?idxno=335734
2498,2019-04-29,대웅제약나보타유럽서허가승인권고유럽진출박차,http://www.sisaweek.com/news/articleView.html?idxno=121175
2499,2019-04-29,대웅제약나보타유럽CHMP허가승인권고,http://www.bosa.co.kr/news/articleView.html?idxno=2104255
2500,2019-04-29,대웅제약나보타유럽시장진출초읽기,http://www.koreaittimes.com/news/articleView.html?idxno=90528
2501,2019-04-29,대웅제약나보타미국에이어유럽유럽진출노크,http://www.bokuennews.com/news/article.html?no=174992
2502,2019-04-29,대웅제약나보타美이어유럽진출눈앞,https://www.sedaily.com/NewsView/1VI1XYPHOK
2503,2019-04-29,대웅제약나보타CHMP허가승인권고유럽진출박차,http://www.businesskorea.co.kr/news/articleView.html?idxno=31364
2504,2019-04-29,스타★주식인사이드대웅제약주가202500원4월29일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=666653
2505,2019-04-29,ET투자뉴스대웅제약나보타미국에이BUY유지한국투자증권,http://www.etnews.com/20190429000385
2506,2019-04-29,대웅제약나보타유럽에출시되면매출늘고브랜드가치커져,http://www.businesspost.co.kr/BP?command=article_view&num=125161
2507,2019-04-29,대웅제약메디톡스해외서장군멍군,http://www.newstomato.com/ReadNews.aspx?no=892129
2508,2019-04-29,대웅제약전승호號나보타로글로벌보툴리눔톡신시장정조준,http://www.iminju.net/news/articleView.html?idxno=45007
2509,2019-04-29,4월29일장마감주가정보대웅제약205000원,http://www.newsinside.kr/news/articleView.html?idxno=667685
2510,2019-04-29,★주식인사이드대웅제약주가208000원4월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=665604
2511,2019-04-30,★주식인사이드대웅제약주가203500원4월30일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=668769
2512,2019-04-30,대웅제약나보타유럽CHMP허가승인권고 ,http://www.monews.co.kr/news/articleView.html?idxno=202321
2513,2019-04-30,대웅제약주식종목검색30일현재202000원,http://www.nbntv.co.kr/news/articleView.html?idxno=338052
2514,2019-04-30,대웅제약올해1Q영업익101억전년비272↑,http://www.newspim.com/news/view/20190430000590
2515,2019-04-30,실적속보대웅제약별도20191Q영업이익102억원전년비272,http://www.fntimes.com/html/view.php?ud=2019043012375975115dfa8f3bd6_18
2516,2019-04-30,코스피대웅제약2019년1분기누적매출액2381억원영업이익102억원,http://news.kmib.co.kr/article/view.asp?arcid=0013274390&code=61141211&cp=nv
2517,2019-04-30,잠정실적대웅제약올해1Q영업익101억전년비272↑,http://www.itooza.com/common/iview.php?no=2019043012382419886
2518,2019-04-30,대웅제약1분기영업이익101억원전년비272↑,http://news.mt.co.kr/mtview.php?no=2019043012462043991
2519,2019-04-30,대웅제약1Q영업익102억원전년比27증가,http://news1.kr/articles/?3610161
2520,2019-04-30,공시대웅제약1Q영업익102억원전년比272↑,http://www.newsway.co.kr/news/view?tp=1&ud=2019043012531876166
2521,2019-04-30,대웅제약1분기영업익102억전년비272↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=252161&REFERER=NP
2522,2019-04-30,스타★주식인사이드대웅제약주가202500원4월30일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=669799
2523,2019-04-30,공시대웅제약1분기영업익102억원전년比27↑,http://www.newsis.com/view/?id=NISX20190430_0000636981&cID=10401&pID=10400
2524,2019-04-30,ET투자뉴스대웅제약19년1분기실적발표영업이익102억원전년동기대비272증가,http://www.etnews.com/20190430000215
2525,2019-04-30,실적속보대웅제약올해1Q영업이익대폭상승전분기보다1174올라개별잠정,https://www.hankyung.com/article/201904308893L
2526,2019-04-30,대웅제약1분기영업익102억원272증가,https://www.sedaily.com/NewsView/1VI2ELS6O4
2527,2019-04-30,대웅제약1분기영업이익101억9700만원272↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=353289
2528,2019-04-30,대웅제약1Q영업익102억나보타美매출로수익성향상,http://view.asiae.co.kr/news/view.htm?idxno=2019043013294448066
2529,2019-04-30,대웅제약1Q영업익27↑나보타미국매출발생,http://www.dailypharm.com/Users/News/NewsView.html?ID=252166&REFERER=NP
2530,2019-04-30,대웅제약1Q매출2381억‥나보타효과로수익성향상,http://medipana.com/news/news_viewer.asp?NewsNum=238308&MainKind=A&NewsKind=5&vCount=12&vKind=1
2531,2019-04-30,대웅제약1분기영업익102억원전년대비27증가,http://www.sisafocus.co.kr/news/articleView.html?idxno=208749
2532,2019-04-30,대웅제약나보타미국향신규매출발생으로수익성향상,http://www.wsobi.com/news/articleView.html?idxno=72873
2533,2019-04-30,대웅제약올1분기영업익102억원271증가,http://www.newsway.co.kr/news/view?tp=1&ud=2019043013223050050
2534,2019-04-30,대웅제약1분기영업이익27증가나보타美매출발생,https://www.hankyung.com/article/2019043089296
2535,2019-04-30,대웅제약올1분기매출액2381억원영업이익102억원기록,http://www.ekn.kr/news/article.html?no=429441
2536,2019-04-30,대웅제약1분기영업익102억원272증가,http://yna.kr/AKR20190430107000008?did=1195m
2537,2019-04-30,대웅제약보툴리눔톡신나보타미국매출증가로수익성개선,http://www.ceoscoredaily.com/news/article.html?no=54977
2538,2019-04-30,대웅제약1Q영업익102억272↑매출2381억103↑,http://www.upinews.kr/news/newsview.php?ncode=1065588254170042
2539,2019-04-30,대웅제약1분기영업익102억원전년비272↑,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201904300332&t=NN
2540,2019-04-30,대웅제약1Q영업익102억원전년비272증가,http://view.asiae.co.kr/news/view.htm?idxno=2019043013512538819
2541,2019-04-30,대웅제약1분기영업익27증가나보타미국매출발생,http://www.newspim.com/news/view/20190430000657
2542,2019-04-30,대웅제약1분기영업익전년比272증가,http://www.ajunews.com/view/20190430135237183
2543,2019-04-30,대웅제약올해1분기실적개선매출2381억원,http://www.mhj21.com/121078
2544,2019-04-30,대웅제약1분기나보타美매출로영업이익27↑,http://www.kpinews.co.kr/news/articleView.html?idxno=95324
2545,2019-04-30,대웅제약1분기영업이익272늘었다나보타의힘”,https://www.sedaily.com/NewsView/1VI2FZV01N
2546,2019-04-30,대웅제약1분기영업익102억원전년대비27↑,http://moneys.mt.co.kr/news/mwView.php?no=2019043013538069590
2547,2019-04-30,대웅제약1분기영업이익102억원전년比272↑,http://www.nspna.com/news/?mode=view&newsid=356150
2548,2019-04-30,대웅제약1분기매출2381억원전년比103↑,http://www.economytalk.kr/news/articleView.html?idxno=184481
2549,2019-04-30,대웅제약1Q영업익102억원전년대비272↑,http://www.viva100.com/main/view.php?key=20190430010010850
2550,2019-04-30,대웅제약1분기영업익102억원전년比272↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03299686622461368
2551,2019-04-30,대웅제약1Q영업익전년比27증가나보타美매출반영,http://www.newsis.com/view/?id=NISX20190430_0000637090&cID=13001&pID=13000
2552,2019-04-30,대웅제약1분기매출10영업이익27성장,http://news.heraldcorp.com/view.php?ud=20190430000625
2553,2019-04-30,대웅제약1분기영업이익27증가나보타미국매출로실적향상,http://biz.chosun.com/site/data/html_dir/2019/04/30/2019043001645.html
2554,2019-04-30,대웅제약1분기매출2381억원전년比103상승,http://www.medisobizanews.com/news/articleView.html?idxno=59415
2555,2019-04-30,전승호대웅제약대표나보타로미국이어유럽까지진출,http://www.newsway.co.kr/news/view?tp=1&ud=2019042918071464560
2556,2019-04-30,대웅제약1분기매출103영업이익272증가,http://www.koreaittimes.com/news/articleView.html?idxno=90574
2557,2019-04-30,대웅제약올1분기매출영업익두마리토끼,http://www.dailymedi.com/detail.php?number=842560&thread=22r05
2558,2019-04-30,대웅제약나보타美수출전년동기대비1107성장양호한이익개선기대,http://www.segye.com/content/html/2019/04/30/20190430509091.html?OutUrl=naver
2559,2019-04-30,대웅제약1분기영업이익102억원전년동기대비272↑,http://news.mk.co.kr/newsRead.php?year=2019&no=277825
2560,2019-04-30,대웅제약1분기매출2381억원103증가영업이익102억원,http://www.getnews.co.kr/view.php?ud=20190430145629395041d0c69529_16
2561,2019-04-30,대웅제약1분기매출2381억원103증가영업이익102억원,http://www.getnews.co.kr/view.php?ud=20190430145629395041d0c69529_16
2562,2019-04-30,대웅제약1분기매출2381억원달성전년比103↑,http://www.inthenews.co.kr/news/article.html?no=15117
2563,2019-04-30,대웅제약美나보타수출실적반영본격화되나,http://www.biospectator.com/view/news_view.php?varAtcId=7560
2564,2019-04-30,대웅제약1Q영업익102억원전년比27↑,http://www.seoulfn.com/news/articleView.html?idxno=341541
2565,2019-04-30,대웅제약1분기영업이익272↑나보타수출실적가시화,http://news.donga.com/3/all/20190430/95321454/1
2566,2019-04-30,대웅제약1분기영업익102억원전년비272↑,http://www.dailian.co.kr/news/view/791908/?sc=naver
2567,2019-04-30,대웅제약1분기영업익102억전년比272↑,http://www.newsprime.co.kr/news/article.html?no=457819
2568,2019-04-30,대웅제약보툴리눔톡신나보타미국매출증가로1분기실적개선,http://www.etoday.co.kr/news/section/newsview.php?idxno=1750895
2569,2019-04-30,실적대웅제약영업익102억전년比27증가전문및일반의약품고른성장세,http://www.ezyeconomy.com/news/articleView.html?idxno=90296
2570,2019-04-30,대웅제약1분기영업익102억나보타미국진출효과톡톡,http://www.newstomato.com/ReadNews.aspx?no=892521
2571,2019-04-30,대웅제약1분기영업익102억전년比272↑,http://www.rapportian.com/news/articleView.html?idxno=117354
2572,2019-04-30,4월30일장마감주가정보대웅제약203000원,http://www.newsinside.kr/news/articleView.html?idxno=670845
2573,2019-04-30,대웅제약1분기실적전년比매출103영업익272증가,http://www.joseilbo.com/news/news_read.php?uid=375755&class=17&grp=
2574,2019-04-30,대웅제약2019년1분기영업이익102억원달성,http://www.sisaon.co.kr/news/articleView.html?idxno=92947
2575,2019-04-30,대웅제약1분기실적발표매출2381억원영업이익102억원,http://www.medigatenews.com/news/1861452453
2576,2019-04-30,대웅제약1분기실적매출2381억원영업이익102억원,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55126
2577,2019-04-30,보툴리눔톡신3사3색대웅제약메디톡스휴젤치열한경쟁,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019043016044862854
2578,2019-04-30,대웅제약실적대박1분기매출2381억원전년대비103성장,http://www.econovill.com/news/articleView.html?idxno=362135
2579,2019-04-30,대웅제약1분기성적표맑음영업이익102억원돌파,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019043016402217461
2580,2019-04-30,대웅제약1분기전년比매출103영업익272상승,http://www.wolyo.co.kr/news/articleView.html?idxno=83079
2581,2019-04-30,대웅제약1분기영업이익102억원전년비27증가,http://www.metroseoul.co.kr/news/newsview?newscd=2019043000121
2582,2019-04-30,대웅제약나보타승승장구로1Q실적개선,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067801
2583,2019-04-30,대웅제약1Q매출2381억전년비10↑,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019043017154303555&objId=A2019043017154303555&portalCode=naver
2584,2019-04-30,대웅제약나보타미국매출신규발생등실적개선,http://www.100ssd.co.kr/news/articleView.html?idxno=61071
2585,2019-04-30,제약사1분기실적보니대웅제약한미약품종근당성공적GC녹십자아쉬움,http://daily.hankooki.com/lpage/ittech/201904/dh20190430172200145630.htm
2586,2019-04-30,휴젤중국에서도메디톡스대웅제약과보톡스경쟁불가피,http://www.businesspost.co.kr/BP?command=article_view&num=125432
2587,2019-04-30,대웅제약장애인일자리창출노력,http://www.wsobi.com/news/articleView.html?idxno=72899
2588,2019-04-30,대웅제약보톡스나보타의미국수출힘입어1분기실적늘어,http://www.businesspost.co.kr/BP?command=article_view&num=125465
2589,2019-04-30,대웅제약2019년1분기실적발표매출2381억원,http://www.newscj.com/news/articleView.html?idxno=627310
2590,2019-05-01,대웅제약2019년1분기매출2381억원영업이익102억원전년동기대비103272,http://www.lawissue.co.kr/view.php?ud=20190430235058364d7f4c63cc6_12
2591,2019-05-01,대웅제약1분기영업이익102억원전년대비27늘어나,http://www.econonews.co.kr/news/articleView.html?idxno=63332
2592,2019-05-01,대웅제약1분기매출2381억원전년比103↑,http://www.bokuennews.com/news/article.html?no=175068
2593,2019-05-01,나보타가보톡스아성깨뜨린다전승호대웅제약사장미국이어유럽진출눈앞,http://www.ekn.kr/news/article.html?no=429641
2594,2019-05-02,오늘의추천종목한국투자증권대웅제약삼성전기등,http://www.asiatoday.co.kr/view.php?key=20190502010000651
2595,2019-05-02,퀵리포트대웅제약매수유지목표가30만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019050207393052869
2596,2019-05-02,대웅제약미국시장매출실적반영에목표가상향KB증권,http://www.ajunews.com/view/20190502073846277
2597,2019-05-02,대웅제약미국향나보타매출반영시작목표가↑,http://www.asiatoday.co.kr/view.php?key=20190502010000659
2598,2019-05-02,퀵리포트대웅제약매수유지목표가24만5000원유지신영證,http://www.itooza.com/common/iview.php?no=2019050207541215336
2599,2019-05-02,대웅제약목표가30만원유지전일종가20만3000원KTB證,http://www.newspim.com/news/view/20190502000126
2600,2019-05-02,대웅제약목표가24만5000원유지전일종가20만3000원신영證,http://www.newspim.com/news/view/20190502000153
2601,2019-05-02,대웅제약목표가26만원유지전일종가20만3000원SK證,http://www.newspim.com/news/view/20190502000179
2602,2019-05-02,퀵리포트대웅제약매수유지목표가26만원유지SK證,http://www.itooza.com/common/iview.php?no=2019050208141114549
2603,2019-05-02,신한금투대웅제약2분기나보타본격美수출목표가↑,http://www.newsis.com/view/?id=NISX20190502_0000638683&cID=10401&pID=10400
2604,2019-05-02,더벨대웅제약나보타수출계약금만130억,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904300100056710003520
2605,2019-05-02,엇갈리는1분기실적한미약품대웅제약맑음녹십자흐림,http://www.rapportian.com/news/articleView.html?idxno=117361
2606,2019-05-02,대웅제약목표가4↑25만원제시KB證,http://www.newspim.com/news/view/20190502000204
2607,2019-05-02,유한양행듀오웰에이대웅제약올로맥스급여,http://www.medisobizanews.com/news/articleView.html?idxno=59440
2608,2019-05-02,대웅제약목표가26만원유지전일종가20만3000원유안타證,http://www.newspim.com/news/view/20190502000223
2609,2019-05-02,대웅제약나보타매출24분기부터본격화SK증권,http://www.fnnews.com/news/201905020823339578
2610,2019-05-02,퀵리포트대웅제약매수유지목표가26만원유지유안타證,http://www.itooza.com/common/iview.php?no=2019050208302729862
2611,2019-05-02,대웅제약1분기컨센서스상회신한금투,http://www.newstomato.com/ReadNews.aspx?no=892724
2612,2019-05-02,대웅제약전문의약품의힘에6분기만에영업익증가목표가↑신한,http://www.edaily.co.kr/news/newspath.asp?newsid=02017206622484984
2613,2019-05-02,대웅제약2분기영업이익률64전망,http://www.nspna.com/news/?mode=view&newsid=356496
2614,2019-05-02,대웅제약2분기영업이익률64전망,http://www.nspna.com/news/?mode=view&newsid=356496
2615,2019-05-02,SK증권대웅제약나보타매출액2분기부터본격화”,http://www.newsway.co.kr/news/view?tp=1&ud=2019050208475674473
2616,2019-05-02,대웅제약목표가4↑25만원제시신한금투,http://www.newspim.com/news/view/20190502000296
2617,2019-05-02,퀵리포트대웅제약매수유지목표가8↑27만원대신證,http://www.itooza.com/common/iview.php?no=2019050208491415849
2618,2019-05-02,퀵리포트대웅제약매수유지목표가4↑25만원신한금투,http://www.itooza.com/common/iview.php?no=2019050208523576147
2619,2019-05-02,대웅제약컨센서스상회한1분기실적,http://www.newsprime.co.kr/news/article.html?no=458022
2620,2019-05-02,대웅제약나보타유럽진출눈앞,http://weekly.cnbnews.com/news/article.html?no=127704
2621,2019-05-02,GET투자리포트대웅제약투자의견매수유지하이투자증권,http://www.getnews.co.kr/view.php?ud=201905021030304895tpgetnews_16
2622,2019-05-02,★주식인사이드대웅제약주가203500원5월2일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=672089
2623,2019-05-02,ET투자뉴스대웅제약나보타의이익개선효BUY유지하이투자증권,http://www.etnews.com/20190502000050
2624,2019-05-02,GET투자리포트대웅제약투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=201905021030304904tpgetnews_16
2625,2019-05-02,GET투자리포트대웅제약투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=201905021030304912tpgetnews_16
2626,2019-05-02,ET투자뉴스대웅제약나보타수출시작BUY유지SK증권,http://www.etnews.com/20190502000074
2627,2019-05-02,KB증권대웅제약나보타미국매출확대가능성목표가상향”,http://www.sporbiz.co.kr/news/articleView.html?idxno=333911
2628,2019-05-02,대웅제약주가상승가능나보타미국수출로이익늘어,http://www.businesspost.co.kr/BP?command=article_view&num=125598
2629,2019-05-02,GET투자리포트대웅제약투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=201905021030304948tpgetnews_16
2630,2019-05-02,ET투자뉴스대웅제약미국향나보타매출BUY유지대신증권,http://www.etnews.com/20190502000095
2631,2019-05-02,5월2일대웅제약주식증권204500원074,http://www.nbntv.co.kr/news/articleView.html?idxno=340664
2632,2019-05-02,GET투자리포트대웅제약투자의견매수유지유안타증권,http://www.getnews.co.kr/view.php?ud=201905021030305058tpgetnews_16
2633,2019-05-02,대웅제약나보타유럽진출눈앞에웅비기대,http://view.asiae.co.kr/news/view.htm?idxno=2019050210312105646
2634,2019-05-02,스타★주식인사이드대웅제약주가203000원5월2일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=673152
2635,2019-05-02,ET투자뉴스대웅제약실적개선의시그널BUY유지유안타증권,http://www.etnews.com/20190502000317
2636,2019-05-02,ET투자뉴스대웅제약좋았던1분기보다BUY유지신한금융투자,http://www.etnews.com/20190502000472
2637,2019-05-02,대웅제약사회공헌활동참지마요대학생봉사단모집,http://moneys.mt.co.kr/news/mwView.php?no=2019050214528076943
2638,2019-05-02,대웅제약발달장애인과아름다운동행나서참지마요프로젝트봉사단모집,http://kpenews.com/View.aspx?No=32618
2639,2019-05-02,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.ebn.co.kr/news/view/983268
2640,2019-05-02,대웅제약대학생교육봉사단모집발달장애인들건강한삶돕자,http://www.medisobizanews.com/news/articleView.html?idxno=59479
2641,2019-05-02,대웅제약사회공헌프로그램참지마요프로젝트봉사단모집,http://www.metroseoul.co.kr/news/newsview?newscd=2019050200176
2642,2019-05-02,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230080
2643,2019-05-02,대웅제약참지마요프로젝트대학생봉사자모집,http://www.newsprime.co.kr/news/article.html?no=458157
2644,2019-05-02,대웅제약과발달장애인이함께하는아름다운동행참지마요프로젝트교육봉사단모집,http://www.etoday.co.kr/news/section/newsview.php?idxno=1751575
2645,2019-05-02,대웅제약종근당1분기순항1조클럽굳히기청신호,http://www.newstomato.com/ReadNews.aspx?no=892866
2646,2019-05-02,대웅제약참지마요프로젝트대학생교육봉사단모집,http://medipana.com/news/news_viewer.asp?NewsNum=238420&MainKind=A&NewsKind=5&vCount=12&vKind=1
2647,2019-05-02,대웅제약참지마요프로젝트대학생봉사단모집질병증상표현진료처방돕는다”,https://www.sedaily.com/NewsView/1VIZHQECW3
2648,2019-05-02,5월2일장마감주가정보대웅제약203500원,http://www.newsinside.kr/news/articleView.html?idxno=674209
2649,2019-05-02,대웅제약과발달장애인이함께하는아름다운동행,http://news.donga.com/3/all/20190502/95356198/1
2650,2019-05-02,대웅제약발달장애인과함께하는참지마요프로젝트대학생교육봉사단모집,http://www.asiatime.co.kr/news/articleView.html?idxno=243462
2651,2019-05-02,대웅제약발달장애인이함께하는아름다운동행,http://daily.hankooki.com/lpage/ittech/201905/dh20190502163628145630.htm
2652,2019-05-02,대웅제약발달장애인질병증상표현교육참여할대학생봉사자모집,http://news.mk.co.kr/newsRead.php?year=2019&no=286699
2653,2019-05-02,대웅제약1분기매출2381억원전년동기대비103증가,http://www.kukinews.com/news/article.html?no=658521
2654,2019-05-02,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.mdtoday.co.kr/mdtoday/index.html?no=353476
2655,2019-05-02,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.econovill.com/news/articleView.html?idxno=362303
2656,2019-05-02,대웅제약발달장애인이함께하는아름다운동행,http://www.newscj.com/news/articleView.html?idxno=628139
2657,2019-05-02,신한금융투자대웅제약2분기주름개선제나보타본격미국수출목표가↑,http://www.econonews.co.kr/news/articleView.html?idxno=63589
2658,2019-05-03,대웅제약3제복합제올로맥스로고혈압고지혈증동시공략,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230099
2659,2019-05-03,대웅제약3제복합개량신약올로맥스출시,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85483
2660,2019-05-03,★주식인사이드대웅제약주가204000원5월3일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=675544
2661,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://medipana.com/news/news_viewer.asp?NewsNum=238445&MainKind=A&NewsKind=5&vCount=12&vKind=1
2662,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.newsway.co.kr/news/view?tp=1&ud=2019050309110650226
2663,2019-05-03,섞고또섞고대웅제약고혈압고지혈증3제복합제출시,http://moneys.mt.co.kr/news/mwView.php?no=2019050309028014248
2664,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.economytalk.kr/news/articleView.html?idxno=184603
2665,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019050309002193437
2666,2019-05-03,대웅제약올로맥스출시고혈압고지혈증공략,http://www.ebn.co.kr/news/view/983361
2667,2019-05-03,대웅제약올로맥스출시고혈압고지혈증동시공략,http://www.seoulwire.com/news/articleView.html?idxno=122704
2668,2019-05-03,대웅제약고혈압고지혈증한번에조절,http://www.sisaon.co.kr/news/articleView.html?idxno=93094
2669,2019-05-03,GET투자리포트대웅제약투자의견매수유지KB증권,http://www.getnews.co.kr/view.php?ud=201905031030305141tpgetnews_16
2670,2019-05-03,대웅제약세계최초3제복합개량신약올로맥스출시,http://www.viva100.com/main/view.php?key=20190503010000994
2671,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://www.newspim.com/news/view/20190503000190
2672,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://www.medisobizanews.com/news/articleView.html?idxno=59495
2673,2019-05-03,대웅제약과발달장애인이함께하는아름다운동행,http://www.seoulwire.com/news/articleView.html?idxno=122709
2674,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://yna.kr/AKR20190503045500017?did=1195m
2675,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://view.asiae.co.kr/news/view.htm?idxno=2019050310063514740
2676,2019-05-03,주요리서치센터추천주현대차LG생건대웅제약아스트반도체IT車중국관련株저점매수를,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=288071
2677,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증시장동시공략,http://www.econovill.com/news/articleView.html?idxno=362326
2678,2019-05-03,대웅제약고혈압고지혈증복합신약올로맥스출시,http://www.upinews.kr/news/newsview.php?ncode=1065574657327894
2679,2019-05-03,대웅제약올로맥스출시고혈압고지혈증동시공략,http://www.asiatime.co.kr/news/articleView.html?idxno=243572
2680,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.joseilbo.com/news/news_read.php?uid=375931&class=27&grp=
2681,2019-05-03,GET투자리포트대웅제약투자의견보유유지DB금융투자,http://www.getnews.co.kr/view.php?ud=201905021030305191tpgetnews_16
2682,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.ekn.kr/news/article.html?no=430056
2683,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905030154&t=NN
2684,2019-05-03,대웅제약올로맥스출시해고혈압고지혈증동시공략,http://www.etoday.co.kr/news/section/newsview.php?idxno=1751937
2685,2019-05-03,대웅제약3제복합제올로맥스출시고혈압고지혈증동시공략,http://www.bokuennews.com/news/article.html?no=175194
2686,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=10189
2687,2019-05-03,대웅제약올로맥스출시고혈압고지혈동시공략,http://www.newstomato.com/ReadNews.aspx?no=893083
2688,2019-05-03,5월3일대웅제약증권플러스202000원074,http://www.nbntv.co.kr/news/articleView.html?idxno=343034
2689,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.asiatoday.co.kr/view.php?key=20190503010001889
2690,2019-05-03,대웅제약올로맥스출시고혈압고지혈증시장공략,http://www.newsis.com/view/?id=NISX20190503_0000640397&cID=13001&pID=13000
2691,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55176
2692,2019-05-03,대웅제약올로맥스출시고혈압고지혈증동시공략,http://www.dailymedi.com/detail.php?number=842687&thread=22r05
2693,2019-05-03,대웅제약고혈압고지혈증동시공략올로맥스출시,http://www.bosa.co.kr/news/articleView.html?idxno=2104558
2694,2019-05-03,대웅제약세계최초3제복합개량신약올로맥스출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067897
2695,2019-05-03,2019제약사경영분석③대웅제약보톡스나보타효과로실적상승세탔다,http://www.naeil.com/news_view/?id_art=312056
2696,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.medigatenews.com/news/1176448054
2697,2019-05-03,스타★주식인사이드대웅제약주가203000원5월3일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=676659
2698,2019-05-03,ET투자뉴스대웅제약나보타미국보툴BUY유지KB증권,http://www.etnews.com/20190503000234
2699,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.mdtoday.co.kr/mdtoday/index.html?no=353575
2700,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.etnews.com/20190503000275
2701,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.newsway.co.kr/news/view?tp=1&ud=2019050314051670754
2702,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,https://www.sedaily.com/NewsView/1VIZYCFG6D
2703,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=238474&MainKind=A&NewsKind=5&vCount=12&vKind=1
2704,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230128
2705,2019-05-03,대웅제약나보타FDA승인기념태국서심포지엄개최,http://www.koreaittimes.com/news/articleView.html?idxno=90625
2706,2019-05-03,대웅제약美FDA승인기념태국NABOTASparklingNight심포지엄성황리마쳐,http://www.medisobizanews.com/news/articleView.html?idxno=59520
2707,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.fnnews.com/news/201905031433070871
2708,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2104574
2709,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.newsprime.co.kr/news/article.html?no=458347
2710,2019-05-03,대웅제약나보타美FDA승인기념태국심포지엄개최,http://www.ftoday.co.kr/news/articleView.html?idxno=108354
2711,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.seoulfn.com/news/articleView.html?idxno=341894
2712,2019-05-03,대웅제약참지마요프로젝트교육봉사단모집,http://www.skyedaily.com/news/news_view.html?ID=84380
2713,2019-05-03,대웅제약고혈압고지혈증한번에잡는올로맥스출시,http://www.ezyeconomy.com/news/articleView.html?idxno=90370
2714,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1298054
2715,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.ekn.kr/news/article.html?no=430122
2716,2019-05-03,대웅제약나보타NABOTASparklingNight개최,http://www.ebn.co.kr/news/view/983438
2717,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019050300093
2718,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019050300094
2719,2019-05-03,5월3일장마감주가정보대웅제약203000원,http://www.newsinside.kr/news/articleView.html?idxno=677690
2720,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄성료,http://www.m-i.kr/news/articleView.html?idxno=519555
2721,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.wsobi.com/news/articleView.html?idxno=73080
2722,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=353604
2723,2019-05-03,대웅제약올로맥스로고혈압고지혈증공략,http://daily.hankooki.com/lpage/ittech/201905/dh20190503164233145630.htm
2724,2019-05-03,대웅제약고혈압고지혈증치료3제복합제올로맥스출시,http://news.mk.co.kr/newsRead.php?year=2019&no=290127
2725,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.dt.co.kr/contents.html?article_no=2019050302109931102003&ref=naver
2726,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.finomy.com/news/articleView.html?idxno=65464
2727,2019-05-03,대웅제약올로맥스출시해고혈압과고지혈증동시에공략,http://www.businesspost.co.kr/BP?command=article_view&num=125869
2728,2019-05-03,대웅제약올로맥스출시고혈압고지혈증시장동시공략,http://biz.chosun.com/site/data/html_dir/2019/05/03/2019050302158.html
2729,2019-05-03,사람중심대웅제약인재육성프로그램에눈길,http://www.news2day.co.kr/126371
2730,2019-05-03,대웅제약나보타첫수출국태국서미국시판승인기념심포지엄개최,http://news.mk.co.kr/newsRead.php?year=2019&no=290243
2731,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄NABOTASparklingNight개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55192
2732,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.getnews.co.kr/view.php?ud=20190503172258351541d0c69529_16
2733,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://news.donga.com/3/all/20190503/95373556/1
2734,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄성료,http://daily.hankooki.com/lpage/ittech/201905/dh20190503190946145630.htm
2735,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄NABOTASparklingNight개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=31539
2736,2019-05-03,대웅제약올로맥스 출시로고혈압 고지혈증동시공략,http://www.businesskorea.co.kr/news/articleView.html?idxno=31545
2737,2019-05-03,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.kpanews.co.kr/article/show.asp?idx=203682&table=article&category=D
2738,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄열어,http://www.kpanews.co.kr/article/show.asp?idx=203684&table=article&category=D
2739,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스선봬,http://www.kpanews.co.kr/article/show.asp?idx=203686&table=article&category=D
2740,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.ajunews.com/view/20190503211932009
2741,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.newscj.com/news/articleView.html?idxno=628439
2742,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.newscj.com/news/articleView.html?idxno=628436
2743,2019-05-04,대웅제약나보타FDA승인기념태국심포지엄NABOTASparklingNight개최,http://www.lawissue.co.kr/view.php?ud=201905040011493549d7f4c63cc6_12
2744,2019-05-04,대웅제약이지엔6진통제시장블록버스터도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=252299&REFERER=NP
2745,2019-05-04,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.ekn.kr/news/article.html?no=430199
2746,2019-05-04,대웅제약나보타美승인기념태국심포지엄개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067937
2747,2019-05-05,전승호대웅제약의새성장동력을바이오뷰티에서찾다,http://www.businesspost.co.kr/BP?command=article_view&num=125968
2748,2019-05-05,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.seoulwire.com/news/articleView.html?idxno=123780
2749,2019-05-05,대웅제약나보타FDA승인기념태국NABOTASparklingNight개최,http://www.getnews.co.kr/view.php?ud=20190505102547524541d0c69529_16
2750,2019-05-05,대웅제약고혈압고지혈증복합제올로맥스출시,http://yna.kr/PYH20190503032800017?did=1196m
2751,2019-05-05,대웅제약올로맥스출시고혈압고지혈증시장공략,http://www.econonews.co.kr/news/articleView.html?idxno=63925
2752,2019-05-06,대웅제약나보타FDA승인기념태국심포지엄성료,http://www.newswatch.kr/news/articleView.html?idxno=19197
2753,2019-05-06,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.newswatch.kr/news/articleView.html?idxno=19201
2754,2019-05-06,대웅제약발달장애인지원아름다운동행실시,http://www.kukinews.com/news/article.html?no=659277
2755,2019-05-07,대웅제약의신약가치성과로입증할것,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55194
2756,2019-05-07,대웅제약B형간염치료제비리바정서울아산병원입성,http://medipana.com/news/news_viewer.asp?NewsNum=238495&MainKind=A&NewsKind=5&vCount=12&vKind=1
2757,2019-05-07,★주식인사이드대웅제약주가199500원5월7일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=679412
2758,2019-05-07,대웅제약NABOTASparklingNight개최,http://www.monews.co.kr/news/articleView.html?idxno=202405
2759,2019-05-07,대웅제약올로맥스출시고혈압고지혈증시장공략,http://www.monews.co.kr/news/articleView.html?idxno=202403
2760,2019-05-07,대웅제약한미약품1분기성적순항1조클럽굳히기성공할까,http://www.ekn.kr/news/article.html?no=430373
2761,2019-05-07,대웅제약나보타FDA승인기념태국심포지엄NABOTASparklingNight개최,http://www.wsobi.com/news/articleView.html?idxno=73122
2762,2019-05-07,5월7일대웅제약주식시세현황123200500원,http://www.nbntv.co.kr/news/articleView.html?idxno=346025
2763,2019-05-07,대웅제약박준석신약센터장제2제3의나보타나온다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019050711055129389
2764,2019-05-07,스타★주식인사이드대웅제약주가200000원5월7일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=680535
2765,2019-05-07,5월7일장마감주가정보대웅제약201000원,http://www.newsinside.kr/news/articleView.html?idxno=681581
2766,2019-05-07,박준석대웅제약신약센터장제2제3의나보타로신화이어간다,http://www.dailysmart.co.kr/news/articleView.html?idxno=10342
2767,2019-05-07,대웅제약고혈압고지혈증3제복합제올로맥스출시자체특허이층정제형적용,http://www.updownnews.co.kr/news/articleView.html?idxno=202968
2768,2019-05-08,대웅제약나보타글로벌진출드라이브NO1도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=252360&REFERER=NP
2769,2019-05-08,오늘의추천종목한국투자증권대웅제약LG전자등,http://www.asiatoday.co.kr/view.php?key=20190508010003856
2770,2019-05-08,DS투자증권대웅제약나보타매출기대감매수”,http://www.fnnews.com/news/201905080906037208
2771,2019-05-08,대웅제약나보타美매출기대감목표가↑DS,http://www.edaily.co.kr/news/newspath.asp?newsid=02017206622486952
2772,2019-05-08,★주식인사이드대웅제약주가197000원5월8일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=682919
2773,2019-05-08,GET투자리포트대웅제약투자의견매수DS투자증권,http://www.getnews.co.kr/view.php?ud=201905081030305395tpgetnews_16
2774,2019-05-08,ET투자뉴스대웅제약주가가1년이나쉬BUYDS투자증권,http://www.etnews.com/20190508000104
2775,2019-05-08,대웅제약주가오늘시세8일현재198500원,http://www.gokorea.kr/news/articleView.html?idxno=183324
2776,2019-05-08,스타★주식인사이드대웅제약주가199000원5월8일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=684057
2777,2019-05-08,5월8일대웅제약주식시세현황199000원100,http://www.nbntv.co.kr/news/articleView.html?idxno=348432
2778,2019-05-08,5월8일장마감주가정보대웅제약198000원,http://www.newsinside.kr/news/articleView.html?idxno=685074
2779,2019-05-09,★주식인사이드대웅제약주가198000원5월9일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=686431
2780,2019-05-09,대웅제약오늘증권시세9일현재196500원,http://www.nbntv.co.kr/news/articleView.html?idxno=350688
2781,2019-05-09,스타★주식인사이드대웅제약주가197000원5월9일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=687551
2782,2019-05-09,5월9일장마감주가정보대웅제약193500원,http://www.newsinside.kr/news/articleView.html?idxno=688639
2783,2019-05-10,오늘의추천종목한국투자증권대웅제약BGF리테일등,http://www.asiatoday.co.kr/view.php?key=20190510010005689
2784,2019-05-10,★주식인사이드대웅제약주가195500원5월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=689929
2785,2019-05-10,스타★주식인사이드대웅제약주가189500원5월10일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=691085
2786,2019-05-10,5월10일장마감주가정보대웅제약189000원,http://www.newsinside.kr/news/articleView.html?idxno=692125
2787,2019-05-13,주요제약사7곳중가족친화기업대웅제약한미약품2곳뿐,http://www.ceoscoredaily.com/news/article.html?no=55384
2788,2019-05-13,USITC대웅제약나보타균주메디톡스지정전문가에게제출”,http://www.econovill.com/news/articleView.html?idxno=362902
2789,2019-05-13,메디톡스美ITC대웅제약에나보타균주및관련서류정보제출명령,http://news.mk.co.kr/newsRead.php?year=2019&no=312124
2790,2019-05-13,★주식인사이드대웅제약주가187000원5월13일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=693909
2791,2019-05-13,메디톡스美국제무역위대웅제약에나보타균주제출명령”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1754735
2792,2019-05-13,美국제무역위대웅제약은나보타균주제출하라,http://daily.hankooki.com/lpage/ittech/201905/dh20190513090521145630.htm
2793,2019-05-13,美국제무역위원회대웅제약에나보타균주제출명령,https://www.hankyung.com/article/2019051377486
2794,2019-05-13,美무역위대웅제약나보타균주출처공개하라,http://news.mt.co.kr/mtview.php?no=2019051308505519044
2795,2019-05-13,美국제무역위원회대웅제약은나보타균주제출하라”,http://www.newsway.co.kr/news/view?tp=1&ud=2019051309142020316
2796,2019-05-13,美무역위대웅제약나보타균주관련정보제출명령,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051309125653499
2797,2019-05-13,대웅제약메디톡스균주포자감정통해허위주장입증확신,http://www.econovill.com/news/articleView.html?idxno=362904
2798,2019-05-13,美국제무역委대웅제약나보타균주15일까지메디톡스전문가에제출해야”,https://www.sedaily.com/NewsView/1VJ4IJ3II5
2799,2019-05-13,美ITC대웅제약에15일까지나보타균주제출명령,http://www.newsis.com/view/?id=NISX20190513_0000648350&cID=13001&pID=13000
2800,2019-05-13,대웅제약메디톡스허위주장종지부찍겠다”,http://www.whosaeng.com/109981
2801,2019-05-13,미국국제무역위원회대웅제약나보타균주15일까지제출하라”,http://www.newspim.com/news/view/20190513000251
2802,2019-05-13,대웅제약메디톡스균주감정통해허위주장입증확신,http://www.dailian.co.kr/news/view/794800/?sc=naver
2803,2019-05-13,대웅제약나보타균주포자감정으로분쟁종결할것,http://www.newspim.com/news/view/20190513000274
2804,2019-05-13,대웅제약메디톡스균주포자감정을통해사실관계입증확신”,https://www.sedaily.com/NewsView/1VJ4JU2FDR
2805,2019-05-13,대웅제약국내외소송서메디톡스균주포자감정통해허위주장입증확신,http://www.sisafocus.co.kr/news/articleView.html?idxno=209680
2806,2019-05-13,메디톡스美ITC서류제출명령vs대웅제약포자검증으로분쟁종결,https://view.asiae.co.kr/news/view.htm?idxno=2019051309491262036
2807,2019-05-13,대웅제약ITC균주증거수집절차성실임할것,http://www.bosa.co.kr/news/articleView.html?idxno=2104982
2808,2019-05-13,특징주대웅제약대웅나보타관련美소송본격화소식에급락,http://www.edaily.co.kr/news/newspath.asp?newsid=02302566622488592
2809,2019-05-13,대웅제약美ITC증거수집성실히임해균주도용논란종지부찍을것,http://news.mk.co.kr/newsRead.php?year=2019&no=312352
2810,2019-05-13,대웅제약균주감정통해메디톡스허위주장입증확신,http://www.viva100.com/main/view.php?key=20190513010003625
2811,2019-05-13,보톡스논란미국ITC대웅제약나보타균주제출하라,http://yna.kr/AKR20190513038400017?did=1195m
2812,2019-05-13,메디톡스美행정법원대웅제약에나보타균주제출하라,http://www.medisobizanews.com/news/articleView.html?idxno=59689
2813,2019-05-13,종합美국제무역위나보타균주제출명령메디톡스VS대웅제약입장팽팽,http://www.etoday.co.kr/news/section/newsview.php?idxno=1754789
2814,2019-05-13,대웅제약전일대비약9하락한171500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905130230&t=NN
2815,2019-05-13,fnRASSI대웅제약거래량확대되며6거래일연속하락,http://www.fnnews.com/news/201905131004485077
2816,2019-05-13,美국제무역위원회ITC대웅제약에나보타균주제출명령,http://news.mk.co.kr/newsRead.php?year=2019&no=312422
2817,2019-05-13,대웅제약vs메디톡스보툴리눔균주출처공방美ITC증거수집개시,http://biz.chosun.com/site/data/html_dir/2019/05/13/2019051300937.html
2818,2019-05-13,대웅제약나보타균주포자감정통해분쟁종지부,http://www.ebn.co.kr/news/view/984534
2819,2019-05-13,특징주대웅대웅제약보톡스소송본격화소식에약세,http://yna.kr/AKR20190513049300008?did=1195m
2820,2019-05-13,대웅제약국내외소송서메디톡스균주포자감정진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230362
2821,2019-05-13,대웅제약메디톡스균주분쟁이번기회에종지부,http://www.medisobizanews.com/news/articleView.html?idxno=59692
2822,2019-05-13,대웅제약국내외소송에서균주포자감정통해허위주장입증할것,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55270
2823,2019-05-13,美ITC대웅제약은나보타균주를메디톡스지정전문가에게제출해야”,http://www.ceoscoredaily.com/news/article.html?no=55421
2824,2019-05-13,대웅제약美ITC의나보타균주제출요구성실히임할것,http://www.ceoscoredaily.com/news/article.html?no=55422
2825,2019-05-13,대웅제약나보타균주제출하고도용분쟁종결할것”,http://www.ajunews.com/view/20190513101614347
2826,2019-05-13,미국국제무역위원회대웅제약오는15일까지나보타균주제출할것,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55268
2827,2019-05-13,대웅제약균주감정통해메디톡스허위주장입증확신,http://www.newsway.co.kr/news/view?tp=1&ud=2019051310232302656
2828,2019-05-13,보톡스균주논란미국국제무역위원회ITC대웅제약균주정보제출하라”,http://www.ajunews.com/view/20190513102209354
2829,2019-05-13,대웅제약나보타균주출처논쟁포자감정으로종지부찍을것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051310111085172
2830,2019-05-13,특징주대웅대웅제약보톡스소송본격화소식에약세,http://www.ajunews.com/view/20190513102635360
2831,2019-05-13,메디톡스와소송대웅제약균주증거수집성실히임할것,http://www.newsprime.co.kr/news/article.html?no=459426
2832,2019-05-13,대웅제약미국나보타관련소송에하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=354313
2833,2019-05-13,대웅제약균주포자감정통해메디톡스허위주장입증확신,http://medipana.com/news/news_viewer.asp?NewsNum=238800&MainKind=A&NewsKind=5&vCount=12&vKind=1
2834,2019-05-13,美국제무역위대웅제약나보타균주제출하라”,http://health.chosun.com/site/data/html_dir/2019/05/13/2019051301063.html
2835,2019-05-13,美무역위대웅제약나보타균주출처공개명령,http://www.inews24.com/view/1178350
2836,2019-05-13,대웅제약나보타도용논란막바지국면美국제무역위나보타균주출처메디톡스에공개하라,http://www.ezyeconomy.com/news/articleView.html?idxno=90555
2837,2019-05-13,대웅제약메디톡스균주포자감정해허위주장입증확신,http://www.newsis.com/view/?id=NISX20190513_0000648460&cID=13001&pID=13000
2838,2019-05-13,대웅제약ITC결정존중메디톡스허위주장규명할것,http://news.mt.co.kr/mtview.php?no=2019051310095841478
2839,2019-05-13,미국ITC대웅제약나보타균주제출하라,http://www.asiatoday.co.kr/view.php?key=20190513010007097
2840,2019-05-13,대웅제약메디톡스보톡스출처논란미국ITC조사본격화,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3833225
2841,2019-05-13,대웅제약메디톡스의허위주장입증확신”,http://daily.hankooki.com/lpage/ittech/201905/dh20190513105543145630.htm
2842,2019-05-13,대웅대웅제약보톡스소송美ITC조사본격화소식에약세,http://www.seoulwire.com/news/articleView.html?idxno=128329
2843,2019-05-13,대웅제약메디톡스보톡스출처논란관련허위입증,http://www.kyeongin.com/main/view.php?key=20190513010004883
2844,2019-05-13,특징주대웅제약나보타관련미국소송본격화7급락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1754862
2845,2019-05-13,대웅제약메디톡스보톡스공방재점화美ITC균주정보제출명령,http://sports.chosun.com/news/ntype.htm?id=201905140100093130006267&servicedate=20190513
2846,2019-05-13,대웅제약메디톡스나보타원료제출두고기싸움,http://www.finomy.com/news/articleView.html?idxno=65697
2847,2019-05-13,미ITC보톡스논란조사본격화대웅제약메디톡스허위입증총력,http://www.asiatoday.co.kr/view.php?key=20190513010007119
2848,2019-05-13,대웅제약vs메디톡스美ITC증거수집진실공방결과는,http://www.mdtoday.co.kr/mdtoday/index.html?no=354323
2849,2019-05-13,메디톡스대웅제약과기술절취소송전서승기잡나,http://www.shinailbo.co.kr/news/articleView.html?idxno=1166396
2850,2019-05-13,대웅제약균주증거수집성실히임해도용분쟁종결할것,http://www.seoulwire.com/news/articleView.html?idxno=128344
2851,2019-05-13,5월13일대웅제약주가그래프899172000원,http://www.nbntv.co.kr/news/articleView.html?idxno=354805
2852,2019-05-13,메디톡스대웅제약균주출처논란종지부찍나,http://www.dailymedi.com/detail.php?number=842972&thread=22r05
2853,2019-05-13,보톡스논란미국ITC대웅제약증거제출하라”,https://cnbc.sbs.co.kr/article_hub/10000941218?division=NAVER
2854,2019-05-13,메디톡스vs대웅제약균주논란끝내자종합,http://www.edaily.co.kr/news/newspath.asp?newsid=02961846622488592
2855,2019-05-13,국제무역위원회대웅제약나보타균주제출명령,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1126391&REFERER=NP
2856,2019-05-13,대웅제약보톡스메디톡스관련상대방의허위주장입증하고분쟁종결할수있다,http://www.econonews.co.kr/news/articleView.html?idxno=64834
2857,2019-05-13,메디톡스미국ITC대웅제약나보타균주출처제공명령,http://www.rapportian.com/news/articleView.html?idxno=117521
2858,2019-05-13,허위주장입증자신”美ITC명령에대웅제약메디톡스신경전치열,http://www.viva100.com/main/view.php?key=20190513010003738
2859,2019-05-13,대웅대웅제약주식2만6455주장내매수결정,http://news.mt.co.kr/mtview.php?no=2019051313020977485
2860,2019-05-13,나보타균주검증속도대웅제약도둑혐의벗나,http://news.bizwatch.co.kr/article/consumer/2019/05/13/0008/naver
2861,2019-05-13,공시대웅자회사대웅제약주식2만6544주장내취득결정,http://www.newsway.co.kr/news/view?tp=1&ud=2019051313051796548
2862,2019-05-13,대웅제약vs메디톡스보톡스전쟁마침표찍나,http://www.mhj21.com/121261
2863,2019-05-13,대웅50억대웅제약주식취득자회사지분확대,http://www.dailypharm.com/Users/News/NewsView.html?ID=252554&REFERER=NP
2864,2019-05-13,메디톡스vs대웅제약보톡스균주진실게임가려지나,http://www.straightnews.co.kr/news/articleView.html?idxno=48541
2865,2019-05-13,ITC나보타균주정보제출명령메디톡스vs대웅제약,http://medicalworldnews.co.kr/news/view.php?idx=1510930738
2866,2019-05-13,대웅제약메디톡스보툴리눔톡신균주전쟁2라운드,http://www.monews.co.kr/news/articleView.html?idxno=202519
2867,2019-05-13,대웅자회사대웅제약주식50억원규모인수결정,http://yna.kr/AKR20190513088300008?did=1195m
2868,2019-05-13,대웅자회사대웅제약주식2만6455주장내취득결정,http://www.newspim.com/news/view/20190513000606
2869,2019-05-13,대웅자회사대웅제약주식50억규모취득결정,http://news.heraldcorp.com/view.php?ud=20190513000537
2870,2019-05-13,대웅대웅제약주식장내매수결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=354358
2871,2019-05-13,대웅대웅제약주식2만6455주매입,http://www.ceoscoredaily.com/news/article.html?no=55454
2872,2019-05-13,대웅자회사대웅제약주식50억원규모취득결정,http://www.seoulwire.com/news/articleView.html?idxno=128797
2873,2019-05-13,대웅제약메디톡스보톡스균4년공방끝낼까,http://moneys.mt.co.kr/news/mwView.php?no=2019051311058031608
2874,2019-05-13,대웅50억원규모대웅제약주식매입자회사지분확대,https://view.asiae.co.kr/news/view.htm?idxno=2019051313530244693
2875,2019-05-13,대웅대웅제약지분확대지속성장가능성무게”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1754934
2876,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.mediapen.com/news/view/433284
2877,2019-05-13,美ITC대웅제약에나보타균주제출명령,https://www.hankyung.com/article/201905138805f
2878,2019-05-13,보톨리눔균주누가도용했나대웅제약vs메디톡스조사본격화,http://www.metroseoul.co.kr/news/newsview?newscd=2019051300128
2879,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230381
2880,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.newsway.co.kr/news/view?tp=1&ud=2019051313580099632
2881,2019-05-13,대웅50억원규모대웅제약주식매입,http://www.edaily.co.kr/news/newspath.asp?newsid=03230806622488592
2882,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://www.wsobi.com/news/articleView.html?idxno=73469
2883,2019-05-13,대웅대웅제약주식2만6455주매입윤재춘대표나보타미국진출등성장기대,http://biz.chosun.com/site/data/html_dir/2019/05/13/2019051301402.html
2884,2019-05-13,대웅대웅제약주식2만6455주매입지분확대,http://www.ebn.co.kr/news/view/984577
2885,2019-05-13,대웅자회사대웅제약주식26만주매입,http://news.mt.co.kr/mtview.php?no=2019051314145538011
2886,2019-05-13,㈜대웅대웅제약2만6455주매입나보타수출기대커,http://www.metroseoul.co.kr/news/newsview?newscd=2019051300140
2887,2019-05-13,대웅자회사지분늘려지속성장박차대웅제약주식2만6455주매입,http://kpenews.com/View.aspx?No=33224
2888,2019-05-13,대웅제약vs메디톡스보톡스원료공방美ITC조사본격화,http://www.etnews.com/20190513000419
2889,2019-05-13,대웅제약나보타15일美전격출시보톡스보다가격경쟁력우위,http://news1.kr/articles/?3619935
2890,2019-05-13,㈜대웅대웅제약주식50억원규모매입자회사지분확대차원”,http://www.viva100.com/main/view.php?key=20190513010003885
2891,2019-05-13,대웅대웅제약주식50억원규모인수결정”,https://www.sedaily.com/NewsView/1VJ4JLZB8S
2892,2019-05-13,대웅자회사대웅제약주식50억어치매입,http://www.medisobizanews.com/news/articleView.html?idxno=59706
2893,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://kormedi.com/?p=1292700
2894,2019-05-13,대웅50억원규모대웅제약주식매입자회사지분확대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051314184722022
2895,2019-05-13,대웅제약주식매입한지주사대웅지속성장가능성확신”,http://news.donga.com/3/all/20190513/95499533/1
2896,2019-05-13,대웅대웅제약주식50억원매입자회사지분확대,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905130474&t=NN
2897,2019-05-13,대웅대웅제약주식50억원매입자회사지분확대,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905130474&t=NN
2898,2019-05-13,대웅제약오는15일나보타美론칭ITC조사본격화에찬물,http://biz.newdaily.co.kr/site/data/html/2019/05/13/2019051300139.html
2899,2019-05-13,대웅50억규모대웅제약주식매입,http://www.newstomato.com/ReadNews.aspx?no=894837
2900,2019-05-13,주대웅대웅제약주식50억원어치매입,http://news.mk.co.kr/newsRead.php?year=2019&no=313373
2901,2019-05-13,메디톡스vs대웅제약4년악연美에서곧종지부,http://news.mt.co.kr/mtview.php?no=2019051311200752098
2902,2019-05-13,대웅자회사대웅제약주식50억원어치매입,http://www.newsis.com/view/?id=NISX20190513_0000648888&cID=13001&pID=13000
2903,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.bosa.co.kr/news/articleView.html?idxno=2105030
2904,2019-05-13,대웅대웅제약주식50억원어치매입자회사지분확대,http://www.sisafocus.co.kr/news/articleView.html?idxno=209725
2905,2019-05-13,대웅50억원들여대웅제약주식매입지속성장가능성입증돼,http://www.newspim.com/news/view/20190513000727
2906,2019-05-13,대웅대웅제약주식50억어치매입지분확대,http://www.whosaeng.com/110001
2907,2019-05-13,대웅50억규모대웅제약주식매입,http://www.newsprime.co.kr/news/article.html?no=459487
2908,2019-05-13,대웅제약메디톡스보톡스공방美ITC조사본격화,https://cnbc.sbs.co.kr/article_hub/10000941246?division=NAVER
2909,2019-05-13,대웅대웅제약주식2만6455주매입자회사지분확대,http://www.newsprime.co.kr/news/article.html?no=459500
2910,2019-05-13,종근당대웅제약올해굿스타트,http://www.ebn.co.kr/news/view/984587
2911,2019-05-13,종목썰쩐대웅제약메디톡스공방종지부드디어유전체분석실시,https://www.hankyung.com/article/2019051399536
2912,2019-05-13,대웅제약vs메디톡스나보타균주분쟁새국면ITC자료제출하라,http://www.asiatime.co.kr/news/articleView.html?idxno=245190
2913,2019-05-13,대웅대웅제약주식50억원어치매입,http://www.kpanews.co.kr/article/show.asp?idx=203859&table=article&category=D
2914,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.economytalk.kr/news/articleView.html?idxno=185346
2915,2019-05-13,대웅제약국내외소송에서나보타균주포자감정,http://www.kpanews.co.kr/article/show.asp?idx=203860&table=article&category=D
2916,2019-05-13,대웅제약vs메디톡스보톡스전쟁2R진짜주인진실공방종지부찍을까,http://www.00news.co.kr/news/articleView.html?idxno=57905
2917,2019-05-13,대웅대웅제약지분확대,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051315512702688&objId=A2019051315512702688&portalCode=naver
2918,2019-05-13,대웅제약메디톡스균주출처공방재점화美ITC조사본격화,http://www.wolyo.co.kr/news/articleView.html?idxno=83868
2919,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.asiatime.co.kr/news/articleView.html?idxno=245237
2920,2019-05-13,ITC대웅제약에나보타균주제출요구,http://www.bosa.co.kr/news/articleView.html?idxno=2105031
2921,2019-05-13,대웅대웅제약주식50억어치매입,http://www.rapportian.com/news/articleView.html?idxno=117531
2922,2019-05-13,미국무역위대웅제약에게나보타균주출처공개해야명령,http://www.businesspost.co.kr/BP?command=article_view&num=127003
2923,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.ekn.kr/news/article.html?no=431721
2924,2019-05-13,대웅제약메디톡스균주전쟁ITC자료제출명령두고동상이몽,http://www.newstomato.com/ReadNews.aspx?no=894907
2925,2019-05-13,주대웅대웅제약주식매입통해자회사지분확대나서,http://www.inthenews.co.kr/news/article.html?no=15386
2926,2019-05-13,대웅 대웅제약주식26455주매입자회사지분확대,http://www.businesskorea.co.kr/news/articleView.html?idxno=31765
2927,2019-05-13,대웅대웅제약주식매입자회사지분확대,http://www.ajunews.com/view/20190513162801829
2928,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://daily.hankooki.com/lpage/ittech/201905/dh20190513163731145630.htm
2929,2019-05-13,대웅제약美ITC균주증거수집절차성실히임할것,http://www.ekn.kr/news/article.html?no=431754
2930,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.dailian.co.kr/news/view/795030/?sc=naver
2931,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55276
2932,2019-05-13,대웅제약VS메디톡스보톡스공방끝낼까,https://www.sedaily.com/NewsView/1VJ4L2DRD1
2933,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.medigatenews.com/news/3376551755
2934,2019-05-13,메디톡스vs대웅제약보톡스전쟁미국서크게붙었다,http://www.insightkorea.co.kr//news/articleView.html?idxno=36493
2935,2019-05-13,대웅제약과메디톡스자사주취득하며기싸움,http://www.mhj21.com/121276
2936,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.wolyo.co.kr/news/articleView.html?idxno=83909
2937,2019-05-13,대웅제약메디톡스보톡스대전,https://www.nocutnews.co.kr/news/5149916
2938,2019-05-13,대웅대웅제약주식2만6455주매입,http://www.dailysmart.co.kr/news/articleView.html?idxno=10703
2939,2019-05-13,대웅제약나보타균주출처논란종지부찍을것,http://www.newspost.kr/news/articleView.html?idxno=71275
2940,2019-05-13,전승호메디톡스공세뚫고대웅제약나보타미국수출이뤄낼까,http://www.businesspost.co.kr/BP?command=article_view&num=127039
2941,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://www.econovill.com/news/articleView.html?idxno=362988
2942,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://www.getnews.co.kr/view.php?ud=20190513183922157541d0c69529_16
2943,2019-05-13,대웅대웅제약주식50억어치매입성장가능성입증하고있어,http://www.businesspost.co.kr/BP?command=article_view&num=127067
2944,2019-05-13,대웅제약나보타균주공개명령에주가급락,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051319033003622&objId=A2019051319033003622&portalCode=naver
2945,2019-05-13,메디톡스대웅제약美보톡스소송전본격화,http://www.segye.com/content/html/2019/05/13/20190513511513.html?OutUrl=naver
2946,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://www.lawissue.co.kr/view.php?ud=201905132150247842d7f4c63cc6_12
2947,2019-05-13,대웅제약vs메디톡스나보타분쟁엔드게임자사주취득氣싸움,http://www.upinews.kr/news/newsview.php?ncode=1065615403604769
2948,2019-05-13,대웅제약국내외소송에서메디톡스균주포자감정을통해허위주장입증확신,http://www.lawissue.co.kr/view.php?ud=201905132308018879d7f4c63cc6_12
2949,2019-05-13,미국국제무역위원회ITC대웅제약은나보타균주를오는15일까지메디톡스가지정한전문가에게제출하라”,http://www.lawissue.co.kr/view.php?ud=201905132321128972d7f4c63cc6_12
2950,2019-05-14,ITC보톡스공방증거제출명령메디톡스대웅제약소송본격화,http://www.hankookilbo.com/news/npath/201905131641756632?did=NA
2951,2019-05-14,㈜대웅대웅제약주식2만6455주매입,http://www.sisaon.co.kr/news/articleView.html?idxno=93640
2952,2019-05-14,메디톡스대웅제약보툴리눔균주논란이번엔끝장보나,http://www.rapportian.com/news/articleView.html?idxno=117538
2953,2019-05-14,대웅제약나보타출시는계획대로KTB증권,http://www.newstomato.com/ReadNews.aspx?no=894979
2954,2019-05-14,대웅제약16일기업설명회개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1755266
2955,2019-05-14,대웅대웅제약주식2만6455주매입,http://www.kukinews.com/news/article.html?no=661904
2956,2019-05-14,대웅대웅제약주식매입통한자회사지분확대,http://www.bokuennews.com/news/article.html?no=175548
2957,2019-05-14,대웅제약균주제출위해메디톡스와조율중적법성증명할것,http://moneys.mt.co.kr/news/mwView.php?no=2019051409348025119
2958,2019-05-14,대웅제약메디톡스와보톨리눔균주정밀비교분석진행예정,http://www.econovill.com/news/articleView.html?idxno=363014
2959,2019-05-14,대웅제약ITC소송증거수집절차통해균주정밀비교분석할것,http://www.dailian.co.kr/news/view/795131/?sc=naver
2960,2019-05-14,대웅제약ITC소송의증거수집절차를통해균주정밀비교분석진행예정,http://www.sisafocus.co.kr/news/articleView.html?idxno=209771
2961,2019-05-14,​대웅제약ITC증거수집절차서균주정밀비교분석진행,http://medipana.com/news/news_viewer.asp?NewsNum=238872&MainKind=A&NewsKind=5&vCount=12&vKind=1
2962,2019-05-14,대웅제약ITC 소송의증거수집절차를통해균주정밀비교분석진행예정 ,http://www.fetv.co.kr/news/article.html?no=28302
2963,2019-05-14,대웅제약ITC증거수집절차통해균주정밀비교분석예정,http://news.mk.co.kr/newsRead.php?year=2019&no=314989
2964,2019-05-14,㈜대웅대웅제약주식매입통한자회사지분확대,http://www.ftoday.co.kr/news/articleView.html?idxno=108584
2965,2019-05-14,대웅제약목표가24만원신규제시전일종가17만4000원메리츠證,http://www.newspim.com/news/view/20190514000326
2966,2019-05-14,퀵리포트대웅제약매수목표가24만원신규제시메리츠證,http://www.itooza.com/common/iview.php?no=2019051409581814504
2967,2019-05-14,대웅제약ITC소송서양사균주비교분석할것,http://www.newspim.com/news/view/20190514000318
2968,2019-05-14,대웅제약ITC증거수집절차통해균주정밀비교분석진행,http://www.ekn.kr/news/article.html?no=431847
2969,2019-05-14,다시불붙은보톡스전쟁대웅제약도메디톡스균주제공요구맞불,http://www.etoday.co.kr/news/section/newsview.php?idxno=1755334
2970,2019-05-14,대웅제약메디톡스와나보타균주정밀비교할것,http://www.metroseoul.co.kr/news/newsview?newscd=2019051400040
2971,2019-05-14,대웅제약나보타균주정밀비교분석하겠다,http://www.medisobizanews.com/news/articleView.html?idxno=59720
2972,2019-05-14,대웅제약ITC결정따라메디톡스에균주제출키로,https://www.sedaily.com/NewsView/1VJ50KF1I6
2973,2019-05-14,대웅제약메디톡스와나보타균주정밀비교분석할것”,http://www.newsway.co.kr/news/view?tp=1&ud=2019051410312705125
2974,2019-05-14,대웅제약ITC소송증거수집절차통해균주정밀비교분석진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230411
2975,2019-05-14,대웅제약ITC소송증거수집절차로균주정밀비교분석예정,http://www.asiatime.co.kr/news/articleView.html?idxno=245401
2976,2019-05-14,대웅제약ITC소송의증거수집절차진행균주정밀비교분석할것,http://www.segye.com/content/html/2019/05/14/20190514505165.html?OutUrl=naver
2977,2019-05-14,대웅제약메디톡스균주도전문가들검증대상,http://news.mt.co.kr/mtview.php?no=2019051409343028000
2978,2019-05-14,대웅제약주가5월14일현재177500원,http://www.gokorea.kr/news/articleView.html?idxno=189525
2979,2019-05-14,대웅제약美ITC에균주제출메디톡스와결착짓는다,http://www.inews24.com/view/1178594
2980,2019-05-14,실시간분석대웅제약31상승증권사목표가24만원제시,http://www.itooza.com/common/iview.php?no=2019051411173017137
2981,2019-05-14,대웅제약ITC소송증거수집절차통해균주정밀비교분석진행예정,http://www.mdtoday.co.kr/mdtoday/index.html?no=354451
2982,2019-05-14,대웅제약메디톡스균주와나보타균주정밀비교분석진행,http://www.ceoscoredaily.com/news/article.html?no=55518
2983,2019-05-14,대웅제약오늘주식장14일현재179000원,http://www.nbntv.co.kr/news/articleView.html?idxno=357149
2984,2019-05-14,대웅제약vs메디톡스균주전쟁포자생성여부가관건,http://www.newsis.com/view/?id=NISX20190514_0000649993&cID=13001&pID=13000
2985,2019-05-14,대웅제약ITC소송통해메디톡스주장허구성입증자신,http://www.rapportian.com/news/articleView.html?idxno=117543
2986,2019-05-14,대웅제약메디톡스균주요청정밀비교분석진행예정,http://www.ajunews.com/view/20190514114642438
2987,2019-05-14,대웅제약메디톡스균주받아포자형성여부비교할것,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068236
2988,2019-05-14,나보타분쟁재점화메디톡스대웅제약입장차여전,http://www.shinailbo.co.kr/news/articleView.html?idxno=1166840
2989,2019-05-14,대웅제약ITC소송의증거수집절차통해균주정밀비교분석진행예정,http://www.wsobi.com/news/articleView.html?idxno=73529
2990,2019-05-14,ET투자뉴스대웅제약_상장주식수대비거래량은037로적정수준,http://www.etnews.com/20190514000236
2991,2019-05-14,대웅제약ITC소송의증거수집절차를통해균주정밀비교분석진행예정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55294
2992,2019-05-14,증시상황실식량보다는개성공단대웅제약메디톡스균주공방,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003585493
2993,2019-05-14,대웅제약균주정밀분석통해나보타적법성증명할것,http://www.viva100.com/main/view.php?key=20190514010004237
2994,2019-05-14,대웅제약메디톡스균주제공받아정밀비교분석진행,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051412560851745
2995,2019-05-14,대웅제약ITC증거수집절차통해균주비교분석예정메디톡스대웅제약소송본격화,http://biz.chosun.com/site/data/html_dir/2019/05/14/2019051401595.html
2996,2019-05-14,대웅제약메디톡스균주비교해적법성증명,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051413473402069&objId=A2019051413473402069&portalCode=naver
2997,2019-05-14,대웅제약메디톡스머리맞대긴하는데,http://www.bosa.co.kr/news/articleView.html?idxno=2105100
2998,2019-05-14,대웅제약메디톡스보톡스균주포자감정앞두고공방전포자생성여부가관건,http://www.ezyeconomy.com/news/articleView.html?idxno=90600
2999,2019-05-14,대웅제약포자검증vs메디톡스염기서열분석균주전쟁결판,http://www.newsis.com/view/?id=NISX20190514_0000650228&cID=13001&pID=13000
3000,2019-05-14,대웅제약안구건조증치료제임상3상진입해성공기대높여,http://www.businesspost.co.kr/BP?command=article_view&num=127188
3001,2019-05-14,대웅제약ITC소송증거수집절차통해균주정밀비교분석할것,http://www.seoulwire.com/news/articleView.html?idxno=129890
3002,2019-05-14,대웅제약ITC소송증거수집절차통해균주정밀비교분석진행예정,http://www.etnews.com/20190514000431
3003,2019-05-14,대웅제약메디톡스주장허구밝힌다,http://www.whosaeng.com/110037
3004,2019-05-14,나보타적법성증명할것”대웅제약ITC소송서균주비교진행,http://www.inthenews.co.kr/news/article.html?no=15419
3005,2019-05-14,대웅제약반격우리도메디톡스균주받아분석하겠다,http://news1.kr/articles/?3621204
3006,2019-05-14,대웅제약vs메디톡스균주출처논란美ITC개입으로재점화,http://www.wikileaks-kr.org/news/articleView.html?idxno=55321
3007,2019-05-14,메디톡스대웅제약보톡스전쟁종지부찍나,http://www.kpinews.co.kr/news/articleView.html?idxno=96206
3008,2019-05-14,대웅제약ITC소송의증거수집절차로균주정밀비교분석진행예정,http://www.newscj.com/news/articleView.html?idxno=631756
3009,2019-05-14,대웅제약ITC소송의증거수집절차를통해균주정밀비교분석진행예정,http://www.lawissue.co.kr/view.php?ud=201905142231221751d7f4c63cc6_12
3010,2019-05-15,대웅제약ITC소송위해증거수집균주정밀비교예정,http://www.kpanews.co.kr/article/show.asp?idx=203915&table=article&category=D
3011,2019-05-15,정현호메디톡스대표대웅제약균주출처논란에로또6번당첨확률”반박,http://www.ajunews.com/view/20190514152755658
3012,2019-05-15,대웅제약나보타미국시장출격소송영향無,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068270
3013,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장공략,http://www.ebn.co.kr/news/view/984906
3014,2019-05-15,대웅제약보툴리눔톡신글로벌시장본격공략,http://www.sisafocus.co.kr/news/articleView.html?idxno=209887
3015,2019-05-15,대웅제약나보타치료적응증사업착수글로벌3조시장공략,http://www.etoday.co.kr/news/section/newsview.php?idxno=1755755
3016,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략차세대성장동력될것,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=531526
3017,2019-05-15,대웅제약나보타치료적응증사업확대,http://moneys.mt.co.kr/news/mwView.php?no=2019051509068017437
3018,2019-05-15,대웅제약 보툴리눔톡신글로벌치료시장본격공략  ,http://www.fetv.co.kr/news/article.html?no=28407
3019,2019-05-15,대웅대웅제약주식매입자회사지분확대,http://www.monews.co.kr/news/articleView.html?idxno=202541
3020,2019-05-15,대웅제약보툴리눔톡신글로벌치료적응증사업착수,http://www.dailian.co.kr/news/view/795442/?sc=naver
3021,2019-05-15,대웅제약美파트너사새CEO영입나보타글로벌치료사업탄력,http://www.medisobizanews.com/news/articleView.html?idxno=59747
3022,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.newsway.co.kr/news/view?tp=1&ud=2019051509251432904
3023,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230460
3024,2019-05-15,대웅제약보툴리눔톡신글로벌치료적응증사업본격화,http://www.seoulwire.com/news/articleView.html?idxno=130341
3025,2019-05-15,대웅제약보툴리눔톡신치료시장공략본격화,http://news.mt.co.kr/mtview.php?no=2019051509111078421
3026,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.ekn.kr/news/article.html?no=432042
3027,2019-05-15,대웅제약톡신해외치료시장공략美파트너사신규CEO선임,http://www.newspim.com/news/view/20190515000283
3028,2019-05-15,대웅제약보툴리눔톡신의글로벌치료적응증사업본격화,http://www.inthenews.co.kr/news/article.html?no=15437
3029,2019-05-15,대웅제약미국파트너사치료용나보타개발위해앨러간출신CEO영입,http://news.mk.co.kr/newsRead.php?year=2019&no=317951
3030,2019-05-15,대웅제약보툴리눔톡신글로벌시장본격공략,http://www.koreaittimes.com/news/articleView.html?idxno=90777
3031,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.wolyo.co.kr/news/articleView.html?idxno=84053
3032,2019-05-15,대웅제약보툴리눔톡신글로벌치료적응증사업본격착수,http://www.mdtoday.co.kr/mdtoday/index.html?no=354579
3033,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.ceoscoredaily.com/news/article.html?no=55573
3034,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.econovill.com/news/articleView.html?idxno=363109
3035,2019-05-15,대웅제약국내외소송서메디톡스허위주장입증확신,http://www.skyedaily.com/news/news_view.html?ID=84721
3036,2019-05-15,대웅제약치료용보툴리눔톡신시장공략본격화,http://www.newsis.com/view/?id=NISX20190515_0000651212&cID=13001&pID=13000
3037,2019-05-15,대웅제약질병치료용보툴리눔톡신사업본격화,http://yna.kr/AKR20190515050800017?did=1195m
3038,2019-05-15,대웅제약나보타글로벌치료적응증사업본격착수,http://www.dailysmart.co.kr/news/articleView.html?idxno=10812
3039,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.bokuennews.com/news/article.html?no=175637
3040,2019-05-15,대웅제약3조규모치료적응증시장진출착수,http://biz.chosun.com/site/data/html_dir/2019/05/15/2019051500946.html
3041,2019-05-15,대웅제약나보타글로벌치료적응증사업본격화,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051510432301411&objId=A2019051510432301411&portalCode=naver
3042,2019-05-15,메디톡스ITC행정명령대웅제약나보타균주에만해당,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230474
3043,2019-05-15,균주기원논란대웅제약의무리한아전인수해석눈쌀,http://www.edaily.co.kr/news/newspath.asp?newsid=03014326622489248
3044,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장공략실시,http://www.asiatime.co.kr/news/articleView.html?idxno=245641
3045,2019-05-15,대웅제약보툴리눔톡신치료시장공략,http://www.seoulfn.com/news/articleView.html?idxno=342965
3046,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.businesskorea.co.kr/news/articleView.html?idxno=31843
3047,2019-05-15,메디톡스ITC행정명령은대웅제약만해당우리는균주제공의무없어,http://www.etoday.co.kr/news/section/newsview.php?idxno=1755906
3048,2019-05-15,대웅제약보툴리눔톡신미용외치료분야공략,http://www.bosa.co.kr/news/articleView.html?idxno=2105159
3049,2019-05-15,대웅제약보툴리눔톡신제제글로벌진출박차,http://www.sisaon.co.kr/news/articleView.html?idxno=93729
3050,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55314
3051,2019-05-15,메디톡스美ITC행정명령대웅제약나보타균주만해당,http://www.medisobizanews.com/news/articleView.html?idxno=59758
3052,2019-05-15,뉴스투데이L대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.news2day.co.kr/127211
3053,2019-05-15,대웅제약질병치료용보툴리눔톡신사업본격화,http://www.dt.co.kr/contents.html?article_no=2019051502109931102001&ref=naver
3054,2019-05-15,메디톡스ITC의행정명령은대웅제약나보타균주에만해당,http://www.sisafocus.co.kr/news/articleView.html?idxno=209906
3055,2019-05-15,5월15일대웅제약증권매매173000원226,http://www.nbntv.co.kr/news/articleView.html?idxno=359378
3056,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장공략,https://view.asiae.co.kr/news/view.htm?idxno=2019051511510525806
3057,2019-05-15,메디톡스ITC증거제출명령은대웅제약에만해당된다반박,http://www.metroseoul.co.kr/news/newsview?newscd=2019051500098
3058,2019-05-15,대웅제약나보타치료적응증확대잰걸음,http://www.whosaeng.com/110074
3059,2019-05-15,메디톡스ITC행정명령은대웅제약나보타균주에만해당”,http://www.mdtoday.co.kr/mdtoday/index.html?no=354600
3060,2019-05-15,대웅제약나보타미용이외치료시장확대추진,http://www.rapportian.com/news/articleView.html?idxno=117563
3061,2019-05-15,균주출처2라운드대웅제약균주강제제출한다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051510571568021
3062,2019-05-15,메디톡스美ITC증거제출명령은대웅제약에만해당,http://news.mk.co.kr/newsRead.php?year=2019&no=318820
3063,2019-05-15,대웅제약미국파트너사가새CEO영입해나보타치료시장공략,http://www.businesspost.co.kr/BP?command=article_view&num=127346
3064,2019-05-15,대웅제약나보타글로벌치료적응증사업착수,http://www.newstomato.com/ReadNews.aspx?no=895328
3065,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장공략한다,http://www.medigatenews.com/news/690703760
3066,2019-05-15,상승세타던대웅제약나보타균주싸움으로삐끗,http://www.ajunews.com/view/20190515135838571
3067,2019-05-15,대웅제약질병치료용보툴리눔톡신사업본격화,http://www.asiatoday.co.kr/view.php?key=20190515010009170
3068,2019-05-15,대웅제약한올바이오파마5조원안구건조증시장도전,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905150341&t=NN
3069,2019-05-15,메디톡스ITC의행정명령은대웅제약나보타균주에만해당되는것,http://www.lawissue.co.kr/view.php?ud=201905151449028349d7f4c63cc6_12
3070,2019-05-15,대웅제약글로벌치료용보톨리눔톡신사업본격화,http://www.metroseoul.co.kr/news/newsview?newscd=2019051500106
3071,2019-05-15,대웅제약보툴리눔톡신나보타치료용으로사용범위확대,http://www.ezyeconomy.com/news/articleView.html?idxno=90640
3072,2019-05-15,대웅제약보툴리눔톡신글로벌치료적응증사업착수,http://www.newsprime.co.kr/news/article.html?no=459850
3073,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.economytalk.kr/news/articleView.html?idxno=185550
3074,2019-05-15,대웅제약나보타치료적응증시장진출본격화,http://www.viva100.com/main/view.php?key=20190515010004947
3075,2019-05-15,메디톡스ITC의행정명령은대웅제약나보타균주만해당되는것,http://www.ceoscoredaily.com/news/article.html?no=55629
3076,2019-05-15,대웅제약1분기연결영업이익126억전년비135↑,http://www.newspim.com/news/view/20190515002132
3077,2019-05-15,실적속보대웅제약1Q영업이익126억전년비135↑,http://www.itooza.com/common/iview.php?no=2019051517030012075
3078,2019-05-15,전승호대웅제약나보타잇는신약으로폐섬유증치료제힘쏟아,http://www.businesspost.co.kr/BP?command=article_view&num=127377
3079,2019-05-15,대웅제약치료용보툴리눔톡신사업추진美파트너사새CEO선임,http://news.donga.com/3/all/20190515/95539770/1
3080,2019-05-15,공시봇대웅제약최대주주지분020증가,http://www.ajunews.com/view/20190515171370877
3081,2019-05-15,대웅제약보툴리눔톡신치료시장공략 ,http://www.monews.co.kr/news/articleView.html?idxno=202566
3082,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.getnews.co.kr/view.php?ud=20190515180425728341d0c69529_16
3083,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.lawissue.co.kr/view.php?ud=201905152231201632d7f4c63cc6_12
3084,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.newswatch.kr/news/articleView.html?idxno=19570
3085,2019-05-16,ITC행정명령두고해석분분대웅제약vs메디톡스,http://medicalworldnews.co.kr/news/view.php?idx=1510930769
3086,2019-05-16,대웅제약보툴리눔톡신나보타치료적응증획득채비,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068288
3087,2019-05-16,대웅제약보툴리눔톡신제제주보미국공식발매,https://www.hankyung.com/article/2019051606206
3088,2019-05-16,대웅제약보툴리눔톡신미국공식발매최대시장공략,http://www.metroseoul.co.kr/news/newsview?newscd=2019051600004
3089,2019-05-16,대웅제약보툴리눔톡신美출시FDA승인4개월만에쾌거,http://www.medisobizanews.com/news/articleView.html?idxno=59772
3090,2019-05-16,대웅제약보툴리눔톡신나보타美공식발매,http://www.biospectator.com/view/news_view.php?varAtcId=7646
3091,2019-05-16,대웅제약나보타미국현지서공식출시돼,http://news.mk.co.kr/newsRead.php?year=2019&no=320767
3092,2019-05-16,대웅제약보툴리눔톡신나보타미국공식발매,http://www.econovill.com/news/articleView.html?idxno=363195
3093,2019-05-16,대웅제약보툴리눔톡신주보美출시,http://www.edaily.co.kr/news/newspath.asp?newsid=01899126622489576
3094,2019-05-16,대웅제약보툴리눔톡신미국공식발매전세계최대톡신시장공략,http://www.fetv.co.kr/news/article.html?no=28525
3095,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.sentv.co.kr/news/view/553722
3096,2019-05-16,대웅제약보툴리눔톡신미국공식발매전세계최대톡신시장공략,http://www.ekn.kr/news/article.html?no=432295
3097,2019-05-16,대웅제약보툴리눔톡신나보타美발매,http://news.mt.co.kr/mtview.php?no=2019051608223729075
3098,2019-05-16,대웅제약보툴리눔톡신주보미국공식출시,http://www.fnnews.com/news/201905160834037395
3099,2019-05-16,대웅제약나보타美공식출시,http://www.newsis.com/view/?id=NISX20190516_0000652332&cID=13001&pID=13000
3100,2019-05-16,대웅제약보툴리눔톡신주보미국출시최대시장공략,http://www.newspim.com/news/view/20190516000175
3101,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.bosa.co.kr/news/articleView.html?idxno=2105230
3102,2019-05-16,대웅제약보툴리눔톡신나보타주보미국공식발매,http://www.inthenews.co.kr/news/article.html?no=15473
3103,2019-05-16,대웅제약보툴리눔톡신주보미국공식발매,http://www.ajunews.com/view/20190516084748137
3104,2019-05-16,대웅제약보툴리눔톡신주보美출시2조시장공략자신”,http://www.viva100.com/main/view.php?key=20190516010005051
3105,2019-05-16,대웅제약보툴리눔톡신미국발매세계최대시장공략,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230535
3106,2019-05-16,대웅제약보툴리눔톡신주보미국공식출시,http://www.rpm9.com/news/article.html?id=20190516090007
3107,2019-05-16,대웅제약주보미국공식발매‥세계최대톡신시장공략,http://medipana.com/news/news_viewer.asp?NewsNum=239019&MainKind=A&NewsKind=5&vCount=12&vKind=1
3108,2019-05-16,대웅제약나보타미공식출시,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=52837
3109,2019-05-16,대웅제약보툴리눔톡신美공식발매현지파트너사에볼루스통해,http://news.mk.co.kr/newsRead.php?year=2019&no=320941
3110,2019-05-16,대웅제약나보타美공식발매세계최대톡신시장공략,http://news1.kr/articles/?3622651
3111,2019-05-16,대웅제약국내첫보툴리눔톡신주보미국출시,https://www.sedaily.com/NewsView/1VJ5WPKD2X
3112,2019-05-16,대웅제약보툴리눔톡신나보타미국공식발매,http://yna.kr/AKR20190516045300017?did=1195m
3113,2019-05-16,대웅제약보툴리눔톡신미국공식발매전세계최대톡신시장공략,http://www.ceoscoredaily.com/news/article.html?no=55657
3114,2019-05-16,대웅제약미국서보툴리눔톡신주보공식발매,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051608261316026
3115,2019-05-16,대웅제약디엔컴퍼니성년x부부의날셀리시스EX제안,http://www.thekpm.com/view.php?ud=2019051609351944124506bdf1_17
3116,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.newsway.co.kr/news/view?tp=1&ud=2019051609323161240
3117,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.asiatoday.co.kr/view.php?key=20190516010009653
3118,2019-05-16,대웅제약보톡스주보美출시본격매출발생,http://www.dailypharm.com/Users/News/NewsView.html?ID=252679&REFERER=NP
3119,2019-05-16,대웅제약보툴리눔톡신나보타美공식발매,http://www.seoulwire.com/news/articleView.html?idxno=131390
3120,2019-05-16,대웅제약보툴리눔톡신美공식발매,http://www.etoday.co.kr/news/section/newsview.php?idxno=1756397
3121,2019-05-16,대웅제약글로벌시장공략강화현지화로승부수,http://www.newsis.com/view/?id=NISX20190516_0000652542&cID=13001&pID=13000
3122,2019-05-16,대웅제약글로벌시장공략강화현지화로승부한다,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=52845
3123,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.economytalk.kr/news/articleView.html?idxno=185650
3124,2019-05-16,대웅제약1Q영업익135↑RD비3수출30↓,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230549
3125,2019-05-16,대웅제약1Q영업익135↑RD비3수출30↓,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230549
3126,2019-05-16,대웅제약나보타미국공식발매국산보톡스중처음,http://www.hankookilbo.com/news/npath/201905161075076559?did=NA
3127,2019-05-16,대웅제약보툴리눔톡신나보타美공식발매,https://view.asiae.co.kr/news/view.htm?idxno=2019051610262427582
3128,2019-05-16,대웅제약나보타美시장공식출시,http://www.rapportian.com/news/articleView.html?idxno=117580
3129,2019-05-16,대웅제약보툴리눔톡신나보타미국서공식발매,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905160262&t=NN
3130,2019-05-16,대웅제약보툴리눔톡신미국공식발매세계최대톡신시장공략,http://www.etnews.com/20190516000120
3131,2019-05-16,대웅제약5기글로벌우수인재프로그램킥오프글로벌리더육성본격화,http://www.businesskorea.co.kr/news/articleView.html?idxno=31889
3132,2019-05-16,대웅제약보톡스주보미국공식발매,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051610404001337&objId=A2019051610404001337&portalCode=naver
3133,2019-05-16,대웅제약직무전문가현지법인배치로글로벌사업강화,http://medipana.com/news/news_viewer.asp?NewsNum=239037&MainKind=A&NewsKind=5&vCount=12&vKind=1
3134,2019-05-16,대웅제약보툴리눔톡신주보미국공식발매,http://www.bokuennews.com/news/article.html?no=175720
3135,2019-05-16,대웅제약나보타美시장입성국내제약사위상높일것,http://www.dailysmart.co.kr/news/articleView.html?idxno=10897
3136,2019-05-16,대웅제약주보美공식출시,http://www.dt.co.kr/contents.html?article_no=2019051602109931102001&ref=naver
3137,2019-05-16,세계최대톡신시장공략대웅제약보툴리눔톡신美발매,http://www.koreaittimes.com/news/articleView.html?idxno=90801
3138,2019-05-16,대웅제약보툴리눔톡신미국공식출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55343
3139,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55346
3140,2019-05-16,대웅제약글로벌리더육성강화현지화전략에박차,http://www.medisobizanews.com/news/articleView.html?idxno=59784
3141,2019-05-16,대웅제약글로벌리더육성박차5기글로벌우수인재프로그램개시,http://kpenews.com/View.aspx?No=33545
3142,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.wolyo.co.kr/news/articleView.html?idxno=84176
3143,2019-05-16,대웅제약보톡스나보타美공식발매,http://www.kyeongin.com/main/view.php?key=20190516010006689
3144,2019-05-16,대웅제약보툴리눔톡신제제주보미국공식발매,http://www.kukinews.com/news/article.html?no=662833
3145,2019-05-16,대웅제약글로벌리더육성현지화전략박차,http://www.dailymedi.com/detail.php?number=843108&thread=22r05
3146,2019-05-16,증권플러스대웅제약주가16일현재170000원,http://www.nbntv.co.kr/news/articleView.html?idxno=361881
3147,2019-05-16,대웅제약전일대비약4하락한169500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905160440&t=NN
3148,2019-05-16,대웅제약보툴리눔톡신주보미국공식발매,http://www.newsprime.co.kr/news/article.html?no=460003
3149,2019-05-16,대웅제약자체개발보툴리눔톡신美공식발매,http://www.dailymedi.com/detail.php?number=843115&thread=22r05
3150,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.wsobi.com/news/articleView.html?idxno=73718
3151,2019-05-16,대웅제약나보타미국시장공식출시글로벌시장공략박차,http://news.donga.com/3/all/20190516/95554046/1
3152,2019-05-16,대웅제약보툴리눔톡신주보세계최대시장미국서공식발매,http://daily.hankooki.com/lpage/ittech/201905/dh20190516140044145630.htm
3153,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.mdtoday.co.kr/mdtoday/index.html?no=354753
3154,2019-05-16,대웅제약디엔컴퍼니성년x부부의날셀리시스EX제안,http://www.getnews.co.kr/view.php?ud=20190516143315532841d0c69529_16
3155,2019-05-16,대웅제약글로벌리더육성으로현지화전략박차,http://news.donga.com/3/all/20190516/95554972/1
3156,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.ekn.kr/news/article.html?no=432429
3157,2019-05-16,대웅제약나보타미국공식발매글로벌최대시장공략시동,http://www.newstomato.com/ReadNews.aspx?no=895762
3158,2019-05-16,스타★주식인사이드대웅제약주가167500원5월16일14시55분기준,http://www.newsinside.kr/news/articleView.html?idxno=706342
3159,2019-05-16,대웅제약글로벌리더육성현지화전략박차,http://www.ezyeconomy.com/news/articleView.html?idxno=90681
3160,2019-05-16,대웅제약미국에서자체개발보툴리눔톡신공식출시,http://www.businesspost.co.kr/BP?command=article_view&num=127537
3161,2019-05-16,대웅제약미국서보툴리눔톡신주보출시,http://www.finomy.com/news/articleView.html?idxno=65840
3162,2019-05-16,대웅제약보툴리눔톡신미국공식발매전세계최대톡신시장공략,http://www.medigatenews.com/news/2350349416
3163,2019-05-16,대웅제약우수인재현지법인배치글로벌사업강화,http://www.newsis.com/view/?id=NISX20190516_0000653152&cID=13001&pID=13000
3164,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.bosa.co.kr/news/articleView.html?idxno=2105283
3165,2019-05-16,대웅제약보툴리눔톡신나보타미국공식발매,http://www.seoulfn.com/news/articleView.html?idxno=343111
3166,2019-05-16,5월16일장마감주가정보대웅제약169500원,http://www.newsinside.kr/news/articleView.html?idxno=707356
3167,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.wsobi.com/news/articleView.html?idxno=73758
3168,2019-05-16,대웅제약제5기글로벌우수인재프로그램첫발,http://news.mk.co.kr/newsRead.php?year=2019&no=322874
3169,2019-05-16,대웅제약글로벌리더육성으로현지화전략강화,http://www.getnews.co.kr/view.php?ud=20190516170058645641d0c69529_16
3170,2019-05-16,대웅제약글로벌리더육성현지화전략박차,http://www.wolyo.co.kr/news/articleView.html?idxno=84205
3171,2019-05-16,국내최초로미국진출했지만불안한대웅제약주보,https://www.sedaily.com/NewsView/1VJ5Y9AMSD
3172,2019-05-16,대웅제약보툴리눔톡신미국공식발매전세계최대시장공략,http://www.getnews.co.kr/view.php?ud=20190516173928253241d0c69529_16
3173,2019-05-16,대웅제약보툴리눔톡신나보타美공식출시,http://www.sporbiz.co.kr/news/articleView.html?idxno=338121
3174,2019-05-16,대웅제약보톡스주보국내제약사최초美출시,https://www.hankyung.com/article/2019051641751
3175,2019-05-16,대웅제약보툴리눔톡신글로벌시장본격공략,http://www.skyedaily.com/news/news_view.html?ID=84784
3176,2019-05-16,대웅제약현지법인에직무전문가전진배치,http://www.mhj21.com/121345
3177,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.newscj.com/news/articleView.html?idxno=632488
3178,2019-05-16,대웅제약나보타미국공식출시국내보툴리눔톡신최초,http://www.upinews.kr/news/newsview.php?ncode=1065603109746371
3179,2019-05-16,대웅제약나보타미국공식출시파트너사에볼루스통해보툴리눔톡신판매,http://www.econonews.co.kr/news/articleView.html?idxno=65430
3180,2019-05-17,대웅제약글로벌리더육성으로현지화전략에박차,http://www.lawissue.co.kr/view.php?ud=201905162338589449d7f4c63cc6_12
3181,2019-05-17,대웅제약보툴리눔톡신미국공식발매전세계최대톡신시장공략,http://www.lawissue.co.kr/view.php?ud=201905170051451900d7f4c63cc6_12
3182,2019-05-17,대웅제약자체개발보툴리눔톡신제제나보타美공식출시,http://www.dailian.co.kr/news/view/796057/?sc=naver
3183,2019-05-17,더벨대웅제약현지화전략으로2년내100개국진출,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905160100027770001740
3184,2019-05-17,대웅제약메디톡스제품제조허가관련보도전혀연관성없어,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230601
3185,2019-05-17,메디톡신생산공정조작의혹메디톡스대웅제약또충돌,http://www.kukinews.com/news/article.html?no=663130
3186,2019-05-17,★주식인사이드대웅제약주가168500원5월17일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=709126
3187,2019-05-17,특징주대웅제약나보타판매美파트너사주가하락에약세,http://news.mk.co.kr/newsRead.php?year=2019&no=324008
3188,2019-05-17,대웅제약jTBC의메디톡스허가등관련보도와무관,http://www.medisobizanews.com/news/articleView.html?idxno=59803
3189,2019-05-17,대웅제약장초반약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=354834
3190,2019-05-17,5월17일대웅제약오늘증시265165000원,http://www.nbntv.co.kr/news/articleView.html?idxno=364222
3191,2019-05-17,대웅제약메디톡스또진흙탕싸움균주훔쳐간직원이악성제보,http://www.upinews.kr/news/newsview.php?ncode=1065574179081896
3192,2019-05-17,메디톡스불량보톡스유통의혹폭로출처는대웅제약,http://www.breaknews.com/655311
3193,2019-05-17,대웅자회사대웅제약주식2만9498주50억원에취득,http://www.edaily.co.kr/news/newspath.asp?newsid=02699446622489904
3194,2019-05-17,대웅50억원에대웅제약주식2만9498만주취득,http://news.mt.co.kr/mtview.php?no=2019051712164546376
3195,2019-05-17,공시대웅자회사대웅제약주식50억규모취득,http://www.newsway.co.kr/news/view?tp=1&ud=2019051712172807710
3196,2019-05-17,대웅제약전일대비약4하락한162500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905170411&t=NN
3197,2019-05-17,스타★주식인사이드대웅제약주가163000원5월17일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=710291
3198,2019-05-17,메디톡스대웅제약불량보톡스공방근본원인은보툴리눔균주장기소송,http://www.betanews.net:8080/article/1010103.html
3199,2019-05-17,JTBC보도후대웅제약vs메디톡스신경전격화,http://www.insightkorea.co.kr//news/articleView.html?idxno=36607
3200,2019-05-17,공시대웅자회사대웅제약주식50억규모인수결정,http://www.fnnews.com/news/201905171350498770
3201,2019-05-17,대웅대웅제약주식2만9498주50억에취득결정,https://view.asiae.co.kr/news/view.htm?idxno=2019051713554857612
3202,2019-05-17,대웅제약보툴리눔톡신글로벌치료시장공략,http://www.wsobi.com/news/articleView.html?idxno=73838
3203,2019-05-17,대웅50억원규모대웅제약주식2만9498주취득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1756966
3204,2019-05-17,대웅제약국산미간주름개선주보美출시,http://www.munhwa.com/news/view.html?no=2019051701071827107001
3205,2019-05-17,대웅대웅제약주식2만9498주50억원에취득,http://www.mdtoday.co.kr/mdtoday/index.html?no=354870
3206,2019-05-17,대웅자회사대웅제약주식50억규모취득,http://news.heraldcorp.com/view.php?ud=20190517000440
3207,2019-05-17,메디톡신생산공정조작의혹대웅제약보도와연관없다”,http://www.mdtoday.co.kr/mdtoday/index.html?no=354848
3208,2019-05-17,대웅자회사대웅제약주식50억원규모인수결정,https://www.sedaily.com/NewsView/1VJ6EWK922
3209,2019-05-17,공시대웅자회사대웅제약주식50억원규모취득,http://moneys.mt.co.kr/news/mwView.php?no=2019051715038055160
3210,2019-05-17,대웅자회사대웅제약주식50억원규모인수결정,http://daily.hankooki.com/lpage/ittech/201905/dh20190517150024145630.htm
3211,2019-05-17,5월17일장마감주가정보대웅제약163500원,http://www.newsinside.kr/news/articleView.html?idxno=711333
3212,2019-05-17,메디톡스대웅제약보톡스전쟁진흙탕싸움되나,http://www.kpinews.co.kr/news/articleView.html?idxno=96439
3213,2019-05-17,대웅제약메디톡스불량보톡스논란으로점유율확대기회잡아,http://www.businesspost.co.kr/BP?command=article_view&num=127771
3214,2019-05-17,대웅제약vs메디톡스균주전쟁최후승자는,http://www.economytalk.kr/news/articleView.html?idxno=185785
3215,2019-05-17,메디톡스토종보톡스메디톡신생산공정서조작의혹제기돼경쟁사대웅제약음해주장,http://www.ntoday.co.kr/news/articleView.html?idxno=66814
3216,2019-05-17,대웅제약보툴리눔톡신미국공식발매,http://www.kpanews.co.kr/article/show.asp?idx=204012&table=article&category=D
3217,2019-05-18,대웅50억규모대웅제약지분취득자회사지분확대위해,http://www.econonews.co.kr/news/articleView.html?idxno=65547
3218,2019-05-18,끝나지않는보톡스전쟁메디톡스대웅제약비방전,http://yna.kr/AKR20190517124300017?did=1195m
3219,2019-05-18,균주도용둘러싼대웅제약메디톡스소송전막바지로치닫나,https://www.sedaily.com/NewsView/1VJ6UL9034
3220,2019-05-19,대웅제약현지화전략일환글로벌리더육성본격화,http://www.viva100.com/main/view.php?key=20190519010005839
3221,2019-05-20,★주식인사이드대웅제약주가161000원5월20일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=714009
3222,2019-05-20,GET투자리포트대웅제약투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201905201030306265tpgetnews_16
3223,2019-05-20,ET투자뉴스대웅제약바이오시밀러콜레BUY유지NH투자증권,http://www.etnews.com/20190520000058
3224,2019-05-20,메디톡스vs대웅제약화해불가끝까지간다,http://news.mt.co.kr/mtview.php?no=2019051821563573206
3225,2019-05-20,대웅제약주가5월20일현재159500원,http://www.gokorea.kr/news/articleView.html?idxno=197128
3226,2019-05-20,대웅제약배당주식20일현재158500원,http://www.nbntv.co.kr/news/articleView.html?idxno=367213
3227,2019-05-20,스타★주식인사이드대웅제약주가158500원5월20일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=715840
3228,2019-05-20,대웅제약보툴리눔톡신美공식발매세계최대시장공략,http://news.heraldcorp.com/view.php?ud=20190520000652
3229,2019-05-20,5월20일장마감주가정보대웅제약156000원,http://www.newsinside.kr/news/articleView.html?idxno=716873
3230,2019-05-20,대웅제약전승호글로벌시장공략강화2년내100개국진출자신,http://www.newsway.co.kr/news/view?tp=1&ud=2019052015441656195
3231,2019-05-20,대웅제약메디톡스톡신공방이르면12월판가름,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019052016471145051
3232,2019-05-20,대웅제약보툴리눔톡신주보미국공략가속화한다,http://www.wikileaks-kr.org/news/articleView.html?idxno=55863
3233,2019-05-20,메디톡스검정통과위해불량제품바꿔치기의혹메디톡스대웅제약악의적행위,http://www.betanews.net:8080/article/1010849.html
3234,2019-05-21,★주식인사이드대웅제약주가162500원5월21일9시17분기준,http://www.newsinside.kr/news/articleView.html?idxno=718650
3235,2019-05-21,대웅제약5이상상승외국인기관각각4일연속순매수4일연속순매도,https://www.hankyung.com/article/201905217249L
3236,2019-05-21,5월21일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=199073
3237,2019-05-21,대웅제약주식시세현황21일현재162000원,http://www.nbntv.co.kr/news/articleView.html?idxno=369622
3238,2019-05-21,대웅제약신약개발파이프라인통해넥스트나보타연구박차,http://www.ajunews.com/view/20190521110313510
3239,2019-05-21,대웅제약대웅RD위원회글로벌연구개발성과기대,http://www.betanews.net:8080/article/1011230.html
3240,2019-05-21,대웅제약APA항궤양제안구건조증치료제임상3상순항,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230734
3241,2019-05-21,대웅제약전승호사장난치성치료제개발주력넥스트나보타준비,http://biz.chosun.com/site/data/html_dir/2019/05/21/2019052101216.html
3242,2019-05-21,대웅제약신약개발잘나갑니다,http://www.medisobizanews.com/news/articleView.html?idxno=59879
3243,2019-05-21,스타★주식인사이드대웅제약주가162500원5월21일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=719787
3244,2019-05-21,대웅제약신약개발순항中넥스트나보타성과기대,http://www.viva100.com/main/view.php?key=20190521010006689
3245,2019-05-21,대웅제약RD위원회글로벌도전약물나온다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019052113280389320
3246,2019-05-21,대웅제약글로벌신약연구개발어디까지왔나,http://medipana.com/news/news_viewer.asp?NewsNum=239275&MainKind=A&NewsKind=5&vCount=12&vKind=1
3247,2019-05-21,대웅제약난치질환치료제로넥스트나보타준비,http://www.metroseoul.co.kr/news/newsview?newscd=2019052100112
3248,2019-05-21,대웅제약난치성질환치료제개발박차RD위원회글로벌연구개발성과기대,http://kpenews.com/View.aspx?No=33870
3249,2019-05-21,전승호대웅제약사장넥스트나보타위한준비이상무,http://www.ebn.co.kr/news/view/985752
3250,2019-05-21,전승호대웅제약사장대웅RD위원회주도글로벌연구개발성과기대,http://www.businesskorea.co.kr/news/articleView.html?idxno=32062
3251,2019-05-21,제약업종내상승종목이글벳690JW생명과학499대웅제약481순,http://aitimes.co.kr/news/view/48414
3252,2019-05-21,대웅제약넥스트나보타신약개발박차난치성질환치료제개발순항”,http://news.donga.com/3/all/20190521/95625213/1
3253,2019-05-21,대웅제약항궤양제안구건조증치료제연구개발박차,http://www.rapportian.com/news/articleView.html?idxno=117653
3254,2019-05-21,대웅제약난치성질환치료제개발제2의나보타준비,http://www.newsprime.co.kr/news/article.html?no=460519
3255,2019-05-21,대웅제약난치성질환치료제개발넥스트나보타연구집중할것”,https://www.sedaily.com/NewsView/1VJ88CNJ74
3256,2019-05-21,5월21일장마감주가정보대웅제약163000원,http://www.newsinside.kr/news/articleView.html?idxno=721255
3257,2019-05-21,대웅제약넥스트나보타준비난치성치료제개발박차,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905210384&t=NN
3258,2019-05-21,대웅제약APA항궤양제안구건조증치료제임상순항중,http://www.mdtoday.co.kr/mdtoday/index.html?no=355179
3259,2019-05-21,대웅제약글로벌RD성과기대,http://www.dailymedi.com/detail.php?number=843281&thread=22r05
3260,2019-05-21,대웅제약난치성치료제개발주력넥스트나보타준비,http://www.seoulwire.com/news/articleView.html?idxno=135492
3261,2019-05-21,대웅제약차세대APA항궤양제와안구건조증치료제임상3상순항”,http://www.dailian.co.kr/news/view/797177/?sc=naver
3262,2019-05-21,대웅제약글로벌50위제약사도약,http://www.monews.co.kr/news/articleView.html?idxno=202693
3263,2019-05-21,대웅제약차세대APA항궤양제등신약개발순항,http://www.shinailbo.co.kr/news/articleView.html?idxno=1169045
3264,2019-05-21,대웅제약항궤양제와안구건조증치료제개발가시화,http://www.bokuennews.com/news/article.html?no=175972
3265,2019-05-21,대웅제약RD위원회글로벌연구개발성과기대,http://www.getnews.co.kr/view.php?ud=20190521180223480741d0c69529_16
3266,2019-05-21,전승호대웅제약난치성질환치료제로제2의나보타토대다져,http://www.businesspost.co.kr/BP?command=article_view&num=128206
3267,2019-05-21,대웅제약메로페넴이어나보타로미국진출본격화,http://www.finomy.com/news/articleView.html?idxno=65990
3268,2019-05-22,대웅제약차세대APA항궤양제와안구건조증치료제임상3상지속순항중,http://www.lawissue.co.kr/view.php?ud=201905212348506006d7f4c63cc6_12
3269,2019-05-22,★주식인사이드대웅제약주가163500원5월22일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=722936
3270,2019-05-22,대웅제약오늘주식22일현재162500원,http://www.nbntv.co.kr/news/articleView.html?idxno=372138
3271,2019-05-22,대웅제약보툴리눔톡신나보타美공식출시,http://news.heraldcorp.com/view.php?ud=20190522000377
3272,2019-05-22,스타★주식인사이드대웅제약주가163000원5월22일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=724484
3273,2019-05-22,극으로치닫는메디톡스대웅제약원료탈취공방전종지부찍나,http://www.enewstoday.co.kr/news/articleView.html?idxno=1303930
3274,2019-05-22,대웅제약vs메디톡스끝까지간다균주싸움점입가경,http://www.newsway.co.kr/news/view?tp=1&ud=2019052214563418776
3275,2019-05-22,대웅제약차세대APA항궤양제등임상3상지속,http://www.100ssd.co.kr/news/articleView.html?idxno=61515
3276,2019-05-22,신약개발성과기대하는대웅제약RD위원회통해글로벌제약사도약노린다,http://www.updownnews.co.kr/news/articleView.html?idxno=203795
3277,2019-05-22,5월22일장마감주가정보대웅제약162500원,http://www.newsinside.kr/news/articleView.html?idxno=725551
3278,2019-05-22,대웅제약메로페넴이어나보타로미국본격공략,http://www.viva100.com/main/view.php?key=20190522010007318
3279,2019-05-23,대웅제약보툴리눔톡신나보타美시장공식출시제품명주보,http://www.betanews.net:8080/article/1011867.html
3280,2019-05-23,보톡스논란에주가추락한대웅제약메디톡스바닥설솔솔,http://www.edaily.co.kr/news/newspath.asp?newsid=01134886622491872
3281,2019-05-23,★주식인사이드대웅제약주가162500원5월23일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=727095
3282,2019-05-23,코막히나코메키나졸음유발줄인대웅제약의비염치료제 ,http://kormedi.com/?p=1293524
3283,2019-05-23,대웅제약제2의나보타는항궤양제섬유증치료제주목,http://news1.kr/articles/?3628440
3284,2019-05-23,공시봇대웅제약최대주주지분010증가,http://www.ajunews.com/view/20190523111070475
3285,2019-05-23,대웅웅대웅제약보통주1만2343주장내매수,http://www.newspim.com/news/view/20190523000313
3286,2019-05-23,대웅제약상습탈세국세청요주의기업,http://www.ekoreanews.co.kr/news/articleView.html?idxno=31797
3287,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.economytalk.kr/news/articleView.html?idxno=186329
3288,2019-05-23,5월23일대웅제약증권매매160500원123,http://www.nbntv.co.kr/news/articleView.html?idxno=374432
3289,2019-05-23,대웅제약우루사미국소화기학회서임상시험결과공개,http://www.newspim.com/news/view/20190523000345
3290,2019-05-23,대웅제약우루사위절제후담석예방효과있다,http://www.medisobizanews.com/news/articleView.html?idxno=59951
3291,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.dailian.co.kr/news/view/797712/?sc=naver
3292,2019-05-23,대웅제약우루사위절제후담석예방미국소화기학회서임상결과공개,http://kpenews.com/View.aspx?No=40217
3293,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://medipana.com/news/news_viewer.asp?NewsNum=239399&MainKind=A&NewsKind=5&vCount=12&vKind=1
3294,2019-05-23,스타★주식인사이드대웅제약주가161000원5월23일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=728660
3295,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2105710
3296,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.wsobi.com/news/articleView.html?idxno=74275
3297,2019-05-23,대웅제약vs메디톡스화해불가보톡스전쟁점입가경,http://ilyo.co.kr/?ac=article_view&entry_id=335816
3298,2019-05-23,대웅제약우루사우수성입증미국소화기학회DDW에서우루사300mg임상시험결과구두발표,http://www.updownnews.co.kr/news/articleView.html?idxno=203859
3299,2019-05-23,대웅제약전문의약품우루사위절제후담석예방효과입증,http://www.metroseoul.co.kr/news/newsview?newscd=2019052300157
3300,2019-05-23,대웅제약우루사300mg위절제후담석예방효과입증,http://www.fnnews.com/news/201905231430301966
3301,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230855
3302,2019-05-23,대웅제약우루사적응증추가목표미국학회서임상결과알려,http://moneys.mt.co.kr/news/mwView.php?no=2019052314378042143
3303,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2019052315205908275
3304,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.betanews.net:8080/article/1012300.html
3305,2019-05-23,대웅제약우루사위암환자담석예방효과입증적응증추가추진,http://news.donga.com/3/all/20190523/95665456/1
3306,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.fetv.co.kr/news/article.html?no=29220
3307,2019-05-23,대웅제약미국학회에서위암환자대상우루사담석예방입증,http://www.businesspost.co.kr/BP?command=article_view&num=128517
3308,2019-05-23,대웅제약우루사위절제후담석예방효과입증”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1759027
3309,2019-05-23,대웅제약美DDW서우루사의위절제후담석예방효과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=343545
3310,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.dailymedi.com/detail.php?number=843365&thread=22r05
3311,2019-05-23,5월23일장마감주가정보대웅제약159000원,http://www.newsinside.kr/news/articleView.html?idxno=730721
3312,2019-05-23,대웅제약美소화기학회서우루사300mg임상결과공개,http://www.ebn.co.kr/news/view/986202
3313,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1304485
3314,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=355459
3315,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.getnews.co.kr/view.php?ud=20190523182823737341d0c69529_16
3316,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.lawissue.co.kr/view.php?ud=201905232351562549d7f4c63cc6_12
3317,2019-05-24,더벨대웅제약美줄기세포치료제회사지분20획득,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905230100040280002513
3318,2019-05-24,대웅제약해외법인늘리고연구생산도현지에서글로벌2020잰걸음,http://www.rapportian.com/news/articleView.html?idxno=117714
3319,2019-05-24,★주식인사이드대웅제약주가159500원5월24일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=731640
3320,2019-05-24,대웅제약우루사위절제후담석예방효과,http://www.sisaon.co.kr/news/articleView.html?idxno=94259
3321,2019-05-24,대웅제약우루사300mg임상결과발표위절제후담석예방효과입증,http://www.ezyeconomy.com/news/articleView.html?idxno=90937
3322,2019-05-24,대웅제약이지덤과함께다둥이마라톤즐기세요,http://www.ibabynews.com/news/articleView.html?idxno=74902
3323,2019-05-24,스타★주식인사이드대웅제약주가160000원5월24일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=733262
3324,2019-05-24,메조미디어큐피트대웅제약과이지덤뷰티특집퀴즈쇼진행,http://biz.newdaily.co.kr/site/data/html/2019/05/24/2019052400092.html
3325,2019-05-24,대웅제약사회공헌프로그램으로장애인과동행하는삶앞장,http://www.g-enews.com/ko-kr/news/article/news_all/201905231825125528f67c3fc824_1/article.html
3326,2019-05-24,SR경제라이프생방송 모바일 퀴즈쇼큐피트대웅제약과이지덤뷰티특집퀴즈쇼진행,http://www.srtimes.kr/news/articleView.html?idxno=40250
3327,2019-05-24,대웅제약차별화된줄기세포치료제연구순항,http://daily.hankooki.com/lpage/ittech/201905/dh20190524145228145630.htm
3328,2019-05-24,대웅제약진행중인줄기세포치료제연구첫공개,http://www.etoday.co.kr/news/section/newsview.php?idxno=1759392
3329,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55483
3330,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.bosa.co.kr/news/articleView.html?idxno=2105796
3331,2019-05-24,대웅제약K바이오이끌줄기세포치료제첫공개,http://www.medisobizanews.com/news/articleView.html?idxno=59985
3332,2019-05-24,대웅제약줄기세포치료제연구박차미래의학춘계포럼서DWMSC공개,http://kpenews.com/View.aspx?No=40317
3333,2019-05-24,대웅제약개발중인차별화된줄기세포치료제공개,http://www.metroseoul.co.kr/news/newsview?newscd=2019052400081
3334,2019-05-24,대웅제약넥스트나보타줄기세포치료제DWMSC공개,http://www.viva100.com/main/view.php?key=20190524010007966
3335,2019-05-24,대웅제약차별화된줄기세포치료제연구순항,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230920
3336,2019-05-24,대웅제약연구진행중인줄기세포치료제공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=355546
3337,2019-05-24,대웅제약줄기세포치료제최초공개,https://www.sedaily.com/NewsView/1VJ9MJRDNW
3338,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.ebn.co.kr/news/view/986352
3339,2019-05-24,넥스트나보타준비하는대웅제약줄기세포연구,http://www.mhj21.com/121504
3340,2019-05-24,대웅제약줄기세포치료제공개,http://www.newspim.com/news/view/20190524000545
3341,2019-05-24,대웅제약미래의학춘계포럼서줄기세포치료제공개,http://medipana.com/news/news_viewer.asp?NewsNum=239477&MainKind=A&NewsKind=5&vCount=12&vKind=1
3342,2019-05-24,대웅제약줄기세포연구진행10일연구내용발표,http://www.newsprime.co.kr/news/article.html?no=461053
3343,2019-05-24,5월24일장마감주가정보대웅제약159500원,http://www.newsinside.kr/news/articleView.html?idxno=734433
3344,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.ekn.kr/news/article.html?no=433922
3345,2019-05-24,대웅제약줄기세포치료제첫공개기술차별화로미래K바이오이끌것”,http://news.donga.com/3/all/20190524/95685984/1
3346,2019-05-24,대웅제약미래의학춘계포럼서줄기세포치료제첫공개,http://moneys.mt.co.kr/news/mwView.php?no=2019052416558018038
3347,2019-05-24,대웅제약연구중인줄기세포치료제DWMSC첫공개,http://www.medigatenews.com/news/1377035999
3348,2019-05-24,대웅제약제3회미래의학춘계포럼서줄기세포치료제공개발표,http://www.getnews.co.kr/view.php?ud=20190524172129938541d0c69529_16
3349,2019-05-24,대웅제약개발중인줄기세포치료제첫공개,http://www.seoulwire.com/news/articleView.html?idxno=138469
3350,2019-05-24,대웅제약상업화가능한줄기세포연구내용처음공개,http://www.businesspost.co.kr/BP?command=article_view&num=128726
3351,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.asiatime.co.kr/news/articleView.html?idxno=247589
3352,2019-05-24,대웅제약제3회미래의학춘계포럼서줄기세포치료제첫공개발표,http://www.updownnews.co.kr/news/articleView.html?idxno=203963
3353,2019-05-24,대웅제약미래의학춘계포럼서줄기세포치료제연구경과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=348244
3354,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.newscj.com/news/articleView.html?idxno=634908
3355,2019-05-24,대웅제약줄기세포치료제공개발표,http://www.kpanews.co.kr/article/show.asp?idx=204198&table=article&category=D
3356,2019-05-25,대웅제약차별화된줄기세포치료제연구순항중,http://www.betanews.net:8080/article/1012803.html
3357,2019-05-25,대웅제약제2의나보타는항궤양제섬유증치료제주목,http://www.fntoday.co.kr/news/articleView.html?idxno=189818
3358,2019-05-26,대웅제약줄기세포치료제연구순항,http://www.dt.co.kr/contents.html?article_no=2019052602109931102006&ref=naver
3359,2019-05-27,대웅제약한올바이오파마안구건조증치료신약개발에총력,http://www.mdtoday.co.kr/mdtoday/index.html?no=355560
3360,2019-05-27,더벨대웅균주논란속대웅제약주가방어총력,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905240100042230002637
3361,2019-05-27,★주식인사이드대웅제약주가156000원5월27일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=738125
3362,2019-05-27,대웅제약발달장애인채용이어사회공헌프로그램으로장애인과동행하는삶에앞장서,http://www.seoulwire.com/news/articleView.html?idxno=138719
3363,2019-05-27,주식현재가대웅제약주가27일현재157000원,http://www.nbntv.co.kr/news/articleView.html?idxno=379662
3364,2019-05-27,스타★주식인사이드대웅제약주가157000원5월27일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=739615
3365,2019-05-27,대웅제약줄기세포치료제연구첫공개,http://www.bokuennews.com/news/article.html?no=176231
3366,2019-05-27,5월27일장마감주가정보대웅제약156000원,http://www.newsinside.kr/news/articleView.html?idxno=740699
3367,2019-05-27,건강하게여름나기대웅제약나보타눈가미간주름팽팽하게,https://www.sedaily.com/NewsView/1VJB05IGRO
3368,2019-05-27,대웅제약제3회미래의학춘계포럼통해줄기세포치료제공개발표,http://www.lawissue.co.kr/view.php?ud=201905272221155270d7f4c63cc6_12
3369,2019-05-28,★주식인사이드대웅제약주가158500원5월28일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=742010
3370,2019-05-28,5월28일대웅제약종목검색156000원000,http://www.nbntv.co.kr/news/articleView.html?idxno=382136
3371,2019-05-28,더벨대웅제약나보타제품명으로부서명만든이유,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905280100048860003061
3372,2019-05-28,대웅제약최대주주가9451주장내매수,http://news.mt.co.kr/mtview.php?no=2019052815034620809
3373,2019-05-28,공시대웅제약최대주주대웅이9451주장내매수,http://www.newsway.co.kr/news/view?tp=1&ud=2019052815383432206
3374,2019-05-28,대웅제약최대주주대웅9451주장내매수,http://www.mdtoday.co.kr/mdtoday/index.html?no=355847
3375,2019-05-28,5월28일장마감주가정보대웅제약156000원,http://www.newsinside.kr/news/articleView.html?idxno=745084
3376,2019-05-29,★주식인사이드대웅제약주가155500원5월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=745982
3377,2019-05-29,한국다이이찌산쿄대웅제약3중복합제공동판매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85967
3378,2019-05-29,ET투자뉴스대웅제약_주가등락폭이작아,http://www.etnews.com/20190529000083
3379,2019-05-29,다이이찌산쿄대웅제약올로맥스공동판촉계약체결,http://www.bosa.co.kr/news/articleView.html?idxno=2106060
3380,2019-05-29,다이이찌산쿄대웅제약올로맥스도입,http://www.whosaeng.com/110375
3381,2019-05-29,대웅제약한국다이이찌산쿄올로맥스정공동판매계약,http://www.medisobizanews.com/news/articleView.html?idxno=60078
3382,2019-05-29,5월29일대웅제약주식주가417149500원,http://www.nbntv.co.kr/news/articleView.html?idxno=384593
3383,2019-05-29,다이이찌산쿄대웅제약올로맥스공동판매,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068788
3384,2019-05-29,한국다이이찌산쿄대웅제약과올로맥스공동판매계약,http://www.rapportian.com/news/articleView.html?idxno=117803
3385,2019-05-29,대웅제약장애인과동행하는삶앞장,http://www.m-i.kr/news/articleView.html?idxno=607448
3386,2019-05-29,다이이찌산쿄대웅제약올로맥스공동판촉계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231095
3387,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.metroseoul.co.kr/news/newsview?newscd=2019052900050
3388,2019-05-29,대웅제약우루사존재감쑤욱,http://www.whosaeng.com/110384
3389,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증추가,http://www.medisobizanews.com/news/articleView.html?idxno=60088
3390,2019-05-29,대웅제약우루사위절제후담석예방적응증획득,http://www.inthenews.co.kr/news/article.html?no=15840
3391,2019-05-29,다이이찌산쿄대웅제약올로맥스공동판촉계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=355913
3392,2019-05-29,스타★주식인사이드대웅제약주가148000원5월29일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=747610
3393,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231099
3394,2019-05-29,대웅제약우루사300㎎위절제후담석예방,http://www.dt.co.kr/contents.html?article_no=2019052902109931102004&ref=naver
3395,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방에대한적응증획득,http://www.updownnews.co.kr/news/articleView.html?idxno=204131
3396,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.seoulwire.com/news/articleView.html?idxno=141218
3397,2019-05-29,대웅제약 우루사 300mg전세계최초로 위절제후담석예방에대한적응증획득,http://www.fetv.co.kr/news/article.html?no=29743
3398,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.etnews.com/20190529000211
3399,2019-05-29,대웅제약우루사위절제후담석예방효과입증,http://biz.chosun.com/site/data/html_dir/2019/05/29/2019052901598.html
3400,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방적응증획득,http://www.asiatoday.co.kr/view.php?key=20190529010018253
3401,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.ebn.co.kr/news/view/986978
3402,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증승인획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1760853
3403,2019-05-29,대웅제약우루사300mg전세계최초위절제후담석예방적응증획득,http://www.segye.com/content/html/2019/05/29/20190529508198.html?OutUrl=naver
3404,2019-05-29,대웅제약우루사전세계최초신규적응증획득,http://www.mhj21.com/121611
3405,2019-05-29,대웅제약우루사위절제후담석예방적응증획득,http://www.biospectator.com/view/news_view.php?varAtcId=7735
3406,2019-05-29,대웅제약우루사위절제후담석예방적응증획득전세계최초,http://daily.hankooki.com/lpage/ittech/201905/dh20190529144021145630.htm
3407,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방적응증획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=56830
3408,2019-05-29,대웅제약전문약우루사300㎎적응증추가영역확대앞장,http://moneys.mt.co.kr/news/mwView.php?no=2019052914508074836
3409,2019-05-29,대웅제약오송스마트공장바이오헬스산업전초기지로,http://www.newstomato.com/ReadNews.aspx?no=898411
3410,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방적응증획득,http://www.newstomato.com/ReadNews.aspx?no=898401
3411,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방에대한적응증획득,http://www.fnnews.com/news/201905291518113367
3412,2019-05-29,대웅제약우루사세계최초위절제후담석예방적응증획득,http://news.donga.com/3/all/20190529/95753870/1
3413,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.newsprime.co.kr/news/article.html?no=461606
3414,2019-05-29,대웅제약우루사위절제후담석예방효과입증,http://news.bizwatch.co.kr/article/consumer/2019/05/29/0017/naver
3415,2019-05-29,대웅제약우루사300㎎위절제후담석예방적응증획득,http://www.ajunews.com/view/20190529154553223
3416,2019-05-29,대웅제약우루사위절제후담석예방적응증추가,http://www.rapportian.com/news/articleView.html?idxno=117809
3417,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.economytalk.kr/news/articleView.html?idxno=186887
3418,2019-05-29,대웅제약우루사위절제후담석예방효과입증,http://www.newsis.com/view/?id=NISX20190529_0000665700&cID=13001&pID=13000
3419,2019-05-29,5월29일장마감주가정보대웅제약148500원,http://www.newsinside.kr/news/articleView.html?idxno=748949
3420,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=355924
3421,2019-05-29,대웅제약해외의사교육프로그램으로나보타홍보,http://www.monews.co.kr/news/articleView.html?idxno=202034
3422,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방적응증획득,http://www.viva100.com/main/view.php?key=20190529010009616
3423,2019-05-29,대웅제약우루사300mg전세계최초로위절제후담석예방에대한적응증획득,https://www.sedaily.com/NewsView/1VJBXBQ6NF
3424,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.econovill.com/news/articleView.html?idxno=364246
3425,2019-05-29,대웅제약우루사위절제후담석예방적응증획득,http://www.monews.co.kr/news/articleView.html?idxno=202881
3426,2019-05-29,대웅제약우루사300mg위절제후담석예방에대한적응증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019052916411367536
3427,2019-05-29,대웅제약우루사위절제후담석예방적응증획득,http://www.shinailbo.co.kr/news/articleView.html?idxno=1171638
3428,2019-05-29,대웅제약우루사300mg전세계최초위절제후담석예방에대한적응증획득,http://www.betanews.net:8080/article/1014363.html
3429,2019-05-29,대웅제약우루사300mg위절제후담석예방효능추가,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905290333&t=NN
3430,2019-05-29,대웅제약우루사300mg세계최초위절제담석예방인정,http://www.newspost.kr/news/articleView.html?idxno=71743
3431,2019-05-29,대웅제약우루사정위절제후담석예방적응증획득,http://www.kpinews.co.kr/news/articleView.html?idxno=97156
3432,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.k-health.com/news/articleView.html?idxno=44129
3433,2019-05-29,대웅제약우루사300mg위절제후담석예방에대한적응증획득,http://www.medigatenews.com/news/2545908376
3434,2019-05-29,대웅제약우루사위절제뒤담석예방적응증최초로획득,http://www.businesspost.co.kr/BP?command=article_view&num=129389
3435,2019-05-29,대웅제약우루사300mg세계최초로위절제후담석예방적응증획득,http://www.businesskorea.co.kr/news/articleView.html?idxno=32354
3436,2019-05-29,대웅제약우루사300mg세계최초로위절제후담석예방적응증획득,http://www.asiatime.co.kr/news/articleView.html?idxno=248555
3437,2019-05-29,한국다이이찌산쿄대웅제약올로맥스공동판촉계약,http://www.kpanews.co.kr/article/show.asp?idx=204318&table=article&category=D
3438,2019-05-29,대웅제약우루사300mg전세계최초로위절제후담석예방에대한적응증획득,http://www.lawissue.co.kr/view.php?ud=201905292345549174d7f4c63cc6_12
3439,2019-05-30,★주식인사이드대웅제약주가149000원5월30일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=750477
3440,2019-05-30,대웅제약우루사300㎎위절제후담석예방효과입증,http://www.ezyeconomy.com/news/articleView.html?idxno=91096
3441,2019-05-30,대웅제약우루사위절제후담석예방적응증획득,http://www.joseilbo.com/news/news_read.php?uid=377579&class=27&grp=
3442,2019-05-30,특징주대웅제약시너지기술수출한올바이오파마개선되고있다,http://www.sisaon.co.kr/news/articleView.html?idxno=94586
3443,2019-05-30,대웅제약나보타전세계80개국공략4조원시장잡는다,http://www.metroseoul.co.kr/news/newsview?newscd=2019053000063
3444,2019-05-30,한올바이오파마대웅제약에인수된뒤영업과신약개발시너지내,http://www.businesspost.co.kr/BP?command=article_view&num=129450
3445,2019-05-30,대웅제약우루사300㎎위절제후담석예방공인,http://news.heraldcorp.com/view.php?ud=20190530000336
3446,2019-05-30,대웅제약창립이래최다건수임상진행‥1000억이상투자,http://medipana.com/news/news_viewer.asp?NewsNum=239767&MainKind=A&NewsKind=5&vCount=12&vKind=1
3447,2019-05-30,대웅제약올30여건임상시험추가혁신신약의명가꿈꾼다,http://www.medisobizanews.com/news/articleView.html?idxno=60117
3448,2019-05-30,대웅제약올해창립이래최다건수임상돌입,http://www.monews.co.kr/news/articleView.html?idxno=202897
3449,2019-05-30,대웅제약올30여건임상시험추가1000억이상투자,http://www.seoulwire.com/news/articleView.html?idxno=142204
3450,2019-05-30,대웅제약우루사위절제후담석예방적응증획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068843
3451,2019-05-30,대웅제약신약RD경쟁력업그레이드올해30여건신규임상추가,http://kpenews.com/View.aspx?No=40883
3452,2019-05-30,스타★주식인사이드대웅제약주가146500원5월30일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=752873
3453,2019-05-30,대웅제약올해창사이래가장많은임상진행신약RD경쟁력강화”,https://www.sedaily.com/NewsView/1VJCCXE7H2
3454,2019-05-30,대웅제약30여건신규임상추가창립이래최다,http://www.kpinews.co.kr/news/articleView.html?idxno=97200
3455,2019-05-30,대웅제약올30여건신규임상시험RD투자도1000억,http://daily.hankooki.com/lpage/ittech/201905/dh20190530140536145630.htm
3456,2019-05-30,대웅제약올해창사이래최다임상진행1천억원이상투자,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905300294&t=NN
3457,2019-05-30,대웅제약나보타혼란속RD고삐더죈다,http://www.whosaeng.com/110419
3458,2019-05-30,대웅제약올해창사이래가장많은임상진행RD역량강화,https://view.asiae.co.kr/news/view.htm?idxno=2019053014293481538
3459,2019-05-30,대웅제약연구개발비에1000억투자신약RD경쟁력강화로미래성장비전제시​,http://www.updownnews.co.kr/news/articleView.html?idxno=204161
3460,2019-05-30,대웅제약올해신규임상30여건추가창립이래최다,http://www.viva100.com/main/view.php?key=20190530010009944
3461,2019-05-30,대웅제약신약RD경쟁력강화올신규임상30여건추가,http://www.wikileaks-kr.org/news/articleView.html?idxno=56945
3462,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시​,http://www.economytalk.kr/news/articleView.html?idxno=187007
3463,2019-05-30,대웅제약올해창립이래최다임상진행목표,http://www.newstomato.com/ReadNews.aspx?no=898644
3464,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시​,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231156
3465,2019-05-30,대웅제약신약RD경쟁력강화창립이후최다건수임상실시,http://www.asiatime.co.kr/news/articleView.html?idxno=248718
3466,2019-05-30,대웅제약신약RD경쟁력강화미래성장비전제시,http://www.wolyo.co.kr/news/articleView.html?idxno=85270
3467,2019-05-30,대웅제약올해신규임상30여건추가신약경쟁력강화”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1761317
3468,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시,http://www.newsway.co.kr/news/view?tp=1&ud=2019053015345019119
3469,2019-05-30,대웅제약올해신규임상시험추가신약RD경쟁력강화,http://www.newsprime.co.kr/news/article.html?no=461803
3470,2019-05-30,5월30일장마감주가정보대웅제약148000원,http://www.newsinside.kr/news/articleView.html?idxno=753182
3471,2019-05-30,대웅제약올해30여건신규임상시험진행,http://www.ajunews.com/view/20190530161452300
3472,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시,http://www.ekn.kr/news/article.html?no=435037
3473,2019-05-30,대웅제약올해신약파이프라인공격적임상추진,http://www.bokuennews.com/news/article.html?no=176416
3474,2019-05-30,대웅제약신약RD경쟁력강화국내외40여건임상예정,http://www.dt.co.kr/contents.html?article_no=2019053002109931102003&ref=naver
3475,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55593
3476,2019-05-30,대웅제약나보타차별화된경쟁력으로글로벌시장공략,http://www.upinews.kr/news/newsview.php?ncode=1065602798180290
3477,2019-05-30,대웅제약올해신규임상30건추가창사이래최다임상진행,http://www.newspim.com/news/view/20190530001143
3478,2019-05-30,대웅제약올해30여건신규임상시험추가한다,http://www.medigatenews.com/news/2457822073
3479,2019-05-30,대웅제약올해40여건의임상진행전승호연구개발경쟁력강화,http://www.businesspost.co.kr/BP?command=article_view&num=129555
3480,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시​,http://www.newscj.com/news/articleView.html?idxno=636972
3481,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시​,http://www.lawissue.co.kr/view.php?ud=201905302321256703d7f4c63cc6_12
3482,2019-05-31,식약처대웅제약SGLT2억제당뇨치료제국내2상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=356156
3483,2019-05-31,대웅제약신약RD경쟁력강화로미래성장비전제시,http://www.betanews.net:8080/article/1014986.html
3484,2019-05-31,대웅제약기술로탄생한이지듀리더마체험이벤트,http://www.sportsseoul.com/news/read/770290
3485,2019-05-31,한화證대웅제약나보타美출시기대목표가23만원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905310072&t=NN
3486,2019-05-31,★주식인사이드대웅제약주가146500원5월31일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=754897
3487,2019-05-31,대웅제약디엔컴퍼니이지듀리더마출시기념체험이벤트열어,http://www.econovill.com/news/articleView.html?idxno=364371
3488,2019-05-31,대웅제약오송스마트공장바이오헬스산업전초기지로부상,http://www.getnews.co.kr/view.php?ud=20190531092426504441d0c69529_16
3489,2019-05-31,퀵리포트대웅제약매수목표가23만원제시한화證,http://www.itooza.com/common/iview.php?no=2019053108101218250
3490,2019-05-31,대웅제약우루사위암수술후담석예방추가,http://www.sportsseoul.com/news/read/770329
3491,2019-05-31,대웅제약주가증권그래프및종목동정과증시정보31일현재150500원,http://www.gokorea.kr/news/articleView.html?idxno=215903
3492,2019-05-31,디엔컴퍼니대웅제약이지듀리더마출시기념1만명체험키트이벤트실시,http://www.techholic.co.kr/news/articleView.html?idxno=182670
3493,2019-05-31,대웅제약디엔컴퍼니이지듀리더마출시기념이벤트1만명대상5일분체험키트제공,http://www.ezyeconomy.com/news/articleView.html?idxno=91146
3494,2019-05-31,5월31일대웅제약주식증권270152000원,http://www.nbntv.co.kr/news/articleView.html?idxno=388060
3495,2019-05-31,대웅제약올30건임상시험혁신신약개발박차,http://www.munhwa.com/news/view.html?no=2019053101071827107001
3496,2019-05-31,스타★주식인사이드대웅제약주가151500원5월31일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=756545
3497,2019-05-31,대웅제약살빠지는당뇨병치료제임상2상돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231175
3498,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.getnews.co.kr/view.php?ud=20190531145144157041d0c69529_16
3499,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상IND승인,http://www.viva100.com/main/view.php?key=20190531010010322
3500,2019-05-31,대웅제약디엔컴퍼니이지듀리더마1만명체험키트이벤트,http://www.kpinews.co.kr/news/articleView.html?idxno=97294
3501,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55615
3502,2019-05-31,대웅제약SGLT2억제제2상임상승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=86046
3503,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.fnnews.com/news/201905311456583898
3504,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://medipana.com/news/news_viewer.asp?NewsNum=240859&MainKind=A&NewsKind=5&vCount=12&vKind=1
3505,2019-05-31,대웅제약韓식약처서당뇨약SGLT2억제제후보물질임상2상승인,http://news.mk.co.kr/newsRead.php?year=2019&no=370888
3506,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231206
3507,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.etnews.com/20190531000275
3508,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2019053115112132126
3509,2019-05-31,대웅제약SGLT2당뇨신약국내2상승인환자200명대상평가,http://www.medisobizanews.com/news/articleView.html?idxno=60153
3510,2019-05-31,대웅제약당뇨병치료신약DWP16001국내임상2상승인,https://www.hankyung.com/article/2019053149116
3511,2019-05-31,대웅제약당뇨병치료제신약국내임상2상계획승인,http://www.kpinews.co.kr/news/articleView.html?idxno=97296
3512,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상IND승인,http://www.wikileaks-kr.org/news/articleView.html?idxno=57040
3513,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://biz.chosun.com/site/data/html_dir/2019/05/31/2019053101979.html
3514,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.ekn.kr/news/article.html?no=435193
3515,2019-05-31,대웅제약당뇨병치료제후보물질임상2상승인,http://www.rapportian.com/news/articleView.html?idxno=117852
3516,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://news.mk.co.kr/newsRead.php?year=2019&no=371101
3517,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.joseilbo.com/news/news_read.php?uid=377709&class=27&grp=
3518,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.newspim.com/news/view/20190531000753
3519,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.inthenews.co.kr/news/article.html?no=15914
3520,2019-05-31,대웅제약당뇨병치료제DWP16001임상2상승인,http://www.ebn.co.kr/news/view/987384
3521,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.newstomato.com/ReadNews.aspx?no=898983
3522,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.seoulwire.com/news/articleView.html?idxno=143593
3523,2019-05-31,대웅제약창립이래최다올40여건임상진행,http://www.dailymedi.com/detail.php?number=843673&thread=22r05
3524,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.etoday.co.kr/news/section/newsview.php?idxno=1761804
3525,2019-05-31,대웅제약당뇨병치료제DWP16001식약처2상승인,http://news.heraldcorp.com/view.php?ud=20190531000542
3526,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.metroseoul.co.kr/news/newsview?newscd=2019053100089
3527,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.ajunews.com/view/20190531161640142
3528,2019-05-31,대웅제약당뇨병치료신약DWP16001임상2상승인,http://news.donga.com/3/all/20190531/95791027/1
3529,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.newsis.com/view/?id=NISX20190531_0000668446&cID=13001&pID=13000
3530,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=356231
3531,2019-05-31,5월31일장마감주가정보대웅제약153000원,http://www.newsinside.kr/news/articleView.html?idxno=758493
3532,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.dailian.co.kr/news/view/799815/?sc=naver
3533,2019-05-31,대웅제약당뇨병치료제신약식약처2상승인,http://www.skyedaily.com/news/news_view.html?ID=85272
3534,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.asiatime.co.kr/news/articleView.html?idxno=249014
3535,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://news1.kr/articles/?3635505
3536,2019-05-31,대웅제약뷰티브랜드이지듀리더마1만명무료체험행사,http://www.busan.com/view/busan/view.php?code=2019053116502038001
3537,2019-05-31,대웅제약제3회미래의학춘계포럼개최,http://www.wsobi.com/news/articleView.html?idxno=74901
3538,2019-05-31,대웅제약향후나보타의행보에기대를,http://www.wikitree.co.kr/main/news_view.php?id=432930
3539,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.wolyo.co.kr/news/articleView.html?idxno=85419
3540,2019-05-31,대웅제약당뇨병신약DWP16001임상2상승인,http://www.mhj21.com/121662
3541,2019-05-31,대웅제약당뇨병신약임상2상승인,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019053118071903212&objId=A2019053118071903212&portalCode=naver
3542,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://daily.hankooki.com/lpage/ittech/201905/dh20190531183411145630.htm
3543,2019-05-31,대웅제약이지듀이지듀리더마출시기념이벤트개최,http://www.k-health.com/news/articleView.html?idxno=44186
3544,2019-05-31,대웅제약당뇨병치료제DWP16001의국내임상2상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=129766
3545,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.newscj.com/news/articleView.html?idxno=637390
3546,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.betanews.net:8080/article/1015373.html
3547,2019-05-31,대웅제약당뇨병치료제DWP16001한국임상2상승인,http://www.econovill.com/news/articleView.html?idxno=364455
3548,2019-06-02,전승호대웅제약주1회부착치매패치제개발로글로벌진출추진,http://www.businesspost.co.kr/BP?command=article_view&num=129803
3549,2019-06-02,대웅제약당뇨병치료제신약DWP16001국내임상2상최종승인,http://www.econonews.co.kr/news/articleView.html?idxno=67766
3550,2019-06-02,대웅제약SGLT2억제제당뇨약국내임상2상승인,http://www.dailymedi.com/detail.php?number=843713&thread=22r05
3551,2019-06-02,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.dt.co.kr/contents.html?article_no=2019060202109931102004&ref=naver
3552,2019-06-03,대웅제약베트남현지화전략통해신사업모델구축,http://www.ajunews.com/view/20190602112757625
3553,2019-06-03,더벨thebellnote대웅제약의이너inner이노베이션,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905310100056750003584
3554,2019-06-03,대웅제약제약빅5중광고선전비최다매출의6,http://www.datanews.co.kr/news/article.html?no=103297
3555,2019-06-03,대웅제약SGLT2억제제당뇨신약개발전진,http://www.monews.co.kr/news/articleView.html?idxno=202928
3556,2019-06-03,★주식인사이드대웅제약주가149500원6월3일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=759970
3557,2019-06-03,대웅제약주가증권투자정보및주체별매매동향3일현재153500원,http://www.gokorea.kr/news/articleView.html?idxno=218283
3558,2019-06-03,주식장대웅제약주가3일현재154500원,http://www.nbntv.co.kr/news/articleView.html?idxno=389739
3559,2019-06-03,스타★주식인사이드대웅제약주가155500원6월3일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=761714
3560,2019-06-03,공정위대웅제약비방광고메디톡스에과징금2100만원,http://www.upinews.kr/news/newsview.php?ncode=1065578503407061
3561,2019-06-03,대웅제약나보타100개국수출로글로벌제약사톱50목표세워,http://www.businesspost.co.kr/BP?command=article_view&num=129903
3562,2019-06-03,대웅제약오송스마트공장글로벌사업진출가속화,http://daily.hankooki.com/lpage/ittech/201906/dh20190603163217145630.htm
3563,2019-06-03,6월3일장마감주가정보대웅제약155000원,http://www.newsinside.kr/news/articleView.html?idxno=763571
3564,2019-06-04,★주식인사이드대웅제약주가155500원6월4일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=764525
3565,2019-06-04,대웅제약올해30여건신규임상시험추가,http://weekly.cnbnews.com/news/article.html?no=128219
3566,2019-06-04,6월4일대웅제약종목검색154500원032,http://www.nbntv.co.kr/news/articleView.html?idxno=391041
3567,2019-06-04,스타★주식인사이드대웅제약주가154500원6월4일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=766210
3568,2019-06-04,보톡스전쟁상대웅제약메디톡스보톡스칼날대치왜,http://www.sporbiz.co.kr/news/articleView.html?idxno=343744
3569,2019-06-04,6월4일장마감주가정보대웅제약154000원,http://www.newsinside.kr/news/articleView.html?idxno=767242
3570,2019-06-04,대웅제약글로벌RD네트워크적극강화로차세대제약산업선도,http://www.ftoday.co.kr/news/articleView.html?idxno=109117
3571,2019-06-05,증권사추천주무작정따라하기급락하는대웅제약소송노이즈에흔들,http://www.newstomato.com/ReadNews.aspx?no=899550
3572,2019-06-05,★주식인사이드대웅제약주가154500원6월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=769522
3573,2019-06-05,대웅제약올로맥스고혈압이상지질혈증동시에잡는다,http://www.bosa.co.kr/news/articleView.html?idxno=2106541
3574,2019-06-05,대웅제약당뇨치료신약임상2상승인,http://weekly.cnbnews.com/news/article.html?no=128260
3575,2019-06-05,스타★주식인사이드대웅제약주가151500원6월5일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=770559
3576,2019-06-05,메디톡스중국허가심사중단설대웅제약음해주장,http://news.bizwatch.co.kr/article/consumer/2019/06/05/0016/naver
3577,2019-06-05,6월5일장마감주가정보대웅제약152500원,http://www.newsinside.kr/news/articleView.html?idxno=771797
3578,2019-06-05,대웅제약류마티스관절염신약임상시작,http://www.finomy.com/news/articleView.html?idxno=66456
3579,2019-06-06,대웅제약RD현지화전략으로글로벌시장승부수,http://www.etoday.co.kr/news/section/newsview.php?idxno=1763651
3580,2019-06-07,국내10개제약사대웅제약올로스타특허회피첫도전,http://medipana.com/news/news_viewer.asp?NewsNum=241122&MainKind=A&NewsKind=5&vCount=12&vKind=1
3581,2019-06-07,류마티스관절염치료제경쟁에대웅제약가세하나,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069095
3582,2019-06-07,★주식인사이드대웅제약주가154500원6월7일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=774769
3583,2019-06-07,대웅제약보툴리눔톡신나보타미국시장본격공략돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231423
3584,2019-06-07,대웅제약미국서나보타마케팅돌입2년내점유율2위달성목표,http://moneys.mt.co.kr/news/mwView.php?no=2019060709458067092
3585,2019-06-07,대웅제약보툴리눔톡신미국시장공략위해소비자대상체험프로그램론칭,http://news.mk.co.kr/newsRead.php?year=2019&no=392024
3586,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.asiatoday.co.kr/view.php?key=20190607010003754
3587,2019-06-07,대웅제약보툴리눔톡신나보타미국시장본격공략,http://medipana.com/news/news_viewer.asp?NewsNum=241132&MainKind=A&NewsKind=5&vCount=12&vKind=1
3588,2019-06-07,대웅제약보툴리눔톡신주보미국시장본격공략,http://www.ajunews.com/view/20190607095428298
3589,2019-06-07,대웅제약보툴리눔톡신주보미국시장본격공략나서,http://daily.hankooki.com/lpage/ittech/201906/dh20190607095523145630.htm
3590,2019-06-07,대웅제약보툴리눔톡신미국시장공략,http://www.nextdaily.co.kr/news/article.html?id=20190607800016
3591,2019-06-07,대웅제약보툴리눔톡신미국시장공략본격화,http://www.mdtoday.co.kr/mdtoday/index.html?no=356725
3592,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.dailian.co.kr/news/view/801283/?sc=naver
3593,2019-06-07,대웅제약보툴리눔톡신나보타미국시장본격공략,http://www.seoulwire.com/news/articleView.html?idxno=147301
3594,2019-06-07,대웅제약보툴리눔톡신美소비자러브콜받을까,http://www.bokuennews.com/news/article.html?no=176732
3595,2019-06-07,대웅제약보툴리눔톡신나보타미국시장공략마케팅본격화,http://www.etoday.co.kr/news/section/newsview.php?idxno=1763820
3596,2019-06-07,대웅제약보툴리눔톡신소비자마케팅시작하며美시장본격공략,http://www.dailysmart.co.kr/news/articleView.html?idxno=12026
3597,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.bosa.co.kr/news/articleView.html?idxno=2106617
3598,2019-06-07,대웅제약보툴리눔톡신美본격공략체험프로그램론칭,http://www.newsprime.co.kr/news/article.html?no=462742
3599,2019-06-07,대웅제약 보툴리눔톡신美시장본격공략,http://www.medisobizanews.com/news/articleView.html?idxno=60277
3600,2019-06-07,대웅제약나보타美소비자공략나선다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1173975
3601,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나선다,http://www.newspim.com/news/view/20190607000201
3602,2019-06-07,대웅제약보툴리눔톡신美시장본격공략나서,http://www.sisafocus.co.kr/news/articleView.html?idxno=211673
3603,2019-06-07,대웅제약나보타美마케팅본격화”,http://weekly.cnbnews.com/news/article.html?no=128293
3604,2019-06-07,대웅제약美에서보툴리눔톡신주보마케팅활동펼쳐,https://www.sedaily.com/NewsView/1VKBPPMOQW
3605,2019-06-07,대웅제약주보미국시장본격공략,http://www.finomy.com/news/articleView.html?idxno=66491
3606,2019-06-07,대웅제약보툴리눔톡신주보로미국시장본격공략,http://www.sporbiz.co.kr/news/articleView.html?idxno=344584
3607,2019-06-07,대웅제약주보미국마케팅본격개시,http://www.viva100.com/main/view.php?key=20190607010001922
3608,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략,http://www.economytalk.kr/news/articleView.html?idxno=187737
3609,2019-06-07,대웅제약보툴리눔톡신미국소비자공략본격화,http://biz.chosun.com/site/data/html_dir/2019/06/07/2019060701077.html
3610,2019-06-07,대웅제약보툴리눔톡신美시장공략나서,http://www.ebn.co.kr/news/view/988248
3611,2019-06-07,대웅제약보툴리눔톡신주보미국시장서마케팅돌입,http://news1.kr/articles/?3640224
3612,2019-06-07,대웅제약보툴리눔톡신美소비자마케팅본격돌입,http://www.metroseoul.co.kr/news/newsview?newscd=2019060700019
3613,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.econovill.com/news/articleView.html?idxno=364886
3614,2019-06-07,6월7일대웅제약실시간주식현황295157000원,http://www.nbntv.co.kr/news/articleView.html?idxno=393771
3615,2019-06-07,대웅제약전일대비약4상승한159000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906070309&t=NN
3616,2019-06-07,대웅제약美서나보타마케팅돌입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069111
3617,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략2년안에미국톡신시장2위목표,http://www.updownnews.co.kr/news/articleView.html?idxno=204498
3618,2019-06-07,대웅제약글로벌50위제약사진입세계RD네트워크강화,http://kpenews.com/View.aspx?No=53669
3619,2019-06-07,스타★주식인사이드대웅제약주가158000원6월7일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=776219
3620,2019-06-07,대웅제약보툴리눔톡신주보미국소비자공략나서,http://www.wikileaks-kr.org/news/articleView.html?idxno=57542
3621,2019-06-07,ET투자뉴스대웅제약_상장주식수대비거래량은05로적정수준,http://www.etnews.com/20190607000147
3622,2019-06-07,대웅제약보툴리눔톡신美마케팅돌입시장공략본격화,http://www.ezyeconomy.com/news/articleView.html?idxno=91315
3623,2019-06-07,대웅제약미국에서보툴리눔톡신마케팅시작,http://www.businesspost.co.kr/BP?command=article_view&num=130587
3624,2019-06-07,대웅제약나보타美시장공략본격화,http://www.wolyo.co.kr/news/articleView.html?idxno=85907
3625,2019-06-07,대웅제약나보타미국소비자공략본격화,http://www.newstomato.com/ReadNews.aspx?no=900216
3626,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.enewstoday.co.kr/news/articleView.html?idxno=1309700
3627,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.lawissue.co.kr/view.php?ud=201906071522126006d7f4c63cc6_12
3628,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.joseilbo.com/news/news_read.php?uid=378049&class=27&grp=
3629,2019-06-07,6월7일장마감주가정보대웅제약157000원,http://www.newsinside.kr/news/articleView.html?idxno=777228
3630,2019-06-07,대웅제약나보타美시장공략박차내달소비자마케팅전개,http://news.donga.com/3/all/20190607/95887594/1
3631,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.betanews.net:8080/article/1017484.html
3632,2019-06-07,가격경쟁력내세운대웅제약보툴리눔톡신미국시장정조준,http://www.iminju.net/news/articleView.html?idxno=46026
3633,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55705
3634,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.getnews.co.kr/view.php?ud=20190607182905243841d0c69529_16
3635,2019-06-07,대웅제약2년내美톡신시장2위야망,http://www.whosaeng.com/110580
3636,2019-06-07,대웅제약보툴리눔톡신미국시장마케팅돌입,http://www.kpanews.co.kr/article/show.asp?idx=204554&table=article&category=D
3637,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.newscj.com/news/articleView.html?idxno=639498
3638,2019-06-08,대웅제약보툴리눔톡신美시장본격공략나서,http://www.ekn.kr/news/article.html?no=436420
3639,2019-06-08,대웅제약미국보톡스시장점유율2위진입작전본격화,http://www.seoulfn.com/news/articleView.html?idxno=345341
3640,2019-06-08,대웅제약7월부터美소비자대상보툴리눔톡신체험마케팅,http://news.heraldcorp.com/view.php?ud=20190608000042
3641,2019-06-10,대웅제약아리셉트등도네페질성분의약품허가사항변경,http://www.yakup.com/news/index.html?mode=view&cat=11&nid=231454
3642,2019-06-10,신약개발의지강화한한미약품RD비중더줄인대웅제약,http://www.datanews.co.kr/news/article.html?no=103273
3643,2019-06-10,★주식인사이드대웅제약주가158000원6월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=780801
3644,2019-06-10,대웅제약주가오늘시세10일현재159000원,http://www.gokorea.kr/news/articleView.html?idxno=227177
3645,2019-06-10,대웅제약보툴리눔톡신주보미국서마케팅활동돌입,http://www.rapportian.com/news/articleView.html?idxno=117969
3646,2019-06-10,6월10일대웅제약오늘주식158500원096,http://www.nbntv.co.kr/news/articleView.html?idxno=395604
3647,2019-06-10,스타★주식인사이드대웅제약주가158500원6월10일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=782372
3648,2019-06-10,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.wsobi.com/news/articleView.html?idxno=75293
3649,2019-06-10,6월10일장마감주가정보대웅제약159000원,http://www.newsinside.kr/news/articleView.html?idxno=784197
3650,2019-06-11,대웅제약미국보툴리눔톡신시장공략나서 ,http://www.monews.co.kr/news/articleView.html?idxno=203067
3651,2019-06-11,대웅제약나보타유럽허가지연보완자료제출요구,http://news.mt.co.kr/mtview.php?no=2019061109332417899
3652,2019-06-11,대웅제약글로벌제약기업으로외연확대박차,http://www.iminju.net/news/articleView.html?idxno=46098
3653,2019-06-11,주가차트대웅제약주가11일현재157000원,http://www.nbntv.co.kr/news/articleView.html?idxno=396841
3654,2019-06-11,스타★주식인사이드대웅제약주가157000원6월11일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=785811
3655,2019-06-11,대웅제약나보타EU집행위자료요구에유럽허가지연가능성↑,http://www.newstomato.com/ReadNews.aspx?no=900734
3656,2019-06-11,대웅제약나보타추가자료제출요구에유럽허가지연,http://moneys.mt.co.kr/news/mwView.php?no=2019061113198091965
3657,2019-06-11,6월11일장마감주가정보대웅제약157500원,http://www.newsinside.kr/news/articleView.html?idxno=786984
3658,2019-06-11,대웅제약연구소현지화전략글로벌50위제약사진입목표,http://www.wolyo.co.kr/news/articleView.html?idxno=86216
3659,2019-06-11,대웅제약유럽연합에서보완자료요구해나보타유럽진출지연,http://www.businesspost.co.kr/BP?command=article_view&num=131040
3660,2019-06-12,대웅제약나보타보완자료요구로유럽허가지연,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069228
3661,2019-06-12,★주식인사이드대웅제약주가156500원6월12일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=788732
3662,2019-06-12,금일증시대웅제약주가12일현재155500원,http://www.nbntv.co.kr/news/articleView.html?idxno=399014
3663,2019-06-12,스타★주식인사이드대웅제약주가156000원6월12일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=790307
3664,2019-06-12,보톡스양대강자희비교차메디톡스중국진출주춤vs대웅제약미국출시진행,http://www.sporbiz.co.kr/news/articleView.html?idxno=346193
3665,2019-06-12,6월12일장마감주가정보대웅제약156000원,http://www.newsinside.kr/news/articleView.html?idxno=791616
3666,2019-06-12,대웅제약메디톡스보톡스전쟁글로벌진출발목잡나,http://www.kpinews.co.kr/news/articleView.html?idxno=97882
3667,2019-06-13,★주식인사이드대웅제약주가155500원6월13일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=793229
3668,2019-06-13,대웅제약 이온채널플랫폼바탕난청치료제개발추진,http://medipana.com/news/news_viewer.asp?NewsNum=241369&MainKind=A&NewsKind=5&vCount=12&vKind=1
3669,2019-06-13,대웅제약연세대와난청치료혁신신약개발추진,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231629
3670,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.segye.com/content/html/2019/06/13/20190613503891.html?OutUrl=naver
3671,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.viva100.com/main/view.php?key=20190613010003673
3672,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.dailian.co.kr/news/view/802737/?sc=naver
3673,2019-06-13,대웅제약이온채널플랫폼활용난청치료제개발,http://www.dailypharm.com/Users/News/NewsView.html?ID=253661&REFERER=NP
3674,2019-06-13,대웅제약연세대와난청치료제신약개발자체개발플랫폼활용,http://www.metroseoul.co.kr/news/newsview?newscd=2019061300018
3675,2019-06-13,대웅제약이온채널플랫폼기술력활용연세대와난청치료제신약개발,http://kpenews.com/View.aspx?No=54232
3676,2019-06-13,대웅제약 이온채널 플랫폼 기술로난청치료제신약개발 추진,http://www.medisobizanews.com/news/articleView.html?idxno=60403
3677,2019-06-13,대웅제약자체기술로2022년까지소음성난청치료제개발한다,http://moneys.mt.co.kr/news/mwView.php?no=2019061309428015883
3678,2019-06-13,대웅제약이온채널플랫폼기술을바탕으로연세대와난청치료제신약개발추진,http://www.etnews.com/20190613000062
3679,2019-06-13,대웅제약연세대와난청치료제신약개발자체개발플랫폼활용,http://www.seoulwire.com/news/articleView.html?idxno=151632
3680,2019-06-13,대웅제약연세대와치료제없는난청신약개발추진,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019061309441177327
3681,2019-06-13,대웅제약난청치료제개발추진,http://www.rapportian.com/news/articleView.html?idxno=118045
3682,2019-06-13,대웅제약이온채널플랫폼기술로연세대와난청치료제신약개발추진,http://www.asiatime.co.kr/news/articleView.html?idxno=251135
3683,2019-06-13,대웅제약연세대와난청치료제혁신신약개발추진2022년1상목표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1765779
3684,2019-06-13,대웅제약연세대소음성난청치료제혁신신약개발나서,https://view.asiae.co.kr/article/2019061310171172875
3685,2019-06-13,대웅제약이온채널플랫폼기술을바탕으로연세대와난청치료제신약개발추진,http://www.fetv.co.kr/news/article.html?no=30830
3686,2019-06-13,대웅제약연세대공동개발소음성난청치료제정부지원선정,http://www.newspim.com/news/view/20190613000321
3687,2019-06-13,대웅제약소음성난청혁신신약개발착수,http://www.sportsseoul.com/news/read/775552
3688,2019-06-13,대웅제약이온채널플랫폼기술활용난청치료제신약개발추진,http://www.ceoscoredaily.com/news/article.html?no=56657
3689,2019-06-13,대웅제약연세대와난청치료신약개발추진,http://news.heraldcorp.com/view.php?ud=20190613000290
3690,2019-06-13,대웅제약난청치료혁신신약개발나서,http://www.newstomato.com/ReadNews.aspx?no=901284
3691,2019-06-13,대웅제약이온채널플랫폼기술을바탕으로연세대와신약개발추진,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55812
3692,2019-06-13,대웅제약연세대와손잡고소음성난청치료제신약개발착수,http://www.ezyeconomy.com/news/articleView.html?idxno=91450
3693,2019-06-13,대웅제약이온채널플랫폼기술로난청치료제신약개발추진,http://daily.hankooki.com/lpage/ittech/201906/dh20190613110300145630.htm
3694,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.economytalk.kr/news/articleView.html?idxno=188305
3695,2019-06-13,대웅제약연세대와난청치료제신약개발FirstinClass추진,http://www.koreaittimes.com/news/articleView.html?idxno=91263
3696,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.bosa.co.kr/news/articleView.html?idxno=2106986
3697,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.sisafocus.co.kr/news/articleView.html?idxno=212139
3698,2019-06-13,대웅제약이온채널플랫폼기술바탕으로연세대와난청치료제신약개발추진,http://www.wsobi.com/news/articleView.html?idxno=75572
3699,2019-06-13,대웅제약자체기술로소음성난청치료제신약개발추진,http://www.sporbiz.co.kr/news/articleView.html?idxno=346550
3700,2019-06-13,대웅제약이온채널플랫폼기술바탕연세대와난청치료제신약개발추진,http://www.ekn.kr/news/article.html?no=437318
3701,2019-06-13,스타★주식인사이드대웅제약주가157500원6월13일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=794843
3702,2019-06-13,대웅제약이온채널플랫폼기술로연세대와난청치료제신약개발,http://www.mdtoday.co.kr/mdtoday/index.html?no=357230
3703,2019-06-13,대웅제약연세대와난청치료신약개발추진,http://biz.chosun.com/site/data/html_dir/2019/06/13/2019061301468.html
3704,2019-06-13,대웅제약난청치료제프로젝트과기부서후보물질도출RD지원받기로,http://news.mk.co.kr/newsRead.php?year=2019&no=414746
3705,2019-06-13,대웅제약소음성난청치료제신약개발나선다,http://www.joseilbo.com/news/news_read.php?uid=378415&class=17&grp=
3706,2019-06-13,대웅제약연세대와손잡고소음성난청치료제신약개발추진,http://www.businesspost.co.kr/BP?command=article_view&num=131275
3707,2019-06-13,대웅제약이온채널플랫폼기술로난청치료제신약개발추진,http://www.getnews.co.kr/view.php?ud=20190613150524508941d0c69529_16
3708,2019-06-13,대웅제약난청치료제신약개발나선다,http://www.bokuennews.com/news/article.html?no=177010
3709,2019-06-13,대웅제약난청치료제혁신신약개발추진연세대이비인후과협업,http://news.donga.com/3/all/20190613/95979911/1
3710,2019-06-13,대웅제약이온채널플랫폼기술난청치료제신약개발추진,http://www.ajunews.com/view/20190613153758001
3711,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.shinailbo.co.kr/news/articleView.html?idxno=1175922
3712,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.ebn.co.kr/news/view/989047
3713,2019-06-13,대웅제약연세대소음성난청치료제개발 ,http://www.seoulfn.com/news/articleView.html?idxno=345931
3714,2019-06-13,6월13일장마감주가정보대웅제약158000원,http://www.newsinside.kr/news/articleView.html?idxno=795917
3715,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.medigatenews.com/news/3425349422
3716,2019-06-13,대웅제약연세대와난청치료신약개발추진,http://www.dailymedi.com/detail.php?number=844145&thread=22r05
3717,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.100ssd.co.kr/news/articleView.html?idxno=62004
3718,2019-06-13,대웅제약연세대이온채널플랫폼기술활용난청치료제개발추진,http://www.wolyo.co.kr/news/articleView.html?idxno=86365
3719,2019-06-13,대웅제약이온채널플랫폼기술기반연세대와난청치료제신약개발추진,http://www.enewstoday.co.kr/news/articleView.html?idxno=1311845
3720,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://news.mt.co.kr/mtview.php?no=2019061317373875398
3721,2019-06-13,대웅제약소음성난청치료제신약개발나선다,http://www.mhj21.com/121899
3722,2019-06-13,대웅제약연세대와난청치료용혁신신약개발추진,http://www.econovill.com/news/articleView.html?idxno=365406
3723,2019-06-13,대웅제약이온채널플랫폼기술바탕으로연세대와난청치료제신약개발추진,https://www.insight.co.kr/news/232102
3724,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.newscj.com/news/articleView.html?idxno=641317
3725,2019-06-14,대웅제약이온채널플랫폼기술로연세대와난청치료제신약개발추진,http://www.lawissue.co.kr/view.php?ud=201906140312001496d7f4c63cc6_12
3726,2019-06-14,★주식인사이드대웅제약주가155500원6월14일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=797778
3727,2019-06-14,6월14일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=235591
3728,2019-06-14,6월14일대웅제약주식증권155000원190,http://nbntv.co.kr/news/view/401644
3729,2019-06-14,난청치료신약개발나선대웅제약퍼스트인클래스목표,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069337
3730,2019-06-14,스타★주식인사이드대웅제약주가155500원6월14일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=799364
3731,2019-06-14,6월14일장마감주가정보대웅제약154500원,http://www.newsinside.kr/news/articleView.html?idxno=800537
3732,2019-06-14,대웅제약나보타성공비결은선택과집중”전담조직설립해전사역량투입,http://news.donga.com/3/all/20190614/96000118/1
3733,2019-06-17,대웅제약연세대와난청치료제신약개발나서 ,http://www.monews.co.kr/news/articleView.html?idxno=203183
3734,2019-06-17,★주식인사이드대웅제약주가153500원6월17일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=804410
3735,2019-06-17,6월17일대웅제약종목검색153500원065,http://nbntv.co.kr/news/view/405056
3736,2019-06-17,스타★주식인사이드대웅제약주가154000원6월17일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=806461
3737,2019-06-17,대웅제약美에서두번째IR나보타앞세워기업가치알린다,http://www.metroseoul.co.kr/news/newsview?newscd=2019061700108
3738,2019-06-17,보톡스분쟁에발목잡힌메디톡스대웅제약글로벌진출적신호,http://www.enewstoday.co.kr/news/articleView.html?idxno=1312832
3739,2019-06-17,6월17일장마감주가정보대웅제약154000원,http://www.newsinside.kr/news/articleView.html?idxno=806896
3740,2019-06-17,전승호대웅제약사장나보타잇는폐섬유증신약도전발빠른행보,http://www.ekn.kr/news/article.html?no=438003
3741,2019-06-18,★주식인사이드대웅제약주가154000원6월18일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=808544
3742,2019-06-18,6월18일대웅제약주식현재가032154500원,http://nbntv.co.kr/news/view/407981
3743,2019-06-18,스타★주식인사이드대웅제약주가153500원6월18일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=810117
3744,2019-06-18,6월18일장마감주가정보대웅제약152500원,http://www.newsinside.kr/news/articleView.html?idxno=811621
3745,2019-06-19,지긋지긋메디톡스대웅제약그래도갈길간다,http://news.bizwatch.co.kr/article/consumer/2019/06/18/0026/naver
3746,2019-06-19,★주식인사이드대웅제약주가154000원6월19일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=813048
3747,2019-06-19,6월19일대웅제약주식창153500원066,http://nbntv.co.kr/news/view/410886
3748,2019-06-19,바른의료연구소감사원대웅제약우루사TV광고에서간수치개선부분사용할수없다판단,http://www.medigatenews.com/news/1432987227
3749,2019-06-19,바른의료연구소대웅제약우루사TV광고간수치개선부분사용할수없어,http://www.mdtoday.co.kr/mdtoday/index.html?no=357753
3750,2019-06-19,스타★주식인사이드대웅제약주가153000원6월19일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=814597
3751,2019-06-19,대웅제약넥스트나보타준비한창RD경쟁력승부수,http://www.wolyo.co.kr/news/articleView.html?idxno=86849
3752,2019-06-19,전승호대웅제약나보타로엘러간보톡스의아성미국과유럽도전,http://www.businesspost.co.kr/BP?command=article_view&num=132078
3753,2019-06-20,★주식인사이드대웅제약주가154500원6월20일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=817405
3754,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴MOU체결,http://www.fetv.co.kr/news/article.html?no=31295
3755,2019-06-20,대웅제약생명공학연구원실험동물자원센터와전략적제휴체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231885
3756,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.viva100.com/main/view.php?key=20190620010006016
3757,2019-06-20,​대웅제약 생명硏실험동물자원센터와모델링공동연구,http://medipana.com/news/news_viewer.asp?NewsNum=241697&MainKind=A&NewsKind=5&vCount=12&vKind=1
3758,2019-06-20,대웅제약한국생명공학硏과모델링및시뮬레이션공동연구나선다,http://daily.hankooki.com/lpage/ittech/201906/dh20190620094810145630.htm
3759,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.newsway.co.kr/news/view?tp=1&ud=2019062009480619215
3760,2019-06-20,대웅제약생명연과전략적제휴체결,http://www.whosaeng.com/110893
3761,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터MOU체결,http://biz.chosun.com/site/data/html_dir/2019/06/20/2019062000882.html
3762,2019-06-20,대웅제약생명연실험동물자원센터와공동연구개발MOU체결,http://www.edaily.co.kr/news/newspath.asp?newsid=02023766622523688
3763,2019-06-20,대웅제약생명공학연구원실험동물자원센터와MOU,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3866413
3764,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.newspim.com/news/view/20190620000243
3765,2019-06-20,대웅제약우루사간수치개선TV광고철퇴,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062009044113860
3766,2019-06-20,대웅제약생명공학硏모델링공동연구개발맞손,https://view.asiae.co.kr/article/2019062010103775135
3767,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴MOU체결,http://www.betanews.net:8080/article/1021713.html
3768,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU,http://www.segye.com/content/html/2019/06/20/20190620504693.html?OutUrl=naver
3769,2019-06-20,대웅제약생명硏실험동물자원센터와약효예측등기술개발MOU,http://www.medisobizanews.com/news/articleView.html?idxno=60564
3770,2019-06-20,대웅제약생명硏실험동물자원센터와공동연구MOU,http://www.kpinews.co.kr/news/articleView.html?idxno=98245
3771,2019-06-20,대웅제약생명硏실험동물자원센터와MOU,http://www.bosa.co.kr/news/articleView.html?idxno=2107396
3772,2019-06-20,대웅제약한생연공동연구개발MOU오픈컬래버레이션확대,http://moneys.mt.co.kr/news/mwView.php?no=2019062010098063137
3773,2019-06-20,대웅제약생명연과동물임상전략적제휴,http://news.mt.co.kr/mtview.php?no=2019062009531269001
3774,2019-06-20,대웅제약생명공학연구원과연구개발업무협약맺어,http://www.rapportian.com/news/articleView.html?idxno=118174
3775,2019-06-20,대웅제약한국생명공학연구원과공동연구개발MOU체결,https://www.sedaily.com/NewsView/1VKHP3M2PB
3776,2019-06-20,대웅제약생명공학연구원과모델링시뮬레이션기법개발맞손,http://news.mk.co.kr/newsRead.php?year=2019&no=438234
3777,2019-06-20,대웅제약생명공학硏실험동물자원센터협력MOU,http://news.heraldcorp.com/view.php?ud=20190620000266
3778,2019-06-20,대웅제약생명공학硏실험동물자원센터와MOU체결,http://www.dailymedi.com/detail.php?number=844387&thread=22r05
3779,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.seoulwire.com/news/articleView.html?idxno=157091
3780,2019-06-20,대웅제약한국생명공학연구원과공동연구개발MOU체결,http://www.enewstoday.co.kr/news/articleView.html?idxno=1313921
3781,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터공동연구개발MOU,http://www.newsprime.co.kr/news/article.html?no=464344
3782,2019-06-20,대웅제약생명硏실험동물자원센터와공동연구MOU,http://kormedi.com/?p=1295789
3783,2019-06-20,6월20일대웅제약주식추천주154500원131,http://nbntv.co.kr/news/view/413802
3784,2019-06-20,대웅제약생명연과협약모델링시뮬레이션기법활용,http://www.dailypharm.com/Users/News/NewsView.html?ID=253891&REFERER=NP
3785,2019-06-20,대웅제약모델링및시뮬레이션기술로임상기간비용축소박차,http://www.100ssd.co.kr/news/articleView.html?idxno=62185
3786,2019-06-20,대웅제약한국생명공학연구원과산연협력MOU통한콜라보레이션,http://www.updownnews.co.kr/news/articleView.html?idxno=205061
3787,2019-06-20,대웅제약모델링연구착수신약성공률↑비용시간↓,http://www.econovill.com/news/articleView.html?idxno=365885
3788,2019-06-20,대웅제약모델링시뮬레이션협업강화한국생명공학연구원과MOU,http://kpenews.com/View.aspx?No=55014
3789,2019-06-20,대웅제약생명硏실험동물자원센터와MOU체결,http://www.ebn.co.kr/news/view/989841
3790,2019-06-20,대웅제약BestInClass항궤양제DWP14012연구박차,http://medipana.com/news/news_viewer.asp?NewsNum=241719&MainKind=A&NewsKind=5&vCount=12&vKind=1
3791,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴MOU체결,http://www.etnews.com/20190620000109
3792,2019-06-20,스타★주식인사이드대웅제약주가154000원6월20일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=819774
3793,2019-06-20,대웅제약신약개발에모델링시뮬레이션활용,http://www.finomy.com/news/articleView.html?idxno=66899
3794,2019-06-20,대웅제약한국생명공학연구원과약물효과예측기술개발,http://www.businesspost.co.kr/BP?command=article_view&num=132207
3795,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴,http://www.dailian.co.kr/news/view/804500/?sc=naver
3796,2019-06-20,대웅제약한국생명공학연구원공동연구개발MOU체결,http://www.wolyo.co.kr/news/articleView.html?idxno=86936
3797,2019-06-20,대웅제약모델링시뮬레이션도입해신약개발기간단축”생명硏과업무협약,http://www.donga.com/news/article/all/20190620/96085891/1
3798,2019-06-20,대웅제약시뮬레이션기법신약개발적극활용,http://www.sisaon.co.kr/news/articleView.html?idxno=95771
3799,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.medigatenews.com/news/785603280
3800,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.wsobi.com/news/articleView.html?idxno=76030
3801,2019-06-20,대웅제약생명공학연구원실험동물자원센터와MOU체결,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062014473386915
3802,2019-06-20,대웅제약생명공학연구원실험동물자원센터와MOU,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1215521
3803,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU,http://www.bokuennews.com/news/article.html?no=177345
3804,2019-06-20,​대웅제약한국생명공학硏실험동물자원센터와MOU신약개발성공률제고”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1768441
3805,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴MOU체결,http://www.newstomato.com/ReadNews.aspx?no=902846
3806,2019-06-20,대웅제약생명연실험동물자원센터신약기술공동연구,http://www.seoulfn.com/news/articleView.html?idxno=346694
3807,2019-06-20,6월20일장마감주가정보대웅제약155500원,http://www.newsinside.kr/news/articleView.html?idxno=820096
3808,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU,http://www.mhj21.com/122084
3809,2019-06-20,대웅제약생명공학연구원공동연구개발업무협약,http://www.metroseoul.co.kr/news/newsview?newscd=2019062000177
3810,2019-06-20,대웅제약생명硏과공동RD추진,http://weekly.cnbnews.com/news/article.html?no=128541
3811,2019-06-20,대웅제약생명硏실험동물자원센터와MOU체결,http://www.wikileaks-kr.org/news/articleView.html?idxno=58510
3812,2019-06-20,대웅제약모델링시뮬레이션기술로신약개발박차,http://www.k-health.com/news/articleView.html?idxno=44437
3813,2019-06-20,대웅제약생명연실험동물센자원센터와MOU체결,http://www.biospectator.com/view/news_view.php?varAtcId=7883
3814,2019-06-20,대웅제약생명공학연구원과모델링시뮬레이션기법개발MOU,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906200516&t=NN
3815,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.getnews.co.kr/view.php?ud=20190620192806969241d0c69529_16
3816,2019-06-20,대웅제약 한국생명공학연구원실험동물자원센터와MOU 체결,http://www.businesskorea.co.kr/news/articleView.html?idxno=33098
3817,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.lawissue.co.kr/view.php?ud=201906202158221752d7f4c63cc6_12
3818,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.newscj.com/news/articleView.html?idxno=643551
3819,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55930
3820,2019-06-21,대웅제약한국생명공학연구원과약효예측모델링기술개발,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069524
3821,2019-06-21,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.ekn.kr/news/article.html?no=438733
3822,2019-06-21,★주식인사이드대웅제약주가155500원6월21일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=822169
3823,2019-06-21,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.asiatime.co.kr/news/articleView.html?idxno=252804
3824,2019-06-21,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.sporbiz.co.kr/news/articleView.html?idxno=349142
3825,2019-06-21,대웅제약주가6월21일현재153500원,http://www.gokorea.kr/news/articleView.html?idxno=246192
3826,2019-06-21,대웅제약증권플러스21일현재154000원,http://nbntv.co.kr/news/view/416605
3827,2019-06-21,스타★주식인사이드대웅제약주가154000원6월21일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=824143
3828,2019-06-21,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴,http://www.kukinews.com/news/article.html?no=674528
3829,2019-06-21,6월21일장마감주가정보대웅제약154500원,http://www.newsinside.kr/news/articleView.html?idxno=824843
3830,2019-06-21,대웅제약생명공학연구원실험동물자원센터와전략적제휴,http://www.joseilbo.com/news/news_read.php?uid=378908&class=27&grp=
3831,2019-06-21,우루사타격대웅제약바른의료연구소가잘못된주장,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062117042559153
3832,2019-06-21,바른의료연구소대웅제약우루사효과놓고설왕설래감사원답변에또마찰,http://www.ntoday.co.kr/news/articleView.html?idxno=67266
3833,2019-06-21,대웅제약우루사광고관련바른의료연주장사실과달라,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231968
3834,2019-06-21,대웅제약바른의료연구소우르사관련주장일부사실과달라,http://www.mdtoday.co.kr/mdtoday/index.html?no=358006
3835,2019-06-21,대웅제약우루사저격에깨알반박,http://www.whosaeng.com/110935
3836,2019-06-22,대웅제약간판제품우루사효능구설수,http://www.ajunews.com/view/20190621222804053
3837,2019-06-24,우루사효능재논란에대웅제약한숨,http://www.bosa.co.kr/news/articleView.html?idxno=2107546
3838,2019-06-24,대웅제약나보타주연구자임상시험유독많은이유는,http://www.ceoscoredaily.com/news/article.html?no=57016
3839,2019-06-24,대웅제약주식매수의견유지나보타미국수출로2분기실적기대,http://www.businesspost.co.kr/BP?command=article_view&num=132579
3840,2019-06-24,퀵리포트대웅제약매수유지목표가30만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019062407502211325
3841,2019-06-24,대웅제약나보타수출호조에높아진2Q기대감KTB,http://www.ebn.co.kr/news/view/990191
3842,2019-06-24,★주식인사이드대웅제약주가160000원6월24일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=826889
3843,2019-06-24,대웅제약5이상상승주가상승흐름단기이평선정배열중기이평선역배열,https://www.hankyung.com/finance/article/201906243015L
3844,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득미용치료분야에서지속적으로적응증확대해나갈것,http://www.segye.com/content/html/2019/06/24/20190624503226.html?OutUrl=naver
3845,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232000
3846,2019-06-24,대웅제약보툴리눔톡신나보타눈꺼풀경련적응증추가획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1769328
3847,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가획득,http://news.heraldcorp.com/view.php?ud=20190624000186
3848,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가획득,http://www.businesskorea.co.kr/news/articleView.html?idxno=33155
3849,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1314887
3850,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득총4개적응증확보,http://www.viva100.com/main/view.php?key=20190624010007053
3851,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.newspim.com/news/view/20190624000194
3852,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득총4개의적응증확보”,https://www.sedaily.com/NewsView/1VKJIPV7PW
3853,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,https://view.asiae.co.kr/article/2019062410204580986
3854,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062410090893182
3855,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.medisobizanews.com/news/articleView.html?idxno=60638
3856,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.ekn.kr/news/article.html?no=439140
3857,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.medisobizanews.com/news/articleView.html?idxno=60638
3858,2019-06-24,대웅제약나보타주눈꺼풀경련적응증추가,http://www.dailypharm.com/Users/News/NewsView.html?ID=253988&REFERER=NP
3859,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가획득,http://www.kpinews.co.kr/news/articleView.html?idxno=98437
3860,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.etnews.com/20190624000075
3861,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://daily.hankooki.com/lpage/ittech/201906/dh20190624103550145630.htm
3862,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=358084
3863,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://news.mk.co.kr/newsRead.php?year=2019&no=449162
3864,2019-06-24,대웅제약나보타식약처로부터눈꺼풀경련적응증획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=12625
3865,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.econovill.com/news/articleView.html?idxno=366128
3866,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.metroseoul.co.kr/news/newsview?newscd=2019062400063
3867,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.fetv.co.kr/news/article.html?no=31505
3868,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.ajunews.com/view/20190624105139958
3869,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.dailian.co.kr/news/view/805276/?sc=naver
3870,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가획득,http://medipana.com/news/news_viewer.asp?NewsNum=241834&MainKind=A&NewsKind=5&vCount=12&vKind=1
3871,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.seoulwire.com/news/articleView.html?idxno=159308
3872,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.dailymedi.com/detail.php?number=844493&thread=22r05
3873,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://biz.chosun.com/site/data/html_dir/2019/06/24/2019062401116.html
3874,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.bokuennews.com/news/article.html?no=177466
3875,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.biospectator.com/view/news_view.php?varAtcId=7897
3876,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://news.mt.co.kr/mtview.php?no=2019062409583070800
3877,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019062411243516114
3878,2019-06-24,대웅제약보툴리눔톡신나보타눈꺼풀경련개선추가,http://www.sportsseoul.com/news/read/780299
3879,2019-06-24,6월24일대웅제약주식장160000원356,http://nbntv.co.kr/news/view/419480
3880,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득치료분야로확대,http://www.koreaittimes.com/news/articleView.html?idxno=91455
3881,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.bosa.co.kr/news/articleView.html?idxno=2107602
3882,2019-06-24,대웅제약나보타식품의약품안전처로부터눈꺼풀경련적응증따내,http://www.businesspost.co.kr/BP?command=article_view&num=132617
3883,2019-06-24,대웅제약보툴리눔톡신나보타눈꺼풀경련적응증획득,https://www.hankyung.com/it/article/201906243588f
3884,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069600
3885,2019-06-24,대웅제약바른의료연구소우루사광고지적사실아냐”,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069605
3886,2019-06-24,식약처대웅제약나보타눈꺼풀경련적응증추가승인,http://www.ezyeconomy.com/news/articleView.html?idxno=91703
3887,2019-06-24,대웅제약보툴리눔톡신나보타눈꺼풀경련적응증추가,http://news1.kr/articles/?3653004
3888,2019-06-24,스타★주식인사이드대웅제약주가158500원6월24일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=829262
3889,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가,http://www.shinailbo.co.kr/news/articleView.html?idxno=1178775
3890,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득총4개적응증확보,http://www.wolyo.co.kr/news/articleView.html?idxno=87256
3891,2019-06-24,대웅제약나보타미국으로의수출지속”,http://www.wikitree.co.kr/main/news_view.php?id=439274
3892,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.newstomato.com/ReadNews.aspx?no=903309
3893,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=58727
3894,2019-06-24,대웅제약우루사간기능개선효과있다바른의료연구소주장반박나서,http://www.medigatenews.com/news/3017778715
3895,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.medigatenews.com/news/1869566252
3896,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55979
3897,2019-06-24,대웅제약나보타눈꺼풀경련적응증받아,http://news.mk.co.kr/newsRead.php?year=2019&no=450184
3898,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.ebn.co.kr/news/view/990311
3899,2019-06-24,대웅제약나보타식약처로부터눈꺼풀경련적응증획득,http://www.mhj21.com/122134
3900,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.marketnews.co.kr/view.php?ud=20190624144916515323217b15af_24
3901,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.paxnetnews.com/articles/49963
3902,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가획득,http://www.newsprime.co.kr/news/article.html?no=464729
3903,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.economytalk.kr/news/articleView.html?idxno=189309
3904,2019-06-24,대웅제약나보타식약처로부터눈꺼풀경련적응증받아총4총획득,http://www.updownnews.co.kr/news/articleView.html?idxno=205187
3905,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.joseilbo.com/news/news_read.php?uid=379007&class=27&grp=
3906,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.fnnews.com/news/201906241549050718
3907,2019-06-24,대웅제약나보타美판매중단가능성공시안해,http://www.shinailbo.co.kr/news/articleView.html?idxno=1178798
3908,2019-06-24,대웅제약나보타100유닛눈꺼풀경련적응증획득치료분야경쟁력↑,http://www.donga.com/news/article/all/20190624/96158540/1
3909,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.getnews.co.kr/view.php?ud=2019062416232398241d0c69529_16
3910,2019-06-24,6월24일장마감주가정보대웅제약158500원,http://www.newsinside.kr/news/articleView.html?idxno=830430
3911,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906240317&t=NN
3912,2019-06-24,대웅제약전일대비약5상승한161500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906240367&t=NN
3913,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://weekly.cnbnews.com/news/article.html?no=128609
3914,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.asiatime.co.kr/news/articleView.html?idxno=253439
3915,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.seoulfn.com/news/articleView.html?idxno=347006
3916,2019-06-24,특징주주가정보6월24일대웅제약158500원으로장마감,http://nbntv.co.kr/news/view/421668
3917,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.newscj.com/news/articleView.html?idxno=644499
3918,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.lawissue.co.kr/view.php?ud=201906242351095671d7f4c63cc6_12
3919,2019-06-25,대웅제약나보타눈꺼풀경련적응증획득,http://www.kpanews.co.kr/article/show.asp?idx=204943&table=article&category=D
3920,2019-06-25,★주식인사이드대웅제약주가157500원6월25일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=831686
3921,2019-06-25,ET투자뉴스대웅제약_투심과거래량은약세현재주가는보통,http://www.etnews.com/20190625000097
3922,2019-06-25,증권플러스대웅제약주가25일현재155500원,http://nbntv.co.kr/news/view/422656
3923,2019-06-25,대웅제약만성통증치료제DWP17061글로벌심포지엄서주목,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232084
3924,2019-06-25,대웅제약글로벌심포지엄에서만성통증치료제전임상결과발표,https://www.hankyung.com/it/article/201906257052f
3925,2019-06-25,대웅제약만성통증치료제글로벌심포지엄서시선집중,http://www.medisobizanews.com/news/articleView.html?idxno=60673
3926,2019-06-25,대웅제약2019이온채널심포지엄비마약성통증치료제전임상결과발표,http://www.segye.com/content/html/2019/06/25/20190625507058.html?OutUrl=naver
3927,2019-06-25,대웅제약Nav17만성통증치료제글로벌심포지엄서주목받아,http://www.businesskorea.co.kr/news/articleView.html?idxno=33231
3928,2019-06-25,대웅제약Nav17만성통증치료제DWP17061글로벌심포지엄서주목,http://www.betanews.net:8080/article/1023536.html
3929,2019-06-25,대웅제약나보타에웃고우루사에울고,http://www.econovill.com/news/articleView.html?idxno=366233
3930,2019-06-25,스타★주식인사이드대웅제약주가153000원6월25일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=833243
3931,2019-06-25,대웅제약만성통증신약후보물질글로벌심포지엄서소개,http://www.sportsseoul.com/news/read/780855
3932,2019-06-25,대웅제약개발중인만성통증치료제국제심포지엄서주목,http://www.metroseoul.co.kr/news/newsview?newscd=2019062500077
3933,2019-06-25,대웅제약비마약성통증치료제전임상결과공개통증신호전달억제,http://www.ceoscoredaily.com/news/article.html?no=57115
3934,2019-06-25,대웅제약글로벌심포지엄서만성통증치료제전임상결과공개,http://www.etoday.co.kr/news/section/newsview.php?idxno=1769856
3935,2019-06-25,대웅제약Nav17타겟만성통증신약세계적주목,http://www.bosa.co.kr/news/articleView.html?idxno=2107697
3936,2019-06-25,대웅제약비마약성만성통증신약효능입증,http://news.mt.co.kr/mtview.php?no=2019062512031648964
3937,2019-06-25,대웅제약비마약성만성통증치료제DWP1706전임상결과공개,http://www.viva100.com/main/view.php?key=20190625010007639
3938,2019-06-25,대웅제약2019이온채널심포지엄에서비마약성통증치료제전임상결과발표,https://www.sedaily.com/NewsView/1VKJZUFLZF
3939,2019-06-25,비마약통증치료제관심폭발대웅제약전임상결과발표,http://kpenews.com/View.aspx?No=55543
3940,2019-06-25,대웅제약비마약성만성통증치료제DWP17061전임상결과발표유효성입증,http://www.ezyeconomy.com/news/articleView.html?idxno=91743
3941,2019-06-25,대웅제약2019이온채널심포지엄에서비마약성통증치료제전임상결과발표,http://www.etnews.com/20190625000235
3942,2019-06-25,신약개발통한글로벌시장진출초읽기대웅제약2019이온채널심포지엄참석해전임상결과공개,http://www.updownnews.co.kr/news/articleView.html?idxno=205238
3943,2019-06-25,대웅제약2019이온채널심포지엄서비마약성통증치료제전임상결과공개,http://www.ekn.kr/news/article.html?no=439433
3944,2019-06-25,뉴스투데이L대웅제약글로벌무대서만성통증치료제DWP17061주목받아,http://www.news2day.co.kr/130449
3945,2019-06-25,대웅제약만성통증신약후보영국심포지엄서소개,http://www.dailypharm.com/Users/News/NewsView.html?ID=254055&REFERER=NP
3946,2019-06-25,대웅제약이온채널심포지엄서비마약성통증치료제전임상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=454600
3947,2019-06-25,대웅제약영국에서열린심포지엄에서만성통증치료제효능공개,http://www.businesspost.co.kr/BP?command=article_view&num=132804
3948,2019-06-25,대웅제약비마약성만성통증치료제DWP17061전임상결과공개,http://www.newsprime.co.kr/news/article.html?no=464924
3949,2019-06-25,대웅제약비마약성통증치료제전임상결과공개,http://www.shinailbo.co.kr/news/articleView.html?idxno=1179400
3950,2019-06-25,6월25일장마감주가정보대웅제약152000원,http://www.newsinside.kr/news/articleView.html?idxno=834562
3951,2019-06-25,대웅제약만성통증치료제DWP17061전임상결과공개,http://www.ebn.co.kr/news/view/990591
3952,2019-06-25,대웅제약글로벌심포지엄서만성통증치료제DWP17061전임상결과공개,http://www.seoulwire.com/news/articleView.html?idxno=160970
3953,2019-06-25,대웅제약만성통증치료제DWP17061글로벌심포지엄서주목,http://www.wolyo.co.kr/news/articleView.html?idxno=87403
3954,2019-06-25,대웅제약진통제혁신신약전임상결과공개,http://weekly.cnbnews.com/news/article.html?no=128629
3955,2019-06-25,대웅제약비마약성통증치료제DWP17061개발중,http://www.econovill.com/news/articleView.html?idxno=366250
3956,2019-06-25,대웅제약비마약성만성통증치료제전임상결과발표,http://www.newspim.com/news/view/20190625001017
3957,2019-06-25,대웅제약2019이온채널심포지엄에서비마약성통증치료제전임상결과발표,http://www.joseilbo.com/news/news_read.php?uid=379099&class=27&grp=
3958,2019-06-25,25일마감주가정보대웅제약주가152000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=250629
3959,2019-06-25,전승호치료용나보타위해대웅제약의적응증임상에힘실어,http://www.businesspost.co.kr/BP?command=article_view&num=132859
3960,2019-06-25,대웅제약2019이온채널심포지엄에서비마약성통증치료제전임상결과발표,http://www.getnews.co.kr/view.php?ud=20190625181644951841d0c69529_16
3961,2019-06-25,대웅제약비마약성통증치료제전임상결과발표,http://www.medigatenews.com/news/1332276408
3962,2019-06-25,인기종목매매동향6월25일대웅제약152000원으로장마감,http://nbntv.co.kr/news/view/424851
3963,2019-06-25,대웅제약英서만성통증치료제신약후보전임상결과공개,http://www.donga.com/news/article/all/20190625/96182031/1
3964,2019-06-25,대웅제약비마약성만성통증치료제글로벌심포지엄서주목,https://www.insight.co.kr/news/233940
3965,2019-06-25,대웅제약만성통증치료제DWP17061글로벌심포지엄서주목,http://www.newscj.com/news/articleView.html?idxno=645027
3966,2019-06-26,대웅제약英캠브리지서만성통증치료신약연구발표,http://news.heraldcorp.com/view.php?ud=20190626000031
3967,2019-06-26,★주식인사이드대웅제약주가154500원6월26일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=836564
3968,2019-06-26,애브비의앨러간인수메디톡스휴젤대웅제약등국내톡신필러업체주가에긍정적”한국투자증권,http://www.fntimes.com/html/view.php?ud=201906260902369823f09e13944d_18
3969,2019-06-26,대웅제약통증치료제DWP17061글로벌심포지엄서주목,http://kormedi.com/?p=1296189
3970,2019-06-26,대웅제약80여개국가와나보타판매계약4조시장정조준,http://www.insightkorea.co.kr//news/articleView.html?idxno=42499
3971,2019-06-26,대웅제약나보타주100단위눈꺼풀경련적응증추가획득,http://news.heraldcorp.com/view.php?ud=20190626000352
3972,2019-06-26,주식창대웅제약주가26일현재152500원,http://nbntv.co.kr/news/view/427268
3973,2019-06-26,스타★주식인사이드대웅제약주가153000원6월26일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=838091
3974,2019-06-26,대웅제약만성통증치료제후보물질통증신호전달억제효능,http://www.monews.co.kr/news/articleView.html?idxno=203398
3975,2019-06-26,대웅제약나보타눈꺼풀경련적응증획득,http://www.kukinews.com/news/article.html?no=675858
3976,2019-06-26,대웅제약디엔컴퍼니주름개선앰플출시,http://www.inews24.com/view/1189037
3977,2019-06-26,6월26일장마감주가정보대웅제약153000원,http://www.newsinside.kr/news/articleView.html?idxno=839274
3978,2019-06-26,대웅제약디엔컴퍼니주름개선DWEGF링클컨트롤앰플출시,http://www.ekn.kr/news/article.html?no=439664
3979,2019-06-26,대웅제약DWP17061통증효과적으로억제,http://www.finomy.com/news/articleView.html?idxno=67104
3980,2019-06-26,26일마감주가정보대웅제약주가153000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=252582
3981,2019-06-26,인기주분석종목정보26일대웅제약마감증시153000원,http://nbntv.co.kr/news/view/429366
3982,2019-06-27,6월27일대웅제약주식창153000원000,http://nbntv.co.kr/news/view/431423
3983,2019-06-27,스타★주식인사이드대웅제약주가153500원6월27일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=841894
3984,2019-06-27,돈잘버는증권맨에게듣는다개별호재만발한제약株낮아진주가대비양호한실적메디톡스휴젤대웅제약등주목,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062715001129952
3985,2019-06-27,6월27일장마감주가정보대웅제약152000원,http://www.newsinside.kr/news/articleView.html?idxno=843890
3986,2019-06-27,27일장마감매매동향대웅제약주가152000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=254354
3987,2019-06-27,인기주매매동향6월27일대웅제약152000원으로장마감,http://nbntv.co.kr/news/view/433467
3988,2019-06-28,미국제약사애브비보톡스업체앨러간인수에국내보톡스株↑메디톡스대웅제약등수혜,http://www.econonews.co.kr/news/articleView.html?idxno=72171
3989,2019-06-28,더벨보톡스1위엘러간빅딜에대웅제약메디톡스희비,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201906270100047090002970
3990,2019-06-28,★주식인사이드대웅제약주가152000원6월28일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=845209
3991,2019-06-28,우루사간기능개선효과있다”대웅제약바른의료연구소에전면반박,http://www.todaykorea.co.kr/news/view.php?no=262699
3992,2019-06-28,대웅제약직원성장위해CDP제도활용,http://www.econovill.com/news/articleView.html?idxno=366502
3993,2019-06-28,6월28일대웅제약종목검색148500원230,http://nbntv.co.kr/news/view/435487
3994,2019-06-28,스타★주식인사이드대웅제약주가149500원6월28일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=847552
3995,2019-06-28,6월28일장마감주가정보대웅제약150000원,http://www.newsinside.kr/news/articleView.html?idxno=847914
3996,2019-06-28,28일마감정보대웅제약150000원마감,http://www.gokorea.kr/news/articleView.html?idxno=256116
3997,2019-06-28,인기주주가정보28일대웅제약마감증시150000원,http://nbntv.co.kr/news/view/437583
3998,2019-06-29,대웅제약만성통증치료제DWP17061통증신호전달억제효과,http://www.sisaon.co.kr/news/articleView.html?idxno=96388
3999,2019-07-01,★주식인사이드대웅제약주가150500원7월1일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=852618
4000,2019-07-01,대웅제약올로맥스출시기념전국심포지엄통해제품우수성알려,http://www.fetv.co.kr/news/article.html?no=31912
4001,2019-07-01,대웅제약올로맥스출시기념전국심포지엄우수성알려,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232295
4002,2019-07-01,대웅제약올로맥스출시기념전국심포지엄통해제품우수성알려심혈관질환예방위한중요한치료옵션,http://www.segye.com/content/html/2019/07/01/20190701504161.html?OutUrl=naver
4003,2019-07-01,대웅제약올로맥스전국심포지엄통해제품우수성알려,http://www.ebn.co.kr/news/view/991296
4004,2019-07-01,대웅제약올로맥스출시기념전국심포지엄통해제품우수성알려,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56099
4005,2019-07-01,대웅제약심포지엄통해올로맥스제품우수성알려,http://daily.hankooki.com/lpage/ittech/201907/dh20190701104828145630.htm
4006,2019-07-01,대웅제약전국800여의료진에올로맥스제품우수성알렸다,https://www.sedaily.com/NewsView/1VLIWUJZR0
4007,2019-07-01,대웅제약세계첫3제복합제올로맥스전국심포지엄성황리마쳐,http://www.medisobizanews.com/news/articleView.html?idxno=60803
4008,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성료,http://moneys.mt.co.kr/news/mwView.php?no=2019070110438090608
4009,2019-07-01,7월1일대웅제약주가그래프033149500원,http://nbntv.co.kr/news/view/440068
4010,2019-07-01,대웅제약고혈압등치료신약올로맥스순회심포지움완료,http://news.heraldcorp.com/view.php?ud=20190701000315
4011,2019-07-01,대웅제약올로맥스출시기념전국심포지엄개최,http://www.youthdaily.co.kr/news/articleView.html?idxno=12561
4012,2019-07-01,대웅제약올로맥스출시기념전국16개도시순회,http://www.newsis.com/view/?id=NISX20190701_0000697035&cID=13001&pID=13000
4013,2019-07-01,대웅제약올로맥스전국심포지엄통해제품우수성알려,http://www.seoulwire.com/news/articleView.html?idxno=164783
4014,2019-07-01,대웅제약올로맥스출시기념전국심포지엄‥우수성알려,http://medipana.com/news/news_viewer.asp?NewsNum=242172&MainKind=A&NewsKind=5&vCount=12&vKind=1
4015,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성공리에마쳐,http://www.insightkorea.co.kr//news/articleView.html?idxno=42968
4016,2019-07-01,대웅제약올로맥스출시기념심포지엄성료,http://www.bosa.co.kr/news/articleView.html?idxno=2108044
4017,2019-07-01,대웅제약올로맥스출시기념심포지엄제품우수성알려,http://www.metroseoul.co.kr/news/newsview?newscd=2019070100081
4018,2019-07-01,올로맥스차별화시장검증통해안착대웅제약전국릴레이심포지엄통해우수성재확인,http://www.updownnews.co.kr/news/articleView.html?idxno=205436
4019,2019-07-01,대웅제약올로맥스전국심포지엄통해우수성알려,http://www.economytalk.kr/news/articleView.html?idxno=190028
4020,2019-07-01,대웅제약올로맥스전국심포지엄통해제품우수성알려,http://www.wikileaks-kr.org/news/articleView.html?idxno=59236
4021,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성료,http://www.newsway.co.kr/news/view?tp=1&ud=2019070113070515582
4022,2019-07-01,스타★주식인사이드대웅제약주가149500원7월1일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=854213
4023,2019-07-01,대웅제약고혈압이상지질혈증치료제올로맥스심혈관질환예방극대화,http://www.econovill.com/news/articleView.html?idxno=366693
4024,2019-07-01,대웅제약올로맥스고혈압고지혈환자복약순응도↑,http://news.mt.co.kr/mtview.php?no=2019070111363931537
4025,2019-07-01,대웅제약증권사목표주가높은데주가는하락세왜,https://www.hankyung.com/finance/article/201907012449M
4026,2019-07-01,대웅제약올로맥스론칭심포지엄마무리800여의료진이목집중,http://www.viva100.com/main/view.php?key=20190701010000309
4027,2019-07-01,대웅제약올로맥스출시기념전국16개도시서심포지엄개최,http://www.newspim.com/news/view/20190701000794
4028,2019-07-01,대웅제약올로맥스전국심포지엄통해제품우수성알려,http://www.wolyo.co.kr/news/articleView.html?idxno=87851
4029,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성료,http://www.bokuennews.com/news/article.html?no=177759
4030,2019-07-01,대웅제약개량신약올로맥스전국심포지엄성료복약순응도주목”,http://www.donga.com/news/article/all/20190701/96269453/1
4031,2019-07-01,대웅제약고혈압고지혈증치료3제복합제올로맥스심포지엄성료,http://news.mk.co.kr/newsRead.php?year=2019&no=475584
4032,2019-07-01,대웅제약올로맥스출시기념전국심포지엄개최,http://www.shinailbo.co.kr/news/articleView.html?idxno=1181209
4033,2019-07-01,대웅제약올로맥스출시기념심포지엄성료,http://www.marketnews.co.kr/view.php?ud=20190701151830872323217b15af_24
4034,2019-07-01,대웅제약올로맥스출시기념전국심포지엄통해제품우수성알려,http://www.medigatenews.com/news/2554197881
4035,2019-07-01,대웅제약올로맥스출시기념전국심포지엄마무리,http://www.mdtoday.co.kr/mdtoday/index.html?no=358713
4036,2019-07-01,7월1일장마감주가정보대웅제약151500원,http://www.newsinside.kr/news/articleView.html?idxno=855393
4037,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성료,http://www.mhj21.com/122286
4038,2019-07-01,1일증시종목마감동향대웅제약151500원마감,http://www.gokorea.kr/news/articleView.html?idxno=258140
4039,2019-07-01,대웅제약올로맥스출시기념전국심포지엄통해제품우수성알려,http://www.businesskorea.co.kr/news/articleView.html?idxno=33450
4040,2019-07-01,특징주매매동향7월1일대웅제약151500원으로장마감,http://nbntv.co.kr/news/view/442224
4041,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성료,http://www.lawissue.co.kr/view.php?ud=201907012307302051d7f4c63cc6_12
4042,2019-07-02,대웅제약올2분기도순항나보타안고1조클럽간다,http://www.ekn.kr/news/article.html?no=440518
4043,2019-07-02,대웅제약올로맥스전국심포지엄개최 ,http://www.monews.co.kr/news/articleView.html?idxno=203478
4044,2019-07-02,대웅제약올로맥스출시기념전국심포지엄성료,http://weekly.cnbnews.com/news/article.html?no=128769
4045,2019-07-02,★주식인사이드대웅제약주가150500원7월2일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=857482
4046,2019-07-02,대웅제약올로맥스출시기념전국심포지엄성료,http://www.nbnnews.co.kr/news/articleView.html?idxno=287510
4047,2019-07-02,대웅제약올로맥스출시기념전국심포지엄개최,http://www.wsobi.com/news/articleView.html?idxno=76806
4048,2019-07-02,대웅제약욜로맥스출시기념심포지엄서임상3상결과공개고혈압고지혈환자복약효과높아,http://www.ezyeconomy.com/news/articleView.html?idxno=91914
4049,2019-07-02,7월2일대웅제약오늘주식시장330156500원,http://nbntv.co.kr/news/view/444410
4050,2019-07-02,대웅제약전일대비약4상승한158000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907020320&t=NN
4051,2019-07-02,스타★주식인사이드대웅제약주가158000원7월2일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=859873
4052,2019-07-02,7월2일장마감주가정보대웅제약157500원,http://www.newsinside.kr/news/articleView.html?idxno=860335
4053,2019-07-02,증시매매동향2일대웅제약마감증시157500원,http://nbntv.co.kr/news/view/446465
4054,2019-07-03,증권사추천주무작정따라하기대웅제약악재에연우까지수익률와장창,http://www.newstomato.com/ReadNews.aspx?no=905196
4055,2019-07-03,★주식인사이드대웅제약주가157000원7월3일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=862335
4056,2019-07-03,실시간증시대웅제약주가3일현재158000원,http://nbntv.co.kr/news/view/448416
4057,2019-07-03,스타★주식인사이드대웅제약주가158000원7월3일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=863889
4058,2019-07-03,7월3일장마감주가정보대웅제약157500원,http://www.newsinside.kr/news/articleView.html?idxno=865930
4059,2019-07-03,3일코스닥코스피마감정보대웅제약157500원마감,http://www.gokorea.kr/news/articleView.html?idxno=261495
4060,2019-07-03,특징주주가정보3일대웅제약마감증시157500원,http://nbntv.co.kr/news/view/450299
4061,2019-07-04,대웅제약메디톡스균주싸움변곡점포자감정개시,http://www.newsis.com/view/?id=NISX20190703_0000700472&cID=13001&pID=13000
4062,2019-07-04,★주식인사이드대웅제약주가154500원7월4일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=867164
4063,2019-07-04,한미약품얀센기술반환소식에52주신저가경신한미사이언스유한양행대웅제약등관련주현황은,http://www.topstarnews.net/news/articleView.html?idxno=642305
4064,2019-07-04,대웅제약실시간주식현황4일현재153000원,http://nbntv.co.kr/news/view/452596
4065,2019-07-04,스타★주식인사이드대웅제약주가153500원7월4일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=869004
4066,2019-07-04,7월4일장마감주가정보대웅제약155000원,http://www.newsinside.kr/news/articleView.html?idxno=869826
4067,2019-07-04,4일장마감매매동향대웅제약주가155000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=263235
4068,2019-07-04,인기주종목정보7월4일대웅제약155000원으로장마감,http://nbntv.co.kr/news/view/454727
4069,2019-07-04,대웅제약메디톡스균주싸움변곡점포자감정개시감정인및기관선정,http://www.econonews.co.kr/news/articleView.html?idxno=73609
4070,2019-07-05,★주식인사이드대웅제약주가156500원7월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=871960
4071,2019-07-05,7월5일대웅제약주식그래프032154500원,http://nbntv.co.kr/news/view/456848
4072,2019-07-05,스타★주식인사이드대웅제약주가155000원7월5일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=874404
4073,2019-07-05,대웅제약올로맥스출시전국심포지엄개최,http://www.g-enews.com/ko-kr/news/article/news_all/2019070515282086269d76442fa_1/article.html
4074,2019-07-05,7월5일장마감주가정보대웅제약158000원,http://www.newsinside.kr/news/articleView.html?idxno=874786
4075,2019-07-05,5일장마감매매동향대웅제약158000원마감,http://www.gokorea.kr/news/articleView.html?idxno=265025
4076,2019-07-08,★주식인사이드대웅제약주가156500원7월8일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=879930
4077,2019-07-08,대웅제약전일대비약3하락한152500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907080496&t=NN
4078,2019-07-08,스타★주식인사이드대웅제약주가152000원7월8일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=881462
4079,2019-07-08,ET투자뉴스대웅제약_투심과거래량은약세현재주가는보통,http://www.etnews.com/20190708000179
4080,2019-07-08,7월8일장마감주가정보대웅제약151500원,http://www.newsinside.kr/news/articleView.html?idxno=882661
4081,2019-07-08,8일주식장마감동향대웅제약151500원마감,http://www.gokorea.kr/news/articleView.html?idxno=267054
4082,2019-07-08,상장주종목정보7월8일대웅제약151500원으로장마감,http://nbntv.co.kr/news/view/463316
4083,2019-07-09,대웅제약확실히달라진이익레벨NH투자증권,http://news.mt.co.kr/mtview.php?no=2019070907374775102
4084,2019-07-09,클릭e종목대웅제약나보타美수출본격화2Q영업익증가기대,https://view.asiae.co.kr/article/2019070907584805156
4085,2019-07-09,퀵리포트대웅제약매수유지목표가16↓20만원NH證,http://www.itooza.com/common/iview.php?no=2019070908121010507
4086,2019-07-09,대웅제약보톡스균주소송부담목표가↓NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01466166622552880
4087,2019-07-09,HotLine대웅제약실적시즌상위제약사중최선호목표가↓,http://news.mk.co.kr/newsRead.php?year=2019&no=500052
4088,2019-07-09,하이로우대웅제약나보타美수출본격화2Q영업익↑NH투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019070908493646320
4089,2019-07-09,룬드벡에빅사단독판매접고대웅제약선택,http://www.monews.co.kr/news/articleView.html?idxno=203596
4090,2019-07-09,★주식인사이드대웅제약주가151000원7월9일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=884707
4091,2019-07-09,대웅제약국제미용성형학회서나보타글로벌임상결과발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1774757
4092,2019-07-09,대웅제약목표주가하향제약업종가치하락에도나보타실적은호조,http://www.businesspost.co.kr/BP?command=article_view&num=134580
4093,2019-07-09,대웅제약 나보타세계의료진에미용성형의최강자알려,http://www.medisobizanews.com/news/articleView.html?idxno=60974
4094,2019-07-09,대웅제약미국수출본격화기대,http://www.choicenews.co.kr/news/articleView.html?idxno=62366
4095,2019-07-09,대웅제약나보타국제미용학회서K뷰티亞공감대확산,http://news.heraldcorp.com/view.php?ud=20190709000127
4096,2019-07-09,대웅제약나보타IMCASAsia2019참가‥우수성알려,http://medipana.com/news/news_viewer.asp?NewsNum=242557&MainKind=A&NewsKind=5&vCount=12&vKind=1
4097,2019-07-09,대웅제약나보타IMCASAsia2019참가전세계의료진대상우수성알려,http://www.etnews.com/20190709000043
4098,2019-07-09,대웅제약IMCAS아시아2019참가전세계의료진에나보타우수성알려,http://www.asiatime.co.kr/news/articleView.html?idxno=256481
4099,2019-07-09,대웅제약나보타전세계의료진대상우수성알려,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232588
4100,2019-07-09,대웅제약아시아대표미용성형학회참가나보타우수성홍보,http://www.newspim.com/news/view/20190709000177
4101,2019-07-09,대웅제약나보타IMCASAsia2019참가전세계의료진대상우수성알려,http://www.ceoscoredaily.com/news/article.html?no=57739
4102,2019-07-09,대웅제약2분기영업익전년대비약85성장전망,http://www.econovill.com/news/articleView.html?idxno=367224
4103,2019-07-09,대웅제약세계최대국제미용성형학회참가나보타우수성알렸다”,https://www.sedaily.com/NewsView/1VLMKNILEJ
4104,2019-07-09,대웅제약국제노화학회에서나보타우수성알려,https://www.sedaily.com/NewsView/1VLMKL30YE
4105,2019-07-09,대웅제약나보타IMCASAsia2019서전세계의료진만나,http://www.newsis.com/view/?id=NISX20190709_0000705028&cID=13001&pID=13000
4106,2019-07-09,대웅제약나보타IMCASAsia2019참가,http://www.dailian.co.kr/news/view/809204/?sc=naver
4107,2019-07-09,대웅제약발리국제미용성형학회참가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3882895
4108,2019-07-09,대웅제약IMCASAsia2019참가나보타우수성알려,http://www.viva100.com/main/view.php?key=20190709010003041
4109,2019-07-09,대웅제약나보타포자감정개시이르면이번주결판,http://news.mt.co.kr/mtview.php?no=2019070817193733257
4110,2019-07-09,대웅제약아시아시장잡아라임카스아시아참가,http://news1.kr/articles/?3665634
4111,2019-07-09,대웅제약나보타글로벌브랜드육성박차,http://www.whosaeng.com/111304
4112,2019-07-09,대웅제약나보타국제미용성형학회참가,https://www.hankyung.com/it/article/201907091054f
4113,2019-07-09,대웅제약나보타IMCASAsia2019참가전세계의료진대상우수성알려,http://www.mdtoday.co.kr/mdtoday/index.html?no=359416
4114,2019-07-09,리포트브리핑대웅제약확실히달라진이익레벨목표가200000원NH투자증권,http://www.newspim.com/news/view/20190709000459
4115,2019-07-09,GET투자리포트대웅제약투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201907091030307851tpgetnews_16
4116,2019-07-09,뉴스투데이L대웅제약IMCASAsia2019서나보타우수성알려,http://www.news2day.co.kr/131449
4117,2019-07-09,대웅제약IMCASAsia2019참가나보타알리기나서,http://inthenews.co.kr/article-6071/
4118,2019-07-09,ET투자뉴스대웅제약확실히달라진이익BUY유지NH투자증권,http://www.etnews.com/20190709000122
4119,2019-07-09,IMCAS아시아2019나보타우수성알린대웅제약세계의료진주목,http://www.sisaweek.com/news/articleView.html?idxno=124005
4120,2019-07-09,대웅제약나보타전세계의료진대상우수성알려,http://www.bosa.co.kr/news/articleView.html?idxno=2108591
4121,2019-07-09,대웅제약나보타들고IMCASAsia2019참가 ,http://www.monews.co.kr/news/articleView.html?idxno=203608
4122,2019-07-09,대웅제약전일대비약4하락한146000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907090259&t=NN
4123,2019-07-09,대웅제약IMCASAsia2019참가나보타우수성세계의료진에알려,http://www.wikileaks-kr.org/news/articleView.html?idxno=59794
4124,2019-07-09,대웅제약투자주식9일현재146000원,http://nbntv.co.kr/news/view/465511
4125,2019-07-09,대웅제약IMCASAsia2019참가,http://www.fetv.co.kr/news/article.html?no=32352
4126,2019-07-09,대웅제약나보타IMCASAsia2019참가,http://www.bokuennews.com/news/article.html?no=178168
4127,2019-07-09,대웅제약나보타IMCASAsia2019참가,http://www.ebn.co.kr/news/view/992377
4128,2019-07-09,대웅제약국제미용성형학회IMCASAsia2019참가,http://www.youthdaily.co.kr/news/articleView.html?idxno=13161
4129,2019-07-09,스타★주식인사이드대웅제약주가146500원7월9일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=887153
4130,2019-07-09,세계3대미용성형학회참석한대웅제약나보타글로벌브랜드육성박차우수성알려,http://www.updownnews.co.kr/news/articleView.html?idxno=205786
4131,2019-07-09,대웅제약국제학회서보툴리눔나보타우수성알려,http://health.chosun.com/site/data/html_dir/2019/07/09/2019070901400.html
4132,2019-07-09,대웅제약발리국제미용성형학회참가,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1217168
4133,2019-07-09,대웅제약나보타아시아학회참가우수성알려,http://www.metroseoul.co.kr/news/newsview?newscd=2019070900121
4134,2019-07-09,식약처대웅제약항궤양제DWP14012임상1상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232605
4135,2019-07-09,대웅제약나보타우수성세계미용성형의료진에어필,http://www.sisaon.co.kr/news/articleView.html?idxno=96988
4136,2019-07-09,대웅제약국제미용성형학회서나보타성과홍보아시아진출교두보마련,http://www.ezyeconomy.com/news/articleView.html?idxno=92093
4137,2019-07-09,대웅제약국제미용성형학회에서나보타임상결과발표,http://www.joseilbo.com/news/news_read.php?uid=379950&class=27&grp=
4138,2019-07-09,대웅제약국제미용성형학회에서보툴리눔톡신나보타우수성알려,http://www.businesspost.co.kr/BP?command=article_view&num=134625
4139,2019-07-09,대웅제약나보타로IMCASAsia2019참가,http://www.kpanews.co.kr/article/show.asp?idx=205336&table=article&category=D
4140,2019-07-09,대웅제약나보타IMCASAsia2019참가우수성알려,http://www.getnews.co.kr/view.php?ud=20190709154450593641d0c69529_16
4141,2019-07-09,대웅제약나보타IMCASAsia2019참가,http://www.economytalk.kr/news/articleView.html?idxno=190911
4142,2019-07-09,7월9일장마감주가정보대웅제약146500원,http://www.newsinside.kr/news/articleView.html?idxno=887527
4143,2019-07-09,대웅제약국제미용학회서나보타우수성알려,http://www.seoulwire.com/news/articleView.html?idxno=172033
4144,2019-07-09,대웅제약나보타IMCASAsia2019참가전세계의료진대상우수성알려,http://www.enewstoday.co.kr/news/articleView.html?idxno=1320090
4145,2019-07-09,대웅제약나보타IMCASAsia2019참가전세계의료진대상우수성알려,http://www.medigatenews.com/news/1752340616
4146,2019-07-09,9일주가마감정보대웅제약주가146500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=268827
4147,2019-07-09,대웅제약국제미용성형학회아시아학술대회서나보타홍보나서,http://news.mk.co.kr/newsRead.php?year=2019&no=503245
4148,2019-07-09,인기종목종목정보7월9일대웅제약146500원으로장마감,http://nbntv.co.kr/news/view/467107
4149,2019-07-09,대웅제약세계3대미용성형학회IMCAS아시아참가나보타글로벌임상발표,http://www.donga.com/news/article/all/20190709/96400636/1
4150,2019-07-09,대웅제약IMCASAsia2019참가해나보타우수성알려,http://www.newscj.com/news/articleView.html?idxno=649866
4151,2019-07-10,법원나보타포자감정실시자신감내비치는대웅제약,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1070119
4152,2019-07-10,대웅제약국제미용성형학회서나보타우수성알려,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1070099
4153,2019-07-10,대웅제약주가오를힘다져새수익원나보타수출로실적늘어,http://www.businesspost.co.kr/BP?command=article_view&num=134743
4154,2019-07-10,퀵리포트대웅제약매수유지목표가24만원유지메리츠證,http://www.itooza.com/common/iview.php?no=2019071008074719447
4155,2019-07-10,★주식인사이드대웅제약주가147500원7월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=889627
4156,2019-07-10,GET투자리포트대웅제약투자의견매수메리츠종금증권,http://www.getnews.co.kr/view.php?ud=201907101030307867tpgetnews_16
4157,2019-07-10,리포트브리핑대웅제약나보타주보순항중목표가240000원메리츠종금증권,http://www.newspim.com/news/view/20190710000205
4158,2019-07-10,대웅제약자체개발나보타세계시장에소개,http://www.beyondpost.co.kr/view.php?ud=2019071009174325930145927ff6_30
4159,2019-07-10,ET투자뉴스대웅제약나보타주보순항중BUY메리츠종금증권,http://www.etnews.com/20190710000038
4160,2019-07-10,대웅제약RD비중확대통해넥스트나보타개발박차,http://www.wikileaks-kr.org/news/articleView.html?idxno=59872
4161,2019-07-10,대웅제약나보타IMCAS아시아참가,http://www.wsobi.com/news/articleView.html?idxno=77337
4162,2019-07-10,스타★주식인사이드대웅제약주가151500원7월10일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=891260
4163,2019-07-10,대웅제약에투영된윤재승전회장의그림자여전,http://www.shinailbo.co.kr/news/articleView.html?idxno=1184140
4164,2019-07-10,상반기임상국내사선전종근당대웅제약선봉에,http://www.newstomato.com/ReadNews.aspx?no=906895
4165,2019-07-10,7월10일장마감주가정보대웅제약150500원,http://www.newsinside.kr/news/articleView.html?idxno=893209
4166,2019-07-10,대웅제약2분기매출액2271억원영업이익132억원전망”,http://www.wikitree.co.kr/main/news_view.php?id=444073
4167,2019-07-10,10일증시종목마감동향대웅제약주가150500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=270664
4168,2019-07-10,대웅제약인도네시아학술행사에서나보타홍보,http://weekly.cnbnews.com/news/article.html?no=128934
4169,2019-07-10,인기주매매동향7월10일대웅제약150500원으로장마감,http://nbntv.co.kr/news/view/471470
4170,2019-07-11,메디톡스메디톡신허가전유통의혹에대웅제약과균추출처다툼덩달아관심↑현재재판과정은,http://www.newsinside.kr/news/articleView.html?idxno=894323
4171,2019-07-11,★주식인사이드대웅제약주가154000원7월11일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=894394
4172,2019-07-11,대웅제약5이상상승나보타주보순항중메리츠종금증권BUY,https://www.hankyung.com/finance/article/201907116514L
4173,2019-07-11,메디톡스보톡스메디톡신이슈에52주신저가경신대웅제약신라젠등관련주는,http://www.topstarnews.net/news/articleView.html?idxno=644747
4174,2019-07-11,특징주대웅제약실적견조나보타순항에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02286166622553536
4175,2019-07-11,대웅제약나보타수출기여로실적개선전망에上,http://www.mdtoday.co.kr/mdtoday/index.html?no=359621
4176,2019-07-11,대웅제약나보타국제미용성형학회참가,http://www.nbnnews.co.kr/news/articleView.html?idxno=291562
4177,2019-07-11,7월11일대웅제약주식주가157500원465,http://nbntv.co.kr/news/view/473672
4178,2019-07-11,대웅제약글로벌RD네트워크로현지지배력강화장기전돌입,http://www.ceoscoredaily.com/news/article.html?no=57784
4179,2019-07-11,스타★주식인사이드대웅제약주가157500원7월11일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=895724
4180,2019-07-11,특징주대웅제약나보타수출확대기대감4급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1775812
4181,2019-07-11,대웅제약쿨비즈와스마트오피스로업무환경유연성자율성강화,http://www.lawissue.co.kr/view.php?ud=2019071114574527689817d053b9_12
4182,2019-07-11,대웅제약글로벌무대서나보타우수성알려IMCASAsia2019참가,http://www.g-enews.com/ko-kr/news/article/news_all/20190711144639643169d76442fa_1/article.html
4183,2019-07-11,7월11일장마감주가정보대웅제약157500원,http://www.newsinside.kr/news/articleView.html?idxno=896866
4184,2019-07-11,파월효과코스피껑충삼성전자SK하이닉스대웅제약아시아나계열급등,http://www.choicenews.co.kr/news/articleView.html?idxno=62476
4185,2019-07-11,동아대웅제약이어종근당도인도네시아진출,http://www.finomy.com/news/articleView.html?idxno=67566
4186,2019-07-11,11일주가마감정보대웅제약주가157500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=272421
4187,2019-07-11,삼성전자SK하이닉스대웅제약아시아나계열급등코스피2080회복,http://www.betanews.net:8080/article/1029481.html
4188,2019-07-11,특징주분석종목정보11일대웅제약마감증시157500원,http://nbntv.co.kr/news/view/475739
4189,2019-07-12,대웅제약vs종근당1조클럽진입경쟁,http://www.sportsseoul.com/news/read/789587
4190,2019-07-12,★주식인사이드대웅제약주가155000원7월12일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=898997
4191,2019-07-12,대웅제약직원자율성높이고효율올리고사내문화눈길,http://www.mhj21.com/122576
4192,2019-07-12,보톡스3년전쟁새국면메디톡스대웅제약진위가리기로,https://view.asiae.co.kr/article/2019071211130899058
4193,2019-07-12,대웅제약투자주식12일현재155500원,http://nbntv.co.kr/news/view/477783
4194,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션진행한다,http://www.sisafocus.co.kr/news/articleView.html?idxno=215028
4195,2019-07-12,대웅제약룬드벡알츠하이머치료제에빅사공동프로모션,http://medipana.com/news/news_viewer.asp?NewsNum=242773&MainKind=A&NewsKind=5&vCount=12&vKind=1
4196,2019-07-12,대웅제약한국룬드벡과치매치료제에빅사공동판매계약,http://www.medisobizanews.com/news/articleView.html?idxno=61095
4197,2019-07-12,대웅제약알츠하이머병치료제에빅사판매,http://www.whosaeng.com/111401
4198,2019-07-12,대웅제약룬드벡치매약에빅사공동판매계약,https://www.hankyung.com/it/article/201907120245f
4199,2019-07-12,대웅제약한국룬드벡에빅사코프로모션계약체결,http://www.bosa.co.kr/news/articleView.html?idxno=2108845
4200,2019-07-12,대웅제약룬드벡알츠하이머치료제에박사공동프로모션,http://www.econovill.com/news/articleView.html?idxno=367445
4201,2019-07-12,스타★주식인사이드대웅제약주가154000원7월12일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=900717
4202,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사코프로모션계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232735
4203,2019-07-12,대웅제약한국룬드벡알츠하이머치료제에빅사공동프로모션계약체결,https://www.sedaily.com/NewsView/1VLNZ8ECX7
4204,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약,http://www.newsway.co.kr/news/view?tp=1&ud=2019071213112163255
4205,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.fnnews.com/news/201907121347110838
4206,2019-07-12,대웅제약룬드벡치매약에빅사공동판매,https://cnbc.sbs.co.kr/article_hub/10000948314?division=NAVER
4207,2019-07-12,대웅제약한국룬드벡알츠하이머치료제에빅사공동프로모션,http://www.dailian.co.kr/news/view/810189/?sc=naver
4208,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.etnews.com/20190712000143
4209,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.etnews.com/20190712000143
4210,2019-07-12,대웅제약한국룬드벡과공동으로알츠하이머병치료제에빅사영업마케팅진행,http://www.newspim.com/news/view/20190712000612
4211,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제공동판매,http://www.seoulfn.com/news/articleView.html?idxno=349103
4212,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.ceoscoredaily.com/news/article.html?no=57916
4213,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.lawissue.co.kr/view.php?ud=201907121420462000204ead0791_12
4214,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약,http://www.upinews.kr/news/newsview.php?ncode=1065590375675893
4215,2019-07-12,대웅제약한국룬드벡과알츠하이머치료제공동프로모션,http://news.mt.co.kr/mtview.php?no=2019071213225741800
4216,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제공동프로모션계약,http://www.newsprime.co.kr/news/article.html?no=467251
4217,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동판매계약체결,http://www.getnews.co.kr/view.php?ud=20190712143200192041d0c69529_16
4218,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제공동프로모션,http://news.heraldcorp.com/view.php?ud=20190712000442
4219,2019-07-12,대웅제약룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56278
4220,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1776209
4221,2019-07-12,대웅제약룬드벡알츠하이머약에빅사공동판매,http://www.newsis.com/view/?id=NISX20190712_0000709299&cID=13001&pID=13000
4222,2019-07-12,대웅제약한국룬드벡과공동프로모션통해알츠하이머병치료제에빅사병의원에공급,http://www.updownnews.co.kr/news/articleView.html?idxno=205938
4223,2019-07-12,대웅제약한국룬드벡에빅사공동프로모션계약체결,http://www.ajunews.com/view/20190712150739588
4224,2019-07-12,대웅제약한국룬드벡알츠하이머치료제에빅사공동프로모션계약체결,http://inthenews.co.kr/article-6879/
4225,2019-07-12,대웅제약한국룬드백과손잡고알츠하이머치료제에빅사공급,http://www.insightkorea.co.kr//news/articleView.html?idxno=44283
4226,2019-07-12,대웅제약한국룬드벡알츠하이머치료제공동판매한다,http://moneys.mt.co.kr/news/mwView.php?no=2019071215438082483
4227,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사프로모션계약,http://biz.chosun.com/site/data/html_dir/2019/07/12/2019071201933.html
4228,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=359750
4229,2019-07-12,대웅제약한국룬드벡과알츠하이머병치료제공동판매계약,http://www.rapportian.com/news/articleView.html?idxno=118601
4230,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.medigatenews.com/news/1877785649
4231,2019-07-12,대웅제약한국룬드벡에빅사공동프로모션계약체결,http://www.wolyo.co.kr/news/articleView.html?idxno=88879
4232,2019-07-12,대웅제약룬드벡의치매약에빅사공동판매키로,http://news.mk.co.kr/newsRead.php?year=2019&no=515048
4233,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.enewstoday.co.kr/news/articleView.html?idxno=1321198
4234,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션,http://daily.hankooki.com/lpage/ittech/201907/dh20190712162425145630.htm
4235,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약,http://www.newstomato.com/ReadNews.aspx?no=907427
4236,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제프로모션계약,http://www.ebn.co.kr/news/view/992962
4237,2019-07-12,대웅제약한국룬드벡치매치료제에빅사공동판매계약,http://health.chosun.com/site/data/html_dir/2019/07/12/2019071202004.html
4238,2019-07-12,7월12일장마감주가정보대웅제약154000원,http://www.newsinside.kr/news/articleView.html?idxno=902704
4239,2019-07-12,대웅제약한국룬드벡알츠하이머치료제에빅사공동프로모션계약,http://www.asiatime.co.kr/news/articleView.html?idxno=257377
4240,2019-07-12,대웅제약한국룬드벡알츠하이머치매환자들의더나은삶위해,http://www.k-health.com/news/articleView.html?idxno=44719
4241,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.segye.com/content/html/2019/07/12/20190712509101.html?OutUrl=naver
4242,2019-07-12,대웅제약한국룬드벡과알츠하이머치료제에빅사공동판매,http://www.finomy.com/news/articleView.html?idxno=67600
4243,2019-07-12,대웅제약알츠하이머병치료제에빅사마케팅진행,http://www.economytalk.kr/news/articleView.html?idxno=191320
4244,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션,http://www.edaily.co.kr/news/newspath.asp?newsid=03539126622553864
4245,2019-07-12,12일마감증시대웅제약154000원마감,http://www.gokorea.kr/news/articleView.html?idxno=274180
4246,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.wikileaks-kr.org/news/articleView.html?idxno=60090
4247,2019-07-12,대웅제약룬드벡에빅사공동프로모션,http://www.fnnews.com/news/201907121746462323
4248,2019-07-12,대웅제약한국룬드벡에빅사공동프로모션계약,http://www.kpinews.co.kr/news/articleView.html?idxno=99466
4249,2019-07-12,대웅제약한국룬드벡알츠하이머치료제에빅사공동영업마케팅진행,http://www.donga.com/news/article/all/20190712/96450428/1
4250,2019-07-12,상장주매매동향12일대웅제약마감증시154000원,http://nbntv.co.kr/news/view/479847
4251,2019-07-12,대웅제약한국룬드벡에빅사공동프로모션계약,http://www.kpanews.co.kr/article/show.asp?idx=205422&table=article&category=D
4252,2019-07-12,대웅제약룬드벡의치매약에빅사공동판매,http://www.nbnnews.co.kr/news/articleView.html?idxno=292330
4253,2019-07-12,대웅제약한국룬드벡과에빅사공동프로모션계약체결,http://www.newscj.com/news/articleView.html?idxno=650988
4254,2019-07-13,대웅제약한국룬드벡알츠하이머약에빅사공동판매프로모션계약체결,http://www.econonews.co.kr/news/articleView.html?idxno=75562
4255,2019-07-14,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.viva100.com/main/view.php?key=20190714010004676
4256,2019-07-14,대웅제약룬드벡알츠하이머치매치료제에빅사공동판매,http://www.sportsseoul.com/news/read/790380
4257,2019-07-14,대웅제약알츠하이머치료제에빅사시장확장가속화,http://www.sisaon.co.kr/news/articleView.html?idxno=97286
4258,2019-07-15,현지제약사지분품은대웅제약58조베트남시장공략,http://news.mt.co.kr/mtview.php?no=2019071214363568793
4259,2019-07-15,대웅제약ITC메디톡스에침해영업비밀소명지시,https://www.hankyung.com/finance/article/2019071537296
4260,2019-07-15,대웅제약메디톡스엘러간ITC소송유리한전환점맞아,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232763
4261,2019-07-15,대웅제약ITC메디톡스에침해영업비밀밝혀라명령,http://www.newsis.com/view/?id=NISX20190715_0000710489&cID=13001&pID=13000
4262,2019-07-15,대웅제약美소송에서승기잡나ITC대웅제약이침해했다고주장하는메디톡스영업비밀무엇인지명확히밝힐것,http://www.segye.com/content/html/2019/07/15/20190715502061.html?OutUrl=naver
4263,2019-07-15,대웅제약美ITC메디톡스에균주영업비밀침해규명명령,http://www.medisobizanews.com/news/articleView.html?idxno=61117
4264,2019-07-15,대웅제약ITC소송에서유리한전환점맞았다는데,http://medipana.com/news/news_viewer.asp?NewsNum=242812&MainKind=A&NewsKind=5&vCount=12&vKind=1
4265,2019-07-15,ITC메디톡스영업비밀이뭐냐”대웅제약유리한고지점령”,http://news.heraldcorp.com/view.php?ud=20190715000064
4266,2019-07-15,대웅제약ITC소송에서유리한전환점맞아,http://www.newsway.co.kr/news/view?tp=1&ud=2019071508583574613
4267,2019-07-15,대웅제약美ITC메디톡스에침해영업비밀밝혀라명령”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1776599
4268,2019-07-15,대웅제약메디톡스와의ITC소송에서유리한상황,http://www.ajunews.com/view/20190715084624614
4269,2019-07-15,대웅제약ITC메디톡스에침해당한영업비밀소명지시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019071509004584430
4270,2019-07-15,대웅제약국제보툴리눔소송서유리해져ITC메디톡스에영업비밀소명명령,http://www.newspim.com/news/view/20190715000039
4271,2019-07-15,대웅제약ITC메디톡스에대웅침해영업비밀밝혀라명령,http://www.seoulwire.com/news/articleView.html?idxno=175499
4272,2019-07-15,대웅제약ITC메디톡스에침해영업비밀소명지시,http://moneys.mt.co.kr/news/mwView.php?no=2019071509048070036
4273,2019-07-15,★주식인사이드대웅제약주가153500원7월15일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=906947
4274,2019-07-15,대웅제약ITC소송전환점맞아ITC메디톡스대웅이침해한비밀뭔지밝혀라,http://www.asiatime.co.kr/news/articleView.html?idxno=257639
4275,2019-07-15,대웅제약ITC가메디톡스에침해당한영업비밀설명하라고명령,http://news.mk.co.kr/newsRead.php?year=2019&no=521149
4276,2019-07-15,메디톡스4거래일연속하락대웅제약ITC메디톡스에침해당한영업비밀설명하라고명령,http://www.econonews.co.kr/news/articleView.html?idxno=75736
4277,2019-07-15,대웅제약ITC메디톡스에영업비밀명확히밝힐것명령”,http://daily.hankooki.com/lpage/ittech/201907/dh20190715094055145630.htm
4278,2019-07-15,대웅제약ITC메디톡스에영업비밀설명요구”,http://www.shinailbo.co.kr/news/articleView.html?idxno=1185343
4279,2019-07-15,대웅제약고함량비타민임팩타민TV광고첫전개,http://www.dailypharm.com/Users/News/NewsView.html?ID=254699&REFERER=NP
4280,2019-07-15,대웅제약임팩타민SKY캐슬염정아오나라모델발탁,http://medipana.com/news/news_viewer.asp?NewsNum=242830&MainKind=A&NewsKind=5&vCount=12&vKind=1
4281,2019-07-15,대웅제약미국ITC메디톡스에영업비밀소명지시,http://www.sportsseoul.com/news/read/790751
4282,2019-07-15,대웅제약보톡스관련ITC소송에서유리한전환점맞아,http://www.getnews.co.kr/view.php?ud=20190715095708427541d0c69529_16
4283,2019-07-15,대웅제약美ITC메디톡스에침해당한영업비밀밝혀라명령”,http://www.mdtoday.co.kr/mdtoday/index.html?no=359823
4284,2019-07-15,대웅제약보톡스관련ITC소송서유리한고지선점ITC메디톡스영업기밀침해했다는구체적사유소명해야,http://www.ezyeconomy.com/news/articleView.html?idxno=92210
4285,2019-07-15,미국ITC메디톡스에대웅제약이침해했다는영업비밀밝혀라,http://news1.kr/articles/?3670242
4286,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.mdtoday.co.kr/mdtoday/index.html?no=359825
4287,2019-07-15,대웅제약메디톡스와ITC소송서유리승리확신,http://www.upinews.kr/news/newsview.php?ncode=1065574502847508
4288,2019-07-15,대웅제약ITC가메디톡스에영업비밀설명요구했다”,http://www.hankookilbo.com/news/npath/201907151077063496?did=NA
4289,2019-07-15,대웅제약비타민B임팩타민소비자마케팅강화,http://www.newsprime.co.kr/news/article.html?no=467386
4290,2019-07-15,대웅제약ITC소송에서유리한전환점맞아”,http://www.viva100.com/main/view.php?key=20190715010004961
4291,2019-07-15,ITC메디톡스에대웅제약이침해한영업비밀밝힐것명령,http://www.newsprime.co.kr/news/article.html?no=467390
4292,2019-07-15,대웅제약ITC소송유리한전환점맞아,http://www.bokuennews.com/news/article.html?no=178373
4293,2019-07-15,제약오늘​​​​​​​대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.sisaon.co.kr/news/articleView.html?idxno=97310
4294,2019-07-15,대웅제약염정아오나라모델임팩타민TV광고온에어,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232779
4295,2019-07-15,대웅제약ITC메디톡스에침해당한영업비밀밝혀라명령,http://www.rapportian.com/news/articleView.html?idxno=118625
4296,2019-07-15,대웅제약美ITC메디톡스에침해영업비밀밝혀라명령,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907150231&t=NN
4297,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.medisobizanews.com/news/articleView.html?idxno=61129
4298,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.dailysmart.co.kr/news/articleView.html?idxno=13396
4299,2019-07-15,대웅제약ITC소송에서유리한전환점맞아,http://www.wikileaks-kr.org/news/articleView.html?idxno=60213
4300,2019-07-15,대웅제약보툴리눔톡신소송전서전환점맞나,http://www.monews.co.kr/news/articleView.html?idxno=203719
4301,2019-07-15,대웅제약ITC메디톡스에침해영업비밀밝혀라명령소송유리한고지선점,http://www.updownnews.co.kr/news/articleView.html?idxno=205983
4302,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고,http://www.bosa.co.kr/news/articleView.html?idxno=2108929
4303,2019-07-15,대웅제약고함량비타민임팩타민TV광고온에어,http://www.newsis.com/view/?id=NISX20190715_0000710869&cID=13001&pID=13000
4304,2019-07-15,대웅제약ITC메디톡스에침해영업비밀밝혀라명령,http://biz.chosun.com/site/data/html_dir/2019/07/15/2019071501154.html
4305,2019-07-15,대웅제약주가종목그래프15일현재154000원,http://www.gokorea.kr/news/articleView.html?idxno=275295
4306,2019-07-15,대웅제약ITC소송에서유리한전환점맞아,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56290
4307,2019-07-15,대웅제약ITC소송에서유리한명령나와”,http://weekly.cnbnews.com/news/article.html?no=128995
4308,2019-07-15,스타★주식인사이드대웅제약주가154000원7월15일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=908615
4309,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.enewstoday.co.kr/news/articleView.html?idxno=1321657
4310,2019-07-15,대웅제약ITC소송에서유리한전환점맞아,http://www.asiatoday.co.kr/view.php?key=20190715010009146
4311,2019-07-15,대웅제약ITC메디톡스에침해영업비밀소명지시,http://www.dailian.co.kr/news/view/810613/?sc=naver
4312,2019-07-15,대웅제약소송전환점맞나ITC메디톡스에영업비밀밝혀라명령,http://www.metroseoul.co.kr/news/newsview?newscd=2019071500161
4313,2019-07-15,대웅제약비타민B더블임팩트”임팩타민광고시작,http://www.econovill.com/news/articleView.html?idxno=367578
4314,2019-07-15,제약업종내상승종목중앙백신441동화약품294대웅제약195순,http://aitimes.co.kr/news/view/77736
4315,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.wikileaks-kr.org/news/articleView.html?idxno=60241
4316,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.getnews.co.kr/view.php?ud=20190715153216386541d0c69529_16
4317,2019-07-15,대웅제약보톡스소송서유리한전환점美ITC메디톡스영업비밀밝혀라”,http://www.donga.com/news/article/all/20190715/96486046/1
4318,2019-07-15,7월15일장마감주가정보대웅제약155500원,http://www.newsinside.kr/news/articleView.html?idxno=910599
4319,2019-07-15,7월15일장마감주가정보대웅제약155500원,http://www.newsinside.kr/news/articleView.html?idxno=910598
4320,2019-07-15,대웅제약비파민B임팩타민TV광고전개염정아오나라발탁,http://www.donga.com/news/article/all/20190715/96486719/1
4321,2019-07-15,대웅제약vs메디톡스사활건보톡스전쟁4년전말,http://www.insightkorea.co.kr//news/articleView.html?idxno=44732
4322,2019-07-15,대웅제약비타민B임팩타민TV광고선보여,http://www.finomy.com/news/articleView.html?idxno=67654
4323,2019-07-15,15일장마감매매동향대웅제약주가155500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=276221
4324,2019-07-15,대웅제약임펙타민출시후첫TV광고송출,http://weekly.cnbnews.com/news/article.html?no=129007
4325,2019-07-15,메디톡스ITC명령은대웅제약의영업비밀침해행위설명하라는것,http://news.mk.co.kr/newsRead.php?year=2019&no=524205
4326,2019-07-15,대웅제약메디톡스대웅제약침해주장영업비밀밝혀라”,https://jhealthmedia.joins.com/article/article_view.asp?pno=20651
4327,2019-07-15,대웅제약룬드벡공동프로모션계약알츠하이머치료제에빅사시장확대,http://www.dt.co.kr/contents.html?article_no=2019071602101931102002&ref=naver
4328,2019-07-15,대웅제약알츠하이머치료제에빅사코프로모션진행,http://weekly.cnbnews.com/news/article.html?no=129012
4329,2019-07-15,ITC메디톡스에영업비밀공개명령대웅제약메디톡스다른해석,http://www.newspim.com/news/view/20190715000925
4330,2019-07-15,대웅제약VS메디톡스독한보톡스전쟁왜,http://www.etoday.co.kr/news/section/newsview.php?idxno=1776943
4331,2019-07-15,인기종목매매동향7월15일대웅제약155500원으로장마감,http://nbntv.co.kr/news/view/484488
4332,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.newscj.com/news/articleView.html?idxno=651578
4333,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고선봬,http://www.kpanews.co.kr/article/show.asp?idx=205480&table=article&category=D
4334,2019-07-15,대웅제약미국국제무역위원회ITC메디톡스에침해영업비밀밝혀라명령,http://www.econonews.co.kr/news/articleView.html?idxno=75916
4335,2019-07-16,대웅제약vs메디톡스보톡스균주소송승자는,http://www.econovill.com/news/articleView.html?idxno=367609
4336,2019-07-16,美ITC메디톡스에대웅제약에게침해당한영업비밀실체공개요구,http://www.industrynews.co.kr/news/articleView.html?idxno=33361
4337,2019-07-16,★주식인사이드대웅제약주가161500원7월16일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=911828
4338,2019-07-16,대웅제약5이상상승나보타주보순항중메리츠종금증권BUY,https://www.hankyung.com/finance/article/201907166754L
4339,2019-07-16,대웅제약5이상상승나보타주보순항중메리츠종금증권,http://www.betanews.net:8080/article/1030626.html
4340,2019-07-16,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.nbnnews.co.kr/news/articleView.html?idxno=293444
4341,2019-07-16,제약업종오전시황상승률상위종목KPX생명과학1790테라젠이텍스404대웅제약289등,http://www.gokorea.kr/news/articleView.html?idxno=276914
4342,2019-07-16,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.wsobi.com/news/articleView.html?idxno=77721
4343,2019-07-16,대웅제약ITC소송에서유리한전환점맞아,http://www.wsobi.com/news/articleView.html?idxno=77726
4344,2019-07-16,7월16일대웅제약주식그래프225159000원,http://nbntv.co.kr/news/view/486672
4345,2019-07-16,대웅제약디엔컴퍼니호텔마리나베이서울과손잡고스파패키지할인이벤트전개,http://www.ezyeconomy.com/news/articleView.html?idxno=92262
4346,2019-07-16,대웅제약한국룬드벡과알츠하이머병치료제에빅사공동프로모션계약체결,http://www.wsobi.com/news/articleView.html?idxno=77704
4347,2019-07-16,스타★주식인사이드대웅제약주가158500원7월16일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=913451
4348,2019-07-16,영업비밀공개명령한ITC대웅제약메디톡스해석온도차,http://www.shinailbo.co.kr/news/articleView.html?idxno=1185858
4349,2019-07-16,7월16일장마감주가정보대웅제약155500원,http://www.newsinside.kr/news/articleView.html?idxno=914844
4350,2019-07-16,전승호대웅제약빈혈치료제할랄인증추진해20억이슬람시장공략,http://www.businesspost.co.kr/BP?command=article_view&num=135573
4351,2019-07-16,16일장마감증권시세대웅제약주가155500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=278226
4352,2019-07-16,특징주종목정보7월16일대웅제약155500원으로장마감,http://nbntv.co.kr/news/view/488413
4353,2019-07-17,대웅제약NEWTOX마케팅활발2년내보톡스시장점유율2위넘본다,http://www.ceoscoredaily.com/news/article.html?no=58022
4354,2019-07-17,메디톡스vs대웅제약국내외균주다툼계속,http://www.mdtoday.co.kr/mdtoday/index.html?no=359991
4355,2019-07-17,★주식인사이드대웅제약주가155000원7월17일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=916739
4356,2019-07-17,대웅제약직원자율성높아지니업무효율따라와”,http://www.dailian.co.kr/news/view/811206/?sc=naver
4357,2019-07-17,대웅제약주가그래프17일현재159000원,http://nbntv.co.kr/news/view/490348
4358,2019-07-17,스타★주식인사이드대웅제약주가159500원7월17일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=918336
4359,2019-07-17,대웅제약이침해했다고주장하는메디톡스의영업비밀이무엇인가,http://www.kukinews.com/news/article.html?no=682789
4360,2019-07-17,대웅제약종근당1조클럽굳히기청신호,http://www.ebn.co.kr/news/view/993470
4361,2019-07-17,7월17일장마감주가정보대웅제약158500원,http://www.newsinside.kr/news/articleView.html?idxno=919657
4362,2019-07-17,17일마감정보대웅제약158500원마감,http://www.gokorea.kr/news/articleView.html?idxno=280178
4363,2019-07-17,상장주주식시세7월17일대웅제약158500원으로장마감,http://nbntv.co.kr/news/view/492512
4364,2019-07-18,막말퇴진윤재승전대웅제약회장관계사통해지배력행사,http://www.ajunews.com/view/20190717151010024
4365,2019-07-18,대웅제약글로벌진출15년세계시장공략속도,http://www.kpinews.co.kr/news/articleView.html?idxno=99720
4366,2019-07-18,대웅제약원하는직무에자유롭게도전직원육성프로그램주목,http://www.metroseoul.co.kr/news/newsview?newscd=2019071800040
4367,2019-07-18,제약업종내상승종목씨케이에이치2389뉴트리400대웅제약347등,http://aitimes.co.kr/news/view/79448
4368,2019-07-18,스타★주식인사이드대웅제약주가162000원7월18일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=922259
4369,2019-07-18,7월18일장마감주가정보대웅제약160500원,http://www.newsinside.kr/news/articleView.html?idxno=923450
4370,2019-07-18,18일장마감증권시세대웅제약160500원마감,http://www.gokorea.kr/news/articleView.html?idxno=281381
4371,2019-07-18,특징주주가정보18일대웅제약마감증시160500원,http://nbntv.co.kr/news/view/494893
4372,2019-07-19,대웅제약의바이오중간성적표는,http://moneys.mt.co.kr/news/mwView.php?no=2019070817218054228
4373,2019-07-19,대웅제약관계사디엔컴퍼니자외선차단제출시,http://moneys.mt.co.kr/news/mwView.php?no=2019071908468055777
4374,2019-07-19,주식종목검색대웅제약주가19일현재166000원,http://nbntv.co.kr/news/view/495964
4375,2019-07-19,오늘의신상품대웅제약디엔컴퍼니이지듀이지썬아웃도어선블록출시,http://www.econovill.com/news/articleView.html?idxno=367892
4376,2019-07-19,스타★주식인사이드대웅제약주가167500원7월19일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=926257
4377,2019-07-19,메디톡스대웅제약보톡스분쟁전세역전되나,http://www.enewstoday.co.kr/news/articleView.html?idxno=1323071
4378,2019-07-19,7월19일장마감주가정보대웅제약167000원,http://www.newsinside.kr/news/articleView.html?idxno=927609
4379,2019-07-19,19일증시종목마감동향대웅제약167000원마감,http://www.gokorea.kr/news/articleView.html?idxno=283443
4380,2019-07-19,인기주분석매매동향7월19일대웅제약167000원으로장마감,http://nbntv.co.kr/news/view/498137
4381,2019-07-22,신약개발이미래넥스트나보타에도전대웅제약RD매진,http://www.newsis.com/view/?id=NISX20190719_0000715871&cID=13001&pID=13000
4382,2019-07-22,★주식인사이드대웅제약주가165000원7월22일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=931921
4383,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.segye.com/content/html/2019/07/22/20190722503027.html?OutUrl=naver
4384,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233021
4385,2019-07-22,대웅제약발달장애인지원봉사단제1기창단,http://www.insightkorea.co.kr//news/articleView.html?idxno=45823
4386,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.wsobi.com/news/articleView.html?idxno=78060
4387,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.viva100.com/main/view.php?key=20190722010007303
4388,2019-07-22,대웅제약소화기PM3인방초격차1위꿈아닌현실”,http://www.viva100.com/main/view.php?key=20190722010007274
4389,2019-07-22,대웅제약발달장애인위해참지마요프로젝트가동,http://www.whosaeng.com/111581
4390,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.newsway.co.kr/news/view?tp=1&ud=2019072210470319613
4391,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.newsway.co.kr/news/view?tp=1&ud=2019072210470319613
4392,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트교육봉사단창단,http://www.dailysmart.co.kr/news/articleView.html?idxno=13605
4393,2019-07-22,대웅제약참치마요프로젝트교육봉사단창단식,http://www.newsprime.co.kr/news/article.html?no=468345
4394,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.newswatch.kr/news/articleView.html?idxno=21903
4395,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.seoulwire.com/news/articleView.html?idxno=179702
4396,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.segyefn.com/newsView/20190722000926?OutUrl=naver
4397,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56396
4398,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://medipana.com/news/news_viewer.asp?NewsNum=243193&MainKind=A&NewsKind=5&vCount=12&vKind=1
4399,2019-07-22,아프면참지마요대웅제약발달장애인에질병증상표현교육지원,http://www.100ssd.co.kr/news/articleView.html?idxno=62922
4400,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.newsis.com/view/?id=NISX20190722_0000717937&cID=13001&pID=13000
4401,2019-07-22,대웅제약발달장애인위한제1기교육봉사단창단식,http://www.youthdaily.co.kr/news/articleView.html?idxno=14007
4402,2019-07-22,대웅제약발달장애인위한교육봉사단창단,http://www.bosa.co.kr/news/articleView.html?idxno=2109356
4403,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.asiatime.co.kr/news/articleView.html?idxno=259230
4404,2019-07-22,대웅제약발달장애인지원봉사단창단,http://www.finomy.com/news/articleView.html?idxno=67849
4405,2019-07-22,대웅제약발달장애인도우미역할톡톡,http://www.sisaon.co.kr/news/articleView.html?idxno=97747
4406,2019-07-22,대웅제약발달장애인건강한삶위한봉사단창단,http://www.straightnews.co.kr/news/articleView.html?idxno=52308
4407,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.mdtoday.co.kr/mdtoday/index.html?no=360392
4408,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.businesskorea.co.kr/news/articleView.html?idxno=34149
4409,2019-07-22,스타★주식인사이드대웅제약주가169500원7월22일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=933475
4410,2019-07-22,대웅제약발달장애인교육봉사단창단,http://news.mt.co.kr/mtview.php?no=2019072210212811805
4411,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.metroseoul.co.kr/news/newsview?newscd=2019072200129
4412,2019-07-22,대웅제약발달장애인위한교육봉사단창단,http://www.dt.co.kr/contents.html?article_no=2019072202109919807017&ref=naver
4413,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.etnews.com/20190722000179
4414,2019-07-22,대웅제약발달장애인위한교육봉사단창단,http://www.seoulfn.com/news/articleView.html?idxno=349984
4415,2019-07-22,발달장애인도우리와하나대웅제약발달장애인건강한삶위한교육봉사단창단,http://www.updownnews.co.kr/news/articleView.html?idxno=206285
4416,2019-07-22,대웅제약발달장애인건강한삶위한교육봉사단창단,http://daily.hankooki.com/lpage/ittech/201907/dh20190722150820145630.htm
4417,2019-07-22,대웅제약주가7월22일현재169500원,http://www.gokorea.kr/news/articleView.html?idxno=285121
4418,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.econovill.com/news/articleView.html?idxno=368044
4419,2019-07-22,대웅제약발달장애인에질병증상표현법교육할참지마요봉사단창단,http://news.mk.co.kr/newsRead.php?year=2019&no=551448
4420,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.lawissue.co.kr/view.php?ud=201907221555136534204ead0791_12
4421,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.enewstoday.co.kr/news/articleView.html?idxno=1323644
4422,2019-07-22,대웅제약발달장애인돕는참지마요봉사단창단,http://health.chosun.com/site/data/html_dir/2019/07/22/2019072201790.html
4423,2019-07-22,대웅제약발달장애인위해참지마요프로젝트진행,http://www.mhj21.com/122852
4424,2019-07-22,7월22일장마감주가정보대웅제약168500원,http://www.newsinside.kr/news/articleView.html?idxno=935541
4425,2019-07-22,뉴스워커_대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.newsworker.co.kr/news/articleView.html?idxno=34197
4426,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.bokuennews.com/news/article.html?no=178696
4427,2019-07-22,22일주가마감정보대웅제약168500원마감,http://www.gokorea.kr/news/articleView.html?idxno=285740
4428,2019-07-22,상장주주식시세22일대웅제약마감증시168500원,http://nbntv.co.kr/news/view/502959
4429,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.getnews.co.kr/view.php?ud=20190722175948374541d0c69529_16
4430,2019-07-22,뉴스투데이L대웅제약발달장애닝건강교육책임질참지마요교육봉사단창단,http://www.news2day.co.kr/132377
4431,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.newscj.com/news/articleView.html?idxno=653486
4432,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.kpanews.co.kr/article/show.asp?idx=205625&table=article&category=D
4433,2019-07-23,★주식인사이드대웅제약주가169000원7월23일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=936813
4434,2019-07-23,대웅제약상반기원외처방실적9성장3628억원,http://www.bosa.co.kr/news/articleView.html?idxno=2109405
4435,2019-07-23,대웅제약상반기원외처방상위제약사중1위최강면모과시,http://www.medisobizanews.com/news/articleView.html?idxno=61330
4436,2019-07-23,7월23일대웅제약실시간주식현황089170000원,http://nbntv.co.kr/news/view/505177
4437,2019-07-23,사회공헌대웅제약발달장애인건강한삶지원참지마요프로젝트제1기교육봉사단창설,http://www.ezyeconomy.com/news/articleView.html?idxno=92432
4438,2019-07-23,대웅제약원외처방시장명가재확인,http://www.whosaeng.com/111614
4439,2019-07-23,스타★주식인사이드대웅제약주가166500원7월23일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=937474
4440,2019-07-23,7월23일장마감주가정보대웅제약166500원,http://www.newsinside.kr/news/articleView.html?idxno=938038
4441,2019-07-23,대웅제약발달장애인위한교육봉사단창단,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3895535
4442,2019-07-23,특징주매매동향23일대웅제약마감증시166500원,http://nbntv.co.kr/news/view/507363
4443,2019-07-23,23일마감주가정보대웅제약166500원마감,http://www.gokorea.kr/news/articleView.html?idxno=289074
4444,2019-07-24,제약업계소식일양약품셀트리온동아에스티대웅제약,http://www.g-enews.com/ko-kr/news/article/news_all/2019072316105117969d76442fa_1/article.html
4445,2019-07-24,대웅제약상반기원외처방3628억상위5개사중최고성장률,http://www.rapportian.com/news/articleView.html?idxno=118857
4446,2019-07-24,★주식인사이드대웅제약주가167000원7월24일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=938873
4447,2019-07-24,대웅제약오늘증권시세24일현재165000원,http://nbntv.co.kr/news/view/509579
4448,2019-07-24,대웅제약주가7월24일현재164000원,http://www.gokorea.kr/news/articleView.html?idxno=290885
4449,2019-07-24,스타★주식인사이드대웅제약주가164000원7월24일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=939511
4450,2019-07-24,7월24일장마감주가정보대웅제약164000원,http://www.newsinside.kr/news/articleView.html?idxno=940092
4451,2019-07-24,24일증시종목마감동향대웅제약주가164000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=292008
4452,2019-07-24,인기종목주가정보24일대웅제약마감증시164000원,http://nbntv.co.kr/news/view/511741
4453,2019-07-25,대웅제약임팩타민소비자대상마케팅강화,http://www.asiatoday.co.kr/view.php?key=20190725010015644
4454,2019-07-25,★주식인사이드대웅제약주가164500원7월25일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=941248
4455,2019-07-25,대웅제약아큐네탄연질캡슐10mg생산중단,http://www.bokuennews.com/news/article.html?no=178856
4456,2019-07-25,국민연금대웅제약주가상승에보유지분가치2년새두배로커져,http://www.ceoscoredaily.com/news/article.html?no=58398
4457,2019-07-25,대웅제약Next나보타신약파이프라인들,http://www.biospectator.com/view/news_view.php?varAtcId=8107
4458,2019-07-25,주식현재가대웅제약주가25일현재162500원,http://nbntv.co.kr/news/view/513889
4459,2019-07-25,스타★주식인사이드대웅제약주가161500원7월25일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=941847
4460,2019-07-25,7월25일장마감주가정보대웅제약162000원,http://www.newsinside.kr/news/articleView.html?idxno=942188
4461,2019-07-25,대웅제약참지마요프로젝트봉사단창단,http://weekly.cnbnews.com/news/article.html?no=129191
4462,2019-07-25,25일마감주가정보대웅제약주가162000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=294882
4463,2019-07-25,인기주종목정보25일대웅제약마감증시162000원,http://nbntv.co.kr/news/view/516031
4464,2019-07-26,대웅제약주식장26일현재161500원,http://nbntv.co.kr/news/view/518224
4465,2019-07-26,스타★주식인사이드대웅제약주가160000원7월26일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=943943
4466,2019-07-26,대웅제약넥스트나보타연구박차파이프라인충분,http://www.dailypharm.com/Users/News/NewsView.html?ID=255157&REFERER=NP
4467,2019-07-26,대웅제약현지화전략으로글로벌헬스케어그룹앞당긴다,http://www.insightkorea.co.kr//news/articleView.html?idxno=46496
4468,2019-07-26,대웅제약베트남지분투자현지화전략으로지속성장,http://www.bosa.co.kr/news/articleView.html?idxno=2109717
4469,2019-07-26,대웅제약주가오늘시세26일현재161000원,http://www.gokorea.kr/news/articleView.html?idxno=297079
4470,2019-07-26,7월26일장마감주가정보대웅제약160000원,http://www.newsinside.kr/news/articleView.html?idxno=944497
4471,2019-07-26,메디톡스대웅제약중기부기술침해조사첫사례나와,http://www.newspim.com/news/view/20190726000855
4472,2019-07-26,대웅제약오송스마트공장을전초기지로삼아글로벌사업속도붙여,http://www.businesspost.co.kr/BP?command=article_view&num=137079
4473,2019-07-29,대웅제약소화기계분야1위비결오리지널리티강화,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1070696
4474,2019-07-29,7월29일대웅제약증권플러스154500원344,http://nbntv.co.kr/news/view/523090
4475,2019-07-29,지난해의약품생산실적한미약품종근당셀트리온대웅제약순,http://medicalworldnews.co.kr/news/view.php?idx=1510931829
4476,2019-07-29,한미종근당셀트리온대웅제약녹십자順,http://www.dailymedi.com/detail.php?number=845742&thread=22r05
4477,2019-07-29,스타★주식인사이드대웅제약주가155000원7월29일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=948765
4478,2019-07-29,7월29일대웅제약오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=300079
4479,2019-07-29,7월29일장마감주가정보대웅제약155000원,http://www.newsinside.kr/news/articleView.html?idxno=949083
4480,2019-07-29,29일장마감증권시세대웅제약주가155000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=300753
4481,2019-07-29,인기주분석종목정보29일대웅제약마감증시155000원,http://nbntv.co.kr/news/view/525249
4482,2019-07-30,★주식인사이드대웅제약주가155500원7월30일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=949938
4483,2019-07-30,7월30일대웅제약실시간증시158000원194,http://nbntv.co.kr/news/view/527450
4484,2019-07-30,스타★주식인사이드대웅제약주가159000원7월30일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=950571
4485,2019-07-30,대웅제약주가정보30일현재160500원,http://www.gokorea.kr/news/articleView.html?idxno=303049
4486,2019-07-30,7월30일장마감주가정보대웅제약158000원,http://www.newsinside.kr/news/articleView.html?idxno=951158
4487,2019-07-30,상장주매매동향7월30일대웅제약158000원으로장마감,http://nbntv.co.kr/news/view/529565
4488,2019-07-30,30일마감정보대웅제약주가158000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=303906
4489,2019-07-31,대웅제약고지혈증약크레스토장기집권특허만료前매출로U턴성장,http://www.medisobizanews.com/news/articleView.html?idxno=61490
4490,2019-07-31,★주식인사이드대웅제약주가158500원7월31일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=951986
4491,2019-07-31,7월31일대웅제약주식추천주222154500원,http://nbntv.co.kr/news/view/531774
4492,2019-07-31,스타★주식인사이드대웅제약주가155000원7월31일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=952556
4493,2019-07-31,컨센부합대웅제약올해2Q영업익170억컨센비34↑,http://www.itooza.com/common/iview.php?no=2019073115404719809
4494,2019-07-31,7월31일대웅제약오늘시세및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=305919
4495,2019-07-31,코스피대웅제약2019년2분기누적매출액5016억원영업이익273억원,http://news.kmib.co.kr/article/view.asp?arcid=0013556692&code=61141211&cp=nv
4496,2019-07-31,실적속보대웅제약별도20192Q영업이익17095억원,http://www.fntimes.com/html/view.php?ud=2019073115410012225dfa8f2ce9_18
4497,2019-07-31,대웅제약2Q영업익171억전년비71↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=255324&REFERER=NP
4498,2019-07-31,대웅제약2Q영업익171억원전년比706↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03883526622560096
4499,2019-07-31,공시대웅제약2분기영업익171억전년比706↑,http://www.newsway.co.kr/news/view?tp=1&ud=2019073115491217826
4500,2019-07-31,대웅제약2분기영업익170억전년比706↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1783119
4501,2019-07-31,대웅제약2Q영업익171억전년比71↑,http://news.mt.co.kr/mtview.php?no=2019073115562324538
4502,2019-07-31,대웅제약2분기영업이익171억원706증가,http://yna.kr/AKR20190731126400008?did=1195m
4503,2019-07-31,대웅제약2분기영업익170억전년比706↑,http://www.sportsseoul.com/news/read/798633
4504,2019-07-31,공시대웅제약0696202분기영업익170억전년比706↑,http://www.startuptoday.co.kr/news/articleView.html?idxno=27947
4505,2019-07-31,대웅제약2분기역대최대분기매출달성,http://www.economytalk.kr/news/articleView.html?idxno=193166
4506,2019-07-31,대웅제약2분기영업익171억원전년동기대비706증가,https://www.sedaily.com/NewsView/1VLWPBTH84
4507,2019-07-31,7월31일장마감주가정보대웅제약158500원,http://www.newsinside.kr/news/articleView.html?idxno=953096
4508,2019-07-31,대웅제약올2분기역대최대분기매출달성전년동기대비영업이익은706폭발적성장,http://www.segye.com/content/html/2019/07/31/20190731510394.html?OutUrl=naver
4509,2019-07-31,대웅제약2분기역대최대분기매출2634억달성,http://www.fnnews.com/news/201907311610318499
4510,2019-07-31,대웅제약2분기영업익171억원전년比706↑,http://www.seoulwire.com/news/articleView.html?idxno=186721
4511,2019-07-31,대웅제약2분기역대최대분기매출달성나보타덕분,http://www.newsway.co.kr/news/view?tp=1&ud=2019073116111120221
4512,2019-07-31,대웅제약2분기매출액2634억원창사이래최대분기매출달성,http://www.ceoscoredaily.com/news/article.html?no=58700
4513,2019-07-31,대웅제약2분기매출2643억원역대최대분기매출달성,http://www.viva100.com/main/view.php?key=20190731010010796
4514,2019-07-31,대웅제약2Q매출액2634억영업익171억기록역대분기최대매출,http://www.dailysmart.co.kr/news/articleView.html?idxno=13946
4515,2019-07-31,대웅제약나보타美진출로2분기영업익70증가,http://www.kpinews.co.kr/news/articleView.html?idxno=100446
4516,2019-07-31,대웅제약2Q역대최대분기매출달성‥영업이익급증,http://medipana.com/news/news_viewer.asp?NewsNum=243657&MainKind=A&NewsKind=5&vCount=12&vKind=1
4517,2019-07-31,대웅제약2분기영업익171억원전년대비71증가,http://moneys.mt.co.kr/news/mwView.php?no=2019073116158045136
4518,2019-07-31,대웅제약2Q2634억매출역대최대분기매출달성,http://www.newsis.com/view/?id=NISX20190731_0000728115&cID=13001&pID=13000
4519,2019-07-31,대웅제약나보타수출등에업고역대최대분기매출,http://www.newspim.com/news/view/20190731000959
4520,2019-07-31,대웅제약2분기영업이익171억원706증가종합,http://yna.kr/AKR20190731126451008?did=1195m
4521,2019-07-31,대웅제약2분기역대최대매출영업이익급증,http://www.mhj21.com/123088
4522,2019-07-31,대웅제약2분기영업이익171억원전년比706↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=361212
4523,2019-07-31,대웅제약2분기매출2634억원역대분기최대,http://www.medisobizanews.com/news/articleView.html?idxno=61519
4524,2019-07-31,대웅제약2분기사상최대매출달성,http://www.dailian.co.kr/news/view/814874/?sc=naver
4525,2019-07-31,대웅제약2분기영업이익706증가한171억,http://www.mediapen.com/news/view/451947
4526,2019-07-31,대웅제약2분기역대최대분기매출달성으로영업이익급증,http://www.medigatenews.com/news/2104257328
4527,2019-07-31,대웅제약2분기역대최대매출달성영업익급증,http://www.metroseoul.co.kr/news/newsview?newscd=2019073100237
4528,2019-07-31,대웅제약2분기영업이익171억원706↑,http://www.asiatoday.co.kr/view.php?key=20190731010019970
4529,2019-07-31,대웅제약2분기영업익171억전년比706증가,http://biz.newdaily.co.kr/site/data/html/2019/07/31/2019073100181.html
4530,2019-07-31,대웅제약2분기매출2634억원전년比106↑,http://news.mt.co.kr/mtview.php?no=2019073116382846137
4531,2019-07-31,대웅제약2Q매출2634억나보타미국출시로분기최대실적,http://news1.kr/articles/?3684738
4532,2019-07-31,대웅제약2분기매출2634억원달성역대최대분기매출기록,http://inthenews.co.kr/article-10275/
4533,2019-07-31,대웅제약2분기영업이익171억원전년동기대비706↑,http://news.mk.co.kr/newsRead.php?year=2019&no=585833
4534,2019-07-31,대웅제약역대최대분기매출달성,http://www.newstomato.com/ReadNews.aspx?no=911276
4535,2019-07-31,대웅제약실적발표영업이익171억원전분기대비676증가개별잠정,http://www.newspim.com/news/view/20190731001025
4536,2019-07-31,ETCOTC부문에서안정적인성장견인대웅제약2Q사상최대분기매출및영업이익대폭성장,http://www.updownnews.co.kr/news/articleView.html?idxno=206686
4537,2019-07-31,대웅제약2019년2분기역대최대분기매출달성,http://daily.hankooki.com/lpage/ittech/201907/dh20190731170735145630.htm
4538,2019-07-31,나보타의힘대웅제약2분기매출역대최대영업이익70↑,http://www.donga.com/news/article/all/20190731/96776743/1
4539,2019-07-31,대웅제약2분기매출역대최대영업이익전년대비706급증,http://www.econovill.com/news/articleView.html?idxno=368717
4540,2019-07-31,대웅제약2Q영업익171억원전년比706↑,http://www.wolyo.co.kr/news/articleView.html?idxno=90144
4541,2019-07-31,대웅제약2분기매출2634억원분기매출역대최대,http://www.etoday.co.kr/news/section/newsview.php?idxno=1783200
4542,2019-07-31,대웅제약2Q역대최대매출VS유한양행영업익98↓,http://www.edaily.co.kr/news/newspath.asp?newsid=04234486622560096
4543,2019-07-31,대웅제약ETCOTC고른성장세2분기영업익전년比71↑,http://www.newsprime.co.kr/news/article.html?no=469816
4544,2019-07-31,대웅제약2Q영업익171억나보타미국진출로706↑,http://www.ajunews.com/view/20190731171700760
4545,2019-07-31,대웅제약2분기영업익170억전년비706↑,http://www.ebn.co.kr/news/view/995395
4546,2019-07-31,대웅제약2분기영업익170억전년대비706↑,http://biz.chosun.com/site/data/html_dir/2019/07/31/2019073101928.html
4547,2019-07-31,대웅제약2분기최대실적전년比매출106↑영업이익706↑,http://www.joseilbo.com/news/news_read.php?uid=381385&class=17&grp=
4548,2019-07-31,31일마감증시대웅제약주가158500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=306444
4549,2019-07-31,실적대웅제약2Q영업이익171억706↑전문일반의약품호조세,http://www.ezyeconomy.com/news/articleView.html?idxno=92670
4550,2019-07-31,공시대웅제약2분기영업익171억전년比706↑,http://www.newsis.com/view/?id=NISX20190731_0000728106&cID=10401&pID=10400
4551,2019-07-31,대웅제약2분기역대최대분기매출달성,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1070815
4552,2019-07-31,대웅제약2분기영업익171억원분기최대매출,https://view.asiae.co.kr/article/2019073117500496046
4553,2019-07-31,대웅제약2분기영업이익171억원전년비706↑,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907310622&t=NN
4554,2019-07-31,대웅제약2분기영업익171억전년比706↑,http://www.segyefn.com/newsView/20190731000631?OutUrl=naver
4555,2019-07-31,대웅제약2분기역대최대분기매출2634억달성,http://www.nbnnews.co.kr/news/articleView.html?idxno=299983
4556,2019-07-31,대웅제약19년2분기역대최대분기매출달성,http://www.lawissue.co.kr/view.php?ud=201907311809138925204ead0791_12
4557,2019-07-31,인기종목주가정보31일대웅제약마감증시158500원,http://nbntv.co.kr/news/view/533891
4558,2019-07-31,대웅제약2Q사상최대매출영업이익71↑,http://www.upinews.kr/news/newsview.php?ncode=1065603813872511
4559,2019-07-31,대웅제약2Q영업익171억원전년比706증가,http://www.seoulfn.com/news/articleView.html?idxno=351132
4560,2019-07-31,대웅제약19년2분기역대최대매출달성영업이익급증,http://www.getnews.co.kr/view.php?ud=20190731184623749641d0c69529_16
4561,2019-07-31,대웅제약의약품부문성장과나보타미국수출로2분기실적급등,http://www.businesspost.co.kr/BP?command=article_view&num=137675
4562,2019-07-31,대웅제약2분기영업이익171억원전년比706↑,http://www.nspna.com/news/?mode=view&newsid=374957
4563,2019-07-31,대웅제약역대최대분기매출달성으로영업이익급증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56596
4564,2019-07-31,대웅제약2분기역대최대매출달성매출2634억원영업익171억원기록,http://www.g-enews.com/ko-kr/news/article/news_all/20190731180232849869d76442fa_1/article.html
4565,2019-07-31,대웅제약2Q매출2634억원전년比106↑,http://www.newswatch.kr/news/articleView.html?idxno=22183
4566,2019-07-31,뉴스워커_대웅제약2분기역대최대분기매출달성으로영업이익급증,http://www.newsworker.co.kr/news/articleView.html?idxno=35061
4567,2019-08-01,대웅제약2분기영업이익171억전년대비706늘어나,http://www.econonews.co.kr/news/articleView.html?idxno=78941
4568,2019-08-01,대웅제약2분기매출액2634억역대최대분기매출달성,http://www.thefirstmedia.net/news/articleView.html?idxno=47175
4569,2019-08-01,대웅제약2분기역대최대분기매출달성영업익급증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233415
4570,2019-08-01,보령제약대웅제약상반기영업익쑥유한양행실적나홀로뒷걸음질,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=532856
4571,2019-08-01,클릭e종목대웅제약호실적은나보타덕분,https://view.asiae.co.kr/article/2019080107330064535
4572,2019-08-01,퀵리포트대웅제약매수유지목표가16↓21만원한투證,http://www.itooza.com/common/iview.php?no=2019080107532510522
4573,2019-08-01,빅데이터MSI시장심리톱5삼성SDI대웅제약코웨이대우건설KB금융,http://www.newsis.com/view/?id=NISX20190801_0000728484&cID=10401&pID=10400
4574,2019-08-01,대웅제약2Q어닝서프라이즈신영,http://news.mt.co.kr/mtview.php?no=2019080108102029757
4575,2019-08-01,대웅제약나보타균주소송비용부담목표가↓키움,http://www.edaily.co.kr/news/newspath.asp?newsid=01607206622583056
4576,2019-08-01,대웅제약나보타흥행하반기도계속매수신영증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1783313
4577,2019-08-01,KTB투자증권대웅제약소송이슈에가려진펀더멘탈개선주목목표가는↓”,http://www.newsway.co.kr/news/view?tp=1&ud=2019080108173311745
4578,2019-08-01,퀵리포트대웅제약중립으로유지목표가미제시미래에셋대우,http://www.itooza.com/common/iview.php?no=2019080108282218529
4579,2019-08-01,대웅제약목표주가낮아져나보타관련소송의불확실성은부담,http://www.businesspost.co.kr/BP?command=article_view&num=137742
4580,2019-08-01,대웅제약2Q미국향나보타수출증가로호실적키움증권,http://www.ebn.co.kr/news/view/995411
4581,2019-08-01,퀵리포트대웅제약매수유지목표가12↓22만원키움證,http://www.itooza.com/common/iview.php?no=2019080108525714114
4582,2019-08-01,대웅제약美나보타판매호조에최대분기매출경신,http://www.asiatoday.co.kr/view.php?key=20190801010000090
4583,2019-08-01,5000억원돌파한대웅제약2분기사상최대매출,http://www.monews.co.kr/news/articleView.html?idxno=204163
4584,2019-08-01,실시간분석대웅제약34상승2Q영업익170억,http://www.itooza.com/common/iview.php?no=2019080109014426949
4585,2019-08-01,퀵리포트대웅제약강력매수로상향목표가6↓28만원KTB證,http://www.itooza.com/common/iview.php?no=2019080108305314628
4586,2019-08-01,★주식인사이드대웅제약주가161500원8월1일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=954157
4587,2019-08-01,대웅제약나보타서프라이즈하반기에도유지신영증권,http://www.fnnews.com/news/201908010911313444
4588,2019-08-01,퀵리포트대웅제약매수유지목표가27만원유지대신證,http://www.itooza.com/common/iview.php?no=2019080107352516066
4589,2019-08-01,퀵리포트대웅제약매수유지목표가24만5000원유지신영證,http://www.itooza.com/common/iview.php?no=2019080108361918110
4590,2019-08-01,대웅제약2분기역대최대매출달성,http://www.wsobi.com/news/articleView.html?idxno=78754
4591,2019-08-01,리포트브리핑대웅제약분기최대매출달성목표가200000원DB금융투자,http://www.newspim.com/news/view/20190801000228
4592,2019-08-01,GET투자리포트대웅제약투자의견보유유지DB금융투자,http://www.getnews.co.kr/view.php?ud=201908011030309082tpgetnews_16
4593,2019-08-01,퀵리포트대웅제약보유유지목표가20만원유지DB금투,http://www.itooza.com/common/iview.php?no=2019080109403914429
4594,2019-08-01,막말퇴진대웅제약윤재승회장자숙은생략뒤에숨어서실세경영,http://viewers.heraldcorp.com/news/articleView.html?idxno=41048
4595,2019-08-01,리포트브리핑대웅제약나보타효과반영목표가270000원대신증권,http://www.newspim.com/news/view/20190801000245
4596,2019-08-01,GET투자리포트대웅제약투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=201908011030309088tpgetnews_16
4597,2019-08-01,GET투자리포트대웅제약투자의견매수유지KB증권,http://www.getnews.co.kr/view.php?ud=201908011030309103tpgetnews_16
4598,2019-08-01,리포트브리핑대웅제약역대최대분기매출액달성목표가250000원KB증권,http://www.newspim.com/news/view/20190801000308
4599,2019-08-01,대웅제약소송비용없었다면2분기209억원영업이익도가능”,http://www.wikitree.co.kr/main/news_view.php?id=450483
4600,2019-08-01,대웅제약2분기매출2634억영업이익171억기록,http://www.bokuennews.com/news/article.html?no=179099
4601,2019-08-01,GET투자리포트대웅제약투자의견NotRated미래에셋대우,http://www.getnews.co.kr/view.php?ud=201908011030309121tpgetnews_16
4602,2019-08-01,리포트브리핑대웅제약2Q19사상최대분기매출로시장기대치충족NotRated미래에셋대우,http://www.newspim.com/news/view/20190801000453
4603,2019-08-01,8월1일대웅제약오늘주식162000원221,http://nbntv.co.kr/news/view/536083
4604,2019-08-01,실적속보대웅제약올해2Q영업이익대폭상승전분기보다676올라개별잠정,https://www.hankyung.com/finance/article/201908015969L
4605,2019-08-01,리포트브리핑대웅제약나보타로개선되는실적목표가260000원유안타증권,http://www.newspim.com/news/view/20190801000574
4606,2019-08-01,GET투자리포트대웅제약투자의견매수유안타증권,http://www.getnews.co.kr/view.php?ud=201908011030309149tpgetnews_16
4607,2019-08-01,GET투자리포트대웅제약투자의견매수유지키움증권,http://www.getnews.co.kr/view.php?ud=201908011030309160tpgetnews_16
4608,2019-08-01,리포트브리핑대웅제약뚜렷한실적개선목표가220000원키움증권,http://www.newspim.com/news/view/20190801000635
4609,2019-08-01,GET투자리포트대웅제약투자의견매수유지한국투자증권,http://www.getnews.co.kr/view.php?ud=201908011030309162tpgetnews_16
4610,2019-08-01,리포트브리핑대웅제약눈으로확인된Jeuveau효과목표가210000원한국투자증권,http://www.newspim.com/news/view/20190801000638
4611,2019-08-01,스타★주식인사이드대웅제약주가162500원8월1일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=954520
4612,2019-08-01,대웅제약2분기실적역대최대분기매출달성,http://www.sisaon.co.kr/news/articleView.html?idxno=98421
4613,2019-08-01,대웅제약주가증권그래프및주체별매매동향1일현재162500원,http://www.gokorea.kr/news/articleView.html?idxno=308711
4614,2019-08-01,퀵리포트대웅제약매수유지목표가19만5000원유지신한금투,http://www.itooza.com/common/iview.php?no=2019080114161313505
4615,2019-08-01,대웅제약나보타의美수출증가와실적개선기대”,http://www.wikitree.co.kr/main/news_view.php?id=450590
4616,2019-08-01,8월1일장마감주가정보대웅제약161000원,http://www.newsinside.kr/news/articleView.html?idxno=955055
4617,2019-08-01,나보타효과대웅제약역대최대분기매출,http://www.fnnews.com/news/201908011706513948
4618,2019-08-01,대웅제약주보최고분기매출견인,http://www.whosaeng.com/111762
4619,2019-08-01,1일증시종목마감동향대웅제약주가161000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=309462
4620,2019-08-01,대웅제약리스크요인은끝나지않은균주소송”,http://www.wikitree.co.kr/main/news_view.php?id=450673
4621,2019-08-01,상장주주가정보1일대웅제약마감증시161000원,http://nbntv.co.kr/news/view/538243
4622,2019-08-02,더벨300성장나보타힘입어대웅제약최대분기매출,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908010100000290000022
4623,2019-08-02,★주식인사이드대웅제약주가157000원8월2일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=955977
4624,2019-08-02,GET투자리포트대웅제약투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=201908011030309231tpgetnews_16
4625,2019-08-02,8월2일대웅제약주식추천주280156500원,http://nbntv.co.kr/news/view/540428
4626,2019-08-02,GET투자리포트대웅제약투자의견매수유지KB증권,http://www.getnews.co.kr/view.php?ud=201908011030309237tpgetnews_16
4627,2019-08-02,대웅제약2분기실적나보타美수출높은수익성확인,http://medipana.com/news/news_viewer.asp?NewsNum=243761&MainKind=A&NewsKind=5&vCount=12&vKind=1
4628,2019-08-02,대웅제약2분기매출2634억역대최대,http://www.munhwa.com/news/view.html?no=2019080201071827107001
4629,2019-08-02,대웅제약주가8월2일현재159500원,http://www.gokorea.kr/news/articleView.html?idxno=311350
4630,2019-08-02,스타★주식인사이드대웅제약주가158000원8월2일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=956313
4631,2019-08-02,대웅제약통합정보시스템최신업그레이드,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87134
4632,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입글로벌헬스케어그룹기반강화,http://www.segye.com/content/html/2019/08/02/20190802506718.html?OutUrl=naver
4633,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입글로벌헬스케어그룹강화,http://www.segyefn.com/newsView/20190802001721?OutUrl=naver
4634,2019-08-02,대웅제약IT인프라고도화글로벌헬스케어그룹기반강화,http://www.etoday.co.kr/news/section/newsview.php?idxno=1783990
4635,2019-08-02,대웅제약19년2분기역대최대분기매출달성,http://www.kukinews.com/news/article.html?no=688131
4636,2019-08-02,대웅제약차세대SAPERP시스템구축글로벌헬스케어그룹도약할것”,http://inthenews.co.kr/article-10605/
4637,2019-08-02,대웅제약S4HANA시스템도입으로글로벌헬스케어그룹기반강화,http://www.businesskorea.co.kr/news/articleView.html?idxno=34557
4638,2019-08-02,대웅제약S4HANA시스템구축글로벌헬스케어기반강화,http://www.medisobizanews.com/news/articleView.html?idxno=61579
4639,2019-08-02,대웅제약SAPERP고도화시스템도입,http://www.newsis.com/view/?id=NISX20190802_0000730325&cID=13001&pID=13000
4640,2019-08-02,대웅제약S4HANA시스템도입글로벌헬스케어기반강화,http://www.seoulwire.com/news/articleView.html?idxno=188519
4641,2019-08-02,대웅제약전사적자원관리시스템도입글로벌헬스케어그룹기반강화,http://www.getnews.co.kr/view.php?ud=20190802142917145141d0c69529_16
4642,2019-08-02,대웅제약SAPERP고도화완료글로벌신경망구축,http://www.etnews.com/20190802000202
4643,2019-08-02,대웅제약차세대SAPERP시스템구축글로벌헬스케어기반강화,http://www.mdtoday.co.kr/mdtoday/index.html?no=361407
4644,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://www.mhj21.com/123161
4645,2019-08-02,대웅제약표준화된글로벌신경망체제구축,http://www.bosa.co.kr/news/articleView.html?idxno=2110118
4646,2019-08-02,대웅제약IT인프라고도화작업착착,http://www.sisaon.co.kr/news/articleView.html?idxno=98522
4647,2019-08-02,대웅제약SAPERP고도화글로벌헬스케어그룹기반강화,http://medipana.com/news/news_viewer.asp?NewsNum=243765&MainKind=A&NewsKind=5&vCount=12&vKind=1
4648,2019-08-02,대웅제약차세대SAPERP시스템도입글로벌신경망체제구축,http://www.wolyo.co.kr/news/articleView.html?idxno=90303
4649,2019-08-02,대웅제약차세대SAPERP고도화글로벌신경망체제구축,http://www.ebn.co.kr/news/view/995678
4650,2019-08-02,식약처대웅제약니코프리패취에15일제조업무정지,http://daily.hankooki.com/lpage/ittech/201908/dh20190802150540145630.htm
4651,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233480
4652,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233480
4653,2019-08-02,대웅제약SAPERP고도화S4프로젝트달성,http://www.wikileaks-kr.org/news/articleView.html?idxno=61906
4654,2019-08-02,알레락후쿠시마의약품대웅제약안전성문제없다,http://www.newsprime.co.kr/news/article.html?no=470130
4655,2019-08-02,대웅제약 SAPERP 고도화S4HANA 시스템 도입,http://www.ezyeconomy.com/news/articleView.html?idxno=92758
4656,2019-08-02,대웅제약제약업계최초로SAPERP최신버전구축해,http://news.mk.co.kr/newsRead.php?year=2019&no=593356
4657,2019-08-02,대웅제약전사IT인프라고도화글로벌헬스케어그룹기반강화,http://www.newspim.com/news/view/20190802000671
4658,2019-08-02,8월2일장마감주가정보대웅제약155500원,http://www.newsinside.kr/news/articleView.html?idxno=956879
4659,2019-08-02,대웅제약차세대SAPERP시스템으로글로벌네트워크구축,http://www.newsfc.co.kr/news/articleView.html?idxno=37304
4660,2019-08-02,2일주식장마감동향대웅제약주가155500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=312765
4661,2019-08-02,대웅제약IT인프라업그레이드전승호일하는방식혁신,http://www.businesspost.co.kr/BP?command=article_view&num=138001
4662,2019-08-02,대웅제약S4HANA시스템도입글로벌기반강화,http://daily.hankooki.com/lpage/ittech/201908/dh20190802171352145630.htm
4663,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://www.lawissue.co.kr/view.php?ud=201908021722007523204ead0791_12
4664,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://sports.hankooki.com/lpage/economy/201908/sp20190802172408137020.htm
4665,2019-08-02,대웅제약IT인프라고도화글로벌헬스케어기반다져,http://www.econovill.com/news/articleView.html?idxno=368894
4666,2019-08-02,대웅제약차세대SAPERP고도화,http://biz.chosun.com/site/data/html_dir/2019/08/02/2019080202349.html
4667,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,https://www.kpanews.co.kr/article/show.asp?idx=205885&category=D
4668,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입글로벌헬스케어그룹기반강화,http://www.newscj.com/news/articleView.html?idxno=656548
4669,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56627
4670,2019-08-03,대웅제약상반기원외처방3628억원9대성장,http://www.dailypharm.com/Users/News/NewsView.html?ID=255442&REFERER=NP
4671,2019-08-03,대웅제약SAPERP전사적자원관리시스템고도화시스템도입,http://www.econonews.co.kr/news/articleView.html?idxno=79626
4672,2019-08-04,대웅제약S4프로젝트완료글로벌헬스케어그룹기반강화,http://www.viva100.com/main/view.php?key=20190804010000898
4673,2019-08-04,대웅제약고도화ERP시스템도입으로글로벌그룹기반강화,http://www.metroseoul.co.kr/news/newsview?newscd=2019080400048
4674,2019-08-04,대웅제약ERPSAPS4HANA시스템업그레이드,http://weekly.cnbnews.com/news/article.html?no=129348
4675,2019-08-04,대웅제약차세대SAPERP시스템구축,http://www.whosaeng.com/111770
4676,2019-08-05,식약처대웅제약니코프리패취제조업무정지15일행정처분,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233501
4677,2019-08-05,★주식인사이드대웅제약주가157000원8월5일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=959839
4678,2019-08-05,대웅제약2분기매출액사상최대나보타美시장진출영향,http://www.rapportian.com/news/articleView.html?idxno=119134
4679,2019-08-05,대웅제약주가8월5일현재148000원,http://www.gokorea.kr/news/articleView.html?idxno=314853
4680,2019-08-05,8월5일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=314849
4681,2019-08-05,스타★주식인사이드대웅제약주가148500원8월5일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=960193
4682,2019-08-05,대웅제약전사적자원관리시스템업그레이드,http://www.monews.co.kr/news/articleView.html?idxno=204219
4683,2019-08-05,대웅제약SAPERP고도화완료글로벌신경망구축,http://www.nbnnews.co.kr/news/articleView.html?idxno=301574
4684,2019-08-05,8월5일장마감주가정보대웅제약145500원,http://www.newsinside.kr/news/articleView.html?idxno=960746
4685,2019-08-05,5일주가마감정보대웅제약145500원마감,http://www.gokorea.kr/news/articleView.html?idxno=317483
4686,2019-08-05,대웅제약올상반기대박터트렸다,http://www.beyondpost.co.kr/view.php?ud=2019080517234463546a9e4dd7f_30
4687,2019-08-05,대웅제약SAPERP고도화S4HANA시스템도입글로벌헬스케어그룹기반강화,http://www.thefirstmedia.net/news/articleView.html?idxno=47265
4688,2019-08-05,대웅제약ERP고도화로글로벌헬스케어그룹도약기반다진다,http://www.industrynews.co.kr/news/articleView.html?idxno=33767
4689,2019-08-06,★주식인사이드대웅제약주가140000원8월6일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=961612
4690,2019-08-06,대웅제약SAPERP고도화S4HANA시스템도입,http://www.wsobi.com/news/articleView.html?idxno=79009
4691,2019-08-06,GET투자리포트대웅제약투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=201908011030309405tpgetnews_16
4692,2019-08-06,8월6일대웅제약종목그래프및주식시황069변동해,http://www.gokorea.kr/news/articleView.html?idxno=318699
4693,2019-08-06,스타★주식인사이드대웅제약주가148000원8월6일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=962273
4694,2019-08-06,8월6일장마감주가정보대웅제약142000원,http://www.newsinside.kr/news/articleView.html?idxno=962887
4695,2019-08-06,6일장마감매매동향대웅제약주가142000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=320317
4696,2019-08-07,★주식인사이드대웅제약주가145500원8월7일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=964053
4697,2019-08-07,대웅제약주가0696208월7일오늘거래가141000원증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=321695
4698,2019-08-07,스타★주식인사이드대웅제약주가143000원8월7일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=964436
4699,2019-08-07,7일마감증시대웅제약주가143000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=323560
4700,2019-08-07,상반기실속빠진제약업계승자는한미약품대웅제약,http://weekly.cnbnews.com/news/article.html?no=129416
4701,2019-08-07,대웅제약S4HANA시스템도입글로벌헬스케어그룹기반강화,http://www.sisaweek.com/news/articleView.html?idxno=125028
4702,2019-08-07,인기주주가정보7일대웅제약마감증시143000원,http://nbntv.co.kr/news/view/544812
4703,2019-08-08,★주식인사이드대웅제약주가145500원8월8일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=965869
4704,2019-08-08,8월8일대웅제약증권매매210146000원,http://nbntv.co.kr/news/view/546519
4705,2019-08-08,대웅제약5이상상승뚜렷한실적개선키움증권BUY유지,https://www.hankyung.com/finance/article/201908081522L
4706,2019-08-08,특징주대웅제약152000원8일11시25분등락률629,http://www.getnews.co.kr/view.php?ud=201908081126141138c20b9ec572_16
4707,2019-08-08,대웅제약734상승중주가단기급락후반등시도,http://www.newspim.com/news/view/20190808001103
4708,2019-08-08,대웅제약주가오늘시세8일오늘거래가153500원거래,http://www.gokorea.kr/news/articleView.html?idxno=325098
4709,2019-08-08,일본약불매운동바람대웅제약일본산원료부터완제약까지좌불안석,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019080811330140580
4710,2019-08-08,스타★주식인사이드대웅제약주가153000원8월8일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=966231
4711,2019-08-08,8월8일장마감주가정보대웅제약153000원,http://www.newsinside.kr/news/articleView.html?idxno=966899
4712,2019-08-08,오늘Who전승호대웅제약제2의나보타될항궤양제개발에박차,http://www.businesspost.co.kr/BP?command=article_view&num=138765
4713,2019-08-09,★주식인사이드대웅제약주가154000원8월9일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=967912
4714,2019-08-09,8월9일대웅제약및증권시세및종목관련동향정보000변화해,http://www.gokorea.kr/news/articleView.html?idxno=328071
4715,2019-08-09,8월9일대웅제약배당주식065154000원,http://nbntv.co.kr/news/view/550329
4716,2019-08-09,스타★주식인사이드대웅제약주가155000원8월9일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=968746
4717,2019-08-09,8월9일장마감주가정보대웅제약154500원,http://www.newsinside.kr/news/articleView.html?idxno=969326
4718,2019-08-09,9일상장기업장마감정보대웅제약주가154500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=329899
4719,2019-08-09,인기주매매동향8월9일대웅제약154500원으로장마감,http://nbntv.co.kr/news/view/552694
4720,2019-08-10,대웅제약글로벌전초기지8곳캐시카우될까,http://www.dailypharm.com/Users/News/NewsView.html?ID=255566&REFERER=NP
4721,2019-08-11,상반기제약업계한미약품대웅제약맑음유한양행흐림,http://www.m-i.kr/news/articleView.html?idxno=629074
4722,2019-08-12,★주식인사이드대웅제약주가155000원8월12일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=972428
4723,2019-08-12,실시간주식현황대웅제약주가12일현재160500원,http://nbntv.co.kr/news/view/554757
4724,2019-08-12,대웅제약주가8월12일현재161500원정보,http://www.gokorea.kr/news/articleView.html?idxno=331680
4725,2019-08-12,스타★주식인사이드대웅제약주가161500원8월12일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=972917
4726,2019-08-12,대웅제약5이상상승주가상승세단기이평선역배열구간,https://www.hankyung.com/finance/article/201908129256L
4727,2019-08-12,제약업종내상승종목이수앱지스1296삼성바이오로직스631대웅제약518순,http://aitimes.co.kr/news/view/110044
4728,2019-08-12,제약업종마감시황상승률상위종목이수앱지스1064삼성바이오로직스724대웅제약550등,http://www.gokorea.kr/news/articleView.html?idxno=333054
4729,2019-08-12,8월12일장마감주가정보대웅제약163000원,http://www.newsinside.kr/news/articleView.html?idxno=973463
4730,2019-08-12,특징주분석종목정보12일대웅제약마감증시163000원,http://nbntv.co.kr/news/view/556853
4731,2019-08-13,대웅제약상반기순항1조클럽굳히기,http://www.dailian.co.kr/news/view/817595/?sc=naver
4732,2019-08-13,퀵리포트대웅제약강력매수유지목표가28만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019081308585514487
4733,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://biz.chosun.com/site/data/html_dir/2019/08/13/2019081300812.html
4734,2019-08-13,대웅제약폐섬유증치료제美FDA희귀의약품지정,https://view.asiae.co.kr/article/2019081309415169708
4735,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1328991
4736,2019-08-13,대웅제약FDA로부터폐섬유증치료제ODD지정RD가속,http://moneys.mt.co.kr/news/mwView.php?no=2019081309358051158
4737,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://fn.segye.com/content/html/2019/08/13/20190813503233.html?OutUrl=naver
4738,2019-08-13,대웅제약폐섬유증신약美FDA서희귀의약품지정,http://www.asiatime.co.kr/news/articleView.html?idxno=263728
4739,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.newspim.com/news/view/20190813000246
4740,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정”,https://www.sedaily.com/NewsView/1VMYCPUWCR
4741,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://health.chosun.com/site/data/html_dir/2019/08/13/2019081300875.html
4742,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정쾌거,http://www.koreaittimes.com/news/articleView.html?idxno=92350
4743,2019-08-13,대웅제약폐섬유증신약FDA희귀의약품지정,http://www.newstomato.com/ReadNews.aspx?no=913651
4744,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.viva100.com/main/view.php?key=20190813010003851
4745,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019081309582131205
4746,2019-08-13,대웅제약폐섬유증신약DWN12088미FDA희귀의약품지정,http://www.fnnews.com/news/201908130957475602
4747,2019-08-13,대웅제약폐섬유증혁신신약美FDA희귀의약품지정쾌거,http://www.medisobizanews.com/news/articleView.html?idxno=61768
4748,2019-08-13,대웅제약폐섬유증신약미FDA희귀의약품지정,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003684424
4749,2019-08-13,대웅제약폐섬유증신약후보물질미국FDA희귀약지정,http://yna.kr/AKR20190813050400017?did=1195m
4750,2019-08-13,대웅제약폐섬유증신약미국FDA희귀의약품지정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233771
4751,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.econovill.com/news/articleView.html?idxno=369598
4752,2019-08-13,美FDA대웅제약폐섬유증신약희귀의약품지정,http://news.mt.co.kr/mtview.php?no=2019081309473325101
4753,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.sisafocus.co.kr/news/articleView.html?idxno=217973
4754,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정쾌거달성,http://www.metroseoul.co.kr/news/newsview?newscd=2019081300041
4755,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.newsprime.co.kr/news/article.html?no=471304
4756,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.wsobi.com/news/articleView.html?idxno=79363
4757,2019-08-13,대웅제약폐섬유증신약후보물질미국FDA희귀약지정,http://www.asiatoday.co.kr/view.php?key=20190813010007007
4758,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://kormedi.com/?p=1299646
4759,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정쾌거,http://www.100ssd.co.kr/news/articleView.html?idxno=63396
4760,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.dailian.co.kr/news/view/817720/?sc=naver
4761,2019-08-13,대웅제약폐섬유증신약FDA희귀의약품지정,https://www.paxnetnews.com/articles/51305
4762,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1787574
4763,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.ajunews.com/view/20190813102914424
4764,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거,http://www.newswatch.kr/news/articleView.html?idxno=22441
4765,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.seoulwire.com/news/articleView.html?idxno=195737
4766,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.edaily.co.kr/news/newspath.asp?newsid=02581366622586992
4767,2019-08-13,대웅제약폐섬유증치료제美FDA희귀의약품지정,http://www.insightkorea.co.kr//news/articleView.html?idxno=50438
4768,2019-08-13,대웅제약폐섬유증신약후보물질미국FDA희귀약지정,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908130142&t=NN
4769,2019-08-13,대웅제약주식장13일현재167000원,http://nbntv.co.kr/news/view/558923
4770,2019-08-13,대웅제약폐섬유증신약DWN12088FDA희귀의약품지정,http://www.newsis.com/view/?id=NISX20190813_0000739501&cID=13001&pID=13000
4771,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,https://www.hankyung.com/it/article/201908131276f
4772,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정영예,http://www.segye.com/content/html/2019/08/13/20190813504684.html?OutUrl=naver
4773,2019-08-13,대웅제약폐섬유증신약DWN12088미국FDA희귀의약품지정,http://www.ezyeconomy.com/news/articleView.html?idxno=92995
4774,2019-08-13,제약업종내상승종목이수앱지스350대웅제약245녹십자홀딩스2우222순,http://aitimes.co.kr/news/view/111433
4775,2019-08-13,8월13일대웅제약069620증권그래프153변동해,http://www.gokorea.kr/news/articleView.html?idxno=334753
4776,2019-08-13,대웅제약특발성폐섬유증PRS저해제美ODD지정,http://www.biospectator.com/view/news_view.php?varAtcId=8251
4777,2019-08-13,대웅제약폐섬유증치료제美FDA희귀의약품지정신약허가심사비용면제등혜택,http://www.updownnews.co.kr/news/articleView.html?idxno=207143
4778,2019-08-13,대웅제약폐섬유증신약미FDA희귀의약품지정,http://www.bosa.co.kr/news/articleView.html?idxno=2110593
4779,2019-08-13,대웅제약폐섬유증신약미FDA희귀의약품지정,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1128292&REFERER=NP
4780,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.bokuennews.com/news/article.html?no=179526
4781,2019-08-13,대웅제약신약미국희귀의약품에지정전승호섬유질환연구확대,http://www.businesspost.co.kr/BP?command=article_view&num=139296
4782,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.ebn.co.kr/news/view/996983
4783,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.economytalk.kr/news/articleView.html?idxno=194266
4784,2019-08-13,美FDA대웅제약폐섬유증신약희귀의약품지정,http://www.dailymedi.com/detail.php?number=846313&thread=22r05
4785,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.etnews.com/20190813000181
4786,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://news.mk.co.kr/newsRead.php?year=2019&no=624271
4787,2019-08-13,대웅제약폐섬유증신약미국FDA희귀의약품지정,http://news.bizwatch.co.kr/article/consumer/2019/08/13/0008/naver
4788,2019-08-13,스타★주식인사이드대웅제약주가166500원8월13일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=975454
4789,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.nbnnews.co.kr/news/articleView.html?idxno=304740
4790,2019-08-13,대웅제약보툴리눔톡신미국에서첫분기매출28억수출늘어난다,http://www.businesspost.co.kr/BP?command=article_view&num=139319
4791,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://news.heraldcorp.com/view.php?ud=20190813000591
4792,2019-08-13,대웅제약폐섬유증신약후보물질DWN12088美희귀약지정,http://www.sportsseoul.com/news/read/804598
4793,2019-08-13,대웅제약폐섬유증신약DWN12088FDA희귀의약품지정,http://www.k-health.com/news/articleView.html?idxno=45072
4794,2019-08-13,대웅제약폐섬유증신약FDA희귀의약품지정 ,http://www.monews.co.kr/news/articleView.html?idxno=204366
4795,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.wolyo.co.kr/news/articleView.html?idxno=91158
4796,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://daily.hankooki.com/lpage/ittech/201908/dh20190813144025145630.htm
4797,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.wikileaks-kr.org/news/articleView.html?idxno=62811
4798,2019-08-13,대웅제약폐섬유증신약후보물질미국FDA희귀약지정,http://www.seoulfn.com/news/articleView.html?idxno=352539
4799,2019-08-13,대웅제약의특발성폐섬유증치료신약후보물질美FDA희귀의약품지정,http://news.mk.co.kr/newsRead.php?year=2019&no=624880
4800,2019-08-13,대웅제약폐섬유증신약FDA희귀의약품지정,http://sports.khan.co.kr/news/sk_index.html?art_id=201908131501003&sec_id=561801&pt=nv
4801,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.newsfc.co.kr/news/articleView.html?idxno=37436
4802,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.kpinews.co.kr/news/articleView.html?idxno=101155
4803,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.ceoscoredaily.com/news/article.html?no=59227
4804,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.medigatenews.com/news/2564202381
4805,2019-08-13,대웅제약먹는폐섬유증신약美FDA희귀의약품지정,http://www.donga.com/news/article/all/20190813/96950167/1
4806,2019-08-13,대웅제약폐섬유증혁신신약시선집중,http://www.whosaeng.com/111959
4807,2019-08-13,대웅제약폐섬유증신약미FDA희귀약지정,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87266
4808,2019-08-13,8월13일장마감주가정보대웅제약163500원,http://www.newsinside.kr/news/articleView.html?idxno=976017
4809,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.lawissue.co.kr/view.php?ud=20190813161321795204ead0791_12
4810,2019-08-13,뉴스워커_대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.newsworker.co.kr/news/articleView.html?idxno=36452
4811,2019-08-13,대웅제약폐섬유증신약후보물질미FDA희귀의약품지정쾌거,http://www.mdtoday.co.kr/mdtoday/index.html?no=362214
4812,2019-08-13,대웅제약폐섬유증신약DWN12088미국FDA희귀의약품지정,http://www.dailysmart.co.kr/news/articleView.html?idxno=14404
4813,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56737
4814,2019-08-13,대웅제약폐섬유증신약후보물질美FDA희귀약지정,http://www.dt.co.kr/contents.html?article_no=2019081302109931102002&ref=naver
4815,2019-08-13,전승호다국적제약사당뇨치료제넘어설대웅제약신약개발에박차,http://www.businesspost.co.kr/BP?command=article_view&num=139365
4816,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.joseilbo.com/news/news_read.php?uid=382115&class=27&grp=
4817,2019-08-13,13일주가마감정보대웅제약주가163500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=336566
4818,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.getnews.co.kr/view.php?ud=20190813174738490041d0c69529_16
4819,2019-08-13,인기종목주가정보13일대웅제약마감증시163500원,http://nbntv.co.kr/news/view/561032
4820,2019-08-13,대웅제약특발성폐섬유증신약미국FDA희귀의약품지정,http://www.fnnews.com/news/201908131826396661
4821,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.businesskorea.co.kr/news/articleView.html?idxno=34901
4822,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.newscj.com/news/articleView.html?idxno=659049
4823,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.thefirstmedia.net/news/articleView.html?idxno=47499
4824,2019-08-14,대웅제약나보타잘나가네美서한달반만에2만3000명시술”,https://www.sedaily.com/NewsView/1VMYT270Q7
4825,2019-08-14,대웅제약나보타美초반인기한달반만에2만3000명시술,http://www.dt.co.kr/contents.html?article_no=2019081402109931102001&ref=naver
4826,2019-08-14,대웅제약보톡스나보타미국서한달반만에2만3000명시술,http://www.asiatoday.co.kr/view.php?key=20190814010007662
4827,2019-08-14,★주식인사이드대웅제약주가162000원8월14일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=977349
4828,2019-08-14,대웅제약나보타미국출시한달반만에2만3000명시술,http://www.viva100.com/main/view.php?key=20190814010004301
4829,2019-08-14,8월14일대웅제약실시간주식현황092162000원,http://nbntv.co.kr/news/view/563235
4830,2019-08-14,대웅제약주가오늘시세14일오늘거래가162500원거래,http://www.gokorea.kr/news/articleView.html?idxno=338056
4831,2019-08-14,스타★주식인사이드대웅제약주가162000원8월14일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=978129
4832,2019-08-14,대웅제약세계최초혁신신약DWN12088美FDA희귀의약품지정,http://www.ftoday.co.kr/news/articleView.html?idxno=110617
4833,2019-08-14,8월14일장마감주가정보대웅제약162000원,http://www.newsinside.kr/news/articleView.html?idxno=978574
4834,2019-08-14,14일마감정보대웅제약162000원마감,http://www.gokorea.kr/news/articleView.html?idxno=339992
4835,2019-08-14,인기종목종목정보14일대웅제약마감증시162000원,http://nbntv.co.kr/news/view/565450
4836,2019-08-14,대웅제약특발성폐섬유증신약DWN12088미국FDA희귀의약품지정,http://www.econonews.co.kr/news/articleView.html?idxno=81475
4837,2019-08-14,코스피대웅제약반기누적매출액5563억원영업이익354억원연결기준,http://news.kmib.co.kr/article/view.asp?arcid=0013604920&code=61141211&cp=nv
4838,2019-08-14,실적속보대웅제약2Q영업이익227억전년비165↑,http://www.itooza.com/common/iview.php?no=2019081423361780370
4839,2019-08-15,대웅제약보툴리눔톡신해외경쟁우위선점,http://www.newstomato.com/ReadNews.aspx?no=914029
4840,2019-08-15,전승호대웅제약보툴리눔톡신나보타로탈모치료가능성찾아,http://www.businesspost.co.kr/BP?command=article_view&num=139654
4841,2019-08-16,대웅제약특발성폐섬유증치료신약美희귀의약품지정,http://weekly.cnbnews.com/news/article.html?no=129604
4842,2019-08-16,★주식인사이드대웅제약주가161000원8월16일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=981011
4843,2019-08-16,8월16일대웅제약오늘주식시세161500원031,http://nbntv.co.kr/news/view/567946
4844,2019-08-16,8월16일대웅제약069620종목그래프및종목동정과증시정보062변동,http://www.gokorea.kr/news/articleView.html?idxno=341889
4845,2019-08-16,스타★주식인사이드대웅제약주가161000원8월16일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=981456
4846,2019-08-16,8월16일장마감주가정보대웅제약162500원,http://www.newsinside.kr/news/articleView.html?idxno=981887
4847,2019-08-16,인기주종목정보8월16일대웅제약162500원으로장마감,http://nbntv.co.kr/news/view/570122
4848,2019-08-17,대웅제약상반기활짝올해최대실적기대,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071355
4849,2019-08-17,대웅제약美FDA로부터폐섬유증신약희귀의약품지정”,https://www.sedaily.com/NewsView/1VN07G4RBZ
4850,2019-08-18,국내보톡스업계희비대웅제약웃고메디톡스눈물,http://www.viva100.com/main/view.php?key=20190818010005136
4851,2019-08-19,대웅제약상반기매출11증가매출비RD비13,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233885
4852,2019-08-19,★주식인사이드대웅제약주가161500원8월19일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=985840
4853,2019-08-19,8월19일대웅제약오늘증시092161000원,http://nbntv.co.kr/news/view/572781
4854,2019-08-19,대웅제약주가종목그래프및주체별매매동향19일오늘거래가161000원거래,http://www.gokorea.kr/news/articleView.html?idxno=345525
4855,2019-08-19,스타★주식인사이드대웅제약주가162500원8월19일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=986560
4856,2019-08-19,대웅제약메디톡스보톡스포자감정종료곧승패나온다,http://www.finomy.com/news/articleView.html?idxno=68568
4857,2019-08-19,나보타업은대웅제약상반기굿올해최대실적찍나,http://www.ebn.co.kr/news/view/997564
4858,2019-08-19,8월19일장마감주가정보대웅제약163000원,http://www.newsinside.kr/news/articleView.html?idxno=987057
4859,2019-08-19,19일증시종목마감동향대웅제약163000원마감,http://www.gokorea.kr/news/articleView.html?idxno=347380
4860,2019-08-19,무더위뒤건강관리대웅제약임팩타민활성비타민으로구성,https://www.sedaily.com/NewsView/1VN15CZWUX
4861,2019-08-19,상장주매매동향19일대웅제약마감증시163000원,http://nbntv.co.kr/news/view/574905
4862,2019-08-20,최다기술수출제약바이오기업대웅제약최다국가미국,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233969
4863,2019-08-20,★주식인사이드대웅제약주가163000원8월20일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=987994
4864,2019-08-20,오늘주식시세대웅제약주가20일현재162500원,http://nbntv.co.kr/news/view/577043
4865,2019-08-20,대웅제약주가0696208월20일오늘가격162000원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=348659
4866,2019-08-20,스타★주식인사이드대웅제약주가162000원8월20일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=988443
4867,2019-08-20,대웅제약발달장애인질병증상이해도서참지마요기부,http://www.ebn.co.kr/news/view/997724
4868,2019-08-20,대웅제약참지마요도서기부발달장애인질병증상이해도울것”,https://www.sedaily.com/NewsView/1VN1LJ74WU
4869,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.newsway.co.kr/news/view?tp=1&ud=2019082015271815839
4870,2019-08-20,대웅제약발달장애인위한쉬운글도서참지마요기부,http://www.medisobizanews.com/news/articleView.html?idxno=61921
4871,2019-08-20,대웅제약발달장애인질병증상이해돕는도서참지마요기부,http://www.koreaittimes.com/news/articleView.html?idxno=92465
4872,2019-08-20,대웅제약발달장애인의료진간소통위한도서참지마요기부,http://www.wolyo.co.kr/news/articleView.html?idxno=91607
4873,2019-08-20,대웅제약발달장애증상이해돕는도서참치마요기부,http://www.mhj21.com/123633
4874,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.thefirstmedia.net/news/articleView.html?idxno=47651
4875,2019-08-20,대웅제약발달장애증상이해돕는도서참지마요4000권기부,http://www.newspim.com/news/view/20190820000931
4876,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.wsobi.com/news/articleView.html?idxno=79811
4877,2019-08-20,제약오늘대웅제약발달장애인질병증상이해돕는도서참지마요기부,http://www.sisaon.co.kr/news/articleView.html?idxno=99485
4878,2019-08-20,대웅제약발달장애인질병증상이해돕는도서참지마요기부,http://www.medigatenews.com/news/3041201799
4879,2019-08-20,대웅제약발달장애인질병증상이해돕는도서참지마요기부,http://www.newsprime.co.kr/news/article.html?no=472154
4880,2019-08-20,8월20일장마감주가정보대웅제약162500원,http://www.newsinside.kr/news/articleView.html?idxno=988942
4881,2019-08-20,대웅제약발달장애인질병증상이해돕는서적참지마요기부,http://www.asiatime.co.kr/news/articleView.html?idxno=265031
4882,2019-08-20,대웅제약발달장애인증상이해돕는도서참지마요기부,http://www.econovill.com/news/articleView.html?idxno=370123
4883,2019-08-20,대웅제약전국특수학교병의원에참지마요도서기부,http://daily.hankooki.com/lpage/ittech/201908/dh20190820160931145630.htm
4884,2019-08-20,대웅제약발달장애인위한도서4000권기부,http://news.mt.co.kr/mtview.php?no=2019082015380738749
4885,2019-08-20,대웅제약발달장애인위한책참지마요기부,http://www.bosa.co.kr/news/articleView.html?idxno=2110929
4886,2019-08-20,대웅제약나보타업고올해최대실적달성하나,http://fn.segye.com/content/html/2019/08/20/20190820509358.html?OutUrl=naver
4887,2019-08-20,대웅제약발달장애인질병증상이해돕는책참지마요기부,http://www.enewstoday.co.kr/news/articleView.html?idxno=1330423
4888,2019-08-20,대웅제약발달장애인의질병이해돕는도서참지마요기부,http://www.dailian.co.kr/news/view/819436/?sc=naver
4889,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://fn.segye.com/content/html/2019/08/20/20190820509840.html?OutUrl=naver
4890,2019-08-20,대웅제약발달장애인위한교육도서4000권기부,http://health.chosun.com/site/data/html_dir/2019/08/20/2019082001960.html
4891,2019-08-20,대웅제약발달장애인위한질병증상표현법담은도서참지마요기부,http://news.mk.co.kr/newsRead.php?year=2019&no=645515
4892,2019-08-20,대웅제약발달장애인위한도서참지마요4000권기부,http://sports.hankooki.com/lpage/economy/201908/sp20190820165757137020.htm
4893,2019-08-20,대웅제약발달장애인질병증상이해돕는도서참지마요기부,http://www.donga.com/news/article/all/20190820/97038836/1
4894,2019-08-20,대웅제약발달장애인위한쉬운글도서참지마요4000권기부,http://www.etoday.co.kr/news/section/newsview.php?idxno=1789998
4895,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.lawissue.co.kr/view.php?ud=201908201732501582204ead0791_12
4896,2019-08-20,대웅제약발달장애인과의소통을위한참지마요도서기부,http://www.newsfc.co.kr/news/articleView.html?idxno=37514
4897,2019-08-20,대웅제약발달장애인위한참지마요프로젝트진행,http://www.kpinews.co.kr/news/articleView.html?idxno=101572
4898,2019-08-20,20일코스닥코스피마감정보대웅제약주가162500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=350148
4899,2019-08-20,대웅제약발달장애인에도서수천권제공,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87387
4900,2019-08-20,발달장애인아프면참지마요대웅제약쉬운글도서제작,http://www.newsis.com/view/?id=NISX20190820_0000745828&cID=13001&pID=13000
4901,2019-08-20,대웅제약발달장애인증상이해돕는도서참지마요기부,http://www.metroseoul.co.kr/news/newsview?newscd=2019082000218
4902,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.businesskorea.co.kr/news/articleView.html?idxno=35105
4903,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.getnews.co.kr/view.php?ud=20190820185403194741d0c69529_16
4904,2019-08-20,특징주매매동향20일대웅제약마감증시162500원,http://nbntv.co.kr/news/view/579073
4905,2019-08-20,대웅제약발달장애이해높이는참지마요책기부,https://www.kpanews.co.kr/article/show.asp?idx=206115&category=D
4906,2019-08-20,셀트리온한미약품반기1000억이상RD투자유한양행GC녹십자대웅제약종근당JW중외제약도대폭늘려,http://www.econonews.co.kr/news/articleView.html?idxno=82387
4907,2019-08-21,대웅제약발달장애인위한질병증상표현법담은도서참지마요기부,http://www.nbnnews.co.kr/news/articleView.html?idxno=307352
4908,2019-08-21,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56819
4909,2019-08-21,대웅제약발달장애인질병증상이해위한책참지마요기부,http://www.sportsseoul.com/news/read/807648
4910,2019-08-21,★주식인사이드대웅제약주가163000원8월21일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=990066
4911,2019-08-21,참지마요대웅제약전국특수학교병원500곳에발달장애인돕는책기부,http://news.heraldcorp.com/view.php?ud=20190821000134
4912,2019-08-21,대웅제약발달장애인의질병증상이해돕는도서참지마요4000권기부,http://www.updownnews.co.kr/news/articleView.html?idxno=207402
4913,2019-08-21,8월21일대웅제약증권주식160500원123,http://nbntv.co.kr/news/view/581249
4914,2019-08-21,대웅제약주가8월21일오늘거래가160500원정보,http://www.gokorea.kr/news/articleView.html?idxno=351816
4915,2019-08-21,대웅제약발달장애인도서참지마요기부,http://www.dailymedi.com/detail.php?number=846571&thread=22r05
4916,2019-08-21,스타★주식인사이드대웅제약주가160000원8월21일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=990830
4917,2019-08-21,대웅제약발달장애인이해돕는도서참지마요전국특수학교및병의원에기부,http://www.ntoday.co.kr/news/articleView.html?idxno=68107
4918,2019-08-21,8월21일장마감주가정보대웅제약163000원,http://www.newsinside.kr/news/articleView.html?idxno=991257
4919,2019-08-21,대웅제약전국특수학교에서적참지마요기부,http://viewers.heraldcorp.com/news/articleView.html?idxno=42567
4920,2019-08-21,대웅제약전국특수학교병원에발달장애인돕는책기부,http://www.sisaweek.com/news/articleView.html?idxno=125449
4921,2019-08-21,21일마감주가정보대웅제약주가163000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=353724
4922,2019-08-21,상장주주가정보21일대웅제약마감증시163000원,http://nbntv.co.kr/news/view/583308
4923,2019-08-21,대웅제약발달장애인이해돕는도서참지마요기부,http://www.newscj.com/news/articleView.html?idxno=660999
4924,2019-08-22,★주식인사이드대웅제약주가164000원8월22일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=992025
4925,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234094
4926,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입,https://view.asiae.co.kr/article/2019082210232022406
4927,2019-08-22,대웅제약폐섬유증신약글로벌임상돌입,https://www.sedaily.com/NewsView/1VN2HFEXLK
4928,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2019082210254677127
4929,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.viva100.com/main/view.php?key=20190822010006700
4930,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://fn.segye.com/content/html/2019/08/22/20190822504626.html?OutUrl=naver
4931,2019-08-22,대웅제약폐섬유증신약9월호주임상1상본격돌입,http://moneys.mt.co.kr/news/mwView.php?no=2019082210228091914
4932,2019-08-22,대웅제약개발폐섬유증신약DWN12088글로벌임상1상돌입,http://www.newspim.com/news/view/20190822000395
4933,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1790649
4934,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.sisafocus.co.kr/news/articleView.html?idxno=218738
4935,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019082210290532316
4936,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입美FDA희귀의약품지정돼향후신속심사지원받아,http://www.segye.com/content/html/2019/08/22/20190822504794.html?OutUrl=naver
4937,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.dailysmart.co.kr/news/articleView.html?idxno=14648
4938,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상돌입,http://www.medisobizanews.com/news/articleView.html?idxno=61971
4939,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.ajunews.com/view/20190822103746377
4940,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.fnnews.com/news/201908221040097101
4941,2019-08-22,대웅제약폐섬유증신약미FDA희귀약달고글로벌첫발,http://www.econovill.com/news/articleView.html?idxno=370286
4942,2019-08-22,대웅제약9월폐섬유증신약후보물질글로벌임상1상돌입,http://www.edaily.co.kr/news/newspath.asp?newsid=02256646622589944
4943,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상돌입,http://www.asiatime.co.kr/news/articleView.html?idxno=265423
4944,2019-08-22,대웅제약DWN12088글로벌임상1상돌입,http://medipana.com/news/news_viewer.asp?NewsNum=244465&MainKind=A&NewsKind=5&vCount=12&vKind=1
4945,2019-08-22,대웅제약특발성폐섬유증신약글로벌임상돌입,http://www.mhj21.com/123704
4946,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://kormedi.com/?p=1300285
4947,2019-08-22,대웅제약간질성폐질환신약글로벌임상9월돌입,http://news.heraldcorp.com/view.php?ud=20190822000261
4948,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.enewstoday.co.kr/news/articleView.html?idxno=1330889
4949,2019-08-22,대웅제약폐섬유증신약호주1상9월돌입,http://www.dailypharm.com/Users/News/NewsView.html?ID=255973&REFERER=NP
4950,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상돌입,http://www.donga.com/news/article/all/20190822/97065516/1
4951,2019-08-22,대웅제약폐섬유증신약호주서임상1상승인,http://news.mt.co.kr/mtview.php?no=2019082210512930200
4952,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상돌입,http://www.newsprime.co.kr/news/article.html?no=472424
4953,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=362973
4954,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌1상돌입,http://www.bosa.co.kr/news/articleView.html?idxno=2111052
4955,2019-08-22,8월22일대웅제약주식증권092164500원,http://nbntv.co.kr/news/view/585299
4956,2019-08-22,대웅제약폐섬유증신약후보물질호주서임상1상승인,http://yna.kr/AKR20190822066800017?did=1195m
4957,2019-08-22,대웅제약세계최초PRS저해제글로벌임상1상돌입,http://daily.hankooki.com/lpage/ittech/201908/dh20190822111245145630.htm
4958,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://news1.kr/articles/?3701252
4959,2019-08-22,대웅제약특발성폐섬유증치료후보물질글로벌임상돌입예정,http://news.mk.co.kr/newsRead.php?year=2019&no=651866
4960,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상착수,http://www.newsis.com/view/?id=NISX20190822_0000747666&cID=13001&pID=13000
4961,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.ceoscoredaily.com/news/article.html?no=59527
4962,2019-08-22,대웅제약폐섬유증신약의글로벌임상1상9월부터시작,http://www.businesspost.co.kr/BP?command=article_view&num=140479
4963,2019-08-22,대웅제약PRS저해폐섬유증신약호주1상승인,http://www.biospectator.com/view/news_view.php?varAtcId=8314
4964,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,https://www.hankyung.com/it/article/201908220083f
4965,2019-08-22,대웅제약주가0696208월22일오늘거래가165000원및증권시세및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=355189
4966,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입 ,http://www.updownnews.co.kr/news/articleView.html?idxno=207453
4967,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입,http://www.economytalk.kr/news/articleView.html?idxno=195069
4968,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.dailian.co.kr/news/view/819956/?sc=naver
4969,2019-08-22,대웅제약폐섬유증신약글로벌임상1상착수,http://www.etnews.com/20190822000116
4970,2019-08-22,대웅제약폐섬유증신약호주서글로벌임상1상돌입,http://www.metroseoul.co.kr/news/newsview?newscd=2019082200060
4971,2019-08-22,대웅제약폐섬유증치료제글로벌임상1상돌입,http://www.finomy.com/news/articleView.html?idxno=68664
4972,2019-08-22,스타★주식인사이드대웅제약주가163500원8월22일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=992716
4973,2019-08-22,대웅제약폐섬유증신약DWN12088임상1상돌입,http://health.chosun.com/site/data/html_dir/2019/08/22/2019082201276.html
4974,2019-08-22,대웅제약개발폐섬유증신약호주임상승인,http://www.seoulfn.com/news/articleView.html?idxno=353365
4975,2019-08-22,대웅제약폐섬유증신약글로벌임상착수,http://www.insightkorea.co.kr//news/articleView.html?idxno=52781
4976,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://news.mk.co.kr/newsRead.php?year=2019&no=652513
4977,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.rpm9.com/news/article.html?id=20190822090019
4978,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.g-enews.com/ko-kr/news/article/news_all/201908221346457756aca1a8c21a_1/article.html
4979,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.lawissue.co.kr/view.php?ud=201908221401387799204ead0791_12
4980,2019-08-22,뉴스워커_대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.newsworker.co.kr/news/articleView.html?idxno=37450
4981,2019-08-22,대웅제약폐섬유증신약글로벌임상착수,http://www.kpinews.co.kr/news/articleView.html?idxno=101691
4982,2019-08-22,대웅제약폐섬유증신약올해9월글로벌임상시험돌입,http://biz.chosun.com/site/data/html_dir/2019/08/22/2019082201447.html
4983,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.getnews.co.kr/view.php?ud=20190822140927306941d0c69529_16
4984,2019-08-22,대웅제약폐섬유증신약후보물질호주서임상1상승인,http://www.youthdaily.co.kr/news/article.html?no=16019
4985,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.medigatenews.com/news/1639057961
4986,2019-08-22,대웅제약폐섬유증신약후보물질호주서임상1상승인,http://www.asiatoday.co.kr/view.php?key=20190822010012363
4987,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56855
4988,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.bokuennews.com/news/article.html?no=179789
4989,2019-08-22,대웅제약폐섬유증신약호주서임상1상돌입,http://www.mediapen.com/news/view/456564
4990,2019-08-22,대웅제약페섬유증신약9월글로벌임상돌입,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908220298&t=NN
4991,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.wolyo.co.kr/news/articleView.html?idxno=91804
4992,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.wsobi.com/news/articleView.html?idxno=79977
4993,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://inthenews.co.kr/article-13286/
4994,2019-08-22,대웅제약폐섬유증치료신약글로벌임상착수,http://www.shinailbo.co.kr/news/articleView.html?idxno=1197095
4995,2019-08-22,대웅제약신약DWN12088글로벌임상1상돌입,http://www.joseilbo.com/news/news_read.php?uid=382572&class=17&grp=
4996,2019-08-22,8월22일장마감주가정보대웅제약163500원,http://www.newsinside.kr/news/articleView.html?idxno=993109
4997,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.seoulwire.com/news/articleView.html?idxno=202909
4998,2019-08-22,대웅제약나보타미국수출성장견인,https://www.paxnetnews.com/articles/51596
4999,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입,http://www.monews.co.kr/news/articleView.html?idxno=204529
5000,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.thefirstmedia.net/news/articleView.html?idxno=47729
5001,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상올9월본격돌입,http://www.newswatch.kr/news/articleView.html?idxno=22748
5002,2019-08-22,특징주분석매매동향8월22일대웅제약163500원으로장마감,http://nbntv.co.kr/news/view/587429
5003,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.businesskorea.co.kr/news/articleView.html?idxno=35222
5004,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌1상돌입,https://www.kpanews.co.kr/article/show.asp?idx=206170&category=D
5005,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.newscj.com/news/articleView.html?idxno=661276
5006,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입,http://www.ebn.co.kr/news/view/998133
5007,2019-08-22,대웅제약폐섬유증신약후보물질호주서임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3919448
5008,2019-08-23,★주식인사이드대웅제약주가162000원8월23일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=993946
5009,2019-08-23,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.nbnnews.co.kr/news/articleView.html?idxno=308422
5010,2019-08-23,대웅제약특발성폐섬유증신약DWN12088글로벌임상1상돌입,http://www.ftoday.co.kr/news/articleView.html?idxno=110826
5011,2019-08-23,대웅제약특발성폐섬유증신약DWN12088해외임상1상돌입,http://www.ezyeconomy.com/news/articleView.html?idxno=93209
5012,2019-08-23,8월23일대웅제약주식현황162500원061,http://nbntv.co.kr/news/view/589572
5013,2019-08-23,8월23일대웅제약069620종목그래프061변동,http://www.gokorea.kr/news/articleView.html?idxno=358470
5014,2019-08-23,대웅제약폐섬유증신약글로벌임상돌입호주서1상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071551
5015,2019-08-23,대웅제약특발성폐섬유증신약후보물질호주서임상1상승인,http://www.rapportian.com/news/articleView.html?idxno=119516
5016,2019-08-23,스타★주식인사이드대웅제약주가162500원8월23일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=994372
5017,2019-08-23,8월23일장마감주가정보대웅제약162500원,http://www.newsinside.kr/news/articleView.html?idxno=994802
5018,2019-08-23,23일주식장마감동향대웅제약162500원마감,http://www.gokorea.kr/news/articleView.html?idxno=360429
5019,2019-08-23,특징주종목정보23일대웅제약마감증시162500원,http://nbntv.co.kr/news/view/591708
5020,2019-08-26,퀵리포트대웅제약매수유지목표가22만원유지키움證,http://www.itooza.com/common/iview.php?no=2019082609152014287
5021,2019-08-26,대웅제약2년내보톡스시장점유율2위달성이가능할듯”,http://www.wikitree.co.kr/main/news_view.php?id=457232
5022,2019-08-26,8월26일대웅제약주식현황215159000원,http://nbntv.co.kr/news/view/594010
5023,2019-08-26,스타★주식인사이드대웅제약주가159500원8월26일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=997509
5024,2019-08-26,대웅제약공격적마케팅으로미국보톡시시장점유율2위달성가능,http://www.businesspost.co.kr/BP?command=article_view&num=140918
5025,2019-08-26,8월26일장마감주가정보대웅제약157000원,http://www.newsinside.kr/news/articleView.html?idxno=997951
5026,2019-08-26,26일주가마감정보대웅제약157000원마감,http://www.gokorea.kr/news/articleView.html?idxno=363858
5027,2019-08-26,인기주분석종목정보8월26일대웅제약157000원으로장마감,http://nbntv.co.kr/news/view/596091
5028,2019-08-27,대웅제약심혈관계질환치료제임상3상진입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234227
5029,2019-08-27,★주식인사이드대웅제약주가158500원8월27일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=999041
5030,2019-08-27,8월27일대웅제약증권매매096155500원,http://nbntv.co.kr/news/view/597791
5031,2019-08-27,8월27일대웅제약및증권시세159변화해,http://www.gokorea.kr/news/articleView.html?idxno=365212
5032,2019-08-27,스타★주식인사이드대웅제약주가153500원8월27일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=999451
5033,2019-08-27,8월27일장마감주가정보대웅제약153500원,http://www.newsinside.kr/news/articleView.html?idxno=999964
5034,2019-08-27,27일마감정보대웅제약153500원마감,http://www.gokorea.kr/news/articleView.html?idxno=367088
5035,2019-08-27,27일기관순매도Top10현대차583억대덕전자32억대웅제약24억대상17억외국인순매도나서코스닥시장에서는헬릭스미스케이엠더블유테스상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=65127
5036,2019-08-28,대웅제약넥스트나보타연구개발에역량집중,http://www.rapportian.com/news/articleView.html?idxno=119609
5037,2019-08-28,전승호미국에서나보타순항으로대웅제약해외사업자신감커져,http://www.businesspost.co.kr/BP?command=article_view&num=141137
5038,2019-08-28,대웅제약폐섬유증혁신신약내달호주서글로벌임상돌입,http://news.heraldcorp.com/view.php?ud=20190828000490
5039,2019-08-28,대웅제약주가종목그래프외매매동향28일현재150000원,http://www.gokorea.kr/news/articleView.html?idxno=368529
5040,2019-08-28,스타★주식인사이드대웅제약주가152000원8월28일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1001721
5041,2019-08-28,실시간분석대웅제약32상승증권사목표가22만원제시,http://www.itooza.com/common/iview.php?no=2019082814083515911
5042,2019-08-28,인기종목종목정보8월27일대웅제약153500원으로장마감,http://nbntv.co.kr/news/view/599895
5043,2019-08-28,8월28일대웅제약오늘증권시세150000원228,http://nbntv.co.kr/news/view/602078
5044,2019-08-28,대웅제약폐섬유증신약글로벌임상,http://news.mk.co.kr/newsRead.php?year=2019&no=673748
5045,2019-08-29,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.doctorsnews.co.kr/news/articleView.html?idxno=130722
5046,2019-08-29,★주식인사이드대웅제약주가157000원8월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1003225
5047,2019-08-29,희귀의약품분야에본격뛰어든대웅제약,http://www.edaily.co.kr/news/newspath.asp?newsid=02050006622592240
5048,2019-08-29,시세보기대웅제약주가29일현재156500원,http://nbntv.co.kr/news/view/606228
5049,2019-08-29,대웅제약주가8월29일오늘가격157000원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=371468
5050,2019-08-29,스타★주식인사이드대웅제약주가159000원8월29일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1003609
5051,2019-08-29,8월29일장마감주가정보대웅제약157500원,http://www.newsinside.kr/news/articleView.html?idxno=1004084
5052,2019-08-29,29일마감증시대웅제약157500원마감,http://www.gokorea.kr/news/articleView.html?idxno=373392
5053,2019-08-29,인기종목종목정보8월29일대웅제약157500원으로장마감,http://nbntv.co.kr/news/view/608372
5054,2019-08-30,대웅제약나보타포자나왔다메디톡스균주와달라1보,http://news1.kr/articles/?3707837
5055,2019-08-30,대웅제약나보타균주메디톡스제품과달라포자형성확인,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019083008561184522
5056,2019-08-30,대웅제약상승출발508이시각거래량5762주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908300059&t=NN
5057,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234379
5058,2019-08-30,대웅제약나보타포자형성확인메디톡스와달라속보,http://www.newstomato.com/ReadNews.aspx?no=917122
5059,2019-08-30,대웅제약급등전일대비857↑,http://www.newspim.com/news/view/20190830000102
5060,2019-08-30,대웅제약보툴리눔톡신균주포자형성메디톡스균주와다른것으로나타나,http://www.ceoscoredaily.com/news/article.html?no=59884
5061,2019-08-30,대웅제약5이상상승최근3일간기관대량순매도,https://www.hankyung.com/finance/article/201908308330L
5062,2019-08-30,대웅제약균주메디톡스와달라포자감정시험서입증,http://www.newsway.co.kr/news/view?tp=1&ud=2019083009065978687
5063,2019-08-30,특징주대웅제약보톡스소송에유리한분석결과나와강세,http://news.mk.co.kr/newsRead.php?year=2019&no=679689
5064,2019-08-30,★주식인사이드대웅제약주가170500원8월30일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1005190
5065,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적입증,http://medipana.com/news/news_viewer.asp?NewsNum=244795&MainKind=A&NewsKind=5&vCount=12&vKind=1
5066,2019-08-30,3년끈보톡스분쟁종지부찍나대웅제약메디톡스균주와다르다는것입증,http://biz.chosun.com/site/data/html_dir/2019/08/30/2019083000795.html
5067,2019-08-30,대웅제약나보타균주메디톡스와달라포자감정시험입증”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1793601
5068,2019-08-30,대웅제약균주메디톡스와달라포자감정으로입증,http://www.dailypharm.com/Users/News/NewsView.html?ID=256234&REFERER=NP
5069,2019-08-30,특징주대웅제약균주논란종결발표에강세,http://news.mt.co.kr/mtview.php?no=2019083009125564546
5070,2019-08-30,대웅제약나보타균주포자감정결과메디톡스균주와다른점입증돼,http://news.mk.co.kr/newsRead.php?year=2019&no=679732
5071,2019-08-30,대웅제약포자감정통해메디톡스균주와다름입증”,http://www.ajunews.com/view/20190830090058062
5072,2019-08-30,대웅제약메디톡스와보톡스균주달랐다,http://daily.hankooki.com/lpage/ittech/201908/dh20190830091839145630.htm
5073,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.fnnews.com/news/201908300920004995
5074,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.fnnews.com/news/201908300920004995
5075,2019-08-30,특징주대웅제약메디톡스와보톡스균주달라강세,http://www.asiatime.co.kr/news/articleView.html?idxno=267198
5076,2019-08-30,대웅제약나보타균주메디톡스와다르다는것명백히입증민형사상책임물을것,http://www.sisafocus.co.kr/news/articleView.html?idxno=219541
5077,2019-08-30,대웅제약메디톡스와균주달라포자감정시험통해과학적으로입증,http://www.segye.com/content/html/2019/08/30/20190830503128.html?OutUrl=naver
5078,2019-08-30,대웅제약포자형성확인메디톡스균주안훔쳤다,http://www.newsis.com/view/?id=NISX20190830_0000755693&cID=13001&pID=13000
5079,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://news.mk.co.kr/newsRead.php?year=2019&no=679803
5080,2019-08-30,대웅제약나보타균주메디톡스와달라포자감정시험서입증,http://www.seoulwire.com/news/articleView.html?idxno=208026
5081,2019-08-30,대웅제약나보타균주메디톡스와달라메디톡스에법적책임을물을것”,http://moneys.mt.co.kr/news/mwView.php?no=2019083009168013779
5082,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.lawissue.co.kr/view.php?ud=201908300930469790204ead0791_12
5083,2019-08-30,특징주대웅제약보톡스소송승소가능성에강세,http://www.ebn.co.kr/news/view/999164
5084,2019-08-30,특징주대웅제약보톡스소송유리한분석결과에강세,http://www.dailian.co.kr/news/view/822057/?sc=naver
5085,2019-08-30,대웅제약나보타포자형성확인메디톡스와달라,http://www.newspim.com/news/view/20190830000127
5086,2019-08-30,특징주대웅제약메디톡스와다른균주입증에강세,http://www.inews24.com/view/1205343
5087,2019-08-30,대웅제약나보타포자감정시험결과발표메디톡스와달라책임물을것상보,http://www.newstomato.com/ReadNews.aspx?no=917130
5088,2019-08-30,대웅제약나보타포자형성선명메디톡신과다름입증상보,http://news1.kr/articles/?3707903
5089,2019-08-30,대웅제약보툴리눔분쟁승소눈앞메디톡스것과다르다”확인,http://news.heraldcorp.com/view.php?ud=20190830000146
5090,2019-08-30,뉴스워커_대웅제약대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.newsworker.co.kr/news/articleView.html?idxno=38508
5091,2019-08-30,특징주대웅제약보톡스소송유리한분석결과에상승세,http://news1.kr/articles/?3707906
5092,2019-08-30,fnRASSI대웅제약571오르며거래량증가,http://www.fnnews.com/news/201908300941534793
5093,2019-08-30,대웅제약보툴리눔균주포자형성확인메디톡스에민형사책임물을것”,https://www.sedaily.com/NewsView/1VN65PS1JZ
5094,2019-08-30,대웅제약보툴리눔균주메디톡스와달라포자감정서입증,http://yna.kr/AKR20190830037200017?did=1195m
5095,2019-08-30,나보타균주포자형성대웅제약메디톡스출처논쟁종결되나,http://www.sportsseoul.com/news/read/812321
5096,2019-08-30,대웅제약균주메디톡스와달랐다”포자감정통해입증,http://www.dailian.co.kr/news/view/822050/?sc=naver
5097,2019-08-30,대웅제약보톡스민사소송유리한결과발표에강세특징주,http://www.kukinews.com/news/article.html?no=696460
5098,2019-08-30,대웅제약메디톡스와보톡스균주소송서결정적승기잡아,http://www.edaily.co.kr/news/newspath.asp?newsid=01882726622592568
5099,2019-08-30,법원대웅제약균주메디톡스와다르다결론,http://www.bosa.co.kr/news/articleView.html?idxno=2111501
5100,2019-08-30,특징주대웅제약메디톡스와다른균주입증8급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1793653
5101,2019-08-30,대웅제약나보타포자메디톡스균주와달라”검증시험서포자형성,http://www.viva100.com/main/view.php?key=20190830010009671
5102,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.betanews.net:8080/article/1045474.html
5103,2019-08-30,대웅제약메디톡스에민형사책임물을것,http://www.whosaeng.com/112305
5104,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=14991
5105,2019-08-30,대웅제약균주서포자생성확인메디톡스와다른균주,http://www.medisobizanews.com/news/articleView.html?idxno=62148
5106,2019-08-30,특징주대웅제약메디톡스와다른보톡스균주입증에급등,http://www.fntimes.com/html/view.php?ud=2019083009555223606c0eb6f11e_18
5107,2019-08-30,대웅제약나보타포자형성선명메디톡신과다름입증상보,http://www.fntoday.co.kr/news/articleView.html?idxno=201356
5108,2019-08-30,대웅제약메디톡스대웅제약발표이후희비엇갈려대웅제약급등VS메디톡스급락,http://www.econonews.co.kr/news/articleView.html?idxno=83979
5109,2019-08-30,특징주대웅제약메디톡스보톡스소송분석결과에명암,http://moneys.mt.co.kr/news/mwView.php?no=2019083010178022551
5110,2019-08-30,대웅제약균주입증소식에상승곡선,http://www.mdtoday.co.kr/mdtoday/index.html?no=363672
5111,2019-08-30,대웅제약균주전쟁서결정적승기잡아메디톡스와달라상보,http://www.newsis.com/view/?id=NISX20190830_0000755789&cID=13001&pID=13000
5112,2019-08-30,제약업종오전시황상승률상위종목현성바이탈1074대웅제약984대웅730등,http://www.gokorea.kr/news/articleView.html?idxno=374520
5113,2019-08-30,대웅제약보툴리눔균주메디톡스와다르다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908300156&t=NN
5114,2019-08-30,특징주대웅제약균주메디톡스와다르다는소식에강세,http://www.newsway.co.kr/news/view?tp=1&ud=2019083010225312865
5115,2019-08-30,균주포자형성입증한대웅제약명백한메디톡스음해,https://www.paxnetnews.com/articles/51782
5116,2019-08-30,대웅제약균주메디톡스와다르다,http://www.koreaittimes.com/news/articleView.html?idxno=92687
5117,2019-08-30,대웅제약자사보톨리눔톡신균주메디톡스와다르다”,http://www.kukinews.com/news/article.html?no=696498
5118,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.getnews.co.kr/view.php?ud=20190830102927947741d0c69529_16
5119,2019-08-30,특징주대웅제약보톡스원료도용논란일축에강세,http://yna.kr/AKR20190830056800008?did=1195m
5120,2019-08-30,대웅제약메디톡스균주포자형성하지않아,http://www.bokuennews.com/news/article.html?no=180137
5121,2019-08-30,대웅제약나보타균주메디톡스와다르다포자감정시험서포자형성,http://www.newsprime.co.kr/news/article.html?no=473398
5122,2019-08-30,대웅제약메디톡스와균주다르다”포자감정서입증,http://health.chosun.com/site/data/html_dir/2019/08/30/2019083001172.html
5123,2019-08-30,대웅제약균주포자감정시험통해메디톡스와다른것확인,http://www.asiatime.co.kr/news/articleView.html?idxno=267200
5124,2019-08-30,대웅제약보톡스원료도용논란일축에급등메디톡스는약세,http://www.seoulwire.com/news/articleView.html?idxno=208143
5125,2019-08-30,머니e종목대웅제약메디톡스와다른보톡스균주입증에상승,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019083010501994126
5126,2019-08-30,주식증권대웅제약주가30일현재175000원,http://nbntv.co.kr/news/view/610566
5127,2019-08-30,메디톡스대웅제약균주입증소식에하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=363686
5128,2019-08-30,메디톡스대웅제약혐의는ITC에제출되는균주조사결과로완벽히밝혀질것,http://www.ceoscoredaily.com/news/article.html?no=59902
5129,2019-08-30,특징주대웅제약보톡스원료도용논란해명에상승세,http://www.ajunews.com/view/20190830105314178
5130,2019-08-30,대웅제약나보타균주메디톡스균주와다르다,http://www.econovill.com/news/articleView.html?idxno=370921
5131,2019-08-30,메디톡스대웅제약혐의미국ITC에제출되는균주조사결과로밝혀질것,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56981
5132,2019-08-30,메디톡스대웅제약포자감정시험편협한해석동의할수없어,http://www.newspim.com/news/view/20190830000610
5133,2019-08-30,대웅제약보툴리눔균주시험결과메디톡스와별개포자입증,http://www.kyeongin.com/main/view.php?key=20190830001110285
5134,2019-08-30,대웅제약나보타균주메디톡스와달라메디톡스美ITC에희망,http://biz.newdaily.co.kr/site/data/html/2019/08/30/2019083000072.html
5135,2019-08-30,승기잡은대웅제약떨어지는메디톡스기다릴이벤트는,http://news.mt.co.kr/mtview.php?no=2019083010163296746
5136,2019-08-30,특징주대웅제약보톡스소송유리한분석결과에강세,http://www.asiatoday.co.kr/view.php?key=20190830010017073
5137,2019-08-30,대웅제약도용혐의9월20일드러날것,http://www.whosaeng.com/112306
5138,2019-08-30,메디톡스대웅제약에반격美ITC균주조사까지지켜봐야,http://daily.hankooki.com/lpage/ittech/201908/dh20190830112923145630.htm
5139,2019-08-30,대웅제약주가0696208월30일오늘거래가172000원종목그래프및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=374882
5140,2019-08-30,제약업종11시현재주식시황상승률상위종목대웅제약14500원921대웅1100원698코스맥스엔비티450원630,http://www.cctvnews.co.kr/news/articleView.html?idxno=134484
5141,2019-08-30,대웅제약나보타균주메디톡스와다르다”포자감정시험서포자형성,http://inthenews.co.kr/article-14333/
5142,2019-08-30,대웅제약포자감정에서독자균주입증메디톡스美서진실규명,https://www.ytn.co.kr/_ln/0103_201908301134014604
5143,2019-08-30,포자형성이가른향배대웅제약균주도용의혹해명,http://www.mhj21.com/123931
5144,2019-08-30,메디톡스대웅제약모든혐의美ITC통해밝혀질것반박,http://www.econovill.com/news/articleView.html?idxno=370929
5145,2019-08-30,대웅제약보툴리눔균주메디톡스와달라포자감정서입증,https://view.asiae.co.kr/article/2019083011362403928
5146,2019-08-30,나보타균주출처논란해소한대웅제약탄탄대로달리나,http://medipana.com/news/news_viewer.asp?NewsNum=244818&MainKind=A&NewsKind=5&vCount=12&vKind=1
5147,2019-08-30,대웅제약나보타균주메디톡스와달라포자감정시험으로입증,http://www.metroseoul.co.kr/news/newsview?newscd=2019083000050
5148,2019-08-30,대웅제약메디톡스균주와달라포자검증서입증종합,https://view.asiae.co.kr/article/2019083011495852628
5149,2019-08-30,대웅제약균주메디톡스와달라과학적으로입증,http://www.economytalk.kr/news/articleView.html?idxno=196106
5150,2019-08-30,대웅제약포자소송서승기메디톡스ITC서밝혀질것종합,http://news1.kr/articles/?3708118
5151,2019-08-30,대웅제약나보타균주메디톡스균주와달라vs메디톡스美ITC조사로밝혀질것,http://www.updownnews.co.kr/news/articleView.html?idxno=207822
5152,2019-08-30,한미가로지른대웅제약메디톡스전쟁최종결판언제종합,http://www.newsis.com/view/?id=NISX20190830_0000755984&cID=13001&pID=13000
5153,2019-08-30,대웅제약나보타균주메디톡스균주와다르다,http://www.dailymedi.com/detail.php?number=846921&thread=22r05
5154,2019-08-30,특징주대웅제약↑vs메디톡스↓보톡스논란일단락,http://www.enewstoday.co.kr/news/articleView.html?idxno=1332664
5155,2019-08-30,대웅제약보톡스법정다툼에서메디톡스이겼다,http://www.newsfc.co.kr/news/articleView.html?idxno=37659
5156,2019-08-30,대웅제약보툴리눔균주포자감정시험결과메디톡스와달라,http://www.joseilbo.com/news/news_read.php?uid=383088&class=27&grp=
5157,2019-08-30,메디톡스대웅제약주장은일부만부각한편협한해석절대동의못해,http://www.sisafocus.co.kr/news/articleView.html?idxno=219564
5158,2019-08-30,대웅제약보톡스균주포자형성확인메디톡스균주와달라,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071795
5159,2019-08-30,메디톡스대웅제약도용혐의여전미국서명확히밝혀질것,http://www.sportsseoul.com/news/read/812439
5160,2019-08-30,스타★주식인사이드대웅제약주가169500원8월30일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1005784
5161,2019-08-30,메디톡신대웅제약에아직끝나지않았다,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87589
5162,2019-08-30,대웅제약메디톡스와보톡스전쟁서승기,http://news.bizwatch.co.kr/article/consumer/2019/08/30/0009/naver
5163,2019-08-30,종합대웅제약메디톡스와다른균주입증VS메디톡스美ITC서진실규명,http://www.etoday.co.kr/news/section/newsview.php?idxno=1793728
5164,2019-08-30,메디톡스대웅제약혐의美ITC균주조사로밝혀질것”,http://www.viva100.com/main/view.php?key=20190830010009785
5165,2019-08-30,메디톡스대웅제약혐의내달미국ITC결과로완벽히밝혀질것,http://www.ajunews.com/view/20190830134611257
5166,2019-08-30,제약업종오후시황상승률상위종목현성바이탈906대웅제약667코스맥스엔비티616등,http://www.gokorea.kr/news/articleView.html?idxno=375697
5167,2019-08-30,메디톡스미국ITC균주조사결과로대웅제약혐의밝힐것,http://www.dailian.co.kr/news/view/822117/?sc=naver
5168,2019-08-30,대웅제약보톡스원료도용논란일축에주가강세,http://www.ggilbo.com/news/articleView.html?idxno=699096
5169,2019-08-30,대웅제약보툴리눔톡신균주포자감정에서메디톡스와다름확인,http://www.businesspost.co.kr/BP?command=article_view&num=141583
5170,2019-08-30,특징주보톡스균주포자감정결과에대웅제약메디톡스희비엇갈려,http://news.mk.co.kr/newsRead.php?year=2019&no=681372
5171,2019-08-30,제약업종14시현재주식시황상승률상위종목대웅제약11000원698현성바이탈195원654씨케이에이치19원635,http://www.cctvnews.co.kr/news/articleView.html?idxno=134607
5172,2019-08-30,대웅제약주가상승세보톡스소송관련입장발표,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20190830.99099013304
5173,2019-08-30,대웅제약나보타균주포자생성확인메디톡스에민형사상책임물을것,http://www.sporbiz.co.kr/news/articleView.html?idxno=371041
5174,2019-08-30,Talk쏘는종목오이솔루션대웅제약삼륭물산GOvsSTOP,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019083014062143115
5175,2019-08-30,간장약은우루사옛말셀트리온제약뜨고대웅제약지고,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019083013535757862
5176,2019-08-30,대웅제약나보타균주포자형성메디톡스와다른균주입증,http://www.rapportian.com/news/articleView.html?idxno=119694
5177,2019-08-30,메디톡스균주와달라대웅제약나보타균주포자형성확인,http://www.ezyeconomy.com/news/articleView.html?idxno=93408
5178,2019-08-30,대웅제약포자감정서메디톡스와다른균주입증,https://www.hankyung.com/it/article/201908309563f
5179,2019-08-30,대웅제약메디톡스와4년째보톡스분쟁서승기잡나,http://www.insightkorea.co.kr//news/articleView.html?idxno=54622
5180,2019-08-30,특징주대웅제약보톡스원료도용논란일축에강세종합,http://yna.kr/AKR20190830056851008?did=1195m
5181,2019-08-30,메디톡스일부만부각한편협한해석대웅제약반박,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908300398&t=NN
5182,2019-08-30,8월30일장마감주가정보대웅제약167500원,http://www.newsinside.kr/news/articleView.html?idxno=1006281
5183,2019-08-30,제약업종마감시황상승률상위종목코스맥스엔비티644대웅제약635씨케이에이치569등,http://www.gokorea.kr/news/articleView.html?idxno=376450
5184,2019-08-30,대웅제약균주포자로다름입증vs메디톡스인정못해,http://www.newspim.com/news/view/20190830001058
5185,2019-08-30,탐나는키워드대웅제약균주논란해소로주가탄탄대로,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019083015482260663
5186,2019-08-30,대웅제약보톡스균주입증소식에상승마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=363727
5187,2019-08-30,대웅제약vs메디톡스보톡스전쟁재발,http://www.seoulfn.com/news/articleView.html?idxno=354383
5188,2019-08-30,대웅제약균주포자형성으로메디톡스와다른균주입증,http://www.news2day.co.kr/135573
5189,2019-08-30,대웅제약보톡스분쟁서승기잡아포자형성,http://www.finomy.com/news/articleView.html?idxno=68949
5190,2019-08-30,30일장마감증권시세대웅제약167500원마감,http://www.gokorea.kr/news/articleView.html?idxno=376802
5191,2019-08-30,대웅제약메티톡스균주와서로다름증명독자생산입증,http://www.100ssd.co.kr/news/articleView.html?idxno=63849
5192,2019-08-30,대웅제약포자감정시험서메디톡스와다른균주입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1332785
5193,2019-08-30,대웅제약포자감정에서독자균주입증메디톡스美서진실규명,https://science.ytn.co.kr/program/program_view.php?s_mcd=0082&s_hcd=&key=201908301646387616
5194,2019-08-30,대웅제약균주포자생성한다메디톡스와달라,http://www.ftoday.co.kr/news/articleView.html?idxno=111044
5195,2019-08-30,나보타균주전쟁대웅제약선승균주조사결과촉각,http://www.shinailbo.co.kr/news/articleView.html?idxno=1199697
5196,2019-08-30,균주전쟁승기잡은대웅제약메디톡스美ITC결과기다려야,http://www.ntoday.co.kr/news/articleView.html?idxno=68295
5197,2019-08-30,3년끈보톡스분쟁대웅제약유리한고지점령,http://news.mk.co.kr/newsRead.php?year=2019&no=682514
5198,2019-08-30,상장주매매동향8월30일대웅제약167500원으로장마감,http://nbntv.co.kr/news/view/612693
5199,2019-08-30,전승호균주분쟁벗어나대웅제약나보타점유율확대공격앞으로,http://www.businesspost.co.kr/BP?command=article_view&num=141639
5200,2019-08-30,대웅제약메디톡스와균주다르다포자감정서입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=311480
5201,2019-08-30,대웅제약보툴리눔균주메디톡스와달라메디톡스美서진실규명할것,https://cnbc.sbs.co.kr/article_hub/10000953685?division=NAVER
5202,2019-08-30,메디톡스미국ITC에제출되는균주조사결과로대웅제약혐의완벽히밝혀질것,http://www.thefirstmedia.net/news/articleView.html?idxno=47986
5203,2019-08-30,대웅제약균주포자감정시험통해과학적으로입증밝혀,http://www.thefirstmedia.net/news/articleView.html?idxno=47990
5204,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.newscj.com/news/articleView.html?idxno=663382
5205,2019-08-31,대웅제약메디톡스와보툴리눔톡신균주달라포자감정시험으로과학적입증,http://www.g-enews.com/ko-kr/news/article/news_all/20190830152054781469d76442fa_1/article.html
5206,2019-08-31,대웅제약독자균주입증메디톡스美서진실규명,https://www.ytn.co.kr/_ln/0103_201908310041571517
5207,2019-08-31,대웅제약나보타균주출처포자검증서입증메디톡스ITC서진실밝힐것,http://www.mdtoday.co.kr/mdtoday/index.html?no=363730
5208,2019-08-31,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://www.ekn.kr/news/article.html?no=450759
5209,2019-08-31,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://www.tourtimes.net/120387
5210,2019-08-31,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://newsbrite.net/125830
5211,2019-08-31,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://newsbrite.net/125823
5212,2019-08-31,대웅제약vs메디톡스질긴악연의고리,https://www.sedaily.com/NewsView/1VN6N06P9T
5213,2019-09-01,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.idjnews.kr/news/articleView.html?idxno=89834
5214,2019-09-01,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://www.lawissue.co.kr/view.php?ud=2019083102401459326cf2d78c68_12
5215,2019-09-01,끝이보이는보톡스전쟁대웅제약승기잡나,http://www.sporbiz.co.kr/news/articleView.html?idxno=371251
5216,2019-09-01,절정치닫는보톡스분쟁대웅제약승기잡았다,http://www.skyedaily.com/news/news_view.html?ID=89632
5217,2019-09-01,대웅제약메디톡스서로다른균주소송전행방은,http://www.monews.co.kr/news/articleView.html?idxno=204688
5218,2019-09-01,대웅제약보툴리늄톡신생산사용균주포자형성확인메디톡스균주안훔쳤다,http://www.econonews.co.kr/news/articleView.html?idxno=84293
5219,2019-09-02,매출라이벌대웅제약종근당임상시험도맞대결,http://www.sportsseoul.com/news/read/813292
5220,2019-09-02,클릭e종목대웅제약균주소송우려해소,https://view.asiae.co.kr/article/2019090208013032323
5221,2019-09-02,대웅제약균주논란해소KTB투자증권,http://news.mt.co.kr/mtview.php?no=2019090207583655741
5222,2019-09-02,대웅제약균주소송우려해소강력매수,https://www.sedaily.com/NewsView/1VO38IKCL0
5223,2019-09-02,대웅제약균주소송우려해소에불확실성감소매수KTB증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1794125
5224,2019-09-02,하이로우대웅제약보톡스균주소송우려해소KTB투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019090208235219141
5225,2019-09-02,대웅제약주식상승가능보툴리눔톡신균주소송불확실성해소,http://www.businesspost.co.kr/BP?command=article_view&num=141780
5226,2019-09-02,대웅제약나보타균주논란해소전망KTB증권,http://www.seoulfn.com/news/articleView.html?idxno=354478
5227,2019-09-02,대웅제약균주소송우려해소KTB,http://www.fnnews.com/news/201909020833338637
5228,2019-09-02,HotLine대웅제약균주출처소송우려해소돼,http://news.mk.co.kr/newsRead.php?year=2019&no=686347
5229,2019-09-02,메디톡스대웅제약균주분쟁이달말ITC감정결과에주목”한국투자증권,http://www.fntimes.com/html/view.php?ud=201909020842097964f09e13944d_18
5230,2019-09-02,대웅제약균주소송우려해소로주가긍정적KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01584246622616184
5231,2019-09-02,가장혁신적인제약사20위권에한미약품대웅제약랭크,http://www.beyondpost.co.kr/view.php?ud=2019090208454951646a9e4dd7f_30
5232,2019-09-02,퀵리포트대웅제약매수로상향목표가10↑22만원DB금투,http://www.itooza.com/common/iview.php?no=2019090208584413177
5233,2019-09-02,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.gnmaeil.com/news/articleView.html?idxno=425126
5234,2019-09-02,한미약품대웅제약가장혁신적인제약사20위권랭크,http://www.newsis.com/view/?id=NISX20190901_0000757032&cID=13001&pID=13000
5235,2019-09-02,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.beyondpost.co.kr/view.php?ud=201908310242586436cf2d78c68_30
5236,2019-09-02,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.kidstvnews.co.kr/view.php?ud=2019083102421078346cf2d78c68_29
5237,2019-09-02,대웅제약폐섬유증신약글로벌임상1상돌입,http://weekly.hankooki.com/lpage/economy/201909/wk20190902090035146390.htm
5238,2019-09-02,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://www.thebigdata.co.kr/view.php?ud=2019083102410985246cf2d78c68_23
5239,2019-09-02,한미약품대웅제약APAC의혁신적인대형제약사20위권등극,http://biz.newdaily.co.kr/site/data/html/2019/09/02/2019090200007.html
5240,2019-09-02,APAC제약혁신랭킹한미약품대웅제약등포함,http://www.ebn.co.kr/news/view/999313
5241,2019-09-02,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://www.ksmnews.co.kr/default/index_view_page.php?idx=261239&part_idx=373
5242,2019-09-02,퀵리포트대웅제약강력매수유지목표가28만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019090208060811959
5243,2019-09-02,KTB투자대웅제약균주소송우려해소펀더멘탈개선전망”,http://www.sentv.co.kr/news/view/559869
5244,2019-09-02,대웅제약주가불확실성해소KTB투자증권,http://www.ajunews.com/view/20190902083535176
5245,2019-09-02,★주식인사이드대웅제약주가171000원9월2일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1009941
5246,2019-09-02,실시간분석대웅제약32상승증권사목표가22만원제시,http://www.itooza.com/common/iview.php?no=2019090209163113957
5247,2019-09-02,한미약품대웅제약제넥신휴온스APAC혁신제약사상위20위권내올라,http://www.medigatenews.com/news/1717109172
5248,2019-09-02,특징주보톡스균주논란일단락대웅제약메디톡스강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01846646622616184
5249,2019-09-02,메디톡스대웅제약의균주소송영향제한적,http://www.sisafocus.co.kr/news/articleView.html?idxno=219706
5250,2019-09-02,리포트브리핑대웅제약유리한고지를선점목표가220000원DB금융투자,http://www.newspim.com/news/view/20190902000147
5251,2019-09-02,GET투자리포트대웅제약투자의견매수상향DB금융투자,http://www.getnews.co.kr/view.php?ud=2019090210303010760tpgetnews_16
5252,2019-09-02,한미약품대웅제약등혁신제약사분야에올라,http://www.bosa.co.kr/news/articleView.html?idxno=2111552
5253,2019-09-02,한미약품대웅제약APAC혁신제약사20위권랭크,http://www.seoulwire.com/news/articleView.html?idxno=209397
5254,2019-09-02,KTB증권보톡스논란벗어난대웅제약강력매수의견,http://www.enewstoday.co.kr/news/articleView.html?idxno=1332978
5255,2019-09-02,대웅제약메디톡스모두매수세쏟아지며상승특히대웅제약전날급등이어강세,http://www.econonews.co.kr/news/articleView.html?idxno=84379
5256,2019-09-02,GET투자리포트대웅제약투자의견매수KB증권,http://www.getnews.co.kr/view.php?ud=2019083010303010782tpgetnews_16
5257,2019-09-02,대웅제약메디톡스와의균주도용의혹민사소송에서유리한고지를선점”,http://www.wikitree.co.kr/main/news_view.php?id=459497
5258,2019-09-02,9월2일대웅제약주식종목170500원179,http://nbntv.co.kr/news/view/615279
5259,2019-09-02,보톡스균주논란에도대웅제약메디톡스장중동반강세,http://www.choicenews.co.kr/news/articleView.html?idxno=63838
5260,2019-09-02,클래리베이트분석아시아혁신제약사한미약품대웅제약20위권,http://news1.kr/articles/?3709729
5261,2019-09-02,9월2일대웅제약증권투자정보및주식시황209변동해,http://www.gokorea.kr/news/articleView.html?idxno=378618
5262,2019-09-02,루프린경쟁자대웅제약특허무효소송패소,http://www.dailypharm.com/Users/News/NewsView.html?ID=256304&REFERER=NP
5263,2019-09-02,한미약품대웅제약아태지역혁신제약사선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1200149
5264,2019-09-02,스타★주식인사이드대웅제약주가171000원9월2일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1010646
5265,2019-09-02,대웅제약나보타균주출처포자검증서입증메디톡스도나란히上,http://www.mdtoday.co.kr/mdtoday/index.html?no=363827
5266,2019-09-02,대웅제약보톡스균주논란일단락에주가↑DB금융매수로상향,http://www.whitepaper.co.kr/news/articleView.html?idxno=171270
5267,2019-09-02,아태지역혁신제약사에한미약품대웅제약각각1112위올라,http://www.sisajournal-e.com/news/articleView.html?idxno=205515
5268,2019-09-02,대웅제약국내민사소송결과가가시화되면ITC소송역시긍정적인방향으로”,http://www.wikitree.co.kr/main/news_view.php?id=459685
5269,2019-09-02,대웅제약RD강화로넥스타나보타기대높인다,http://www.newspim.com/news/view/20190902000822
5270,2019-09-02,공정위2일오전대웅제약본사상대조사,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019090215501427942
5271,2019-09-02,9월2일장마감주가정보대웅제약170000원,http://www.newsinside.kr/news/articleView.html?idxno=1011143
5272,2019-09-02,승기잡은대웅제약메디톡스와보툴리눔톡신전쟁끝내나,http://www.g-enews.com/ko-kr/news/article/news_all/2019090216042432269d76442fa_1/article.html
5273,2019-09-02,대웅제약신기업문화로밀레니얼세대와通한다,http://www.ebn.co.kr/news/view/999552
5274,2019-09-02,대웅제약메디톡스균주논란ITC결과까지가봐야,http://www.newsis.com/view/?id=NISX20190902_0000758350&cID=13001&pID=13000
5275,2019-09-02,대웅제약메디톡스균주전쟁끝나나,http://www.economytalk.kr/news/articleView.html?idxno=196428
5276,2019-09-02,대웅제약심혈관현대약품치매제약사들임상3상잇달아진입,https://www.hankyung.com/it/article/2019090246081
5277,2019-09-02,2일증시종목마감동향대웅제약170000원마감,http://www.gokorea.kr/news/articleView.html?idxno=380549
5278,2019-09-02,IR52장영실상시지바이오대웅제약망상골형골이식재,http://news.mk.co.kr/newsRead.php?year=2019&no=690099
5279,2019-09-02,상장주주가정보9월2일대웅제약170000원으로장마감,http://nbntv.co.kr/news/view/617358
5280,2019-09-02,소송우려일단락대웅제약반등채비,http://www.fnnews.com/news/201909021807248109
5281,2019-09-02,대웅제약vs메디톡스보톡스균주도용20일ITC소송분수령,http://www.dt.co.kr/contents.html?article_no=2019090302101531102001&ref=naver
5282,2019-09-02,보툴리눔균주포자감정시험결과대웅제약vs메디톡스,http://medicalworldnews.co.kr/news/view.php?idx=1510932252
5283,2019-09-03,대웅제약루프린6개월지속제형무효심서패소,http://www.mdtoday.co.kr/mdtoday/index.html?no=363873
5284,2019-09-03,★주식인사이드대웅제약주가170500원9월3일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1012218
5285,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.dailysmart.co.kr/news/articleView.html?idxno=15115
5286,2019-09-03,대웅제약한국제약바이오산업채용박람회참가,http://www.ebn.co.kr/news/view/999659
5287,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.metroseoul.co.kr/news/newsview?newscd=2019090300034
5288,2019-09-03,대웅제약2019제약바이오산업채용박람회참가현장면접도,http://www.medisobizanews.com/news/articleView.html?idxno=62233
5289,2019-09-03,공정위대웅제약현장조사역지불합의사유,http://www.sisajournal-e.com/news/articleView.html?idxno=205548
5290,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.newsway.co.kr/news/view?tp=1&ud=2019090310431945671
5291,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가현장면접통해우수인재찾아하반기상시채용서류면제혜택제공,http://www.segye.com/content/html/2019/09/03/20190903505011.html?OutUrl=naver
5292,2019-09-03,증권주식대웅제약주가3일현재167000원,http://nbntv.co.kr/news/view/619497
5293,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.lawissue.co.kr/view.php?ud=201909031056507261204ead0791_12
5294,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://medipana.com/news/news_viewer.asp?NewsNum=244940&MainKind=A&NewsKind=5&vCount=12&vKind=1
5295,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://sports.hankooki.com/lpage/economy/201909/sp20190903111223137020.htm
5296,2019-09-03,뉴스워커_대웅제약 2019한국제약바이오산업채용박람회참가,http://www.newsworker.co.kr/news/articleView.html?idxno=40024
5297,2019-09-03,대웅제약제약바이오산업채용박람회참가현장면접진행,http://www.newsprime.co.kr/news/article.html?no=473808
5298,2019-09-03,대웅제약이원하는인재직무기업이해도높은사람,http://news.mt.co.kr/mtview.php?no=2019090310523261805
5299,2019-09-03,9월3일대웅제약오늘시세206,http://www.gokorea.kr/news/articleView.html?idxno=382016
5300,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.bokuennews.com/news/article.html?no=180308
5301,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.betanews.net:8080/article/1046696.html
5302,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.newswatch.kr/news/articleView.html?idxno=23079
5303,2019-09-03,스타★주식인사이드대웅제약주가168500원9월3일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1012944
5304,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57030
5305,2019-09-03,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.gukjenews.com/news/articleView.html?idxno=1166567
5306,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://fn.segye.com/content/html/2019/09/03/20190903507442.html?OutUrl=naver
5307,2019-09-03,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.fntoday.co.kr/news/articleView.html?idxno=202022
5308,2019-09-03,대웅제약한국제약바이오산업채용박람회참가,http://www.asiatime.co.kr/news/articleView.html?idxno=268000
5309,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.wolyo.co.kr/news/articleView.html?idxno=92636
5310,2019-09-03,대웅제약제약바이오산업채용박람회참가,http://www.finomy.com/news/articleView.html?idxno=69036
5311,2019-09-03,대웅제약vs메디톡스보톡스전쟁종지부찍을까3년소송전승자는,http://ilyo.co.kr/?ac=article_view&entry_id=346423
5312,2019-09-03,쉴때도일할때도제대로밀레니얼세대눈길사로잡는대웅제약의기업문화,http://www.businesskorea.co.kr/news/articleView.html?idxno=35628
5313,2019-09-03,대웅제약제약바이오산업채용박람회참가해우수인재확보나서,http://news.mk.co.kr/newsRead.php?year=2019&no=693448
5314,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.viva100.com/main/view.php?key=20190903010001068
5315,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가국내외인재적극발굴,http://www.ntoday.co.kr/news/articleView.html?idxno=68325
5316,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.straightnews.co.kr/news/articleView.html?idxno=54838
5317,2019-09-03,나보타끌고OTC밀고대웅제약방긋,http://www.econovill.com/news/articleView.html?idxno=371211
5318,2019-09-03,9월3일장마감주가정보대웅제약167000원,http://www.newsinside.kr/news/articleView.html?idxno=1013472
5319,2019-09-03,대웅제약제약바이오산업채용박람회참가현장면접진행,http://www.seoulwire.com/news/articleView.html?idxno=211155
5320,2019-09-03,3일주식장마감동향대웅제약주가167000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=383949
5321,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.joseilbo.com/news/news_read.php?uid=383329&class=17&grp=
5322,2019-09-03,대웅제약제약바이오산업채용박람회참가해우수인재확보나섰다,http://www.nbnnews.co.kr/news/articleView.html?idxno=312858
5323,2019-09-03,상장주매매동향9월3일대웅제약167000원으로장마감,http://nbntv.co.kr/news/view/621661
5324,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.newscj.com/news/articleView.html?idxno=664399
5325,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3928591
5326,2019-09-04,대웅제약2019한국제약바이오산업채용박람회참가,http://www.thefirstmedia.net/news/articleView.html?idxno=48126
5327,2019-09-04,대웅제약2019한국제약바이오산업채용박람회참가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1333492
5328,2019-09-04,대웅제약2019한국제약바이오산업채용박람회참가,http://www.wsobi.com/news/articleView.html?idxno=80668
5329,2019-09-04,올해들어허가취소2131품목대웅제약64품목최다,http://medipana.com/news/news_viewer.asp?NewsNum=245013&MainKind=A&NewsKind=5&vCount=12&vKind=1
5330,2019-09-04,9월4일대웅제약주가차트167000원000,http://nbntv.co.kr/news/view/624448
5331,2019-09-04,9월4일대웅제약투자주식000167000원,http://nbntv.co.kr/news/view/624473
5332,2019-09-04,스타★주식인사이드대웅제약주가165500원9월4일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1015111
5333,2019-09-04,대웅제약주가오늘시세및주식시황4일오늘거래가165500원거래,http://www.gokorea.kr/news/articleView.html?idxno=386119
5334,2019-09-04,9월4일대웅제약069620오늘시세060변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=386140
5335,2019-09-04,단독대웅제약나보타ITC시험서도포자형성확인,http://news.mt.co.kr/mtview.php?no=2019090413411448788
5336,2019-09-04,대웅제약메디톡스보톡스균주와다름입증증권가매수제시,http://www.whitepaper.co.kr/news/articleView.html?idxno=171688
5337,2019-09-04,9월4일장마감주가정보대웅제약171000원,http://www.newsinside.kr/news/articleView.html?idxno=1015613
5338,2019-09-04,4일장마감증권시세대웅제약주가171000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=388577
5339,2019-09-04,특징주주가정보4일대웅제약마감증시171000원,http://nbntv.co.kr/news/view/627788
5340,2019-09-05,대웅제약우루사우리몸의공장간기능살려체내노폐물배출촉진,http://news.mk.co.kr/newsRead.php?year=2019&no=700002
5341,2019-09-05,퀵리포트대웅제약매수유지목표가9↑24만원삼성證,http://www.itooza.com/common/iview.php?no=2019090507303122898
5342,2019-09-05,대웅제약美ITC소송감정시험서도균주포자형성확인,http://www.ebn.co.kr/news/view/999995
5343,2019-09-05,★주식인사이드대웅제약주가170000원9월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1016381
5344,2019-09-05,대웅제약나보타미국ITC소송감정에서도포자형성1보,http://news1.kr/articles/?3712855
5345,2019-09-05,대웅제약미국ITC소송의감정시험에서도포자형성입증,http://www.dailian.co.kr/news/view/823676/?sc=naver
5346,2019-09-05,대웅제약美ITC소송감정시험에서도균주포자형성확인,http://www.segye.com/content/html/2019/09/05/20190905503583.html?OutUrl=naver
5347,2019-09-05,대웅제약美ITC소송감정시험서도균주포자형성확인,http://www.viva100.com/main/view.php?key=20190905010001754
5348,2019-09-05,대웅제약美ITC소송감정시험서도 자사균주 포자형성  ,http://www.medisobizanews.com/news/articleView.html?idxno=62288
5349,2019-09-05,대웅제약美ITC소송서나보타균주포자형성확인,http://www.kpinews.co.kr/news/articleView.html?idxno=102609
5350,2019-09-05,보톡스분쟁대웅제약나보타미국ITC소송감정시험균주포자형성확인,http://biz.chosun.com/site/data/html_dir/2019/09/05/2019090500788.html
5351,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성확인,https://www.sedaily.com/NewsView/1VO4LY0IVZ
5352,2019-09-05,대웅제약美ITC감정시험에서도메디톡스와다른균주규명”,http://www.ajunews.com/view/20190905092847119
5353,2019-09-05,미국ITC감정서도대웅제약메디톡스균주달랐다,http://news.heraldcorp.com/view.php?ud=20190905000148
5354,2019-09-05,대웅제약美ITC소송감정시험에서도균주포자형성확인,http://medipana.com/news/news_viewer.asp?NewsNum=245051&MainKind=A&NewsKind=5&vCount=12&vKind=1
5355,2019-09-05,대웅제약美ITC소송감정시험서도균주의포자형성확인,http://www.newsway.co.kr/news/view?tp=1&ud=2019090509340113198
5356,2019-09-05,대웅제약미국ITC소송서도균주포자형성확인,http://www.newsis.com/view/?id=NISX20190905_0000761570&cID=13001&pID=13000
5357,2019-09-05,대웅제약美ITC시험서도포자형성확인,https://view.asiae.co.kr/article/2019090509394431547
5358,2019-09-05,대웅제약관계사디엔컴퍼니추석선물세트준비다양한혜택까지,http://moneys.mt.co.kr/news/mwView.php?no=2019090509278019502
5359,2019-09-05,대웅제약美ITC소송감정시험서균주의포자형성확인,http://www.asiatime.co.kr/news/articleView.html?idxno=268592
5360,2019-09-05,GET투자리포트대웅제약투자의견매수삼성증권,http://www.getnews.co.kr/view.php?ud=2019090410303010841tpgetnews_16
5361,2019-09-05,대웅제약미국ITC소송서도균주포자형성확인메디톡스균주와다르다,http://moneys.mt.co.kr/news/mwView.php?no=2019090509358050875
5362,2019-09-05,대웅제약우리균포자형성입증메디톡스와다르다”,http://www.hankookilbo.com/news/npath/201909050941066100?did=NA
5363,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성확인,http://www.kukinews.com/news/article.html?no=698367
5364,2019-09-05,대웅제약美ITC감정인이나보타균주포자형성확인”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1795728
5365,2019-09-05,보톡스전쟁승기잡은대웅제약美소송감정시험서도포자형성확인,http://www.newspim.com/news/view/20190905000198
5366,2019-09-05,대웅제약미국ITC소송서나보타균주포자형성확인,http://www.econovill.com/news/articleView.html?idxno=371377
5367,2019-09-05,대웅제약미국ITC소송서균주포자형성확인,http://www.newsprime.co.kr/news/article.html?no=474143
5368,2019-09-05,대웅제약미국ITC소송서도균주포자형성확인,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019090510165226544
5369,2019-09-05,대웅제약미ITC소송감정서도대웅균주포자형성,http://www.bosa.co.kr/news/articleView.html?idxno=2111884
5370,2019-09-05,대웅제약미국ITC소송의감정시험서도균주의포자형성확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=364152
5371,2019-09-05,대웅제약하고싶은거다해혁신기업문화,http://www.newspost.kr/news/articleView.html?idxno=72974
5372,2019-09-05,투자종목삼성證대웅제약美향나보타수출순조롭게확대중,http://www.newswatch.kr/news/articleView.html?idxno=23156
5373,2019-09-05,대웅제약美ITC소송감정시험서균주포자형성확인,http://www.ceoscoredaily.com/news/article.html?no=60111
5374,2019-09-05,추석특집추석명절과식으로더부룩한속에는대웅제약베아제,http://www.metroseoul.co.kr/news/newsview?newscd=2019090500047
5375,2019-09-05,대웅제약보툴리눔균주미국ITC소송에서도포자형성,http://www.sportsseoul.com/news/read/815152
5376,2019-09-05,대웅제약美ITC감정에서도균주포자형성확인,http://news.mk.co.kr/newsRead.php?year=2019&no=701177
5377,2019-09-05,대웅제약메디톡스균주소송서유리한고지선점,http://www.dailymedi.com/detail.php?number=847098&thread=22r05
5378,2019-09-05,대웅제약미국ITC소송의감정시험통해균주의포자형성을확인,http://www.updownnews.co.kr/news/articleView.html?idxno=208080
5379,2019-09-05,리포트브리핑대웅제약2019KBKoreaConference참가기업BUYKB증권,http://www.newspim.com/news/view/20190905000440
5380,2019-09-05,대웅제약美ITC소송감정시험서균주포자형성확인,http://www.seoulwire.com/news/articleView.html?idxno=212366
5381,2019-09-05,GET투자리포트대웅제약투자의견매수KB증권,http://www.getnews.co.kr/view.php?ud=2019090510303010881tpgetnews_16
5382,2019-09-05,대웅제약디엔컴퍼니셀리시스EX이지듀에스테메드등추석선물세트출시최대60할인,http://www.ezyeconomy.com/news/articleView.html?idxno=93565
5383,2019-09-05,대웅제약보톡스미국소송서도포자형성주장,http://www.edaily.co.kr/news/newspath.asp?newsid=02253366622617168
5384,2019-09-05,대웅제약ITC소송감정에서도균주명확하게포자형성,http://www.rapportian.com/news/articleView.html?idxno=119809
5385,2019-09-05,주식주가대웅제약주가5일현재169500원,http://nbntv.co.kr/news/view/629972
5386,2019-09-05,대웅제약미국ITC소송감정시험에서도균주의포자형성확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57072
5387,2019-09-05,보툴리눔균주출처논란대웅제약미국ITC서도승기,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1128749&REFERER=NP
5388,2019-09-05,대웅제약美ITC소송감정시험에서균주포자형성확인염기서열도불일치,http://www.ezyeconomy.com/news/articleView.html?idxno=93568
5389,2019-09-05,대웅제약미국ITC소송감정시험에서도균주포자형성확인,http://www.businesskorea.co.kr/news/articleView.html?idxno=35727
5390,2019-09-05,대웅제약주가0696209월5일오늘가격169000원증권투자정보외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=390687
5391,2019-09-05,대웅제약나보타균주리스크완전해소기대감,http://medipana.com/news/news_viewer.asp?NewsNum=245066&MainKind=A&NewsKind=5&vCount=12&vKind=1
5392,2019-09-05,대웅제약메디톡스3년걸친보톡스전쟁끝나나,http://www.skyedaily.com/news/news_view.html?ID=89932
5393,2019-09-05,대웅제약美ITC소송서도균주포자형성확인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071977
5394,2019-09-05,스타★주식인사이드대웅제약주가169000원9월5일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1016792
5395,2019-09-05,대웅제약ITC감정서도포자형성”남은건염기서열검증,http://www.news2day.co.kr/136044
5396,2019-09-05,대웅제약미국ITC소송서균주포자형성확인,http://www.nbnnews.co.kr/news/articleView.html?idxno=313769
5397,2019-09-05,대웅제약보툴리눔톡신균주분쟁해소로나보타가치평가받아,http://www.businesspost.co.kr/BP?command=article_view&num=142328
5398,2019-09-05,대웅제약나보타균주포자생성거듭주장메디톡스신뢰할수없다,https://www.hankyung.com/finance/article/2019090526356
5399,2019-09-05,대웅제약미국보툴리눔톡신균주소송에서도메디톡스에승기잡아,http://www.businesspost.co.kr/BP?command=article_view&num=142343
5400,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성을확인,http://www.lawissue.co.kr/view.php?ud=201909051443452659204ead0791_12
5401,2019-09-05,대웅제약미국ITC소송서도균주의포자형성확인,http://www.economytalk.kr/news/articleView.html?idxno=196807
5402,2019-09-05,점입가경보톡스전쟁대웅제약美ITC도포자확인”VS메디톡스대웅의말장난”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1795971
5403,2019-09-05,대웅제약미국ITC소송감정시험에서도균주포자형성확인,http://www.ftoday.co.kr/news/articleView.html?idxno=111175
5404,2019-09-05,대웅제약美ITC소송서도균주포자형성확인,http://www.whosaeng.com/112442
5405,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성을확인,http://www.newswatch.kr/news/articleView.html?idxno=23170
5406,2019-09-05,대웅제약미국ITC소송시험서균주포자형성확인,http://www.seoulfn.com/news/articleView.html?idxno=355066
5407,2019-09-05,9월5일장마감주가정보대웅제약168500원,http://www.newsinside.kr/news/articleView.html?idxno=1017248
5408,2019-09-05,뉴스워커_대웅제약 미국ITC소송의감정시험에서도균주의포자형성을확인,http://www.newsworker.co.kr/news/articleView.html?idxno=40489
5409,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성확인,http://www.betanews.net:8080/article/1047711.html
5410,2019-09-05,대웅제약ITC감정서도포자형성확인염기서열결과에촉각,http://sports.hankooki.com/lpage/economy/201909/sp20190905164315137020.htm
5411,2019-09-05,5일마감주가정보대웅제약주가168500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=392299
5412,2019-09-05,대웅제약美ITC소송의감정서도나보타균주의포자형성확인돼,http://news.mk.co.kr/newsRead.php?year=2019&no=704065
5413,2019-09-05,인기주매매동향5일대웅제약마감증시168500원,http://nbntv.co.kr/news/view/632088
5414,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성확인,http://www.getnews.co.kr/view.php?ud=20190905181248941041d0c69529_16
5415,2019-09-05,대웅제약미국ITC시험서도균주포자형성확인,http://www.newscj.com/news/articleView.html?idxno=665045
5416,2019-09-06,대웅제약미국ITC소송감정시험에서균주의포자형성확인,http://www.thefirstmedia.net/news/articleView.html?idxno=48222
5417,2019-09-06,★주식인사이드대웅제약주가168000원9월6일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1018285
5418,2019-09-06,대웅제약VS메디톡스균주포자생성유무가핵심쟁점,http://inthenews.co.kr/article-15232/
5419,2019-09-06,대웅제약나보타美ITC소송감정시험통해균주포자형성확인,http://www.donga.com/news/article/all/20190906/97303347/1
5420,2019-09-06,대웅제약美ITC소송의감정시험에서도균주포자형성확인,http://www.wsobi.com/news/articleView.html?idxno=80813
5421,2019-09-06,대웅제약주식종목6일현재167000원,http://nbntv.co.kr/news/view/634230
5422,2019-09-06,9월6일대웅제약증권그래프000변화,http://www.gokorea.kr/news/articleView.html?idxno=393814
5423,2019-09-06,스타★주식인사이드대웅제약주가168500원9월6일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=1019034
5424,2019-09-06,9월6일장마감주가정보대웅제약169000원,http://www.newsinside.kr/news/articleView.html?idxno=1019504
5425,2019-09-06,인기종목주가정보9월6일대웅제약169000원으로장마감,http://nbntv.co.kr/news/view/636361
5426,2019-09-06,대웅제약미국ITC소송감정서도균주포자확인,https://www.kpanews.co.kr/article/show.asp?idx=206532&category=D
5427,2019-09-08,대웅제약나보타미국진출후가동률업계1위등극,http://www.ceoscoredaily.com/news/article.html?no=60195
5428,2019-09-09,대웅제약vs메디톡스균주전쟁최종결론은언제쯤,http://www.dailian.co.kr/news/view/824232/?sc=naver
5429,2019-09-09,종국으로치닫는보톡스전쟁1R대웅제약이웃었다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1334430
5430,2019-09-09,★주식인사이드대웅제약주가168500원9월9일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1022381
5431,2019-09-09,9월9일대웅제약주식현재가167000원118,http://nbntv.co.kr/news/view/638889
5432,2019-09-09,대웅제약주가069620정보및종목동정과증시정보9일오늘가격166000원,http://www.gokorea.kr/news/articleView.html?idxno=397379
5433,2019-09-09,스타★주식인사이드대웅제약주가165500원9월9일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=1022634
5434,2019-09-09,9월9일장마감주가정보대웅제약166000원,http://www.newsinside.kr/news/articleView.html?idxno=1023120
5435,2019-09-09,인기주종목정보9월9일대웅제약166000원으로장마감,http://nbntv.co.kr/news/view/641002
5436,2019-09-10,대웅제약나보타탈모치료임상승인5번째적응증기대,http://www.medisobizanews.com/news/articleView.html?idxno=62367
5437,2019-09-10,★주식인사이드대웅제약주가167000원9월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1024447
5438,2019-09-10,증권플러스대웅제약주가10일현재165500원,http://nbntv.co.kr/news/view/642271
5439,2019-09-10,9월10일대웅제약종목그래프및증권정보와종목동정000변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=400640
5440,2019-09-10,스타★주식인사이드대웅제약주가165500원9월10일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1025237
5441,2019-09-10,기업은지원하고직원은성장하고대웅제약의남다른기업문화,http://www.dailysmart.co.kr/news/articleView.html?idxno=15450
5442,2019-09-10,9월10일장마감주가정보대웅제약165000원,http://www.newsinside.kr/news/articleView.html?idxno=1025683
5443,2019-09-10,10일장마감매매동향대웅제약165000원마감,http://www.gokorea.kr/news/articleView.html?idxno=402501
5444,2019-09-11,대웅제약나보타탈모치료도국내2b상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072153
5445,2019-09-11,★주식인사이드대웅제약주가166500원9월11일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1026986
5446,2019-09-11,9월11일대웅제약오늘주식시세165500원030,http://nbntv.co.kr/news/view/645524
5447,2019-09-11,대웅제약주가오늘시세외매매동향11일오늘가격166000원거래,http://www.gokorea.kr/news/articleView.html?idxno=403992
5448,2019-09-11,스타★주식인사이드대웅제약주가166000원9월11일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1027708
5449,2019-09-11,대웅제약상시공개채용실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=364687
5450,2019-09-11,글로벌헬스케어산업이끌맞춤형인재찾는다대웅제약 상시채용실시,http://www.businesskorea.co.kr/news/articleView.html?idxno=35944
5451,2019-09-11,대웅제약상시채용실시글로벌헬스케어산업이끌맞춤형인재찾는다,http://www.thefirstmedia.net/news/articleView.html?idxno=48455
5452,2019-09-11,대웅제약상시공개채용전환인재채용시작,http://www.sisafocus.co.kr/news/articleView.html?idxno=220792
5453,2019-09-11,대웅제약정기공채에서상시공개채용으로전환,http://www.sportsseoul.com/news/read/817696
5454,2019-09-11,대웅제약글로벌헬스케어산업이끌맞춤형인재찾는다,http://medipana.com/news/news_viewer.asp?NewsNum=245343&MainKind=A&NewsKind=5&vCount=12&vKind=1
5455,2019-09-11,글로벌인재찾는대웅제약연구개발직등상시공개채용,http://www.medisobizanews.com/news/articleView.html?idxno=62419
5456,2019-09-11,대웅제약맞춤형인재찾는다상시채용시작,http://www.ajunews.com/view/20190911155422755
5457,2019-09-11,글로벌헬스케어인재찾는다대웅제약상시채용시작,http://www.newsis.com/view/?id=NISX20190911_0000768257&cID=13001&pID=13000
5458,2019-09-11,9월11일장마감주가정보대웅제약165500원,http://www.newsinside.kr/news/articleView.html?idxno=1028168
5459,2019-09-11,대웅제약글로벌맞춤인재채용상시채용실시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234847
5460,2019-09-11,대웅제약글로벌헬스케어산업이끌맞춤형인재찾는다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57177
5461,2019-09-11,대웅제약현업부서가직접인재선발하는상시공개채용도입,http://news.mk.co.kr/newsRead.php?year=2019&no=724838
5462,2019-09-11,대웅제약글로벌맞춤형인재상시채용실시,http://www.joseilbo.com/news/news_read.php?uid=383928&class=17&grp=
5463,2019-09-11,대웅제약상시채용으로맞춤형인재찾는다,http://www.newspim.com/news/view/20190911001113
5464,2019-09-11,대웅제약상시채용으로맞춤형인재찾는다,http://www.newspim.com/news/view/20190911001113
5465,2019-09-11,대웅제약경력직상시공개채용진행서류접수24일까지,http://www.donga.com/news/article/all/20190911/97386641/1
5466,2019-09-11,인기주종목정보9월11일대웅제약165500원으로장마감,http://nbntv.co.kr/news/view/647333
5467,2019-09-11,대웅제약상시채용으로대웅인뽑아요,http://moneys.mt.co.kr/news/mwView.php?no=2019091117028048015
5468,2019-09-11,11일주식장마감동향대웅제약주가165500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=405941
5469,2019-09-11,대웅제약상시공개채용진행24일까지서류접수,http://weekly.cnbnews.com/news/article.html?no=130152
5470,2019-09-11,대웅제약상시채용실시글로벌헬스케어산업이끌맞춤형인재찾는다,http://www.wikileaks-kr.org/news/articleView.html?idxno=65301
5471,2019-09-11,대웅제약상시채용진행우수인재확보총력,https://www.kpanews.co.kr/article/show.asp?idx=206651&category=D
5472,2019-09-11,대웅제약상시공개채용전환연구개발등모집,http://www.biospectator.com/view/news_view.php?varAtcId=8467
5473,2019-09-12,대웅제약공기채용에서상시채용으로인재채용방식전환,http://www.ftoday.co.kr/news/articleView.html?idxno=111313
5474,2019-09-12,대웅제약상시채용으로전환맞춤형인재찾아요,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072189
5475,2019-09-12,대웅제약글로벌헬스케어산업이끌맞춤형인재상시채용,http://www.koreaittimes.com/news/articleView.html?idxno=92926
5476,2019-09-12,대웅제약현업서인재직접선발상시채용실시,http://www.ebn.co.kr/news/view/1001016
5477,2019-09-12,종목시세두산인프라코어주가6340원032샘표식품31450원032코오롱글로벌우16500원03대웅제약165500원03삼양패키징16700원03↑주가주식가격올,http://www.fintechpost.co.kr/news/articleView.html?idxno=70047
5478,2019-09-14,대웅제약영업연구생산부문등상시채용실시,http://www.finomy.com/news/articleView.html?idxno=69347
5479,2019-09-15,대웅제약상시공개채용방식전환글로벌인재찾는다”,http://www.viva100.com/main/view.php?key=20190915010004443
5480,2019-09-15,대웅제약맞춤형인재채용위한상시채용실시,http://www.g-enews.com/ko-kr/news/article/news_all/20190915142709435669d76442fa_1/article.html
5481,2019-09-16,대웅제약채용현업부서선배가주체정기→상시공채로,http://news.heraldcorp.com/view.php?ud=20190916000020
5482,2019-09-16,대웅제약오송공장환경안전보건국제인증ISO1400145001동시획득,http://www.metroseoul.co.kr/news/newsview?newscd=2019091600021
5483,2019-09-16,대웅제약오송공장ISO14001ISO45001동시획득,http://medipana.com/news/news_viewer.asp?NewsNum=245388&MainKind=A&NewsKind=5&vCount=12&vKind=1
5484,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.wsobi.com/news/articleView.html?idxno=81170
5485,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=15565
5486,2019-09-16,대웅제약오송공장환경안전보건국제인증ISO14001ISO45001획득,http://daily.hankooki.com/lpage/ittech/201909/dh20190916094411145630.htm
5487,2019-09-16,대웅제약환경안전보건국제인증ISO1400145001동시획득,https://www.sedaily.com/NewsView/1VO9OOI1WY
5488,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.fnnews.com/news/201909160948275195
5489,2019-09-16,대웅제약 전생산시설환경안전보건국제표준인증,http://www.medisobizanews.com/news/articleView.html?idxno=62437
5490,2019-09-16,대웅제약환경안전보건국제인증ISO1400145001동시획득,http://www.asiatime.co.kr/news/articleView.html?idxno=270267
5491,2019-09-16,대웅제약생산시설국제표준인증획득환경안전우수성입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1335625
5492,2019-09-16,취업대웅제약하반기현업부문인재상시채용직무중심선발,http://www.ezyeconomy.com/news/articleView.html?idxno=93745
5493,2019-09-16,대웅제약오송공장환경안전보건국제인증획득,http://www.newspim.com/news/view/20190916000232
5494,2019-09-16,대웅제약오송공장환경안전보건국제표준ISO1400145001인증받아,http://news.mk.co.kr/newsRead.php?year=2019&no=730753
5495,2019-09-16,대웅제약환경안전보건인증ISO14001ISO45001동시획득,http://www.ebn.co.kr/news/view/1001164
5496,2019-09-16,대웅제약오송공장환경안전보건국제표준인증획득,http://news.mt.co.kr/mtview.php?no=2019091609312661413
5497,2019-09-16,대웅제약오송공장환경안전보건국제인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2019091609538037112
5498,2019-09-16,대웅제약환경안전보건국제인증동시획득글로벌수준생산시설기반으로대내외고객신뢰도제고기대,http://www.segye.com/content/html/2019/09/16/20190916503717.html?OutUrl=naver
5499,2019-09-16,대웅제약환경안전보건국제인증동시획득,http://www.dailian.co.kr/news/view/826037/?sc=naver
5500,2019-09-16,대웅제약오송공장환경안전보건국제표준ISO1400145001인증받아,http://www.nbnnews.co.kr/news/articleView.html?idxno=317206
5501,2019-09-16,현업적합한인재찾는다대웅제약상시채용실시 ,http://www.monews.co.kr/news/articleView.html?idxno=204947
5502,2019-09-16,대웅제약오송공장환경안전보건국제인증ISO14001ISO45001획득,http://www.sportsseoul.com/news/read/818774
5503,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019091609573677547
5504,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234875
5505,2019-09-16,대웅제약환경안전보건국제이증ISO1400145001동시획득,http://www.econovill.com/news/articleView.html?idxno=372157
5506,2019-09-16,제약오늘대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.sisaon.co.kr/news/articleView.html?idxno=101003
5507,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://fn.segye.com/content/html/2019/09/16/20190916504018.html?OutUrl=naver
5508,2019-09-16,대웅제약오송공장ISO14001ISO45001동시획득,http://www.newsprime.co.kr/news/article.html?no=475043
5509,2019-09-16,대웅제약오송공장환경․안전우수입증,http://www.whosaeng.com/112558
5510,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.newsfc.co.kr/news/articleView.html?idxno=37896
5511,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=364788
5512,2019-09-16,대웅제약오송공장환경경영안전경영시스템국제표준인증,http://www.rapportian.com/news/articleView.html?idxno=119974
5513,2019-09-16,대웅제약환경안전보건경영시스템국제표준획득전생산시설국제인증확보,http://www.donga.com/news/article/all/20190916/97420292/1
5514,2019-09-16,대웅제약환경안전보건국제인증ISO1400145001동시획득,http://www.seoulwire.com/news/articleView.html?idxno=217842
5515,2019-09-16,대웅제약전생산시설환경안전보건국제인증획득,http://www.ftoday.co.kr/news/articleView.html?idxno=111355
5516,2019-09-16,9월16일대웅제약시세보기091167000원,http://nbntv.co.kr/news/view/649193
5517,2019-09-16,대웅제약오송공장환경안전보건국제인증ISO400145001동시획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1798823
5518,2019-09-16,대웅제약ISO14001ISO45001동시획득,http://www.bokuennews.com/news/article.html?no=180722
5519,2019-09-16,대웅제약환경안전보건국제인증ISO1400145001획득,http://www.ajunews.com/view/20190916111658193
5520,2019-09-16,대웅제약오송공장ISO1400145001동시획득,http://www.mhj21.com/124272
5521,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.lawissue.co.kr/view.php?ud=201909161133379905204ead0791_12
5522,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.newswatch.kr/news/articleView.html?idxno=23397
5523,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001획득,http://www.koreaittimes.com/news/articleView.html?idxno=92946
5524,2019-09-16,대웅제약환경안전보건국제인증2개동시획득,http://www.economytalk.kr/news/articleView.html?idxno=197924
5525,2019-09-16,9월16일대웅제약069620오늘시세및증권정보와종목동정181변동해,http://www.gokorea.kr/news/articleView.html?idxno=407823
5526,2019-09-16,대웅제약오송공장안전하고친환경적국제공인,http://www.bosa.co.kr/news/articleView.html?idxno=2112360
5527,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.updownnews.co.kr/news/articleView.html?idxno=208449
5528,2019-09-16,대웅제약오송공장환경안전보건국제인증동시획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072211
5529,2019-09-16,스타★주식인사이드대웅제약주가169000원9월16일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=1034892
5530,2019-09-16,대웅제약오송공장국제표준인증ISO14001ISO45001동시획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=65428
5531,2019-09-16,대웅제약오송공장환경안전보건국제인증ISO14001ISO45001동시획득,http://www.viva100.com/main/view.php?key=20190916010004808
5532,2019-09-16,대웅제약오송공장환경안전보건ISO인증획득,http://www.dt.co.kr/contents.html?article_no=2019091602109931102003&ref=naver
5533,2019-09-16,대웅제약오송공장환경안전보건국제인증동시획득,http://www.etnews.com/20190916000187
5534,2019-09-16,대웅제약환경안전보건ISO인증2건동시획득,http://news.heraldcorp.com/view.php?ud=20190916000647
5535,2019-09-16,대웅제약환경안전보건국제인증 ISO14001ISO 45001 동시 획득 ,http://www.businesskorea.co.kr/news/articleView.html?idxno=35986
5536,2019-09-16,뉴스워커_대웅제약환경안전보건국제인증ISO14001ISO45001동시획득 ,http://www.newsworker.co.kr/news/articleView.html?idxno=41655
5537,2019-09-16,대웅제약오송공장환경안전보건경영시스템국제인증획득,http://www.businesspost.co.kr/BP?command=article_view&num=143324
5538,2019-09-16,대웅제약오송공장환경안전보건국제인증동시획득,http://www.wolyo.co.kr/news/articleView.html?idxno=93503
5539,2019-09-16,대웅제약오송공장환경안전보건국제인증획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201909160358&t=NN
5540,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57194
5541,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.sisafocus.co.kr/news/articleView.html?idxno=220992
5542,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.thefirstmedia.net/news/articleView.html?idxno=48492
5543,2019-09-16,9월16일장마감주가정보대웅제약168500원,http://www.newsinside.kr/news/articleView.html?idxno=1035316
5544,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.getnews.co.kr/view.php?ud=20190916161905952241d0c69529_16
5545,2019-09-16,16일주식장마감동향대웅제약168500원마감,http://www.gokorea.kr/news/articleView.html?idxno=409411
5546,2019-09-16,특징주주가정보16일대웅제약마감증시168500원,http://nbntv.co.kr/news/view/650990
5547,2019-09-16,대웅제약오송공장ISO1400145001동시획득,http://www.shinailbo.co.kr/news/articleView.html?idxno=1204374
5548,2019-09-16,대웅제약오송공장환경안전국제인증2종획득,http://www.finomy.com/news/articleView.html?idxno=69423
5549,2019-09-16,제약산업대웅제약24일까지연구생산영업경영관리등채용外,http://www.kukinews.com/news/article.html?no=700721
5550,2019-09-16,대웅제약메디톡스보톡스전쟁20일분수령에촉각,http://www.newspim.com/news/view/20190916001165
5551,2019-09-16,대웅제약오송공장글로벌수준친환경생산시설공인,http://www.kpinews.co.kr/news/articleView.html?idxno=103387
5552,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.newscj.com/news/articleView.html?idxno=667278
5553,2019-09-16,대웅제약오송공장ISO1400145001획득,http://www.seoulfn.com/news/articleView.html?idxno=355964
5554,2019-09-17,대웅제약환경안전보건국제인증ISO1400145001동시획득,http://www.straightnews.co.kr/news/articleView.html?idxno=55639
5555,2019-09-17,대웅제약주가정보17일오늘거래가169000원거래,http://www.gokorea.kr/news/articleView.html?idxno=410719
5556,2019-09-17,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.munhwa.com/news/view.html?no=20190917MW141900113614
5557,2019-09-18,대웅제약보톡스수출중장기성장세견인SK증권,http://www.dailian.co.kr/news/view/826686/?sc=naver
5558,2019-09-18,대웅제약보톡스균주논란점진적해소중,https://www.hankyung.com/it/article/2019091860776
5559,2019-09-18,대웅제약보톡스수출로체질개선균주논란점진적해소SK,http://www.edaily.co.kr/news/newspath.asp?newsid=01449766622621432
5560,2019-09-18,대웅제약보톡스수출로전통제약사체질개선SK증권,http://www.fnnews.com/news/201909180806132394
5561,2019-09-18,대웅제약보톡스수출로중장기성장견인,http://www.asiatoday.co.kr/view.php?key=20190918010009418
5562,2019-09-18,I리포트대웅제약보톡스수출로체질개선–SK證,http://www.inews24.com/view/1208961
5563,2019-09-18,대웅제약보톡스수출로체질개선시작매수SK증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1799720
5564,2019-09-18,SK證대웅제약美보톡스MS3위균주논란도점진적해소”,http://www.sentv.co.kr/news/view/560732
5565,2019-09-18,퀵리포트대웅제약매수유지목표가26만원유지SK證,http://www.itooza.com/common/iview.php?no=2019091807404718294
5566,2019-09-18,대웅제약보톡스글로벌수출로체질개선,http://www.newsprime.co.kr/news/article.html?no=475408
5567,2019-09-18,대웅제약보톡스수출로중장기성장세견인SK證,http://www.seoulfn.com/news/articleView.html?idxno=356133
5568,2019-09-18,SK증권보톡스글로벌수출성장견인전망대웅제약매수,http://www.whitepaper.co.kr/news/articleView.html?idxno=173302
5569,2019-09-18,SK증권대웅제약나보타의미국보톡스시장내성장으로체질개선중”,http://www.lawissue.co.kr/view.php?ud=2019091809264971399817d053b9_12
5570,2019-09-18,대웅제약주가오를힘갖춰마국에서보톡스나보타판매호조,http://www.businesspost.co.kr/BP?command=article_view&num=143605
5571,2019-09-18,리포트브리핑대웅제약보톡스수출로체질개선시작목표가260000원SK증권,http://www.newspim.com/news/view/20190918000464
5572,2019-09-18,GET투자리포트대웅제약투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=2019091810303011170tpgetnews_16
5573,2019-09-18,9월18일대웅제약069620종목그래프059변화해,http://www.gokorea.kr/news/articleView.html?idxno=412937
5574,2019-09-18,대웅제약보톡스수출로체질개선전망,http://www.skyedaily.com/news/news_view.html?ID=90498
5575,2019-09-18,대웅제약보톡스수출규모가3년안에1000억원을넘어설가능성높다”,http://www.wikitree.co.kr/main/news_view.php?id=464408
5576,2019-09-19,대웅제약나보타치료적응증다각적확대박차글로벌치료시장진출로미래큰성장동력기대,http://www.segye.com/content/html/2019/09/19/20190919503309.html?OutUrl=naver
5577,2019-09-19,9월19일대웅제약금일증시170000원059,http://nbntv.co.kr/news/view/652950
5578,2019-09-19,대웅제약vs메디톡스균주전쟁끝날까20일ITC에보고서제출,http://www.metroseoul.co.kr/news/newsview?newscd=2019091900170
5579,2019-09-19,대웅제약나보타미용보다큰치료목적보톡스시장공략박차,http://news.mk.co.kr/newsRead.php?year=2019&no=746517
5580,2019-09-19,환절기건강관리대웅제약임팩타민프리미엄,https://www.sedaily.com/NewsView/1VOB2OUX05
5581,2019-09-20,직원성장기업성장밀레니얼세대품는대웅제약,http://www.sportsseoul.com/news/read/821413
5582,2019-09-20,대웅제약심각한적자난속고배당속내는,http://www.startuptoday.co.kr/news/articleView.html?idxno=31020
5583,2019-09-20,생생한취업정보전달대웅제약채용설명회성황,http://medipana.com/news/news_viewer.asp?NewsNum=245634&MainKind=A&NewsKind=5&vCount=12&vKind=1
5584,2019-09-20,대웅제약채용설명회진행오는24일까지공채,http://www.wsobi.com/news/articleView.html?idxno=81494
5585,2019-09-20,대웅제약24일까지RD생산영업마케팅관리등부문별채용,http://daily.hankooki.com/lpage/ittech/201909/dh20190920093811145630.htm
5586,2019-09-20,예비대웅인모여라”대웅제약채용설명회성황,http://www.dailian.co.kr/news/view/827460/?sc=naver
5587,2019-09-20,대웅제약채용설명회개최,http://www.ceoscoredaily.com/news/article.html?no=60597
5588,2019-09-20,대웅제약직무별멘토단이정보공유해주는채용설명회개최,http://news.mk.co.kr/newsRead.php?year=2019&no=748233
5589,2019-09-20,대웅제약채용설명회성황24일까지공채진행,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019092009462851603
5590,2019-09-20,예비대웅인모여라대웅제약채용설명회,http://www.newsis.com/view/?id=NISX20190920_0000775039&cID=13001&pID=13000
5591,2019-09-20,대웅제약취업준비생위해직무멘토링제공,http://www.econovill.com/news/articleView.html?idxno=372581
5592,2019-09-20,대웅제약채용길잡이직무멘토단이떴다,http://www.medisobizanews.com/news/articleView.html?idxno=62565
5593,2019-09-20,올해부터직무중심채용전환대웅제약채용설명회열어,http://www.jobnjoy.com/portal/job/hotnews_view.jsp?nidx=363059&depth1=1&depth2=1&depth3=2
5594,2019-09-20,예비대웅인모여라대웅제약채용설명회개최,http://www.newspim.com/news/view/20190920000162
5595,2019-09-20,대웅제약채용설명회개최예비대웅인모여라,http://www.viva100.com/main/view.php?key=20190920010006572
5596,2019-09-20,대웅제약채용설명회진행직무별취업정보제공,http://www.newsprime.co.kr/news/article.html?no=475845
5597,2019-09-20,예비대웅인모여라대웅제약채용설명회성황,http://www.bosa.co.kr/news/articleView.html?idxno=2112652
5598,2019-09-20,예비대웅인모여라대웅제약채용설명회성황,http://newsbrite.net/126768
5599,2019-09-20,예비대웅인모여라대웅제약채용설명회성황,http://www.mdtoday.co.kr/mdtoday/index.html?no=365224
5600,2019-09-20,9월20일대웅제약종목검색168000원059,http://nbntv.co.kr/news/view/654374
5601,2019-09-20,예비대웅인모여라대웅제약채용설명회성황,http://www.dailysmart.co.kr/news/articleView.html?idxno=15745
5602,2019-09-20,예비대웅인모여라대웅제약채용설명회성료,http://www.ekn.kr/news/article.html?no=454025
5603,2019-09-20,대웅제약채용설명회성황,http://www.lawissue.co.kr/view.php?ud=201909201107526982204ead0791_12
5604,2019-09-20,대웅제약취업준비생대상2019하반기신입사원채용설명회개최,http://www.ezyeconomy.com/news/articleView.html?idxno=93910
5605,2019-09-20,대웅제약채용설명회개최예비대웅인모여라,http://fn.segye.com/content/html/2019/09/20/20190920503766.html?OutUrl=naver
5606,2019-09-20,대웅제약유럽서​SGLT2당뇨병치료신약DWP16001임상결과발표 ,http://www.businesskorea.co.kr/news/articleView.html?idxno=36188
5607,2019-09-20,9월20일대웅제약069620증권그래프및매매동향059변화,http://www.gokorea.kr/news/articleView.html?idxno=416260
5608,2019-09-20,대웅제약취준생대상채용설명회성황,http://www.dailymedi.com/detail.php?number=847544&thread=22r05
5609,2019-09-20,대웅제약SGLT2당뇨병치료신약DWP16001에대한임상1상결과포스터로발표,http://www.updownnews.co.kr/news/articleView.html?idxno=208722
5610,2019-09-20,대웅제약당뇨병치료제뛰어난혈당강하로최고신약도전,http://www.medisobizanews.com/news/articleView.html?idxno=62576
5611,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약임상결과발표,http://www.joseilbo.com/news/news_read.php?uid=384316&class=27&grp=
5612,2019-09-20,대웅제약SGLT2i신약EASD서임상결과발표,http://medipana.com/news/news_viewer.asp?NewsNum=245657&MainKind=A&NewsKind=5&vCount=12&vKind=1
5613,2019-09-20,대웅제약유럽당뇨병학회서신약DWP16001임상발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235095
5614,2019-09-20,대웅제약유럽당뇨병학회서​당뇨신약DWP16001임상결과발표,http://biz.chosun.com/site/data/html_dir/2019/09/20/2019092001017.html
5615,2019-09-20,대웅제약유럽당뇨병학회서신약DWP16001임상결과발표,http://www.newspim.com/news/view/20190920000476
5616,2019-09-20,대웅제약유럽당뇨병학회서DWP16001임상결과발표,http://www.mhj21.com/124391
5617,2019-09-20,EASD2019대웅제약당뇨병신약DWP16001임상결과발표,http://www.econovill.com/news/articleView.html?idxno=372598
5618,2019-09-20,대웅제약EASD서당뇨병신약DWP16001임상결과발표,http://inthenews.co.kr/article-16837/
5619,2019-09-20,대웅제약유럽서당뇨병치료신약임상결과발표,http://www.economytalk.kr/news/articleView.html?idxno=198487
5620,2019-09-20,대웅제약분비효능뛰어난당뇨신약유럽학회서임상결과발표,http://www.newsfc.co.kr/news/articleView.html?idxno=37986
5621,2019-09-20,예비대웅人모여라대웅제약채용설명회개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072383
5622,2019-09-20,대웅제약유럽당뇨병학회EASD서SGLT2당뇨병치료신약DWP16001임상결과발표,http://newsbrite.net/126787
5623,2019-09-20,대웅제약유럽당뇨병학회서당뇨신약DWP16001임상결과발표,http://www.newsway.co.kr/news/view?tp=1&ud=2019092012400367850
5624,2019-09-20,대웅제약유럽당뇨병학회서SGLT2당뇨병치료신약임상결과발표,http://www.koreaittimes.com/news/articleView.html?idxno=93061
5625,2019-09-20,대웅제약유럽당뇨병학회서​SGLT2당뇨병치료신약임상결과발표,http://www.updownnews.co.kr/news/articleView.html?idxno=208730
5626,2019-09-20,대웅제약당뇨병치료신약DWP16001임상결과발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1336947
5627,2019-09-20,대웅제약당뇨병신약혈당강하효과입증,http://news.mt.co.kr/mtview.php?no=2019092013160065597
5628,2019-09-20,대웅제약취업준비생대상채용설명회개최 ,http://www.monews.co.kr/news/articleView.html?idxno=205100
5629,2019-09-20,대웅제약​유럽서당뇨병신약DWP16001임상결과발표,http://health.chosun.com/site/data/html_dir/2019/09/20/2019092001238.html
5630,2019-09-20,대웅제약유럽당뇨병학회서SGLT2억제제후보물질임상1상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=749380
5631,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약DWP16001임상결과발표,http://www.ceoscoredaily.com/news/article.html?no=60620
5632,2019-09-20,대웅제약당뇨병신약임상1상서혈당강화효과우수,https://view.asiae.co.kr/article/2019092013481464558
5633,2019-09-20,대웅제약채용설명회성황임직원직접생생한취업정보직무에대한멘토링제공,http://www.newswatch.kr/news/articleView.html?idxno=23592
5634,2019-09-20,대웅제약유럽당뇨병학회서SGLT2당뇨병신약DWP16001임상결과발표,http://www.newswatch.kr/news/articleView.html?idxno=23598
5635,2019-09-20,대웅제약유럽당뇨병학회서신약임상결과발표,https://www.sedaily.com/NewsView/1VOBJQHIOX
5636,2019-09-20,대웅제약SGLT2당뇨병치료신약DWP16001임상결과발표,http://fn.segye.com/content/html/2019/09/20/20190920506832.html?OutUrl=naver
5637,2019-09-20,대웅제약유럽당뇨병학회서DWP16001임상결과발표,http://www.ebn.co.kr/news/view/1001894
5638,2019-09-20,대웅제약유럽당뇨병학회서SGLT2억제신약임상발표,http://www.newsis.com/view/?id=NISX20190920_0000775406&cID=13001&pID=13000
5639,2019-09-20,대웅제약EASD서SGLT2신약DWP16001임상결과발표,http://daily.hankooki.com/lpage/ittech/201909/dh20190920143718145630.htm
5640,2019-09-20,대웅제약유럽당뇨병학회서DWP16001임상결과발표,http://www.medigatenews.com/news/1459407111
5641,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약임상결과발표,http://www.fnnews.com/news/201909201439528996
5642,2019-09-20,대웅제약당뇨병치료신약임상1상결과발표,http://www.newsprime.co.kr/news/article.html?no=475891
5643,2019-09-20,예비대웅인모여라대웅제약채용설명회성황,http://www.segye.com/content/html/2019/09/20/20190920507360.html?OutUrl=naver
5644,2019-09-20,대웅제약SGLT2억제제임상1상결과발표,http://www.biospectator.com/view/news_view.php?varAtcId=8513
5645,2019-09-20,대웅제약유럽당뇨병학회신약DWP16001임상결과발표,http://www.ezyeconomy.com/news/articleView.html?idxno=93924
5646,2019-09-20,대웅제약유럽당뇨병학회서DWP16001임상1상발표,http://www.rapportian.com/news/articleView.html?idxno=120108
5647,2019-09-20,대웅제약PPI넥시어드식약처허가AZ와동행은지속,http://daily.hankooki.com/lpage/ittech/201909/dh20190920151539145630.htm
5648,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약임상결과발표,http://www.wolyo.co.kr/news/articleView.html?idxno=93923
5649,2019-09-20,대웅제약나보타적응증확보박차글로벌시장공략,http://www.wolyo.co.kr/news/articleView.html?idxno=93935
5650,2019-09-20,한미약품종근당대웅제약등유럽당뇨학회서임상결과발표눈길,http://www.asiatime.co.kr/news/articleView.html?idxno=271516
5651,2019-09-20,대웅제약유럽당뇨병학회EASD서​SGLT2당뇨병치료신약DWP16001임상결과발표,http://www.lawissue.co.kr/view.php?ud=201909201616564824204ead0791_12
5652,2019-09-20,대웅제약채용설명회성황,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57283
5653,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약DWP16001임상결과발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57285
5654,2019-09-20,대웅제약유럽당뇨병학회서신약후보물질1상결과발표,http://www.sportsseoul.com/news/read/821684
5655,2019-09-20,대웅제약유럽당뇨병학회서당뇨병신약임상결과발표,http://www.newstomato.com/ReadNews.aspx?no=921266
5656,2019-09-20,대웅제약유럽당뇨병학회당뇨병치료신약DWP16001임상결과발표,http://www.getnews.co.kr/view.php?ud=20190920164810150841d0c69529_16
5657,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약임상결과발표,http://www.dailian.co.kr/news/view/827685/?sc=naver
5658,2019-09-20,대웅제약유럽당뇨병학회서SGLT2당뇨병치료신약DWP16001임상결과발표,http://www.dailysmart.co.kr/news/articleView.html?idxno=15774
5659,2019-09-20,대웅제약취업준비생대상멘토링채용설명회성황,http://www.100ssd.co.kr/news/articleView.html?idxno=64207
5660,2019-09-20,대웅제약유럽당뇨병학회에신약의혈당강하효과발표,http://www.businesspost.co.kr/BP?command=article_view&num=144060
5661,2019-09-20,대웅제약아태지역혁신제약사12위비결은끊임없는연구개발,http://www.news2day.co.kr/137214
5662,2019-09-20,대웅제약유럽당뇨병학회서당뇨병신약임상1상결과발표,http://www.donga.com/news/article/all/20190920/97502251/1
5663,2019-09-20,단독대웅제약메디톡스미국균주소송내년6월결론,http://news1.kr/articles/?3724826
5664,2019-09-20,대웅제약예비대웅인모여라채용설명회성황,http://www.newscj.com/news/articleView.html?idxno=668533
5665,2019-09-20,대웅제약오송공장환경안전보건국제인증획득,http://www.womennews.co.kr/news/articleView.html?idxno=193056
5666,2019-09-21,대웅제약오송공장환경안전보건국제인증획득,http://www.betanews.net:8080/article/1052203.html
5667,2019-09-21,대웅제약유럽당뇨병학회EASD서SGLT2당뇨병치료신약DWP16001임상결과발표,http://www.thefirstmedia.net/news/articleView.html?idxno=48733
5668,2019-09-21,인재채용방식전환한대웅제약채용설명회성황,http://www.thefirstmedia.net/news/articleView.html?idxno=48738
5669,2019-09-22,대웅제약EASD서SGLT2당뇨병신약임상결과발표,http://www.bosa.co.kr/news/articleView.html?idxno=2112693
5670,2019-09-22,대웅제약당뇨신약DWP16001뛰어난혈당강하효과”,http://www.viva100.com/main/view.php?key=20190922010006932
5671,2019-09-22,대웅제약유럽당뇨병학회EASD서당뇨병신약임상결과발표,http://www.metroseoul.co.kr/news/newsview?newscd=2019092200046
5672,2019-09-22,대웅제약유럽학회서당뇨치료신약효능공유,http://news.heraldcorp.com/view.php?ud=20190922000179
5673,2019-09-22,대웅제약SGLT2당뇨신약기존약물대비효과,http://www.dailymedi.com/detail.php?number=847588&thread=22r05
5674,2019-09-23,美ITC대웅제약보톡스균주유전자분석결과보게됐다,http://www.edaily.co.kr/news/newspath.asp?newsid=01426806622623072
5675,2019-09-23,대웅제약당뇨신약우수한혈당강하효과입증,http://www.monews.co.kr/news/articleView.html?idxno=205130
5676,2019-09-23,대웅제약실시간주식현황23일현재168000원,http://nbntv.co.kr/news/view/656083
5677,2019-09-23,대웅제약아태지역혁신제약사12위에선정돼,http://www.betanews.net:8080/article/1052517.html
5678,2019-09-23,경기침체우려속셀트리온유한양행동아에스티대웅제약일동제약GC녹십자이연제약한미약품광동제약등주목,http://www.econonews.co.kr/news/articleView.html?idxno=87589
5679,2019-09-24,WhoIs윤재춘대웅제약대표이사사장,http://www.businesspost.co.kr/BP?command=article_view&num=144355
5680,2019-09-24,대웅제약주가9월24일오늘거래가167500원정보및종목동정과증시정보,http://www.gokorea.kr/news/articleView.html?idxno=501165
5681,2019-09-24,대웅제약주가그래프24일현재167500원,http://nbntv.co.kr/news/view/658165
5682,2019-09-24,대웅제약나보타치료적응증시장확대박차,http://www.seoulwire.com/news/articleView.html?idxno=224249
5683,2019-09-25,fnRASSI대웅제약거래량확대되며3거래일연속하락,http://www.fnnews.com/news/201909251030588220
5684,2019-09-25,9월25일대웅제약실시간증시160000원361,http://nbntv.co.kr/news/view/659919
5685,2019-09-25,금주의채용정보대웅제약하반기상시채용,http://www.news2day.co.kr/137571
5686,2019-09-25,대웅제약채용설명회합격자양분,http://www.newsclaim.co.kr/news/articleView.html?idxno=2032
5687,2019-09-25,대웅제약유럽당뇨병학회서SGLT2억제계열당뇨병신약임상발표,http://www.econonews.co.kr/news/articleView.html?idxno=87986
5688,2019-09-26,대웅제약라니티딘파동에직격탄600억증발위기,https://www.paxnetnews.com/articles/52431
5689,2019-09-26,라니티딘처방중지대웅제약알비스휘청 ,http://www.monews.co.kr/news/articleView.html?idxno=205239
5690,2019-09-26,대웅제약라니티딘사태발암우려위장약잔탁등판매중지에주가무너지나15만원선마저무너져,http://www.econonews.co.kr/news/articleView.html?idxno=88063
5691,2019-09-26,2019제6회대한민국보건의료대상대상식품의약품안전처장상대웅제약자체개발나보타FDA판매허가美시장진출,http://news.heraldcorp.com/view.php?ud=20190926000563
5692,2019-09-26,9월26일대웅제약증권투자577147000원,http://nbntv.co.kr/news/view/662107
5693,2019-09-26,라니티딘제품판매중지GSK일동대웅제약등비상,http://www.dailymedi.com/detail.php?number=847777&thread=22r05
5694,2019-09-26,발암물질검출에대웅제약등급락하락과도,http://news.mt.co.kr/mtview.php?no=2019092613282039561
5695,2019-09-26,동성제약대웅제약제약주희비엇갈려잔탁등269개판매중지대웅제약하락락,http://www.econonews.co.kr/news/articleView.html?idxno=88117
5696,2019-09-26,대웅제약메디톡스美균주소송전서승기잡아,http://www.newsclaim.co.kr/news/articleView.html?idxno=2040
5697,2019-09-26,대웅제약알비스일동제약큐란발암물질기준초과판매중단,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=109469
5698,2019-09-26,26일외국인순매수Top10우리금융지주3554억호텔신라55억Famp;F28억대웅제약25억외국인순매수나서코스닥시장에서는헬릭스미스메지온케이엠더블유상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=73998
5699,2019-09-27,대웅제약알비스판매중지에대한우려목표가↓NH,https://www.hankyung.com/finance/article/2019092776336
5700,2019-09-27,퀵리포트대웅제약매수유지목표가5↓19만원NH證,http://www.itooza.com/common/iview.php?no=2019092707451410132
5701,2019-09-27,대웅제약알비스판매중지우려과도목표가하향NH투자,http://www.newstomato.com/ReadNews.aspx?no=922759
5702,2019-09-27,대웅제약알비스판매중지조치에실적하향불가피목표가↓KTB증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1803315
5703,2019-09-27,I리포트대웅제약알비스판매중지주가에기반영목표가↓KTB證,http://www.inews24.com/view/1211120
5704,2019-09-27,대웅제약역류성식도염치료제판매중지직격탄목표가↓NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01462886622624384
5705,2019-09-27,대웅제약목표주가낮아져소화성궤양치료제판매중지로실적부담,http://www.businesspost.co.kr/BP?command=article_view&num=144868
5706,2019-09-27,클릭e종목대웅제약대표품목매출타격우려목표가↓,https://view.asiae.co.kr/article/2019092708391469967
5707,2019-09-27,대웅제약알비스판매중지관련주가하락과도”NH證,http://www.newspim.com/news/view/20190927000054
5708,2019-09-27,KTB투자발암우려위장약여파로대웅제약매출감소,http://yna.kr/AKR20190927030500008?did=1195m
5709,2019-09-27,NH證대웅제약알비스판매중지우려주가하락지나쳐,http://www.newsis.com/view/?id=NISX20190927_0000782332&cID=10401&pID=10400
5710,2019-09-27,대웅제약알비스판매중지우려과도NH,http://www.ebn.co.kr/news/view/1002793
5711,2019-09-27,위장약269개품목서발암물질대웅제약주가하락과도”NH투자증권,http://www.fntimes.com/html/view.php?ud=20190927084958986f09e13944d_18
5712,2019-09-27,대웅제약대체의약품으로알비스매출하락일부방어대신,http://www.newspim.com/news/view/20190927000077
5713,2019-09-27,대웅제약위장약알비스판매중지로실적에영향예상,https://www.sedaily.com/NewsView/1VOEP7Q47M
5714,2019-09-27,대웅제약과도한주가하락에상승여력↑,http://www.newsprime.co.kr/news/article.html?no=476962
5715,2019-09-27,KTB투자대웅제약발암우려위장약실적에영향줄것목표가↓,http://www.seoulwire.com/news/articleView.html?idxno=226400
5716,2019-09-27,KTB투자證대웅제약발암우려위장약여파매출감소목표가7↓”,http://www.kukinews.com/news/article.html?no=704536
5717,2019-09-27,퀵리포트대웅제약강력매수유지목표가7↓26만원KTB證,http://www.itooza.com/common/iview.php?no=2019092707350714195
5718,2019-09-27,KTB투자발암우려위장약여파로대웅제약매출감소,http://nbntv.co.kr/news/view/663777
5719,2019-09-27,대웅제약라니티딘사태위장약잔탁등판매중지에도5거래일만에반등15만원선회복,http://www.econonews.co.kr/news/articleView.html?idxno=88281
5720,2019-09-27,이슈발암우려식약처발표에대웅제약주춤,https://www.hankyung.com/economy/article/2019092779896
5721,2019-09-27,리포트브리핑대웅제약알비스판매중지에대한우려로과도한주가하락목표가190000원NH투자증권,http://www.newspim.com/news/view/20190927000318
5722,2019-09-27,GET투자리포트대웅제약투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=2019092710303011437tpgetnews_16
5723,2019-09-27,특징주대웅제약알비스판매중지우려로과도한주가하락,http://www.sisaon.co.kr/news/articleView.html?idxno=101718
5724,2019-09-27,9월27일대웅제약및증권시세및증권정보와종목동정100변화해,http://www.gokorea.kr/news/articleView.html?idxno=507087
5725,2019-09-27,9월27일대웅제약투자주식067150500원,http://nbntv.co.kr/news/view/664326
5726,2019-09-27,NH투자증권알비스판매중지주가과도하게하락대웅제약매수,http://www.whitepaper.co.kr/news/articleView.html?idxno=174690
5727,2019-09-27,보툴리눔공방대웅제약으로기우나,http://www.insightkorea.co.kr//news/articleView.html?idxno=58618
5728,2019-09-29,전승호대웅제약항궤양제알비스판매중단에대체약품개발서둘러,http://www.businesspost.co.kr/BP?command=article_view&num=145082
5729,2019-09-30,대웅제약보톨리눔톡신논쟁일단락짓나,http://www.bosa.co.kr/news/articleView.html?idxno=2113154
5730,2019-09-30,대웅제약3분기소송비용증가로이익부진목표가↓키움,http://www.dailian.co.kr/news/view/829710/?sc=naver
5731,2019-09-30,대웅제약목표주가하향알비스판매중단돼4분기실적기대이하,http://www.businesspost.co.kr/BP?command=article_view&num=145106
5732,2019-09-30,대웅제약알비스판매중지반영목표가↓키움증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1804026
5733,2019-09-30,퀵리포트대웅제약매수유지목표가9↓20만원키움證,http://www.itooza.com/common/iview.php?no=2019093008483111491
5734,2019-09-30,하이로우대웅제약소송비용증가로매출부진예상키움증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019093008522739343
5735,2019-09-30,대웅제약알비스판매중단4분기영향목표주가↓키움증권,http://www.ajunews.com/view/20190930083629536
5736,2019-09-30,대웅제약3분기영업이익123억원전망,http://www.nspna.com/news/?mode=view&newsid=385408
5737,2019-09-30,메리츠證대웅제약라니티딘판매중단에수익성하락불가피,http://www.newsis.com/view/?id=NISX20190930_0000784232&cID=10401&pID=10400
5738,2019-09-30,대웅제약나보타국제피부외과학회서홍보,http://medipana.com/news/news_viewer.asp?NewsNum=246117&MainKind=A&NewsKind=5&vCount=12&vKind=1
5739,2019-09-30,대웅제약나보타국제피부외과학회참가경쟁력홍보,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235462
5740,2019-09-30,대웅제약 국제피부외과학회서 나보타우수성 홍보,http://www.medisobizanews.com/news/articleView.html?idxno=62766
5741,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.segye.com/content/html/2019/09/30/20190930503566.html?OutUrl=naver
5742,2019-09-30,리포트브리핑대웅제약UpDown이모두존재목표가220000원메리츠종금증권,http://www.newspim.com/news/view/20190930000204
5743,2019-09-30,GET투자리포트대웅제약투자의견매수메리츠종금증권,http://www.getnews.co.kr/view.php?ud=2019093010303011463tpgetnews_16
5744,2019-09-30,대웅제약국제피부외과학회서보톨리눔톡신제제나보타소개,https://www.sedaily.com/NewsView/1VOG3P16A6
5745,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.dailysmart.co.kr/news/articleView.html?idxno=16067
5746,2019-09-30,대웅제약나보타국제피부외과학회서최신임상결과알려,http://moneys.mt.co.kr/news/mwView.php?no=2019093009548017434
5747,2019-09-30,대웅제약알비스의빈자리를타제품이얼마나대체하는지가중요”,http://www.wikitree.co.kr/main/news_view.php?id=467959
5748,2019-09-30,대웅제약나보타글로벌학회서최신시술법시연및강의진행,http://www.econovill.com/news/articleView.html?idxno=373382
5749,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.ebn.co.kr/news/view/1003052
5750,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.newsway.co.kr/news/view?tp=1&ud=2019093010230324533
5751,2019-09-30,대웅제약국제피부외과학회통해나보타우수성홍보,http://www.ekn.kr/news/article.html?no=455587
5752,2019-09-30,대웅제약나보타국제피부외과학회참가경쟁력홍보,http://www.ceoscoredaily.com/news/article.html?no=60936
5753,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.wsobi.com/news/articleView.html?idxno=82080
5754,2019-09-30,대웅제약국제피부외과학회에서나보타홍보,http://www.newspim.com/news/view/20190930000297
5755,2019-09-30,대웅제약나보타국제피부외과학회서글로벌경쟁력과시,http://www.ftoday.co.kr/news/articleView.html?idxno=111676
5756,2019-09-30,GET투자리포트대웅제약투자의견매수유지키움증권,http://www.getnews.co.kr/view.php?ud=2019093010303011483tpgetnews_16
5757,2019-09-30,대웅제약ISDS2019참가세계대상나보타경쟁력홍보,http://www.wikileaks-kr.org/news/articleView.html?idxno=66548
5758,2019-09-30,대웅제약국제피부외과학회참가나보타홍보 ,http://www.monews.co.kr/news/articleView.html?idxno=205341
5759,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://newsbrite.net/127257
5760,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://fn.segye.com/content/html/2019/09/30/20190930503564.html?OutUrl=naver
5761,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.betanews.net:8080/article/1054950.html
5762,2019-09-30,대웅제약주가0696209월30일현재149000원정보,http://www.gokorea.kr/news/articleView.html?idxno=509267
5763,2019-09-30,대웅제약나보타글로벌무대서경쟁력홍보,http://www.newsprime.co.kr/news/article.html?no=477240
5764,2019-09-30,대웅제약영업력NOAC시장에서도빛났다,http://medipana.com/news/news_viewer.asp?NewsNum=246146&MainKind=A&NewsKind=5&vCount=12&vKind=1
5765,2019-09-30,대웅제약 나보타 국제피부외과학회참가 글로벌우수성알려,http://www.businesskorea.co.kr/news/articleView.html?idxno=36514
5766,2019-09-30,대웅제약나보타글로벌을무대서훨훨,http://www.whosaeng.com/112909
5767,2019-09-30,9월30일대웅제약실시간증시149500원033,http://nbntv.co.kr/news/view/666602
5768,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.newsis.com/view/?id=NISX20190930_0000784680&cID=13001&pID=13000
5769,2019-09-30,대웅제약나보타국제피부외과학회서글로벌경쟁력과시,http://www.seoulwire.com/news/articleView.html?idxno=227702
5770,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.newswatch.kr/news/articleView.html?idxno=23919
5771,2019-09-30,대웅제약국제피부외과학회서나보타소개글로벌제품알리기박차,http://www.donga.com/news/article/all/20190930/97654553/1
5772,2019-09-30,대웅제약국제피부외과학회참가주름개선제나보타해외네트워크확대,http://www.sportsseoul.com/news/read/826119
5773,2019-09-30,대웅제약나보타국제피부외과학회서경쟁력홍보,http://daily.hankooki.com/lpage/ittech/201909/dh20190930135941145630.htm
5774,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.dailian.co.kr/news/view/829746/?sc=naver
5775,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌경쟁력홍보,http://www.metroseoul.co.kr/news/newsview?newscd=2019093000201
5776,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.lawissue.co.kr/view.php?ud=201909301501418395204ead0791_12
5777,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.medigatenews.com/news/1290015044
5778,2019-09-30,국제피부외과학회참가한대웅제약나보타국제무대서경쟁력알려,http://www.updownnews.co.kr/news/articleView.html?idxno=209140
5779,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1339108
5780,2019-09-30,대웅제약나보타글로벌무대서경쟁력홍보,http://www.wolyo.co.kr/news/articleView.html?idxno=94579
5781,2019-09-30,대웅제약국제학회서나보타경쟁력적극홍보,http://www.dailymedi.com/detail.php?number=847920&thread=22r05
5782,2019-09-30,대웅제약국제피부외과학회학술대회서나보타홍보나서,http://news.mk.co.kr/newsRead.php?year=2019&no=781834
5783,2019-09-30,대웅제약국제피부외과학회서나보타알려,http://weekly.cnbnews.com/news/article.html?no=130398
5784,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.getnews.co.kr/view.php?ud=20190930165233269241d0c69529_16
5785,2019-09-30,뉴스워커_대웅제약 나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.newsworker.co.kr/news/articleView.html?idxno=44175
5786,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.economytalk.kr/news/articleView.html?idxno=199145
5787,2019-09-30,대웅제약국제피부외과학회참가나보타세계무대서경쟁력홍보,http://www.newslock.co.kr/news/articleView.html?idxno=21787
5788,2019-09-30,대웅제약알비스판매중단사태로4분기실적불투명대체품목이관건,http://www.whitepaper.co.kr/news/articleView.html?idxno=175044
5789,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.newscj.com/news/articleView.html?idxno=671034
5790,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.thefirstmedia.net/news/articleView.html?idxno=49066
5791,2019-10-01,대웅제약국제피부외과학회에서나보타홍보,http://www.nbnnews.co.kr/news/articleView.html?idxno=323556
5792,2019-10-01,대웅제약나보타임상비임상에서뛰어난역가지속력입증,http://www.metroseoul.co.kr/news/newsview?newscd=2019100100034
5793,2019-10-01,대웅제약나보타임상비임상시험서뛰어난역가지속력입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235544
5794,2019-10-01,대웅제약나보타임상시험서효과지속력입증,http://biz.chosun.com/site/data/html_dir/2019/10/01/2019100100843.html
5795,2019-10-01,대웅제약나보타효과SCI급국제피부과학학술지게재,http://news.heraldcorp.com/view.php?ud=20191001000149
5796,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.newsway.co.kr/news/view?tp=1&ud=2019100109565502229
5797,2019-10-01,대웅제약 나보타 임상비임상서 역가 지속력으뜸,http://www.medisobizanews.com/news/articleView.html?idxno=62811
5798,2019-10-01,대웅제약나보타역가지속력우월성입증,http://medipana.com/news/news_viewer.asp?NewsNum=246213&MainKind=A&NewsKind=5&vCount=12&vKind=1
5799,2019-10-01,대웅제약나보타임상서효과유지력입증,http://health.chosun.com/site/data/html_dir/2019/10/01/2019100100875.html
5800,2019-10-01,대웅제약나보타역가지속력입증냉동보관에도효과유지,http://www.econovill.com/news/articleView.html?idxno=373503
5801,2019-10-01,대웅제약나보타역가지속력입증냉동보관에도효과유지,http://www.econovill.com/news/articleView.html?idxno=373503
5802,2019-10-01,대웅제약나보타효과입증SCI급국제학술지에게재,http://www.koreaittimes.com/news/articleView.html?idxno=93250
5803,2019-10-01,대웅제약나보타임상비임상시험서역가지속력입증,http://www.newspim.com/news/view/20191001000353
5804,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.ceoscoredaily.com/news/article.html?no=60982
5805,2019-10-01,대웅제약나보타임상시험서역가지속력입증,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019100110180736870
5806,2019-10-01,대웅제약나보타임상시험서효과유지력입증,https://www.sedaily.com/NewsView/1VPCPUCEN6
5807,2019-10-01,대웅제약나보타뛰어난역가지속력입증,http://www.newsprime.co.kr/news/article.html?no=477421
5808,2019-10-01,대웅제약나보타임상시험서역가지속력입증,http://www.ftoday.co.kr/news/articleView.html?idxno=111724
5809,2019-10-01,대웅제약나보타임상연구서역가지속력입증 ,http://www.monews.co.kr/news/articleView.html?idxno=205379
5810,2019-10-01,대웅제약나보타뛰어난역가지속력입증,http://www.viva100.com/main/view.php?key=20191001010000143
5811,2019-10-01,대웅제약나보타뛰어난역가지속력입증,http://www.viva100.com/main/view.php?key=20191001010000143
5812,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=16135
5813,2019-10-01,대웅제약나보타희석후효과국내시판제품중최고”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1804730
5814,2019-10-01,대웅제약보툴리눔톡신나보타역가지속력입증,https://www.hankyung.com/it/article/201910016064f
5815,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://newsbrite.net/127348
5816,2019-10-01,대웅제약나보타임상비임상시험서역가지속력입증,http://www.newsis.com/view/?id=NISX20191001_0000785999&cID=13001&pID=13000
5817,2019-10-01,대웅제약주가10월1일현재152500원오늘시세및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=511270
5818,2019-10-01,10월1일대웅제약주식종목검색153500원302,http://nbntv.co.kr/news/view/668759
5819,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=366162
5820,2019-10-01,대웅제약나보타역가지속력입증”SCI급국제학술지게재,http://www.donga.com/news/article/all/20191001/97674119/1
5821,2019-10-01,대웅제약전일대비503상승중이시각거래량3만2882주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910010308&t=NN
5822,2019-10-01,대웅제약5이상상승최근3일간외국인대량순매수,https://www.hankyung.com/finance/article/201910016472L
5823,2019-10-01,대웅제약나보타임상비임상통해역가지속력확인,http://www.rapportian.com/news/articleView.html?idxno=120355
5824,2019-10-01,대웅제약나보타임상비임상서뛰어난역가지속력입증”,http://inthenews.co.kr/article-18397/
5825,2019-10-01,대웅제약나보타뛰어난역가지속력입증,http://news1.kr/articles/?3733169
5826,2019-10-01,대웅제약보툴리눔톡신나보타의뛰어난효과유지력입증,http://www.businesspost.co.kr/BP?command=article_view&num=145333
5827,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.lawissue.co.kr/view.php?ud=201910011458342904204ead0791_12
5828,2019-10-01,대웅제약나보타지속력안정성증명국내보툴리눔톡신중최우수,http://www.100ssd.co.kr/news/articleView.html?idxno=64399
5829,2019-10-01,대웅제약나보타임상시험서효과지속력입증SCI급국제피부과학학술지게재,http://www.updownnews.co.kr/news/articleView.html?idxno=209213
5830,2019-10-01,대웅제약비임상연구자임상결과나보타의역가지속력입증,http://news.mk.co.kr/newsRead.php?year=2019&no=786101
5831,2019-10-01,대웅제약나보타임상비임상에서뛰어난역가지속력입증,http://daily.hankooki.com/lpage/ittech/201910/dh20191001152947145630.htm
5832,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.wikileaks-kr.org/news/articleView.html?idxno=66718
5833,2019-10-01,대웅제약나보타임상비임상통해역가지속력입증,http://www.seoulwire.com/news/articleView.html?idxno=229291
5834,2019-10-01,대웅제약나보타임상비임상시험에서효과지속력확인,http://www.ajunews.com/view/20191001160902244
5835,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.wsobi.com/news/articleView.html?idxno=82156
5836,2019-10-01,대웅제약나보타역가지속력입증,http://www.economytalk.kr/news/articleView.html?idxno=199234
5837,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.medigatenews.com/news/2011359549
5838,2019-10-01,대웅제약나보타역가지속력임상시험서입증,http://www.wolyo.co.kr/news/articleView.html?idxno=94697
5839,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.getnews.co.kr/view.php?ud=20191001191213518541d0c69529_16
5840,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.thefirstmedia.net/news/articleView.html?idxno=49119
5841,2019-10-02,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.betanews.net:8080/article/1055481.html
5842,2019-10-02,아스트라제네카녹십자대웅제약일부품목판권회수결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=366229
5843,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1339591
5844,2019-10-02,대웅제약보톡스누시바유럽허가내년발매,http://www.dailypharm.com/Users/News/NewsView.html?ID=257236&REFERER=NP
5845,2019-10-02,대웅제약보툴리눔톡신제제누시바유럽판매허가승인,http://www.fnnews.com/news/201910020750013338
5846,2019-10-02,대웅제약보툴리눔톡신유럽허가유럽30개국진출,https://view.asiae.co.kr/article/2019100207534292318
5847,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235587
5848,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://biz.chosun.com/site/data/html_dir/2019/10/02/2019100200538.html
5849,2019-10-02,대웅제약보툴리눔톡신나보타글로벌연타석홈런,http://www.medisobizanews.com/news/articleView.html?idxno=62834
5850,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가,http://news.heraldcorp.com/view.php?ud=20191002000041
5851,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://www.newsis.com/view/?id=NISX20191002_0000787119&cID=13001&pID=13000
5852,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.ebn.co.kr/news/view/1003384
5853,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.lawissue.co.kr/view.php?ud=201910020841259116204ead0791_12
5854,2019-10-02,GC녹십자RD인력비중매출1조클럽중최고대웅제약최저,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=534027
5855,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.newsway.co.kr/news/view?tp=1&ud=2019100208483407652
5856,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.joseilbo.com/news/news_read.php?uid=384959&class=27&grp=
5857,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.shinailbo.co.kr/news/articleView.html?idxno=1209690
5858,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://www.seoulwire.com/news/articleView.html?idxno=229431
5859,2019-10-02,대웅제약누시바유럽판매허가획득‥연내캐나다발매,http://medipana.com/news/news_viewer.asp?NewsNum=246263&MainKind=A&NewsKind=5&vCount=12&vKind=1
5860,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.mhj21.com/124710
5861,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.mhj21.com/124710
5862,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.dailian.co.kr/news/view/830403/?sc=naver
5863,2019-10-02,대웅제약보톡스유럽서내년부터판매,http://moneys.mt.co.kr/news/mwView.php?no=2019100209008066499
5864,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019100209030812619
5865,2019-10-02,대웅제약누시바유럽판매가능해졌다,http://www.ftoday.co.kr/news/articleView.html?idxno=111746
5866,2019-10-02,대웅제약보툴리눔톡신미국이어유럽진출내년출시예정,http://www.newspim.com/news/view/20191002000084
5867,2019-10-02,대웅제약나보타국산보툴리눔톡신최초로미국유럽동시진출,http://news.tf.co.kr/read/economy/1764287.htm
5868,2019-10-02,대웅제약누시바유럽판매허가획득2020년유럽발매,http://www.asiatoday.co.kr/view.php?key=20191002010001044
5869,2019-10-02,대웅제약보툴리눔톡신제제유럽판매승인,http://news.mt.co.kr/mtview.php?no=2019100208173799279
5870,2019-10-02,대웅제약보툴리눔톡신나보타유럽판매허가획득,http://www.econovill.com/news/articleView.html?idxno=373617
5871,2019-10-02,대웅제약나보타미국에이어유럽판매승인,http://www.kpinews.co.kr/news/articleView.html?idxno=104496
5872,2019-10-02,대웅제약보툴리눔톡신나보타유럽판매허가,http://yna.kr/AKR20191002034100017?did=1195m
5873,2019-10-02,대웅제약누시바미간주름적응증에유럽판매허가획득,http://www.getnews.co.kr/view.php?ud=20191002092344407041d0c69529_16
5874,2019-10-02,대웅제약미국에이어누시바유럽판매허가획득발표,http://www.newslock.co.kr/news/articleView.html?idxno=21858
5875,2019-10-02,대웅제약나보타국산보툴리눔톡신최초美이어유럽진출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1805147
5876,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://daily.hankooki.com/lpage/ittech/201910/dh20191002093103145630.htm
5877,2019-10-02,대웅제약보툴리눔톡신나보타유럽서시판허가받아,http://news.mk.co.kr/newsRead.php?year=2019&no=788458
5878,2019-10-02,대웅제약보툴리눔톡신나보타유럽판매허가,http://www.fetv.co.kr/news/article.html?no=37325
5879,2019-10-02,대웅제약누시바유럽판매허가획득발표韓보툴리눔톡신최초미국유럽동시진출,http://www.segye.com/content/html/2019/10/02/20191002503841.html?OutUrl=naver
5880,2019-10-02,대웅제약나보타유럽판매허가획득,http://www.newstomato.com/ReadNews.aspx?no=923842
5881,2019-10-02,대웅제약나보타유럽판매허가획득캐나다출시도앞둬,http://www.rapportian.com/news/articleView.html?idxno=120380
5882,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.economytalk.kr/news/articleView.html?idxno=199257
5883,2019-10-02,대웅제약누시바유럽시장본격진출,https://www.kpanews.co.kr/article/show.asp?idx=207155&category=D
5884,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.k-health.com/news/articleView.html?idxno=45753
5885,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://www.newsprime.co.kr/news/article.html?no=477614
5886,2019-10-02,대웅제약나보타유럽허가미국유럽모두진출,http://www.hankookilbo.com/news/npath/201910021065328299?did=NA
5887,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.dt.co.kr/contents.html?article_no=2019100202109931102001&ref=naver
5888,2019-10-02,대웅제약보톡스누시바미국이어유럽시장도뚫었다,http://www.edaily.co.kr/news/newspath.asp?newsid=02282886622648984
5889,2019-10-02,대웅제약유럽서보툴리눔톡신누시바판매승인,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910020186&t=NN
5890,2019-10-02,대웅제약누시바유럽판매허가획득,http://kormedi.com/?p=1303026
5891,2019-10-02,대웅제약보툴리눔톡신나보타유럽판매허가,http://news.mk.co.kr/newsRead.php?year=2019&no=788839
5892,2019-10-02,대웅제약누시바유럽품목허가2020년발매,http://news1.kr/articles/?3734192
5893,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57470
5894,2019-10-02,대웅제약나보타미국이어유럽진출국내보툴리눔톡신최초,http://www.upinews.kr/news/newsview.php?ncode=1065577077764237
5895,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.dailysmart.co.kr/news/articleView.html?idxno=16194
5896,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://newsbrite.net/127422
5897,2019-10-02,대웅제약누시바유럽판매허가획득,http://news.heraldcorp.com/view.php?ud=20191002000415
5898,2019-10-02,대웅제약보툴리눔톡신유럽진출판매허가획득성공,http://www.ceoscoredaily.com/news/article.html?no=61040
5899,2019-10-02,대웅제약주가069620증권그래프2일오늘가격157500원,http://www.gokorea.kr/news/articleView.html?idxno=513283
5900,2019-10-02,대웅제약보툴리눔톡신누시바美이어유럽판매허가획득,http://www.opinionnews.co.kr/news/articleView.html?idxno=24083
5901,2019-10-02,대웅제약해외주름개선제시장주름잡기도전장나보타유럽까지진출,http://www.sportsseoul.com/news/read/827392
5902,2019-10-02,대웅제약보톨리눔톡신누시바유럽판매허가획득발표,http://www.metroseoul.co.kr/news/newsview?newscd=2019100200072
5903,2019-10-02,증권투자대웅제약주가2일현재157500원,http://nbntv.co.kr/news/view/670759
5904,2019-10-02,대웅제약나보타유럽판매허가승인내년발매,http://www.donga.com/news/article/all/20191002/97694913/1
5905,2019-10-02,대웅제약나보타유럽판매허가획득2020년발매예정,http://inthenews.co.kr/article-18649/
5906,2019-10-02,대웅제약보툴리눔톡신누시바의유럽판매허가따내,http://www.businesspost.co.kr/BP?command=article_view&num=145541
5907,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.etnews.com/20191002000102
5908,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.betanews.net:8080/article/1055620.html
5909,2019-10-02,대웅제약보툴리눔톡신누시바유럽최종품목허가승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=366282
5910,2019-10-02,대웅제약누시바유럽판매허가획득,https://www.paxnetnews.com/articles/52630
5911,2019-10-02,대웅제약보툴리눔톡신제제유럽시장진출,http://www.sisafocus.co.kr/news/articleView.html?idxno=222556
5912,2019-10-02,대웅제약비임상연구자임상결과나보타의역가지속력입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=324359
5913,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.newswatch.kr/news/articleView.html?idxno=24015
5914,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.wsobi.com/news/articleView.html?idxno=82220
5915,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.nbnnews.co.kr/news/articleView.html?idxno=324413
5916,2019-10-02,대웅제약보툴리눔제제나보타유럽도진출,https://www.nocutnews.co.kr/news/5222172
5917,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.bokuennews.com/news/article.html?no=181481
5918,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매승인,http://www.medigatenews.com/news/3067458831
5919,2019-10-02,대웅제약개발나보타유럽판매허가획득,http://www.seoulfn.com/news/articleView.html?idxno=357841
5920,2019-10-02,대웅제약나보타이번엔유럽이다 ,http://www.monews.co.kr/news/articleView.html?idxno=205417
5921,2019-10-02,대웅제약누시바국산보툴리눔톡신최초유럽미국판매허가획득,http://www.updownnews.co.kr/news/articleView.html?idxno=209276
5922,2019-10-02,대웅제약유럽서보톡스누시바판매허가획득,http://www.finomy.com/news/articleView.html?idxno=70048
5923,2019-10-02,대웅제약누시바유럽판매허가획득,https://www.sedaily.com/NewsView/1VPD7XE1D6
5924,2019-10-02,대웅제약나보타美이어유럽간다,https://www.hankyung.com/it/article/2019100299941
5925,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://www.ajunews.com/view/20191002172508172
5926,2019-10-02,대웅제약알비스복합제개발중단,https://www.paxnetnews.com/articles/52655
5927,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.ekn.kr/news/article.html?no=456100
5928,2019-10-02,대웅제약보툴리눔톡신누시바국내최초유럽진출,http://www.100ssd.co.kr/news/articleView.html?idxno=64432
5929,2019-10-02,대웅제약누시바美유럽동시진출,http://www.fnnews.com/news/201910021824346710
5930,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.newscj.com/news/articleView.html?idxno=671745
5931,2019-10-03,대웅제약토종주름개선제美이어유럽서팔린다,http://www.ajunews.com/view/20191002194527230
5932,2019-10-03,대웅제약자체개발보툴리눔톡신제제나보타국제피부외과학회참가,http://www.econonews.co.kr/news/articleView.html?idxno=89211
5933,2019-10-04,대웅제약삼중고윤재춘전승호대웅제약공동대표리더십시험대에,http://www.ajunews.com/view/20191003132307392
5934,2019-10-04,10월4일대웅제약069620및증권시세및주체별매매동향160,http://www.gokorea.kr/news/articleView.html?idxno=515233
5935,2019-10-04,시세보기대웅제약주가4일현재153000원,http://nbntv.co.kr/news/view/672967
5936,2019-10-04,위클리제약바이오대웅제약나보타유럽품목허가획득外,http://www.etoday.co.kr/news/section/newsview.php?idxno=1806033
5937,2019-10-04,대웅제약누시바유럽판매허가획득발표,http://www.thefirstmedia.net/news/articleView.html?idxno=49178
5938,2019-10-05,대웅제약보툴리눔톡신제제나보타임상비임상시험서역가지속력입증,http://www.econonews.co.kr/news/articleView.html?idxno=89566
5939,2019-10-06,라니티딘성분처방량상위10개품목공개대웅제약알비스정1위,http://www.mdtoday.co.kr/mdtoday/index.html?no=366590
5940,2019-10-06,2019국감발암우려위장약3년간1억여건처방대웅제약알비스정최다,http://www.seoulwire.com/news/articleView.html?idxno=231321
5941,2019-10-06,대웅제약나보타역가지속력뛰어남입증”,http://weekly.cnbnews.com/news/article.html?no=130476
5942,2019-10-07,대웅제약나보타미국서승승장구미용시장성장올라타,http://www.econovill.com/news/articleView.html?idxno=373859
5943,2019-10-07,특징주보톡스균주출처분쟁새국면에대웅제약메디톡스희비엇갈려,http://news.mk.co.kr/newsRead.php?year=2019&no=803118
5944,2019-10-07,대웅제약메디톡스말바꾸기즉각중단해야,http://medipana.com/news/news_viewer.asp?NewsNum=246510&MainKind=A&NewsKind=5&vCount=12&vKind=1
5945,2019-10-07,메디톡스대웅제약보톡스균주분쟁관련주가희비교차,http://www.mdtoday.co.kr/mdtoday/index.html?no=366638
5946,2019-10-07,대웅제약제2인보사사태우려메디톡스균주출처부터검증받아야,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235742
5947,2019-10-07,대웅제약메디톡스균주출처검증받아야,http://www.medisobizanews.com/news/articleView.html?idxno=62918
5948,2019-10-07,대웅제약포자형성메디톡스거짓말멈춰야,http://news.mt.co.kr/mtview.php?no=2019100710173075040
5949,2019-10-07,10월7일대웅제약증권투자정보362변화해,http://www.gokorea.kr/news/articleView.html?idxno=517202
5950,2019-10-07,잠망경라니티딘1천억손실대웅제약스티렌제네릭으로방향,http://medipana.com/news/news_viewer.asp?NewsNum=246343&MainKind=A&NewsKind=5&vCount=12&vKind=1
5951,2019-10-07,주식추천주대웅제약주가7일현재146000원,http://nbntv.co.kr/news/view/675269
5952,2019-10-07,대웅제약메디톡스포자시험조건처음부터동의,http://news1.kr/articles/?3737543
5953,2019-10-07,대웅제약메디톡스톡신균주도포자형성한다고,http://www.bosa.co.kr/news/articleView.html?idxno=2113645
5954,2019-10-07,동아에스티와일동손잡고대웅제약은자사제품대체유도,http://www.dailymedi.com/detail.php?number=848140&thread=22r05
5955,2019-10-07,대웅제약메디톡스균주포자형성스스로거짓말시인한것”,http://daily.hankooki.com/lpage/ittech/201910/dh20191007134726145630.htm
5956,2019-10-07,발암물질원료라니티딘성분처방량대웅제약알비스정최다,http://www.kukinews.com/news/article.html?no=707274
5957,2019-10-07,대웅제약메디톡스균주포자형성주장비판스스로거짓말시인한것,http://www.updownnews.co.kr/news/articleView.html?idxno=209412
5958,2019-10-07,동성제약대웅제약제약주희비엇갈려특히동성제약마감앞두고갑작스런급등,http://www.econonews.co.kr/news/articleView.html?idxno=89841
5959,2019-10-07,대웅제약메디톡스말바꾸기즉각중단하라,http://www.dailian.co.kr/news/view/831908/?sc=naver
5960,2019-10-07,대웅제약메디톡스거짓말과말바꾸기즉각중단해야”,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=534115
5961,2019-10-07,메디톡스vs대웅제약분쟁재점화포자형성결과놓고기싸움,http://www.upinews.kr/newsView/upi201910070081
5962,2019-10-07,메디톡스보툴리눔톡신균주포자형성”대웅제약거짓말그만해야”,http://www.ajunews.com/view/20191007191250563
5963,2019-10-07,대웅제약메디톡스의포자형성주장은설득력떨어지는거짓말,http://www.businesspost.co.kr/BP?command=article_view&num=146120
5964,2019-10-07,대웅제약메디톡스균주포자형성주장스스로거짓말시인한것,http://www.businesskorea.co.kr/news/articleView.html?idxno=36748
5965,2019-10-08,대웅제약포자형성일반적인실험방법,http://www.mdtoday.co.kr/mdtoday/index.html?no=366684
5966,2019-10-08,메디톡스대웅제약미국소송에뉴욕검찰출신변호사선임,http://moneys.mt.co.kr/news/mwView.php?no=2019100809058051601
5967,2019-10-08,메디톡스거물변호사선임하고대웅제약과美법적다툼채비,http://www.edaily.co.kr/news/newspath.asp?newsid=01902406622650952
5968,2019-10-08,10월8일대웅제약069620및증권시세068변동,http://www.gokorea.kr/news/articleView.html?idxno=519089
5969,2019-10-08,10월8일대웅제약주식증권102148500원,http://nbntv.co.kr/news/view/677572
5970,2019-10-08,리포트브리핑대웅제약나보타해외수출이알비스관련실적악화를방어할전망목표가260000원SK증권,http://www.newspim.com/news/view/20191008000587
5971,2019-10-08,GET투자리포트대웅제약투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=2019100810303011736tpgetnews_16
5972,2019-10-08,대웅제약말바꾸는메디톡스명백한소송사기,http://www.dailymedi.com/detail.php?number=848191&thread=22r05
5973,2019-10-08,메디톡스대웅제약과소송에미국검찰검사장출신선임,http://www.upinews.kr/newsView/upi201910080055
5974,2019-10-08,메디톡스대웅제약과美ITC소송법정대리인에뉴욕검사장출신선임,http://biz.chosun.com/site/data/html_dir/2019/10/08/2019100801635.html
5975,2019-10-09,국내서보톡스전쟁대웅제약⋅메디톡스해외경쟁도가열,http://biz.chosun.com/site/data/html_dir/2019/10/08/2019100802455.html
5976,2019-10-09,메디톡스대웅제약과美ITC소송법정대리인에뉴욕검사장출신선임,http://www.updownnews.co.kr/news/articleView.html?idxno=209487
5977,2019-10-10,대웅제약vs메디톡스보툴리눔톡신자존심넘어회사명운사활,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235869
5978,2019-10-10,대웅제약주가10월10일현재151500원및증권시세및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=521040
5979,2019-10-10,10월10일대웅제약증권매매154000원233,http://nbntv.co.kr/news/view/679997
5980,2019-10-10,대웅제약메디톡스거짓말말바꾸기즉각중단해야”,http://www.skyedaily.com/news/news_view.html?ID=91730
5981,2019-10-10,대웅제약vs메디톡스보툴리눔톡신균주논란이어져,http://medicalworldnews.co.kr/news/view.php?idx=1510932747
5982,2019-10-11,대웅제약실시간증시11일현재151500원,http://nbntv.co.kr/news/view/682354
5983,2019-10-11,대웅제약메디톡스균주포자형성에제2의인보사우려,http://www.newsprime.co.kr/news/article.html?no=478688
5984,2019-10-12,굿닥터글로벌블록버스터로기대감높이는대웅제약나보타,http://www.g-enews.com/ko-kr/news/article/news_all/20191010171147795569d76442fa_1/article.html
5985,2019-10-14,대웅제약주가종목그래프14일오늘가격150500원,http://www.gokorea.kr/news/articleView.html?idxno=524502
5986,2019-10-14,대웅제약증권주식14일현재150500원,http://nbntv.co.kr/news/view/684637
5987,2019-10-14,한올바이오파마대웅제약공동개발안구건조증치료제中임상2상완료,http://www.dt.co.kr/contents.html?article_no=2019101402109931102002&ref=naver
5988,2019-10-14,전승호대웅제약제2의나보타안구건조증치료제개발에속도붙여,http://www.businesspost.co.kr/BP?command=article_view&num=146853
5989,2019-10-15,대웅제약과메디톡스의균주유전적으로달라,http://www.newsway.co.kr/news/view?tp=1&ud=2019101507224418237
5990,2019-10-15,대웅제약유전자분석결과메디톡스균주와달라1보,http://news1.kr/articles/?3743470
5991,2019-10-15,대웅제약메디톡스균주유전적으로다르다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019101507362959886
5992,2019-10-15,메디톡스대웅제약보툴리눔균주메디톡스에서유래했다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236075
5993,2019-10-15,대웅제약메디톡스와균주유전적달라소송전승리자신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236074
5994,2019-10-15,대웅제약메디톡스균주유전적으로달라전문가통해입증,http://www.medisobizanews.com/news/articleView.html?idxno=63128
5995,2019-10-15,대웅제약보툴리눔균주메디톡스와유전적으로달라,http://www.newspim.com/news/view/20191015000049
5996,2019-10-15,대웅제약美ITC소송에서메디톡스와균주유전적으로다름입증”,http://www.ajunews.com/view/20191015083837833
5997,2019-10-15,메디톡스대웅제약이균주훔쳤다는분석나와,http://news.mt.co.kr/mtview.php?no=2019101508394333953
5998,2019-10-15,메디톡스대웅제약이균주도용했다는사실이명백해져,http://www.newspim.com/news/view/20191015000061
5999,2019-10-15,대웅제약메디톡스균주와유전적다름명백히입증상보,http://news1.kr/articles/?3743504
6000,2019-10-15,대웅제약메디톡스균주유전적으로달라,http://www.ebn.co.kr/news/view/1004775
6001,2019-10-15,대웅제약메디톡스균주유전적으로달라美소송자신,http://www.newsis.com/view/?id=NISX20191015_0000798735&cID=13001&pID=13000
6002,2019-10-15,대웅제약나보타균주메디톡스균주와유전적으로달라,http://news.mt.co.kr/mtview.php?no=2019101508514716422
6003,2019-10-15,균주전쟁대웅제약메디톡스ITC제출자료로재충돌,http://www.newstomato.com/ReadNews.aspx?no=926139
6004,2019-10-15,대웅제약메디톡스균주유전적으로달라전문가통해입증,http://www.seoulwire.com/news/articleView.html?idxno=235632
6005,2019-10-15,메디톡스대웅제약균주전쟁점입가경우리가맞다,http://www.sisafocus.co.kr/news/articleView.html?idxno=223364
6006,2019-10-15,메디톡스측전문가보고서는오류투성이대웅제약전문가반박보고서공개,http://www.segye.com/content/html/2019/10/15/20191015503123.html?OutUrl=naver
6007,2019-10-15,대웅제약보툴리눔균메디톡스균과유전적으로다르다,http://www.econovill.com/news/articleView.html?idxno=374652
6008,2019-10-15,대웅제약메디톡스균주와유전형표현형차이입증했다”,http://daily.hankooki.com/lpage/ittech/201910/dh20191015091421145630.htm
6009,2019-10-15,대웅제약메디톡스의균주유전적으로달라美ITC소송에서전문가통해입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=16585
6010,2019-10-15,대웅제약메디톡스균주와다르다,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88381
6011,2019-10-15,메디톡스대웅제약균주메디톡스균주에서유래주장,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910150042&t=NN
6012,2019-10-15,메디톡스대웅제약끝나지않은보톡스전쟁美ITC소송보고서공개,https://biz.chosun.com/site/data/html_dir/2019/10/15/2019101500711.html
6013,2019-10-15,메디톡스대웅제약이균주훔친것으로결론”대웅의견반박,http://daily.hankooki.com/lpage/ittech/201910/dh20191015093245145630.htm
6014,2019-10-15,종합끝없는보톡스전쟁대웅제약메디톡스ITC보고서도평행선,http://www.newspim.com/news/view/20191015000226
6015,2019-10-15,대웅제약자사균주메디톡스와유전자포자명확히달라,http://www.sportsseoul.com/news/read/833344
6016,2019-10-15,대웅제약메디톡스거짓말무고법적책임묻겠다,http://www.bosa.co.kr/news/articleView.html?idxno=2114064
6017,2019-10-15,대웅제약vs메디톡스균주전쟁점입가경美ITC판단은,http://news.mt.co.kr/mtview.php?no=2019101509491569672
6018,2019-10-15,10월15일대웅제약및증권시세및증권정보와종목동정000변동해,http://www.gokorea.kr/news/articleView.html?idxno=526289
6019,2019-10-15,대웅제약나보타치료적응증시장확대박차,http://www.lawissue.co.kr/view.php?ud=201910151034375250204ead0791_12
6020,2019-10-15,대웅제약메디톡스균주유전적으로달라ITC소송보고서공개,http://www.newsprime.co.kr/news/article.html?no=479015
6021,2019-10-15,대웅제약과메디톡스의균주유전적으로달라미국ITC소송에서유전자분석전문가통해입증,http://newsbrite.net/128116
6022,2019-10-15,이지보고서대웅제약메디톡스美ITC소송보고서공개균주감정결과입장차여전,http://www.ezyeconomy.com/news/articleView.html?idxno=94505
6023,2019-10-15,10월15일대웅제약주식장033150500원,http://nbntv.co.kr/news/view/686929
6024,2019-10-15,대웅제약메디톡스또진실게임ITC보고서도정면대립,https://www.hankyung.com/finance/article/2019101552686
6025,2019-10-15,대웅제약메디톡스상반된균주분석발표ITC판단주목,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1073200
6026,2019-10-15,균주놓고엇갈린분석대웅제약vs메디톡스공방전지속,http://www.monews.co.kr/news/articleView.html?idxno=205731
6027,2019-10-15,대웅제약메디톡스균주분석간극못좁힌채美공방시작,http://www.newsis.com/view/?id=NISX20191015_0000799216&cID=13001&pID=13000
6028,2019-10-15,갈수록헷갈리는메디톡스대웅제약보톡스전쟁,http://www.seouleconews.com/news/articleView.html?idxno=51928
6029,2019-10-15,대웅제약메디톡스균주유전적으로달라미국ITC소송서유전자분석전문가통해입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=367414
6030,2019-10-15,메디톡스vs대웅제약불붙은보툴리눔톡신ITC공방전,http://asiatime.co.kr/news/newsview.php?ncode=1065588369003954
6031,2019-10-15,더벨대웅제약복수주관사단구성수요부진의식했나,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910140100022100001373
6032,2019-10-15,메디톡스대웅제약보톡스출처놓고ITC제출보고서결론공개,http://news.mk.co.kr/newsRead.php?year=2019&no=833320
6033,2019-10-15,대웅제약메디톡스의균주유전적으로달라,http://www.fnnews.com/news/201910151441162936
6034,2019-10-15,대웅제약메디톡스균주유전적으로달라전문가통해입증,https://www.kpanews.co.kr/article/show.asp?idx=207546&category=D
6035,2019-10-15,진흙탕싸움된보톡스공방메디톡스대웅제약메디톡신균주받아시험진행,http://www.newspim.com/news/view/20191015000815
6036,2019-10-15,메디톡스대웅제약셔먼박사보고서전체공개하라,http://www.newsprime.co.kr/news/article.html?no=479089
6037,2019-10-15,대웅제약메디톡스균주전쟁점입가경내년2월재판시작,http://www.etnews.com/20191015000262
6038,2019-10-15,나보타균주공방재가열대웅제약유전적으로달라vs메디톡스도용확실,http://www.etoday.co.kr/news/section/newsview.php?idxno=1809548
6039,2019-10-15,대웅제약메디톡스균주와유전적차이입증,https://www.hankyung.com/it/article/201910156011i
6040,2019-10-15,메디톡스대웅제약이메디톡스균주훔쳤다”,http://www.sporbiz.co.kr/news/articleView.html?idxno=383141
6041,2019-10-15,메디톡스vs대웅제약또정면충돌ITC보고서상반된결과,http://biz.newdaily.co.kr/site/data/html/2019/10/15/2019101500145.html
6042,2019-10-15,전체보고서공개하자메디톡스대웅제약압박,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019101515501176834
6043,2019-10-15,포자에이어유전자까지대웅제약메디톡스보톡스전쟁2라운드,https://www.nocutnews.co.kr/news/5228154
6044,2019-10-15,메디톡스ITC제출보고서전체공개하자”대웅제약에제안,http://www.hankookilbo.com/news/npath/201910151575747080?did=NA
6045,2019-10-15,보톡스균주도용다툼대웅제약vs메디톡스장외공방전시끌,http://www.edaily.co.kr/news/newspath.asp?newsid=03719526622653248
6046,2019-10-15,메디톡스대웅제약균주한국에서분리동정불가능,https://www.hankyung.com/it/article/201910156177i
6047,2019-10-15,고혈압치료제강자아타칸판권향배는대웅제약종근당물망,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019101511313923006
6048,2019-10-15,대웅제약나보타메디톡스의균주유전적으로달라,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57658
6049,2019-10-15,대웅제약메디톡스보톡스전쟁의기원은,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019101509541219396
6050,2019-10-15,메디톡스ITC제출보고서전체공개압박대웅제약입장은,http://inthenews.co.kr/article-19906/
6051,2019-10-15,메디톡스대웅제약ITC제출전문가보고서두고설전,http://www.upinews.kr/newsView/upi201910150093
6052,2019-10-15,궁지몰린메디톡스대웅제약균주소송전유리,http://www.newsclaim.co.kr/news/articleView.html?idxno=2273
6053,2019-10-15,대웅제약메디톡스ITC보고서혈투,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910150155&t=NNv
6054,2019-10-15,메디톡스대웅제약ITC에제출된전체보고서공개에동의해야,http://www.newstomato.com/ReadNews.aspx?no=926405
6055,2019-10-15,메디톡스대웅제약전체보고서공개에동의해야,http://www.ebn.co.kr/news/view/1004934
6056,2019-10-15,메디톡스대웅제약보톡스균주출처두고서로다른결론공방,https://cnbc.sbs.co.kr/article_hub/10000958525?division=NAVER
6057,2019-10-15,질긴대웅제약과메디톡스보툴리눔톡신균주보고서결과로재충돌,http://www.businesspost.co.kr/BP?command=article_view&num=147046
6058,2019-10-15,대웅제약메디톡스美법정서도진흙탕싸움,http://www.dt.co.kr/contents.html?article_no=2019101602101531102002&ref=naver
6059,2019-10-15,대웅제약미국ITC전문가반박보고서공개대웅제약과메디톡스의균주유전적으로달라,http://www.thefirstmedia.net/news/articleView.html?idxno=49498
6060,2019-10-16,대웅제약vs메디톡스균주두고논란지속미국ITC재판부제출보고서일부공개,http://medicalworldnews.co.kr/news/view.php?idx=1510932769
6061,2019-10-16,대웅제약메디톡스상대미국ICT소송승리자신,http://www.dailymedi.com/detail.php?number=848483&thread=22r05
6062,2019-10-16,대웅제약메디톡스ITC발표마다난타전왜,http://www.econovill.com/news/articleView.html?idxno=374770
6063,2019-10-16,대웅제약메디톡스보툴리눔균주논란누가거짓말하나,http://www.rapportian.com/news/articleView.html?idxno=120667
6064,2019-10-16,대웅제약메디톡스의균주유전적으로달라,http://www.nbnnews.co.kr/news/articleView.html?idxno=329155
6065,2019-10-16,대웅제약메디톡스보톡스균주전쟁심화ITC최종결론언제,http://moneys.mt.co.kr/news/mwView.php?no=2019101608558082775
6066,2019-10-16,보톡스균주출처논란메디톡스유전자분석내용전부공개하자대웅제약거부강력대응,http://www.wsobi.com/news/articleView.html?idxno=82847
6067,2019-10-16,대웅제약주가069620증권그래프및주식시황16일현재150500원,http://www.gokorea.kr/news/articleView.html?idxno=528199
6068,2019-10-16,보톡스균주주인은대웅제약메디톡스美서도공방,https://cnbc.sbs.co.kr/article_hub/10000958599?division=NAVER
6069,2019-10-16,대웅제약미국 ITC 소송서유전자전문가통해입증메디톡스균주우리와유전적차이있어,http://www.newslock.co.kr/news/articleView.html?idxno=22214
6070,2019-10-16,대웅제약미국 ITC 소송서유전자전문가통해입증메디톡스균주우리와유전적차이있어,http://www.newslock.co.kr/news/articleView.html?idxno=22214
6071,2019-10-16,또엇갈린주장대웅제약메디톡스염기서열분석결과도달라,http://news.tf.co.kr/read/economy/1765532.htm
6072,2019-10-16,대웅제약vs메디톡스보톡스전쟁은계속된다상반된보고서공개,http://www.thevaluenews.co.kr/news/view.php?idx=157079
6073,2019-10-16,마켓인사이트대웅제약회사채1000억발행,https://www.hankyung.com/finance/article/201910168892u
6074,2019-10-16,보톡스전쟁혼전대웅제약균주독자발견에메디톡스반응은,http://www.sporbiz.co.kr/news/articleView.html?idxno=383444
6075,2019-10-16,대웅제약VS메디톡스보툴리눔균주전쟁브레이크가없다,http://www.straightnews.co.kr/news/articleView.html?idxno=57662
6076,2019-10-16,대웅제약1000억원규모회사채발행추진,http://www.mdtoday.co.kr/mdtoday/index.html?no=367568
6077,2019-10-16,이슈체크메디톡스대웅제약보툴리눔보톡스균주공방,https://cnbc.sbs.co.kr/article_hub/10000958697?division=NAVER
6078,2019-10-17,대웅제약보톡스누시바캐나다본격출시,https://view.asiae.co.kr/article/2019101707215801579
6079,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.bosa.co.kr/news/articleView.html?idxno=2114205
6080,2019-10-17,대웅제약보툴리눔톡신제제누시바캐나다출시,https://www.hankyung.com/finance/article/2019101702366
6081,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.lawissue.co.kr/view.php?ud=20191017073945284204ead0791_12
6082,2019-10-17,대웅제약제조보툴리눔톡신캐나다출시,https://biz.chosun.com/site/data/html_dir/2019/10/17/2019101700569.html
6083,2019-10-17,대웅제약보톨리눔톡신캐나다출시,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88419
6084,2019-10-17,대웅제약나보타수출로영업이익개선기대매수신한금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1810331
6085,2019-10-17,대웅제약보툴리눔톡신누시바캐나다출시美유럽이어,http://www.medisobizanews.com/news/articleView.html?idxno=63212
6086,2019-10-17,대웅제약낮아진눈높이목표주가유지신한,http://news.mt.co.kr/mtview.php?no=2019101708103958092
6087,2019-10-17,대웅제약나보타수출확대이익증가기대신한금융투자,http://www.fnnews.com/news/201910170816201488
6088,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://news.heraldcorp.com/view.php?ud=20191017000024
6089,2019-10-17,신한금융투자대웅제약경쟁업체와불확실한소송여전낮아진눈높이”,http://www.newsway.co.kr/news/view?tp=1&ud=2019101708221558353
6090,2019-10-17,대웅제약내년영업익견조한증가세주가도상승전망신한금융투자,http://www.dailian.co.kr/news/view/834351/?sc=naver
6091,2019-10-17,대웅제약3분기실적시장기대치밑돌듯”,https://www.sedaily.com/NewsView/1VPK1OO3K4
6092,2019-10-17,대웅제약보툴리눔톡신누시바캐나다출시,http://www.ajunews.com/view/20191017081822593
6093,2019-10-17,대웅제약3분기영업이익151억원전망,http://www.nspna.com/news/?mode=view&newsid=388197
6094,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019101708302728802
6095,2019-10-17,대웅제약보툴리눔톡신국산최초미국이어캐나다출시,http://www.newsis.com/view/?id=NISX20191017_0000801330&cID=13001&pID=13000
6096,2019-10-17,대웅제약보톡스캐나다출시클라리온과맞손,http://moneys.mt.co.kr/news/mwView.php?no=2019101708408071077
6097,2019-10-17,대웅제약나보타수출증가내년실적견조할것신한,http://www.edaily.co.kr/news/newspath.asp?newsid=01689206622653904
6098,2019-10-17,대웅제약보툴리눔톡신제제누시바캐나다서출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=367613
6099,2019-10-17,대웅제약제조보툴리눔톡신누시바캐나다본격출시,http://www.ceoscoredaily.com/news/article.html?no=61487
6100,2019-10-17,대웅제약보툴리눔톡신나보타캐나다본격출시,http://www.sportsseoul.com/news/read/834559
6101,2019-10-17,신한금투대웅제약3Q영업익컨센서스하회예상,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910170054&t=NN
6102,2019-10-17,대웅제약국산보툴리눔톡신최초美이어캐나다출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1810373
6103,2019-10-17,대웅제약보톡스제품누시바캐나다출시,http://www.edaily.co.kr/news/newspath.asp?newsid=01738406622653904
6104,2019-10-17,대웅제약나보타미국유럽이어캐나다진출,http://www.newspim.com/news/view/20191017000059
6105,2019-10-17,대웅제약보툴리눔톡신나보타캐나다시장출시,http://medipana.com/news/news_viewer.asp?NewsNum=247074&MainKind=A&NewsKind=5&vCount=12&vKind=1
6106,2019-10-17,특징주대웅제약보툴리눔톡신캐나다수출소식에강세,http://www.newsis.com/view/?id=NISX20191017_0000801405&cID=10401&pID=10400
6107,2019-10-17,대웅제약제조보툴리눔톡신캐나다출시,http://www.ebn.co.kr/news/view/1005158
6108,2019-10-17,대웅제약보툴리눔톡신누시바캐나다출사표,http://www.econovill.com/news/articleView.html?idxno=374928
6109,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.joseilbo.com/news/news_read.php?uid=385725&class=27&grp=
6110,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://news.mk.co.kr/newsRead.php?year=2019&no=840772
6111,2019-10-17,신한금투대웅제약내년실적예상보다낮아질듯목표주가는유지,http://www.newsis.com/view/?id=NISX20191017_0000801406&cID=10401&pID=10400
6112,2019-10-17,신한금융투자대웅제약3분기실적기대이하내년반등전망,http://www.viva100.com/main/view.php?key=20191017010005379
6113,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://daily.hankooki.com/lpage/ittech/201910/dh20191017091718145630.htm
6114,2019-10-17,대웅제약보툴리눔톡신 캐나다본격출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=37061
6115,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=16715
6116,2019-10-17,대웅제약보툴리눔톡신미국에이어캐나다본격출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019101700038
6117,2019-10-17,대웅제약보툴리눔톡신캐나다출시,http://news.mt.co.kr/mtview.php?no=2019101709012395525
6118,2019-10-17,대웅제약보툴리눔톡신제제캐나다공식출시,http://www.mhj21.com/125047
6119,2019-10-17,대웅제약보툴리눔톡신누시바캐나다출시,http://www.etnews.com/20191017000017
6120,2019-10-17,대웅제약제조보툴리눔톡신캐나다출시,http://www.rpm9.com/news/article.html?id=20191017090007
6121,2019-10-17,대웅제약눈높이낮춰야할실적,http://www.newsprime.co.kr/news/article.html?no=479398
6122,2019-10-17,대웅제약나보타→제품명누시바로캐나다공식출시,http://inthenews.co.kr/article-20190/
6123,2019-10-17,리포트브리핑대웅제약눈높이낮추어야할실적목표가195000원신한금융투자,http://www.newspim.com/news/view/20191017000238
6124,2019-10-17,대웅제약보툴리눔톡신캐나다출시,http://fn.segye.com/content/html/2019/10/17/20191017503944.html?OutUrl=naver
6125,2019-10-17,GET투자리포트대웅제약투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=2019101710303012083tpgetnews_16
6126,2019-10-17,대웅제약보툴리눔톡신美이어캐나다출시북미시장적극공략,http://www.newswatch.kr/news/articleView.html?idxno=24415
6127,2019-10-17,대웅제약누시바국산보톡스최초캐나다출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=257879&REFERER=NP
6128,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시로미주시장본격공략,http://www.getnews.co.kr/view.php?ud=2019101709562729841d0c69529_16
6129,2019-10-17,대웅제약국산보툴리눔톡신누시바캐나다진출본격화,http://www.newslock.co.kr/news/articleView.html?idxno=22256
6130,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236204
6131,2019-10-17,대웅제약보툴리눔톡신누시바캐나다본격출시,http://www.viva100.com/main/view.php?key=20191017010005426
6132,2019-10-17,특징주대웅제약투자의견매수목표주가19만5000원,http://www.sisaon.co.kr/news/articleView.html?idxno=102716
6133,2019-10-17,북미시장공략박차”대웅제약나보타美이어캐나다서공식출시,http://www.donga.com/news/article/all/20191017/97916821/1
6134,2019-10-17,대웅제약보툴리눔톡신제제누시바캐나다공식출시,http://www.newsprime.co.kr/news/article.html?no=479409
6135,2019-10-17,대웅제약캐나다서보툴리눔톡신제품출시,http://www.dailymedi.com/detail.php?number=848534&thread=22r05
6136,2019-10-17,대웅제약보톡스제제캐나다서공식출시,http://www.upinews.kr/newsView/upi201910170027
6137,2019-10-17,대웅제약보툴리눔톡신누시바캐나다출시소식에上,http://www.mdtoday.co.kr/mdtoday/index.html?no=367643
6138,2019-10-17,대웅제약3분기실적주춤보톡스수출장중주가반등,http://www.choicenews.co.kr/news/articleView.html?idxno=64981
6139,2019-10-17,대웅제약보툴리눔톡신제제누시바미국이어캐나다출시,http://www.updownnews.co.kr/news/articleView.html?idxno=209839
6140,2019-10-17,대웅제약주가및증권시세17일오늘가격150000원형성,http://www.gokorea.kr/news/articleView.html?idxno=530068
6141,2019-10-17,대웅제약보툴리눔툭신나보타캐나다공식출시,http://www.kpinews.co.kr/news/articleView.html?idxno=105331
6142,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57700
6143,2019-10-17,대웅제약국산보툴리눔톡신최초로캐나다진출북미시장적극공략,http://www.ekn.kr/news/article.html?no=458546
6144,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.asiatoday.co.kr/view.php?key=20191017010009569
6145,2019-10-17,10월17일대웅제약주식창033150000원,http://nbntv.co.kr/news/view/691608
6146,2019-10-17,대웅제약누시바캐나다본격출시,http://www.economytalk.kr/news/articleView.html?idxno=199807
6147,2019-10-17,대웅제약캐나다서보툴리눔톡신누시바출시,http://news.mk.co.kr/newsRead.php?year=2019&no=841907
6148,2019-10-17,대웅제약제조보툴리눔톡신누시바캐나다본격출시,http://newsbrite.net/128290
6149,2019-10-17,대웅제약나보타캐나다시장출시현지제품명은누시바,http://www.rapportian.com/news/articleView.html?idxno=120711
6150,2019-10-17,대웅제약보툴리눔톡신누시바캐나다공식출시,http://www.youthdaily.co.kr/news/article.html?no=20248
6151,2019-10-17,대웅제약보툴리눔톡신제재나보타美이어캐나다에본격출시,https://www.sedaily.com/NewsView/1VPK2XVU9V
6152,2019-10-17,대웅제약자체개발보툴리눔톡신누시바를캐나다에서출시,http://www.businesspost.co.kr/BP?command=article_view&num=147308
6153,2019-10-17,대웅제약보툴리눔톡신나보타캐나다출시북미시장적극공략,http://www.g-enews.com/ko-kr/news/article/news_all/20191017143636478469d76442fa_1/article.html
6154,2019-10-17,대웅제약보툴리눔톡신제제나보타캐나다출시,http://yna.kr/AKR20191017112800017?did=1195m
6155,2019-10-17,대웅제약보툴리눔톡신캐나다본격출시누시바라는제품명으로북미시장출사표,http://www.segye.com/content/html/2019/10/17/20191017510786.html?OutUrl=naver
6156,2019-10-17,대웅제약토종주름개선제美이어캐나다진출,https://www.ajunews.com/view/20191017150719092
6157,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.bokuennews.com/news/article.html?no=182069
6158,2019-10-17,식약처회수명령받은메디톡스대웅제약과보톡스전쟁영향은,http://www.etoday.co.kr/news/section/newsview.php?idxno=1810711
6159,2019-10-17,대웅제약보툴리눔톡신캐나다본격출시,http://health.chosun.com/site/data/html_dir/2019/10/17/2019101702034.html
6160,2019-10-17,대웅제약나보타캐나다본격출시,http://www.newstomato.com/ReadNews.aspx?no=926998
6161,2019-10-17,대웅제약제조보툴리눔톡신누시바캐나다공식출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=67884
6162,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.munhwa.com/news/view.html?no=20191017MW165308538640
6163,2019-10-17,대웅제약캐나다서보툴리눔톡신출시,http://www.finomy.com/news/articleView.html?idxno=70520
6164,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.wolyo.co.kr/news/articleView.html?idxno=95765
6165,2019-10-17,대웅제약메디톡스보툴리눔톡신전쟁중희비엇갈려,http://www.newspim.com/news/view/20191017001175
6166,2019-10-17,대웅제약보툴리눔톡신제제나보타캐나다출시,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3961772
6167,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.betanews.net:8080/article/1056937.html
6168,2019-10-18,대웅제약나보타균주출처논란에도잘나가는이유는,http://news.tf.co.kr/read/economy/1765665.htm
6169,2019-10-18,대웅제약나보타미국이어캐나다에서도출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1214595
6170,2019-10-18,소송중두회사의엇갈린행보메디톡스주춤vs대웅제약비상,http://kpenews.com/View.aspx?No=294306
6171,2019-10-18,10월18일대웅제약실시간증시067149500원,http://nbntv.co.kr/news/view/693823
6172,2019-10-18,대웅제약해외의사교육나보타마스터클래스통해우수성전파,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236267
6173,2019-10-18,대웅제약보툴리눔톡신나보타캐나다진출,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1073332
6174,2019-10-18,대웅제약해외의사대상나보타마스터클래스개최,http://medipana.com/news/news_viewer.asp?NewsNum=247163&MainKind=A&NewsKind=5&vCount=12&vKind=1
6175,2019-10-18,대웅제약K뷰티세몰이각국의사상대나보타클래스릴레이,http://news.heraldcorp.com/view.php?ud=20191018000498
6176,2019-10-18,대웅제약나보타캐나다본격출시 ,http://www.monews.co.kr/news/articleView.html?idxno=205818
6177,2019-10-18,대웅제약해외의사대상나보타교육프로그램진행,http://news.mt.co.kr/mtview.php?no=2019101811403291928
6178,2019-10-18,대웅제약외국의사교육나보타 마스터클래스성료,http://www.medisobizanews.com/news/articleView.html?idxno=63259
6179,2019-10-18,대웅제약나보타마스터클래스해외의사교육으로나보타우수성전파,http://www.newslock.co.kr/news/articleView.html?idxno=22323
6180,2019-10-18,대웅제약해외의사교육나보타마스터클래스진행,http://www.bosa.co.kr/news/articleView.html?idxno=2114320
6181,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019101800059
6182,2019-10-18,대웅제약해외의사대상나보타마스터클래스개최,http://www.seoulwire.com/news/articleView.html?idxno=238593
6183,2019-10-18,대웅제약이틀간나보타마스터클래스진행해외의사초청,http://www.youthdaily.co.kr/news/article.html?no=20361
6184,2019-10-18,대웅제약나보타마스터클래스통해우수성전파,http://www.ebn.co.kr/news/view/1005372
6185,2019-10-18,대웅제약해외의사대상나보타마스터클래스개최,http://www.donga.com/news/article/all/20191018/97939594/1
6186,2019-10-18,대웅제약나보타해외전문의대상으로효능뽐내,http://www.econovill.com/news/articleView.html?idxno=375065
6187,2019-10-18,대웅제약나보타마스터클래스로해외의료진대상나보타우수성전파,http://www.getnews.co.kr/view.php?ud=20191018135055446041d0c69529_16
6188,2019-10-18,대웅제약나보타마스터클래스진행,http://moneys.mt.co.kr/news/mwView.php?no=2019101814048045924
6189,2019-10-18,대웅제약해외의료진대상나보타우수성전파,http://www.dailysmart.co.kr/news/articleView.html?idxno=16825
6190,2019-10-18,제약오늘대웅제약해외의사교육프로그램나보타마스터클래스진행,http://www.sisaon.co.kr/news/articleView.html?idxno=102822
6191,2019-10-18,대웅제약해외의사초청해보툴리눔톡신나보타우수성알려,http://www.businesspost.co.kr/BP?command=article_view&num=147481
6192,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스성료,http://www.ekn.kr/news/article.html?no=458797
6193,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스개최,http://www.dailian.co.kr/news/view/834987/?sc=naver
6194,2019-10-18,대웅제약나보타마스터클래스통해나보타우수성전파,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57721
6195,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스통해나보타우수성전파,http://www.lawissue.co.kr/view.php?ud=201910181456317558204ead0791_12
6196,2019-10-18,대웅제약해외의사대상나보타마스터클래스개최,http://www.newspim.com/news/view/20191018000775
6197,2019-10-18,더벨대웅제약위축된A급투심이겨내나,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910170100028130001756
6198,2019-10-18,대웅제약해외의사교육프로그램통해나보타우수성전파,http://daily.hankooki.com/lpage/ittech/201910/dh20191018152944145630.htm
6199,2019-10-18,대웅제약외국의사대상교육프로그램나보타마스터클래스개최,http://news.mk.co.kr/newsRead.php?year=2019&no=847727
6200,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스진행,http://fn.segye.com/content/html/2019/10/18/20191018509461.html?OutUrl=naver
6201,2019-10-18,대웅제약나보타해외의사교육프로그램나보타마스터클래스진행,https://www.sedaily.com/NewsView/1VPKJV4MXM
6202,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스통해나보타우수성전파,http://newsbrite.net/128394
6203,2019-10-18,대웅제약나보타마스터클래스진행,http://www.wolyo.co.kr/news/articleView.html?idxno=95822
6204,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스성료,http://www.mdtoday.co.kr/mdtoday/index.html?no=367827
6205,2019-10-18,대웅제약해외의사교육프로그램진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1343175
6206,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스통해나보타우수성전파,http://www.businesskorea.co.kr/news/articleView.html?idxno=37151
6207,2019-10-18,대웅제약나보타마스터클래스로나보타우수성전파,http://www.newscj.com/news/articleView.html?idxno=676019
6208,2019-10-19,메디톡스대웅제약보톡스전쟁4년전말,https://view.asiae.co.kr/article/2019101900570047232
6209,2019-10-20,대웅제약나보타마스터클래스개최나보타우수성전파,http://www.viva100.com/main/view.php?key=20191020010006137
6210,2019-10-20,전승호대웅제약통증따라다른액상형진통제로시장공략공세,http://www.businesspost.co.kr/BP?command=article_view&num=147603
6211,2019-10-20,대웅제약자체개발보툴리눔톡신국산최초미국이어캐나다출시,http://www.econonews.co.kr/news/articleView.html?idxno=91536
6212,2019-10-21,대웅제약해외의사교육프로그램나보타마스터클래스통해나보타우수성전파,http://www.thefirstmedia.net/news/articleView.html?idxno=49656
6213,2019-10-21,대웅제약해외의사대상나보타마스터클래스개최,http://www.monews.co.kr/news/articleView.html?idxno=205822
6214,2019-10-21,대웅제약주가06962010월21일오늘거래가148500원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=533996
6215,2019-10-21,대웅제약증권매매21일현재148500원,http://nbntv.co.kr/news/view/696138
6216,2019-10-21,대웅제약무보증사채신용등급A,http://www.mdtoday.co.kr/mdtoday/index.html?no=367968
6217,2019-10-22,현대종합상사대웅제약A등급걱정털고자금조달성공할까,http://www.etoday.co.kr/news/section/newsview.php?idxno=1812048
6218,2019-10-22,대웅제약전승호윤재춘대표체제서해외종속기업적자7배↑,http://www.datanews.co.kr/news/article.html?no=104869
6219,2019-10-22,보톡스전쟁에맥빠진메디톡스대웅제약승자는휴젤,http://www.enewstoday.co.kr/news/articleView.html?idxno=1343702
6220,2019-10-22,대웅제약미국신경과학회서만성통증치료제신약연구발표,http://www.newstomato.com/ReadNews.aspx?no=927804
6221,2019-10-22,대웅제약주가10월22일현재150000원종목그래프외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=535960
6222,2019-10-22,10월22일대웅제약주식추천주033149500원,http://nbntv.co.kr/news/view/698432
6223,2019-10-22,대웅제약美SFN서만성통증치료제신약연구발표,http://www.economytalk.kr/news/articleView.html?idxno=200002
6224,2019-10-23,대웅제약분기최고실적이위축된투자심리이겨낼까,https://www.ajunews.com/view/20191022154915878
6225,2019-10-23,대웅제약주가및증권시세및종목관련동향정보23일오늘가격150000원,http://www.gokorea.kr/news/articleView.html?idxno=537820
6226,2019-10-23,대웅제약증권매매23일현재149500원,http://nbntv.co.kr/news/view/700673
6227,2019-10-23,대웅제약미국신경과학회서만성통증치료제신약연구발표,http://asiatime.co.kr/news/newsview.php?ncode=1065597679743859
6228,2019-10-23,제약업계3분기실적공개임박대웅제약동아ST주목,http://www.sisajournal-e.com/news/articleView.html?idxno=207912
6229,2019-10-24,대웅제약관계사디엔컴퍼니이지듀홈앤쇼핑서판매,http://moneys.mt.co.kr/news/mwView.php?no=2019102410128043898
6230,2019-10-24,대웅제약유럽서위식도역류질환치료제다인종임상1상결과발표,http://www.viva100.com/main/view.php?key=20191024010007859
6231,2019-10-24,대웅제약위식도역류질환치료제DWP14012다인종1상임상결과발표,http://www.ftoday.co.kr/news/articleView.html?idxno=112213
6232,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제1상발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236511
6233,2019-10-24,대웅제약유럽소화기학회서DWP14012다인종1상임상결과발표,http://www.newspim.com/news/view/20191024000558
6234,2019-10-24,대웅제약유럽소화기학회서DWP140121상임상결과발표,http://www.ebn.co.kr/news/view/1006179/?sc=naver
6235,2019-10-24,대웅제약유럽학회서차세대위식도역류질환치료제임상데이터발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1813421
6236,2019-10-24,대웅제약이지듀DWEGF프레좀RX크림홈앤쇼핑24일방송,http://www.news2day.co.kr/139997
6237,2019-10-24,대웅제약위식도역류질환치료제다인종1상임상결과발표,http://daily.hankooki.com/lpage/ittech/201910/dh20191024112044145630.htm
6238,2019-10-24,대웅제약위식도역류치료제다인종서약효확인,http://www.medisobizanews.com/news/articleView.html?idxno=63430
6239,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제DWP14012다인종1상임상결과발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=368352
6240,2019-10-24,대웅제약DWP14012다인종1상임상결과발표,http://www.bosa.co.kr/news/articleView.html?idxno=2114671
6241,2019-10-24,대웅제약유럽소화기학회서역류성식도염신약후보물질임상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=867803
6242,2019-10-24,대웅제약스페인서PPI약물DWP14012임상데이터공개,http://moneys.mt.co.kr/news/mwView.php?no=2019102411288077356
6243,2019-10-24,대웅제약인니재생의료사업지원RD생산기지구축착착,http://www.maeilnews.co.kr/news/article.html?no=5597
6244,2019-10-24,막말윤재승 대웅제약회장의막후경영노림수,http://www.ilyosisa.co.kr/news/articleView.html?idxno=209732
6245,2019-10-24,대웅제약유럽소화기학회서DWP14012다인종1상결과발표,http://medipana.com/news/news_viewer.asp?NewsNum=247493&MainKind=A&NewsKind=5&vCount=12&vKind=1
6246,2019-10-24,대웅제약유럽소화기학회서위식도역류질환신약1상임상결과발표,https://biz.chosun.com/site/data/html_dir/2019/10/24/2019102401384.html
6247,2019-10-24,대웅제약유럽소화기학회에서위식도역류질환치료제DWP14012다인종1상임상결과발표,http://newsbrite.net/128774
6248,2019-10-24,대웅제약위식도역류신약물질여러인종서동일한효능보여,http://news1.kr/articles/?3751672
6249,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제다인종1상임상결과발표,http://www.sisafocus.co.kr/news/articleView.html?idxno=224129
6250,2019-10-24,대웅제약 유럽소화기학회에서위식도역류질환치료제 DWP14012 다인종 1상임상결과발표,http://www.businesskorea.co.kr/news/articleView.html?idxno=37333
6251,2019-10-24,대웅제약위식도역류질환치료제DWP14012임상결과유럽소화기학회발표,http://www.getnews.co.kr/view.php?ud=20191024131141440541d0c69529_16
6252,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제1상발표,http://www.seoulwire.com/news/articleView.html?idxno=241847
6253,2019-10-24,대웅제약위식도역류질환치료제BestinClass목표,http://www.econovill.com/news/articleView.html?idxno=375581
6254,2019-10-24,대웅제약DWP14012다인종1상임상결과발표,http://www.medigatenews.com/news/2756863562
6255,2019-10-24,대웅제약위식도역류질환치료제DWP14012다인종1상임상결과발표,http://kormedi.com/?p=1304288
6256,2019-10-24,대웅제약바르셀로나서위식도역류질환치료제발표,http://www.youthdaily.co.kr/news/article.html?no=20872
6257,2019-10-24,대웅제약유럽서위식도역류질환치료제임상결과발표,http://www.etnews.com/20191024000274
6258,2019-10-24,대웅제약위식도역류치료제DWP14012임상결과인종간차이없어,http://www.newslock.co.kr/news/articleView.html?idxno=22582
6259,2019-10-24,대웅제약유럽학회서위식도역류질환치료제임상발표,https://www.paxnetnews.com/articles/53213
6260,2019-10-24,대웅제약위식도역류질환치료제다인종1상임상결과발표,http://www.wolyo.co.kr/news/articleView.html?idxno=96257
6261,2019-10-24,대웅제약유럽서위식도역류질환치료제1상결과발표,http://www.newsway.co.kr/news/view?tp=1&ud=2019102414381133801
6262,2019-10-24,대웅제약위식도역류질환치료제다인종1상임상결과발표약력학적인종간차이없다,http://www.updownnews.co.kr/news/articleView.html?idxno=210165
6263,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제DWP14012다인종1상임상결과발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57839
6264,2019-10-24,대웅제약유럽소화기학회위식도역류질환다인종1상발표,http://www.newsis.com/view/?id=NISX20191024_0000809084&cID=13001&pID=13000
6265,2019-10-24,대웅제약위식도역류질환치료제다인종1상임상결과발표,http://www.newstomato.com/ReadNews.aspx?no=928573
6266,2019-10-24,대웅제약유럽소화기학회서DW14012임상발표,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019102415221873532
6267,2019-10-24,대웅제약유럽소화기학회서위식도역류질환신약1상임상결과발표,http://www.ajunews.com/view/20191024153543672
6268,2019-10-24,대웅제약위식도역류질환신약임상1상효과확인,http://news.mt.co.kr/mtview.php?no=2019102413140364503
6269,2019-10-24,대웅제약위식도역류질환치료제다인종1상결과발표,http://health.chosun.com/site/data/html_dir/2019/10/24/2019102402181.html
6270,2019-10-24,대웅제약위식도역류질환신약다인종임상1상서효과확인,https://view.asiae.co.kr/article/2019102416183381112
6271,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료신약임상연구결과공개,http://www.g-enews.com/ko-kr/news/article/news_all/20191024160859732169d76442fa_1/article.html
6272,2019-10-24,대웅제약위식도역류질환치료제임상1상다인종간효과확인,http://kpenews.com/View.aspx?No=300458
6273,2019-10-24,대웅제약유럽학회서위식도역류질환치료제DWP14012임상결과발표,http://www.news2day.co.kr/140056
6274,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제다인종1상임상결과발표,http://www.sporbiz.co.kr/news/articleView.html?idxno=385933
6275,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제DWP140121상임상결과발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1344449
6276,2019-10-24,대웅제약유럽서위식도역류질환치료제임상결과발표,http://www.economytalk.kr/news/articleView.html?idxno=200164
6277,2019-10-24,대웅제약유럽학회서신약DWP14012임상결과발표,http://www.mhj21.com/125261
6278,2019-10-24,대웅제약위식도역류질환치료제다양한인종에효과확인,http://www.businesspost.co.kr/BP?command=article_view&num=148281
6279,2019-10-24,대웅제약위식도역류질환신약후보물질DWP14012유럽소개,http://www.sportsseoul.com/news/read/838661
6280,2019-10-24,대웅제약유럽서위식도역류질환치료제펙수프라잔다인종임상결과발표,http://www.donga.com/news/article/all/20191024/98057445/1
6281,2019-10-24,대웅제약DWP14012위산분비억제효과확인,http://www.finomy.com/news/articleView.html?idxno=70840
6282,2019-10-24,대웅제약위식도역류질환치료제다인종1상임상결과발표,http://www.newscj.com/news/articleView.html?idxno=677623
6283,2019-10-24,대웅제약국민20가알레르기비염코메키나로잡으세요,http://www.getnews.co.kr/view.php?ud=20191024212109739341d0c69529_16
6284,2019-10-25,대웅제약위식도역류질환치료제다인종1상결과발표,http://www.nbnnews.co.kr/news/articleView.html?idxno=332999
6285,2019-10-25,대웅제약유럽소화기학회에서위식도역류질환치료제DWP14012다인종1상임상결과발표,http://www.betanews.net:8080/article/1057739.html
6286,2019-10-25,대웅제약차세대위식도역류질환치료제인종간차이없어 ,http://www.monews.co.kr/news/articleView.html?idxno=205976
6287,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성증대,http://medipana.com/news/news_viewer.asp?NewsNum=247535&MainKind=A&NewsKind=5&vCount=12&vKind=1
6288,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성증대,http://www.ebn.co.kr/news/view/1006323/?sc=naver
6289,2019-10-25,대웅제약이지엔6프로리뉴얼알약축소,http://moneys.mt.co.kr/news/mwView.php?no=2019102509118028350
6290,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236541
6291,2019-10-25,대웅제약액상형진통제이지엔6프로먹기편해졌다,http://www.econovill.com/news/articleView.html?idxno=375647
6292,2019-10-25,대웅제약 작아진이지엔6프로출시복용편의성개선,http://www.medisobizanews.com/news/articleView.html?idxno=63448
6293,2019-10-25,대웅제약이지엔6프로리뉴얼로소비자복용편의성높인다,http://www.newspim.com/news/view/20191025000252
6294,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.dailysmart.co.kr/news/articleView.html?idxno=17156
6295,2019-10-25,대웅제약복용편의성확대한이지엔6프로출시,http://www.viva100.com/main/view.php?key=20191025010008164
6296,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성개선,http://www.seoulwire.com/news/articleView.html?idxno=242104
6297,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성증대,http://www.newsis.com/view/?id=NISX20191025_0000809734&cID=13001&pID=13000
6298,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성개선,http://www.dailymedi.com/detail.php?number=848843&thread=22r05
6299,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57845
6300,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성증대,http://daily.hankooki.com/lpage/ittech/201910/dh20191025095329145630.htm
6301,2019-10-25,작아진이지엔6프로대웅제약약제리뉴얼,http://www.mhj21.com/125274
6302,2019-10-25,대웅제약DWP14012다인종1상임상결과발표,http://www.bokuennews.com/news/article.html?no=182419
6303,2019-10-25,대웅제약이지엔6프로리뉴얼,http://www.enewstoday.co.kr/news/articleView.html?idxno=1344627
6304,2019-10-25,대웅제약이지엔6프로리뉴얼,http://www.enewstoday.co.kr/news/articleView.html?idxno=1344627
6305,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.ceoscoredaily.com/news/article.html?no=61781
6306,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.bokuennews.com/news/article.html?no=182428
6307,2019-10-25,대웅제약이지엔6프로리뉴얼,http://www.bosa.co.kr/news/articleView.html?idxno=2114762
6308,2019-10-25,대웅제약크기줄인진통제이지엔6프로재출시,http://health.chosun.com/site/data/html_dir/2019/10/25/2019102500968.html
6309,2019-10-25,대웅제약실시간주식현황25일현재149500원,http://nbntv.co.kr/news/view/705079
6310,2019-10-25,대웅제약소비자의견반영해액상형진통제이지엔6프로리뉴얼,http://news.mk.co.kr/newsRead.php?year=2019&no=872384
6311,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.economytalk.kr/news/articleView.html?idxno=200198
6312,2019-10-25,대웅제약복용편의성개선위해작아진이지엔6프로출시,http://www.updownnews.co.kr/news/articleView.html?idxno=210227
6313,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성증대,http://www.youthdaily.co.kr/news/article.html?no=20975
6314,2019-10-25,대웅제약액상형진통제이지엔6프로리뉴얼소비자복용편의성증대,http://www.newslock.co.kr/news/articleView.html?idxno=22645
6315,2019-10-25,대웅제약이지엔6프로리뉴얼출시,http://www.ezyeconomy.com/news/articleView.html?idxno=94817
6316,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://newsbrite.net/128847
6317,2019-10-25,대웅제약이지엔6프로재출시크기줄여,http://www.finomy.com/news/articleView.html?idxno=70889
6318,2019-10-25,대웅제약이지엔6프로리뉴얼출시,http://www.ajunews.com/view/20191025152225377
6319,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.asiatoday.co.kr/view.php?key=20191025010014624
6320,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.news2day.co.kr/140155
6321,2019-10-25,대웅제약진통제이지엔6프로복용편의성개선,http://www.kpinews.co.kr/news/articleView.html?idxno=105938
6322,2019-10-25,대웅제약이지엔6프로리뉴얼제형크기줄여복용편의성증대,http://kpenews.com/View.aspx?No=301622
6323,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.segye.com/content/html/2019/10/25/20191025510899.html?OutUrl=naver
6324,2019-10-25,더작고부드럽게대웅제약복용편의성높아진이지엔6프로출시,http://www.100ssd.co.kr/news/articleView.html?idxno=64949
6325,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.getnews.co.kr/view.php?ud=20191025171637777641d0c69529_16
6326,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성높여,http://www.wikileaks-kr.org/news/articleView.html?idxno=68514
6327,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.wsobi.com/news/articleView.html?idxno=83365
6328,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.mdtoday.co.kr/mdtoday/index.html?no=368461
6329,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.newscj.com/news/articleView.html?idxno=677943
6330,2019-10-26,대웅제약크기줄인진통제이지엔6프로재출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=333422
6331,2019-10-27,대웅제약이지엔6프로리뉴얼로소비자편의성증대,http://asiatime.co.kr/news/newsview.php?ncode=1065577392331202
6332,2019-10-28,갑질로물러난윤재승전대웅제약회장재단이사장등요직지키며영향력행사,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=534514
6333,2019-10-28,대웅제약유럽소화기학회서위식도역류질환치료제임상결과발표,http://www.ekn.kr/news/article.html?no=459906
6334,2019-10-28,대웅제약복용편의성높인이지엔6프로선봬,http://www.ekn.kr/news/article.html?no=460092
6335,2019-10-28,대웅제약주가069620및증권시세28일오늘거래가148500원형성,http://www.gokorea.kr/news/articleView.html?idxno=543449
6336,2019-10-28,오늘증권시세대웅제약주가28일현재148000원,http://nbntv.co.kr/news/view/707517
6337,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57871
6338,2019-10-28,대웅제약 인도네시아 소방관1000명대상의료봉사,http://www.medisobizanews.com/news/articleView.html?idxno=63492
6339,2019-10-28,대웅제약인니소방관에의료봉사활동진행,http://moneys.mt.co.kr/news/mwView.php?no=2019102811258065945
6340,2019-10-28,대웅제약인도네시아현지서의료봉사진행,http://www.economytalk.kr/news/articleView.html?idxno=200262
6341,2019-10-28,대웅제약인도네시아소방관대상의료봉사진행,http://weekly.cnbnews.com/news/article.html?no=130834
6342,2019-10-28,대웅제약의료봉사와협업으로인도네시아시장적극공략,http://www.metroseoul.co.kr/news/newsview?newscd=2019102800096
6343,2019-10-28,대웅제약위역류치료제유럽임상1상서효과확인,http://www.munhwa.com/news/view.html?no=2019102801072327107001
6344,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.lawissue.co.kr/view.php?ud=201910281228149171204ead0791_12
6345,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.betanews.net:8080/article/1057974.html
6346,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.ekn.kr/news/article.html?no=460561
6347,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.viva100.com/main/view.php?key=20191028010009031
6348,2019-10-28,브릿지바이오코스닥행확정에유한양행대웅제약투자가치↑,http://news1.kr/articles/?3754281
6349,2019-10-28,대웅제약인니소방관상대현지의료봉사,https://www.nocutnews.co.kr/news/5234257
6350,2019-10-28,더벨대웅제약A급자존심세웠다첫1대금리조달,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910250100046250002884
6351,2019-10-28,대웅제약인니현지소방관에게의료봉사실시,http://asiatime.co.kr/news/newsview.php?ncode=1065588555826277
6352,2019-10-28,대웅제약인도네시아소방관대상의료봉사진행,http://news.mk.co.kr/newsRead.php?year=2019&no=881268
6353,2019-10-28,대웅제약인도네시아소방관대상의료봉사진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236612
6354,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.newsway.co.kr/news/view?tp=1&ud=2019102814463595516
6355,2019-10-28,대웅제약인도네시아소방관대상의료봉사활동전개,http://www.rapportian.com/news/articleView.html?idxno=120968
6356,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사향후지원대상확대할것,http://www.segye.com/content/html/2019/10/28/20191028509655.html?OutUrl=naver
6357,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사,http://www.bokuennews.com/news/article.html?no=182506
6358,2019-10-28,대웅제약인도네시아소방관대상의료봉사진행,http://www.kpinews.co.kr/news/articleView.html?idxno=106063
6359,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사,http://www.bosa.co.kr/news/articleView.html?idxno=2114884
6360,2019-10-28,사회공헌대웅제약인도네시아현지소방관대상의료봉사,http://www.ezyeconomy.com/news/articleView.html?idxno=94865
6361,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=368594
6362,2019-10-28,대웅제약인도네시아현지소방관대상의료봉사진행,http://www.seoulwire.com/news/articleView.html?idxno=243751
6363,2019-10-28,대웅제약인도네시아소방관대상의료봉사,http://news.mt.co.kr/mtview.php?no=2019102815224077407
6364,2019-10-28,대웅제약인도네시아소방관대상의료봉사진행,http://www.youthdaily.co.kr/news/article.html?no=21152
6365,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://newsbrite.net/129001
6366,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://medipana.com/news/news_viewer.asp?NewsNum=247649&MainKind=A&NewsKind=5&vCount=12&vKind=1
6367,2019-10-28,대웅제약인도네시아현지소방관1000여명에의료봉사진행인도네시아바이오산업발전에기여할것,http://www.updownnews.co.kr/news/articleView.html?idxno=210302
6368,2019-10-28,대웅제약인도네시아현지소방관대상의료봉사진행,http://www.dailian.co.kr/news/view/837927/?sc=naver
6369,2019-10-28,대웅제약인도네시아소방관대상의료봉사,http://www.skyedaily.com/news/news_view.html?ID=92776
6370,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사,http://www.dailysmart.co.kr/news/articleView.html?idxno=17277
6371,2019-10-28,대웅제약인도네시아와협력강화소방관대상의료봉사진행,http://www.econovill.com/news/articleView.html?idxno=375895
6372,2019-10-28,대웅제약그룹압수수색현장조사매출손실등겹악재에곤혹,http://www.sisajournal-e.com/news/articleView.html?idxno=208116
6373,2019-10-28,대웅제약印泥소방관대상해외의료봉사진행,http://daily.hankooki.com/lpage/ittech/201910/dh20191028174814145630.htm
6374,2019-10-28,대웅제약인도네시아소방관1000여명대상의료봉사,http://www.etoday.co.kr/news/section/newsview.php?idxno=1814871
6375,2019-10-28,대웅제약인도네시아현지소방관대상의료봉사진행,http://www.wikileaks-kr.org/news/articleView.html?idxno=68690
6376,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.getnews.co.kr/view.php?ud=20191028183450740541d0c69529_16
6377,2019-10-28,대웅제약인도네시아소방관대상해외의료봉사,http://www.news2day.co.kr/140339
6378,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.newscj.com/news/articleView.html?idxno=678537
6379,2019-10-29,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.thefirstmedia.net/news/articleView.html?idxno=49983
6380,2019-10-29,대웅제약매출원가율줄여영업이익154↑,http://www.datanews.co.kr/news/article.html?no=104935
6381,2019-10-29,★주식인사이드대웅제약주가148500원10월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1042834
6382,2019-10-29,대웅제약SAPS4HANA로전사업무혁신,http://www.etnews.com/20191029000074
6383,2019-10-29,대웅제약차세대ERPUX솔루션RPA로일하는방식바꿨다,http://www.dt.co.kr/contents.html?article_no=2019102902109931650004&ref=naver
6384,2019-10-29,대웅제약오늘주식시세29일현재149500원,http://nbntv.co.kr/news/view/709770
6385,2019-10-29,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1345415
6386,2019-10-29,더벨대웅제약고함량치매치료제출시두고고심,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910280100051920003237
6387,2019-10-29,대웅제약SAPS4HANARPA로업무방식개선,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20191029151917
6388,2019-10-29,대웅제약SAPS4HANA도입,http://www.ddaily.co.kr/news/article.html?no=187540
6389,2019-10-29,대웅제약SAPS4HANA도입해전사업무혁신,http://www.datanet.co.kr/news/articleView.html?idxno=138606
6390,2019-10-29,대웅제약SAP차세대EPR솔루션도입,http://www.inews24.com/view/1218268
6391,2019-10-29,제약산업대웅제약이지엔6프로복용편의성높여리뉴얼外,http://www.kukinews.com/news/article.html?no=714413
6392,2019-10-29,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.g-enews.com/ko-kr/news/article/news_all/201910291912396109aca1a8c21a_1/article.html
6393,2019-10-30,★주식인사이드대웅제약주가149500원10월30일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1043320
6394,2019-10-30,대웅제약주가10월30일오늘거래가149500원및증권시세외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=547282
6395,2019-10-30,종목검색대웅제약주가30일현재149500원,http://nbntv.co.kr/news/view/712016
6396,2019-10-31,대웅제약주가06962010월31일오늘가격151500원오늘시세및종목동정과증시정보,http://www.gokorea.kr/news/articleView.html?idxno=549174
6397,2019-10-31,대웅제약주식현재가31일현재151000원,http://nbntv.co.kr/news/view/714256
6398,2019-10-31,대웅제약인도네시아소방관대상의료봉사진행,http://www.wsobi.com/news/articleView.html?idxno=83712
6399,2019-11-01,국민연금나보타美수출길연대웅제약지분율높여,http://www.ceoscoredaily.com/news/article.html?no=62002
6400,2019-11-01,★주식인사이드대웅제약주가150500원11월1일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1044205
6401,2019-11-01,더벨대웅제약완판에도성과보수불가주관사입맛만,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910300100057710003586
6402,2019-11-01,대웅제약혁신형제약기업복지부장관상수상,http://www.viva100.com/main/view.php?key=20191101010000076
6403,2019-11-01,신약파이프확충대웅제약혁신형제약기업정부상받았다,http://news.heraldcorp.com/view.php?ud=20191101000172
6404,2019-11-01,나보타의글로벌진출대웅제약혁신형제약기업정부포상,http://www.dailysmart.co.kr/news/articleView.html?idxno=17516
6405,2019-11-01,대웅제약우수혁신형제약기업선정복지부장관상수상,http://moneys.mt.co.kr/news/mwView.php?no=2019110109488072936
6406,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.dailypharm.com/Users/News/NewsView.html?ID=258477&REFERER=NP
6407,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.mdtoday.co.kr/mdtoday/index.html?no=369045
6408,2019-11-01,대웅제약우수혁신형제약기업선정복지부장관상수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817012
6409,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.econovill.com/news/articleView.html?idxno=376283
6410,2019-11-01,대웅제약우수혁신형제약기업보건복지부장관상수상,https://biz.chosun.com/site/data/html_dir/2019/11/01/2019110100935.html
6411,2019-11-01,대웅제약혁신형제약기업정부포상쾌거,http://www.todaykorea.co.kr/news/view.php?no=265434
6412,2019-11-01,대웅제약우수혁신형제약기업선정정부포상,http://www.medisobizanews.com/news/articleView.html?idxno=63641
6413,2019-11-01,대웅제약우수혁신형제약기업정부포상,http://medipana.com/news/news_viewer.asp?NewsNum=247947&MainKind=A&NewsKind=5&vCount=12&vKind=1
6414,2019-11-01,대웅제약우수혁신형제약기업포상받아,http://news.mk.co.kr/newsRead.php?year=2019&no=897305
6415,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.etnews.com/20191101000046
6416,2019-11-01,대웅제약혁신형기업정부포상,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88699
6417,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.newsway.co.kr/news/view?tp=1&ud=2019110110215349444
6418,2019-11-01,대웅제약제약산업기여공로인정받아혁신형제약기업정부포상수여,https://asiatime.co.kr/news/newsview.php?ncode=1065574518204415
6419,2019-11-01,대웅제약혁신형제약기업복지부장관상등수상,http://www.rapportian.com/news/articleView.html?idxno=121097
6420,2019-11-01,대웅제약주가069620종목그래프1일오늘가격150500원거래,http://www.gokorea.kr/news/articleView.html?idxno=551092
6421,2019-11-01,대웅제약우수혁신형제약기업선정정부포상,http://www.ftoday.co.kr/news/articleView.html?idxno=112383
6422,2019-11-01,대웅제약신약개발로혁신형제약기업정부포상,http://www.getnews.co.kr/view.php?ud=20191101103200354641d0c69529_16
6423,2019-11-01,대웅제약2019보건산업성과교류회에서우수혁신형제약기업으로선정정부포상,http://newsbrite.net/129310
6424,2019-11-01,대웅제약혁신형제약기업정부포상나보타수출혁신신약개발공로”,https://www.sedaily.com/NewsView/1VQMNDH3RD
6425,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.newsis.com/view/?id=NISX20191101_0000816900&cID=13001&pID=13000
6426,2019-11-01,보툴리눔톡신성과인정대웅제약혁신형제약기업정부포상,http://kpenews.com/View.aspx?No=307890
6427,2019-11-01,11월1일대웅제약오늘주식시장150000원164,http://nbntv.co.kr/news/view/716439
6428,2019-11-01,대웅제약혁신형제약기업정부포상신약개발경쟁력강화에기여,http://www.newslock.co.kr/news/articleView.html?idxno=22923
6429,2019-11-01,제약워치대웅제약혁신형제약기업정부포상外,http://www.newswatch.kr/news/articleView.html?idxno=24780
6430,2019-11-01,대웅제약혁신형제약기업정부포상,http://news.mt.co.kr/mtview.php?no=2019110111190616886
6431,2019-11-01,대웅제약우수혁신형제약기업으로복지부장관상수상,http://www.newspim.com/news/view/20191101000352
6432,2019-11-01,국민연금보톡스전쟁중인대웅제약지분꾸준히늘려왜,http://news.tf.co.kr/read/economy/1767147.htm
6433,2019-11-01,동정대웅제약혁신형제약기업정부포상,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1073821
6434,2019-11-01,대웅제약혁신형제약기업정부포상,https://view.asiae.co.kr/article/2019110113235104746
6435,2019-11-01,대웅제약혁신형제약기업선정,http://www.wikileaks-kr.org/news/articleView.html?idxno=69066
6436,2019-11-01,대웅제약혁신형제약기업정부포상수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1346315
6437,2019-11-01,대웅제약우수혁신형제약기업선정보건복지부장관상수상,http://www.seoulwire.com/news/articleView.html?idxno=246942
6438,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.lawissue.co.kr/view.php?ud=201911011343068690204ead0791_12
6439,2019-11-01,대웅제약신약개발경쟁력인정혁신형제약기업정부포상,http://www.straightnews.co.kr/news/articleView.html?idxno=59162
6440,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.bosa.co.kr/news/articleView.html?idxno=2115239
6441,2019-11-01,대웅제약혁신형제약기업선정보건복지부장관상수상,http://www.youthdaily.co.kr/news/article.html?no=21542
6442,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.monews.co.kr/news/articleView.html?idxno=206178
6443,2019-11-01,대웅제약혁신형제약기업선정보건복지부장관상수상,http://www.donga.com/news/article/all/20191101/98175141/1
6444,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.bokuennews.com/news/article.html?no=182741
6445,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.fnnews.com/news/201911011442218519
6446,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.dailian.co.kr/news/view/839485/?sc=naver
6447,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57985
6448,2019-11-01,대웅제약혁신형제약기업선정정부포상,http://www.dailymedi.com/detail.php?number=849103&thread=22r05
6449,2019-11-01,혁신신약파이프라인강화인정받은대웅제약혁신형제약기업정부포상,http://www.updownnews.co.kr/news/articleView.html?idxno=210537
6450,2019-11-01,대웅제약혁신형제약기업선정돼정부포상,http://www.mhj21.com/125446
6451,2019-11-01,대웅제약3Q실적매출액2425억원전분기대비80감소영업이익836↓개별잠정,http://www.newspim.com/news/view/20191101001001
6452,2019-11-01,실적속보잠정대웅제약별도20193Q영업이익2801억원,http://www.fntimes.com/html/view.php?ud=2019110116350926105dfa8f3599_18
6453,2019-11-01,코스피대웅제약2019년3분기누적매출액7440억원영업이익301억원,http://news.kmib.co.kr/article/view.asp?arcid=0013885327&code=61141211&cp=nv
6454,2019-11-01,대웅제약3Q영업익28억원전년대비652감소,http://news.mt.co.kr/mtview.php?no=2019110116363456853
6455,2019-11-01,대웅제약3Q영업익28억전년비65↓,http://www.dailypharm.com/Users/News/NewsView.html?ID=258502&REFERER=NP
6456,2019-11-01,대웅제약3분기영업익28억원전년비65감소,http://www.edaily.co.kr/news/newspath.asp?newsid=03345606622681456
6457,2019-11-01,대웅제약3분기영업익28억원전년비652↓,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817273
6458,2019-11-01,대웅제약3분기영업이익28억원전년동기대비652감소,https://view.asiae.co.kr/article/2019110116531487362
6459,2019-11-01,공시대웅제약3분기영업익28억원전년比652감소,http://www.newsway.co.kr/news/view?tp=1&ud=2019110116525425369
6460,2019-11-01,대웅제약3Q영업익28억원전년比65감소,http://news1.kr/articles/?3758936
6461,2019-11-01,대웅제약3분기매출2425억원영업이익28억원,http://daily.hankooki.com/lpage/ittech/201911/dh20191101165856145630.htm
6462,2019-11-01,대웅제약3Q매출2425억원‥영업익65감소한28억,http://medipana.com/news/news_viewer.asp?NewsNum=247976&MainKind=A&NewsKind=5&vCount=12&vKind=1
6463,2019-11-01,대웅제약3분기영업익28억전년比652↓,http://www.economytalk.kr/news/articleView.html?idxno=200519
6464,2019-11-01,대웅제약3분기매출은증가단기비용도증가,http://news.heraldcorp.com/view.php?ud=20191101000661
6465,2019-11-01,대웅제약3분기영업익28억원전년비652감소,http://www.newsway.co.kr/news/view?tp=1&ud=2019110117044704716
6466,2019-11-01,대웅제약3분기매출2425억원달성,http://www.whosaeng.com/113693
6467,2019-11-01,대웅제약3분기매출2425억원영업이익28억원,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236895
6468,2019-11-01,소송및라니티딘회수비용에대웅제약3분기영업이익28억그쳐,http://news.mk.co.kr/newsRead.php?year=2019&no=899432
6469,2019-11-01,대웅제약3분기영업익28억원전년比65감소,http://www.seoulwire.com/news/articleView.html?idxno=247112
6470,2019-11-01,대웅제약3분기영업익28억나보타소송알비스회수에150억출혈,http://www.econovill.com/news/articleView.html?idxno=376352
6471,2019-11-01,대웅제약3Q영업익전년比65↓소송비회수비부담,http://www.newswatch.kr/news/articleView.html?idxno=24802
6472,2019-11-01,대웅제약3분기매출액2425억원45↑,http://www.dailian.co.kr/news/view/839602/?sc=naver
6473,2019-11-01,대웅제약3분기영업익28억원전년대비652↓,http://moneys.mt.co.kr/news/mwView.php?no=2019110117098091356
6474,2019-11-01,대웅제약3분기실적매출2425억원∙영업이익28억원성장세지속,http://www.getnews.co.kr/view.php?ud=20191101171540813041d0c69529_16
6475,2019-11-01,대웅제약3분기매출2425억원영업이익28억원성장세,http://www.asiatoday.co.kr/view.php?key=20191101010000429
6476,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.whosaeng.com/113694
6477,2019-11-01,대웅제약3분기영업익28억전년比652감소,http://www.ajunews.com/view/20191101171324418
6478,2019-11-01,대웅제약3분기영업익28억원전년비652↓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911010387&t=NN
6479,2019-11-01,대웅제약3Q수익성뚝라니티딘회수비용반영,http://www.dailypharm.com/Users/News/NewsView.html?ID=258503&REFERER=NP
6480,2019-11-01,대웅제약3분기영업익28억원전년비652↓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911010387&t=NN
6481,2019-11-01,대웅제약3분기영업익28억원나보타소송알비스회수비용등으로전년比65↓,http://www.dt.co.kr/contents.html?article_no=2019110102109931102002&ref=naver
6482,2019-11-01,대웅제약3Q영업익28억원전년比652감소,http://www.dailysmart.co.kr/news/articleView.html?idxno=17550
6483,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.medigatenews.com/news/2839359850
6484,2019-11-01,대웅제약혁신형제약기업정부포상나보타혁신신약연구덕”,http://inthenews.co.kr/article-22724/
6485,2019-11-01,대웅제약메디톡스와소송전여파로3분기영업익뒷걸음질,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817294
6486,2019-11-01,대웅제약3분기영업익65↓소송라니티딘회수비용탓,http://news.mt.co.kr/mtview.php?no=2019110117214653129
6487,2019-11-01,대웅제약3분기영업익652↓나보타소송라니티딘회수영향,http://www.newspim.com/news/view/20191101001078
6488,2019-11-01,대웅제약3분기어닝쇼크순익3억불과93급감,http://www.edaily.co.kr/news/newspath.asp?newsid=03480086622681456
6489,2019-11-01,대웅제약3분기매출2425억원전년比45↑,http://www.donga.com/news/article/all/20191101/98178501/1
6490,2019-11-01,대웅제약3분기매출2425억원영업이익28억원,http://www.medigatenews.com/news/1616286956
6491,2019-11-01,대웅제약3Q어닝쇼크메디톡스식약처에발목,http://www.upinews.kr/newsView/upi201911010091
6492,2019-11-01,대웅제약3분기영업익65급감나보타소송라니티딘회수영향,http://sports.hankooki.com/lpage/economy/201911/sp20191101173050137020.htm
6493,2019-11-01,대웅제약3분기영업익전년比652↓나보타소송라니티딘회수비용영향,http://www.newsprime.co.kr/news/article.html?no=481575
6494,2019-11-01,대웅제약3Q영업익28억전년比65↓나보타소송비용탓,http://www.newsis.com/view/?id=NISX20191101_0000817508&cID=13001&pID=13000
6495,2019-11-01,대웅제약3분기영업익652↓나보타소송라니티딘회수영향,http://www.seoulwire.com/news/articleView.html?idxno=247128
6496,2019-11-01,대웅제약3분기매출2425억원릭시아나등주력제품고른성장,http://www.medisobizanews.com/news/articleView.html?idxno=63664
6497,2019-11-01,대웅제약3분기매출2425억원영업이익28억원견고한영업이익성장세유지,http://newsbrite.net/129355
6498,2019-11-01,대웅제약3Q영업익28억652↓나보타소송라니티딘회수영향”,http://inthenews.co.kr/article-22733/
6499,2019-11-01,대웅제약3Q영업익65감소소송라니티딘회수비용영향상보,http://news1.kr/articles/?3759023
6500,2019-11-01,대웅제약매출증가했지만영업이익652감소소송라니티딘영향”,http://www.news2day.co.kr/140861
6501,2019-11-01,대웅제약3Q영업익28억원전년比652감소,http://www.viva100.com/main/view.php?key=20191101010000260
6502,2019-11-01,대웅제약3분기아쉬운실적내년유럽진출에따른이익성장기대,http://www.sisaweek.com/news/articleView.html?idxno=127621
6503,2019-11-01,대웅제약3분기영업익전년대비652↓라니티딘회수여파,http://www.newsworks.co.kr/news/articleView.html?idxno=407934
6504,2019-11-01,대웅제약올3분기영업익28억전년비652감소,http://www.finomy.com/news/articleView.html?idxno=71188
6505,2019-11-01,대웅제약나보타소송알비스회수로3Q영업익65↓,http://www.seoulfn.com/news/articleView.html?idxno=361162
6506,2019-11-01,대웅제약보툴리눔톡신소송포함일회성비용탓에3분기이익급감,http://www.businesspost.co.kr/BP?command=article_view&num=149495
6507,2019-11-01,흡연자는서류지원조차안받아인권침해지적받고있는대웅제약,https://www.insight.co.kr/news/253275
6508,2019-11-01,대웅제약3분기영업익28억전년比652↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=369119
6509,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.newscj.com/news/articleView.html?idxno=679756
6510,2019-11-01,대웅제약3Q매출2425억영업익28억라니티딘회수비용반영,https://www.kpanews.co.kr/article/show.asp?idx=208093&category=D
6511,2019-11-01,기흥화성세무서관내녹십자한미약품경동제약대웅제약맑거나흐리거나,http://www.sejungilbo.com/news/articleView.html?idxno=18805
6512,2019-11-01,대웅제약혁신형제약기업정부포상영예,https://www.kpanews.co.kr/article/show.asp?idx=208097&category=D
6513,2019-11-02,대웅제약3분기매출2425억기록영업익은나보타소송비용으로652↓,http://www.g-enews.com/ko-kr/news/article/news_all/20191101181605805769d76442fa_1/article.html
6514,2019-11-02,대웅제약3분기매출액2425억원영업이익28억원기록,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57993
6515,2019-11-02,대웅제약3Q영업익65감소,http://www.fntoday.co.kr/news/articleView.html?idxno=207927
6516,2019-11-02,제약바이오이모저모대웅제약3분기어닝쇼크순익3억불과,http://www.edaily.co.kr/news/newspath.asp?newsid=01148006622681784
6517,2019-11-02,대웅제약3Q영업익28억원전년比65↓,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1073839
6518,2019-11-02,대웅제약3분기나보타임펙타민매출상승견인,http://www.consumuch.com/news/articleView.html?idxno=46427
6519,2019-11-02,대웅제약3분기매출액2425억원달성ETCOTC성장이견인,http://www.todaykorea.co.kr/news/view.php?no=265468
6520,2019-11-02,대웅제약3분기실적발표매출2425억원영업이익28억원,http://www.betanews.net:8080/article/1058651.html
6521,2019-11-02,대웅제약3분기매출2425억원영업이익28억원기록,http://www.thefirstmedia.net/news/articleView.html?idxno=50244
6522,2019-11-02,대웅제약혁신형제약기업정부포상신약파이프라인강화공로인정,http://www.thefirstmedia.net/news/articleView.html?idxno=50250
6523,2019-11-02,대웅제약혁신형제약기업선정돼정부포상받아,http://www.metroseoul.co.kr/news/newsview?newscd=2019110200006
6524,2019-11-02,대웅제약3Q영업익65감소,http://www.fntoday.co.kr/news/articleView.html?idxno=207943
6525,2019-11-02,대웅제약3분기영업이익28억전년比65↓메디톡스와의나보타소송비용탓,http://www.econonews.co.kr/news/articleView.html?idxno=93219
6526,2019-11-03,대웅제약혁신형제약기업정부포상,http://www.ekn.kr/news/article.html?no=461496
6527,2019-11-03,대웅제약혁신형제약기업정부포상받아,http://weekly.cnbnews.com/news/article.html?no=130942
6528,2019-11-04,클릭e종목대웅제약나보타소송불확실성해소해야목표가↓,https://view.asiae.co.kr/article/2019110407362461100
6529,2019-11-04,대웅제약비용부담증가에실적추정치하향목표가↓NH투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817553
6530,2019-11-04,대웅제약실적개선주가상승불확실성해소관건⋯목표가↓한국투자증권,http://www.dailian.co.kr/news/view/839810/?sc=naver
6531,2019-11-04,대웅제약3분기실적발표매출2425억원영업이익28억원,http://www.ftoday.co.kr/news/articleView.html?idxno=112417
6532,2019-11-04,대웅제약예상치못한비용급증불확실성커져목표가↓한국,http://www.edaily.co.kr/news/newspath.asp?newsid=01505526622682440
6533,2019-11-04,대웅제약3분기영업익컨센서스하회목표가하향한국투자증권,http://www.newstomato.com/ReadNews.aspx?no=930735
6534,2019-11-04,대웅제약예상치못한비용증가목표가↓,http://www.asiatoday.co.kr/view.php?key=20191104010001056
6535,2019-11-04,대웅제약목표주가하향균주소송불확실성해소돼야실적개선,http://www.businesspost.co.kr/BP?command=article_view&num=149604
6536,2019-11-04,하이로우3분기어닝쇼크대웅제약목표주가↓NH투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019110408352041482
6537,2019-11-04,대웅제약비용급증및불확실성증가목표주가↓,https://www.sedaily.com/NewsView/1VQO192EBR
6538,2019-11-04,STOCK대웅제약당분간이익개선어렵다목표가↓,http://moneys.mt.co.kr/news/mwView.php?no=2019110408278080917
6539,2019-11-04,대웅제약메디톡스소송장기화에우울한3분기비용늘어어닝쇼크,https://www.hankyung.com/finance/article/2019110413946
6540,2019-11-04,대웅제약4분기일회성비용반영신한금투,http://news.mt.co.kr/mtview.php?no=2019110408132679690
6541,2019-11-04,대웅제약일회성비용으로어닝쇼크내년영업익증가폭클것신한금투,http://www.newspim.com/news/view/20191104000085
6542,2019-11-04,NH투자대웅제약나보타소송관련비용지출↑목표가하향,http://www.seoulwire.com/news/articleView.html?idxno=247342
6543,2019-11-04,NH투자證대웅제약나보타소송구조조정비용부담목표가5↓”,http://www.kukinews.com/news/article.html?no=715816
6544,2019-11-04,대웅제약4분기도일회성비용등으로실적부진전망목표가↓신한금융투자,http://www.fntimes.com/html/view.php?ud=201911040859423373f09e13944d_18
6545,2019-11-04,특징주대웅제약3분기영업이익급감약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817630
6546,2019-11-04,리포트브리핑대웅제약일회성비용등으로어닝쇼크목표가180000원신한금융투자,http://www.newspim.com/news/view/20191104000152
6547,2019-11-04,대웅제약메디톡스소송장기화에실적에도악영향끼치나,http://www.mdtoday.co.kr/mdtoday/index.html?no=369187
6548,2019-11-04,대웅제약3분기영업익28억전년비652↓,http://www.sportsseoul.com/news/read/843388
6549,2019-11-04,GET투자리포트대웅제약투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=2019110410303013417tpgetnews_16
6550,2019-11-04,대웅제약일회성비용에3Q어닝쇼크목표가↓신한,http://www.edaily.co.kr/news/newspath.asp?newsid=01836806622682440
6551,2019-11-04,리포트브리핑대웅제약20년회복을기다려보자목표가170000원키움증권,http://www.newspim.com/news/view/20191104000176
6552,2019-11-04,GET투자리포트대웅제약투자의견Outperform키움증권,http://www.getnews.co.kr/view.php?ud=2019110410303013426tpgetnews_16
6553,2019-11-04,NH투자증권대웅제약3분기실적부진에목표가↓,http://www.viva100.com/main/view.php?key=20191104010000690
6554,2019-11-04,대웅제약3분기매출액2425억영업이익28억,http://www.bokuennews.com/news/article.html?no=182787
6555,2019-11-04,GET투자리포트대웅제약투자의견매수삼성증권,http://www.getnews.co.kr/view.php?ud=2019110310303013427tpgetnews_16
6556,2019-11-04,특징주대웅제약올해3분기어닝쇼크실적에약세,http://www.inews24.com/view/1219400
6557,2019-11-04,특징주대웅제약3분기어닝쇼크에약세,http://news.mk.co.kr/newsRead.php?year=2019&no=903567
6558,2019-11-04,리포트브리핑대웅제약부진한실적4Q19까지이어질전망목표가210000원대신증권,http://www.newspim.com/news/view/20191104000225
6559,2019-11-04,GET투자리포트대웅제약투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=2019110410303013436tpgetnews_16
6560,2019-11-04,리포트브리핑대웅제약3Q19Review리스크해소를기다려야할때목표가210000원KB증권,http://www.newspim.com/news/view/20191104000266
6561,2019-11-04,GET투자리포트대웅제약투자의견매수KB증권,http://www.getnews.co.kr/view.php?ud=2019110410303013450tpgetnews_16
6562,2019-11-04,특징주대웅제약3분기어닝쇼크에하락세,http://www.seoulfn.com/news/articleView.html?idxno=361254
6563,2019-11-04,대웅제약3분기어닝쇼크실적부진에장초반약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=369198
6564,2019-11-04,대웅제약3분기실적발표매출2425억원영업이익28억원,http://www.updownnews.co.kr/news/articleView.html?idxno=210565
6565,2019-11-04,대웅제약3분기영업익65↓나보타소송비용영향,http://www.rapportian.com/news/articleView.html?idxno=121145
6566,2019-11-04,리포트브리핑대웅제약비용부담증가로실적추정치하향목표가180000원NH투자증권,http://www.newspim.com/news/view/20191104000597
6567,2019-11-04,GET투자리포트대웅제약투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=2019110410303013484tpgetnews_16
6568,2019-11-04,리포트브리핑대웅제약설상가상아쉬운실적목표가220000원DB금융투자,http://www.newspim.com/news/view/20191104000682
6569,2019-11-04,GET투자리포트대웅제약투자의견매수유지DB금융투자,http://www.getnews.co.kr/view.php?ud=2019110410303013496tpgetnews_16
6570,2019-11-04,대웅제약나보타소송장기화로3분기어닝쇼크목표가↓,http://www.econovill.com/news/articleView.html?idxno=376477
6571,2019-11-04,대웅제약4분기에도실적악화예상내년에기저효과및악재해소기대”,http://www.wikitree.co.kr/main/news_view.php?id=477424
6572,2019-11-04,리포트브리핑대웅제약3Q19Review알비스사태늘어난판관비목표가250000원유안타증권,http://www.newspim.com/news/view/20191104000703
6573,2019-11-04,GET투자리포트대웅제약투자의견매수유지유안타증권,http://www.getnews.co.kr/view.php?ud=2019110410303013500tpgetnews_16
6574,2019-11-04,대웅제약3분기영업익652감소라니티딘사태직격탄,http://www.monews.co.kr/news/articleView.html?idxno=206204
6575,2019-11-04,대웅제약실적부진나보타수출국확대로회복기대감,http://medipana.com/news/news_viewer.asp?NewsNum=248041&MainKind=A&NewsKind=5&vCount=12&vKind=1
6576,2019-11-04,11월4일대웅제약실시간주식현황144000원368,http://nbntv.co.kr/news/view/718509
6577,2019-11-04,리포트브리핑대웅제약예상치못한일격목표가180000원한국투자증권,http://www.newspim.com/news/view/20191104001009
6578,2019-11-04,GET투자리포트대웅제약투자의견매수유지한국투자증권,http://www.getnews.co.kr/view.php?ud=2019110410303013509tpgetnews_16
6579,2019-11-04,대웅제약알비스판매중단과나보타소송비용증가등악재겹쳤다”,http://www.wikitree.co.kr/main/news_view.php?id=477484
6580,2019-11-04,대웅제약알비스매출중단을반영하여매출액을하향조정”,http://www.wikitree.co.kr/main/news_view.php?id=477514
6581,2019-11-04,GET투자리포트대웅제약투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=2019110410303013522tpgetnews_16
6582,2019-11-04,대웅제약혁신형제약기업정부포상,http://www.skyedaily.com/news/news_view.html?ID=93192
6583,2019-11-04,대웅제약3분기어닝쇼크균주소송라니티딘사태직격탄,http://biz.newdaily.co.kr/site/data/html/2019/11/04/2019110400150.html
6584,2019-11-04,리포트브리핑대웅제약소송비용과알비스회수충당금으로3분기실적예상치하회목표가220000원SK증권,http://www.newspim.com/news/view/20191104001152
6585,2019-11-04,국내제약사1조클럽윤곽잡혔다대웅제약아슬아슬,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019110414311073821
6586,2019-11-04,대웅제약실적쇼크나보타기대감여전,http://www.fnnews.com/news/201911041800375368
6587,2019-11-04,리포트브리핑대웅제약비경상적비용에따른아쉬운실적목표가230000원삼성증권,http://www.newspim.com/news/view/20191104001465
6588,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약,http://www.metroseoul.co.kr/news/newsview?newscd=2019110500036
6589,2019-11-05,한국머크대웅제약과콩코르국내판매계약체결,http://www.viva100.com/main/view.php?key=20191105010001275
6590,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://sports.khan.co.kr/news/sk_index.html?art_id=201911050956003&sec_id=561801&pt=nv
6591,2019-11-05,대웅제약주가실적충격에흔들목표가하향봇물,http://www.g-enews.com/ko-kr/news/article/news_all/201911050942456035c642673384_1/article.html
6592,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=248112&MainKind=A&NewsKind=5&vCount=12&vKind=1
6593,2019-11-05,한국머크바이오파마대웅제약과콩코르판매계약체결,http://www.ebn.co.kr/news/view/1007879/?sc=naver
6594,2019-11-05,한국머크대웅제약심혈관질환치료제콩코르판매계약,http://health.chosun.com/site/data/html_dir/2019/11/05/2019110501027.html
6595,2019-11-05,한국머크바이오파마대웅제약과심혈관치료제콩코르판매계약,http://sports.chosun.com/news/ntype.htm?id=201911060100033510001959&servicedate=20191105
6596,2019-11-05,머크콩코르대웅제약이국내전담판매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88763
6597,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1818257
6598,2019-11-05,한국머크대웅제약과콩코르국내판매계약,http://kormedi.com/?p=1304999
6599,2019-11-05,대웅제약주가069620정보외증시동향5일오늘가격143500원거래,http://www.gokorea.kr/news/articleView.html?idxno=554729
6600,2019-11-05,한국머크대웅제약콩코르국내판매계약체결,http://www.bosa.co.kr/news/articleView.html?idxno=2115397
6601,2019-11-05,머크바이오파마대웅제약콩코르국내판매계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237015
6602,2019-11-05,한국머크바이오파마대웅제약과심혈관약콩코르판매계약,http://www.medisobizanews.com/news/articleView.html?idxno=63726
6603,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.seoulwire.com/news/articleView.html?idxno=248156
6604,2019-11-05,한국머크대웅제약과심부전치료제콩코르국내판매돌입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019110510360729146
6605,2019-11-05,한국머크대웅제약과심혈관치료제공동판매계약체결,http://www.rapportian.com/news/articleView.html?idxno=121176
6606,2019-11-05,한국머크바이오파마대웅제약콩코르국내판매계약체결,http://daily.hankooki.com/lpage/ittech/201911/dh20191105104043145630.htm
6607,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.asiatoday.co.kr/view.php?key=20191105010002032
6608,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=369326
6609,2019-11-05,라니티딘쇼크로휘청대웅제약반등할까,http://www.econovill.com/news/articleView.html?idxno=376562
6610,2019-11-05,대웅제약주식종목5일현재144000원,http://nbntv.co.kr/news/view/720623
6611,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약,https://biz.chosun.com/site/data/html_dir/2019/11/05/2019110501262.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6612,2019-11-05,한국머크대웅제약과만성심부전치료제콩코르판매계약체결,http://www.sportsseoul.com/news/read/844138
6613,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,https://www.sedaily.com/NewsView/1VQOII8DP4
6614,2019-11-05,한국머크대웅제약심혈관질환치료제콩코르판매계약,http://yna.kr/AKR20191105075000017?did=1195m
6615,2019-11-05,머크콩코르대웅제약손에떨어져,http://www.whosaeng.com/113756
6616,2019-11-05,대웅제약3분기이익참혹당기순이익3억여원,http://www.kukinews.com/news/article.html?no=716320
6617,2019-11-05,머크대웅제약과심혈관치료제콩코르판매계약,http://www.newsis.com/view/?id=NISX20191105_0000820161&cID=13001&pID=13000
6618,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약,http://www.fnnews.com/news/201911051334383042
6619,2019-11-05,한국머크대웅제약과콩코르국내판매계약,http://www.finomy.com/news/articleView.html?idxno=71297
6620,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.etnews.com/20191105000121
6621,2019-11-05,대웅제약위장약반품과균주소송에따른비용4분기도이어져,http://www.businesspost.co.kr/BP?command=article_view&num=149835
6622,2019-11-05,한국머크대웅제약과심혈관치료제국내판매계약,http://news.heraldcorp.com/view.php?ud=20191105000718
6623,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.medigatenews.com/news/3092437120
6624,2019-11-05,한국머크대웅제약심혈관질환치료제콩코르판매계약,http://www.seoulfn.com/news/articleView.html?idxno=361471
6625,2019-11-05,한국머크대웅제약과콩코르국내판매계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58032
6626,2019-11-05,한국머크대웅제약과심혈관치료제국내판매계약,http://www.whitepaper.co.kr/news/articleView.html?idxno=179960
6627,2019-11-05,채용서흡연자는제한한다대웅제약기본권침해논란,http://www.todaykorea.co.kr/news/view.php?no=265529
6628,2019-11-05,한국머크바이오파마대웅제약과심부전치료제콩코르국내판매계약체결,http://www.getnews.co.kr/view.php?ud=2019110518000427641d0c69529_16
6629,2019-11-05,대웅제약3분기어닝쇼크4분기비용반영문제이어질수있다”,http://www.wikitree.co.kr/main/news_view.php?id=477954
6630,2019-11-05,대체로맑지만균주소송대웅제약흐림,http://www.dt.co.kr/contents.html?article_no=2019110602101531102002&ref=naver
6631,2019-11-05,한국머크바이오파마대웅제약콩코르국내판매계약,https://www.kpanews.co.kr/article/show.asp?idx=208221&category=D
6632,2019-11-05,한국머크대웅제약심혈관질환치료제콩코르판매계약,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3977700
6633,2019-11-06,대웅제약흡연자취업제한공고사회적토론촉발,http://www.bosa.co.kr/news/articleView.html?idxno=2115452
6634,2019-11-06,대웅제약나보타미국연착륙분기첫매출153억원,http://news.heraldcorp.com/view.php?ud=20191106000018
6635,2019-11-06,대웅제약나보타美서3분기매출153억원달성,http://www.seoulwire.com/news/articleView.html?idxno=248831
6636,2019-11-06,대웅제약ETCOTC꾸준한성장매출확대견인,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132006
6637,2019-11-06,★주식인사이드대웅제약주가145500원11월6일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1044961
6638,2019-11-06,대웅제약보톡스나보타美서3분기150억매출,http://www.dt.co.kr/contents.html?article_no=2019110602109931102001&ref=naver
6639,2019-11-06,대웅제약관계사디엔컴퍼니이지듀메이크업라인선봬,http://moneys.mt.co.kr/news/mwView.php?no=2019110609138060475
6640,2019-11-06,대웅제약디엔컴퍼니이지듀메이크업라인선봬,http://www.yakup.com/news/index.html?mode=view&cat=15&nid=237054
6641,2019-11-06,대웅제약나보타미국서매출150억원달성,http://www.m-i.kr/news/articleView.html?idxno=652485
6642,2019-11-06,대웅제약이지듀EU권고알러지유발물질인공향배제,http://news.heraldcorp.com/view.php?ud=20191106000246
6643,2019-11-06,대웅제약관계사디엔컴퍼니이지듀메이크업라인선보여,https://www.sedaily.com/NewsView/1VQOY2SM4C
6644,2019-11-06,대웅제약주가06962011월6일오늘거래가144000원및증권시세및종목동정과증시정보,http://www.gokorea.kr/news/articleView.html?idxno=556666
6645,2019-11-06,대웅제약나보타미국서3분기매출150억원달성,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911060127&t=NN
6646,2019-11-06,대웅제약디엔컴퍼니건강한피부만들기메이크업라인2종출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1818829
6647,2019-11-06,11월6일대웅제약주식창144000원000,http://nbntv.co.kr/news/view/722905
6648,2019-11-06,대웅제약보톡스나보타미국서분기매출150억원,http://www.hani.co.kr/arti/economy/marketing/915980.html
6649,2019-11-06,대웅제약미국내나보타분기매출150억원돌파,http://www.seoulfn.com/news/articleView.html?idxno=361595
6650,2019-11-06,대웅제약나보타美소비자마음잡았나,http://www.kpinews.co.kr/news/articleView.html?idxno=106573
6651,2019-11-06,올연매출1조원달성종근당유력vs대웅제약안갯속,http://www.sisajournal-e.com/news/articleView.html?idxno=208611
6652,2019-11-06,대웅제약흡연자채용제한응시기회박탈아닌금연독려,http://www.sisaweek.com/news/articleView.html?idxno=127764
6653,2019-11-07,1조클럽제약사올해는④1조클럽아슬아슬대웅제약,http://www.mdtoday.co.kr/mdtoday/index.html?no=369518
6654,2019-11-07,★주식인사이드대웅제약주가141500원11월7일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1045218
6655,2019-11-07,대웅제약나보타의임상결과수술당일투약시우수한흉터개선효과입증,http://news.mk.co.kr/newsRead.php?year=2019&no=917259
6656,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증,http://www.dailian.co.kr/news/view/841107/?sc=naver
6657,2019-11-07,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.betanews.net:8080/article/1059739.html
6658,2019-11-07,대웅제약나보타수술당일투여때흉터관리높은효과,http://www.medisobizanews.com/news/articleView.html?idxno=63788
6659,2019-11-07,대웅제약수술환자흉터제거위한나보타투여최적기규명,http://news.heraldcorp.com/view.php?ud=20191107000163
6660,2019-11-07,대웅제약 나보타 연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=37758
6661,2019-11-07,대웅제약나보타이른투여에따른흉터개선효과입증,http://www.newspim.com/news/view/20191107000249
6662,2019-11-07,대웅제약나보타연구자임상통해투여시점따른흉터관리효과차이입증,http://www.segye.com/content/html/2019/11/07/20191107505124.html?OutUrl=naver
6663,2019-11-07,대웅제약나보타의흉터개선효과입증,http://news.mt.co.kr/mtview.php?no=2019110709564145513
6664,2019-11-07,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://newsbrite.net/129595
6665,2019-11-07,대웅제약주가06962011월7일오늘가격142000원오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=558581
6666,2019-11-07,대웅제약나보타연구자임상서투여시기따른흉터관리입증,http://www.econovill.com/news/articleView.html?idxno=376823
6667,2019-11-07,대웅제약나보타투여시점에따른흉터개선효과확인,http://www.ceoscoredaily.com/news/article.html?no=62260
6668,2019-11-07,대웅제약보툴리눔톡신제제나보타통해흉터관리효과입증,https://www.sedaily.com/NewsView/1VQPFM5F9C
6669,2019-11-07,대웅제약임상통해보툴리눔나보타투여시점별흉터개선확인,http://www.newslock.co.kr/news/articleView.html?idxno=23085
6670,2019-11-07,대웅제약나보타투여시점따른흉터관리효과차확인,http://www.biospectator.com/view/news_view.php?varAtcId=8845
6671,2019-11-07,대웅제약나보타임상결과발표수술당일투여때흉터관리효과,http://www.updownnews.co.kr/news/articleView.html?idxno=210775
6672,2019-11-07,대웅제약나보타투여시점에따른흉터개선효과차이입증,http://www.newsprime.co.kr/news/article.html?no=482241
6673,2019-11-07,대웅제약나보타갑상선수술흉터개선효과개선,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911070259&t=NN
6674,2019-11-07,대웅제약주식주가7일현재142500원,http://nbntv.co.kr/news/view/725178
6675,2019-11-07,보톡스로흉터개선된다대웅제약나보타임상발표,http://moneys.mt.co.kr/news/mwView.php?no=2019110710178069051
6676,2019-11-07,흉터개선효과입증대웅제약나보타연구자임상결과발표,http://kpenews.com/View.aspx?No=314651
6677,2019-11-07,대웅제약나보타흉터관리시적절한보툴리눔톡신제제투여시점확인,http://www.k-health.com/news/articleView.html?idxno=46155
6678,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1819401
6679,2019-11-07,대웅제약나보타연구자임상통해흉터관리효과입증,http://www.etnews.com/20191107000104
6680,2019-11-07,대웅제약나보타투여시점따른흉터관리효과임상결과발표,http://www.metroseoul.co.kr/news/newsview?newscd=2019110700086
6681,2019-11-07,대웅제약나보타시점에따른흉터관리효과차이입증,http://daily.hankooki.com/lpage/ittech/201911/dh20191107115147145630.htm
6682,2019-11-07,대웅제약나보타흉터개선효과입증”,http://www.viva100.com/main/view.php?key=20191107010002288
6683,2019-11-07,대웅제약나보타수술후흉터에효과입증,http://news1.kr/articles/?3763181
6684,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증,http://www.medigatenews.com/news/3084234829
6685,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증,http://www.seoulwire.com/news/articleView.html?idxno=250228
6686,2019-11-07,대웅제약나보타투여시점별흉터개선차이입증,http://health.chosun.com/site/data/html_dir/2019/11/07/2019110701908.html
6687,2019-11-07,대웅제약나보타투여시점별흉터개선차이입증,http://inthenews.co.kr/article-23422/
6688,2019-11-07,대웅제약나보타흉터개선효과입증,https://view.asiae.co.kr/article/2019110714283067705
6689,2019-11-07,법원대웅제약메디톡스美ITC염기서열보고서제출요구,http://www.mdtoday.co.kr/mdtoday/index.html?no=369571
6690,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증,http://www.newsway.co.kr/news/view?tp=1&ud=2019110714480699763
6691,2019-11-07,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.lawissue.co.kr/view.php?ud=20191107145805614204ead0791_12
6692,2019-11-07,대웅제약보툴리눔톡신나보타의흉터관리효과확인,http://www.businesspost.co.kr/BP?command=article_view&num=150172
6693,2019-11-07,대웅제약나보타투여시점따른흉터관리효과입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=17829
6694,2019-11-07,대웅제약연구자임상통해나보타투여시점별흉터관리효과차이입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1347695
6695,2019-11-07,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=369589
6696,2019-11-07,대웅제약나보타흉터개선효과임상결과美SCI급학술지게재,http://www.donga.com/news/article/all/20191107/98262823/1
6697,2019-11-07,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.getnews.co.kr/view.php?ud=20191107164517748441d0c69529_16
6698,2019-11-07,대웅제약나보타연구자임상결과흉터관리효과차이입증,http://www.cnbnews.com/news/article.html?no=426837
6699,2019-11-07,대웅제약나보타흉터관리효과차이입증,http://www.ebn.co.kr/news/view/1008388/?sc=naver
6700,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증,http://www.wikileaks-kr.org/news/articleView.html?idxno=69599
6701,2019-11-07,대웅제약나보타연구자임상통해흉터관리효과차이입증,http://www.ekn.kr/news/article.html?no=462633
6702,2019-11-07,대웅제약나보타흉터개선효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=338517
6703,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과입증,http://www.newscj.com/news/articleView.html?idxno=681365
6704,2019-11-08,★주식인사이드대웅제약주가143000원11월8일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1045507
6705,2019-11-08,대웅제약약대생인턴십PharmDW참가자모집,http://www.ebn.co.kr/news/view/1008445/?sc=naver
6706,2019-11-08,대웅제약약대생심화실습 인턴십PharmDW참가자모집,http://www.medisobizanews.com/news/articleView.html?idxno=63820
6707,2019-11-08,대웅제약약대생인턴십프로그램PharmDW참가자모집,http://www.newsway.co.kr/news/view?tp=1&ud=2019110809423182972
6708,2019-11-08,대웅제약약학대학생대상심화실습인턴십프로그램PharmDW참가자모집,http://newsbrite.net/129657
6709,2019-11-08,대웅제약심화실습인턴십프로그램PharmDW참가자모집,http://www.dailian.co.kr/news/view/841475/?sc=naver
6710,2019-11-08,대웅제약약대생대상PharmDW참가자모집,http://medipana.com/news/news_viewer.asp?NewsNum=248302&MainKind=A&NewsKind=5&vCount=12&vKind=1
6711,2019-11-08,대웅제약올로맥스상위병원잇따라입성하며성장가속화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58094
6712,2019-11-08,대웅제약약대생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58098
6713,2019-11-08,대웅제약약학대학생심화인턴십PharmDW참가자모집,http://www.newspim.com/news/view/20191108000235
6714,2019-11-08,대웅제약약대생대상심화실습인턴십활동PharmDW참가자모집,http://www.ezyeconomy.com/news/articleView.html?idxno=95230
6715,2019-11-08,대웅제약 약학대학생대상심화실습인턴십프로그램 PharmDW 참가자모집,http://www.businesskorea.co.kr/news/articleView.html?idxno=37816
6716,2019-11-08,대웅제약약학전공인턴십프로그램PharmDW참가자모집,http://www.sportsseoul.com/news/read/845972
6717,2019-11-08,대웅제약주가11월8일현재143500원증권그래프및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=560571
6718,2019-11-08,대웅제약약대생대상인턴십PharmDW참가자모집,http://www.econovill.com/news/articleView.html?idxno=376929
6719,2019-11-08,대웅제약우수혁신형제약기업으로선정돼복지부장관상등수상,http://www.newsian.co.kr/news/articleView.html?idxno=37258
6720,2019-11-08,대웅제약팜DW참가자모집,https://asiatime.co.kr/news/newsview.php?ncode=1065575856901598
6721,2019-11-08,대웅제약약학대생인턴십프로그램팜DW참가자모집,http://www.dailysmart.co.kr/news/articleView.html?idxno=17868
6722,2019-11-08,대웅제약약학대학생심화실습인턴십프로그램참가자모집,http://www.enewstoday.co.kr/news/articleView.html?idxno=1347851
6723,2019-11-08,11월8일대웅제약투자주식143500원141,http://nbntv.co.kr/news/view/727446
6724,2019-11-08,약학대학생맞춤형인턴십프로그램대웅제약PharmDW진행,http://kpenews.com/View.aspx?No=315818
6725,2019-11-08,대웅제약약학대학생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.lawissue.co.kr/view.php?ud=20191108111233120204ead0791_12
6726,2019-11-08,안내대웅제약약학대생대상인턴십모집 ,http://www.monews.co.kr/news/articleView.html?idxno=206317
6727,2019-11-08,대웅제약약학대학생대상인턴십프로그램PharmDW참가자모집,http://www.ekn.kr/news/article.html?no=462795
6728,2019-11-08,대웅제약약대생심화실습PharmDW참가자모집,http://www.dailymedi.com/detail.php?number=849350&thread=22r05
6729,2019-11-08,대웅제약약대생인턴십프로그램PharmDW참가자모집,http://www.seoulwire.com/news/articleView.html?idxno=250800
6730,2019-11-08,대웅제약약학대학생대상팜DW50명모집,http://www.kpinews.co.kr/news/articleView.html?idxno=106687
6731,2019-11-08,대한민국굿잡스대웅제약약학대학생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.newslock.co.kr/news/articleView.html?idxno=23145
6732,2019-11-08,대웅제약약학대학생심화실습인턴십프로그램운영,http://www.rapportian.com/news/articleView.html?idxno=121269
6733,2019-11-08,대웅제약약대생대상인턴십진행3개월간실무경험,http://moneys.mt.co.kr/news/mwView.php?no=2019110814168073952
6734,2019-11-08,대웅제약약대생대상심화실습인턴십팜DW참가자모집,http://news.mk.co.kr/newsRead.php?year=2019&no=923337
6735,2019-11-08,대웅제약약대생인턴십프로그램참가자모집,http://www.youthdaily.co.kr/news/article.html?no=22165
6736,2019-11-08,대웅제약약학대학생대상심화실습인턴십참가자모집,http://www.mdtoday.co.kr/mdtoday/index.html?no=369682
6737,2019-11-08,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.thefirstmedia.net/news/articleView.html?idxno=50492
6738,2019-11-08,대웅제약약대생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.wikileaks-kr.org/news/articleView.html?idxno=69664
6739,2019-11-08,대웅제약약학대학생인턴십프로그램참가자모집,http://www.donga.com/news/article/all/20191108/98278700/1
6740,2019-11-08,대웅제약18일까지약학대학생인턴십모집,http://www.finomy.com/news/articleView.html?idxno=71520
6741,2019-11-08,대웅제약심화실습인턴십프로그램PharmDW참가자모집,http://www.getnews.co.kr/view.php?ud=20191108174546377941d0c69529_16
6742,2019-11-08,대웅제약약학대학생대상심화실습인턴십참가자모집,http://www.100ssd.co.kr/news/articleView.html?idxno=65302
6743,2019-11-08,대웅제약약학대학생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.wsobi.com/news/articleView.html?idxno=84869
6744,2019-11-08,대웅제약약학대학학생실습인턴십PharmDW참가자모집,http://www.news2day.co.kr/141512
6745,2019-11-08,대웅제약흉터관리나보타보툴리눔톡신제제투여시점확인,http://www.news2day.co.kr/141445
6746,2019-11-08,대웅제약약학대생대상인턴십프로그램PharmDW참가자모집,http://www.newscj.com/news/articleView.html?idxno=681673
6747,2019-11-09,대웅제약연구자임상으로나보타투여시점에따른흉터관리효과차이입증,http://www.g-enews.com/ko-kr/news/article/news_all/20191107155736627569d76442fa_1/article.html
6748,2019-11-10,대웅제약PharmDW참가자모집,http://weekly.cnbnews.com/news/article.html?no=131059
6749,2019-11-10,대웅제약약대생심화실습인턴십PharmDW참가자모집,http://www.viva100.com/main/view.php?key=20191110010003047
6750,2019-11-10,대웅제약약대생인턴십프로그램PharmDW참가자모집,http://www.metroseoul.co.kr/news/newsview?newscd=2019111000050
6751,2019-11-10,엇갈린보톡스3인방소송발목대웅제약메디톡스vs웃는휴젤,http://www.edaily.co.kr/news/newspath.asp?newsid=01820406622684408
6752,2019-11-10,대웅제약약대생대상심화실습인턴십팜DW참가자모집,http://www.nbnnews.co.kr/news/articleView.html?idxno=339310
6753,2019-11-11,상장사수익성분석③제약업종수익성개선두각대웅제약한미약품등선방,http://www.etoday.co.kr/news/section/newsview.php?idxno=1820125
6754,2019-11-11,★주식인사이드대웅제약주가142000원11월11일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1045852
6755,2019-11-11,대웅제약PharmDW참가자모집,http://www.bokuennews.com/news/article.html?no=183085
6756,2019-11-11,재계톡톡3분기어닝쇼크대웅제약안팎으로시끌,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=929466
6757,2019-11-11,대웅제약증권투자11일현재141500원,http://nbntv.co.kr/news/view/729730
6758,2019-11-11,종근당올1조클럽초읽기대웅제약아슬아슬,http://www.ebn.co.kr/news/view/1008727/?sc=naver
6759,2019-11-11,대웅제약약학대학생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.thefirstmedia.net/news/articleView.html?idxno=50554
6760,2019-11-12,더벨CPhIWorldwide2019대웅제약항궤양제신약임상3상완료,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201911110100017040001061
6761,2019-11-12,★주식인사이드대웅제약주가141000원11월12일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1046149
6762,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.dailysmart.co.kr/news/articleView.html?idxno=18000
6763,2019-11-12,대웅제약자가면역질환후보물질연구성과첫공개,http://www.bosa.co.kr/news/articleView.html?idxno=2115829
6764,2019-11-12,대웅제약미국서자가면역질환치료제연구성과첫공개,http://moneys.mt.co.kr/news/mwView.php?no=2019111210098030191
6765,2019-11-12,대웅제약차세대자가면역질환치료제저용량으로도효과확인,http://news.mt.co.kr/mtview.php?no=2019111210100231837
6766,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.etnews.com/20191112000061
6767,2019-11-12,대웅제약주가11월12일오늘거래가140000원및증권시세및매매동향,http://www.gokorea.kr/news/articleView.html?idxno=564697
6768,2019-11-12,대웅제약차세대자가면역질환치료물질연구성과첫공개,http://www.medisobizanews.com/news/articleView.html?idxno=63906
6769,2019-11-12,대웅제약자가면역질환신약DWP212525전임상서효능확인,http://www.econovill.com/news/articleView.html?idxno=377214
6770,2019-11-12,대웅제약美류마티스학회서자가면역치료제DWP212525연구성과첫공개,http://www.newslock.co.kr/news/articleView.html?idxno=23225
6771,2019-11-12,대웅제약미국서자가면역질환후보물질연구성과첫공개,https://www.sedaily.com/NewsView/1VQRPCMPKO
6772,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.businesskorea.co.kr/news/articleView.html?idxno=37916
6773,2019-11-12,대웅제약미국류마티스학회서자가면역질환치료제연구성과첫공개,http://www.newspim.com/news/view/20191112000390
6774,2019-11-12,대웅제약美학회서자가면역질환신약DWP212525연구성과첫공개,http://www.seoulwire.com/news/articleView.html?idxno=252122
6775,2019-11-12,대웅제약美류마티스학회서DWP212525성과공개,http://medipana.com/news/news_viewer.asp?NewsNum=248483&MainKind=A&NewsKind=5&vCount=12&vKind=1
6776,2019-11-12,대웅제약미류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.asiatoday.co.kr/view.php?key=20191112010006408
6777,2019-11-12,기존치료제보다우수대웅제약DWP212525연구성과공개,http://kpenews.com/View.aspx?No=318537
6778,2019-11-12,대웅제약자가면역질환치료제연구성과첫글로벌공개,http://news.heraldcorp.com/view.php?ud=20191112000316
6779,2019-11-12,대웅제약자가면역질환후보물질연구성과첫공개,http://www.newsway.co.kr/news/view?tp=1&ud=2019111210581041078
6780,2019-11-12,대웅제약美류마티스학회서자가면역질환연구첫공개,http://www.newsis.com/view/?id=NISX20191112_0000826953&cID=13001&pID=13000
6781,2019-11-12,오늘주식장대웅제약주가12일현재139000원,http://nbntv.co.kr/news/view/731942
6782,2019-11-12,대웅제약美류마티스학회서JAK3TFK동시표적의후보물질연구결과공개,http://news.mk.co.kr/newsRead.php?year=2019&no=933724
6783,2019-11-12,대웅제약자가면역질환신약연구성과첫공개내년임상진입”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1821134
6784,2019-11-12,대웅제약자가면역질환치료제전임상결과공개,http://health.chosun.com/site/data/html_dir/2019/11/12/2019111201321.html
6785,2019-11-12,대웅제약단백질JAK3TFK동시억제신약물질효과,http://news1.kr/articles/?3766714
6786,2019-11-12,대웅제약미국에서자가면역질환후보물질연구성과첫공개,http://www.joseilbo.com/news/news_read.php?uid=387191&class=27&grp=
6787,2019-11-12,대웅제약자가면역질환후보물질비임상결과공개,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1130173&REFERER=NP
6788,2019-11-12,대웅제약美학회서자가면역질환치료제연구최초공개,https://view.asiae.co.kr/article/2019111211400068905
6789,2019-11-12,대웅제약美류마티스학회서DWP212525전임상결과공개,http://www.sportsseoul.com/news/read/847457
6790,2019-11-12,대웅제약미류마티스학회에서자가면역질환후보물질연구성과공개,http://www.cnbnews.com/news/article.html?no=427225
6791,2019-11-12,대웅제약美류마티스학회서자가면역질환치료신약연구성과첫공개,http://www.metroseoul.co.kr/news/newsview?newscd=2019111200096
6792,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=369900
6793,2019-11-12,대웅제약미국류마티스학회에서자가면역질환치료제효과입증,http://www.businesspost.co.kr/BP?command=article_view&num=150763
6794,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://newsbrite.net/129855
6795,2019-11-12,제약워치대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개外,http://www.newswatch.kr/news/articleView.html?idxno=25004
6796,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.fnnews.com/news/201911121329574639
6797,2019-11-12,대웅제약美류마티스학회서자가면역질환치료후보물질연구첫공개,http://daily.hankooki.com/lpage/ittech/201911/dh20191112135640145630.htm
6798,2019-11-12,대웅제약자가면역질환후보물질DWP212525연구성과첫공개,http://www.newsian.co.kr/news/articleView.html?idxno=37512
6799,2019-11-12,대웅제약美류마티스학회서DWP212525연구성과첫공개,http://www.medigatenews.com/news/1073674233
6800,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1348675
6801,2019-11-12,대웅제약자가면역치료신약천포창질환개선율우수,http://www.monews.co.kr/news/articleView.html?idxno=206404
6802,2019-11-12,뉴스투데이L대웅제약자가면역질환후보물질연구미학회서첫공개,http://www.news2day.co.kr/141715
6803,2019-11-12,대웅제약美학회서자가면역질환후보물질DWP212525연구성과첫공개,http://kormedi.com/?p=1305562
6804,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질연구성과첫공개,http://www.ekn.kr/news/article.html?no=463422
6805,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질DWP212525연구성과첫공개,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58152
6806,2019-11-12,대웅제약미국류마티스학회서자가면역질환후보물질연구성과공개,http://www.newstomato.com/ReadNews.aspx?no=932763
6807,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525성과발표2020년말임상추진,http://www.ezyeconomy.com/news/articleView.html?idxno=95331
6808,2019-11-12,대웅제약미국류마티스학회서DWP212525연구성과공개,http://www.dailian.co.kr/news/view/842549/?sc=naver
6809,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.betanews.net:8080/article/1099527.html
6810,2019-11-12,대웅제약자가면역치료제연구결과공개2020년말임상목표,http://www.economytalk.kr/news/articleView.html?idxno=200891
6811,2019-11-12,대웅제약美서자가면역질환치료제후보물질전임상결과공개,http://www.donga.com/news/article/all/20191112/98324147/1
6812,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.nbnnews.co.kr/news/articleView.html?idxno=340112
6813,2019-11-12,대웅제약美학회서DWP212525연구성과공개,http://www.kpinews.co.kr/news/articleView.html?idxno=106871
6814,2019-11-12,대웅제약美류마티스학회서DWP212525연구성과첫공개,https://asiatime.co.kr/news/newsview.php?ncode=1065594162421399
6815,2019-11-12,대웅제약부작용은낮춘자가면역치료제개발美류마티스학회에서DWP212525연구성과첫공개,http://www.updownnews.co.kr/news/articleView.html?idxno=210992
6816,2019-11-12,대웅제약美서자가면역질환후보물질DWP212525연구성과첫공개,http://www.ajunews.com/view/20191112161136597
6817,2019-11-12,대웅제약미류마티스학회서DWP212525연구성과첫공개,https://www.kpanews.co.kr/article/show.asp?idx=208450&category=E
6818,2019-11-12,대웅제약美류마티스학회서DWP212525연구성과첫공개,http://inthenews.co.kr/article-24210/
6819,2019-11-12,대웅제약美서자가면역질환후보물질연구성과공개,http://www.whosaeng.com/113904
6820,2019-11-12,​대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.lawissue.co.kr/view.php?ud=201911121716109430204ead0791_12
6821,2019-11-12,대웅제약자가면역질환치료제후보물질연구결과발표,http://weekly.cnbnews.com/news/article.html?no=131127
6822,2019-11-12,대웅제약美학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.getnews.co.kr/view.php?ud=20191112190506583441d0c69529_16
6823,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.newscj.com/news/articleView.html?idxno=682612
6824,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.thefirstmedia.net/news/articleView.html?idxno=50622
6825,2019-11-13,연속순매도기관대웅제약9일째팔아,http://www.itooza.com/common/iview.php?no=2019111217224961732
6826,2019-11-13,대웅제약美류마티스학회서자가면역질환후보물질연구성과공개,http://www.shinailbo.co.kr/news/articleView.html?idxno=1223073
6827,2019-11-13,홈앤쇼핑대웅제약프레좀RX크림방송판매실시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1348865
6828,2019-11-13,★주식인사이드대웅제약주가138500원11월13일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1046455
6829,2019-11-13,홈앤쇼핑대웅제약DWEGF프레좀RX크림단독방송,http://news1.kr/articles/?3767549
6830,2019-11-13,대웅제약DWP212525연구성과첫공개,http://www.bokuennews.com/news/article.html?no=183224
6831,2019-11-13,홈앤쇼핑대웅제약DWEGF프레좀RX크림단독방송,http://4th.kr/View.aspx?No=319966
6832,2019-11-13,주식추천주대웅제약주가13일현재136500원,http://nbntv.co.kr/news/view/734235
6833,2019-11-13,홈앤쇼핑대웅제약프리미엄단백질솔루션크림판매,http://www.etnews.com/20191113000113
6834,2019-11-13,스물넷에창업4년만에대웅제약에매각트라이문김사랑대표,http://premium.mk.co.kr/view.php?no=27108
6835,2019-11-13,홈앤쇼핑대웅제약DWEGF프레좀RX크림선봬,http://www.cnbnews.com/news/article.html?no=427433
6836,2019-11-13,홈앤쇼핑대웅제약프레좀RX크림선봬,http://www.sisaon.co.kr/news/articleView.html?idxno=104235
6837,2019-11-13,홈앤쇼핑대웅제약DWEGF프레좀RX크림방송,http://www.edaily.co.kr/news/newspath.asp?newsid=03952406622685392
6838,2019-11-13,홈앤쇼핑15일대웅제약DWEGF프레좀RX크림단독방송,http://www.insightkorea.co.kr//news/articleView.html?idxno=65290
6839,2019-11-14,★주식인사이드대웅제약주가135000원11월14일9시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1046778
6840,2019-11-14,대웅제약주가06962011월14일현재137000원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=568783
6841,2019-11-14,주식창대웅제약주가14일현재136500원,http://nbntv.co.kr/news/view/736485
6842,2019-11-14,코스피대웅제약3분기누적매출액8258억원영업이익416억원연결기준,http://news.kmib.co.kr/article/view.asp?arcid=0013930341&code=61141211&cp=nv
6843,2019-11-15,대웅제약주가06962011월15일현재137000원종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=570825
6844,2019-11-15,오늘증시대웅제약주가15일현재136500원,http://nbntv.co.kr/news/view/738854
6845,2019-11-15,MTN현장대웅제약메디톡스소송전에비용펑펑울고싶은주주도펑펑,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019111513084444028
6846,2019-11-18,대웅제약주가069620증권그래프및주식시황18일오늘가격139500원거래,http://www.gokorea.kr/news/articleView.html?idxno=572640
6847,2019-11-18,대웅제약주식종목18일현재139000원,http://nbntv.co.kr/news/view/740900
6848,2019-11-18,제약1조클럽3Q하대웅제약과종근당누가마지막에웃을까,http://daily.hankooki.com/lpage/ittech/201911/dh20191118160707145630.htm
6849,2019-11-19,★주식인사이드대웅제약주가138500원11월19일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1047497
6850,2019-11-19,11월19일대웅제약증권투자정보및증권정보와종목동정108변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=574587
6851,2019-11-19,대웅제약vs메디톡스혈투뒤에서미소짓는엘러간,http://www.segye.com/content/html/2019/11/18/20191118510320.html?OutUrl=naver
6852,2019-11-19,11월19일대웅제약시세보기072138500원,http://nbntv.co.kr/news/view/743145
6853,2019-11-19,대웅제약스마트오피스운영업무몰입도높인다,https://www.hankyung.com/economy/article/201911151498i
6854,2019-11-20,AT포커스1조클럽제약사변동가능성有아슬아슬한대웅제약,https://asiatime.co.kr/news/newsview.php?ncode=1065592790980189
6855,2019-11-20,★주식인사이드대웅제약주가136000원11월20일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1047803
6856,2019-11-20,11월20일대웅제약069620증권그래프145변화,http://www.gokorea.kr/news/articleView.html?idxno=576488
6857,2019-11-20,대웅제약CSR필름페스티벌고용노동부장관상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237619
6858,2019-11-20,대웅제약고용노동부장관상수상‥참지마요도서제작,http://medipana.com/news/news_viewer.asp?NewsNum=248894&MainKind=A&NewsKind=5&vCount=12&vKind=1
6859,2019-11-20,대웅제약함께하는기업어워드서고용노동부장관상수상,http://daily.hankooki.com/lpage/ittech/201911/dh20191120105515145630.htm
6860,2019-11-20,대웅제약참지마요장관상함께하는기업어워드,http://news.heraldcorp.com/view.php?ud=20191120000353
6861,2019-11-20,대웅제약주식창20일현재135000원,http://nbntv.co.kr/news/view/745458
6862,2019-11-20,대웅제약CSR필름페스티벌서노동부장관상,http://www.medisobizanews.com/news/articleView.html?idxno=64136
6863,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.businesskorea.co.kr/news/articleView.html?idxno=38272
6864,2019-11-20,대웅제약참지마요CSR필름페스티벌고용노동부장관상수상,http://www.newspim.com/news/view/20191120000500
6865,2019-11-20,대웅제약평등사회위한고용노동부장관상수상,http://www.newsis.com/view/?id=NISX20191120_0000835442&cID=13001&pID=13000
6866,2019-11-20,대웅제약함께하는기업어워드CSR필름페스티벌서고용노동부장관상수상,http://www.segye.com/content/html/2019/11/20/20191120506424.html?OutUrl=naver
6867,2019-11-20,대웅제약참지마요프로젝트CSR필름페스티벌고용노동부장관상수상,http://www.ezyeconomy.com/news/articleView.html?idxno=95549
6868,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://newsbrite.net/130225
6869,2019-11-20,대웅제약함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.economytalk.kr/news/articleView.html?idxno=201163
6870,2019-11-20,대웅제약평등한사회부문고용노동부장관상수상,http://www.bosa.co.kr/news/articleView.html?idxno=2116374
6871,2019-11-20,대웅제약참지마요고용노동부장관상수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1350429
6872,2019-11-20,대웅제약CSR필름페스티벌서고용노동부장관상수상,http://www.ekn.kr/news/article.html?no=464979
6873,2019-11-20,대웅제약CRS필름페스티벌서고용노동부장관상수상,http://www.seoulwire.com/news/articleView.html?idxno=256804
6874,2019-11-20,대웅제약CSR필름페스티벌서고용부장관상수상,http://www.dailysmart.co.kr/news/articleView.html?idxno=18376
6875,2019-11-20,대웅제약CRS필름페스티벌고용부장관상수상,http://www.youthdaily.co.kr/news/article.html?no=23050
6876,2019-11-20,대웅제약2019CSR필름페스티벌고용노동부장관상,http://www.newspost.kr/news/articleView.html?idxno=73868
6877,2019-11-20,대웅제약CSR필름페스티벌에서고용노동부장관상수상,http://www.cnbnews.com/news/article.html?no=428110
6878,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상,http://www.wsobi.com/news/articleView.html?idxno=85437
6879,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.dailian.co.kr/news/view/845113/?sc=naver
6880,2019-11-20,대웅제약참지마요프로젝트고용노동부장관상수상,http://www.sportsseoul.com/news/read/851392
6881,2019-11-20,대웅제약발달장애위한참지마요프로젝트고용노동부장관상수상,http://www.metroseoul.co.kr/news/newsview?newscd=2019112000144
6882,2019-11-20,대웅제약참지마요로고용노동부장관상수상,http://www.finomy.com/news/articleView.html?idxno=71963
6883,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.newslock.co.kr/news/articleView.html?idxno=23522
6884,2019-11-20,대웅제약CSR필름페스티벌서고용노동부장관상수상,http://www.viva100.com/main/view.php?key=20191120010007108
6885,2019-11-20,대웅제약CSR페스티벌고용노동부장관상수상,http://www.etnews.com/20191120000278
6886,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58290
6887,2019-11-20,대웅제약참지마요제작과정CSR필름페스티벌서고용부장관상수상,http://news.mk.co.kr/newsRead.php?year=2019&no=966119
6888,2019-11-20,사회공헌활동인정받은대웅제약2019함께하는기업어워드CSR필름페스티벌에서고용노동부장관상수상 ,http://www.updownnews.co.kr/news/articleView.html?idxno=211347
6889,2019-11-20,대웅제약CSR페스티벌고용노동부장관상수상,http://www.econovill.com/news/articleView.html?idxno=378017
6890,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌평등사회부문고용노동부장관상수상,http://www.ftoday.co.kr/news/articleView.html?idxno=112755
6891,2019-11-20,대웅제약함께하는기업어워드＆CSR필름페스티벌고용부장관상,http://www.mdtoday.co.kr/mdtoday/index.html?no=370663
6892,2019-11-20,대웅제약CSR필름페스티벌고용노동부장관상수상,http://www.ntoday.co.kr/news/articleView.html?idxno=69527
6893,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.lawissue.co.kr/view.php?ud=201911201841589112204ead0791_12
6894,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.newscj.com/news/articleView.html?idxno=684938
6895,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.thefirstmedia.net/news/articleView.html?idxno=50910
6896,2019-11-21,대웅제약시간장소얽매이지않는스마트워크구축,http://news.mk.co.kr/newsRead.php?year=2019&no=967357
6897,2019-11-21,대웅제약참지마요로고용노동부장관상수상,http://moneys.mt.co.kr/news/mwView.php?no=2019112108348026370
6898,2019-11-21,★주식인사이드대웅제약주가134000원11월21일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1048130
6899,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237669
6900,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://medipana.com/news/news_viewer.asp?NewsNum=248995&MainKind=A&NewsKind=5&vCount=12&vKind=1
6901,2019-11-21,대웅제약일하기좋은100대기업대상수상,http://www.monews.co.kr/news/articleView.html?idxno=206631
6902,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상차별화된기업문화로삶의질향상을위한글로벌헬스케어그룹도약위해노력할것,http://www.segye.com/content/html/2019/11/21/20191121504839.html?OutUrl=naver
6903,2019-11-21,대웅제약일하기좋은100대기업,http://www.dt.co.kr/contents.html?article_no=2019112102109931102005&ref=naver
6904,2019-11-21,대웅제약대한민국일하기좋은 100대기업 대상수상,http://www.businesskorea.co.kr/news/articleView.html?idxno=38311
6905,2019-11-21,대웅제약대한민국일하기좋은100대기업대상,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3990586
6906,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.metroseoul.co.kr/news/newsview?newscd=2019112100018
6907,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,https://www.sedaily.com/NewsView/1VQVUNA1MF
6908,2019-11-21,대웅제약일하기좋은100대기업대상수상,http://www.mhj21.com/125829
6909,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.newspim.com/news/view/20191121000305
6910,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.viva100.com/main/view.php?key=20191121010007300
6911,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.newsway.co.kr/news/view?tp=1&ud=2019112110280209210
6912,2019-11-21,대웅제약GPTW대한민국일하기좋은100대기업에제약업계최초로선정돼,http://news.mk.co.kr/newsRead.php?year=2019&no=968330
6913,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.ezyeconomy.com/news/articleView.html?idxno=95580
6914,2019-11-21,대웅제약대한민국일하기좋은100대기업大賞국내제약사최초,http://www.medisobizanews.com/news/articleView.html?idxno=64164
6915,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.dailysmart.co.kr/news/articleView.html?idxno=18434
6916,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.bokuennews.com/news/article.html?no=183547
6917,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.newsis.com/view/?id=NISX20191121_0000836661&cID=13001&pID=13000
6918,2019-11-21,메디톡스vs대웅제약피튀는보톡스전쟁막전막후,http://www.ilyosisa.co.kr/news/articleView.html?idxno=210740
6919,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=370745
6920,2019-11-21,11월21일대웅제약시세보기149132500원,http://nbntv.co.kr/news/view/747787
6921,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.g-enews.com/ko-kr/news/article/news_all/20191121110027707869d76442fa_1/article.html
6922,2019-11-21,대한민국굿잡스대웅제약대한민국일하기좋은100대기업대상수상,http://www.newslock.co.kr/news/articleView.html?idxno=23572
6923,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1350706
6924,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://newsbrite.net/130273
6925,2019-11-21,대웅제약대한민국일하기좋은100대기업선정,http://www.bosa.co.kr/news/articleView.html?idxno=2116464
6926,2019-11-21,대웅제약나보타원조보톡스에도전장유럽북미시장공략,http://news1.kr/articles/?3774726
6927,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.lawissue.co.kr/view.php?ud=201911211343293227204ead0791_12
6928,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.econovill.com/news/articleView.html?idxno=378100
6929,2019-11-21,대웅제약대한민국일하기좋은100대기업대상,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1228589
6930,2019-11-21,메디톡스대웅제약보톡스전쟁에개미등만터지나,http://ilyo.co.kr/?ac=article_view&entry_id=353900
6931,2019-11-21,모두가님으로존중받는대웅제약일하기좋은기업대상,http://www.newspost.kr/news/articleView.html?idxno=73909
6932,2019-11-21,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.newsian.co.kr/news/articleView.html?idxno=37841
6933,2019-11-21,대웅제약대한민국일하기좋은100대기업서대상수상,https://asiatime.co.kr/news/newsview.php?ncode=1065591661104597
6934,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.donga.com/news/article/all/20191121/98477360/1
6935,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.sportsseoul.com/news/read/851939
6936,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.cnbnews.com/news/article.html?no=428267
6937,2019-11-21,대웅제약일하기좋은100대기업대상수상,http://www.ebn.co.kr/news/view/1010271/?sc=naver
6938,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://daily.hankooki.com/lpage/ittech/201911/dh20191121165539145630.htm
6939,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58308
6940,2019-11-21,대웅제약일하기좋은100대기업대상수상,http://www.seoulwire.com/news/articleView.html?idxno=258174
6941,2019-11-21,대웅제약근무환경사회공헌인정연속수상영예,http://www.dailymedi.com/detail.php?number=849824&thread=22r05
6942,2019-11-21,대웅제약보툴리눔톡신나보타품질앞세워해외진출가속,http://www.businesspost.co.kr/BP?command=article_view&num=152126
6943,2019-11-21,뉴스투데이L대웅제약대한민국일하기좋은100대기업대상수상,http://www.news2day.co.kr/142564
6944,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.wikileaks-kr.org/news/articleView.html?idxno=70545
6945,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.getnews.co.kr/view.php?ud=20191121183535505841d0c69529_16
6946,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,https://www.vop.co.kr/A00001449808.html
6947,2019-11-22,대웅제약대한민국일하기좋은100대기업대상수상,http://www.thefirstmedia.net/news/articleView.html?idxno=50979
6948,2019-11-22,대웅제약대한민국일하기좋은100대기업대상수상,http://news.heraldcorp.com/view.php?ud=20191122000069
6949,2019-11-22,대웅제약주가증권투자정보및종목동정과증시정보22일오늘거래가133500원거래,http://www.gokorea.kr/news/articleView.html?idxno=580312
6950,2019-11-22,대웅제약주식실시간22일현재134000원,http://nbntv.co.kr/news/view/750066
6951,2019-11-22,특징주종목정보11월22일대웅제약131500원으로장마감,http://nbntv.co.kr/news/view/751506
6952,2019-11-24,제품수출에그치지않는다대웅제약의글로벌시장승부수,http://www.edaily.co.kr/news/newspath.asp?newsid=01859766622689000
6953,2019-11-25,★주식인사이드대웅제약주가133000원11월25일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1048786
6954,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.viva100.com/main/view.php?key=20191125010008326
6955,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.etnews.com/20191125000020
6956,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.etoday.co.kr/news/section/newsview.php?idxno=1826079
6957,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://daily.hankooki.com/lpage/ittech/201911/dh20191125092457145630.htm
6958,2019-11-25,제조시설우수성재입증대웅제약나보타공장EUGMP인증갱신성공,http://kpenews.com/View.aspx?No=331562
6959,2019-11-25,대웅제약나보타공장EU인증갱신성공,http://news.heraldcorp.com/view.php?ud=20191125000106
6960,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.medisobizanews.com/news/articleView.html?idxno=64225
6961,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.newsway.co.kr/news/view?tp=1&ud=2019112509264252712
6962,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.ceoscoredaily.com/news/article.html?no=62804
6963,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.newsway.co.kr/news/view?tp=1&ud=2019112509264252712
6964,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,https://www.sedaily.com/NewsView/1VQXNZX8J4
6965,2019-11-25,대웅제약나보타공장EUGMP인증갱신제조시설우수성재입증,http://www.econovill.com/news/articleView.html?idxno=378356
6966,2019-11-25,대웅제약나보타공장유럽우수의약품제조관리기준인증갱신,http://www.newspim.com/news/view/20191125000189
6967,2019-11-25,대웅제약나보타공장EUGMP인증갱신‥우수성재입증,http://medipana.com/news/news_viewer.asp?NewsNum=249144&MainKind=A&NewsKind=5&vCount=12&vKind=1
6968,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.dailian.co.kr/news/view/846317/?sc=naver
6969,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.fnnews.com/news/201911250937068480
6970,2019-11-25,대웅제약나보타공장의EUGMP갱신성공,http://news.mk.co.kr/newsRead.php?year=2019&no=979076
6971,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://moneys.mt.co.kr/news/mwView.php?no=2019112509358031198
6972,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=18583
6973,2019-11-25,대웅제약나보타공장EUGMP인증갱신,https://biz.chosun.com/site/data/html_dir/2019/11/25/2019112500820.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6974,2019-11-25,대웅제약나보타공장EUGMP인증갱신제조시설우수성입증,https://asiatime.co.kr/news/newsview.php?ncode=1065573255406361
6975,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.newsis.com/view/?id=NISX20191125_0000839712&cID=13001&pID=13000
6976,2019-11-25,대웅제약나보타공장EUGMP인증갱신 ,http://www.monews.co.kr/news/articleView.html?idxno=206693
6977,2019-11-25,대웅제약주름개선제나보타생산공장유럽인증갱신,http://www.sportsseoul.com/news/read/853188
6978,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.dt.co.kr/contents.html?article_no=2019112502109931102002&ref=naver
6979,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.rapportian.com/news/articleView.html?idxno=121709
6980,2019-11-25,유럽의약품청대웅제약나보타공장적합인증,http://www.100ssd.co.kr/news/articleView.html?idxno=65621
6981,2019-11-25,대웅제약나보타공장EUGMP인증갱신제조시설우수성입증,http://www.metroseoul.co.kr/news/newsview?newscd=2019112500028
6982,2019-11-25,대웅제약나보타팩토리EUGMP인증갱신,http://www.newslock.co.kr/news/articleView.html?idxno=23648
6983,2019-11-25,대웅제약나보타공장우수성인증EUGMP인증갱신,http://www.newsprime.co.kr/news/article.html?no=484406
6984,2019-11-25,대웅제약 나보타공장 EUGMP 인증갱신성공 제조시설우수성재입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=38429
6985,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.consumuch.com/news/articleView.html?idxno=46660
6986,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://news.mt.co.kr/mtview.php?no=2019112509425070910
6987,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58352
6988,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237779
6989,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.lawissue.co.kr/view.php?ud=201911251058402423204ead0791_12
6990,2019-11-25,11월25일대웅제약종목검색133000원114,http://nbntv.co.kr/news/view/752488
6991,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.newstomato.com/ReadNews.aspx?no=935538
6992,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.bokuennews.com/news/article.html?no=183680
6993,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://newsbrite.net/130419
6994,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.bosa.co.kr/news/articleView.html?idxno=2116639
6995,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.koreaittimes.com/news/articleView.html?idxno=94254
6996,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.dailymedi.com/detail.php?number=849923&thread=22r05
6997,2019-11-25,대웅제약나보타공장EUGMP인증갱신제조시설우수성재입증,http://www.worktoday.co.kr/news/articleView.html?idxno=5163
6998,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074464
6999,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=370992
7000,2019-11-25,대웅제약나보타공장제조시설우수성재입증,http://www.edaily.co.kr/news/newspath.asp?newsid=03427606622689328
7001,2019-11-25,대웅제약나보타공장EU인증갱신제조시설우수성재입증,http://www.newspost.kr/news/articleView.html?idxno=73964
7002,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://inthenews.co.kr/article-25666/
7003,2019-11-25,대웅제약보툴리눔톡신공장유럽연합제조품질관리기준인증경신,http://www.businesspost.co.kr/BP?command=article_view&num=152460
7004,2019-11-25,국내제약사제조시설유럽에서도인정했다대웅제약나보타공장EUGMP인증갱신성공,http://www.updownnews.co.kr/news/articleView.html?idxno=211514
7005,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.ebn.co.kr/news/view/1010660/?sc=naver
7006,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.joseilbo.com/news/news_read.php?uid=387894&class=27&grp=
7007,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.wsobi.com/news/articleView.html?idxno=85698
7008,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.wikileaks-kr.org/news/articleView.html?idxno=70794
7009,2019-11-25,대웅제약현지화통한글로벌헬스케어그룹세계시장공략도전이어가,http://www.newslock.co.kr/news/articleView.html?idxno=23682
7010,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.enewstoday.co.kr/news/articleView.html?idxno=1351556
7011,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.cnbnews.com/news/article.html?no=428622
7012,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.finomy.com/news/articleView.html?idxno=72151
7013,2019-11-25,뉴스투데이L대웅제약나보타공장EUGMP인증갱신,http://www.news2day.co.kr/142795
7014,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.medigatenews.com/news/2290989480
7015,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.getnews.co.kr/view.php?ud=2019112519011620041d0c69529_16
7016,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.newscj.com/news/articleView.html?idxno=686097
7017,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.thefirstmedia.net/news/articleView.html?idxno=51094
7018,2019-11-26,대웅제약주식장26일현재133500원,http://nbntv.co.kr/news/view/755058
7019,2019-11-27,대웅제약59년전통간장약1위브랜드강조,http://news.mk.co.kr/newsRead.php?year=2019&no=987602
7020,2019-11-27,대웅제약차세대위식도역류질환신약펙수프라잔임상3상완료,http://www.etoday.co.kr/news/section/newsview.php?idxno=1827133
7021,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237892
7022,2019-11-27,대웅제약PCAB제제Fexuprazan임상3상완료,http://medipana.com/news/news_viewer.asp?NewsNum=249293&MainKind=A&NewsKind=5&vCount=12&vKind=1
7023,2019-11-27,대웅제약글로벌블록버스터신약기대감펙수프라잔임상3상완료,http://kpenews.com/View.aspx?No=335169
7024,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,http://daily.hankooki.com/lpage/ittech/201911/dh20191127094227145630.htm
7025,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상서유의성입증,http://www.viva100.com/main/view.php?key=20191127010009316
7026,2019-11-27,대웅제약위식도역류질환신약임상완료치료율99,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019112709415723144
7027,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,https://www.sedaily.com/NewsView/1VQYL20IDG
7028,2019-11-27,대웅제약차세대위식도역류질환치료제펙수프라잔임상3상완료,http://www.etnews.com/20191127000022
7029,2019-11-27,대웅제약차세대위식도역류질환치료제펙수프라잔임상3상완료,http://www.dailian.co.kr/news/view/847098/?sc=naver
7030,2019-11-27,대웅제약신약펙수프라잔임상서위산분비억제확인,http://www.medisobizanews.com/news/articleView.html?idxno=64311
7031,2019-11-27,대웅제약위식도역류질환신약임상3상성공적완료,http://news.heraldcorp.com/view.php?ud=20191127000123
7032,2019-11-27,대웅제약차세대위식도역류질환치료제펙수프라잔임상3상완료,http://www.newspim.com/news/view/20191127000233
7033,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://news.mk.co.kr/newsRead.php?year=2019&no=988294
7034,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://www.consumuch.com/news/articleView.html?idxno=46688
7035,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,http://www.metroseoul.co.kr/news/newsview?newscd=2019112700034
7036,2019-11-27,대웅제약자체개발차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.ceoscoredaily.com/news/article.html?no=62911
7037,2019-11-27,대웅제약위식도역류질환신약펙수프라잔3상완료,http://news.mt.co.kr/mtview.php?no=2019112709482866076
7038,2019-11-27,대웅제약 차세대위식도역류질환치료제 Fexuprazan 임상3상완료,http://www.businesskorea.co.kr/news/articleView.html?idxno=38544
7039,2019-11-27,대웅제약차세대역류성식도염약펙수프라잔3상완료,http://www.newsis.com/view/?id=NISX20191127_0000842521&cID=13001&pID=13000
7040,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.newswatch.kr/news/articleView.html?idxno=25309
7041,2019-11-27,대웅제약PCAB계열신약3상완료위산억제효과,http://health.chosun.com/site/data/html_dir/2019/11/27/2019112701159.html
7042,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://www.joseilbo.com/news/news_read.php?uid=388022&class=27&grp=
7043,2019-11-27,대웅제약위식도역류질환치료제임상3상완료,http://www.skyedaily.com/news/news_view.html?ID=94622
7044,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,https://view.asiae.co.kr/article/2019112710300836288
7045,2019-11-27,11월27일대웅제약증권투자정보037,http://www.gokorea.kr/news/articleView.html?idxno=585849
7046,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58420
7047,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.dailysmart.co.kr/news/articleView.html?idxno=18733
7048,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://kormedi.com/?p=1306552
7049,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://www.seoulwire.com/news/articleView.html?idxno=260283
7050,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://inthenews.co.kr/article-25975/
7051,2019-11-27,대웅제약위식도역류질환신약임상3상완료,http://www.youthdaily.co.kr/news/article.html?no=23549
7052,2019-11-27,대웅제약차세대위식도역류치료제펙수프라잔임상3상완료,https://asiatime.co.kr/news/newsview.php?ncode=1065574520582390
7053,2019-11-27,대웅제약차세대위식도역류치료제임상완료,https://www.paxnetnews.com/articles/54278
7054,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://news.mk.co.kr/newsRead.php?year=2019&no=988799
7055,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=371209
7056,2019-11-27,대웅제약위식도역류질환치료신약임상3상완료,http://www.monews.co.kr/news/articleView.html?idxno=206743
7057,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔Fexuprazan임상3상완료,http://www.newslock.co.kr/news/articleView.html?idxno=23739
7058,2019-11-27,대웅제약주식창27일현재134500원,http://nbntv.co.kr/news/view/756351
7059,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,https://biz.chosun.com/site/data/html_dir/2019/11/27/2019112701487.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7060,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://yna.kr/AKR20191127077700017?did=1195m
7061,2019-11-27,대웅제약ITC소송서엘러간은빠져라‥자격없다주장,http://medipana.com/news/news_viewer.asp?NewsNum=249310&MainKind=A&NewsKind=5&vCount=12&vKind=1
7062,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.economytalk.kr/news/articleView.html?idxno=201460
7063,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://newsbrite.net/130560
7064,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://www.newsprime.co.kr/news/article.html?no=484828
7065,2019-11-27,대웅제약위식도역류질환신약Fexuprazan3상완료,http://www.bosa.co.kr/news/articleView.html?idxno=2116814
7066,2019-11-27,대웅제약개발신약펙수프라잔임상3상완료,http://www.dailymedi.com/detail.php?number=850018&thread=22r05
7067,2019-11-27,대웅제약PCAB펙수프라잔3상임상완료,http://www.whosaeng.com/114267
7068,2019-11-27,대웅제약위식도역류질환치료제임상3상마쳐전승호연구집중,http://www.businesspost.co.kr/BP?command=article_view&num=152843
7069,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://www.rapportian.com/news/articleView.html?idxno=121784
7070,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.newsway.co.kr/news/view?tp=1&ud=2019112711434928135
7071,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔3상완료,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074561
7072,2019-11-27,대웅제약PCAB펙수프라잔임상3상완료시장진출예고,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132294
7073,2019-11-27,대웅제약차세대위식도역류질환치료신약펙수프라잔임상3상완료,http://www.getnews.co.kr/view.php?ud=20191127130100589941d0c69529_16
7074,2019-11-27,대웅제약신약펙수프라잔임상3상완료,http://www.smedaily.co.kr/news/articleView.html?idxno=87856
7075,2019-11-27,대웅제약위식도역류질환신약임상3상완료,http://www.koreastocknews.com/news/articleView.html?idxno=48369
7076,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://www.asiatoday.co.kr/view.php?key=20191127010016181
7077,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상성공,http://www.econovill.com/news/articleView.html?idxno=378608
7078,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,https://www.hankyung.com/it/article/201911276478i
7079,2019-11-27,대웅제약역류성식도염신약국내임상3상완료,https://cnbc.sbs.co.kr/article_hub/10000963839?division=NAVER
7080,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.lawissue.co.kr/view.php?ud=201911271443184106204ead0791_12
7081,2019-11-27,대웅제약펙수프라잔임상3상완료효과입증,http://www.mhj21.com/125929
7082,2019-11-27,대웅제약위식도역류치료제펙수프라잔임상3상완료,http://www.bokuennews.com/news/article.html?no=183834
7083,2019-11-27,대웅제약위식도역류질환치료제Fexuprazan임상3상완료,http://www.medigatenews.com/news/2278533550
7084,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,http://www.newstomato.com/ReadNews.aspx?no=936247
7085,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료”,http://sports.hankooki.com/lpage/economy/201911/sp20191127155121137020.htm
7086,2019-11-27,대웅제약진화된위식도역류질환치료제임상3상성공,http://www.edaily.co.kr/news/newspath.asp?newsid=03381686622689984
7087,2019-11-27,대웅제약위식도역류질환치료제펙수트라잔임상3상완료,http://www.updownnews.co.kr/news/articleView.html?idxno=211646
7088,2019-11-27,대웅제약나보타공장유럽GMP인증갱신성공제조시설우수성재입증,http://www.ekn.kr/news/article.html?no=465777
7089,2019-11-27,대웅제약역류성식도염신약임상3상완료,https://www.hankyung.com/it/article/2019112771771
7090,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상성공,http://www.newsfc.co.kr/news/articleView.html?idxno=38881
7091,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,http://www.shinailbo.co.kr/news/articleView.html?idxno=1227906
7092,2019-11-27,대웅제약차세대위식도역류질환치료제펙수프라잔임상3상완료,http://www.wikileaks-kr.org/news/articleView.html?idxno=71012
7093,2019-11-27,뉴스투데이L대웅제약차세대위식도역류질환치료제펙수프라잔임상3상완료,http://www.news2day.co.kr/143019
7094,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://www.newscj.com/news/articleView.html?idxno=686842
7095,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상마쳐,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3995661
7096,2019-11-28,대웅제약위식도역류질환치료제펙수프라잔임상3상완료글로벌블록버스터신약으로성장기대,http://www.thefirstmedia.net/news/articleView.html?idxno=51190
7097,2019-11-28,대웅제약나보타성공이을후속신약개발위해RD확대,http://www.kukinews.com/news/article.html?no=723050
7098,2019-11-28,대웅제약위식도역류질환신약높은치료율내약성확인,http://www.seoulfn.com/news/articleView.html?idxno=363872
7099,2019-11-28,대웅제약나보타공장EUGMP인증갱신제조시설우수성재입증,http://www.newsian.co.kr/news/articleView.html?idxno=38047
7100,2019-11-28,★주식인사이드대웅제약주가137000원11월28일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1049494
7101,2019-11-28,대웅제약차별화된전략으로글로벌헬스케어그룹도약,http://www.asiatoday.co.kr/view.php?key=20191128010016916
7102,2019-11-28,대웅제약위식도역류질환신약임상3상완료,http://www.ekn.kr/news/article.html?no=466644
7103,2019-11-28,대웅제약PCAB위식도역류질환신약3상완료,http://weekly.cnbnews.com/news/article.html?no=131364
7104,2019-11-29,일할때는제대로몰입해일하고쉴때는제대로쉬는대웅제약,http://www.kukinews.com/news/article.html?no=723049
7105,2019-11-29,대웅제약펙수프라잔으로PCAB독주케이캡에도전장,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074708
7106,2019-11-29,한화證대웅제약실적부진은단기적이슈매수의견”,http://www.newsway.co.kr/news/view?tp=1&ud=2019112908490028342
7107,2019-11-29,대웅제약실적부진단기적이슈한화투자증권,http://www.ajunews.com/view/20191129084229300
7108,2019-11-29,한화證대웅제약실적부진은단기적이슈매수의견,http://www.newsis.com/view/?id=NISX20191129_0000845171&cID=10401&pID=10400
7109,2019-11-29,★주식인사이드대웅제약주가136000원11월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1049805
7110,2019-11-29,대웅제약하반기실적부진단기적이슈,http://www.newsprime.co.kr/news/article.html?no=485120
7111,2019-11-29,특징주대웅제약실적부진은단기이슈,http://www.sisaon.co.kr/news/articleView.html?idxno=105173
7112,2019-11-29,특징주대웅제약실적부진은단기적이슈목표주가23만원매수의견유지,http://www.shinailbo.co.kr/news/articleView.html?idxno=1228436
7113,2019-11-29,리포트브리핑대웅제약실적부진은단기적이슈목표가230000원한화투자증권,http://www.newspim.com/news/view/20191129000487
7114,2019-11-29,GET투자리포트대웅제약투자의견매수유지한화투자증권,http://www.getnews.co.kr/view.php?ud=2019112910303014879tpgetnews_16
7115,2019-11-29,대웅제약소화성궤양치료제판매중단으로단기적실적부진불가피,http://www.businesspost.co.kr/BP?command=article_view&num=153220
7116,2019-11-29,대웅제약3분기부진한수익성나보타소송비용4분기에도영향끼칠것”,http://www.wikitree.co.kr/main/news_view.php?id=484948
7117,2019-12-02,★주식인사이드대웅제약주가132500원12월2일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1050140
7118,2019-12-02,CJ케이캡항궤양제신약독주에도전장내민대웅제약,http://www.newsway.co.kr/news/view?tp=1&ud=2019112917455214370
7119,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.dt.co.kr/contents.html?article_no=2019120202109931102002&ref=naver
7120,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=18985
7121,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.ceoscoredaily.com/news/article.html?no=63106
7122,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.etnews.com/20191202000051
7123,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238076
7124,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩4종출시,http://news.mk.co.kr/newsRead.php?year=2019&no=1004385
7125,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.asiatoday.co.kr/view.php?key=20191202010000704
7126,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.viva100.com/main/view.php?key=20191202010000367
7127,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.medisobizanews.com/news/articleView.html?idxno=64458
7128,2019-12-02,대웅제약구강연령별맞춤형치약덴티가드랩출시,https://asiatime.co.kr/news/newsview.php?ncode=1065576786568895
7129,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.newswatch.kr/news/articleView.html?idxno=25419
7130,2019-12-02,대웅제약연령대별로골라쓰는맞춤치약덴티가드랩출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019120200062
7131,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://news.mt.co.kr/mtview.php?no=2019120211100603699
7132,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.newspim.com/news/view/20191202000446
7133,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://medipana.com/news/news_viewer.asp?NewsNum=249534&MainKind=A&NewsKind=5&vCount=12&vKind=1
7134,2019-12-02,대웅제약구강토탈솔루션시장진출,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912020258&t=NN
7135,2019-12-02,대웅제약서울대와구강생애주기별맞춤치약개발출시,http://www.newsis.com/view/?id=NISX20191202_0000847380&cID=13001&pID=13000
7136,2019-12-02,대웅제약구강주기별치약덴티가드랩출시,http://www.finomy.com/news/articleView.html?idxno=72436
7137,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.joseilbo.com/news/news_read.php?uid=388277&class=27&grp=
7138,2019-12-02,뉴스투데이L대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.news2day.co.kr/143282
7139,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.lawissue.co.kr/view.php?ud=201912021219055990204ead0791_12
7140,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019120212241060403
7141,2019-12-02,대웅제약치약도나이에맞춰쓰세요,https://www.nocutnews.co.kr/news/5252463
7142,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.wsobi.com/news/articleView.html?idxno=86087
7143,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.dailian.co.kr/news/view/848532/?sc=naver
7144,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.whosaeng.com/114378
7145,2019-12-02,대웅제약구강생애주기맞춤치약덴티가드랩출시,http://www.donga.com/news/article/all/20191202/98623281/1
7146,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://daily.hankooki.com/lpage/ittech/201912/dh20191202140516145630.htm
7147,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.newspost.kr/news/articleView.html?idxno=74161
7148,2019-12-02,출시연령별차별화된구강관리기준제시대웅제약덴티가드랩,http://kpenews.com/View.aspx?No=340126
7149,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=371583
7150,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.ebn.co.kr/news/view/1011677/?sc=naver
7151,2019-12-02,대웅제약연령대별구강관리덴티가드랩출시,http://www.koreastocknews.com/news/articleView.html?idxno=48496
7152,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.sportsseoul.com/news/read/856286
7153,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.getnews.co.kr/view.php?ud=20191202154900591141d0c69529_16
7154,2019-12-02,시지바이오대웅제약공동개발한노보시스IR52장영실상수상,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201912021610018&code=920509
7155,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=347229
7156,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://newsbrite.net/130822
7157,2019-12-02,치약도생애주기별로대웅제약덴티가드랩선보여,http://www.mhj21.com/126014
7158,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.newslock.co.kr/news/articleView.html?idxno=23913
7159,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58506
7160,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.dailymedi.com/detail.php?number=850289&thread=22r05
7161,2019-12-02,대웅제약연령별맞춤형치약덴티가드랩출시,http://www.econovill.com/news/articleView.html?idxno=379043
7162,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩선봬,http://www.cnbnews.com/news/article.html?no=429376
7163,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.newscj.com/news/articleView.html?idxno=688076
7164,2019-12-03,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.thefirstmedia.net/news/articleView.html?idxno=51404
7165,2019-12-03,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.betanews.net:8080/article/1108832.html
7166,2019-12-03,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.bosa.co.kr/news/articleView.html?idxno=2117146
7167,2019-12-03,제약바이오지배구조⑥대웅제약그룹자기주식재단통해경영권방어와승계1석2조,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=535432
7168,2019-12-03,전승호대웅제약차세대위장약으로강자CJ헬스케어에맞설태세,http://www.businesspost.co.kr/BP?command=article_view&num=153680
7169,2019-12-04,제약업계단신광동제약동국제약대웅제약GC녹십자웰빙,http://www.g-enews.com/ko-kr/news/article/news_all/20191203154520135469d76442fa_1/article.html
7170,2019-12-04,★주식인사이드대웅제약주가131500원12월4일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1050640
7171,2019-12-04,12월4일대웅제약주식실시간075131500원,http://nbntv.co.kr/news/view/758041
7172,2019-12-04,대웅제약주가069620오늘시세및종목동정과증시정보4일오늘가격132500원형성,http://www.gokorea.kr/news/articleView.html?idxno=587562
7173,2019-12-05,대웅제약4단계치약덴티가드랩출시,http://weekly.cnbnews.com/news/article.html?no=131474
7174,2019-12-05,★주식인사이드대웅제약주가131500원12월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1050961
7175,2019-12-05,시지바이오국내최초뇌혈관스텐트식약처허가대웅제약판매,http://medipana.com/news/news_viewer.asp?NewsNum=249730&MainKind=A&NewsKind=5&vCount=12&vKind=1
7176,2019-12-05,대웅제약주요의약품중점자표시7개업계최다,http://www.finomy.com/news/articleView.html?idxno=72639
7177,2019-12-06,★주식인사이드대웅제약주가131000원12월6일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1051248
7178,2019-12-06,대웅제약증권매매6일현재132000원,http://nbntv.co.kr/news/view/759761
7179,2019-12-06,대웅제약주가종목그래프및매매동향6일오늘가격132000원거래,http://www.gokorea.kr/news/articleView.html?idxno=589014
7180,2019-12-06,차세대나보타를찾아라대웅제약전승호RD가속페달,http://www.newsway.co.kr/news/view?tp=1&ud=2019120518163246806
7181,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://www.medisobizanews.com/news/articleView.html?idxno=64647
7182,2019-12-06,대웅제약연구개발활동우수성입증ISO9001인증획득,http://kpenews.com/View.aspx?No=345493
7183,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.ezyeconomy.com/news/articleView.html?idxno=96022
7184,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.metroseoul.co.kr/news/newsview?newscd=2019120600013
7185,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.sisafocus.co.kr/news/articleView.html?idxno=227276
7186,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.newswatch.kr/news/articleView.html?idxno=25573
7187,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.newsprime.co.kr/news/article.html?no=486085
7188,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58591
7189,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://medipana.com/news/news_viewer.asp?NewsNum=249826&MainKind=A&NewsKind=5&vCount=12&vKind=1
7190,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.fnnews.com/news/201912061302273751
7191,2019-12-06,대웅제약품질경영시스템국제표준인증획득,http://www.koreastocknews.com/news/articleView.html?idxno=48641
7192,2019-12-06,대웅제약연구개발활동ISO9001국제인증받아,http://health.chosun.com/site/data/html_dir/2019/12/06/2019120601860.html
7193,2019-12-06,대웅제약품질경영시스템ISO9001인증획득,http://www.whosaeng.com/114502
7194,2019-12-06,대웅제약품질경영인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2019120612168084120
7195,2019-12-06,대웅제약품질경영시스템국제표준인증획득,https://www.paxnetnews.com/articles/54634
7196,2019-12-06,대웅제약ISO9001인증획득,https://view.asiae.co.kr/article/2019120613442828770
7197,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.ftoday.co.kr/news/articleView.html?idxno=113087
7198,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1831120
7199,2019-12-06,대웅제약품질경영시스템국제표준인증획득,http://www.newspim.com/news/view/20191206000747
7200,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://www.seoulwire.com/news/articleView.html?idxno=261642
7201,2019-12-06,대웅제약품질경영국제표준ISO9001인증획득,http://www.youthdaily.co.kr/news/article.html?no=24268
7202,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.donga.com/news/article/all/20191206/98691156/1
7203,2019-12-06,대웅제약품질경영시스템ISO9001인증획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912060198&t=NN
7204,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.bosa.co.kr/news/articleView.html?idxno=2117494
7205,2019-12-06,대웅제약품질경영시스템ISO9001획득,http://www.k-health.com/news/articleView.html?idxno=46519
7206,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.newslock.co.kr/news/articleView.html?idxno=24057
7207,2019-12-06,대웅제약연구본부품질경영시스템국제표준ISO9001인증획득,http://news.mk.co.kr/newsRead.php?year=2019&no=1022329
7208,2019-12-06,대웅제약ISO9001인증획득연구개발활동우수성입증,http://www.getnews.co.kr/view.php?ud=20191206142521474641d0c69529_16
7209,2019-12-06,대웅제약품질경영ISO9001인증수출시신뢰제고,http://www.newsis.com/view/?id=NISX20191206_0000852798&cID=13001&pID=13000
7210,2019-12-06,대웅제약품질경영국제인증RD활동우수성입증”,http://news.heraldcorp.com/view.php?ud=20191206000524
7211,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.medigatenews.com/news/405438929
7212,2019-12-06,대웅제약나보타너마저나보타하반기미국매출부진,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019120612053798790
7213,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://www.bokuennews.com/news/article.html?no=184246
7214,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://www.dailymedi.com/detail.php?number=850466&thread=22r05
7215,2019-12-06,대웅제약연구개발활동ISO9001인증획득,http://www.rapportian.com/news/articleView.html?idxno=122012
7216,2019-12-06,대웅제약ISO9001인증획득으로연구개발활동우수성입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=348798
7217,2019-12-06,뉴스투데이L대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.news2day.co.kr/143778
7218,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019120615374266548
7219,2019-12-06,대웅제약ISO9001인증획득,http://www.ebn.co.kr/news/view/1012471/?sc=naver
7220,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238312
7221,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득으로연구개발활동우수성입증,http://newsbrite.net/131067
7222,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://inthenews.co.kr/article-27208/
7223,2019-12-06,대웅제약품질경영시스템국제표준인증획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=19288
7224,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://www.econovill.com/news/articleView.html?idxno=379466
7225,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득연구개발활동우수성입증,http://www.updownnews.co.kr/news/articleView.html?idxno=212063
7226,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.cnbnews.com/news/article.html?no=429931
7227,2019-12-06,대웅제약품질경영시스템ISO9001인증획득,http://www.finomy.com/news/articleView.html?idxno=72711
7228,2019-12-06,대웅제약품질경영국제표준ISO9001인증획득,http://www.shinailbo.co.kr/news/articleView.html?idxno=1230926
7229,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.sportsseoul.com/news/read/858353
7230,2019-12-06,대웅제약ISO9001인증,http://www.seoulfn.com/news/articleView.html?idxno=364939
7231,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=372044
7232,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://daily.hankooki.com/lpage/ittech/201912/dh20191206181222145630.htm
7233,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.newscj.com/news/articleView.html?idxno=689373
7234,2019-12-08,대웅제약품질경영시스템국제표준ISO9001인증획득연구개발활동우수성입증”,http://www.viva100.com/main/view.php?key=20191208010002524
7235,2019-12-08,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.dt.co.kr/contents.html?article_no=2019120802109931102002&ref=naver
7236,2019-12-08,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.ekn.kr/news/article.html?no=468474
7237,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019120900049
7238,2019-12-09,대웅제약주가증권투자정보9일오늘가격131000원형성,http://www.gokorea.kr/news/articleView.html?idxno=590967
7239,2019-12-09,대웅제약 퇴직사우모임 웅비회 제8회송년의밤개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=39000
7240,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤개최,http://www.medisobizanews.com/news/articleView.html?idxno=64676
7241,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://medipana.com/news/news_viewer.asp?NewsNum=249901&MainKind=A&NewsKind=5&vCount=12&vKind=1
7242,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=19364
7243,2019-12-09,대웅제약웅비회제8회송년의밤개최전현직임원130명참석,http://www.viva100.com/main/view.php?key=20191209010002839
7244,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238353
7245,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58623
7246,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤개최,https://asiatime.co.kr/news/newsview.php?ncode=1065575413307958
7247,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.newsway.co.kr/news/view?tp=1&ud=2019120910533017587
7248,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://daily.hankooki.com/lpage/ittech/201912/dh20191209105815145630.htm
7249,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.newswatch.kr/news/articleView.html?idxno=25610
7250,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.newslock.co.kr/news/articleView.html?idxno=24098
7251,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤,http://www.bosa.co.kr/news/articleView.html?idxno=2117580
7252,2019-12-09,대웅제약퇴직사우모임제8회웅비회송년의밤개최,http://www.donga.com/news/article/all/20191209/98716875/1
7253,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.newspost.kr/news/articleView.html?idxno=74358
7254,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.econovill.com/news/articleView.html?idxno=379594
7255,2019-12-09,데일리주식정보대웅제약069620오후12시20분기준및주식시황,https://www.dailysecu.com/news/articleView.html?idxno=84595
7256,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://newsbrite.net/131131
7257,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.enewstoday.co.kr/news/articleView.html?idxno=1354421
7258,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.lawissue.co.kr/view.php?ud=201912091330454100204ead0791_12
7259,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,http://www.metroseoul.co.kr/news/newsview?newscd=2019120900119
7260,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.cnbnews.com/news/article.html?no=430054
7261,2019-12-09,대웅제약아시아통증심포지엄서신약연구발표,http://www.mhj21.com/126148
7262,2019-12-09,대웅제약만성통증치료제DWP17061연구발표,http://medipana.com/news/news_viewer.asp?NewsNum=249930&MainKind=A&NewsKind=5&vCount=12&vKind=1
7263,2019-12-09,대웅제약만성통증치료물질글로벌혁신신약으로개발,http://www.medisobizanews.com/news/articleView.html?idxno=64690
7264,2019-12-09,대웅제약만성통증치료제신약연구발표글로벌파트너링가속”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1831842
7265,2019-12-09,대웅제약만성통증신약아시아통증심포지엄서주목,http://www.viva100.com/main/view.php?key=20191209010002975
7266,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.lawissue.co.kr/view.php?ud=201912091400532469204ead0791_12
7267,2019-12-09,대웅제약웅비회송년의밤개최,http://www.finomy.com/news/articleView.html?idxno=72766
7268,2019-12-09,대웅제약만성통증치료제신약연구발표글로벌임상1상준비,http://www.newsprime.co.kr/news/article.html?no=486302
7269,2019-12-09,대웅제약만성통증치료신약내년상반기글로벌임상1상,https://www.hankyung.com/it/article/201912091805i
7270,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제연구발표,http://daily.hankooki.com/lpage/ittech/201912/dh20191209142115145630.htm
7271,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤개최,http://www.seoulwire.com/news/articleView.html?idxno=261903
7272,2019-12-09,대웅제약골관절염진통제신약전임상성공적,http://news.mt.co.kr/mtview.php?no=2019120914184004369
7273,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤개최,http://www.youthdaily.co.kr/news/article.html?no=24420
7274,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료신약발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238373
7275,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,http://www.dailian.co.kr/news/view/850906/?sc=naver
7276,2019-12-09,대웅제약만성통증치료후보물질효능우수,http://www.monews.co.kr/news/articleView.html?idxno=206974
7277,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,https://www.kpanews.co.kr/article/show.asp?idx=209302&category=D
7278,2019-12-09,대웅제약APS서만성통증치료제신약연구발표주목,http://www.bosa.co.kr/news/articleView.html?idxno=2117605
7279,2019-12-09,대웅제약만성통증치료제DWP17061연구결과발표,http://www.donga.com/news/article/all/20191209/98721403/1
7280,2019-12-09,대웅제약만성통증치료제신약연구발표,http://www.joseilbo.com/news/news_read.php?uid=388736&class=27&grp=
7281,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료후보물질DWP17061연구발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=372200
7282,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=372201
7283,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=349222
7284,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,http://www.newspim.com/news/view/20191209000853
7285,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.nbnnews.co.kr/news/articleView.html?idxno=349230
7286,2019-12-09,대웅제약아시아통증심포지엄서만성통증신약후보물질전임상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=1029121
7287,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.medigatenews.com/news/2114361362
7288,2019-12-09,대웅제약2019아시아통증심포지엄에서만성통증치료제신약프로파일발표,http://www.ftoday.co.kr/news/articleView.html?idxno=113140
7289,2019-12-09,대웅제약국제학술대회서만성통증치료물질발표,http://moneys.mt.co.kr/news/mwView.php?no=2019120916178021434
7290,2019-12-09,대웅제약DWP17061프로파일발표,http://www.ebn.co.kr/news/view/1012725/?sc=naver
7291,2019-12-09,만성통증치료제적용력확인대웅제약DWP17061프로파일발표,http://kpenews.com/View.aspx?No=347685
7292,2019-12-09,대웅제약만성통증치료후보물질효능우수,http://www.seoulwire.com/news/articleView.html?idxno=261951
7293,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://newsbrite.net/131167
7294,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58638
7295,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.ekn.kr/news/article.html?no=468774
7296,2019-12-09,대웅제약만성통증치료제신약연구발표,http://www.economytalk.kr/news/articleView.html?idxno=201995
7297,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.businesskorea.co.kr/news/articleView.html?idxno=39036
7298,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.getnews.co.kr/view.php?ud=20191209184328435941d0c69529_16
7299,2019-12-09,대웅제약아시아통증심포지엄에골관절염통증치료제신약연구발표,http://www.news2day.co.kr/143920
7300,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.news2day.co.kr/143921
7301,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.getnews.co.kr/view.php?ud=20191209193151914541d0c69529_16
7302,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,http://www.newscj.com/news/articleView.html?idxno=689879
7303,2019-12-09,대웅제약아시아통증심포지엄에서만성통증치료제신약연구발표,http://www.thefirstmedia.net/news/articleView.html?idxno=51686
7304,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.thefirstmedia.net/news/articleView.html?idxno=51691
7305,2019-12-10,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,http://www.g-enews.com/ko-kr/news/article/news_all/201912091736469882aca1a8c21a_1/article.html
7306,2019-12-10,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.thefirstmedia.net/news/articleView.html?idxno=51705
7307,2019-12-10,★주식인사이드대웅제약주가130000원12월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1051934
7308,2019-12-10,대웅제약생애주기별맞춤치약덴티가드홈쇼핑서선봬,http://moneys.mt.co.kr/news/mwView.php?no=2019121009138034470
7309,2019-12-10,대웅제약생애주기별맞춤치약덴티가드랩홈쇼핑런칭,http://medipana.com/news/news_viewer.asp?NewsNum=249978&MainKind=A&NewsKind=5&vCount=12&vKind=1
7310,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.dailysmart.co.kr/news/articleView.html?idxno=19417
7311,2019-12-10,대웅제약생애주기별치약덴티가드랩NS홈쇼핑런칭,http://www.medisobizanews.com/news/articleView.html?idxno=64709
7312,2019-12-10,대웅제약12일NS홈쇼핑서생애주기별맞춤치약덴티가드랩판매,http://news.mk.co.kr/newsRead.php?year=2019&no=1031040
7313,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.enewstoday.co.kr/news/articleView.html?idxno=1354563
7314,2019-12-10,대웅제약덴티가드랩NS홈쇼핑론칭,http://www.ebn.co.kr/news/view/1012807/?sc=naver
7315,2019-12-10,대웅제약구강생애주기별치약덴티가드랩NS홈쇼핑론칭,https://asiatime.co.kr/news/newsview.php?ncode=1065573799041296
7316,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.metroseoul.co.kr/news/newsview?newscd=2019121000044
7317,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://newsbrite.net/131188
7318,2019-12-10,대웅제약연령대별구강생애주기맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.newslock.co.kr/news/articleView.html?idxno=24144
7319,2019-12-10,대웅제약연령별맞춤치약덴티가드랩12일NS홈쇼핑서판매,http://www.100ssd.co.kr/news/articleView.html?idxno=65954
7320,2019-12-10,대웅제약덴티가드랩NS홈쇼핑런칭,http://www.dailypharm.com/Users/News/NewsView.html?ID=259814&REFERER=NP
7321,2019-12-10,대웅제약구강생애주기맞춤치약판매채널확대,http://www.newsis.com/view/?id=NISX20191210_0000855408&cID=13001&pID=13000
7322,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.lawissue.co.kr/view.php?ud=201912101050189449204ead0791_12
7323,2019-12-10,대웅제약주가및증권시세10일오늘가격128500원형성,http://www.gokorea.kr/news/articleView.html?idxno=592945
7324,2019-12-10,주식장대웅제약주가10일현재129000원,http://nbntv.co.kr/news/view/763159
7325,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.newsway.co.kr/news/view?tp=1&ud=2019121011095586594
7326,2019-12-10,대웅제약덴티가드랩치약NS홈쇼핑런칭,http://www.bosa.co.kr/news/articleView.html?idxno=2117675
7327,2019-12-10,대웅제약덴티가드랩판매채널확대12일NS홈쇼핑판매,http://kpenews.com/View.aspx?No=348321
7328,2019-12-10,대웅제약덴티가드랩NS홈쇼핑런칭,http://www.cnbnews.com/news/article.html?no=430166
7329,2019-12-10,대웅제약빈혈치료제할랄인증마지막단계20억무슬림시장열린다,http://www.maeilnews.co.kr/news/article.html?no=7171
7330,2019-12-10,대웅제약DWP17061내년상반기글로벌임상1상준비,http://www.bokuennews.com/news/article.html?no=184373
7331,2019-12-10,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.newsian.co.kr/news/articleView.html?idxno=38410
7332,2019-12-10,대웅제약069620오후2시21분기준및매매동향,https://www.dailysecu.com/news/articleView.html?idxno=85105
7333,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩12일NS홈쇼핑서판매,http://www.updownnews.co.kr/news/articleView.html?idxno=212183
7334,2019-12-10,대웅제약당뇨약까지퍼진발암물질공포에깊은한숨,https://asiatime.co.kr/news/newsview.php?ncode=1065587297801912
7335,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩홈쇼핑런칭,http://www.econovill.com/news/articleView.html?idxno=379735
7336,2019-12-10,대웅제약ISO9001인증획득연구개발활동우수성입증,http://www.newsian.co.kr/news/articleView.html?idxno=38450
7337,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.getnews.co.kr/view.php?ud=20191210181633116441d0c69529_16
7338,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.newscj.com/news/articleView.html?idxno=690241
7339,2019-12-10,대웅제약연령별맞춤치약덴티가드랩NS홈쇼핑12일런칭,http://www.news2day.co.kr/144039
7340,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩홈쇼핑런칭,http://www.thefirstmedia.net/news/articleView.html?idxno=51751
7341,2019-12-11,12월11일대웅제약증권그래프038변동,http://www.gokorea.kr/news/articleView.html?idxno=595449
7342,2019-12-11,대웅제약오늘주식시세11일현재130000원,http://nbntv.co.kr/news/view/765386
7343,2019-12-11,대웅제약품질경영국제표준ISO9001인증,http://news.heraldcorp.com/view.php?ud=20191211000318
7344,2019-12-11,대웅제약만성통증치료신약내년상반기글로벌임상1상추진,http://www.newsian.co.kr/news/articleView.html?idxno=38488
7345,2019-12-11,경영스코프대웅제약전통신규사업조화속글로벌정조준,http://www.newstomato.com/ReadNews.aspx?no=939132
7346,2019-12-11,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.wsobi.com/news/articleView.html?idxno=86643
7347,2019-12-12,★주식인사이드대웅제약주가131000원12월12일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1052429
7348,2019-12-12,메디톡스대웅제약소모적인보톡스소송국내업체美시장진출걸림돌일상톡톡플러스,http://www.segye.com/content/html/2019/12/12/20191212503099.html?OutUrl=naver
7349,2019-12-12,12월12일대웅제약주식현황000131000원,http://nbntv.co.kr/news/view/767579
7350,2019-12-12,대웅제약주가12월12일현재131000원종목그래프및주식시황,http://www.gokorea.kr/news/articleView.html?idxno=597892
7351,2019-12-12,대웅제약 美혈액학회서 자가면역질환후보물질 DWP213388 연구성과공개,http://www.businesskorea.co.kr/news/articleView.html?idxno=39178
7352,2019-12-12,자가면역질환후보물질질환개선효과확인대웅제약연구결과공개,http://kpenews.com/View.aspx?No=351615
7353,2019-12-12,대웅제약美혈액학회서자가면역질환치료후보물질성과공개,http://www.medisobizanews.com/news/articleView.html?idxno=64799
7354,2019-12-12,대웅제약美혈액학회서자가면역질환치료후보물질연구결과공개,http://news.mk.co.kr/newsRead.php?year=2019&no=1040776
7355,2019-12-12,대웅제약ASH서자가면역질환ITKBTK저해제첫공개,http://www.biospectator.com/view/news_view.php?varAtcId=9104
7356,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58721
7357,2019-12-12,대웅제약자가면역질환후보물질DWP213388공개,http://medipana.com/news/news_viewer.asp?NewsNum=250158&MainKind=A&NewsKind=5&vCount=12&vKind=1
7358,2019-12-12,대웅제약ASH서자가면역질환후보물질성과공개,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1130856&REFERER=NP
7359,2019-12-12,대웅제약美ASH서자가면역질환신약연구성과공개,http://www.bosa.co.kr/news/articleView.html?idxno=2117903
7360,2019-12-12,대웅제약미국서자가면역질환후보물질연구성과공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238552
7361,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.ezyeconomy.com/news/articleView.html?idxno=96190
7362,2019-12-12,대웅제약자가면역질환후보물질DWP213388연구성과공개,http://www.etnews.com/20191212000105
7363,2019-12-12,대웅제약美혈액학회서자가면역질환치료제후보물질연구성과공개,http://www.pressm.kr/news/articleView.html?idxno=26532
7364,2019-12-12,대웅제약자가면역질환치료제DWP213388전임상서효능확인,http://www.econovill.com/news/articleView.html?idxno=379928
7365,2019-12-12,대웅제약美학회서자가면역질환후보물질공개,https://www.paxnetnews.com/articles/54821
7366,2019-12-12,대웅제약美서자가면역질환치료제DWP213388연구결과첫공개,http://www.viva100.com/main/view.php?key=20191212010004409
7367,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388성과발표,http://news1.kr/articles/?3791667
7368,2019-12-12,대웅제약美학회서자가면역질환치료제연구성과공개,http://www.dailysmart.co.kr/news/articleView.html?idxno=19569
7369,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.newsway.co.kr/news/view?tp=1&ud=2019121214114049844
7370,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질연구결과공개,http://www.newsprime.co.kr/news/article.html?no=486795
7371,2019-12-12,대웅제약美혈액학회서DWP213388연구성과공개,http://www.whosaeng.com/114656
7372,2019-12-12,대웅제약자가면역질환치료제생존율개선,https://www.sedaily.com/NewsView/1VS1NRYJ45
7373,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.etoday.co.kr/news/section/newsview.php?idxno=1833552
7374,2019-12-12,대웅제약美혈액학회서DWP213388연구성과공개,http://www.mhj21.com/126249
7375,2019-12-12,대웅제약美ASH서자가면역질환후보물질연구성과공개,http://inthenews.co.kr/article-27893/
7376,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구결과공개,http://www.newspim.com/news/view/20191212000984
7377,2019-12-12,대웅제약美혈액학회서자가면역질환ITKBTK저해제연구성과공개,http://www.updownnews.co.kr/news/articleView.html?idxno=212324
7378,2019-12-12,대웅제약美혈액학회서DWP213388자가면역질환후보물질연구성과알려,http://www.newslock.co.kr/news/articleView.html?idxno=24222
7379,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=372592
7380,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388성과발표,http://www.ajunews.com/view/20191212153000450
7381,2019-12-12,대웅제약미국서자가면역질환신약연구성과첫공개,http://moneys.mt.co.kr/news/mwView.php?no=2019121215308042898
7382,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.medigatenews.com/news/3018854375
7383,2019-12-12,대웅제약美혈액학회서자가면역질환치료제연구결과공개,http://www.koreastocknews.com/news/articleView.html?idxno=48809
7384,2019-12-12,대웅제약美혈액학회서자가면역질환신약연구발표,http://news.heraldcorp.com/view.php?ud=20191212000718
7385,2019-12-12,대웅제약자가면역치료제GvHD질환개선효과확인,http://www.monews.co.kr/news/articleView.html?idxno=207049
7386,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.nbnnews.co.kr/news/articleView.html?idxno=350237
7387,2019-12-12,대웅제약美서자가면역질환후보물질연구성과공개,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019121216503834231
7388,2019-12-12,대웅제약자가면역질환후보물질DWP213388연구성과美혈액학회서공개,http://www.thefirstmedia.net/news/articleView.html?idxno=51861
7389,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질연구성과공개,http://www.g-enews.com/ko-kr/news/article/news_all/20191212142304354569d76442fa_1/article.html
7390,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://newsbrite.net/131366
7391,2019-12-12,대웅제약미국서자가면역질환후보물질연구성과공개,http://www.economytalk.kr/news/articleView.html?idxno=202115
7392,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과발표,http://www.getnews.co.kr/view.php?ud=20191212173216237241d0c69529_16
7393,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질연구성과공개,http://www.dailian.co.kr/news/view/852164/?sc=naver
7394,2019-12-12,대웅제약자가면역질환신약동물실험서생존률개선,http://news.mt.co.kr/mtview.php?no=2019121218392198398
7395,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질연구성과공개,http://www.newscj.com/news/articleView.html?idxno=690885
7396,2019-12-13,★주식인사이드대웅제약주가133000원12월13일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1052743
7397,2019-12-13,12월13일대웅제약종목그래프114변화,http://www.gokorea.kr/news/articleView.html?idxno=600400
7398,2019-12-13,대웅제약美혈액학회서자가면역질환후보물질연구성과공개,http://www.bokuennews.com/news/article.html?no=184548
7399,2019-12-13,대웅제약美혈액학회서자가면역질환신약연구결과첫공개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075143
7400,2019-12-13,대웅제약차세대자가면역질환치료제후보물질연구결과공개,http://weekly.cnbnews.com/news/article.html?no=131596
7401,2019-12-16,★주식인사이드대웅제약주가132500원12월16일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1053115
7402,2019-12-16,12월16일대웅제약주가차트132000원112,http://nbntv.co.kr/news/view/771705
7403,2019-12-16,대웅제약세계최초최고신약개발로넥스트나보타앞당긴다,http://www.insightkorea.co.kr//news/articleView.html?idxno=71576
7404,2019-12-17,대웅제약나보타미국이어캐나다유럽진출,http://www.mhj21.com/126327
7405,2019-12-17,대웅제약06962017일227변동폭보여오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=602791
7406,2019-12-17,대웅제약나보타를필두로글로벌헬스케어기업도약,http://www.koreaittimes.com/news/articleView.html?idxno=94643
7407,2019-12-17,대웅제약증권투자17일현재130500원,http://nbntv.co.kr/news/view/773623
7408,2019-12-17,17일데일리증권대웅제약069620오후2시20분기준및증권정보와종목동정,https://www.dailysecu.com/news/articleView.html?idxno=87746
7409,2019-12-17,대웅제약나보타필두로글로벌헬스케어그룹도약할것”,http://inthenews.co.kr/article-28438/
7410,2019-12-17,대웅제약내년미국중국서펙수프라잔임상개시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912170337&t=NN
7411,2019-12-18,★주식인사이드대웅제약주가130500원12월18일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1053583
7412,2019-12-18,대웅제약투자주식18일현재131000원,http://nbntv.co.kr/news/view/775767
7413,2019-12-18,대웅제약이지듀6년연속대한민국퍼스트브랜드대상,http://www.medisobizanews.com/news/articleView.html?idxno=64998
7414,2019-12-18,대웅제약차세대나보타개발매진,http://www.seoulfn.com/news/articleView.html?idxno=366198
7415,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58826
7416,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드파이널리스트수상,http://www.viva100.com/main/view.php?key=20191218010006633
7417,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문본상수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1835831
7418,2019-12-18,대웅제약덴티가드랩핀업디자인어워드파이널리스트상수상,http://www.medisobizanews.com/news/articleView.html?idxno=65003
7419,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드파이널리스트수상,http://www.getnews.co.kr/view.php?ud=20191218160128981841d0c69529_16
7420,2019-12-18,대웅제약덴티가드랩핀업디자인어워드파이널리스트수상,http://medipana.com/news/news_viewer.asp?NewsNum=250450&MainKind=A&NewsKind=5&vCount=12&vKind=1
7421,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=373101
7422,2019-12-18,대웅제약덴티가드랩핀업디자인어워드패키지디자인부분수상,https://asiatime.co.kr/news/newsview.php?ncode=1065597152232041
7423,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문 파이널리스트 수상,http://www.businesskorea.co.kr/news/articleView.html?idxno=39352
7424,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://newsbrite.net/131621
7425,2019-12-18,대웅제약덴티가드랩핀업디자인어워드서파이널리스트상수상,http://news.mk.co.kr/newsRead.php?no=1061978&year=2019
7426,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드서파이널리스트상수상,http://www.ekn.kr/news/article.html?no=470819
7427,2019-12-18,대웅제약덴티가드랩핀업디자인어워드파이널리스트수상,http://www.newspim.com/news/view/20191218001096
7428,2019-12-18,메디톡스vs대웅제약국내소송보다美ITC소송에무게실리나,http://biz.newdaily.co.kr/site/data/html/2019/12/18/2019121800203.html
7429,2019-12-18,대웅제약메디톡스균주소송무한반복,http://www.newsis.com/view/?id=NISX20191218_0000864808&cID=13001&pID=13000
7430,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.m-i.kr/news/articleView.html?idxno=665522
7431,2019-12-18,대웅제약덴티가드랩핀업디자인어워드파이널리스트수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1356494
7432,2019-12-18,대웅제약덴티가드랩핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.newswatch.kr/news/articleView.html?idxno=25879
7433,2019-12-18,대웅제약덴티가드랩패키지디자인본상수상,http://www.100ssd.co.kr/news/articleView.html?idxno=66153
7434,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.news2day.co.kr/144704
7435,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.thefirstmedia.net/news/articleView.html?idxno=52113
7436,2019-12-19,대웅제약덴티가드랩2019핀업디자인어워드수상,http://www.bosa.co.kr/news/articleView.html?idxno=2118331
7437,2019-12-19,메디톡스대웅제약지루한균주소송에판사도일침,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075323
7438,2019-12-19,★주식인사이드대웅제약주가130000원12월19일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1053868
7439,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장진출,http://www.etnews.com/20191219000017
7440,2019-12-19,대웅제약나보타할랄시장본격진출,http://www.consumuch.com/news/articleView.html?idxno=46967
7441,2019-12-19,대웅제약나보타국내최초UAE인니품목허가획득,http://www.viva100.com/main/view.php?key=20191219010006861
7442,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238779
7443,2019-12-19,대웅제약나보타할랄시장본격진출,http://www.koreastocknews.com/news/articleView.html?idxno=48986
7444,2019-12-19,대웅제약나보타내년상반기중동출시,http://www.hankookilbo.com/news/npath/201912190944081012?did=NA
7445,2019-12-19,대웅제약나보타국산보툴리눔톡신최초UAE인도네시아진출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1836114
7446,2019-12-19,대웅제약나보타UAE∙인도네시아품목허가획득할랄시장본격진출,http://www.getnews.co.kr/view.php?ud=20191219092557121641d0c69529_16
7447,2019-12-19,대웅제약나보타UAE인니품목허가획득할랄시장저격,http://moneys.mt.co.kr/news/mwView.php?no=2019121909268022494
7448,2019-12-19,대웅제약UAE인도네시아서나보타품목허가획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912190135&t=NN
7449,2019-12-19,대웅제약나보타UAE인도네시아품목허가할랄시장본격진출,http://www.medisobizanews.com/news/articleView.html?idxno=65018
7450,2019-12-19,대웅제약나보타할랄시장뛰어든다UAE인니품목허가획득,http://daily.hankooki.com/lpage/ittech/201912/dh20191219093724145630.htm
7451,2019-12-19,대웅제약06962019일115변동폭보여및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=604705
7452,2019-12-19,대웅제약보툴리눔톡신나보타UAE인도네시아허가,http://yna.kr/AKR20191219045300017?did=1195m
7453,2019-12-19,대웅제약나보타할랄시장진출,https://www.sedaily.com/NewsView/1VS4V68ZY0
7454,2019-12-19,대웅제약나보타할랄시장진출UAE인도네시아품목허가,http://news1.kr/articles/?3796934
7455,2019-12-19,대웅제약나보타아랍에미리트인도네시아품목허가획득할랄시장진출,http://www.ezyeconomy.com/news/articleView.html?idxno=96378
7456,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.newslock.co.kr/news/articleView.html?idxno=24422
7457,2019-12-19,대웅제약나보타UAE인니품목허가할랄시장본격진출,http://news.heraldcorp.com/view.php?ud=20191219000136
7458,2019-12-19,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.nbnnews.co.kr/news/articleView.html?idxno=351867
7459,2019-12-19,대웅제약나보타중동UAE인도네시아진출,http://health.chosun.com/site/data/html_dir/2019/12/19/2019121901092.html
7460,2019-12-19,대웅제약나보타중동할랄시장도진출,https://www.paxnetnews.com/articles/55054
7461,2019-12-19,대웅제약나보타UAE인니품목허가획득,http://www.ebn.co.kr/news/view/1014180/?sc=naver
7462,2019-12-19,대웅제약나보타UAE인도네시아서품목허가승인,http://www.newspim.com/news/view/20191219000332
7463,2019-12-19,대웅제약보툴리눔톡신나보타할랄시장진출,http://it.chosun.com/site/data/html_dir/2019/12/19/2019121901130.html
7464,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://newsbrite.net/131640
7465,2019-12-19,대웅제약나보타첫할랄진출,http://www.newstomato.com/ReadNews.aspx?no=940870
7466,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.newswatch.kr/news/articleView.html?idxno=25882
7467,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.ceoscoredaily.com/news/article.html?no=63847
7468,2019-12-19,대웅제약나보타할랄시장진출UAE인니허가,http://www.newsis.com/view/?id=NISX20191219_0000865278&cID=13001&pID=13000
7469,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58836
7470,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.newsprime.co.kr/news/article.html?no=487567
7471,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=19906
7472,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.m-i.kr/news/articleView.html?idxno=665700
7473,2019-12-19,대웅제약나보타UAE인도네시아서도품목허가획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1356593
7474,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.nbnnews.co.kr/news/articleView.html?idxno=351891
7475,2019-12-19,대웅제약나보타UAE인도네시아서품목허가획득,http://www.econovill.com/news/articleView.html?idxno=380483
7476,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.newsfc.co.kr/news/articleView.html?idxno=39146
7477,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.ekn.kr/news/article.html?no=471005
7478,2019-12-19,대웅제약나보타UAE인도네시아서품목허가,http://www.seoulfn.com/news/articleView.html?idxno=366295
7479,2019-12-19,대웅제약나보타UAE인니등할랄시장진출,http://kormedi.com/?p=1308072
7480,2019-12-19,대웅제약나보타UAE인도네시아품목허가,http://www.dailymedi.com/detail.php?number=850963&thread=22r05
7481,2019-12-19,대웅제약보툴리눔톡신나보타할랄시장진출UAE인도네시아품목허가”,http://sports.hankooki.com/lpage/economy/201912/sp20191219110613137020.htm
7482,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.pressm.kr/news/articleView.html?idxno=26684
7483,2019-12-19,대웅제약나보타UAE인니허가받아이슬람시장진출,http://news.mk.co.kr/newsRead.php?no=1064654&year=2019
7484,2019-12-19,대웅제약나보타UAE인도네시아서품목허가획득,http://www.rapportian.com/news/articleView.html?idxno=122264
7485,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.economytalk.kr/news/articleView.html?idxno=202333
7486,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.biospectator.com/view/news_view.php?varAtcId=9148
7487,2019-12-19,대웅제약UAE와인도네시아에서자체개발보툴리눔톡신허가따내,http://www.businesspost.co.kr/BP?command=article_view&num=155952
7488,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019121912154655864
7489,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장공략본격화,http://inthenews.co.kr/article-28681/
7490,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.bosa.co.kr/news/articleView.html?idxno=2118381
7491,2019-12-19,주식장대웅제약주가19일현재131500원,http://nbntv.co.kr/news/view/777938
7492,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=373199
7493,2019-12-19,대웅제약덴티가드랩2019핀업디자인어워드파이널리스트수상,http://www.newsian.co.kr/news/articleView.html?idxno=38763
7494,2019-12-19,대웅제약나보타UAE인도네시아허가획득할랄시장진출,http://www.metroseoul.co.kr/news/newsview?newscd=2019121900111
7495,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.medigatenews.com/news/3310868178
7496,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.lawissue.co.kr/view.php?ud=201912191405561021204ead0791_12
7497,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아허가,http://www.youthdaily.co.kr/news/article.html?no=25129
7498,2019-12-19,대웅제약나보타UAE인니서품목허가,https://www.nocutnews.co.kr/news/5261444
7499,2019-12-19,대웅제약나보타할랄시장진출,https://asiatime.co.kr/news/newsview.php?ncode=1065592036589418
7500,2019-12-19,대웅제약나보타아랍인도네시아판매허가획득,http://www.finomy.com/news/articleView.html?idxno=73236
7501,2019-12-19,대웅제약나보타인도네시아품목허가할랄시장본격진출,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019121915153798736
7502,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.dailian.co.kr/news/view/854494/?sc=naver
7503,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장진출본격화,http://www.donga.com/news/article/all/20191219/98879927/1
7504,2019-12-19,대웅제약주름개선제나보타UAE인도네시아허가,http://www.sportsseoul.com/news/read/863375
7505,2019-12-19,대웅제약나보타아랍에미레이트인도네시아품목허가,https://cnbc.sbs.co.kr/article_hub/10000966477?division=NAVER
7506,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.ftoday.co.kr/news/articleView.html?idxno=113377
7507,2019-12-19,메디톡스대웅제약보톡스소송갈수록치열,http://www.finomy.com/news/articleView.html?idxno=73280
7508,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.wsobi.com/news/articleView.html?idxno=87101
7509,2019-12-19,대웅제약펙수프라잔내년에전세계시장도전,http://news1.kr/articles/?3797657
7510,2019-12-19,대웅제약자체개발나보타UAE인니서품목허가획득,http://www.dt.co.kr/contents.html?article_no=2019122002101631102001&ref=naver
7511,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.newscj.com/news/articleView.html?idxno=692889
7512,2019-12-19,대웅제약나보타할랄시장본격진출,http://www.bokuennews.com/news/article.html?no=184807
7513,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.thefirstmedia.net/news/articleView.html?idxno=52195
7514,2019-12-20,대웅제약나보타UAE인도네시아허가획득할랄시장본격진출,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075355
7515,2019-12-20,녹십자한미약품대웅제약등제약업계퇴직사우모임활발,http://www.rapportian.com/news/articleView.html?idxno=122275
7516,2019-12-20,대웅제약나보타UAE인도네시아품목허가획득할랄시장진출,http://www.newsian.co.kr/news/articleView.html?idxno=38789
7517,2019-12-20,대웅제약계열사한올바이오파마3개월제조정지위반사항적발,http://moneys.mt.co.kr/news/mwView.php?no=2019122010048021383
7518,2019-12-20,12월20일대웅제약금일증시000131500원,http://nbntv.co.kr/news/view/779242
7519,2019-12-20,12월20일대웅제약시황정보000변동,http://www.gokorea.kr/news/articleView.html?idxno=606387
7520,2019-12-20,20일데일리주식정보대웅제약069620오후12시22분기준,https://www.dailysecu.com/news/articleView.html?idxno=89397
7521,2019-12-20,대웅제약라니티딘대체제파모트라정허가,http://weekly.hankooki.com/lpage/life/201912/wk20191220193511147650.htm
7522,2019-12-20,대웅제약보툴리눔톡신나보타로글로벌시장공략가속화,http://www.betanews.net:8080/article/1115327.html
7523,2019-12-21,대웅제약전사차원의ISO인증통해글로벌경영기반다져,http://www.nbnnews.co.kr/news/articleView.html?idxno=352591
7524,2019-12-21,해피컴퍼니회사가내게해주는것일과육아모두잡아요”대웅제약,http://www.econovill.com/news/articleView.html?idxno=379942
7525,2019-12-23,대웅제약치료용나보타해외수출강화한다,http://moneys.mt.co.kr/news/mwView.php?no=2019122309038092008
7526,2019-12-23,대웅제약나보타글로벌치료제시장출격이온바이오파마와맞손,http://www.viva100.com/main/view.php?key=20191223010007944
7527,2019-12-23,대웅제약보툴리눔톡신글로벌확대위해이온바이오파마와파트너십,http://www.etnews.com/20191223000013
7528,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2019122309102142680
7529,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약,http://daily.hankooki.com/lpage/ittech/201912/dh20191223091135145630.htm
7530,2019-12-23,대웅제약나보타글로벌치료제시장진출이온바이오파마와계약체결,http://www.newspim.com/news/view/20191223000161
7531,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238897
7532,2019-12-23,대웅제약 보툴리눔톡신글로벌치료사업파트너십계약,http://www.medisobizanews.com/news/articleView.html?idxno=65125
7533,2019-12-23,​​대웅제약보툴리눔톡신치료적응증확장글로벌파트너십체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1837173
7534,2019-12-23,대웅제약보툴리눔톡신치료적응증확장파트너십,http://www.biospectator.com/view/news_view.php?varAtcId=9170
7535,2019-12-23,보톡스보툴리눔톡신테마09시현재주식시황상승률상위종목메디톡스9700원325파마리서치프로덕트400원116대웅제약1500원114상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=153765
7536,2019-12-23,대웅제약이온바이오파마와파트너십계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=250640&MainKind=A&NewsKind=5&vCount=12&vKind=1
7537,2019-12-23,대웅제약이온바이오파마와파트너십체결나보타치료사업겨냥,http://inthenews.co.kr/article-29023/
7538,2019-12-23,대웅제약보툴리눔톡신글로벌미용넘어치료사업까지착수,http://news.heraldcorp.com/view.php?ud=20191223000124
7539,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약,http://www.metroseoul.co.kr/news/newsview?newscd=2019122300039
7540,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약,https://www.sedaily.com/NewsView/1VS6PM70EI
7541,2019-12-23,대웅제약미국업체와나보타치료용공급계약체결,http://www.sportsseoul.com/news/read/864458
7542,2019-12-23,대웅제약美이온바이오파마와맞손나보타글로벌시장확대본격화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019122309420919881
7543,2019-12-23,대웅제약치료용보툴리눔톡신글로벌사업확대,http://yna.kr/AKR20191223040500017?did=1195m
7544,2019-12-23,대웅제약보툴리눔톡신글로벌파트너십계약3조원규모시장타겟,http://www.econovill.com/news/articleView.html?idxno=380754
7545,2019-12-23,대웅제약치료용보툴리눔톡신글로벌사업확대美이온바이오파마와파트너십체결,http://www.seoulwire.com/news/articleView.html?idxno=263688
7546,2019-12-23,대웅제약美이온바이오파마와나보타치료용공급계약체결,https://biz.chosun.com/site/data/html_dir/2019/12/23/2019122300925.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7547,2019-12-23,대웅제약 보툴리눔톡신글로벌사업위해이온바이오파마파트너십계약,http://www.newslock.co.kr/news/articleView.html?idxno=24522
7548,2019-12-23,대웅제약보툴리눔톡신치료적응증파트너십,http://www.ebn.co.kr/news/view/1014629/?sc=naver
7549,2019-12-23,대웅제약나보타미용이어치료분야적응증확대,https://www.paxnetnews.com/articles/55148
7550,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=352794
7551,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.getnews.co.kr/view.php?ud=20191223101015189141d0c69529_16
7552,2019-12-23,대웅제약치료용보톡스해외공략강화파트너사맞손,http://www.edaily.co.kr/news/newspath.asp?newsid=02089366622721472
7553,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업탄력이온바이오파마와파트너십체결,http://kpenews.com/View.aspx?No=361999
7554,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약체결,http://www.m-i.kr/news/articleView.html?idxno=666741
7555,2019-12-23,대웅제약이온바이오파마와나보타글로벌진출협력,http://www.rapportian.com/news/articleView.html?idxno=122314
7556,2019-12-23,대웅제약보툴리눔톡신치료사업강화나서 ,http://www.monews.co.kr/news/articleView.html?idxno=207234
7557,2019-12-23,​​대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=373421
7558,2019-12-23,대웅제약나보타치료적응증글로벌파트너십체결,http://www.upinews.kr/newsView/upi201912230048
7559,2019-12-23,대웅제약이온바이오와보툴리눔톡신파트너십계약,http://www.bosa.co.kr/news/articleView.html?idxno=2118558
7560,2019-12-23,대웅제약ISO인증4관왕글로벌경영기반다졌다,http://daily.hankooki.com/lpage/ittech/201912/dh20191223104709145630.htm
7561,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약체결,http://www.dailysmart.co.kr/news/articleView.html?idxno=20081
7562,2019-12-23,대웅제약06962023일342변화및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=607928
7563,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업박차,http://www.newsprime.co.kr/news/article.html?no=487937
7564,2019-12-23,대웅제약보툴리눔톡신제제나보타판로확대,http://www.sisaweek.com/news/articleView.html?idxno=129254
7565,2019-12-23,대웅제약보툴리눔톡신치료사업글로벌확대,https://cnbc.sbs.co.kr/article_hub/10000966813?division=NAVER
7566,2019-12-23,대웅제약이온바이오파마보툴리눔톡신글로벌사업을위한파트너십계약체결,http://www.ekn.kr/news/article.html?no=471662
7567,2019-12-23,대웅제약치료용보툴리눔톡신글로벌확대나섰다,http://it.chosun.com/site/data/html_dir/2019/12/23/2019122301280.html
7568,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.ceoscoredaily.com/news/article.html?no=64006
7569,2019-12-23,주식증권대웅제약주가23일현재135500원,http://nbntv.co.kr/news/view/781621
7570,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약,http://www.newstomato.com/ReadNews.aspx?no=941537
7571,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약체결,http://www.newswatch.kr/news/articleView.html?idxno=25954
7572,2019-12-23,대웅제약이온바이오파마와파트너십계약,http://www.dailymedi.com/detail.php?number=851084&thread=22r05
7573,2019-12-23,대웅제약이온바이오파마와보툴리눔톡신글로벌치료사업파트너십,http://news1.kr/articles/?3799588
7574,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약,https://asiatime.co.kr/news/newsview.php?ncode=1065578437062712
7575,2019-12-23,대웅제약미국이온바이오파마와맞손보툴리눔톡신치료사업확대”,http://sports.hankooki.com/lpage/economy/201912/sp20191223114908137020.htm
7576,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약체결,http://www.pressm.kr/news/articleView.html?idxno=26759
7577,2019-12-23,대웅제약글로벌사업위한파트너십계약체결,http://www.economytalk.kr/news/articleView.html?idxno=202438
7578,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58884
7579,2019-12-23,대웅제약보톡스치료사업추진,http://www.finomy.com/news/articleView.html?idxno=73376
7580,2019-12-23,대웅제약나보타글로벌치료용시장진출본격화,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075438
7581,2019-12-23,보톡스보툴리눔톡신테마오후시황상승률상위종목대웅제약228메디톡스211제테마075등,http://www.gokorea.kr/news/articleView.html?idxno=608535
7582,2019-12-23,23일13시보톡스보툴리눔톡신오후테마시황대웅제약메디톡스등이주도,http://nbntv.co.kr/news/view/782267
7583,2019-12-23,보톡스보툴리눔톡신테마13시현재주식시황상승률상위종목대웅제약4000원304메디톡스6300원211파마리서치프로덕트50원014상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=153950
7584,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://newsbrite.net/131809
7585,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.lawissue.co.kr/view.php?ud=201912231357268505204ead0791_12
7586,2019-12-23,치료용으로진화하는대웅제약나보타글로벌사업계약체결,http://www.donga.com/news/article/all/20191223/98931351/1
7587,2019-12-23,대웅제약치료목적보툴리눔톡신개발위해이온바이오파마와파트너십체결,http://news.mk.co.kr/newsRead.php?no=1076143&year=2019
7588,2019-12-23,대웅제약이온바이오파마와보툴리눔톡신으로해외치료시장진출,http://www.businesspost.co.kr/BP?command=article_view&num=156427
7589,2019-12-23,대웅제약치료용보톡스해외사업확대,http://www.seoulfn.com/news/articleView.html?idxno=366636
7590,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약체결,http://www.segyebiz.com/newsView/20191223507588?OutUrl=naver
7591,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약체결,http://www.enewstoday.co.kr/news/articleView.html?idxno=1357409
7592,2019-12-23,대웅제약나보타할랄시장본격진출글로벌행보속도,http://www.segyebiz.com/newsView/20191223507936?OutUrl=naver
7593,2019-12-23,대웅제약이온바이오파마파트너십계약체결보툴리눔톡신글로벌치료사업목적,http://www.ftoday.co.kr/news/articleView.html?idxno=113439
7594,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약체결,http://www.iminju.net/news/articleView.html?idxno=51094
7595,2019-12-23,대웅제약보툴리눔톡신제제나보타판로확대이온바이오파마와맞손,http://www.updownnews.co.kr/news/articleView.html?idxno=212822
7596,2019-12-23,대웅제약보툴리눔톡신글로벌시장진출위해맞손,http://www.100ssd.co.kr/news/articleView.html?idxno=66247
7597,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업확대3조시장에성큼,http://www.newsian.co.kr/news/articleView.html?idxno=38870
7598,2019-12-23,대웅제약치료용보톡스이온바이오파마파트너계약,http://health.chosun.com/site/data/html_dir/2019/12/23/2019122302552.html
7599,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약체결,http://www.medigatenews.com/news/1640616890
7600,2019-12-23,대웅제약美이온바이오파마와치료용보톡스사업확대,http://www.dt.co.kr/contents.html?article_no=2019122402101931102002&ref=naver
7601,2019-12-23,대웅제약이온바이오파마와계약으로글로벌진출박차,http://www.news2day.co.kr/144994
7602,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.businesskorea.co.kr/news/articleView.html?idxno=39495
7603,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.newscj.com/news/articleView.html?idxno=693757
7604,2019-12-23,대웅제약치료용보툴리눔톡신글로벌사업확대,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4016987
7605,2019-12-24,더벨대웅제약나보타글로벌사업미용치료로이원화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201912231112356120101744
7606,2019-12-24,대웅제약오늘증시24일현재134000원,http://nbntv.co.kr/news/view/784053
7607,2019-12-24,대웅제약보툴리눔톡신글로벌치료사업파트너십체결,http://www.cnbnews.com/news/article.html?no=431821
7608,2019-12-24,대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약체결,http://www.wsobi.com/news/articleView.html?idxno=87350
7609,2019-12-24,대웅제약아프면참지마요질병증상이해돕는사회공헌활동펼쳐,http://www.newscj.com/news/articleView.html?idxno=694150
7610,2019-12-26,대웅제약발달장애인위한참지마요진행질병표현교육,http://www.meconomynews.com/news/articleView.html?idxno=36526
7611,2019-12-26,대웅제약당뇨폐섬유증등난치성질환치료제개발순항,http://www.donga.com/news/article/all/20191225/98956366/1
7612,2019-12-26,★주식인사이드대웅제약주가132500원12월26일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1054724
7613,2019-12-26,선택과집중으로경쟁력확보대웅제약차별화된전략으로글로벌헬스케어그룹도약,http://www.updownnews.co.kr/news/articleView.html?idxno=212901
7614,2019-12-26,12월26일대웅제약시황정보000변동,http://www.gokorea.kr/news/articleView.html?idxno=611781
7615,2019-12-26,증권플러스대웅제약주가26일현재132500원,http://nbntv.co.kr/news/view/786423
7616,2019-12-26,12월26일대웅제약종목정보000변동,http://www.gokorea.kr/news/articleView.html?idxno=611922
7617,2019-12-26,보톨리눔톡신대전2대웅제약vs메디톡스해외확장치열한경쟁,http://www.metroseoul.co.kr/news/newsview?newscd=2019122600170
7618,2019-12-26,대웅제약등43개사로부터행사지원받은건대충주병원김영란법위반여부논란,http://www.sisajournal-e.com/news/articleView.html?idxno=211231
7619,2019-12-27,대웅제약차세대신약파이프라인개발순항,http://www.kukinews.com/news/article.html?no=731737
7620,2019-12-27,★주식인사이드대웅제약주가133000원12월27일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1055033
7621,2019-12-27,대웅제약2019년글로벌신약파이프라인넥스트나보타잇는성과기대,http://www.lawissue.co.kr/view.php?ud=201912271028187603204ead0791_12
7622,2019-12-27,대웅제약글로벌보툴리눔톡신치료시장정조준,http://www.m-i.kr/news/articleView.html?idxno=667669
7623,2019-12-27,대웅제약27일037변동증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=614512
7624,2019-12-27,대웅제약실시간주식현황27일현재134000원,http://nbntv.co.kr/news/view/788767
7625,2019-12-27,대웅제약나보타글로벌치료적응증시장확대박차,http://www.upinews.kr/newsView/upi201912270058
7626,2019-12-27,대웅제약아프면참지마요질병증상이해돕는사회공헌활동펼쳐,http://www.wsobi.com/news/articleView.html?idxno=87478
7627,2019-12-27,대웅제약ISO4관왕글로벌2025비전포석마련,http://www.meconomynews.com/news/articleView.html?idxno=36570
7628,2019-12-28,브릿지바이오대웅제약궤양성대장염신약물질中임상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075600
7629,2019-12-30,★주식인사이드대웅제약주가136000원12월30일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1055312
7630,2019-12-30,대웅제약06962030일111변동증권투자정보외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=616465
7631,2019-12-30,12월30일대웅제약종목검색111137000원,http://nbntv.co.kr/news/view/791218
7632,2019-12-30,아프면참지마요대웅제약장애인질병증상이해돕는사회공헌활동,http://news.tf.co.kr/read/economy/1773590.htm
7633,2019-12-31,대웅제약차세대신약파이프라인개발순항,http://www.economytalk.kr/news/articleView.html?idxno=202638
7634,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239143
7635,2019-12-31,대웅제약보툴리눔톡신나보타중국3상착수,http://www.newsis.com/view/?id=NISX20191231_0000875536&cID=13001&pID=13000
7636,2019-12-31,대웅제약나보타중국임상3상본격착수2022년발매목표,http://www.viva100.com/main/view.php?key=20191231010010564
7637,2019-12-31,대웅제약보툴리눔톡신나보타중국임상3상진행,http://www.fnnews.com/news/201912310936042610
7638,2019-12-31,대웅제약나보타中임상3상착수,https://asiatime.co.kr/news/newsview.php?ncode=1065573093876166
7639,2019-12-31,대웅제약나보타중국임상3상본격착수연구자회의개최,http://www.getnews.co.kr/view.php?ud=20191231093854466741d0c69529_16
7640,2019-12-31,대웅제약보툴리눔톡신나보타중국임상3상착수,http://yna.kr/AKR20191231038200017?did=1195m
7641,2019-12-31,대웅제약나보타중국임상3상착수,http://www.ebn.co.kr/news/view/1015572/?sc=naver
7642,2019-12-31,대웅제약나보타중국임상3상착수‥2022년출시목표,http://medipana.com/news/news_viewer.asp?NewsNum=250981&MainKind=A&NewsKind=5&vCount=12&vKind=1
7643,2019-12-31,대웅제약나보타중국임상3상착수‥2022년출시목표,http://medipana.com/news/news_viewer.asp?NewsNum=250981&MainKind=A&NewsKind=5&vCount=12&vKind=1
7644,2019-12-31,대웅제약나보타미간주름개선중국임상3상본격착수,http://www.medisobizanews.com/news/articleView.html?idxno=65381
7645,2019-12-31,대웅제약中서나보타임상연구자회의,http://news.mt.co.kr/mtview.php?no=2019123109235397949
7646,2019-12-31,대웅제약나보타중국임상3상본격착수,https://www.sedaily.com/NewsView/1VSAEAA4RO
7647,2019-12-31,대웅제약나보타中임상3상착수,http://news.mk.co.kr/newsRead.php?no=1099072&year=2019
7648,2019-12-31,대웅제약나보타중국임상3상본격착수,https://biz.chosun.com/site/data/html_dir/2019/12/31/2019123100741.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7649,2019-12-31,대웅제약나보타중국임상3상본격착수,http://it.chosun.com/site/data/html_dir/2019/12/31/2019123100750.html
7650,2019-12-31,대웅제약나보타중국임상착수2022년출시목표,http://moneys.mt.co.kr/news/mwView.php?no=2019123109488054434
7651,2019-12-31,대웅제약보툴리눔톡신나보타중국임상3상본격착수,http://www.newspim.com/news/view/20191231000160
7652,2019-12-31,대웅제약나보타중국임상착수2020년출시목표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1839891
7653,2019-12-31,대웅제약나보타중국임상착수2020년출시목표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1839891
7654,2019-12-31,대웅제약보툴리눔톡신나보타中임상3상본격착수,http://www.mdtoday.co.kr/mdtoday/index.html?no=374018
7655,2019-12-31,대웅제약보툴리눔톡신제제나보타중국임상3상본격착수,http://www.newslock.co.kr/news/articleView.html?idxno=24720
7656,2019-12-31,대웅제약보툴리눔톡신나보타중국임상3상착수,http://www.fetv.co.kr/news/article.html?no=44083
7657,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.ceoscoredaily.com/news/article.html?no=64318
7658,2019-12-31,대웅제약나보타중국임상3상착수2022년발매목표,http://www.seoulfn.com/news/articleView.html?idxno=367421
7659,2019-12-31,대웅제약나보타중국임상3상착수,http://www.etnews.com/20191231000022
7660,2019-12-31,대웅제약보툴리눔톡신나보타中임상3상착수,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132756
7661,2019-12-31,대웅제약나보타중국임상3상착수,http://www.dailymedi.com/detail.php?number=851317&thread=22r05
7662,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.pressm.kr/news/articleView.html?idxno=26885
7663,2019-12-31,대웅제약나보타中임상3상본격착수2022년출시목표,http://news1.kr/articles/?3805558
7664,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.newswatch.kr/news/articleView.html?idxno=26174
7665,2019-12-31,대웅제약나보타중국임상3상준비본격화,http://www.dailypharm.com/Users/News/NewsView.html?ID=260497&REFERER=NP
7666,2019-12-31,대웅제약나보타中임상착수2022년출시목표,http://www.koreastocknews.com/news/articleView.html?idxno=49279
7667,2019-12-31,대웅제약나보타中임상3상착수2022년출시목표,http://www.rapportian.com/news/articleView.html?idxno=122472
7668,2019-12-31,대웅제약나보타중국임상3상본격착수,http://news.heraldcorp.com/view.php?ud=20191231000238
7669,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://newsbrite.net/132130
7670,2019-12-31,대웅제약나보타中3상착수2022년발매목표,http://www.biospectator.com/view/news_view.php?varAtcId=9225
7671,2019-12-31,대웅제약나보타중국임상3상본격착수임상연구자회의개최,http://www.econovill.com/news/articleView.html?idxno=381430
7672,2019-12-31,대웅제약중국서나보타임상3상본격착수,http://kormedi.com/?p=1308687
7673,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.ezyeconomy.com/news/articleView.html?idxno=96723
7674,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.lawissue.co.kr/view.php?ud=201912311124484342204ead0791_12
7675,2019-12-31,대웅제약중국서나보타임상3상돌입,http://www.finomy.com/news/articleView.html?idxno=73637
7676,2019-12-31,대웅제약나보타中임상3상본격착수,http://www.newsprime.co.kr/news/article.html?no=488702
7677,2019-12-31,대웅제약나보타중국임상3상착수중국임상연구자회의개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019123100026
7678,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.economytalk.kr/news/articleView.html?idxno=202650
7679,2019-12-31,대웅제약자체개발한보툴리눔톡신의중국임상3상본격착수,http://www.businesspost.co.kr/BP?command=article_view&num=157532
7680,2019-12-31,대웅제약나보타중국임상3상본격착수2022년중국시장에서발매목표,http://www.segye.com/content/html/2019/12/31/20191231506199.html?OutUrl=naver
7681,2019-12-31,대웅제약나보타中서안전성입증임상3상본격착수,http://www.newsclaim.co.kr/news/articleView.html?idxno=3449
7682,2019-12-31,대웅제약 경구용장티푸스백신 비보티프 발매,http://www.businesskorea.co.kr/news/articleView.html?idxno=39706
7683,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.lawissue.co.kr/view.php?ud=201912311235264928204ead0791_12
7684,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://medipana.com/news/news_viewer.asp?NewsNum=251003&MainKind=A&NewsKind=5&vCount=12&vKind=1
7685,2019-12-31,ISO4관왕에서잇딴수상등대웅제약연말상복터지네,http://www.pressm.kr/news/articleView.html?idxno=26892
7686,2019-12-31,대웅제약국내유일먹는장티푸스백신비보티프판매개시,http://www.medisobizanews.com/news/articleView.html?idxno=65397
7687,2019-12-31,대웅제약美FDA유럽EMA승인경구용장티푸스백신비보티프발매,http://www.getnews.co.kr/view.php?ud=20191231124634121641d0c69529_16
7688,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://newsbrite.net/132143
7689,2019-12-31,대웅제약경구용장티푸스백신비보티프출시,http://www.newsis.com/view/?id=NISX20191231_0000875877&cID=13001&pID=13000
7690,2019-12-31,게시판대웅제약장티푸스백신비보티프발매,http://yna.kr/AKR20191231074900017?did=1195m
7691,2019-12-31,대웅제약FDAEMA승인경구용장티푸스백신비보티프발매,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239150
7692,2019-12-31,대웅제약국내유일의경구용장티푸스백신비보티프발매,http://www.ftoday.co.kr/news/articleView.html?idxno=113580
7693,2019-12-31,대웅제약장티푸스백신비보티프발매,http://yna.kr/PYH20191231071100017?did=1196m
7694,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.mdtoday.co.kr/mdtoday/index.html?no=374039
7695,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.metroseoul.co.kr/news/newsview?newscd=2019123100048
7696,2019-12-31,대웅제약경구용장티푸스백신비보티프국내에발매,http://news1.kr/articles/?3805800
7697,2019-12-31,대웅제약접종편의성높인경구용장티푸스백신국내판매시작,http://www.businesspost.co.kr/BP?command=article_view&num=157546
7698,2019-12-31,대웅제약나보타中서임상3상착수,https://view.asiae.co.kr/article/2019123113445963869
7699,2019-12-31,대웅제약보톡스제품나보타중국임상3상본격착수,http://www.edaily.co.kr/news/newspath.asp?newsid=02177926622724096
7700,2019-12-31,대웅제약경구용장티푸스백신국내론칭,http://moneys.mt.co.kr/news/mwView.php?no=2019123113528050508
7701,2019-12-31,대웅제약글로벌톡신치료시장정조준적응증확대할것,http://www.meconomynews.com/news/articleView.html?idxno=36680
7702,2019-12-31,대웅제약경구용장티푸스백신비보티프발매국내유일,http://www.edaily.co.kr/news/newspath.asp?newsid=02217286622724096
7703,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.bosa.co.kr/news/articleView.html?idxno=2119060
7704,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4022572
7705,2019-12-31,대웅제약보툴리눔톡신나보타중국임상3상돌입,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4022588
7706,2019-12-31,대웅제약나보타중국임상3상본격착수2022년발매목표,http://www.newsian.co.kr/news/articleView.html?idxno=39084
7707,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,https://www.sedaily.com/NewsView/1VSAEXCQ6M
7708,2019-12-31,대웅제약경구용장티푸스백신국내판매,http://www.shinailbo.co.kr/news/articleView.html?idxno=1238135
7709,2019-12-31,뉴스투데이L대웅제약경구용장티푸스백신비보티프발매,http://www.news2day.co.kr/145506
7710,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.ceoscoredaily.com/news/article.html?no=64346
7711,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.etoday.co.kr/news/section/newsview.php?idxno=1840042
7712,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.bokuennews.com/news/article.html?no=185199
7713,2019-12-31,신상품대웅제약장티푸스백신비보티프,http://www.seoulfn.com/news/articleView.html?idxno=367477
7714,2019-12-31,대웅제약나보타중국임상3상착수임상연구자회의개최,http://inthenews.co.kr/article-29987/
7715,2019-12-31,대웅제약경구용장티푸스백신비보티프판매,http://www.sporbiz.co.kr/news/articleView.html?idxno=405134
7716,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.wikileaks-kr.org/news/articleView.html?idxno=73768
7717,2019-12-31,대웅제약경구용장티푸스백신비보티프도입판매,http://www.sportsseoul.com/news/read/867222
7718,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.updownnews.co.kr/news/articleView.html?idxno=213139
7719,2019-12-31,대웅제약경구용장티푸스백신비보티프국내판매시작,http://www.lcnews.co.kr/news/articleView.html?idxno=2117
7720,2019-12-31,대웅제약먹는장티푸스백신비보티프출시,https://biz.chosun.com/site/data/html_dir/2019/12/31/2019123101766.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7721,2019-12-31,장티푸스예방주사로안맞아도된다대웅제약경구용장티푸스백신비보티프출시,https://www.sisa-news.com/news/article.html?no=122909
7722,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.nbnnews.co.kr/news/articleView.html?idxno=355165
7723,2019-12-31,대웅제약나보타중국임상3상본격화,http://www.news2day.co.kr/145534
7724,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=355174
7725,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.thefirstmedia.net/news/articleView.html?idxno=52552
7726,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.thefirstmedia.net/news/articleView.html?idxno=52545
7727,2019-12-31,대웅제약 경구용장티푸스백신 비보티프판매시작,http://www.newslock.co.kr/news/articleView.html?idxno=24741
7728,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59001
7729,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.newscj.com/news/articleView.html?idxno=695757
7730,2019-12-31,대웅제약나보타中임상3상착수오는2022년발매목표,http://www.donga.com/news/article/all/20191231/99033888/1
